data_6d53_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6d53 _Structure_validation_residue.Date_analyzed 2019-04-19 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.418 HE21 ' HB2' ' C' ' 9' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.442 ' HA ' ' HE3' ' C' ' 10' ' ' MET . 32.5 mmt -77.0 -146.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -49.15 -25.97 2.51 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -52.54 -33.86 47.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.116 0.26 . . . . 0.0 111.51 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.56 HG13 ' N ' ' C' ' 14' ' ' ASN . 4.7 pt -90.54 -32.47 5.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.147 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.56 ' N ' HG13 ' C' ' 13' ' ' ILE . 16.6 m120 -71.11 -36.74 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.752 0.311 . . . . 0.0 110.242 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' C' ' 19' ' ' LYS . 49.5 m -58.5 -33.96 70.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.3 t -68.32 -40.17 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.353 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -62.29 -41.81 98.81 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.704 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.13 -27.17 67.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.614 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' C' ' 15' ' ' SER . 94.1 mttt -85.27 -33.91 22.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.524 0.678 . . . . 0.0 110.286 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' C' ' 27' ' ' LEU . 29.3 mt -85.16 -32.44 22.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.088 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.585 0.707 . . . . 0.0 109.902 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 9.8 41.88 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.218 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.18 -69.73 0.5 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.545 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.674 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 24.2 tttt -76.01 -156.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.93 137.52 3.54 Favored Glycine 0 CA--C 1.498 -0.99 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.674 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.2 ptpt -147.32 132.2 18.07 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.343 -167.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' C' ' 20' ' ' LEU . 9.7 tt -105.63 125.76 51.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.446 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 31.8 m -103.31 135.05 45.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.109 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.474 HD12 ' N ' ' C' ' 29' ' ' LEU . 5.8 mp -100.18 126.05 46.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.513 0.196 . . . . 0.0 111.444 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.5 t -152.49 144.95 24.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.467 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.4 ' HG3' HD21 ' C' ' 36' ' ' LEU . 1.9 mpt? -127.59 141.58 51.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 -176.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.519 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 18.1 m120 -133.07 88.86 2.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 173.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.78 -98.97 0.17 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.949 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.07 24.25 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.669 -0.312 . . . . 0.0 111.157 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.683 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.9 tt0 -143.27 108.25 4.94 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.548 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.632 ' CB ' HG13 ' C' ' 84' ' ' ILE . 3.1 tm? -88.03 124.87 34.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.669 166.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.519 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 41.6 pttt -129.1 103.38 6.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.79 118.87 37.82 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.932 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.0 p -98.4 138.89 34.97 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.29 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 t -111.23 119.51 39.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.333 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 23.6 t -94.84 -172.66 2.77 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.414 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 1.0 OUTLIER 70.73 27.94 3.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 123.854 0.722 . . . . 0.0 110.303 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.86 32.05 21.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.117 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 -6.63 78.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.308 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.539 ' O ' HG23 ' C' ' 72' ' ' VAL . 64.8 m-85 -63.3 161.36 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 0.0 110.47 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -85.51 166.72 40.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.348 -172.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.432 ' HB ' ' HG2' ' C' ' 68' ' ' GLU . 3.7 mp -60.73 -54.62 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 122.196 0.998 . . . . 0.0 109.856 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.7 t -129.34 -169.85 2.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.851 -169.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -132.62 15.8 4.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.389 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.437 ' C ' ' HE3' ' C' ' 69' ' ' LYS . 33.1 mt-10 -125.17 163.13 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.748 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.82 105.31 11.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.552 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.49 140.89 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.468 HD21 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.41 109.35 20.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.466 0.65 . . . . 0.0 109.967 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.608 ' O ' HG22 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.52 165.63 11.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.241 -173.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.52 157.74 29.1 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 118.579 -1.772 . . . . 0.0 115.826 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.55 137.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.106 -1.047 . . . . 0.0 110.619 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' C' ' 89' ' ' ILE . 7.3 m-85 -130.03 126.84 38.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.906 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.433 ' O ' HG12 ' C' ' 58' ' ' VAL . 8.3 p -103.38 111.42 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.184 0.516 . . . . 0.0 110.084 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.8 m120 49.64 43.75 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.575 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.36 -6.69 82.3 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.185 -0.531 . . . . 0.0 114.345 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -108.32 150.14 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.855 0.827 . . . . 0.0 111.072 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -73.59 132.57 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.064 0.459 . . . . 0.0 111.756 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.59 -61.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.728 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -148.74 147.4 28.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.856 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.608 HG22 ' O ' ' C' ' 54' ' ' TRP . 85.5 m -134.14 133.04 40.57 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 49.3 p90 -150.85 -167.12 2.73 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -128.73 144.78 51.24 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.559 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 6.6 mt-10 -70.11 -20.88 63.16 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -175.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.437 ' HE3' ' C ' ' C' ' 50' ' ' GLU . 11.3 ptpt -89.21 7.52 34.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.381 . . . . 0.0 111.035 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.0 m -90.08 165.89 13.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.805 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.09 106.27 8.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.539 HG23 ' O ' ' C' ' 45' ' ' TYR . 0.9 OUTLIER -59.11 -15.85 7.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.862 -173.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.64 -32.9 17.58 Favored Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.645 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.82 -29.13 50.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 45.8 mm -71.68 -57.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.777 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.507 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 37.7 p -60.27 -55.65 31.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.843 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.1 OUTLIER -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.6 OUTLIER -64.02 -46.98 82.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' C' ' 76' ' ' SER . 74.7 mt -53.87 -31.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.333 175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.843 HD21 ' ND2' ' C' ' 77' ' ' ASN . 9.9 m-20 -89.99 -24.16 21.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.55 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 64.0 mttm -55.68 -39.75 71.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 4.6 mt -61.1 -23.07 65.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.778 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.683 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 40.42 77.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.846 0.831 . . . . 0.0 110.833 -174.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.632 HG13 ' CB ' ' C' ' 36' ' ' LEU . 0.5 OUTLIER -93.77 145.61 7.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.514 -171.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.438 ' C ' ' HD2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -81.16 4.46 20.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.356 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.19 109.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.335 0 O-C-N 124.077 0.861 . . . . 0.0 113.618 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.488 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 97.9 Cg_endo -82.26 -55.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.765 2.31 . . . . 0.0 112.28 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.488 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 88.2 t80 -107.95 98.75 8.28 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' C' ' 57' ' ' PHE . 20.9 pt -119.38 123.88 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.749 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.3 105.06 16.98 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.493 ' HB ' HG11 ' C' ' 16' ' ' VAL . 5.4 mt -97.22 99.71 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.407 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . 0.419 ' HA ' ' CH2' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -163.82 148.15 10.34 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -77.08 165.34 24.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.322 0.582 . . . . 0.0 111.072 -177.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.468 HG13 HD21 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.863 -166.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.616 ' N ' HE21 ' C' ' 9' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.484 0.183 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.433 ' O ' HG21 ' C' ' 13' ' ' ILE . 1.0 OUTLIER -117.58 -147.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -41.59 -40.94 2.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -53.71 -39.36 65.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.489 HD13 ' ND2' ' C' ' 17' ' ' ASN . 0.0 OUTLIER -92.39 -33.2 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.487 ' HA ' HD21 ' C' ' 17' ' ' ASN . 20.8 m120 -69.84 -34.77 74.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.081 -0.387 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 40.1 t -59.27 -33.33 70.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.486 0.66 . . . . 0.0 109.29 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.477 HG21 ' O ' ' C' ' 91' ' ' ILE . 49.1 t -71.67 -35.23 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.141 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.489 ' ND2' HD13 ' C' ' 13' ' ' ILE . 16.1 m-80 -58.27 -45.47 87.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -69.03 -31.31 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.379 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.13 -35.17 37.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.196 0.522 . . . . 0.0 109.977 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 71.6 mt -69.2 -32.36 71.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.378 176.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.41 58.69 2.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.515 0.674 . . . . 0.0 110.05 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.473 ' HD2' ' C ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -88.29 9.94 21.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.024 -175.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.47 -72.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.865 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -76.51 -157.71 0.09 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.369 0.268 . . . . 0.0 110.544 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -44.55 135.88 6.21 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' C' ' 40' ' ' SER . 9.8 ptpt -148.38 143.44 26.82 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.876 -162.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.416 HD11 ' N ' ' C' ' 27' ' ' LEU . 3.8 mp -101.25 119.03 38.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.744 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 53.8 m -100.24 99.58 10.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' C' ' 91' ' ' ILE . 1.2 mm? -85.6 147.18 26.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 112.116 -171.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -151.13 129.13 11.76 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.076 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 38.0 mtt -101.9 118.64 37.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.468 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 16.9 m120 -130.74 90.08 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.813 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.79 0.6 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.965 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -102.32 33.71 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.951 0.881 . . . . 0.0 108.965 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.543 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 53.2 tt0 -144.62 138.95 27.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.973 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -116.37 102.81 9.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.57 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 64.4 pttt -105.96 133.22 51.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.1 118.48 6.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.941 -172.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 65.0 p -100.42 148.57 24.59 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.414 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.7 p -109.0 118.95 38.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.42 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.555 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 37.7 t -94.81 178.59 5.53 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.2 OUTLIER 63.08 37.68 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.689 0.618 . . . . 0.0 109.719 -169.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.43 24.99 10.83 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.611 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.94 19.06 73.65 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.09 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.649 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 17.8 m-85 -65.33 164.39 13.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.47 -160.36 35.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.159 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.552 ' CD1' ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -52.99 -66.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.522 0.677 . . . . 0.0 112.165 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.552 ' H ' ' CD1' ' C' ' 47' ' ' ILE . 28.7 p -179.08 -48.1 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.004 -171.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.463 ' H ' HD11 ' C' ' 47' ' ' ILE . 68.5 t80 -171.45 -36.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.414 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -89.92 161.19 16.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -165.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.459 ' HB3' ' CD ' ' C' ' 69' ' ' LYS . 7.0 p-10 -94.21 118.22 31.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.327 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.636 ' HB2' ' CD ' ' C' ' 68' ' ' GLU . 14.1 mmmm -111.98 155.26 24.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.996 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.423 HD21 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -105.97 106.45 16.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.805 -170.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.616 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.59 164.17 11.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.785 -175.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.06 141.64 7.73 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.826 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.427 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.3 mp -117.96 124.48 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 171.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 2.9 m-85 -119.23 141.6 48.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.37 114.64 40.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 63.35 36.34 11.67 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.812 0.695 . . . . 0.0 110.778 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.16 58.9 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.381 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 10.8 pt-20 -140.16 143.81 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.902 0.851 . . . . 0.0 110.913 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.47 116.54 10.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.385 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.59 -29.6 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.933 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -156.27 154.84 31.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.991 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.616 HG21 ' O ' ' C' ' 54' ' ' TRP . 68.5 m -149.55 146.69 27.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.4 -179.73 7.94 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.684 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 18.3 m120 -128.73 135.08 48.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.25 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.636 ' CD ' ' HB2' ' C' ' 52' ' ' LYS . 2.5 mp0 -60.48 -11.1 5.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -172.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.485 ' HB3' HD13 ' C' ' 47' ' ' ILE . 13.5 ptmm? -84.83 -4.55 59.13 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.6 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -81.06 155.06 26.51 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 11.2 p -71.97 121.32 18.91 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.618 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' C' ' 76' ' ' SER . 13.1 t -60.11 -11.76 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.971 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.46 -40.24 9.18 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.077 -1.058 . . . . 0.0 111.212 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.99 -35.6 74.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.428 ' O ' HG13 ' C' ' 79' ' ' ILE . 47.0 mm -67.9 -66.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.486 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.643 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.4 m -59.34 -58.59 7.97 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.583 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 1.4 m120 -72.55 -16.84 61.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -171.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -34.79 69.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.505 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' C' ' 76' ' ' SER . 80.6 mt -56.06 -23.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.609 171.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.6 OUTLIER -79.79 -38.24 33.52 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.296 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -57.44 -34.1 68.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 109.355 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.519 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 3.2 mt -59.49 -28.06 66.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.543 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 36.66 82.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.568 -174.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.03 148.14 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.856 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.421 ' HB3' ' ND2' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -129.58 45.55 2.78 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.296 -174.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.92 158.0 17.52 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.383 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.8 Cg_endo -79.04 -44.82 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.067 -176.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.401 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 33.2 p90 -123.66 117.97 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.406 0.622 . . . . 0.0 109.949 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.75 125.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.784 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.15 99.68 12.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.536 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.477 ' O ' HG21 ' C' ' 16' ' ' VAL . 20.1 mm -109.65 99.62 9.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.935 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 168.82 6.45 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.97 166.23 12.8 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.752 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.423 HG13 HD21 ' C' ' 53' ' ' ASN . 6.7 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.697 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.619 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.4 mp0 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.784 0.326 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.69 -141.38 0.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.044 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -39.8 -36.61 0.45 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -52.65 -46.19 67.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.51 -29.84 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.935 0.397 . . . . 0.0 111.014 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.52 -20.28 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -60.26 -35.22 75.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.651 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 47.8 t -66.54 -37.71 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.399 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.504 ' ND2' HD12 ' C' ' 29' ' ' LEU . 0.9 OUTLIER -65.21 -39.92 93.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.504 -176.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.58 -27.22 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -87.75 -29.33 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.464 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 62.0 mt -70.76 -34.95 72.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.216 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.1 66.13 9.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.402 ' HZ2' HD12 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.2 -25.29 16.44 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.19 -72.81 0.13 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.274 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -90.6 -177.27 4.98 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 168.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.3 100.24 0.01 OUTLIER Glycine 0 CA--C 1.5 -0.882 0 O-C-N 125.139 1.525 . . . . 0.0 116.118 166.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 8.2 ptpt -131.51 155.36 47.56 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.194 -170.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 0.6 OUTLIER -134.77 121.8 21.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.553 -173.035 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.8 m -113.39 112.42 23.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.504 HD12 ' ND2' ' C' ' 17' ' ' ASN . 5.9 mp -99.24 143.94 28.93 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.789 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.1 m -150.19 131.07 14.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.151 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.619 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 81.5 mtp -97.69 120.72 38.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.296 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -122.31 91.4 3.5 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.708 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 31.06 6.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.707 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 27.9 tt0 -143.07 137.45 29.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.219 0.533 . . . . 0.0 111.999 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -111.28 99.55 8.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.549 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 23.2 pttp -96.42 142.95 27.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.2 122.11 7.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -172.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 77.5 p -98.48 143.38 28.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.514 ' OG ' ' HA2' ' C' ' 73' ' ' GLY . 17.6 p -125.52 119.22 27.59 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.1 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.56 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 39.0 t -100.46 173.37 6.6 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.526 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' C' ' 41' ' ' SER . 6.5 m120 81.59 28.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.716 1.26 . . . . 0.0 111.398 -172.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.88 35.92 5.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 167.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . 0.406 ' O ' HG21 ' C' ' 71' ' ' THR . . . 102.53 -10.11 56.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.209 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 76.3 m-85 -70.03 141.56 52.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.3 -150.45 25.22 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.194 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.556 ' CD1' ' HG2' ' C' ' 68' ' ' GLU . 26.6 mm -66.79 -62.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.555 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -175.05 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.079 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -168.48 28.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 12.5 pt-20 -115.76 135.53 53.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.689 -175.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 32.0 t70 -90.38 109.47 20.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.323 0.582 . . . . 0.0 111.809 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -110.82 139.61 45.97 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.988 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -95.55 119.34 33.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.215 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -113.56 165.96 11.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.044 -169.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.18 158.11 27.51 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 119.077 -1.535 . . . . 0.0 115.788 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -114.84 132.95 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 114.771 -0.714 . . . . 0.0 111.015 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.8 OUTLIER -130.41 115.26 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.75 126.49 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.16 24.9 14.23 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.805 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 9.03 83.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.558 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 11.3 tp10 -107.79 120.72 43.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.959 0.409 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 39.7 ttpt -72.6 112.61 8.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.3 -29.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -148.92 134.14 18.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.23 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.415 HG23 ' O ' ' C' ' 54' ' ' TRP . 5.3 m -123.6 147.14 47.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.51 -175.23 4.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.824 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.56 135.58 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.407 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.556 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 17.3 tt0 -62.89 -34.87 78.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.714 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.3 pttp -79.42 1.59 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -74.4 -170.67 1.04 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.448 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.1 p -81.37 108.39 14.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.47 -16.72 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.117 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . 0.514 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -80.24 -40.76 12.92 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -33.55 75.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.483 ' O ' HG12 ' C' ' 79' ' ' ILE . 32.5 mm -76.05 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.415 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.581 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.6 m -54.43 -52.16 62.65 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.506 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.7 m120 -75.91 -15.96 60.11 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.658 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -66.17 -37.25 85.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' C' ' 76' ' ' SER . 36.7 mm -56.4 -25.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.568 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.579 HD21 ' N ' ' C' ' 80' ' ' ASN . 0.6 OUTLIER -82.37 -38.28 24.4 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -50.21 -44.05 52.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -53.69 -36.01 61.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.755 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.707 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.34 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.996 0.81 . . . . 0.0 110.559 -169.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.87 132.16 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.703 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.21 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.25 162.84 29.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.663 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.8 -35.47 0.39 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 123.113 2.542 . . . . 0.0 112.085 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.69 139.64 16.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.93 125.6 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.404 0.621 . . . . 0.0 111.557 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.428 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 15.6 mm-40 -97.26 99.21 10.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.474 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.4 mt -112.26 99.71 9.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -161.09 156.22 24.19 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -81.59 164.77 21.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.95 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.471 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.814 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.137 -165.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.65 -143.98 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -168.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -59.41 -22.53 61.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.929 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.4 m -54.69 -33.27 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 110.297 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -86.52 -41.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -63.52 -37.3 86.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -54.75 -37.36 65.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.52 -36.52 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.487 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -66.35 -38.21 87.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.424 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.07 -30.7 71.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.925 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.532 ' HZ2' ' HB3' ' C' ' 19' ' ' LYS . 9.1 mtpm? -85.65 -37.19 19.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.555 HD22 ' CZ2' ' C' ' 54' ' ' TRP . 75.6 mt -76.35 -33.71 58.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.592 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -81.55 52.57 1.9 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.931 0.872 . . . . 0.0 109.769 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.571 ' HE3' HG12 ' C' ' 47' ' ' ILE . 14.7 pttm -66.24 -40.57 90.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.108 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.15 0.48 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' C' ' 24' ' ' LYS . 10.9 mmpt? -70.64 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -40.44 145.64 0.39 Allowed Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' C' ' 40' ' ' SER . 10.7 ptpt -148.52 130.96 15.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.945 -169.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.513 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -105.02 128.34 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.721 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.1 t -103.61 98.93 8.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.71 121.2 25.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.11 0.481 . . . . 0.0 110.868 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -130.62 134.89 47.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.602 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 73.6 mtp -118.93 134.45 55.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.956 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -149.02 91.01 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.661 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.28 -106.42 0.65 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.245 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 33.78 1.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.5 0.667 . . . . 0.0 109.902 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.614 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.4 tt0 -145.71 139.6 26.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.511 0.672 . . . . 0.0 112.335 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.15 118.98 28.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.496 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 25.6 pttm -127.18 107.93 10.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.758 0.79 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -115.67 121.59 42.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.66 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 45.0 p -96.57 151.21 19.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 40.9 m -123.7 118.58 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.323 0.582 . . . . 0.0 110.848 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.471 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 22.6 t -101.84 -176.61 3.18 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.36 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.461 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.9 OUTLIER 73.01 35.91 0.92 Allowed 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 124.246 0.967 . . . . 0.0 109.746 -170.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.03 19.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.731 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -3.66 65.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.475 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.461 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 55.4 m-85 -58.78 143.51 46.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.847 0.324 . . . . 0.0 110.89 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.09 -158.02 5.4 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.571 HG12 ' HE3' ' C' ' 22' ' ' LYS . 23.0 mt -67.52 -68.6 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 CA-C-O 122.115 0.96 . . . . 0.0 109.781 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -178.26 -146.68 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.833 -165.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -79.22 -24.23 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.442 ' OE1' ' HE2' ' C' ' 52' ' ' LYS . 6.4 pt-20 -73.28 137.26 44.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.545 0.688 . . . . 0.0 112.79 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.62 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 5.6 p-10 -90.62 145.41 24.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.051 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.62 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.4 mptp? -141.8 126.02 17.49 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.771 ' ND2' HG13 ' C' ' 94' ' ' ILE . 66.5 t30 -84.94 112.61 20.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.525 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.645 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.2 OUTLIER -121.05 161.23 22.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -169.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.9 159.18 31.7 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 118.952 -1.594 . . . . 0.0 116.655 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -114.96 131.49 67.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 113.974 -1.113 . . . . 0.0 110.853 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 1.9 m-85 -129.05 107.2 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.84 123.18 47.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.62 31.12 18.61 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 4.09 89.31 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.114 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.1 tp10 -106.48 121.13 43.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.969 0.385 . . . . 0.0 110.701 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 30.0 ttpp -75.05 117.68 17.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.57 -32.58 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.296 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -142.0 131.58 23.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -125.39 141.01 52.3 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' C' ' 75' ' ' ILE . 50.1 p90 -156.78 -173.35 4.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.277 0.844 . . . . 0.0 113.277 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 19.1 p-10 -131.55 131.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.081 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.645 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 34.0 mt-10 -67.02 -12.33 59.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.6 ptmm? -89.59 7.54 35.9 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 15.2 t -79.98 -147.83 0.05 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.09 117.18 32.57 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.513 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 2.4 t -64.47 -14.8 16.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.302 -167.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.38 -39.57 25.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.567 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.55 -30.68 68.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' C' ' 72' ' ' VAL . 67.7 mt -68.28 -70.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.261 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.524 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 2.5 m -65.38 -44.18 88.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.469 HD21 ' ND2' ' C' ' 80' ' ' ASN . 11.6 m120 -80.83 -15.24 56.9 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.426 -171.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.31 -40.23 81.78 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' C' ' 76' ' ' SER . 63.1 mt -58.7 -28.78 38.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.467 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.496 ' CG ' ' HA ' ' C' ' 37' ' ' LYS . 7.9 m-20 -75.19 -37.6 61.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.249 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 7.2 mmpt? -54.43 -40.44 68.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 0.0 109.237 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.496 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -56.12 -34.78 66.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.699 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.614 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.26 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.164 0.915 . . . . 0.0 110.68 -168.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.66 131.07 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.325 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.98 43.27 0.77 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.514 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.87 138.02 14.09 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.097 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.37 -45.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.775 2.317 . . . . 0.0 111.445 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -140.3 123.36 16.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.02 133.92 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.363 0.602 . . . . 0.0 111.352 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.456 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 8.0 mm-40 -92.31 104.51 16.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.485 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.1 mt -112.71 100.85 11.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -157.37 171.4 20.46 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -94.27 167.42 11.55 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.092 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.771 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' C' ' 9' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.468 ' O ' HG13 ' C' ' 13' ' ' ILE . 62.7 mtt -82.29 -142.06 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -49.95 -17.2 0.35 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 41.0 m -53.88 -39.71 65.97 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.246 -0.284 . . . . 0.0 110.846 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.468 HG13 ' O ' ' C' ' 10' ' ' MET . 2.8 pp -91.58 -23.92 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.514 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 17.2 m120 -74.89 -32.58 61.88 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 122.304 -0.248 . . . . 0.0 111.003 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -62.26 -31.1 71.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.451 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.51 -34.69 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.868 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.5 m-20 -61.76 -39.82 92.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.407 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.46 -27.7 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.674 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.91 -28.57 18.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.099 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 34.7 mt -82.94 -28.35 29.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.413 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -88.19 74.49 8.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.561 ' HZ2' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -110.82 -23.67 10.88 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -171.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -81.77 0.09 OUTLIER Glycine 0 CA--C 1.507 -0.414 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.234 -174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 14.9 ttmt -89.75 -179.22 5.71 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 29.89 90.33 0.01 OUTLIER Glycine 0 CA--C 1.503 -0.668 0 O-C-N 124.38 1.05 . . . . 0.0 115.496 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.0 OUTLIER -121.02 137.17 54.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.652 -173.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 31.6 tp -126.93 128.21 46.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.395 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 59.2 m -111.87 111.81 23.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.256 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.552 ' CD2' ' HB ' ' C' ' 91' ' ' ILE . 5.4 mp -86.92 144.58 26.89 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 111.574 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.4 p -155.09 129.78 9.23 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.473 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.409 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 63.4 mtt -128.02 132.33 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.962 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -151.23 92.66 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.569 0.223 . . . . 0.0 110.77 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.79 -93.94 1.18 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.37 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.48 31.78 6.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.447 0.642 . . . . 0.0 109.909 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.537 ' N ' HG22 ' C' ' 84' ' ' ILE . 9.9 pt20 -127.92 130.7 48.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.312 0.577 . . . . 0.0 111.753 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.613 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tm? -124.16 119.03 28.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.625 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -140.37 130.99 25.59 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -143.78 120.1 10.9 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.932 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 44.1 p -97.47 126.12 42.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.4 p -109.27 118.72 37.45 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.582 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 t -103.18 -175.08 2.7 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 81.08 26.33 0.23 Allowed 'General case' 0 C--O 1.222 -0.353 0 O-C-N 124.494 1.121 . . . . 0.0 110.491 -171.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.02 38.35 23.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.93 -5.82 79.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.674 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -64.38 145.21 56.41 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.46 0.63 . . . . 0.0 110.526 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.33 -169.7 46.28 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.002 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.561 HD13 ' HZ2' ' C' ' 22' ' ' LYS . 23.3 mm -59.14 -63.53 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-O 121.652 0.739 . . . . 0.0 110.84 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 p -164.06 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.634 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -169.24 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.873 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.63 136.07 49.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.426 -168.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 1.3 m-20 -75.15 118.43 18.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.417 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -139.28 132.72 30.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 14.7 p-10 -86.91 122.38 30.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.5 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -115.66 161.92 17.99 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.78 148.22 18.79 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.331 -1.414 . . . . 0.0 115.444 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 38.6 mt -122.27 127.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 164.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -121.7 109.04 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.949 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.408 HG21 HG13 ' C' ' 89' ' ' ILE . 2.5 p -90.08 105.74 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 62.36 29.45 17.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.704 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.74 5.19 78.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.766 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -109.08 141.99 40.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.853 0.358 . . . . 0.0 110.467 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -66.74 121.42 15.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.794 174.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -156.88 153.23 27.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.301 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -141.93 159.02 43.07 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 55.8 p90 -166.91 -172.87 2.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 111.39 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -129.42 138.51 51.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.139 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.5 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 10.1 mt-10 -62.96 -33.07 74.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.415 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.1 pttp -82.89 18.89 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.007 0.432 . . . . 0.0 111.367 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -88.87 -150.73 0.2 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 19.9 p -111.27 112.86 24.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.23 -12.33 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.057 -168.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -84.55 -37.92 10.22 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.816 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -68.4 -35.18 77.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 51.5 mm -69.63 -60.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.925 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.668 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 75.2 p -51.73 -60.75 2.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.6 m120 -73.26 -15.98 61.41 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -171.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.543 ' HA ' ' HD3' ' C' ' 81' ' ' LYS . 0.5 OUTLIER -69.65 -36.01 75.7 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.1 167.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.3 mt -58.36 -20.91 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.625 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.7 OUTLIER -84.05 -35.91 23.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' C' ' 78' ' ' ASP . 52.0 mtpt -53.61 -39.92 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 6.1 mt -52.97 -37.33 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.613 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 2.4 tp -44.8 148.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.664 -174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -149.85 22.32 0.88 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.342 0.591 . . . . 0.0 109.718 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.04 171.55 15.29 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.849 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.79 -49.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.775 2.317 . . . . 0.0 113.407 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -132.87 103.35 6.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.363 0.601 . . . . 0.0 110.326 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.442 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.4 mp -122.43 129.62 75.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.145 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 37.9 mt-10 -106.56 119.2 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 0.0 111.658 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.552 ' HB ' ' CD2' ' C' ' 29' ' ' LEU . 34.4 mt -96.91 98.95 8.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 146.1 14.79 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.45 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.4 pt20 -83.16 166.97 18.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.218 0.532 . . . . 0.0 112.325 -173.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.782 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.777 0.322 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 86.9 mmm -66.53 178.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.283 0.563 . . . . 0.0 111.863 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -50.17 -19.6 0.81 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t -46.04 -51.95 12.77 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.569 0.543 . . . . 0.0 112.309 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.43 HD11 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -89.76 -18.58 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.567 -177.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -74.11 -50.95 17.25 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.3 -0.25 . . . . 0.0 111.388 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.3 m -58.3 -29.39 65.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.459 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.456 HG12 ' O ' ' C' ' 91' ' ' ILE . 42.8 t -70.33 -40.09 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.71 172.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.31 -41.03 96.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.831 0.348 . . . . 0.0 110.439 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.47 -31.24 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.408 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.74 -35.42 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.123 0.487 . . . . 0.0 110.617 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.565 HD22 ' CZ2' ' C' ' 54' ' ' TRP . 73.3 mt -73.53 -37.37 65.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.347 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -79.59 68.92 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.814 0.816 . . . . 0.0 109.019 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -89.27 -7.4 55.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.992 -172.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.4 -50.73 0.76 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.734 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 22.5 mmtm -78.96 -160.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -41.34 137.94 2.11 Favored Glycine 0 CA--C 1.507 -0.434 0 O-C-N 123.535 0.522 . . . . 0.0 114.106 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.734 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.5 OUTLIER -141.34 143.21 33.9 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -168.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.478 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.0 mp -117.86 114.54 23.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 8.5 t -86.42 98.47 11.03 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.455 HD11 ' HB ' ' C' ' 91' ' ' ILE . 39.0 mt -83.9 124.36 30.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.246 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 29.8 t -147.13 139.43 24.63 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 54.0 mtm -107.2 145.64 32.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.277 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -148.15 89.82 1.76 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 110.568 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.18 -94.11 0.31 Allowed Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.94 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.4 p-10 -112.94 26.61 10.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 110.512 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.736 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.0 tt0 -140.35 143.39 35.73 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.493 0.663 . . . . 0.0 111.951 -171.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.0 tm? -118.11 117.88 30.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.603 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 22.5 pttp -126.31 148.62 49.5 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.15 135.29 17.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.378 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -98.69 125.57 44.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.618 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 30.9 t -109.47 119.65 40.09 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.672 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.492 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 9.5 t -109.93 178.98 4.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 78.44 27.34 0.5 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.502 1.126 . . . . 0.0 110.639 -174.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.69 32.69 19.84 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.548 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.91 -14.08 66.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.121 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.423 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 39.7 m-85 -55.44 130.36 42.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.058 0.429 . . . . 0.0 110.359 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . 0.403 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -73.85 -94.45 0.11 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.784 -0.643 . . . . 0.0 113.074 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.559 HD13 ' O ' ' C' ' 50' ' ' GLU . 33.6 mt -110.51 -67.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.415 0.626 . . . . 0.0 109.755 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 177.36 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.192 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -166.4 -37.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.657 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.559 ' O ' HD13 ' C' ' 47' ' ' ILE . 11.8 pt-20 -70.18 170.08 12.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.058 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.519 ' HB2' HD22 ' C' ' 67' ' ' ASN . 4.5 p-10 -125.35 152.97 44.04 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 111.33 -177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.449 ' HG3' ' OE2' ' C' ' 68' ' ' GLU . 8.6 mmmm -130.03 143.47 50.81 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.207 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.676 ' ND2' HG13 ' C' ' 94' ' ' ILE . 5.3 t30 -92.34 105.04 17.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.464 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.595 ' O ' HG22 ' C' ' 65' ' ' THR . 0.1 OUTLIER -113.82 165.85 12.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.128 -167.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.424 ' C ' HD11 ' C' ' 56' ' ' ILE . . . -163.78 158.09 30.5 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 119.556 -1.306 . . . . 0.0 114.816 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.424 HD11 ' C ' ' C' ' 55' ' ' GLY . 2.6 mp -119.79 129.39 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.869 169.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.515 ' CE1' ' HD3' ' C' ' 62' ' ' LYS . 40.6 m-85 -123.98 105.49 9.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.31 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.89 112.01 26.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 57.83 32.84 22.48 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.062 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.12 7.53 87.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.085 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.3 tp10 -107.01 139.05 42.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.883 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.515 ' HD3' ' CE1' ' C' ' 57' ' ' PHE . 14.3 mmmm -83.24 118.05 23.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.575 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -107.17 -24.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.358 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -160.22 147.91 16.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 110.778 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.595 HG22 ' O ' ' C' ' 54' ' ' TRP . 41.8 m -139.73 147.73 41.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -159.78 -178.73 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.121 -1.032 . . . . 0.0 113.523 -175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' C' ' 51' ' ' ASP . 51.5 t-20 -120.36 127.95 52.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.836 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 4.7 mt-10 -62.61 -21.53 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 21.0 ptmt -90.53 9.24 30.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.454 ' HB2' HD13 ' C' ' 75' ' ' ILE . 15.5 m -76.38 -118.8 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.299 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -131.71 115.67 16.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.501 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 3.3 t -60.65 -22.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -168.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.88 -37.4 19.36 Favored Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.004 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -72.14 -34.51 68.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' C' ' 70' ' ' SER . 81.9 mt -66.6 -65.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.395 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.627 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 70.8 p -62.42 -50.95 69.45 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -167.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.453 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 27.4 m120 -79.29 -14.51 58.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -172.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.05 -38.83 92.13 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' C' ' 76' ' ' SER . 73.1 mt -59.29 -24.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.497 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -80.12 -40.03 28.29 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 8.0 mmpt? -50.72 -38.68 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 0.0 109.624 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.5 mt -52.25 -35.37 49.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.736 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 37.49 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.131 0.895 . . . . 0.0 110.957 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.473 ' C ' ' H ' ' C' ' 86' ' ' GLY . 31.5 mt -79.28 115.16 21.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.241 -166.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -66.83 35.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.638 169.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' C' ' 84' ' ' ILE . . . -98.74 159.42 20.29 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.096 -171.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.616 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 93.1 Cg_endo -80.5 -75.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.691 2.261 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.616 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 15.3 p90 -115.78 112.64 22.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.666 0.746 . . . . 0.0 109.487 171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.09 114.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.706 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -90.55 96.88 10.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.338 0.589 . . . . 0.0 110.13 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.505 HG22 ' CH2' ' C' ' 54' ' ' TRP . 13.9 mt -96.35 100.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 145.89 22.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.8 pt20 -83.1 167.01 18.23 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.751 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.676 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.565 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.027 0.441 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 71.1 mtp -81.36 -149.26 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.887 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.12 -10.69 11.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -56.62 -42.39 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.09 -28.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.8 -43.99 87.04 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.478 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' C' ' 19' ' ' LYS . 22.3 m -56.97 -34.93 68.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.1 -31.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.208 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -61.31 -48.97 78.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.03 -14.25 60.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.094 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' C' ' 15' ' ' SER . 0.0 OUTLIER -80.52 -45.77 16.92 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 90.0 mt -78.42 -35.08 47.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.985 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -78.65 67.84 4.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.157 0.503 . . . . 0.0 109.961 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.414 ' HE3' HD11 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -104.6 -10.01 17.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.87 -76.6 0.19 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -99.57 -174.49 2.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.89 88.95 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 171.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.6 ptpt -128.97 143.44 50.88 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.646 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.454 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 17.1 tp -125.94 127.98 46.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.366 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -99.98 110.68 23.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -79.84 135.32 36.43 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.028 0.531 . . . . 0.0 111.973 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 41.2 m -143.61 129.11 19.06 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.286 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.577 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 39.5 mtm -123.93 130.9 53.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -148.1 90.89 1.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.05 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.27 -97.67 0.06 OUTLIER Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.713 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.87 33.38 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.37 0.605 . . . . 0.0 109.882 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.545 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.9 tt0 -150.08 136.66 19.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.535 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.2 tm? -119.96 127.41 52.62 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 165.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.412 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 50.1 pttt -144.8 144.74 31.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.43 142.42 22.18 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.732 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 60.6 p -99.07 138.81 35.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 22.2 p -118.07 117.86 30.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.564 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.444 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.2 m -105.04 178.18 4.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.955 -175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.1 38.98 1.41 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.323 1.014 . . . . 0.0 109.071 -168.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.13 27.75 16.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.732 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 11.92 82.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.523 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.478 ' O ' HG23 ' C' ' 72' ' ' VAL . 55.1 m-85 -74.69 176.1 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.248 0.524 . . . . 0.0 110.771 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . 0.481 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -101.01 -154.98 26.97 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.634 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' C' ' 48' ' ' SER . 15.9 mm -51.79 -67.08 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.486 0.66 . . . . 0.0 109.863 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 15.1 t 173.13 -67.78 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.335 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.05 -22.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 7.4 pt-20 -68.94 145.68 53.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 112.315 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.523 ' C ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 t70 -87.56 121.05 29.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.707 -174.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 3.3 mptp? -124.76 134.37 52.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.488 HD21 HG13 ' C' ' 94' ' ' ILE . 0.9 OUTLIER -96.86 105.96 18.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.538 0.685 . . . . 0.0 111.077 -177.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.577 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.66 167.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.61 -173.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.408 ' C ' HD11 ' C' ' 56' ' ' ILE . . . -170.1 165.58 38.88 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 119.291 -1.433 . . . . 0.0 115.612 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.512 HG13 HG13 ' C' ' 91' ' ' ILE . 3.5 mp -124.63 129.54 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.17 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -120.1 117.42 27.9 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -115.62 123.17 70.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.677 0.275 . . . . 0.0 110.362 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' C' ' 87' ' ' PRO . 4.5 m-20 57.56 33.23 22.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.83 90.47 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.851 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.52 130.95 56.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.476 ' HD2' ' OG1' ' C' ' 65' ' ' THR . 40.0 ttpt -74.83 123.67 25.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.934 0.397 . . . . 0.0 110.5 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.69 -43.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -146.31 147.75 31.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.933 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.577 HG23 ' O ' ' C' ' 54' ' ' TRP . 84.6 m -136.46 145.22 44.94 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.44 -170.92 2.96 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 51.3 t-20 -128.2 139.99 52.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.43 ' HB3' HG12 ' C' ' 47' ' ' ILE . 42.3 mt-10 -77.95 -11.29 59.89 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -81.59 -6.63 59.17 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.242 175.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -78.58 163.75 25.25 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -74.22 113.24 11.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.481 HG23 ' HA2' ' C' ' 46' ' ' GLY . 8.7 t -57.52 -15.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.943 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.95 -41.16 12.79 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.371 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -73.41 -33.01 64.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 38.3 mm -65.81 -61.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.532 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.413 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 68.2 p -64.8 -57.81 7.9 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.755 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.6 OUTLIER -67.69 -16.83 64.34 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -171.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.412 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.2 m-20 -64.95 -47.41 77.73 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.645 0.657 . . . . 0.0 109.291 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' C' ' 76' ' ' SER . 65.1 mt -56.78 -30.62 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.844 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.755 HD21 ' ND2' ' C' ' 77' ' ' ASN . 27.7 m-20 -89.67 -17.82 27.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 33.9 mmtp -62.76 -39.31 93.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 11.0 mt -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.302 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.545 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.8 m120 39.51 72.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.625 0.726 . . . . 0.0 110.08 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -54.36 139.99 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.451 -171.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -85.17 26.29 0.89 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.1 125.41 8.17 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.606 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.421 ' HD2' ' OD1' ' C' ' 59' ' ' ASN . 95.6 Cg_endo -79.83 -40.34 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.208 1.939 . . . . 0.0 111.035 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -126.89 120.64 29.68 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.577 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 73.4 mt -126.11 130.53 72.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.521 -172.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.33 98.47 11.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.983 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.554 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.8 tt -105.33 99.89 9.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.24 158.67 19.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.322 -171.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -84.52 158.79 20.86 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.488 HG13 HD21 ' C' ' 53' ' ' ASN . 1.6 pt . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.977 -167.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' C' ' 9' ' ' GLN . 9.8 mt-30 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -81.36 -143.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.622 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.05 -9.77 11.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -48.94 -60.46 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.89 0.476 . . . . 0.0 111.83 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 0.2 OUTLIER -84.83 -18.36 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.06 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.552 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 84.3 m-20 -72.46 -38.96 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.642 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 61.2 m -63.76 -30.18 71.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 89.7 t -68.25 -36.69 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.651 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.8 m-20 -59.87 -45.51 92.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.4 -32.03 70.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.292 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -87.41 -31.63 19.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.975 0.417 . . . . 0.0 110.994 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' C' ' 27' ' ' LEU . 50.8 mt -81.62 -31.41 32.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.705 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -82.67 65.1 7.63 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.44 ' CE ' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.52 -24.15 16.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.012 -173.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.46 -78.36 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.8 ttpt -98.87 -172.97 2.4 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 166.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' C' ' 24' ' ' LYS . . . 32.83 92.66 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 O-C-N 124.747 1.28 . . . . 0.0 115.703 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 7.0 ptpt -130.95 136.74 48.83 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.597 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.43 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.3 tp -116.48 122.09 43.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.581 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.9 m -108.05 104.54 14.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.292 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.472 ' HG ' HG23 ' C' ' 91' ' ' ILE . 1.3 mm? -82.53 138.43 34.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -142.76 129.35 20.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' C' ' 9' ' ' GLN . 36.0 mtm -130.81 125.02 32.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.236 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -148.42 97.21 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 110.654 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -94.63 0.8 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.459 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.43 32.46 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.501 0.667 . . . . 0.0 109.835 -175.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -128.48 136.55 50.97 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.279 0.561 . . . . 0.0 111.607 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.588 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 0.7 OUTLIER -130.39 118.45 21.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 164.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.519 ' O ' ' HD2' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -145.66 103.2 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -109.52 126.66 53.77 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.286 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -96.65 137.76 35.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.075 0.464 . . . . 0.0 109.896 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 29.2 p -109.04 117.59 34.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.644 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 21.2 t -102.63 173.97 6.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.422 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 71.76 39.61 0.84 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.384 1.052 . . . . 0.0 109.569 -166.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.12 27.02 14.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.79 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.97 5.83 88.86 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.051 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.408 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 44.0 m-85 -65.03 156.47 31.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . 0.581 ' O ' ' HG2' ' C' ' 24' ' ' LYS . . . -83.23 -166.52 39.87 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.463 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 15.6 mm -56.46 -61.9 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 121.489 0.662 . . . . 0.0 111.803 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.1 p 176.24 -74.15 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.983 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -159.88 20.99 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.358 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 42.1 mt-10 -115.95 141.87 47.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.765 -176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' C' ' 67' ' ' ASN . 7.0 p-10 -100.99 149.21 24.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.565 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.516 ' HG3' ' OE1' ' C' ' 68' ' ' GLU . 11.3 mmtp -132.9 146.23 51.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.82 ' ND2' HG13 ' C' ' 94' ' ' ILE . 6.5 t30 -96.28 99.25 10.97 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.753 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -102.93 164.35 11.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.238 -166.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.53 143.9 10.2 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 119.403 -1.38 . . . . 0.0 115.114 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.85 124.82 73.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 5.2 m-85 -125.91 155.11 41.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.02 117.87 47.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.81 24.98 14.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.21 36.82 20.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.343 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 16.0 tp10 -133.62 131.11 39.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.82 124.5 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.98 -49.2 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.612 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 56.8 t80 -155.17 150.3 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.712 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.494 HG21 ' O ' ' C' ' 54' ' ' TRP . 16.8 m -135.61 136.55 41.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.419 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 41.9 p90 -152.58 -177.9 6.52 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.793 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' C' ' 51' ' ' ASP . 52.0 t-20 -119.95 130.41 54.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.91 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' HG3' ' C' ' 52' ' ' LYS . 2.2 mt-10 -64.95 -27.06 68.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 13.7 ptmm? -79.55 2.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.374 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 11.5 m -74.63 178.24 5.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -76.63 110.84 11.53 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.39 -11.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.911 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.72 -41.24 13.12 Favored Glycine 0 CA--C 1.51 -0.238 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.971 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -71.54 -32.02 67.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.239 0.542 . . . . 0.0 109.587 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.481 ' O ' HG13 ' C' ' 79' ' ' ILE . 49.1 mm -69.62 -55.73 14.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.515 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' C' ' 38' ' ' ALA . 56.3 p -57.98 -64.65 0.84 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.8 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -67.06 -17.74 65.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -172.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -45.57 66.07 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' C' ' 75' ' ' ILE . 58.2 mt -57.65 -28.29 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.8 HD21 ' ND2' ' C' ' 77' ' ' ASN . 30.0 m-20 -85.86 -27.95 24.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.023 -177.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 68.1 mttm -60.32 -36.65 78.41 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 12.3 mt -52.35 -32.47 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.35 99.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.66 1.225 . . . . 0.0 112.769 -175.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.588 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -42.67 144.42 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 113.965 -1.471 . . . . 0.0 112.867 -173.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.34 15.17 0.89 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.33 0.585 . . . . 0.0 109.586 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.31 179.91 28.41 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.682 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.613 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.5 Cg_endo -82.01 -77.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.668 2.245 . . . . 0.0 111.455 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.613 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.5 p90 -113.83 129.92 56.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 109.798 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.427 HG12 HD12 ' C' ' 84' ' ' ILE . 3.9 mp -116.01 136.71 52.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.374 -174.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 101.69 14.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' C' ' 29' ' ' LEU . 27.0 mm -103.4 98.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 151.56 3.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -91.42 171.7 9.02 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.225 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.82 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.149 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.692 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.41 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.7 mp0 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.445 ' O ' HG22 ' C' ' 13' ' ' ILE . 75.0 mtm -99.5 -143.21 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.481 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -47.58 -35.38 9.03 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' SER . . . . . 0.438 ' O ' HG23 ' C' ' 16' ' ' VAL . 51.0 m -49.25 -48.44 45.77 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.445 HG22 ' O ' ' C' ' 10' ' ' MET . 9.9 tt -84.22 -25.26 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.288 0.566 . . . . 0.0 111.08 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.517 ' HA ' HD21 ' C' ' 17' ' ' ASN . 89.3 m-20 -85.02 -27.84 26.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.58 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 50.6 m -65.07 -31.67 73.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 51.7 t -69.83 -34.34 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.971 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.517 HD21 ' HA ' ' C' ' 14' ' ' ASN . 6.4 m-80 -57.43 -46.27 83.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.775 0.322 . . . . 0.0 110.749 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.9 -15.97 61.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.712 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -88.04 -38.0 15.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 43.3 mt -74.1 -33.9 63.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.45 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . 0.491 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 23.4 m-80 -78.53 69.62 4.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 10.01 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.696 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.91 -67.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.594 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 0.2 OUTLIER -100.44 92.56 5.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 122.616 0.366 . . . . 0.0 110.365 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 126.56 3.14 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 119.833 -1.175 . . . . 0.0 111.668 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.5 ptpt -149.4 146.09 27.3 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.479 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.505 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -115.21 110.68 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.466 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.6 m -85.93 115.6 23.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' C' ' 17' ' ' ASN . 16.5 mt -102.63 132.27 48.85 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.877 0.37 . . . . 0.0 111.82 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 26.4 p -149.58 137.55 20.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.553 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.41 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 88.8 mtp -118.32 128.07 54.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -133.04 92.78 3.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.155 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.91 -93.55 0.41 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.167 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.6 p-10 -107.87 21.73 16.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.68 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.4 tt0 -138.79 145.54 40.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.558 0.694 . . . . 0.0 112.465 -169.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.85 105.07 7.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.476 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 54.5 pttt -109.13 104.95 14.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.638 0.732 . . . . 0.0 109.113 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -104.2 119.35 38.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -104.68 139.09 40.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 26.6 t -109.9 119.19 38.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 42.8 t -93.39 173.78 7.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.288 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' C' ' 41' ' ' SER . 12.4 m120 80.19 26.5 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.757 1.286 . . . . 0.0 110.102 -171.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.28 27.09 16.05 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.061 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.12 67.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.979 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.442 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.0 m-30 -60.19 143.14 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.813 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.82 -169.26 45.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.548 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.572 ' CG1' ' HB3' ' C' ' 68' ' ' GLU . 7.7 mt -48.95 -59.28 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 CA-C-O 121.052 0.453 . . . . 0.0 111.891 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 10.3 t 173.31 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.855 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -166.69 54.4 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.525 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.654 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 5.7 pt-20 -156.45 152.04 26.95 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.73 0.3 . . . . 0.0 111.409 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.466 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 p-10 -97.31 129.62 44.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.662 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.6 mptp? -127.64 133.05 49.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.642 ' ND2' HG13 ' C' ' 94' ' ' ILE . 8.9 t30 -87.48 107.73 18.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.851 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.754 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -113.38 165.62 12.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.869 -171.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.22 167.53 40.64 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.694 -1.241 . . . . 0.0 115.245 174.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.528 HG12 HG13 ' C' ' 91' ' ' ILE . 50.2 mt -131.24 131.47 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.901 -0.65 . . . . 0.0 110.414 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 54.0 m-85 -126.02 122.47 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.808 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -112.46 117.36 55.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 61.21 32.02 19.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.316 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.58 80.06 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.0 OUTLIER -112.95 142.75 45.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.713 0.256 . . . . 0.0 110.799 -178.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.54 100.44 2.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.32 -39.7 13.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.174 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -154.25 153.35 31.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.098 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.58 HG21 ' O ' ' C' ' 54' ' ' TRP . 60.0 m -150.08 142.43 24.27 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -158.6 -179.39 8.03 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.251 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -118.91 127.07 53.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.167 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.754 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 2.1 mt-10 -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.654 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 3.7 ptmm? -76.56 -2.41 32.29 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.581 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.481 ' HB2' HD11 ' C' ' 75' ' ' ILE . 5.4 m -74.74 -170.24 1.02 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 68.6 p -88.36 116.82 26.85 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.179 -0.951 . . . . 0.0 108.749 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.601 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 11.1 t -58.17 -17.21 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.751 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.32 -44.66 8.6 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.748 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -69.17 -28.48 66.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' C' ' 70' ' ' SER . 73.1 mt -66.92 -66.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.539 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -59.78 -48.16 82.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.285 -170.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.565 HD21 ' ND2' ' C' ' 80' ' ' ASN . 12.3 m120 -76.18 -15.63 60.01 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.39 -39.92 81.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.8 mt -58.49 -27.7 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.44 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.565 ' ND2' HD21 ' C' ' 77' ' ' ASN . 7.3 m-20 -77.64 -35.79 52.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.227 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 10.7 mmpt? -52.2 -42.99 63.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.8 mt -56.21 -32.91 64.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.68 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.4 80.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.018 0.823 . . . . 0.0 111.083 -171.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.449 HG21 ' N ' ' C' ' 86' ' ' GLY . 11.8 mt -68.34 124.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.238 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.573 ' HZ1' ' HB3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -91.74 34.83 0.97 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.852 175.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.449 ' N ' HG21 ' C' ' 84' ' ' ILE . . . -79.98 143.6 25.44 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.19 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.6 Cg_endo -80.29 -43.65 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.38 2.054 . . . . 0.0 111.293 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.422 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 40.3 p90 -139.26 128.77 24.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 63.4 mt -121.38 126.15 74.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.615 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -98.9 98.97 9.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.411 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.576 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.3 tt -98.83 104.42 15.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 168.09 19.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.86 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.37 0.605 . . . . 0.0 111.32 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.642 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.599 -166.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' C' ' 89' ' ' ILE . 10.7 mm-40 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.409 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 20.0 mmt -90.44 -143.54 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . 0.409 ' H ' ' HB3' ' C' ' 10' ' ' MET . 4.1 m-20 -56.78 -14.16 3.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t -54.33 -39.45 67.07 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.114 0.259 . . . . 0.0 110.438 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.506 HD12 ' SD ' ' C' ' 31' ' ' MET . 13.1 pt -90.81 -25.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.896 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -64.93 -44.35 89.78 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.757 0.313 . . . . 0.0 110.627 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -57.46 -35.86 70.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.504 HG12 ' O ' ' C' ' 91' ' ' ILE . 61.8 t -68.34 -35.74 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.341 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.59 -41.54 99.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 110.132 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.37 -20.62 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.355 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' C' ' 19' ' ' LYS . 5.5 mmpt? -88.88 -35.22 16.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 110.658 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.487 HD13 HD21 ' C' ' 29' ' ' LEU . 98.9 mt -76.37 -33.14 58.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 28.7 m-80 -79.98 60.05 3.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.544 0.688 . . . . 0.0 109.838 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.447 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -94.21 -34.43 12.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.264 -173.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' C' ' 26' ' ' LYS . . . 166.98 -93.7 0.11 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.464 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -72.66 91.76 1.47 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 125.59 5.19 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.642 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' C' ' 21' ' ' ASN . 8.0 ptpt -152.34 155.63 38.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.39 129.68 43.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.548 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.4 m -107.83 99.36 8.83 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.487 HD21 HD13 ' C' ' 20' ' ' LEU . 0.6 OUTLIER -93.39 136.13 33.96 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 120.818 0.342 . . . . 0.0 111.672 -171.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -153.35 130.62 11.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.273 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.507 ' HG3' ' CD2' ' C' ' 36' ' ' LEU . 1.6 mpt? -103.71 137.49 41.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.981 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -136.04 91.46 2.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.701 0.286 . . . . 0.0 110.278 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.02 -95.03 0.12 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.079 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.5 p-10 -108.03 22.6 15.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.643 0.259 . . . . 0.0 110.938 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.688 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 25.9 tt0 -139.15 137.04 35.74 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.553 0.692 . . . . 0.0 112.398 -170.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' C' ' 31' ' ' MET . 0.6 OUTLIER -113.62 129.67 56.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -142.89 140.78 31.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -152.56 134.54 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.54 0.209 . . . . 0.0 110.996 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 62.0 p -98.28 145.45 26.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m -125.59 116.61 22.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 49.2 m -100.66 -179.47 4.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.741 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.48 31.1 0.61 Allowed 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 124.584 1.178 . . . . 0.0 109.609 -168.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.52 32.58 22.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.112 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 1.03 86.34 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.262 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -66.63 145.67 55.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 111.055 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.71 -160.39 20.19 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.629 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.4 OUTLIER -48.51 -53.04 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 8.2 t 166.87 -62.81 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.273 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -150.37 -33.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 47.9 mm-40 -91.31 167.15 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -163.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.85 92.58 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.238 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.453 ' HB3' ' OE2' ' C' ' 68' ' ' GLU . 10.3 mptt -101.03 157.47 16.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -116.6 120.61 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.0 112.544 -174.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.542 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -102.85 166.56 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.737 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.74 150.13 11.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.117 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.3 mp -108.93 122.96 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 122.735 -0.274 . . . . 0.0 110.705 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -108.38 138.58 44.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.93 117.12 45.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.71 26.2 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.439 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.08 4.91 74.02 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.521 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.67 139.88 52.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.039 0.42 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 53.2 mtmt -82.0 136.87 35.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.721 0.296 . . . . 0.0 111.668 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.93 -39.47 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.695 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -144.7 145.93 31.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.542 HG21 ' O ' ' C' ' 54' ' ' TRP . 66.2 m -136.88 141.93 42.76 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.531 ' CD1' HG22 ' C' ' 75' ' ' ILE . 45.7 p90 -153.85 -175.14 5.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.446 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' C' ' 53' ' ' ASN . 16.8 m120 -126.73 139.48 53.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.287 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.474 ' CD ' ' HD1' ' C' ' 54' ' ' TRP . 3.1 mp0 -62.24 -15.75 49.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.498 ' HB3' HD11 ' C' ' 47' ' ' ILE . 2.4 ptmm? -82.56 1.92 35.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.919 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.6 m -81.54 -173.95 4.68 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.549 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.8 p -97.36 117.54 31.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.56 -21.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.518 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.71 -32.67 23.79 Favored Glycine 0 CA--C 1.504 -0.595 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.988 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -75.52 -38.49 59.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.549 HG12 ' O ' ' C' ' 71' ' ' THR . 42.3 mm -68.09 -58.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.514 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 20.3 m -59.74 -51.45 69.72 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.484 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.704 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -69.92 -18.94 63.41 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.734 -175.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 46.1 m-20 -68.03 -46.88 69.95 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 167.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' C' ' 76' ' ' SER . 96.2 mt -54.56 -29.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.296 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.704 HD21 ' ND2' ' C' ' 77' ' ' ASN . 69.9 m-20 -87.3 -37.35 17.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.327 -172.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 54.2 pttt -60.9 -26.03 67.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 18.5 mt -57.44 -29.05 63.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.819 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.688 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.3 m120 39.52 86.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.941 0.775 . . . . 0.0 110.679 -170.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.4 HG22 ' N ' ' C' ' 86' ' ' GLY . 15.9 mt -80.37 129.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.921 -168.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.4 OUTLIER -87.96 36.64 0.77 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.69 175.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.4 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -82.38 134.66 13.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.291 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -80.98 -47.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.545 2.163 . . . . 0.0 111.708 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.44 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 6.5 m-85 -125.71 99.54 6.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.489 ' H ' ' NE2' ' C' ' 9' ' ' GLN . 19.2 mm -100.54 125.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.424 0.631 . . . . 0.0 110.664 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.03 99.56 9.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.49 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.504 ' O ' HG12 ' C' ' 16' ' ' VAL . 3.4 tt -101.96 99.45 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.814 0.816 . . . . 0.0 109.018 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -161.54 166.12 27.51 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.634 -173.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.613 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -104.19 163.41 12.43 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.312 173.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.513 HG13 HD21 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.649 -161.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.574 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.2 mp0 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' C' ' 10' ' ' MET . 0.0 OUTLIER -110.77 -151.96 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -44.76 -33.71 2.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -50.63 -48.76 57.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.677 0.275 . . . . 0.0 111.605 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tt -85.75 -28.09 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.113 0.482 . . . . 0.0 110.674 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.8 -35.72 75.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.983 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -63.69 -29.82 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 96.8 t -72.49 -35.64 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.647 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.98 -42.2 98.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.67 -24.42 63.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.43 -31.5 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.824 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 98.8 mt -84.88 -33.25 22.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.682 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' C' ' 26' ' ' LYS . 24.4 m-80 -78.73 78.45 5.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.701 ' NZ ' ' HB2' ' C' ' 24' ' ' LYS . 0.6 OUTLIER -120.22 7.09 10.72 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -165.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.32 -76.12 0.4 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.328 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.701 ' HB2' ' NZ ' ' C' ' 22' ' ' LYS . 47.7 mttm -75.51 -158.32 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' C' ' 24' ' ' LYS . . . -42.74 144.21 1.2 Allowed Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 114.615 0.606 . . . . 0.0 114.615 -174.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' C' ' 40' ' ' SER . 12.7 ptpt -151.14 144.61 24.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.464 HD12 HD11 ' C' ' 20' ' ' LEU . 3.3 mp -102.15 136.73 41.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.03 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 9.4 t -115.62 99.83 7.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.441 HD22 HD12 ' C' ' 20' ' ' LEU . 1.3 mm? -86.71 127.84 34.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.916 0.389 . . . . 0.0 111.482 -173.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.6 m -142.09 128.89 20.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.806 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.574 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 30.2 mtt -100.17 121.9 42.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -133.54 91.09 2.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.645 0.26 . . . . 0.0 110.973 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.9 -108.33 1.53 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.161 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.47 21.53 5.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.081 0.44 . . . . 0.0 110.867 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.573 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.8 tt0 -142.93 141.1 31.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.594 0.712 . . . . 0.0 112.105 -169.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.94 122.69 45.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 164.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -127.38 140.35 52.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.66 119.07 5.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 47.0 p -98.03 146.57 25.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 53.2 p -112.0 118.62 35.94 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 21.7 m -88.5 177.21 6.86 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.018 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.436 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.6 OUTLIER 72.54 33.61 1.38 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.285 0.991 . . . . 0.0 109.399 -172.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.8 33.45 23.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.594 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.32 6.92 89.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.189 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 21.4 m-85 -64.02 151.96 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.336 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.73 174.06 46.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.096 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.43 HG13 ' HB3' ' C' ' 68' ' ' GLU . 49.1 mm -60.57 -67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 121.182 0.515 . . . . 0.0 109.714 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 21.5 t -148.48 -88.42 0.08 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.308 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -177.31 25.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.535 0.683 . . . . 0.0 110.338 -173.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.56 146.12 50.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.159 0.504 . . . . 0.0 111.037 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.42 109.7 15.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.088 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 5.9 mptp? -121.18 137.7 54.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.591 ' ND2' HG13 ' C' ' 94' ' ' ILE . 11.4 t30 -88.57 108.53 19.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.676 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.39 162.74 13.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.495 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.72 139.71 6.92 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.159 -1.496 . . . . 0.0 116.141 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -112.75 129.17 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.443 167.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.43 106.99 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.327 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.0 123.01 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 53.76 33.41 16.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.329 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.68 60.79 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.041 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.52 119.71 21.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 5.4 ttpm? -71.2 120.88 17.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.55 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.54 -33.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.559 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.08 143.87 29.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.14 0.495 . . . . 0.0 110.598 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.676 HG21 ' O ' ' C' ' 54' ' ' TRP . 69.2 m -135.76 139.98 43.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' C' ' 75' ' ' ILE . 52.2 p90 -148.45 177.77 9.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.173 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 67.4 m-20 -122.71 139.33 54.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.862 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.43 ' HB3' HG13 ' C' ' 47' ' ' ILE . 26.5 mt-10 -66.36 -14.21 61.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -82.97 -1.26 51.99 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -87.44 -177.9 6.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -83.22 115.6 22.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.95 -15.29 11.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.697 -169.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.81 -43.3 7.29 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.656 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -69.71 -28.55 65.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' C' ' 66' ' ' PHE . 41.0 mm -70.27 -65.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.18 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.571 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.9 m -59.19 -46.64 87.89 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.767 -171.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.761 ' ND2' HD21 ' C' ' 80' ' ' ASN . 12.0 m120 -76.79 -14.83 59.88 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 19.8 m-20 -60.26 -45.62 92.64 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' C' ' 76' ' ' SER . 78.8 mt -57.22 -30.55 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.1 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.761 HD21 ' ND2' ' C' ' 77' ' ' ASN . 33.3 m-20 -90.72 -28.67 18.15 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.43 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 11.5 mmpt? -55.04 -36.02 65.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.7 mt -56.41 -31.79 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.573 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.5 OUTLIER 39.11 79.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 0.0 110.073 -168.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.42 HG22 ' N ' ' C' ' 86' ' ' GLY . 25.6 mt -69.04 131.92 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.003 -168.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -86.69 41.51 0.96 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.323 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.42 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -89.26 129.58 9.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.746 -172.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.22 -38.35 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.418 2.079 . . . . 0.0 110.748 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -150.72 113.28 4.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.119 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.436 HG12 ' SD ' ' C' ' 31' ' ' MET . 15.0 pt -123.01 153.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.876 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.27 129.32 54.33 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.226 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.424 HG23 ' CZ3' ' C' ' 54' ' ' TRP . 3.4 mt -126.89 100.23 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.681 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.37 15.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 174.51 7.32 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.35 -177.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.591 HG13 ' ND2' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.348 -169.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.902 0.382 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 95.7 mmm -108.53 -140.94 0.38 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -41.43 -33.6 0.44 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -53.63 -51.38 63.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.801 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.464 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.4 tt -87.03 -25.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' C' ' 17' ' ' ASN . 83.2 m-20 -72.48 -26.64 61.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.128 -0.358 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.8 t -63.33 -33.64 75.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.9 t -69.6 -34.01 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.053 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' C' ' 14' ' ' ASN . 78.9 m-20 -56.98 -43.42 81.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.02 0.438 . . . . 0.0 110.149 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -76.16 -19.92 58.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.95 -27.78 28.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.188 0.518 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 72.5 mt -91.51 -32.05 15.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.97 73.43 9.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -107.7 -40.7 5.22 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.486 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -168.69 -74.68 0.04 OUTLIER Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.378 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.626 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.3 ttmm -105.81 162.55 13.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 167.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.92 85.32 0.03 OUTLIER Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.199 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.449 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 7.7 ptpt -126.13 128.35 47.18 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.164 0.506 . . . . 0.0 111.169 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 23.7 tp -115.31 126.29 54.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.519 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.1 m -108.52 106.22 16.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.064 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.42 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.7 mm? -90.33 144.67 25.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.017 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.408 ' HB3' ' CE ' ' C' ' 37' ' ' LYS . 39.5 t -158.6 136.39 10.4 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.565 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -96.81 146.03 25.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -141.41 88.73 2.17 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.76 -99.3 0.08 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.33 26.46 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 110.362 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.702 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.2 tt0 -139.01 138.78 37.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.324 0.583 . . . . 0.0 111.654 -171.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -119.06 122.59 42.47 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 167.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.408 ' CE ' ' HB3' ' C' ' 30' ' ' SER . 0.0 OUTLIER -130.79 145.33 51.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.85 133.61 14.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.705 0.288 . . . . 0.0 110.535 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 51.9 p -100.56 144.46 29.52 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.0 p -121.51 118.36 29.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.626 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 30.6 m -104.76 -179.93 4.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.377 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.68 38.73 1.63 Allowed 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 124.208 0.942 . . . . 0.0 108.812 -169.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.68 20.64 12.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.081 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.51 79.19 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.299 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.503 ' O ' HG23 ' C' ' 72' ' ' VAL . 45.1 m-85 -75.92 -179.05 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.866 0.333 . . . . 0.0 111.063 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.54 -159.63 33.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.39 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 11.8 mt -49.21 -67.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.486 0.714 . . . . 0.0 112.53 -172.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 5.4 t 171.05 -75.3 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.788 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -155.31 62.23 0.62 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.352 0.261 . . . . 0.0 111.356 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.664 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 11.6 pt-20 -169.13 176.13 5.41 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.401 -0.187 . . . . 0.0 110.946 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.52 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 12.6 t70 -127.61 113.79 16.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.51 0.506 . . . . 0.0 110.78 -173.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.445 ' HG2' HD11 ' C' ' 47' ' ' ILE . 9.6 mmmm -118.25 158.56 24.93 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.454 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER -108.93 123.21 48.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.474 0.654 . . . . 0.0 110.557 179.049 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.49 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -113.06 166.4 11.46 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.078 -168.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.8 155.89 22.82 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.636 -1.269 . . . . 0.0 115.796 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -116.45 129.38 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.365 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.4 OUTLIER -127.61 99.73 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' C' ' 89' ' ' ILE . 7.4 p -84.11 125.77 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.645 -0.659 . . . . 0.0 109.967 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.49 26.21 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.878 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.41 4.45 76.98 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.977 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 35.9 tt0 -108.24 120.17 41.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.963 0.381 . . . . 0.0 110.609 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 27.6 ttpp -74.55 117.58 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.11 -30.23 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.023 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -137.39 144.63 42.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.49 HG21 ' O ' ' C' ' 54' ' ' TRP . 28.1 m -145.99 141.89 28.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' C' ' 75' ' ' ILE . 45.6 p90 -162.24 -170.65 2.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.407 ' OD1' ' HG2' ' C' ' 69' ' ' LYS . 48.7 t-20 -117.53 138.38 51.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.545 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' C' ' 47' ' ' ILE . 1.9 tt0 -72.84 -29.53 63.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.295 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.664 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 9.4 ptmt -86.66 11.65 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -76.91 -151.15 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.53 ' O ' HG12 ' C' ' 75' ' ' ILE . 18.0 p -106.92 112.24 25.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.024 -1.047 . . . . 0.0 108.984 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' C' ' 45' ' ' TYR . 6.8 t -59.39 -16.47 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.491 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.99 -46.49 7.67 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.094 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -66.79 -36.43 82.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.567 HG22 ' CD1' ' C' ' 66' ' ' PHE . 50.6 mm -68.01 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.542 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 13.5 m -70.59 -44.29 67.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -167.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.754 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -69.56 -17.62 63.58 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.951 -177.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 5.7 m-20 -64.56 -49.63 70.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 167.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' C' ' 76' ' ' SER . 81.1 mt -52.33 -32.64 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.291 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.754 HD21 ' ND2' ' C' ' 77' ' ' ASN . 62.9 m-20 -85.07 -36.3 21.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.37 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 56.6 mtmt -57.92 -30.55 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 109.788 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.3 mt -58.8 -27.98 65.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.577 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.702 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 41.77 82.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.895 0.855 . . . . 0.0 110.713 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.93 127.56 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.249 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -81.26 29.42 0.35 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.296 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.49 112.16 0.6 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.75 -14.16 10.23 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.054 . . . . 0.0 113.278 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -97.19 98.38 9.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' C' ' 58' ' ' VAL . 55.3 mt -125.48 132.68 70.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.5 0.667 . . . . 0.0 112.464 -168.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -90.29 97.37 11.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.127 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.477 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.1 tt -109.58 96.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 122.646 1.212 . . . . 0.0 107.983 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -152.97 177.32 10.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.263 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 163.53 13.11 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.882 174.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.454 HG12 ' O ' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.321 -166.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.424 ' HA ' ' HE2' ' C' ' 31' ' ' MET . 37.7 mt-30 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.014 0.435 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.403 ' O ' HG23 ' C' ' 13' ' ' ILE . 96.6 mmm -105.27 -144.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.175 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.45 -29.43 58.64 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -41.43 75.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 111.319 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.403 HG23 ' O ' ' C' ' 10' ' ' MET . 0.0 OUTLIER -90.62 -30.02 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.535 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.524 ' HA ' HD21 ' C' ' 17' ' ' ASN . 77.2 m-20 -72.68 -24.97 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.118 -0.364 . . . . 0.0 110.933 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -57.88 -36.79 72.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.401 HG12 ' O ' ' C' ' 91' ' ' ILE . 61.1 t -68.43 -32.76 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.524 HD21 ' HA ' ' C' ' 14' ' ' ASN . 8.2 m-80 -59.1 -38.4 79.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 109.97 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -70.36 -40.02 74.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.75 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -40.15 80.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.628 0.728 . . . . 0.0 109.734 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.586 HD21 ' CZ2' ' C' ' 54' ' ' TRP . 36.7 mt -67.19 -41.24 86.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.8 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . 0.438 ' OD1' ' HE2' ' C' ' 26' ' ' LYS . 28.1 m-80 -80.46 37.13 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.528 0.68 . . . . 0.0 110.603 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' C' ' 20' ' ' LEU . 18.3 pttm -48.25 -42.05 29.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.302 1.441 . . . . 0.0 112.84 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.7 -71.23 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -85.84 -166.83 1.64 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 163.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' C' ' 45' ' ' TYR . . . 41.54 74.73 0.15 Allowed Glycine 0 CA--C 1.488 -1.601 0 O-C-N 124.272 0.982 . . . . 0.0 114.515 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.769 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.8 mmpt? -89.14 78.41 7.38 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.974 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.539 ' HB3' HD13 ' C' ' 20' ' ' LEU . 10.8 tp -88.07 105.94 17.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.336 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -101.15 108.08 19.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.579 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -112.62 142.63 44.99 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.361 0.601 . . . . 0.0 112.088 -171.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -144.58 129.74 18.62 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.029 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.521 ' CG ' HD21 ' C' ' 36' ' ' LEU . 71.4 mtm -103.49 145.89 29.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -148.34 92.03 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.424 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.28 -93.45 0.29 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.989 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -108.63 15.02 24.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.598 0.199 . . . . 0.0 111.065 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.677 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.6 tt0 -134.05 139.28 45.89 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.598 0.713 . . . . 0.0 112.454 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.521 HD21 ' CG ' ' C' ' 31' ' ' MET . 3.2 tm? -128.31 120.68 27.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.689 169.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -132.49 139.59 48.01 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.408 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -151.1 145.91 25.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.846 -171.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 74.8 p -118.86 150.77 39.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.769 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 4.1 p -124.32 116.47 22.66 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.315 0.578 . . . . 0.0 111.087 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.673 ' H ' ' HB2' ' C' ' 26' ' ' LYS . 21.6 m -89.5 -178.93 5.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.813 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.02 42.83 15.32 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.822 0.701 . . . . 0.0 109.541 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.96 21.9 12.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.476 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.49 23.44 78.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.456 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.443 ' O ' ' HA2' ' C' ' 25' ' ' GLY . 33.2 m-85 -68.19 158.81 32.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.994 0.397 . . . . 0.0 110.722 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.75 -101.87 0.56 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.311 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.565 HD13 ' HB3' ' C' ' 68' ' ' GLU . 18.6 mt -107.6 -67.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.525 0.679 . . . . 0.0 110.42 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.7 p -176.16 -68.09 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.37 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -149.35 -32.94 0.21 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.413 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.553 ' O ' HD12 ' C' ' 47' ' ' ILE . 13.8 pt-20 -88.21 178.98 6.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.55 139.94 53.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.473 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 28.1 mmmt -115.72 157.35 24.41 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.744 ' ND2' HG13 ' C' ' 94' ' ' ILE . 10.6 t30 -98.3 105.11 17.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.396 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.586 ' CZ2' HD21 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.06 165.99 10.7 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.187 -172.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.46 159.35 28.25 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.602 -1.285 . . . . 0.0 115.318 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.549 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -121.14 128.45 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.773 174.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.1 m-85 -124.04 122.49 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 48.7 t -105.86 111.18 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 60.11 24.88 14.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.084 0.468 . . . . 0.0 110.052 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.14 16.81 58.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.862 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.6 OUTLIER -107.01 128.1 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 0.0 111.357 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -72.12 107.44 4.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 m -95.58 -31.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.365 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -159.35 147.88 17.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.497 HG23 ' O ' ' C' ' 54' ' ' TRP . 71.3 m -140.62 147.78 39.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.79 -173.76 2.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.459 0.572 . . . . 0.0 112.117 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 20.1 m120 -114.37 139.5 49.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.7 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.565 ' HB3' HD13 ' C' ' 47' ' ' ILE . 63.6 tt0 -68.12 -15.83 63.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 14.5 ptmm? -83.66 -5.52 59.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -70.54 159.94 33.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 9.5 p -74.33 112.31 10.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' C' ' 27' ' ' LEU . 2.6 t -58.36 -14.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.71 -170.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.71 -38.96 14.96 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.088 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -72.71 -34.59 67.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.75 -59.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.408 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 66.5 p -58.12 -58.56 7.92 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.125 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.777 ' ND2' HD21 ' C' ' 80' ' ' ASN . 1.1 m120 -67.95 -17.05 64.33 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -67.01 -48.21 69.08 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.497 ' HA ' ' CD1' ' C' ' 82' ' ' LEU . 75.2 mt -56.85 -32.64 39.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.902 174.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.777 HD21 ' ND2' ' C' ' 77' ' ' ASN . 41.7 m-20 -84.06 -22.1 31.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.393 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 67.8 mttm -62.71 -40.95 98.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.3 mt -54.88 -35.43 64.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.224 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.677 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.6 m120 44.08 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 -166.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.82 113.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.475 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.493 ' HZ1' ' HB3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -84.45 64.6 8.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.211 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.68 156.96 26.1 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.585 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.517 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.2 Cg_endo -80.49 -55.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.501 2.134 . . . . 0.0 112.531 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.517 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.0 p90 -124.05 132.86 53.73 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.498 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 64.7 mt -130.3 132.09 65.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.511 0.672 . . . . 0.0 111.889 -169.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 29.2 mm-40 -95.22 98.18 10.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.603 174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.549 HG13 HG13 ' C' ' 56' ' ' ILE . 7.7 tt -108.25 97.94 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 177.24 9.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.818 -168.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.23 163.61 12.67 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.637 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.744 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -165.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.593 0.235 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mtp -72.82 -145.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.3 m-20 -59.9 -16.52 30.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 31.3 t -46.34 -50.78 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.29 0.369 . . . . 0.0 111.317 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.415 HG22 ' HE1' ' C' ' 31' ' ' MET . 2.5 pp -91.27 -21.68 6.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.144 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 5.5 m-20 -63.97 -46.95 82.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.951 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' SER . . . . . 0.645 ' O ' ' HG2' ' C' ' 19' ' ' LYS . 42.6 t -55.42 -41.71 73.14 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.08 -34.5 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.575 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.57 -40.09 95.76 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -72.42 -27.4 62.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.869 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' C' ' 15' ' ' SER . 0.2 OUTLIER -79.82 -34.27 39.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.206 0.526 . . . . 0.0 110.14 -177.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' C' ' 27' ' ' LEU . 93.3 mt -80.21 -38.97 30.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.808 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -79.38 71.64 5.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.43 0.633 . . . . 0.0 109.557 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.474 ' HE3' ' CB ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -113.83 -13.73 12.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.162 -171.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 146.04 -73.21 0.32 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -174.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.474 ' CB ' ' HE3' ' C' ' 22' ' ' LYS . 2.3 mttp -72.17 -159.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -43.1 130.75 5.57 Favored Glycine 0 CA--C 1.512 -0.137 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.7 ptpt -132.05 142.87 49.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.985 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.529 ' HB2' HD11 ' C' ' 20' ' ' LEU . 4.1 mp -117.76 125.34 50.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 42.1 m -94.96 101.26 13.02 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.44 129.4 38.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.613 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -151.24 144.37 24.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.414 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.415 ' HE1' HG22 ' C' ' 13' ' ' ILE . 2.4 mpt? -105.36 146.22 29.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.34 . . . . 0.0 110.319 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -147.86 89.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.229 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.14 -101.43 0.19 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.037 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.81 34.14 2.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.738 0.78 . . . . 0.0 109.305 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.434 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 50.7 tt0 -140.9 139.9 34.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.379 0.609 . . . . 0.0 112.048 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -122.22 105.37 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 167.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.582 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 63.2 pttt -106.25 131.68 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 117.67 6.45 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.25 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 69.8 p -102.43 151.28 22.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.086 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.1 p -111.56 119.51 38.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.545 176.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 12.1 t -103.4 177.65 4.78 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.76 33.6 0.19 Allowed 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 124.619 1.199 . . . . 0.0 110.514 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.43 37.08 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.098 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.81 1.3 89.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.305 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -64.01 135.22 56.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.018 0.409 . . . . 0.0 110.359 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 150.67 50.75 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.777 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 40.6 mt -57.15 -54.56 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 121.872 0.844 . . . . 0.0 110.952 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -127.37 -173.72 2.98 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.063 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -132.52 13.9 4.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.96 0.886 . . . . 0.0 109.011 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' C' ' 52' ' ' LYS . 30.8 mt-10 -131.28 161.38 32.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.943 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.43 91.9 6.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 111.293 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 4.8 mptp? -94.37 144.67 25.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.575 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.2 102.02 14.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.656 0.598 . . . . 0.0 110.359 175.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.499 ' CZ3' HG23 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -105.11 159.28 15.97 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.5 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.459 ' C ' HD13 ' C' ' 56' ' ' ILE . . . -165.17 166.85 38.49 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 118.267 -1.92 . . . . 0.0 116.114 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.459 HD13 ' C ' ' C' ' 55' ' ' GLY . 2.3 mp -120.34 132.31 70.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.509 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 79.7 m-85 -120.84 111.44 17.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -93.76 115.21 32.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.69 34.33 23.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.003 0.43 . . . . 0.0 110.424 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.24 8.9 87.5 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.317 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 37.7 tt0 -107.92 126.96 53.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.281 0.541 . . . . 0.0 110.57 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -72.8 102.03 3.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.849 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.17 -46.57 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.264 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.51 149.43 50.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.472 HG21 ' O ' ' C' ' 54' ' ' TRP . 63.7 m -145.33 143.3 30.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -155.57 -174.95 5.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.796 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 11.6 m120 -128.37 140.99 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.869 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -67.53 -13.16 61.81 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -87.74 -6.17 58.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.021 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -83.69 177.84 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.332 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.47 ' O ' HG12 ' C' ' 75' ' ' ILE . 22.3 p -81.32 112.41 18.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.4 ' CG2' HG13 ' C' ' 47' ' ' ILE . 1.7 t -60.56 -14.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.229 -173.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.53 -38.25 12.67 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -73.89 -30.88 62.85 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.47 HG12 ' O ' ' C' ' 71' ' ' THR . 36.4 mm -67.48 -64.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.714 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.62 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 63.0 p -63.45 -58.26 7.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -169.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.527 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.0 m120 -72.73 -16.38 61.66 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -172.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.52 -41.32 97.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.62 ' HB ' ' O ' ' C' ' 76' ' ' SER . 85.6 mt -55.95 -25.44 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.123 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.5 OUTLIER -83.98 -32.19 25.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.233 -176.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.97 -38.5 76.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.0 -28.81 66.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.386 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.434 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 37.43 85.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.354 1.034 . . . . 0.0 111.567 -173.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.34 143.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.728 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 25.42 11.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.656 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.33 167.7 12.38 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.187 -172.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.618 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.7 Cg_endo -81.31 -72.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.835 2.357 . . . . 0.0 113.22 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.618 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 10.1 p90 -103.55 113.75 27.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.592 0.711 . . . . 0.0 109.993 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.74 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.618 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -91.49 98.35 11.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.411 0.624 . . . . 0.0 110.755 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.499 HG23 ' CZ3' ' C' ' 54' ' ' TRP . 5.0 mt -95.89 104.43 15.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -156.34 143.96 19.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 121.388 0.614 . . . . 0.0 111.602 -172.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 24.6 tm0? -66.0 140.41 58.29 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.872 174.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.575 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.76 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.236 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.639 0.257 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 37.9 mtm -80.14 -144.83 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 110.799 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.8 m-20 -61.45 -17.84 56.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.476 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -52.59 -46.28 66.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.6 pt -89.15 -26.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.81 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.435 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 79.2 m-20 -65.62 -37.15 85.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 47.7 t -54.68 -41.52 70.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 57.4 t -66.21 -37.17 79.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.403 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -67.75 -33.31 74.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.574 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -80.11 -18.7 49.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.671 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -90.61 -38.7 12.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 68.4 mt -80.17 -36.42 35.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.033 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -81.51 74.87 8.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.638 ' NZ ' HG21 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -111.5 -23.01 10.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.858 -172.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.61 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 165.12 -79.99 0.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.648 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 10.3 mttt -73.81 -159.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.33 141.54 1.15 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 -173.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.4 ptpt -149.95 140.17 22.19 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.057 -167.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 6.1 tt -108.39 125.48 51.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.393 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 20.8 m -104.16 123.86 48.05 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.452 ' N ' HD13 ' C' ' 29' ' ' LEU . 5.0 mp -94.58 134.16 37.43 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' C' ' 37' ' ' LYS . 7.0 t -159.59 142.39 13.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.727 170.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 137.98 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.816 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -136.95 89.8 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.767 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.16 -93.31 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.13 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -114.74 31.01 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.175 0.512 . . . . 0.0 110.216 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.671 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 17.1 tt0 -143.98 124.48 13.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -171.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.02 104.93 16.9 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 166.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -100.26 146.74 26.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 118.52 6.78 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.594 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.5 p -99.07 141.47 31.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.916 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 21.7 p -116.93 118.9 33.71 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.069 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.541 ' HB2' ' CD ' ' C' ' 26' ' ' LYS . 45.0 m -91.97 176.42 6.52 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.246 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.5 m120 72.19 36.12 1.15 Allowed 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.261 0.976 . . . . 0.0 109.424 -169.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.63 35.42 26.08 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.476 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.36 79.87 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.274 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 24.0 m-85 -69.69 -179.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.063 0.459 . . . . 0.0 110.872 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.35 169.9 32.21 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.162 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.638 HG21 ' NZ ' ' C' ' 22' ' ' LYS . 47.3 mm -54.04 -64.46 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 121.816 0.817 . . . . 0.0 110.907 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.8 t -174.9 -155.67 0.06 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.087 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -87.81 -15.99 35.32 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.29 0.567 . . . . 0.0 110.257 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 43.2 mt-10 -83.43 127.79 33.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.438 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.79 139.05 31.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -125.52 158.63 34.04 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.493 ' O ' HG13 ' C' ' 94' ' ' ILE . 2.2 p-10 -97.17 103.87 15.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.722 0.772 . . . . 0.0 109.591 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.616 ' O ' HG21 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.18 156.36 17.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.811 -171.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -139.98 132.8 5.71 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 119.459 -1.353 . . . . 0.0 115.582 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.405 HG22 ' CG1' ' C' ' 63' ' ' VAL . 3.0 mp -120.63 126.6 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.069 -0.565 . . . . 0.0 109.487 170.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.74 137.87 47.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.425 HG23 HG12 ' C' ' 63' ' ' VAL . 65.0 t -101.5 117.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 15.5 m120 56.71 30.37 17.47 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.351 0.407 . . . . 0.0 111.243 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 6.96 73.85 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.053 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -107.73 119.91 40.77 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.532 -0.393 . . . . 0.0 110.578 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -57.91 119.06 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.162 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.425 HG12 HG23 ' C' ' 58' ' ' VAL . 4.3 p -119.52 -43.01 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.981 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -137.07 152.39 49.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.616 HG21 ' O ' ' C' ' 54' ' ' TRP . 85.3 m -145.61 148.02 32.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' C' ' 75' ' ' ILE . 45.9 p90 -155.83 172.37 18.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.699 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.62 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.516 ' O ' HG12 ' C' ' 47' ' ' ILE . 4.2 tt0 -52.68 -40.11 62.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.688 -169.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 20.1 pttp -72.91 -0.84 14.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -169.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -71.32 -176.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.2 p -74.23 108.91 7.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 t -60.57 -11.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.951 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.24 -38.35 8.49 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.0 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -74.17 -28.79 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' C' ' 66' ' ' PHE . 50.7 mm -73.77 -64.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.083 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.581 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 8.6 m -60.71 -48.73 80.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.991 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.494 HD21 ' CG ' ' C' ' 80' ' ' ASN . 7.7 m120 -75.6 -15.5 60.34 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.517 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.1 OUTLIER -59.46 -44.85 92.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 166.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' C' ' 76' ' ' SER . 76.6 mt -56.42 -23.27 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.175 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -87.48 -34.39 18.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.106 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' C' ' 78' ' ' ASP . 57.7 mtmt -55.87 -38.89 70.73 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 1.6 mt -60.14 -29.45 68.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.142 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.671 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.66 86.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.275 -170.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.14 99.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.438 -169.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -64.77 125.84 26.07 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.411 162.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 162.79 158.68 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.911 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.562 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.0 Cg_endo -81.15 -62.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.454 2.102 . . . . 0.0 112.585 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.562 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 16.0 p90 -128.37 137.72 52.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.992 0.425 . . . . 0.0 110.166 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.4 mt -122.34 136.45 59.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.97 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -92.2 99.91 12.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.498 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 30.0 mm -113.89 98.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.06 160.73 6.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.36 173.12 12.66 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.831 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.493 HG13 ' O ' ' C' ' 53' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.424 -175.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 54.1 mtt -68.49 -150.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.925 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -60.35 -9.52 3.63 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' SER . . . . . 0.419 ' O ' HG21 ' C' ' 16' ' ' VAL . 15.3 m -48.89 -49.87 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.673 0.389 . . . . 0.0 111.353 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.43 -18.81 7.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.212 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -69.24 -46.16 68.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -56.3 -34.69 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.477 0.656 . . . . 0.0 109.481 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.419 HG21 ' O ' ' C' ' 12' ' ' SER . 93.9 t -69.43 -37.18 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -63.39 -46.7 85.25 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 110.514 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.6 -19.86 65.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.589 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -90.15 -40.22 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.09 0.471 . . . . 0.0 110.378 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.1 mt -83.22 -32.31 26.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.304 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -92.8 79.06 4.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.358 0.599 . . . . 0.0 109.431 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.58 ' NZ ' HG21 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -114.17 -30.69 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.948 -170.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 173.1 -73.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.623 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 54.7 mttp -71.25 -158.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.538 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -45.6 142.47 4.18 Favored Glycine 0 CA--C 1.497 -1.085 0 O-C-N 123.357 0.411 . . . . 0.0 113.547 -177.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.9 ptpt -144.35 150.08 37.2 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.834 -165.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' C' ' 38' ' ' ALA . 0.5 OUTLIER -122.84 113.33 19.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.82 -170.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 74.0 m -103.03 126.2 50.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' C' ' 91' ' ' ILE . 0.7 OUTLIER -98.98 137.76 37.05 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -171.347 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 29.1 m -147.25 130.85 16.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.511 171.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.489 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.7 mtt -122.68 138.67 54.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.329 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -148.68 91.2 1.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.11 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.26 -93.61 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.706 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -108.81 33.17 4.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 109.774 -177.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.739 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.0 tt0 -149.72 139.55 21.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.526 0.679 . . . . 0.0 112.525 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.489 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.4 tm? -118.39 127.58 53.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 167.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 23.6 pttm -130.38 105.78 8.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' C' ' 27' ' ' LEU . . . -111.94 128.25 56.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.4 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -103.48 148.75 25.55 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.073 0.463 . . . . 0.0 110.41 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 64.9 p -119.41 138.25 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.338 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 14.7 m -117.35 179.49 4.03 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 80.18 23.41 0.42 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.424 1.078 . . . . 0.0 111.197 -176.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.4 50.06 13.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.393 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -3.36 86.72 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.59 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.9 m-85 -66.07 152.88 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.862 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.11 163.18 31.53 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.194 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.58 HG21 ' NZ ' ' C' ' 22' ' ' LYS . 34.3 mm -51.55 -63.24 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.16 0.981 . . . . 0.0 111.169 177.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -156.98 -176.52 6.02 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.492 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.39 45.76 1.48 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.584 0.707 . . . . 0.0 109.792 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -140.85 145.23 35.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.102 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.69 114.28 16.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 12.4 mptt -126.37 129.95 49.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.739 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.532 HD21 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -89.24 99.19 12.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.945 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.667 ' O ' HG22 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.874 -175.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.18 167.27 40.42 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.832 -1.651 . . . . 0.0 115.649 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.503 HG12 HG13 ' C' ' 91' ' ' ILE . 87.1 mt -125.99 128.2 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.582 -0.809 . . . . 0.0 111.697 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.7 m-85 -123.03 111.26 16.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.207 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -104.86 128.05 58.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.466 ' HA ' ' CE1' ' C' ' 88' ' ' TYR . 77.0 m-20 54.69 24.71 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.817 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 27.7 29.27 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.543 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.9 pt-20 -143.82 151.13 39.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.292 0.546 . . . . 0.0 110.108 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -82.86 137.86 34.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.78 -32.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -161.9 135.83 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.084 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.667 HG22 ' O ' ' C' ' 54' ' ' TRP . 79.3 m -124.07 142.52 51.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.401 ' CD2' HD11 ' C' ' 75' ' ' ILE . 38.4 p90 -152.72 -178.01 6.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.594 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 13.9 m120 -124.89 130.44 52.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.048 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.491 ' HG2' HG13 ' C' ' 47' ' ' ILE . 31.2 mt-10 -62.89 -22.55 66.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.57 2.04 27.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.443 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -87.01 -179.64 6.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 23.3 p -77.7 118.19 19.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' C' ' 75' ' ' ILE . 2.1 t -64.53 -12.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.8 -41.4 9.74 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.122 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.61 -34.34 78.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.435 ' O ' HG13 ' C' ' 79' ' ' ILE . 74.2 mt -65.45 -68.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.462 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.58 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 3.4 m -56.42 -56.17 24.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.495 HD21 ' ND2' ' C' ' 80' ' ' ASN . 10.2 m120 -76.43 -15.08 60.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.88 -39.64 83.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 166.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' C' ' 76' ' ' SER . 71.7 mt -58.94 -25.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.79 173.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.495 ' ND2' HD21 ' C' ' 77' ' ' ASN . 7.2 m-20 -80.51 -34.16 35.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.61 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -56.53 -38.37 71.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.3 mt -55.81 -35.9 66.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.084 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.739 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 8.1 m120 37.61 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.94 0.775 . . . . 0.0 110.824 -168.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.42 137.82 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.733 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.3 OUTLIER -94.88 113.89 25.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.086 174.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.61 148.82 6.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.367 -1.397 . . . . 0.0 112.929 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.536 ' HG2' ' CD2' ' C' ' 88' ' ' TYR . 98.2 Cg_endo -80.85 -43.81 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.772 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.536 ' CD2' ' HG2' ' C' ' 87' ' ' PRO . 31.8 p90 -123.68 129.65 51.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.475 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 77.1 mt -123.29 123.72 68.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.505 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -92.25 115.08 27.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.528 HG12 ' CH2' ' C' ' 54' ' ' TRP . 15.5 tt -115.98 103.25 14.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.978 0.894 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 159.26 22.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.567 -172.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.4 OUTLIER -90.81 163.04 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.34 0.59 . . . . 0.0 111.077 176.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.532 HG13 HD21 ' C' ' 53' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.808 -167.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mmm -58.6 163.05 3.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.87 -21.54 30.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.091 -165.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -52.19 -42.38 63.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.033 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.09 -32.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.009 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.558 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 11.7 m120 -64.7 -43.75 92.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.707 0.289 . . . . 0.0 111.662 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 -22.55 63.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 50.4 t -85.7 -33.07 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.262 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 12.8 m120 -57.1 -48.0 79.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.22 -16.31 56.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.856 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -80.46 -42.19 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.01 -36.63 75.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.8 76.12 7.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.721 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.579 ' HZ1' HD12 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -118.53 7.34 11.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.12 -68.65 0.54 Allowed Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.515 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.416 ' HB3' ' H ' ' C' ' 25' ' ' GLY . 37.7 mttp -82.16 -160.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.563 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.61 137.88 2.34 Favored Glycine 0 CA--C 1.497 -1.06 0 O-C-N 123.846 0.716 . . . . 0.0 114.863 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.576 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 11.9 ptpt -147.2 162.1 39.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.767 -168.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.424 HD22 HD12 ' C' ' 29' ' ' LEU . 0.6 OUTLIER -138.92 130.08 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.705 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 16.3 t -106.03 106.13 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.486 HD23 HD21 ' C' ' 17' ' ' ASN . 2.2 mm? -92.61 132.14 37.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.241 0.217 . . . . 0.0 111.36 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.1 m -145.91 129.65 17.15 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.747 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.483 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 62.1 mtm -129.31 129.17 44.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.051 -174.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.679 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 4.3 t-20 -150.96 107.01 3.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.165 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.8 -97.26 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.502 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.38 30.21 6.88 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.389 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 11.1 pt20 -126.7 129.65 48.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.325 0.583 . . . . 0.0 111.562 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.6 tm? -130.76 127.14 38.15 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.627 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -144.04 128.94 18.44 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -145.77 118.73 8.75 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.679 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 48.8 p -102.88 152.05 21.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.716 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.56 ' OG ' ' HB ' ' C' ' 72' ' ' VAL . 40.2 t -117.36 118.08 31.27 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 30.7 t -96.98 178.06 5.41 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.88 32.29 0.51 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 124.284 0.99 . . . . 0.0 109.16 -167.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.33 31.66 20.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.214 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.75 80.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.76 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -69.54 168.79 13.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.739 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.37 -175.62 43.37 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.277 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.589 HG12 ' O ' ' C' ' 68' ' ' GLU . 15.3 mm -64.63 -61.74 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.2 t -170.11 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.01 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -157.49 -45.83 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -77.24 150.81 35.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.986 0.422 . . . . 0.0 111.06 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -97.82 126.74 43.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.45 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -111.5 157.36 20.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.439 HD21 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -96.16 112.69 24.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.547 0.689 . . . . 0.0 110.858 178.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.617 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.4 166.56 10.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.351 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.86 150.91 21.16 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.305 -1.426 . . . . 0.0 115.81 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 49.6 mt -124.55 136.06 61.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.985 169.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.425 ' O ' HG21 ' C' ' 89' ' ' ILE . 3.9 m-85 -131.19 134.46 46.52 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.406 HG23 HG12 ' C' ' 63' ' ' VAL . 85.6 t -102.41 114.96 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.16 31.08 19.41 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.337 0.398 . . . . 0.0 111.333 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.9 5.38 73.89 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.307 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.57 126.01 52.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.047 0.424 . . . . 0.0 110.187 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.01 126.07 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.619 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.406 HG12 HG23 ' C' ' 58' ' ' VAL . 1.7 p -120.36 -37.29 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -148.47 152.73 37.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.596 0.236 . . . . 0.0 110.743 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.617 HG23 ' O ' ' C' ' 54' ' ' TRP . 33.2 m -140.54 146.01 37.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.86 -177.86 6.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.23 0.468 . . . . 0.0 111.399 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.04 135.73 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.589 ' O ' HG12 ' C' ' 47' ' ' ILE . 1.3 tt0 -60.1 -47.16 87.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.805 -173.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.8 -2.89 10.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.6 m -71.01 -174.87 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 4.6 p -77.98 104.19 8.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.56 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 2.9 t -60.36 -12.11 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.898 -173.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' C' ' 76' ' ' SER . . . -87.71 -29.12 22.12 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.821 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -81.15 -28.45 35.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.13 -52.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.708 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.638 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.1 p -53.98 -60.79 2.86 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.054 -175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.561 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -70.48 -16.98 62.97 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.694 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 1.3 m-20 -62.68 -41.15 98.94 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 166.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.5 mt -57.83 -22.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.291 175.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -83.82 -38.99 20.52 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.677 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 18.5 ptmt -62.56 -27.77 69.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.78 -31.67 66.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.55 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 37.19 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.083 1.489 . . . . 0.0 113.335 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' C' ' 34' ' ' ASN . 1.6 tp -42.08 145.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.111 -174.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -149.59 18.6 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.613 0.721 . . . . 0.0 109.164 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.85 162.19 14.2 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.768 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.27 -35.39 0.65 Allowed 'Trans proline' 0 CA--C 1.518 -0.284 0 C-N-CA 122.652 2.234 . . . . 0.0 111.487 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -158.81 132.36 7.45 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.834 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.425 HG21 ' O ' ' C' ' 57' ' ' PHE . 70.1 mt -134.81 139.27 47.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.433 -173.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 23.8 mm-40 -91.2 103.49 16.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.96 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 mm -100.75 96.23 4.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -158.56 167.75 28.76 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.467 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 1.9 pt20 -100.25 162.35 13.01 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.402 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.439 HG13 HD21 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 -163.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 . . . . . 0 N--CA 1.461 0.107 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 5.8 mmt -65.04 -171.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -43.31 -36.69 1.94 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.487 0.715 . . . . 0.0 112.841 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 55.2 m -43.04 -54.01 4.54 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.835 0.709 . . . . 0.0 111.918 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -91.12 -19.82 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.549 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.03 -47.78 64.54 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.73 0.3 . . . . 0.0 110.748 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 26.9 p -57.3 -34.45 68.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.79 -37.39 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.58 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.15 -39.29 82.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.169 0.509 . . . . 0.0 109.843 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -78.33 -18.12 55.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.407 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -90.1 -42.58 11.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.676 0.274 . . . . 0.0 110.423 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.08 -32.01 68.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.48 71.07 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.519 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -109.21 -40.55 4.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.519 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -175.07 -68.98 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.675 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.6 ttmm -97.06 -174.59 3.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 166.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' C' ' 24' ' ' LYS . . . 30.73 89.92 0.01 OUTLIER Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.0 ptpt -128.68 125.34 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.579 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.445 HD23 ' HG ' ' C' ' 29' ' ' LEU . 1.5 tt -107.2 115.42 30.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.232 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 18.3 t -86.16 113.94 22.6 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.445 ' HG ' HD23 ' C' ' 27' ' ' LEU . 0.2 OUTLIER -112.72 123.14 49.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.652 0.263 . . . . 0.0 110.823 -173.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 12.5 p -151.43 142.71 23.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.674 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.45 135.44 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.326 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.626 ' OD1' ' HE3' ' C' ' 37' ' ' LYS . 11.9 m120 -139.25 91.68 2.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.564 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.74 -94.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.472 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.25 30.3 7.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.747 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.752 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.3 tt0 -143.64 138.9 29.3 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 2.8 tm? -106.2 106.38 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 164.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.626 ' HE3' ' OD1' ' C' ' 32' ' ' ASN . 22.3 pttp -98.93 151.45 20.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.68 141.57 22.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.396 0.617 . . . . 0.0 112.299 -173.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.4 p -121.44 146.94 46.39 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.903 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 m -127.8 117.12 21.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.4 m -101.94 177.67 4.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.474 -176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.589 ' OD1' ' HG3' ' C' ' 24' ' ' LYS . 0.3 OUTLIER 65.75 42.82 3.38 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.219 0.95 . . . . 0.0 108.859 -167.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 63.39 21.5 12.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.266 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.38 24.38 76.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.701 -0.762 . . . . 0.0 113.33 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.5 ' O ' HG21 ' C' ' 72' ' ' VAL . 35.2 m-85 -80.21 -179.01 6.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.83 0.315 . . . . 0.0 111.249 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.17 -162.64 38.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.324 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.675 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 6.8 mt -49.59 -67.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 112.118 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.6 p 173.57 -73.7 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.976 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -140.67 -16.08 0.91 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.816 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.66 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 4.8 pt-20 -99.43 173.88 6.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.09 121.85 40.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.135 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -124.13 135.44 53.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 111.198 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.714 ' ND2' HG13 ' C' ' 94' ' ' ILE . 9.0 t30 -89.08 116.49 27.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.684 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.547 ' O ' HG22 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.2 163.39 13.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.0 147.22 8.86 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.327 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.523 HG13 HG13 ' C' ' 91' ' ' ILE . 2.6 mp -107.63 129.84 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.067 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 52.9 m-85 -129.94 122.2 28.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.534 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' C' ' 63' ' ' VAL . 4.6 p -108.88 117.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 60.19 28.01 17.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.129 0.49 . . . . 0.0 110.462 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.9 16.46 79.91 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.388 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 30.5 mt-10 -107.06 147.56 29.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.617 0.722 . . . . 0.0 111.064 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.537 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 41.9 tptt -81.77 120.53 25.27 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.037 -169.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.42 ' CG2' HG13 ' C' ' 58' ' ' VAL . 41.2 t -109.71 -70.16 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.923 0.392 . . . . 0.0 110.929 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -137.89 143.66 40.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.909 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.547 HG22 ' O ' ' C' ' 54' ' ' TRP . 67.7 m -136.15 143.21 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' C' ' 75' ' ' ILE . 44.3 p90 -159.75 -172.61 3.74 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -116.91 137.39 52.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.85 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' C' ' 47' ' ' ILE . 0.7 OUTLIER -71.36 -28.68 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.44 -172.174 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.66 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 13.2 ptmm? -93.14 19.22 8.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.844 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 p -76.15 -119.97 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -131.7 107.66 8.95 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 166.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.5 HG21 ' O ' ' C' ' 45' ' ' TYR . 20.7 t -55.96 -24.33 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.043 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.31 -31.34 42.32 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.525 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.22 -33.96 67.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.584 HG22 ' CD1' ' C' ' 66' ' ' PHE . 27.5 mm -78.39 -54.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.158 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.653 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 64.3 p -53.61 -52.61 59.29 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.437 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.475 HD21 ' CG ' ' C' ' 80' ' ' ASN . 7.3 m120 -77.48 -16.44 58.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -64.35 -37.89 89.09 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' C' ' 76' ' ' SER . 82.4 mt -60.31 -22.27 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.979 173.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -81.31 -34.49 31.88 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.545 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -53.13 -41.97 65.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.1 mt -58.83 -30.32 67.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.821 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.752 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.21 85.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.153 0.908 . . . . 0.0 111.227 -170.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 17.2 mm -55.06 138.54 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -169.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.27 170.51 9.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.029 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.34 173.34 15.44 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.352 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.477 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.3 Cg_endo -80.71 -47.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.487 2.125 . . . . 0.0 112.094 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.477 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 44.1 p90 -150.29 141.54 23.2 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.16 132.67 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.496 . . . . 0.0 111.022 -172.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -91.83 98.71 11.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.558 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.523 HG13 HG13 ' C' ' 56' ' ' ILE . 13.8 tt -101.13 99.06 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 173.38 17.06 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.348 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 158.86 16.37 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.934 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.714 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 -166.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 22.2 mmt -70.4 -162.95 0.06 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.421 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -52.26 -23.34 5.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.051 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -49.47 -43.93 45.51 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.148 0.28 . . . . 0.0 110.968 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.422 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 6.7 mt -88.7 -23.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.221 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.04 -49.0 49.65 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.931 -0.48 . . . . 0.0 110.672 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -57.98 -32.54 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.797 0.808 . . . . 0.0 109.429 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' C' ' 13' ' ' ILE . 2.2 t -67.99 -39.29 81.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.915 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.67 -36.44 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.333 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -77.3 -20.17 55.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.665 176.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.19 -34.25 61.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.951 0.881 . . . . 0.0 108.886 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' C' ' 26' ' ' LYS . 49.6 mt -78.05 -40.26 39.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.616 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.11 82.58 4.18 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.624 ' NZ ' HG21 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -5.8 9.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.55 -75.77 0.23 Allowed Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.842 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.6 ttmt -87.36 -156.85 0.36 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.445 ' O ' HD12 ' C' ' 47' ' ' ILE . . . -18.78 106.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.563 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 0.5 OUTLIER -114.08 171.68 7.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.847 -175.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' C' ' 39' ' ' THR . 3.3 tt -156.74 115.47 3.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -173.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 69.3 m -93.9 127.5 39.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.456 ' CD2' HD11 ' C' ' 91' ' ' ILE . 86.7 mt -97.62 139.01 34.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -176.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -148.43 128.12 13.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.826 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.439 ' HG3' HD22 ' C' ' 36' ' ' LEU . 2.9 mpp? -116.7 133.18 56.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.88 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' C' ' 35' ' ' GLN . 5.2 p-10 -149.0 90.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.234 0.54 . . . . 0.0 111.653 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.24 -93.58 0.04 OUTLIER Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.556 173.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -105.71 32.36 4.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 110.494 -176.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.608 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.1 tt0 -150.18 142.01 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.439 HD22 ' HG3' ' C' ' 31' ' ' MET . 3.0 tm? -122.93 116.98 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.494 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 17.3 pttm -123.47 144.81 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -146.05 167.64 22.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.345 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 68.5 p -139.77 143.45 36.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.447 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 68.1 m -127.72 117.43 21.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.129 0.49 . . . . 0.0 109.688 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.563 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 67.9 m -100.81 179.56 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.7 m120 69.57 45.48 0.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 124.299 0.999 . . . . 0.0 109.026 -164.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.65 23.63 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.81 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' C' ' 71' ' ' THR . . . 69.38 21.69 76.06 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.949 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.75 -178.86 1.01 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.207 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.58 159.5 53.15 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.095 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 32.5 mm -52.31 -60.04 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-O 121.516 0.674 . . . . 0.0 111.067 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' C' ' 49' ' ' TYR . 45.5 t -135.62 -84.72 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.875 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.521 ' HB3' ' O ' ' C' ' 48' ' ' SER . 34.1 p90 179.59 -22.88 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.573 ' CG ' ' HE3' ' C' ' 52' ' ' LYS . 0.4 OUTLIER -97.8 172.63 7.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.377 0.608 . . . . 0.0 111.373 -178.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.81 107.18 19.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.813 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.573 ' HE3' ' CG ' ' C' ' 50' ' ' GLU . 27.0 mmtp -120.57 154.24 35.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.855 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' C' ' 93' ' ' GLN . 0.8 OUTLIER -89.25 101.85 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.917 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.495 ' O ' HG22 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.43 159.76 15.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.724 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.402 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -158.09 153.75 24.9 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 118.191 -1.957 . . . . 0.0 116.434 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.412 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.5 mp -120.84 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.172 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.432 ' CE2' ' HG2' ' C' ' 62' ' ' LYS . 36.2 m-85 -126.8 156.34 41.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.2 113.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 110.053 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 54.42 39.39 30.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.535 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.78 -3.62 86.01 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.336 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 148.14 28.99 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.432 ' HG2' ' CE2' ' C' ' 57' ' ' PHE . 53.5 mtpt -91.74 137.93 31.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.991 0.424 . . . . 0.0 110.813 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.93 -50.77 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.077 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -150.49 152.34 34.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.484 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.495 HG22 ' O ' ' C' ' 54' ' ' TRP . 89.2 m -128.07 126.87 42.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.528 ' CG ' HG23 ' C' ' 75' ' ' ILE . 11.5 p90 -133.18 178.49 6.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.031 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 28.6 m-80 -121.77 142.04 50.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.691 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' C' ' 47' ' ' ILE . 5.4 mt-10 -65.24 -10.8 34.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.34 -2.52 52.01 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.26 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -88.29 157.72 18.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' C' ' 44' ' ' GLY . 30.9 p -76.72 113.07 13.97 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -16.22 7.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.185 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.62 -36.32 38.2 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.953 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -77.07 -31.06 55.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.528 HG23 ' CG ' ' C' ' 66' ' ' PHE . 49.5 mm -75.16 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.26 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.627 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 96.6 p -58.76 -50.71 72.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -171.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.497 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.1 m120 -79.33 -17.34 54.73 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -172.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -34.47 74.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.606 167.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' C' ' 76' ' ' SER . 91.6 mt -61.1 -20.83 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.978 173.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.9 OUTLIER -76.01 -43.48 44.02 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.875 179.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -51.87 -38.06 54.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.525 0.679 . . . . 0.0 109.512 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.581 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.6 mt -55.96 -33.1 64.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.885 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.608 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 38.0 79.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.928 0.768 . . . . 0.0 111.201 -172.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.07 136.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.403 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 1.4 ptpt -81.96 39.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.677 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.65 128.15 9.48 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.027 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.39 -40.31 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.263 1.975 . . . . 0.0 110.851 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.78 97.85 5.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -103.45 124.4 57.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.531 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.78 100.75 9.18 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.026 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.456 HD11 ' CD2' ' C' ' 29' ' ' LEU . 4.5 mt -95.19 98.63 8.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.12 149.55 24.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.193 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 53' ' ' ASN . 6.6 tt0 -73.8 144.41 45.57 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.641 -176.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.455 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.599 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.601 ' HG2' ' SD ' ' C' ' 31' ' ' MET . 11.1 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.426 ' O ' HG13 ' C' ' 13' ' ' ILE . 1.5 mpt? -82.95 -143.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -53.44 -18.93 3.03 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' SER . . . . . 0.469 ' O ' HG22 ' C' ' 16' ' ' VAL . 68.9 m -54.44 -33.24 59.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.493 HG23 ' SD ' ' C' ' 31' ' ' MET . 2.4 pp -89.55 -27.79 5.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.987 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -73.31 -43.65 60.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.689 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -58.25 -33.46 69.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.348 0.594 . . . . 0.0 109.448 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 76.3 t -74.13 -34.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.252 175.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.465 HD22 ' HB2' ' C' ' 29' ' ' LEU . 7.7 m-80 -58.99 -40.29 84.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -75.39 -15.85 60.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.358 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -87.93 -31.58 19.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.487 0.66 . . . . 0.0 109.578 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 79.4 mt -82.94 -39.87 20.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.559 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -77.14 64.41 2.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 109.597 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -103.58 7.95 37.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.211 -172.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.42 -61.87 0.64 Allowed Glycine 0 CA--C 1.504 -0.613 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.722 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 26.9 mmmt -79.28 -159.47 0.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.105 175.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -48.71 143.38 8.01 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 121.568 -0.349 . . . . 0.0 113.652 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.722 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 5.8 ptpt -150.44 135.8 17.97 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.455 -164.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.6 mp -92.04 126.92 37.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.881 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 23.8 m -95.65 99.5 11.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' C' ' 17' ' ' ASN . 16.2 mt -82.58 126.2 32.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 46.9 t -146.4 129.19 16.25 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.601 ' SD ' ' HG2' ' C' ' 9' ' ' GLN . 0.5 OUTLIER -113.25 124.04 51.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.47 91.08 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.56 -99.43 0.25 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.115 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.88 13.28 29.29 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.947 0.374 . . . . 0.0 111.147 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.689 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.4 tt0 -136.77 147.26 46.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.617 0.722 . . . . 0.0 112.189 -170.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.426 HD13 ' HG3' ' C' ' 31' ' ' MET . 9.6 tp -130.78 113.56 14.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.885 171.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 19.7 pttp -122.9 104.53 9.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -112.37 118.9 36.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.159 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 42.1 p -97.09 148.06 23.4 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.271 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 67.1 p -109.66 119.46 39.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.487 -175.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.439 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 18.4 t -95.19 175.62 6.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.425 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 4.4 m-20 63.21 31.39 15.6 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.679 0.612 . . . . 0.0 110.32 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.96 10.54 7.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.789 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.1 24.76 28.56 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.167 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.547 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 52.5 m-85 -72.43 -179.24 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.578 0.689 . . . . 0.0 110.31 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.46 -157.62 29.73 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.332 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.544 ' H ' ' HA ' ' C' ' 69' ' ' LYS . 75.7 mt -49.9 -65.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 C-N-CA 123.265 0.626 . . . . 0.0 111.125 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 27.5 t 173.25 -72.68 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.898 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -140.95 -32.51 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.71 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.476 ' O ' HD13 ' C' ' 47' ' ' ILE . 12.7 pt-20 -85.07 177.6 7.85 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.183 -0.323 . . . . 0.0 110.754 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.448 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 27.8 t70 -123.78 141.95 51.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 32.6 mmtm -124.02 153.15 41.74 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.759 173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -98.88 112.6 24.65 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.454 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.576 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -102.53 162.08 13.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.691 -173.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.99 150.51 21.13 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.653 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.477 HG12 HG13 ' C' ' 91' ' ' ILE . 46.5 mt -120.21 135.23 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 170.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' C' ' 62' ' ' LYS . 58.0 m-85 -133.07 148.88 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.6 p -143.56 129.98 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.38 27.96 12.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.132 0.491 . . . . 0.0 111.171 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 1.35 81.39 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.829 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 11.6 pt-20 -112.57 157.33 21.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.642 0.721 . . . . 0.0 110.426 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.422 ' HG2' ' CE1' ' C' ' 57' ' ' PHE . 60.4 mtpt -76.85 131.65 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.68 -49.61 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.346 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -157.0 161.79 39.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.823 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -145.85 159.72 42.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.1 p90 -168.72 -178.41 3.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.0 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -119.89 121.97 40.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.712 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' C' ' 47' ' ' ILE . 43.6 tp10 -61.0 -22.73 64.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.544 ' HA ' ' H ' ' C' ' 47' ' ' ILE . 22.8 ptmt -85.22 4.89 32.6 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.906 -0.496 . . . . 0.0 111.77 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -75.29 -118.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.423 ' O ' HG12 ' C' ' 75' ' ' ILE . 1.5 p -131.22 108.07 9.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 169.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.489 HG22 ' O ' ' C' ' 45' ' ' TYR . 48.0 t -56.72 -22.23 15.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.667 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . 0.48 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.8 -39.17 25.42 Favored Glycine 0 CA--C 1.504 -0.644 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.417 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -68.68 -40.42 80.11 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.472 HG21 ' CD1' ' C' ' 66' ' ' PHE . 48.3 mm -64.79 -63.62 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 50.4 m -53.64 -63.72 1.06 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -169.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.804 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -70.09 -16.78 63.18 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.466 -0.893 . . . . 0.0 113.289 -171.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.631 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 35.8 m-20 -73.75 -37.0 65.2 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.6 168.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 89.4 mt -60.09 -32.59 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.743 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.804 HD21 ' ND2' ' C' ' 77' ' ' ASN . 32.0 m-20 -85.38 -34.39 21.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.052 -172.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 56.4 pttt -57.81 -26.99 62.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 16.4 mt -61.32 -25.73 67.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.767 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.689 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 40.12 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.898 0.856 . . . . 0.0 111.949 -172.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.2 113.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.648 -169.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.456 ' H ' ' HE3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -93.21 119.63 32.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.128 174.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.47 147.99 6.58 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.65 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.46 -37.45 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.285 1.99 . . . . 0.0 111.825 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.3 98.87 6.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -99.76 125.86 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.553 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -122.82 123.64 41.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.862 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.576 HG12 ' CH2' ' C' ' 54' ' ' TRP . 20.1 tt -129.43 99.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 151.56 25.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.447 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -85.65 163.89 18.02 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.946 176.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.332 -164.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 61.0 mtm -87.81 -144.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 18.5 m120 -61.67 -9.02 5.28 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.4 m -49.77 -44.9 49.09 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.13 0.269 . . . . 0.0 110.634 175.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.411 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 21.5 pt -90.85 -24.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.163 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.485 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 2.2 m-20 -64.97 -36.34 84.1 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.921 0.391 . . . . 0.0 110.119 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 37.1 t -55.37 -35.91 65.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.532 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 76.1 t -71.29 -37.53 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.181 174.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' C' ' 28' ' ' SER . 33.4 m-80 -65.88 -47.08 76.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.765 -177.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -68.68 -17.17 64.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.324 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -90.33 -38.2 13.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.266 0.555 . . . . 0.0 110.466 -176.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 55.9 mt -86.57 -26.92 24.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -80.32 84.63 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.485 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -120.7 -40.43 2.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.411 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.485 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . 174.89 -68.95 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -172.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.696 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 45.9 mttp -76.09 -159.03 0.1 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.79 130.49 1.86 Allowed Glycine 0 CA--C 1.501 -0.787 0 O-C-N 123.898 0.749 . . . . 0.0 114.398 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.696 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.9 OUTLIER -134.63 143.4 47.28 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.721 -173.304 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.39 123.44 46.44 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.032 0.444 . . . . 0.0 111.156 -174.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 44.3 m -100.53 104.28 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.152 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.76 133.16 35.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -145.15 131.68 19.8 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.931 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 79.7 mtp -115.54 134.86 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.854 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.577 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 17.9 m120 -134.58 89.49 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.508 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.63 -93.23 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.566 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.9 OUTLIER -108.92 29.58 7.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.556 0.217 . . . . 0.0 110.959 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.658 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 47.7 tt0 -143.88 140.7 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.536 0.684 . . . . 0.0 111.934 -168.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.3 tm? -118.92 118.98 33.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 171.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.577 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 44.8 pttt -129.18 104.56 7.61 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -118.16 119.4 34.6 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 67.8 p -98.01 145.14 26.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.145 0.498 . . . . 0.0 111.193 -174.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 16.6 p -109.61 119.14 38.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.373 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 16.3 t -95.34 -170.39 2.16 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.04 18.54 0.48 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.448 1.093 . . . . 0.0 110.593 -170.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.24 34.21 23.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.673 173.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.13 -18.24 46.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.178 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -57.79 140.15 52.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.311 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -79.51 156.06 40.45 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.709 -174.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.547 ' O ' ' HB2' ' C' ' 24' ' ' LYS . 70.2 mt -56.08 -53.32 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.533 0.683 . . . . 0.0 112.104 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.6 ' HB2' ' OE2' ' C' ' 68' ' ' GLU . 31.2 t -116.61 176.93 4.89 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.912 -169.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -119.61 3.85 11.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.68 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 27.6 mt-10 -125.3 171.24 10.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.442 176.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.58 96.27 10.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.164 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' C' ' 50' ' ' GLU . 17.9 mmmt -98.98 158.98 15.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.793 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.569 HD21 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -101.18 110.86 22.93 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.491 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.534 ' CH2' HG22 ' C' ' 91' ' ' ILE . 0.2 OUTLIER -114.47 165.06 13.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -168.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.42 ' C ' HD13 ' C' ' 56' ' ' ILE . . . -174.12 165.86 37.67 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 119.174 -1.488 . . . . 0.0 115.741 172.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.42 HD13 ' C ' ' C' ' 55' ' ' GLY . 2.0 mp -116.19 134.1 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.983 176.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 82.3 m-85 -121.06 142.06 50.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 178.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -134.34 124.4 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.16 27.36 14.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.66 35.66 31.54 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.235 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 9.5 pt-20 -140.83 153.02 45.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -81.69 130.76 35.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 111.348 -177.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.422 ' CG2' HG13 ' C' ' 58' ' ' VAL . 53.7 t -105.89 -51.87 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.63 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -141.75 147.54 37.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.643 -176.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.403 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 2.3 t -131.89 158.12 42.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -167.82 -174.63 2.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.524 0.678 . . . . 0.0 112.725 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.04 140.22 49.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.743 -177.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.6 ' OE2' ' HB2' ' C' ' 48' ' ' SER . 19.8 tt0 -79.13 -6.83 57.44 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -168.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.0 ptmt -104.18 6.51 35.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.996 -0.44 . . . . 0.0 111.396 -177.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 39.4 p -81.84 -163.57 0.67 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.48 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 20.0 p -93.54 106.94 18.86 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . 0.51 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.2 t -59.68 -15.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.335 -169.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 -35.66 14.68 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.071 -178.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . 0.434 ' N ' HD21 ' C' ' 74' ' ' ASN . 0.9 OUTLIER -69.28 -35.97 76.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.173 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' C' ' 78' ' ' ASP . 46.2 mm -70.96 -63.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.388 -178.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.524 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.0 m -58.15 -46.61 85.38 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.992 -170.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.778 ' ND2' HD21 ' C' ' 80' ' ' ASN . 9.5 m120 -72.89 -14.72 61.54 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.621 -0.832 . . . . 0.0 112.966 -177.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 51.6 m-20 -56.44 -51.76 67.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 165.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' C' ' 76' ' ' SER . 67.5 mt -54.25 -33.41 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.754 176.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.778 HD21 ' ND2' ' C' ' 77' ' ' ASN . 38.9 m-20 -87.8 -37.71 16.34 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.814 -169.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.484 ' CE ' ' HA ' ' C' ' 78' ' ' ASP . 51.2 mtmt -56.39 -28.61 59.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.285 0.564 . . . . 0.0 109.781 176.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.5 mt -59.14 -28.06 66.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.779 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.658 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.7 m120 39.79 75.82 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.717 0.77 . . . . 0.0 110.42 -170.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 25.2 mt -74.2 131.27 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.495 -171.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 2.3 ptpt -83.84 29.59 0.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.292 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.12 142.48 28.48 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.459 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.62 -39.79 0.22 Allowed 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.743 2.296 . . . . 0.0 111.377 176.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -144.45 123.54 12.87 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.744 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.63 128.72 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.755 -175.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.16 110.42 22.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.269 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.534 HG22 ' CH2' ' C' ' 54' ' ' TRP . 5.5 mt -99.87 103.66 15.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.2 154.53 25.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.269 -172.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.23 162.29 19.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.435 0.636 . . . . 0.0 111.693 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.569 HG13 HD21 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.659 -170.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtm -98.04 -141.45 0.3 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.603 -177.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -47.44 -26.92 1.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -175.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -47.8 -46.34 30.49 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.27 0.356 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -90.67 -22.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.268 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.83 -51.48 40.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.259 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 17.7 t -58.37 -32.69 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.521 0.677 . . . . 0.0 109.639 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.608 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 60.0 t -71.39 -34.47 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.064 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -62.74 -37.33 86.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.163 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.22 -30.98 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.571 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -78.21 -33.39 49.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.73 0.776 . . . . 0.0 109.803 -176.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 90.2 mt -80.91 -40.38 24.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.241 -176.364 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -81.77 67.02 7.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.43 0.633 . . . . 0.0 109.831 177.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -100.95 -17.26 16.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.469 -174.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.78 -64.56 0.36 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.306 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 24.3 mmmt -84.02 -157.48 0.27 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -38.82 131.32 1.83 Allowed Glycine 0 CA--C 1.503 -0.697 0 O-C-N 124.048 0.843 . . . . 0.0 115.158 -175.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.75 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.3 OUTLIER -143.15 144.44 32.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.144 -1.028 . . . . 0.0 110.061 -172.411 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.597 ' HG ' HD11 ' C' ' 20' ' ' LEU . 1.4 pt? -123.82 112.64 17.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.681 175.087 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.767 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.2 m -82.61 104.2 12.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.974 -176.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.421 HD11 HG23 ' C' ' 91' ' ' ILE . 13.3 mt -79.78 122.29 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.369 -170.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -129.69 128.51 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.167 172.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.402 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 53.8 mtt -132.24 116.83 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.249 -176.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 46.7 t30 -150.75 96.96 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.606 0.241 . . . . 0.0 111.32 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . 0.423 ' O ' HG21 ' C' ' 84' ' ' ILE . . . 67.15 -92.69 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.682 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -101.22 -20.83 15.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.593 0.711 . . . . 0.0 109.912 -176.657 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 17.4 pt20 -88.68 127.85 35.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.692 0.758 . . . . 0.0 111.899 -171.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.529 ' HB2' HG12 ' C' ' 84' ' ' ILE . 1.6 tm? -131.27 117.69 19.33 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 47.5 pttt -144.64 106.28 4.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.767 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.04 129.0 46.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 3.9 m -95.87 129.84 42.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.651 0.738 . . . . 0.0 110.198 -176.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.75 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 61.7 p -107.26 118.68 37.34 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.68 -176.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 m -121.61 179.14 4.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.757 -175.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.44 ' HB2' ' CE ' ' C' ' 26' ' ' LYS . 0.8 OUTLIER 66.57 42.17 2.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.276 0.985 . . . . 0.0 109.439 -169.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.19 27.47 17.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.98 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.75 19.07 72.91 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.589 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.427 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 36.1 m-85 -70.98 -178.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.204 0.502 . . . . 0.0 110.857 176.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.1 -154.67 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.848 -177.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' C' ' 24' ' ' LYS . 32.2 mt -50.19 -67.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 C-N-CA 123.56 0.744 . . . . 0.0 112.729 -177.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 23.3 t 173.06 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 124.655 1.222 . . . . 0.0 109.656 -175.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -156.07 49.32 0.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.138 0.494 . . . . 0.0 110.633 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.661 ' O ' HD13 ' C' ' 47' ' ' ILE . 12.9 pt-20 -169.05 -178.68 3.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.413 ' HB3' ' HD3' ' C' ' 69' ' ' LYS . 8.7 p-10 -128.8 126.51 40.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.72 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.5 mmmt -104.69 157.59 17.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.549 HD21 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -98.18 101.45 12.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.018 177.144 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.598 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -97.28 166.89 11.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.379 -174.761 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.1 166.68 39.88 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 118.535 -1.793 . . . . 0.0 116.484 176.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 mt -128.6 139.56 51.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 113.799 -1.201 . . . . 0.0 109.747 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 40.6 m-85 -134.02 113.51 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.432 -176.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.453 HG23 ' CG1' ' C' ' 63' ' ' VAL . 41.1 t -80.96 105.59 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.549 ' HA ' ' CE2' ' C' ' 88' ' ' TYR . 0.8 OUTLIER 62.82 28.66 16.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 110.481 -176.112 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.08 67.98 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.4 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.4 tt0 -107.68 123.56 48.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.465 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 86.9 tttt -61.9 103.28 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.372 0.606 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.453 ' CG1' HG23 ' C' ' 58' ' ' VAL . 0.9 OUTLIER -97.29 -53.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 177.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -130.46 149.14 52.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.598 HG23 ' O ' ' C' ' 54' ' ' TRP . 80.0 m -149.66 138.22 20.82 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -150.9 -175.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.644 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -116.93 134.27 54.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' CG1' ' C' ' 47' ' ' ILE . 27.7 tt0 -66.91 -13.58 61.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.423 -171.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.7 ptmm? -84.23 -17.59 39.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.736 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -62.07 154.9 25.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -64.82 111.44 2.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.271 -172.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.38 -15.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.912 -173.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.67 -39.08 14.88 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 120.052 -1.07 . . . . 0.0 111.432 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.05 -36.36 72.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.129 0.49 . . . . 0.0 109.697 177.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.53 -56.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.518 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 80.7 p -57.57 -58.81 6.69 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -171.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.831 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -68.23 -19.1 64.71 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.201 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 0.9 OUTLIER -74.73 -36.19 62.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.846 169.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' C' ' 76' ' ' SER . 58.9 mt -59.59 -31.86 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.81 0.814 . . . . 0.0 109.381 170.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.831 HD21 ' ND2' ' C' ' 77' ' ' ASN . 31.8 m-20 -81.78 -35.1 29.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.919 -172.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 16.0 ptpt -59.97 -31.08 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.9 mt -56.12 -31.47 63.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.224 177.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.19 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.543 1.152 . . . . 0.0 113.189 -173.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' C' ' 34' ' ' ASN . 9.5 mm -35.57 141.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.602 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -143.78 7.93 1.47 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.99 -178.678 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.54 -175.61 20.07 Favored Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 118.997 -1.573 . . . . 0.0 111.988 -173.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.561 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 84.3 Cg_endo -81.01 -87.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.493 2.129 . . . . 0.0 111.836 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.561 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 25.1 p90 -108.23 110.88 22.6 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.623 0.725 . . . . 0.0 110.284 178.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.09 126.53 74.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.85 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.68 141.36 28.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 -174.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.517 HG12 ' CH2' ' C' ' 54' ' ' TRP . 12.0 tt -136.07 99.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.322 1.058 . . . . 0.0 108.37 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 164.52 9.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.114 -171.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.43 ' CB ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -96.66 161.2 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.928 177.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.549 HG13 HD21 ' C' ' 53' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.986 -164.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.468 ' O ' HG21 ' C' ' 13' ' ' ILE . 25.5 mmt -105.64 -142.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.81 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.79 -25.74 30.12 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -177.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -55.0 -50.06 69.93 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.468 HG21 ' O ' ' C' ' 10' ' ' MET . 4.9 tt -73.71 -36.18 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . 0.403 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 77.5 m-20 -72.15 -36.14 69.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.596 -177.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -57.69 -39.41 77.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 72.7 t -66.57 -33.95 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 174.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 11.7 m120 -59.63 -44.9 93.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.834 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.28 -17.02 61.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.566 179.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' C' ' 16' ' ' VAL . 23.3 tptm -87.12 -36.27 18.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.954 -177.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 14.9 mt -82.44 -26.03 33.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.139 -177.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -81.14 61.21 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' C' ' 25' ' ' GLY . 0.0 OUTLIER -91.75 -40.87 11.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.341 -166.683 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.76 -95.67 0.1 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' C' ' 48' ' ' SER . 29.6 ttmt -91.62 145.21 24.78 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.499 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 63.85 127.55 0.01 OUTLIER Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.524 -170.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.8 ptpt -151.14 140.45 21.36 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 121.962 -0.728 . . . . 0.0 112.187 177.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.473 ' N ' HD13 ' C' ' 27' ' ' LEU . 2.5 mp -117.76 124.02 47.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.136 -176.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 6.1 t -97.63 98.86 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 52.7 mt -80.53 136.05 36.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.068 0.461 . . . . 0.0 111.667 -173.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -141.91 128.91 20.75 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.945 171.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.442 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 51.2 mtt -118.31 114.72 23.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.826 -176.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -132.92 90.64 2.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.218 -174.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.86 -104.09 0.41 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.337 175.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.45 34.26 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 109.519 -177.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.57 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 33.4 tt0 -148.65 133.4 17.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.481 0.657 . . . . 0.0 112.656 -178.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.442 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 0.6 OUTLIER -112.89 123.23 49.83 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 165.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -137.0 140.33 42.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.94 132.5 14.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.676 -177.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -96.88 134.34 40.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 10.6 p -109.52 119.7 40.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.593 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.404 ' HB2' ' CG ' ' C' ' 26' ' ' LYS . 16.0 m -106.55 -178.71 3.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.405 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 77.34 27.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 124.439 1.087 . . . . 0.0 109.832 -174.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.27 31.97 17.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.583 174.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.06 -19.69 33.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.154 175.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -56.11 130.71 45.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.542 0.171 . . . . 0.0 110.944 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.92 -45.64 0.81 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 -174.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.594 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.2 OUTLIER -47.91 -46.03 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -159.824 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 73.7 m 75.92 -60.57 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.994 0.809 . . . . 0.0 110.927 -169.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -162.72 -46.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.136 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -139.79 -172.67 3.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.359 0.6 . . . . 0.0 112.134 -172.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 3.8 t70 -82.06 102.15 10.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.542 -177.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.3 28.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.851 176.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.508 HD21 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -95.78 106.55 18.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.69 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.656 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -95.86 158.74 15.31 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.004 -174.837 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.84 145.28 12.66 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.397 -1.382 . . . . 0.0 114.684 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 45.2 mt -130.73 132.27 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 173.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.38 160.54 30.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.2 p -144.55 126.66 10.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.487 ' HA ' ' CZ ' ' C' ' 88' ' ' TYR . 88.3 m-20 57.65 28.89 16.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 111.123 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.94 -3.31 84.66 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.62 177.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.0 pt-20 -107.64 149.91 27.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.515 0.658 . . . . 0.0 109.841 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -81.43 124.84 29.76 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.0 110.329 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 -52.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -138.35 155.56 48.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.151 -173.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.656 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.3 m -150.85 139.24 20.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.676 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' C' ' 75' ' ' ILE . 50.1 p90 -152.8 -170.37 3.61 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.486 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -134.19 157.72 45.53 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.084 0.24 . . . . 0.0 110.7 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' C' ' 47' ' ' ILE . 0.5 OUTLIER -59.3 -45.47 91.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.176 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -53.51 -38.69 63.97 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.8 p -68.86 122.42 18.59 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.403 ' O ' HG12 ' C' ' 75' ' ' ILE . 41.7 p -54.75 126.39 23.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.518 0.675 . . . . 0.0 111.047 -166.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -20.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.043 -175.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.5 -37.59 30.67 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.861 -176.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -75.22 -34.8 61.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.461 HG21 ' CD1' ' C' ' 66' ' ' PHE . 47.3 mm -70.84 -65.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.424 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.5 m -58.66 -52.4 65.85 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.446 -170.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.718 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -74.34 -17.85 60.77 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.991 -172.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.431 ' HA ' ' HE2' ' C' ' 81' ' ' LYS . 13.0 m-20 -66.52 -48.05 70.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 95.7 mt -52.89 -33.0 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.434 174.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.718 HD21 ' ND2' ' C' ' 77' ' ' ASN . 67.5 m-20 -84.45 -32.32 24.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.37 -173.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 58.2 mtmt -60.51 -29.4 69.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.6 mt -60.38 -26.54 66.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.555 178.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.57 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 12.3 m120 39.41 78.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.889 0.743 . . . . 0.0 110.742 -171.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.422 HG21 ' H ' ' C' ' 86' ' ' GLY . 8.9 mt -57.99 145.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.946 -172.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.59 20.0 6.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.401 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . 0.422 ' H ' HG21 ' C' ' 84' ' ' ILE . . . -85.77 141.03 18.43 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.955 -176.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -79.81 -45.16 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.895 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.487 ' CZ ' ' HA ' ' C' ' 59' ' ' ASN . 32.1 p90 -131.06 123.57 28.97 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.421 ' N ' HD13 ' C' ' 89' ' ' ILE . 4.2 mp -112.8 136.93 47.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 40.8 mt-10 -99.51 98.73 9.58 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.976 0.417 . . . . 0.0 109.971 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -113.83 101.46 12.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.057 -178.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.02 147.99 4.88 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.14 157.41 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.358 0.599 . . . . 0.0 111.426 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.508 HG13 HD21 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.935 -163.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.436 ' NE2' ' HB2' ' C' ' 31' ' ' MET . 27.9 mm-40 . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 33.8 mmt -90.07 -153.69 0.3 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.1 -28.19 10.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.866 0.467 . . . . 0.0 112.074 -175.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 25.0 m -47.69 -52.13 19.39 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.685 0.616 . . . . 0.0 111.604 177.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.572 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 19.5 pt -91.89 -23.45 5.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.798 179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.73 -40.53 76.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 108.86 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 71.7 t -70.26 -40.26 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.22 173.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -61.91 -47.95 82.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.497 -176.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.38 -16.58 62.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.541 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.558 ' HB2' ' HZ3' ' C' ' 19' ' ' LYS . 4.4 ttmp? -88.82 -38.45 14.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.076 -177.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 24.8 mt -80.81 -33.04 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.139 -176.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -80.85 62.41 4.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -90.81 -24.02 20.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -174.247 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.97 -77.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.328 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.556 ' HA ' ' OD1' ' C' ' 42' ' ' ASN . 1.0 OUTLIER -83.75 92.62 7.77 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.351 0.595 . . . . 0.0 109.604 177.011 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.7 139.74 8.22 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.404 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.1 ptpt -152.65 136.02 15.88 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.662 -177.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.516 ' HB2' ' CD1' ' C' ' 20' ' ' LEU . 3.8 mp -113.56 122.54 47.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.756 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.5 t -105.33 111.82 24.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 30.1 mt -88.82 125.81 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.003 0.43 . . . . 0.0 111.457 -175.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.94 136.35 26.83 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.266 174.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.436 ' HB2' ' NE2' ' C' ' 9' ' ' GLN . 86.2 mtp -128.1 145.53 50.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -177.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.58 91.13 1.85 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.068 176.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.1 -94.58 0.46 Allowed Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.974 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.3 p-10 -106.21 26.54 9.66 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.684 -0.304 . . . . 0.0 111.323 -174.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.646 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 34.1 tt0 -141.06 137.72 33.09 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -170.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -122.72 114.72 20.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 167.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 21.6 pttm -124.84 106.04 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.86 0.838 . . . . 0.0 108.911 176.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.36 124.68 47.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.626 175.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -94.93 123.73 38.57 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 2.7 p -110.0 119.7 40.12 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.38 -174.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -116.1 -171.04 1.91 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.564 -174.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 81.51 12.71 0.68 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.74 1.275 . . . . 0.0 111.908 -176.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.17 45.86 26.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.68 -28.66 8.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.678 172.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -59.08 129.26 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.194 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.31 -70.57 1.22 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.283 -172.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.662 HD12 ' O ' ' C' ' 50' ' ' GLU . 2.3 mt -113.32 -63.8 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.837 0.827 . . . . 0.0 111.406 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p 174.64 -63.41 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.192 -172.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 9.4 t80 179.7 36.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 O-C-N 123.467 0.48 . . . . 0.0 110.297 175.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.662 ' O ' HD12 ' C' ' 47' ' ' ILE . 42.6 mt-10 -142.23 177.86 7.96 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.438 -175.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . 0.556 ' CG ' ' HE2' ' C' ' 69' ' ' LYS . 1.1 m-20 -103.74 122.08 44.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.298 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.494 ' HB2' HD11 ' C' ' 47' ' ' ILE . 6.2 mptp? -124.24 130.33 52.33 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 112.564 -178.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.584 HD22 HG13 ' C' ' 94' ' ' ILE . 0.5 OUTLIER -88.92 126.64 35.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.629 178.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.607 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.6 OUTLIER -135.78 166.17 23.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -166.176 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.94 158.21 29.62 Favored Glycine 0 C--N 1.347 1.162 0 C-N-CA 119.278 -1.439 . . . . 0.0 116.085 171.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.414 HG13 HG12 ' C' ' 91' ' ' ILE . 1.9 mp -113.03 138.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.338 -0.931 . . . . 0.0 110.684 174.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 3.7 m-85 -131.22 132.87 44.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.567 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 91.1 t -104.08 116.39 47.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.43 27.52 17.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.662 -175.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.62 72.8 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 7.3 pt-20 -107.96 133.54 52.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.921 0.861 . . . . 0.0 109.772 176.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -65.47 128.9 37.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.464 -176.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 95.7 t -111.13 -65.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.887 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 60.5 t80 -128.4 144.8 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 -177.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.6 t -126.55 145.05 50.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . 0.487 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 38.1 p90 -155.0 -178.66 7.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -175.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -118.07 128.86 55.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.642 172.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.647 ' CB ' HG12 ' C' ' 47' ' ' ILE . 37.9 mt-10 -61.84 -27.35 68.71 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.556 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.6 pttp -82.76 14.78 2.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.477 ' HB2' HD13 ' C' ' 75' ' ' ILE . 59.7 m -73.83 -116.92 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 165.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.438 ' O ' HG13 ' C' ' 75' ' ' ILE . 0.9 OUTLIER -134.01 122.2 22.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 165.545 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 t -59.25 -24.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.903 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . 0.633 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.02 -37.0 33.99 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.742 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -76.6 -30.87 57.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 177.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' C' ' 70' ' ' SER . 75.5 mt -71.0 -61.66 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 176.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.564 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -63.91 -52.53 59.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.32 -171.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.791 ' ND2' HD21 ' C' ' 80' ' ' ASN . 9.3 m120 -74.85 -16.01 60.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -171.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . 0.49 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.1 m-20 -59.7 -49.68 76.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 165.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.7 mt -53.32 -32.05 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.288 175.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.791 HD21 ' ND2' ' C' ' 77' ' ' ASN . 27.5 m-20 -88.2 -22.04 24.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.778 -172.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 31.6 mmtp -61.34 -36.47 80.25 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 5.2 mt -64.9 -24.05 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.181 -174.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . 0.646 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 9.5 m120 39.64 87.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.771 0.67 . . . . 0.0 111.384 -172.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.36 122.92 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.815 -172.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.1 OUTLIER -80.36 55.7 2.32 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.237 170.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.78 158.96 13.96 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.597 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 83.9 Cg_endo -81.65 -62.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.668 2.246 . . . . 0.0 111.792 177.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.597 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.9 p90 -134.06 129.65 36.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -102.94 120.25 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.713 -175.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.42 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 6.2 mm-40 -92.47 99.56 12.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.389 -176.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.514 HG23 ' CH2' ' C' ' 54' ' ' TRP . 7.0 mt -110.73 103.75 15.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -162.12 155.43 20.64 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.078 -177.357 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -79.03 164.34 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 179.659 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.584 HG13 HD22 ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.549 -170.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' C' C ' 10' ' ' MET . . . . . 0.652 ' O ' HG21 ' C' ' 13' ' ' ILE . 22.3 mmt -88.61 -146.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.007 177.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 11' ' ' ASN . . . . . 0.437 ' H ' ' HB3' ' C' ' 10' ' ' MET . 47.1 m-80 -53.87 -20.32 5.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -178.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 12' ' ' SER . . . . . 0.46 ' O ' HG22 ' C' ' 16' ' ' VAL . 1.2 m -51.55 -45.1 62.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.753 174.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.652 HG21 ' O ' ' C' ' 10' ' ' MET . 11.6 tt -80.26 -30.12 12.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.588 -177.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -71.87 -40.39 68.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -59.12 -32.76 70.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.033 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.46 HG22 ' O ' ' C' ' 12' ' ' SER . 98.3 t -70.8 -35.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.849 173.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.64 -47.73 84.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.824 0.345 . . . . 0.0 110.391 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.44 -21.2 64.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.722 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -85.37 -36.28 20.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.874 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 61.7 mt -75.89 -32.05 59.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.26 177.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.85 71.51 4.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.533 0.683 . . . . 0.0 109.669 173.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -95.21 10.11 37.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.996 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.98 -48.06 2.47 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -173.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.689 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.5 mmtt -72.01 -159.8 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 168.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' C' ' 46' ' ' GLY . . . -44.02 133.45 6.41 Favored Glycine 0 CA--C 1.502 -0.76 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.183 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 26' ' ' LYS . . . . . 0.689 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER -131.44 135.43 47.13 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.263 -0.469 . . . . 0.0 110.648 -171.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.569 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 2.1 tt -123.16 98.98 6.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 28' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 54.5 m -87.64 101.13 13.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.251 -178.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.08 129.39 42.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.358 -171.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -125.92 127.23 45.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.143 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 31' ' ' MET . . . . . 0.402 ' HE3' ' CD1' ' C' ' 84' ' ' ILE . 47.4 mtp -140.64 113.89 8.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.899 -177.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.563 ' HB2' ' OE1' ' C' ' 35' ' ' GLN . 58.4 m-80 -148.99 111.49 4.74 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.603 175.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.56 -98.49 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.837 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.27 30.28 6.87 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.105 0.479 . . . . 0.0 110.258 -178.94 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' C' C ' 35' ' ' GLN . . . . . 0.563 ' OE1' ' HB2' ' C' ' 32' ' ' ASN . 2.4 pt20 -122.94 123.45 40.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.618 . . . . 0.0 111.491 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 1.4 tp -132.25 112.19 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.552 170.02 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 37' ' ' LYS . . . . . 0.52 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 52.2 pttt -137.24 103.72 5.19 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 38' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -102.6 129.91 49.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.803 173.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' C' ' 28' ' ' SER . 76.0 p -105.44 147.8 27.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.07 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 17.3 p -128.59 157.74 40.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -177.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.432 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 20.1 t -151.6 -174.44 4.84 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.576 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.45 16.67 0.49 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.943 1.297 . . . . 0.0 111.679 -174.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.71 51.17 17.02 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 166.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.97 -21.12 41.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.909 174.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.44 112.58 6.83 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' C' ' 25' ' ' GLY . . . -78.89 -78.31 0.85 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.885 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 47' ' ' ILE . . . . . 0.571 ' CG1' ' HB2' ' C' ' 68' ' ' GLU . 26.5 mt -111.96 -67.33 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 CA-C-O 121.856 0.836 . . . . 0.0 109.063 173.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.4 p 178.88 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.641 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -141.31 -32.67 0.54 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.486 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.535 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 8.4 pt-20 -70.03 160.7 31.47 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.36 109.07 20.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.617 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.481 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.8 mmmt -101.76 141.11 35.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 173.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 53' ' ' ASN . . . . . 0.487 HD21 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -106.09 108.66 20.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.541 0.686 . . . . 0.0 111.109 -173.674 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' C' C ' 54' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -105.25 166.22 10.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.89 -174.019 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.49 160.2 32.14 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 118.976 -1.583 . . . . 0.0 115.39 173.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.512 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -119.61 136.01 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.759 -0.72 . . . . 0.0 110.2 174.119 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 57' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 30.8 m-85 -128.49 111.66 13.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.761 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.416 ' HA ' HG12 ' C' ' 89' ' ' ILE . 26.3 t -79.58 105.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 57.51 28.16 15.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 -174.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 12.9 64.24 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.025 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.8 tt0 -106.81 138.66 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.616 ' HE2' ' OG1' ' C' ' 65' ' ' THR . 13.5 tptm -68.29 130.96 44.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.462 -176.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.491 HG11 ' H ' ' C' ' 64' ' ' TYR . 2.3 p -129.39 -60.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.282 175.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 64' ' ' TYR . . . . . 0.491 ' H ' HG11 ' C' ' 63' ' ' VAL . 69.9 t80 -132.91 133.96 43.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.748 0.308 . . . . 0.0 110.258 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.616 ' OG1' ' HE2' ' C' ' 62' ' ' LYS . 24.5 m -128.28 144.83 51.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -157.97 174.6 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.314 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -121.83 132.22 54.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 68' ' ' GLU . . . . . 0.571 ' HB2' ' CG1' ' C' ' 47' ' ' ILE . 39.6 mt-10 -60.85 -24.41 65.89 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -75.42 4.21 7.76 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -174.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -74.23 -119.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 71' ' ' THR . . . . . 0.525 ' O ' HG12 ' C' ' 75' ' ' ILE . 20.5 p -131.52 122.65 26.51 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.42 -18.91 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.236 -172.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 73' ' ' GLY . . . . . 0.485 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.9 -45.38 10.59 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.276 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -62.35 -29.04 70.18 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 75' ' ' ILE . . . . . 0.525 HG12 ' O ' ' C' ' 71' ' ' THR . 51.3 mm -75.84 -66.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.145 178.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 76' ' ' SER . . . . . 0.569 ' OG ' ' HG ' ' C' ' 27' ' ' LEU . 16.3 m -51.13 -50.03 59.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 77' ' ' ASN . . . . . 0.703 HD21 ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -81.75 -17.57 47.27 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.909 -173.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.7 -34.87 67.42 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.314 166.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' C' ' 76' ' ' SER . 56.4 mt -58.52 -26.44 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.021 174.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 80' ' ' ASN . . . . . 0.703 ' ND2' HD21 ' C' ' 77' ' ' ASN . 38.5 m-20 -83.74 -27.22 29.08 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.567 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -56.61 -41.31 76.85 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.0 mt -54.77 -33.95 61.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.667 177.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.57 104.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.724 1.209 . . . . 0.0 113.762 -174.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 84' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 1.9 tp -45.23 148.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.655 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 85' ' ' LYS . . . . . 0.444 ' C ' ' HD2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -159.02 22.54 0.2 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.241 179.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.73 12.35 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.289 -168.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 87' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 73.2 Cg_endo -80.6 -42.02 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.851 2.367 . . . . 0.0 111.681 177.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 88' ' ' TYR . . . . . 0.409 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 34.7 p90 -145.26 117.5 8.42 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' C' ' 58' ' ' VAL . 58.4 mt -132.93 132.38 59.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 -176.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.15 111.04 22.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.764 -175.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 91' ' ' ILE . . . . . 0.512 HG13 HG13 ' C' ' 56' ' ' ILE . 11.8 tt -108.72 98.17 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.02 156.9 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.795 -170.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 1.1 pt20 -86.78 163.33 17.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.288 0.566 . . . . 0.0 111.331 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 94' ' ' ILE . . . . . 0.487 HG13 HD21 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 -167.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -152.99 -42.52 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 111.756 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -54.71 -22.66 14.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.604 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -37.74 -49.17 1.14 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.855 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.64 -21.16 21.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.18 -105.06 0.11 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.581 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 9.8 mp0 -93.17 -52.54 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.462 -175.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 34.9 mt-10 90.95 -39.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.562 1.164 . . . . 0.0 112.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.418 HE21 ' HB2' ' C' ' 9' ' ' GLN . 0.9 OUTLIER -74.15 18.12 0.16 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.442 ' HA ' ' HE3' ' C' ' 10' ' ' MET . 32.5 mmt -77.0 -146.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -49.15 -25.97 2.51 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -52.54 -33.86 47.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.116 0.26 . . . . 0.0 111.51 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.56 HG13 ' N ' ' C' ' 14' ' ' ASN . 4.7 pt -90.54 -32.47 5.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.147 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.56 ' N ' HG13 ' C' ' 13' ' ' ILE . 16.6 m120 -71.11 -36.74 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.752 0.311 . . . . 0.0 110.242 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' C' ' 19' ' ' LYS . 49.5 m -58.5 -33.96 70.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.3 t -68.32 -40.17 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.353 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -62.29 -41.81 98.81 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.704 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.13 -27.17 67.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.614 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' C' ' 15' ' ' SER . 94.1 mttt -85.27 -33.91 22.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.524 0.678 . . . . 0.0 110.286 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' C' ' 27' ' ' LEU . 29.3 mt -85.16 -32.44 22.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.088 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.585 0.707 . . . . 0.0 109.902 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 9.8 41.88 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.218 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.18 -69.73 0.5 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.545 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.674 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 24.2 tttt -76.01 -156.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.93 137.52 3.54 Favored Glycine 0 CA--C 1.498 -0.99 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.674 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.2 ptpt -147.32 132.2 18.07 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.343 -167.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' C' ' 20' ' ' LEU . 9.7 tt -105.63 125.76 51.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.446 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 31.8 m -103.31 135.05 45.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.109 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.474 HD12 ' N ' ' C' ' 29' ' ' LEU . 5.8 mp -100.18 126.05 46.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.513 0.196 . . . . 0.0 111.444 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.5 t -152.49 144.95 24.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.467 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.4 ' HG3' HD21 ' C' ' 36' ' ' LEU . 1.9 mpt? -127.59 141.58 51.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 -176.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.519 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 18.1 m120 -133.07 88.86 2.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 173.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.78 -98.97 0.17 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.949 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.07 24.25 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.669 -0.312 . . . . 0.0 111.157 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.683 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.9 tt0 -143.27 108.25 4.94 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.548 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.632 ' CB ' HG13 ' C' ' 84' ' ' ILE . 3.1 tm? -88.03 124.87 34.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.669 166.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.519 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 41.6 pttt -129.1 103.38 6.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.79 118.87 37.82 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.932 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.0 p -98.4 138.89 34.97 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.29 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 t -111.23 119.51 39.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.333 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 23.6 t -94.84 -172.66 2.77 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.414 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 1.0 OUTLIER 70.73 27.94 3.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 123.854 0.722 . . . . 0.0 110.303 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.86 32.05 21.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.117 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 -6.63 78.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.308 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.539 ' O ' HG23 ' C' ' 72' ' ' VAL . 64.8 m-85 -63.3 161.36 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 0.0 110.47 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -85.51 166.72 40.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.348 -172.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.432 ' HB ' ' HG2' ' C' ' 68' ' ' GLU . 3.7 mp -60.73 -54.62 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 122.196 0.998 . . . . 0.0 109.856 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.7 t -129.34 -169.85 2.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.851 -169.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -132.62 15.8 4.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.389 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.437 ' C ' ' HE3' ' C' ' 69' ' ' LYS . 33.1 mt-10 -125.17 163.13 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.748 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.82 105.31 11.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.552 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.49 140.89 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.468 HD21 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.41 109.35 20.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.466 0.65 . . . . 0.0 109.967 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.608 ' O ' HG22 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.52 165.63 11.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.241 -173.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.52 157.74 29.1 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 118.579 -1.772 . . . . 0.0 115.826 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.55 137.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.106 -1.047 . . . . 0.0 110.619 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' C' ' 89' ' ' ILE . 7.3 m-85 -130.03 126.84 38.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.906 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.433 ' O ' HG12 ' C' ' 58' ' ' VAL . 8.3 p -103.38 111.42 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.184 0.516 . . . . 0.0 110.084 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.8 m120 49.64 43.75 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.575 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.36 -6.69 82.3 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.185 -0.531 . . . . 0.0 114.345 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -108.32 150.14 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.855 0.827 . . . . 0.0 111.072 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -73.59 132.57 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.064 0.459 . . . . 0.0 111.756 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.59 -61.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.728 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -148.74 147.4 28.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.856 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.608 HG22 ' O ' ' C' ' 54' ' ' TRP . 85.5 m -134.14 133.04 40.57 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 49.3 p90 -150.85 -167.12 2.73 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -128.73 144.78 51.24 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.559 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 6.6 mt-10 -70.11 -20.88 63.16 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -175.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.437 ' HE3' ' C ' ' C' ' 50' ' ' GLU . 11.3 ptpt -89.21 7.52 34.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.381 . . . . 0.0 111.035 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.0 m -90.08 165.89 13.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.805 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.09 106.27 8.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.539 HG23 ' O ' ' C' ' 45' ' ' TYR . 0.9 OUTLIER -59.11 -15.85 7.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.862 -173.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.64 -32.9 17.58 Favored Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.645 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.82 -29.13 50.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 45.8 mm -71.68 -57.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.777 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.507 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 37.7 p -60.27 -55.65 31.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.843 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.1 OUTLIER -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.6 OUTLIER -64.02 -46.98 82.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' C' ' 76' ' ' SER . 74.7 mt -53.87 -31.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.333 175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.843 HD21 ' ND2' ' C' ' 77' ' ' ASN . 9.9 m-20 -89.99 -24.16 21.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.55 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 64.0 mttm -55.68 -39.75 71.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 4.6 mt -61.1 -23.07 65.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.778 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.683 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 40.42 77.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.846 0.831 . . . . 0.0 110.833 -174.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.632 HG13 ' CB ' ' C' ' 36' ' ' LEU . 0.5 OUTLIER -93.77 145.61 7.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.514 -171.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.438 ' C ' ' HD2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -81.16 4.46 20.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.356 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.19 109.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.335 0 O-C-N 124.077 0.861 . . . . 0.0 113.618 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.488 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 97.9 Cg_endo -82.26 -55.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.765 2.31 . . . . 0.0 112.28 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.521 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . 88.2 t80 -107.95 98.75 8.28 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' C' ' 57' ' ' PHE . 20.9 pt -119.38 123.88 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.749 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.3 105.06 16.98 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.493 ' HB ' HG11 ' C' ' 16' ' ' VAL . 5.4 mt -97.22 99.71 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.407 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . 0.419 ' HA ' ' CH2' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -163.82 148.15 10.34 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -77.08 165.34 24.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.322 0.582 . . . . 0.0 111.072 -177.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.468 HG13 HD21 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.863 -166.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.972 0.415 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -138.55 -24.1 0.95 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.244 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' C' ' 10' ' ' MET . 22.2 mp0 -79.6 11.02 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.668 0.746 . . . . 0.0 110.523 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -64.23 -37.1 86.27 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.459 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.83 5.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.636 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' C' ' 8' ' ' GLU . 84.2 mt -90.4 117.13 28.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.628 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' HB2' ' C' ' 10' ' ' MET . 48.7 mp0 -74.57 24.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' C' ' 6' ' ' LEU . 25.5 mt-10 -51.62 -59.36 4.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.37 0.605 . . . . 0.0 110.901 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.616 ' N ' HE21 ' C' ' 9' ' ' GLN . 0.0 OUTLIER -99.18 17.59 19.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.345 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.459 ' HB2' ' HA ' ' C' ' 7' ' ' GLU . 1.0 OUTLIER -117.58 -147.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -41.59 -40.94 2.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -53.71 -39.36 65.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.489 HD13 ' ND2' ' C' ' 17' ' ' ASN . 0.0 OUTLIER -92.39 -33.2 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.487 ' HA ' HD21 ' C' ' 17' ' ' ASN . 20.8 m120 -69.84 -34.77 74.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.081 -0.387 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 40.1 t -59.27 -33.33 70.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.486 0.66 . . . . 0.0 109.29 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.477 HG21 ' O ' ' C' ' 91' ' ' ILE . 49.1 t -71.67 -35.23 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.141 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.489 ' ND2' HD13 ' C' ' 13' ' ' ILE . 16.1 m-80 -58.27 -45.47 87.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -69.03 -31.31 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.379 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.13 -35.17 37.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.196 0.522 . . . . 0.0 109.977 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 71.6 mt -69.2 -32.36 71.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.378 176.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.41 58.69 2.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.515 0.674 . . . . 0.0 110.05 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.473 ' HD2' ' C ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -88.29 9.94 21.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.024 -175.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.47 -72.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.865 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -76.51 -157.71 0.09 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.369 0.268 . . . . 0.0 110.544 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -44.55 135.88 6.21 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' C' ' 40' ' ' SER . 9.8 ptpt -148.38 143.44 26.82 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.876 -162.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.416 HD11 ' N ' ' C' ' 27' ' ' LEU . 3.8 mp -101.25 119.03 38.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.744 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 53.8 m -100.24 99.58 10.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' C' ' 91' ' ' ILE . 1.2 mm? -85.6 147.18 26.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 112.116 -171.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -151.13 129.13 11.76 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.076 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 38.0 mtt -101.9 118.64 37.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.468 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 16.9 m120 -130.74 90.08 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.813 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.79 0.6 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.965 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -102.32 33.71 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.951 0.881 . . . . 0.0 108.965 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.543 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 53.2 tt0 -144.62 138.95 27.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.973 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -116.37 102.81 9.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.57 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 64.4 pttt -105.96 133.22 51.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.1 118.48 6.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.941 -172.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 65.0 p -100.42 148.57 24.59 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.414 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.7 p -109.0 118.95 38.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.42 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.555 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 37.7 t -94.81 178.59 5.53 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.2 OUTLIER 63.08 37.68 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.689 0.618 . . . . 0.0 109.719 -169.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.43 24.99 10.83 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.611 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.94 19.06 73.65 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.09 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.649 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 17.8 m-85 -65.33 164.39 13.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.47 -160.36 35.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.159 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.552 ' CD1' ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -52.99 -66.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.522 0.677 . . . . 0.0 112.165 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.552 ' H ' ' CD1' ' C' ' 47' ' ' ILE . 28.7 p -179.08 -48.1 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.004 -171.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.463 ' H ' HD11 ' C' ' 47' ' ' ILE . 68.5 t80 -171.45 -36.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.414 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -89.92 161.19 16.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -165.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.459 ' HB3' ' CD ' ' C' ' 69' ' ' LYS . 7.0 p-10 -94.21 118.22 31.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.327 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.636 ' HB2' ' CD ' ' C' ' 68' ' ' GLU . 14.1 mmmm -111.98 155.26 24.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.996 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.423 HD21 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -105.97 106.45 16.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.805 -170.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.616 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.59 164.17 11.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.785 -175.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.06 141.64 7.73 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.826 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.427 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.3 mp -117.96 124.48 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 171.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 2.9 m-85 -119.23 141.6 48.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.37 114.64 40.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 63.35 36.34 11.67 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.812 0.695 . . . . 0.0 110.778 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.16 58.9 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.381 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 10.8 pt-20 -140.16 143.81 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.902 0.851 . . . . 0.0 110.913 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.47 116.54 10.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.385 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.59 -29.6 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.933 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -156.27 154.84 31.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.991 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.616 HG21 ' O ' ' C' ' 54' ' ' TRP . 68.5 m -149.55 146.69 27.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.4 -179.73 7.94 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.684 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 18.3 m120 -128.73 135.08 48.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.25 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.636 ' CD ' ' HB2' ' C' ' 52' ' ' LYS . 2.5 mp0 -60.48 -11.1 5.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -172.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.485 ' HB3' HD13 ' C' ' 47' ' ' ILE . 13.5 ptmm? -84.83 -4.55 59.13 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.6 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -81.06 155.06 26.51 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 11.2 p -71.97 121.32 18.91 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.618 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' C' ' 76' ' ' SER . 13.1 t -60.11 -11.76 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.971 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.46 -40.24 9.18 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.077 -1.058 . . . . 0.0 111.212 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.99 -35.6 74.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.428 ' O ' HG13 ' C' ' 79' ' ' ILE . 47.0 mm -67.9 -66.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.486 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.643 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.4 m -59.34 -58.59 7.97 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.583 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 1.4 m120 -72.55 -16.84 61.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -171.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -34.79 69.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.505 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' C' ' 76' ' ' SER . 80.6 mt -56.06 -23.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.609 171.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.6 OUTLIER -79.79 -38.24 33.52 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.296 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -57.44 -34.1 68.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 109.355 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.519 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 3.2 mt -59.49 -28.06 66.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.543 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 36.66 82.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.568 -174.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.03 148.14 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.856 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.421 ' HB3' ' ND2' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -129.58 45.55 2.78 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.296 -174.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.92 158.0 17.52 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.383 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.8 Cg_endo -79.04 -44.82 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.067 -176.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.401 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 33.2 p90 -123.66 117.97 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.406 0.622 . . . . 0.0 109.949 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.75 125.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.784 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.15 99.68 12.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.536 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.477 ' O ' HG21 ' C' ' 16' ' ' VAL . 20.1 mm -109.65 99.62 9.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.935 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 168.82 6.45 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.97 166.23 12.8 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.752 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.423 HG13 HD21 ' C' ' 53' ' ' ASN . 6.7 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.697 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' C' ' 2' ' ' ASN . 16.5 t70 . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . 0.437 ' O ' HD23 ' C' ' 6' ' ' LEU . 0.9 OUTLIER 76.49 -13.86 0.87 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 112.667 175.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.56 ' NE2' ' HG3' ' C' ' 8' ' ' GLU . 6.4 mt-30 -72.77 2.9 5.8 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.77 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -62.76 -38.0 88.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.85 -1.73 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.972 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' C' ' 3' ' ' GLN . 4.3 mm? -89.8 179.15 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.08 0.467 . . . . 0.0 110.316 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.43 18.34 9.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.129 -171.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.56 ' HG3' ' NE2' ' C' ' 3' ' ' GLN . 15.0 mm-40 -66.33 -24.41 66.52 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.24 0.543 . . . . 0.0 110.607 176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.619 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.4 mp0 -80.51 12.46 3.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.567 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.69 -141.38 0.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.044 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -39.8 -36.61 0.45 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -52.65 -46.19 67.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.51 -29.84 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.935 0.397 . . . . 0.0 111.014 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.52 -20.28 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -60.26 -35.22 75.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.651 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 47.8 t -66.54 -37.71 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.399 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.504 ' ND2' HD12 ' C' ' 29' ' ' LEU . 0.9 OUTLIER -65.21 -39.92 93.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.504 -176.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.58 -27.22 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -87.75 -29.33 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.464 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 62.0 mt -70.76 -34.95 72.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.216 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.1 66.13 9.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.402 ' HZ2' HD12 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.2 -25.29 16.44 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.19 -72.81 0.13 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.274 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -90.6 -177.27 4.98 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 168.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.3 100.24 0.01 OUTLIER Glycine 0 CA--C 1.5 -0.882 0 O-C-N 125.139 1.525 . . . . 0.0 116.118 166.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 8.2 ptpt -131.51 155.36 47.56 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.194 -170.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 0.6 OUTLIER -134.77 121.8 21.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.553 -173.035 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.8 m -113.39 112.42 23.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.504 HD12 ' ND2' ' C' ' 17' ' ' ASN . 5.9 mp -99.24 143.94 28.93 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.789 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.1 m -150.19 131.07 14.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.151 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.619 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 81.5 mtp -97.69 120.72 38.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.296 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -122.31 91.4 3.5 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.708 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 31.06 6.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.707 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 27.9 tt0 -143.07 137.45 29.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.219 0.533 . . . . 0.0 111.999 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -111.28 99.55 8.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.549 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 23.2 pttp -96.42 142.95 27.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.2 122.11 7.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -172.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 77.5 p -98.48 143.38 28.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.514 ' OG ' ' HA2' ' C' ' 73' ' ' GLY . 17.6 p -125.52 119.22 27.59 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.1 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.56 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 39.0 t -100.46 173.37 6.6 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.526 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' C' ' 41' ' ' SER . 6.5 m120 81.59 28.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.716 1.26 . . . . 0.0 111.398 -172.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.88 35.92 5.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 167.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . 0.406 ' O ' HG21 ' C' ' 71' ' ' THR . . . 102.53 -10.11 56.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.209 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 76.3 m-85 -70.03 141.56 52.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.3 -150.45 25.22 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.194 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.556 ' CD1' ' HG2' ' C' ' 68' ' ' GLU . 26.6 mm -66.79 -62.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.555 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -175.05 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.079 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -168.48 28.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 12.5 pt-20 -115.76 135.53 53.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.689 -175.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 32.0 t70 -90.38 109.47 20.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.323 0.582 . . . . 0.0 111.809 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -110.82 139.61 45.97 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.988 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -95.55 119.34 33.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.215 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -113.56 165.96 11.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.044 -169.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.18 158.11 27.51 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 119.077 -1.535 . . . . 0.0 115.788 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -114.84 132.95 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 114.771 -0.714 . . . . 0.0 111.015 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.8 OUTLIER -130.41 115.26 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.75 126.49 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.16 24.9 14.23 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.805 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 9.03 83.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.558 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 11.3 tp10 -107.79 120.72 43.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.959 0.409 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 39.7 ttpt -72.6 112.61 8.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.3 -29.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -148.92 134.14 18.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.23 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.415 HG23 ' O ' ' C' ' 54' ' ' TRP . 5.3 m -123.6 147.14 47.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.51 -175.23 4.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.824 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.56 135.58 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.407 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.556 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 17.3 tt0 -62.89 -34.87 78.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.714 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.3 pttp -79.42 1.59 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -74.4 -170.67 1.04 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.448 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.1 p -81.37 108.39 14.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.47 -16.72 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.117 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . 0.514 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -80.24 -40.76 12.92 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -33.55 75.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.483 ' O ' HG12 ' C' ' 79' ' ' ILE . 32.5 mm -76.05 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.415 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.581 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.6 m -54.43 -52.16 62.65 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.506 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.7 m120 -75.91 -15.96 60.11 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.658 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -66.17 -37.25 85.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' C' ' 76' ' ' SER . 36.7 mm -56.4 -25.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.568 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.579 HD21 ' N ' ' C' ' 80' ' ' ASN . 0.6 OUTLIER -82.37 -38.28 24.4 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -50.21 -44.05 52.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -53.69 -36.01 61.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.755 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.707 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.34 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.996 0.81 . . . . 0.0 110.559 -169.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.87 132.16 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.703 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.21 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.25 162.84 29.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.663 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.8 -35.47 0.39 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 123.113 2.542 . . . . 0.0 112.085 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.69 139.64 16.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.93 125.6 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.404 0.621 . . . . 0.0 111.557 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.428 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 15.6 mm-40 -97.26 99.21 10.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.474 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.4 mt -112.26 99.71 9.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -161.09 156.22 24.19 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -81.59 164.77 21.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.95 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.471 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.814 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.137 -165.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -157.47 -10.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.569 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.534 ' HA ' ' OE1' ' C' ' 3' ' ' GLN . 8.3 mm-40 -90.66 21.99 3.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 173.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.426 ' C ' ' HD2' ' C' ' 4' ' ' LYS . 0.4 OUTLIER -52.96 -44.89 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.978 -177.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -25.61 59.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.689 ' HB3' ' SD ' ' C' ' 10' ' ' MET . 64.4 mt -91.7 -166.06 1.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.89 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 24.0 mm-40 -89.22 -10.87 45.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 32.2 mt-10 76.07 -44.96 0.51 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.204 0.602 . . . . 0.0 111.274 178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -76.27 17.3 0.37 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.673 0.789 . . . . 0.0 111.934 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' C' ' 6' ' ' LEU . 87.1 mtp -87.65 -143.98 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -168.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -59.41 -22.53 61.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.929 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.4 m -54.69 -33.27 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 110.297 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -86.52 -41.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -63.52 -37.3 86.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -54.75 -37.36 65.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.52 -36.52 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.487 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -66.35 -38.21 87.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.424 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.07 -30.7 71.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.925 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.532 ' HZ2' ' HB3' ' C' ' 19' ' ' LYS . 9.1 mtpm? -85.65 -37.19 19.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.555 HD22 ' CZ2' ' C' ' 54' ' ' TRP . 75.6 mt -76.35 -33.71 58.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.592 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -81.55 52.57 1.9 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.931 0.872 . . . . 0.0 109.769 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.571 ' HE3' HG12 ' C' ' 47' ' ' ILE . 14.7 pttm -66.24 -40.57 90.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.108 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.15 0.48 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' C' ' 24' ' ' LYS . 10.9 mmpt? -70.64 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -40.44 145.64 0.39 Allowed Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' C' ' 40' ' ' SER . 10.7 ptpt -148.52 130.96 15.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.945 -169.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.513 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -105.02 128.34 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.721 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.1 t -103.61 98.93 8.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.71 121.2 25.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.11 0.481 . . . . 0.0 110.868 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -130.62 134.89 47.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.602 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 73.6 mtp -118.93 134.45 55.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.956 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -149.02 91.01 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.661 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.28 -106.42 0.65 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.245 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 33.78 1.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.5 0.667 . . . . 0.0 109.902 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.614 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.4 tt0 -145.71 139.6 26.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.511 0.672 . . . . 0.0 112.335 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.15 118.98 28.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.496 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 25.6 pttm -127.18 107.93 10.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.758 0.79 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -115.67 121.59 42.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.66 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 45.0 p -96.57 151.21 19.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 40.9 m -123.7 118.58 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.323 0.582 . . . . 0.0 110.848 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.471 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 22.6 t -101.84 -176.61 3.18 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.36 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.461 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.9 OUTLIER 73.01 35.91 0.92 Allowed 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 124.246 0.967 . . . . 0.0 109.746 -170.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.03 19.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.731 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -3.66 65.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.475 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.461 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 55.4 m-85 -58.78 143.51 46.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.847 0.324 . . . . 0.0 110.89 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.09 -158.02 5.4 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.571 HG12 ' HE3' ' C' ' 22' ' ' LYS . 23.0 mt -67.52 -68.6 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 CA-C-O 122.115 0.96 . . . . 0.0 109.781 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -178.26 -146.68 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.833 -165.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -79.22 -24.23 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.442 ' OE1' ' HE2' ' C' ' 52' ' ' LYS . 6.4 pt-20 -73.28 137.26 44.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.545 0.688 . . . . 0.0 112.79 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.62 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 5.6 p-10 -90.62 145.41 24.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.051 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.62 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.4 mptp? -141.8 126.02 17.49 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.771 ' ND2' HG13 ' C' ' 94' ' ' ILE . 66.5 t30 -84.94 112.61 20.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.525 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.645 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.2 OUTLIER -121.05 161.23 22.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -169.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.9 159.18 31.7 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 118.952 -1.594 . . . . 0.0 116.655 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -114.96 131.49 67.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 113.974 -1.113 . . . . 0.0 110.853 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 1.9 m-85 -129.05 107.2 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.84 123.18 47.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.62 31.12 18.61 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 4.09 89.31 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.114 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.1 tp10 -106.48 121.13 43.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.969 0.385 . . . . 0.0 110.701 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 30.0 ttpp -75.05 117.68 17.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.57 -32.58 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.296 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -142.0 131.58 23.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -125.39 141.01 52.3 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' C' ' 75' ' ' ILE . 50.1 p90 -156.78 -173.35 4.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.277 0.844 . . . . 0.0 113.277 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 19.1 p-10 -131.55 131.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.081 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.645 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 34.0 mt-10 -67.02 -12.33 59.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.6 ptmm? -89.59 7.54 35.9 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 15.2 t -79.98 -147.83 0.05 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.09 117.18 32.57 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.513 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 2.4 t -64.47 -14.8 16.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.302 -167.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.38 -39.57 25.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.567 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.55 -30.68 68.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' C' ' 72' ' ' VAL . 67.7 mt -68.28 -70.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.261 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.524 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 2.5 m -65.38 -44.18 88.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.469 HD21 ' ND2' ' C' ' 80' ' ' ASN . 11.6 m120 -80.83 -15.24 56.9 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.426 -171.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.31 -40.23 81.78 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' C' ' 76' ' ' SER . 63.1 mt -58.7 -28.78 38.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.467 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.496 ' CG ' ' HA ' ' C' ' 37' ' ' LYS . 7.9 m-20 -75.19 -37.6 61.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.249 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 7.2 mmpt? -54.43 -40.44 68.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 0.0 109.237 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.496 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -56.12 -34.78 66.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.699 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.614 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.26 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.164 0.915 . . . . 0.0 110.68 -168.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.66 131.07 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.325 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.98 43.27 0.77 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.514 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.87 138.02 14.09 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.097 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.37 -45.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.775 2.317 . . . . 0.0 111.445 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . 82.1 t80 -140.3 123.36 16.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.02 133.92 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.363 0.602 . . . . 0.0 111.352 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.456 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 8.0 mm-40 -92.31 104.51 16.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.485 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.1 mt -112.71 100.85 11.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -157.37 171.4 20.46 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -94.27 167.42 11.55 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.092 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.771 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -103.0 -28.87 11.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.774 0.321 . . . . 0.0 110.551 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.512 ' HG2' ' HB2' ' C' ' 10' ' ' MET . 20.2 mp0 -89.7 22.1 3.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.43 -41.99 81.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.644 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.78 -7.19 53.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 98.6 mt -91.88 -161.73 0.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.117 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 1.6 mp0 -63.67 -28.47 69.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 41.9 mt-10 81.43 -32.31 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.707 0.803 . . . . 0.0 111.468 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' C' ' 7' ' ' GLU . 0.1 OUTLIER -73.87 17.99 0.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.284 0.634 . . . . 0.0 112.287 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.512 ' HB2' ' HG2' ' C' ' 3' ' ' GLN . 62.7 mtt -82.29 -142.06 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -49.95 -17.2 0.35 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 41.0 m -53.88 -39.71 65.97 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.246 -0.284 . . . . 0.0 110.846 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.468 HG13 ' O ' ' C' ' 10' ' ' MET . 2.8 pp -91.58 -23.92 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.514 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 17.2 m120 -74.89 -32.58 61.88 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 122.304 -0.248 . . . . 0.0 111.003 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -62.26 -31.1 71.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.451 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.51 -34.69 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.868 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.5 m-20 -61.76 -39.82 92.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.407 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.46 -27.7 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.674 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.91 -28.57 18.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.099 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 34.7 mt -82.94 -28.35 29.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.413 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -88.19 74.49 8.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.561 ' HZ2' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -110.82 -23.67 10.88 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -171.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -81.77 0.09 OUTLIER Glycine 0 CA--C 1.507 -0.414 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.234 -174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 14.9 ttmt -89.75 -179.22 5.71 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 29.89 90.33 0.01 OUTLIER Glycine 0 CA--C 1.503 -0.668 0 O-C-N 124.38 1.05 . . . . 0.0 115.496 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.0 OUTLIER -121.02 137.17 54.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.652 -173.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 31.6 tp -126.93 128.21 46.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.395 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 59.2 m -111.87 111.81 23.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.256 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.552 ' CD2' ' HB ' ' C' ' 91' ' ' ILE . 5.4 mp -86.92 144.58 26.89 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 111.574 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.4 p -155.09 129.78 9.23 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.473 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.409 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 63.4 mtt -128.02 132.33 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.962 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -151.23 92.66 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.569 0.223 . . . . 0.0 110.77 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.79 -93.94 1.18 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.37 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.48 31.78 6.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.447 0.642 . . . . 0.0 109.909 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.537 ' N ' HG22 ' C' ' 84' ' ' ILE . 9.9 pt20 -127.92 130.7 48.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.312 0.577 . . . . 0.0 111.753 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.613 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tm? -124.16 119.03 28.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.625 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -140.37 130.99 25.59 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -143.78 120.1 10.9 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.932 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 44.1 p -97.47 126.12 42.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.4 p -109.27 118.72 37.45 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.582 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 t -103.18 -175.08 2.7 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 81.08 26.33 0.23 Allowed 'General case' 0 C--O 1.222 -0.353 0 O-C-N 124.494 1.121 . . . . 0.0 110.491 -171.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.02 38.35 23.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.93 -5.82 79.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.674 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -64.38 145.21 56.41 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.46 0.63 . . . . 0.0 110.526 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.33 -169.7 46.28 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.002 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.561 HD13 ' HZ2' ' C' ' 22' ' ' LYS . 23.3 mm -59.14 -63.53 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-O 121.652 0.739 . . . . 0.0 110.84 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 p -164.06 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.634 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -169.24 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.873 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.63 136.07 49.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.426 -168.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 1.3 m-20 -75.15 118.43 18.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.417 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -139.28 132.72 30.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 14.7 p-10 -86.91 122.38 30.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.5 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -115.66 161.92 17.99 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.78 148.22 18.79 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.331 -1.414 . . . . 0.0 115.444 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 38.6 mt -122.27 127.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 164.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -121.7 109.04 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.949 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.408 HG21 HG13 ' C' ' 89' ' ' ILE . 2.5 p -90.08 105.74 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 62.36 29.45 17.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.704 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.74 5.19 78.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.766 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -109.08 141.99 40.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.853 0.358 . . . . 0.0 110.467 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -66.74 121.42 15.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.794 174.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -156.88 153.23 27.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.301 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -141.93 159.02 43.07 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 55.8 p90 -166.91 -172.87 2.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 111.39 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -129.42 138.51 51.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.139 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.5 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 10.1 mt-10 -62.96 -33.07 74.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.415 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.1 pttp -82.89 18.89 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.007 0.432 . . . . 0.0 111.367 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -88.87 -150.73 0.2 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 19.9 p -111.27 112.86 24.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.23 -12.33 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.057 -168.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -84.55 -37.92 10.22 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.816 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -68.4 -35.18 77.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 51.5 mm -69.63 -60.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.925 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.668 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 75.2 p -51.73 -60.75 2.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.6 m120 -73.26 -15.98 61.41 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -171.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.543 ' HA ' ' HD3' ' C' ' 81' ' ' LYS . 0.5 OUTLIER -69.65 -36.01 75.7 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.1 167.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.3 mt -58.36 -20.91 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.625 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.7 OUTLIER -84.05 -35.91 23.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' C' ' 78' ' ' ASP . 52.0 mtpt -53.61 -39.92 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 6.1 mt -52.97 -37.33 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.613 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 2.4 tp -44.8 148.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.664 -174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -149.85 22.32 0.88 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.342 0.591 . . . . 0.0 109.718 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.04 171.55 15.29 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.849 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.79 -49.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.775 2.317 . . . . 0.0 113.407 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -132.87 103.35 6.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.363 0.601 . . . . 0.0 110.326 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.442 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.4 mp -122.43 129.62 75.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.145 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 37.9 mt-10 -106.56 119.2 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 0.0 111.658 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.552 ' HB ' ' CD2' ' C' ' 29' ' ' LEU . 34.4 mt -96.91 98.95 8.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 146.1 14.79 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.45 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.4 pt20 -83.16 166.97 18.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.218 0.532 . . . . 0.0 112.325 -173.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.782 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.59 0.233 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 71.51 5.47 5.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.73 0.812 . . . . 0.0 111.634 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.478 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 2.3 mp0 -67.55 -30.97 70.74 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.89 -20.56 23.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.272 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.6 -70.77 0.67 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.43 . . . . 0.0 111.944 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.32 -78.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -44.01 -62.95 0.97 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -165.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' C' ' 3' ' ' GLN . 1.7 mm-40 -60.09 -19.23 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -173.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -100.59 18.23 19.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.777 0.322 . . . . 0.0 111.641 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 86.9 mmm -66.53 178.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.283 0.563 . . . . 0.0 111.863 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -50.17 -19.6 0.81 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t -46.04 -51.95 12.77 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.569 0.543 . . . . 0.0 112.309 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.43 HD11 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -89.76 -18.58 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.567 -177.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -74.11 -50.95 17.25 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.3 -0.25 . . . . 0.0 111.388 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.3 m -58.3 -29.39 65.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.459 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.456 HG12 ' O ' ' C' ' 91' ' ' ILE . 42.8 t -70.33 -40.09 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.71 172.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.31 -41.03 96.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.831 0.348 . . . . 0.0 110.439 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.47 -31.24 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.408 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.74 -35.42 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.123 0.487 . . . . 0.0 110.617 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.565 HD22 ' CZ2' ' C' ' 54' ' ' TRP . 73.3 mt -73.53 -37.37 65.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.347 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -79.59 68.92 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.814 0.816 . . . . 0.0 109.019 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -89.27 -7.4 55.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.992 -172.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.4 -50.73 0.76 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.734 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 22.5 mmtm -78.96 -160.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -41.34 137.94 2.11 Favored Glycine 0 CA--C 1.507 -0.434 0 O-C-N 123.535 0.522 . . . . 0.0 114.106 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.734 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.5 OUTLIER -141.34 143.21 33.9 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -168.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.478 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.0 mp -117.86 114.54 23.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 8.5 t -86.42 98.47 11.03 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.455 HD11 ' HB ' ' C' ' 91' ' ' ILE . 39.0 mt -83.9 124.36 30.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.246 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 29.8 t -147.13 139.43 24.63 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 54.0 mtm -107.2 145.64 32.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.277 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -148.15 89.82 1.76 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 110.568 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.18 -94.11 0.31 Allowed Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.94 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.4 p-10 -112.94 26.61 10.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 110.512 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.736 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.0 tt0 -140.35 143.39 35.73 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.493 0.663 . . . . 0.0 111.951 -171.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.0 tm? -118.11 117.88 30.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.603 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 22.5 pttp -126.31 148.62 49.5 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.15 135.29 17.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.378 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -98.69 125.57 44.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.618 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 30.9 t -109.47 119.65 40.09 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.672 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.492 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 9.5 t -109.93 178.98 4.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 78.44 27.34 0.5 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.502 1.126 . . . . 0.0 110.639 -174.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.69 32.69 19.84 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.548 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.91 -14.08 66.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.121 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.423 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 39.7 m-85 -55.44 130.36 42.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.058 0.429 . . . . 0.0 110.359 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . 0.403 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -73.85 -94.45 0.11 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.784 -0.643 . . . . 0.0 113.074 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.559 HD13 ' O ' ' C' ' 50' ' ' GLU . 33.6 mt -110.51 -67.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.415 0.626 . . . . 0.0 109.755 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 177.36 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.192 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -166.4 -37.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.657 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.559 ' O ' HD13 ' C' ' 47' ' ' ILE . 11.8 pt-20 -70.18 170.08 12.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.058 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.519 ' HB2' HD22 ' C' ' 67' ' ' ASN . 4.5 p-10 -125.35 152.97 44.04 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 111.33 -177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.449 ' HG3' ' OE2' ' C' ' 68' ' ' GLU . 8.6 mmmm -130.03 143.47 50.81 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.207 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.676 ' ND2' HG13 ' C' ' 94' ' ' ILE . 5.3 t30 -92.34 105.04 17.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.464 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.595 ' O ' HG22 ' C' ' 65' ' ' THR . 0.1 OUTLIER -113.82 165.85 12.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.128 -167.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.424 ' C ' HD11 ' C' ' 56' ' ' ILE . . . -163.78 158.09 30.5 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 119.556 -1.306 . . . . 0.0 114.816 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.424 HD11 ' C ' ' C' ' 55' ' ' GLY . 2.6 mp -119.79 129.39 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.869 169.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.515 ' CE1' ' HD3' ' C' ' 62' ' ' LYS . 40.6 m-85 -123.98 105.49 9.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.31 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.89 112.01 26.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 57.83 32.84 22.48 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.062 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.12 7.53 87.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.085 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.3 tp10 -107.01 139.05 42.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.883 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.515 ' HD3' ' CE1' ' C' ' 57' ' ' PHE . 14.3 mmmm -83.24 118.05 23.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.575 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -107.17 -24.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.358 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -160.22 147.91 16.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 110.778 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.595 HG22 ' O ' ' C' ' 54' ' ' TRP . 41.8 m -139.73 147.73 41.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -159.78 -178.73 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.121 -1.032 . . . . 0.0 113.523 -175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' C' ' 51' ' ' ASP . 51.5 t-20 -120.36 127.95 52.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.836 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 4.7 mt-10 -62.61 -21.53 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 21.0 ptmt -90.53 9.24 30.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.454 ' HB2' HD13 ' C' ' 75' ' ' ILE . 15.5 m -76.38 -118.8 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.299 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -131.71 115.67 16.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.501 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 3.3 t -60.65 -22.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -168.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.88 -37.4 19.36 Favored Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.004 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -72.14 -34.51 68.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' C' ' 70' ' ' SER . 81.9 mt -66.6 -65.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.395 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.627 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 70.8 p -62.42 -50.95 69.45 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -167.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.453 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 27.4 m120 -79.29 -14.51 58.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -172.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.05 -38.83 92.13 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' C' ' 76' ' ' SER . 73.1 mt -59.29 -24.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.497 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -80.12 -40.03 28.29 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 8.0 mmpt? -50.72 -38.68 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 0.0 109.624 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.5 mt -52.25 -35.37 49.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.736 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 37.49 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.131 0.895 . . . . 0.0 110.957 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.473 ' C ' ' H ' ' C' ' 86' ' ' GLY . 31.5 mt -79.28 115.16 21.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.241 -166.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -66.83 35.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.638 169.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' C' ' 84' ' ' ILE . . . -98.74 159.42 20.29 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.096 -171.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.616 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 93.1 Cg_endo -80.5 -75.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.691 2.261 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.616 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 15.3 p90 -115.78 112.64 22.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.666 0.746 . . . . 0.0 109.487 171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.09 114.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.706 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -90.55 96.88 10.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.338 0.589 . . . . 0.0 110.13 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.505 HG22 ' CH2' ' C' ' 54' ' ' TRP . 13.9 mt -96.35 100.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 145.89 22.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.8 pt20 -83.1 167.01 18.23 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.751 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.676 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.565 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -93.55 -32.85 13.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.383 0.611 . . . . 0.0 109.45 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.448 ' CD ' ' H ' ' C' ' 3' ' ' GLN . 19.0 mp0 -62.58 -17.92 61.06 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.55 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -45.99 -59.55 2.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.64 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.85 -23.23 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.706 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.72 174.36 8.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.477 ' HB2' ' NE2' ' C' ' 9' ' ' GLN . 6.4 mp0 -100.35 17.39 21.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.723 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' C' ' 3' ' ' GLN . 56.2 mt-10 66.5 18.99 10.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.499 0.666 . . . . 0.0 111.76 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.477 ' NE2' ' HB2' ' C' ' 7' ' ' GLU . 4.3 mt-30 -82.31 17.2 1.75 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.717 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 71.1 mtp -81.36 -149.26 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.887 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.12 -10.69 11.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -56.62 -42.39 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.09 -28.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.8 -43.99 87.04 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.478 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' C' ' 19' ' ' LYS . 22.3 m -56.97 -34.93 68.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.1 -31.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.208 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -61.31 -48.97 78.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.03 -14.25 60.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.094 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' C' ' 15' ' ' SER . 0.0 OUTLIER -80.52 -45.77 16.92 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 90.0 mt -78.42 -35.08 47.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.985 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -78.65 67.84 4.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.157 0.503 . . . . 0.0 109.961 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.414 ' HE3' HD11 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -104.6 -10.01 17.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.87 -76.6 0.19 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -99.57 -174.49 2.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.89 88.95 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 171.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.6 ptpt -128.97 143.44 50.88 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.646 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.454 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 17.1 tp -125.94 127.98 46.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.366 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -99.98 110.68 23.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -79.84 135.32 36.43 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.028 0.531 . . . . 0.0 111.973 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 41.2 m -143.61 129.11 19.06 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.286 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.577 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 39.5 mtm -123.93 130.9 53.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -148.1 90.89 1.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.05 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.27 -97.67 0.06 OUTLIER Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.713 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.87 33.38 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.37 0.605 . . . . 0.0 109.882 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.545 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.9 tt0 -150.08 136.66 19.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.535 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.2 tm? -119.96 127.41 52.62 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 165.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.412 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 50.1 pttt -144.8 144.74 31.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.43 142.42 22.18 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.732 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 60.6 p -99.07 138.81 35.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 22.2 p -118.07 117.86 30.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.564 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.444 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.2 m -105.04 178.18 4.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.955 -175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.1 38.98 1.41 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.323 1.014 . . . . 0.0 109.071 -168.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.13 27.75 16.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.732 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 11.92 82.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.523 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.478 ' O ' HG23 ' C' ' 72' ' ' VAL . 55.1 m-85 -74.69 176.1 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.248 0.524 . . . . 0.0 110.771 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . 0.481 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -101.01 -154.98 26.97 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.634 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' C' ' 48' ' ' SER . 15.9 mm -51.79 -67.08 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.486 0.66 . . . . 0.0 109.863 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 15.1 t 173.13 -67.78 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.335 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.05 -22.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 7.4 pt-20 -68.94 145.68 53.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 112.315 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.523 ' C ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 t70 -87.56 121.05 29.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.707 -174.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 3.3 mptp? -124.76 134.37 52.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.488 HD21 HG13 ' C' ' 94' ' ' ILE . 0.9 OUTLIER -96.86 105.96 18.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.538 0.685 . . . . 0.0 111.077 -177.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.577 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.66 167.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.61 -173.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.408 ' C ' HD11 ' C' ' 56' ' ' ILE . . . -170.1 165.58 38.88 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 119.291 -1.433 . . . . 0.0 115.612 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.512 HG13 HG13 ' C' ' 91' ' ' ILE . 3.5 mp -124.63 129.54 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.17 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -120.1 117.42 27.9 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -115.62 123.17 70.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.677 0.275 . . . . 0.0 110.362 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' C' ' 87' ' ' PRO . 4.5 m-20 57.56 33.23 22.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.83 90.47 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.851 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.52 130.95 56.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.476 ' HD2' ' OG1' ' C' ' 65' ' ' THR . 40.0 ttpt -74.83 123.67 25.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.934 0.397 . . . . 0.0 110.5 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.69 -43.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -146.31 147.75 31.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.933 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.577 HG23 ' O ' ' C' ' 54' ' ' TRP . 84.6 m -136.46 145.22 44.94 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.44 -170.92 2.96 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 51.3 t-20 -128.2 139.99 52.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.43 ' HB3' HG12 ' C' ' 47' ' ' ILE . 42.3 mt-10 -77.95 -11.29 59.89 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -81.59 -6.63 59.17 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.242 175.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -78.58 163.75 25.25 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -74.22 113.24 11.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.481 HG23 ' HA2' ' C' ' 46' ' ' GLY . 8.7 t -57.52 -15.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.943 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.95 -41.16 12.79 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.371 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -73.41 -33.01 64.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 38.3 mm -65.81 -61.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.532 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.413 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 68.2 p -64.8 -57.81 7.9 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.755 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.6 OUTLIER -67.69 -16.83 64.34 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -171.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.412 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.2 m-20 -64.95 -47.41 77.73 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.645 0.657 . . . . 0.0 109.291 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' C' ' 76' ' ' SER . 65.1 mt -56.78 -30.62 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.844 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.755 HD21 ' ND2' ' C' ' 77' ' ' ASN . 27.7 m-20 -89.67 -17.82 27.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 33.9 mmtp -62.76 -39.31 93.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 11.0 mt -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.302 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.545 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.8 m120 39.51 72.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.625 0.726 . . . . 0.0 110.08 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -54.36 139.99 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.451 -171.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -85.17 26.29 0.89 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.1 125.41 8.17 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.606 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' C' ' 7' ' ' GLU . 95.6 Cg_endo -79.83 -40.34 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.208 1.939 . . . . 0.0 111.035 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -126.89 120.64 29.68 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.577 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 73.4 mt -126.11 130.53 72.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.521 -172.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.33 98.47 11.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.983 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.554 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.8 tt -105.33 99.89 9.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.24 158.67 19.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.322 -171.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -84.52 158.79 20.86 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.488 HG13 HD21 ' C' ' 53' ' ' ASN . 1.6 pt . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.977 -167.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . 0.573 ' HB3' ' CB ' ' C' ' 4' ' ' LYS . 0.8 OUTLIER -118.47 132.49 56.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' C' ' 6' ' ' LEU . 20.2 mp0 -66.01 -9.28 28.94 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.573 ' CB ' ' HB3' ' C' ' 2' ' ' ASN . 3.8 ttmp? -42.78 -44.54 4.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.747 -1.57 . . . . 0.0 111.607 166.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.86 -15.04 30.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.0 110.781 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' C' ' 3' ' ' GLN . 82.8 mt -91.11 -153.1 0.3 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.47 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 8.1 mp0 -101.15 -11.56 19.47 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 4.9 mm-40 70.52 18.85 6.42 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.442 0.639 . . . . 0.0 110.498 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' C' ' 9' ' ' GLN . 9.8 mt-30 -70.38 -6.11 33.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.229 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -81.36 -143.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.622 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.05 -9.77 11.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -48.94 -60.46 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.89 0.476 . . . . 0.0 111.83 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 0.2 OUTLIER -84.83 -18.36 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.06 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.552 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 84.3 m-20 -72.46 -38.96 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.642 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 61.2 m -63.76 -30.18 71.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 89.7 t -68.25 -36.69 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.651 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.8 m-20 -59.87 -45.51 92.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.4 -32.03 70.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.292 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -87.41 -31.63 19.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.975 0.417 . . . . 0.0 110.994 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' C' ' 27' ' ' LEU . 50.8 mt -81.62 -31.41 32.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.705 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -82.67 65.1 7.63 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.44 ' CE ' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.52 -24.15 16.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.012 -173.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.46 -78.36 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.8 ttpt -98.87 -172.97 2.4 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 166.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' C' ' 24' ' ' LYS . . . 32.83 92.66 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 O-C-N 124.747 1.28 . . . . 0.0 115.703 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 7.0 ptpt -130.95 136.74 48.83 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.597 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.43 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.3 tp -116.48 122.09 43.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.581 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.9 m -108.05 104.54 14.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.292 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.472 ' HG ' HG23 ' C' ' 91' ' ' ILE . 1.3 mm? -82.53 138.43 34.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -142.76 129.35 20.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' C' ' 9' ' ' GLN . 36.0 mtm -130.81 125.02 32.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.236 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -148.42 97.21 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 110.654 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -94.63 0.8 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.459 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.43 32.46 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.501 0.667 . . . . 0.0 109.835 -175.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -128.48 136.55 50.97 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.279 0.561 . . . . 0.0 111.607 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.588 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 0.7 OUTLIER -130.39 118.45 21.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 164.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.519 ' O ' ' HD2' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -145.66 103.2 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -109.52 126.66 53.77 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.286 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -96.65 137.76 35.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.075 0.464 . . . . 0.0 109.896 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 29.2 p -109.04 117.59 34.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.644 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 21.2 t -102.63 173.97 6.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.422 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 71.76 39.61 0.84 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.384 1.052 . . . . 0.0 109.569 -166.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.12 27.02 14.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.79 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.97 5.83 88.86 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.051 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.408 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 44.0 m-85 -65.03 156.47 31.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . 0.581 ' O ' ' HG2' ' C' ' 24' ' ' LYS . . . -83.23 -166.52 39.87 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.463 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 15.6 mm -56.46 -61.9 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 121.489 0.662 . . . . 0.0 111.803 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.1 p 176.24 -74.15 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.983 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -159.88 20.99 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.358 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 42.1 mt-10 -115.95 141.87 47.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.765 -176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' C' ' 67' ' ' ASN . 7.0 p-10 -100.99 149.21 24.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.565 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.516 ' HG3' ' OE1' ' C' ' 68' ' ' GLU . 11.3 mmtp -132.9 146.23 51.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.82 ' ND2' HG13 ' C' ' 94' ' ' ILE . 6.5 t30 -96.28 99.25 10.97 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.753 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -102.93 164.35 11.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.238 -166.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.53 143.9 10.2 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 119.403 -1.38 . . . . 0.0 115.114 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.85 124.82 73.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 5.2 m-85 -125.91 155.11 41.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.02 117.87 47.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.81 24.98 14.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.21 36.82 20.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.343 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 16.0 tp10 -133.62 131.11 39.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.82 124.5 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.98 -49.2 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.612 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 56.8 t80 -155.17 150.3 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.712 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.494 HG21 ' O ' ' C' ' 54' ' ' TRP . 16.8 m -135.61 136.55 41.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.419 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 41.9 p90 -152.58 -177.9 6.52 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.793 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' C' ' 51' ' ' ASP . 52.0 t-20 -119.95 130.41 54.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.91 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' HG3' ' C' ' 52' ' ' LYS . 2.2 mt-10 -64.95 -27.06 68.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 13.7 ptmm? -79.55 2.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.374 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 11.5 m -74.63 178.24 5.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -76.63 110.84 11.53 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.39 -11.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.911 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.72 -41.24 13.12 Favored Glycine 0 CA--C 1.51 -0.238 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.971 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -71.54 -32.02 67.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.239 0.542 . . . . 0.0 109.587 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.481 ' O ' HG13 ' C' ' 79' ' ' ILE . 49.1 mm -69.62 -55.73 14.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.515 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' C' ' 38' ' ' ALA . 56.3 p -57.98 -64.65 0.84 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.8 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -67.06 -17.74 65.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -172.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -45.57 66.07 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' C' ' 75' ' ' ILE . 58.2 mt -57.65 -28.29 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.8 HD21 ' ND2' ' C' ' 77' ' ' ASN . 30.0 m-20 -85.86 -27.95 24.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.023 -177.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 68.1 mttm -60.32 -36.65 78.41 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 12.3 mt -52.35 -32.47 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.35 99.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.66 1.225 . . . . 0.0 112.769 -175.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.588 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -42.67 144.42 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 113.965 -1.471 . . . . 0.0 112.867 -173.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.34 15.17 0.89 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.33 0.585 . . . . 0.0 109.586 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.31 179.91 28.41 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.682 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.613 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.5 Cg_endo -82.01 -77.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.668 2.245 . . . . 0.0 111.455 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.613 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.5 p90 -113.83 129.92 56.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 109.798 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.427 HG12 HD12 ' C' ' 84' ' ' ILE . 3.9 mp -116.01 136.71 52.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.374 -174.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 101.69 14.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' C' ' 29' ' ' LEU . 27.0 mm -103.4 98.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 151.56 3.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -91.42 171.7 9.02 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.225 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.82 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.149 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.692 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' C' ' 3' ' ' GLN . 26.1 t70 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.564 0.221 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' C' ' 2' ' ' ASN . 1.7 t-20 69.25 -4.68 1.24 Allowed 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.512 0.725 . . . . 0.0 112.778 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.642 ' HB3' ' CB ' ' C' ' 7' ' ' GLU . 46.6 mt-30 -90.82 22.37 3.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 110.465 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -51.01 -69.73 0.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.206 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.76 -70.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.415 0.626 . . . . 0.0 110.5 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' C' ' 9' ' ' GLN . 77.0 mt -90.69 97.1 10.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.187 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.642 ' CB ' ' HB3' ' C' ' 3' ' ' GLN . 6.0 pt-20 -79.29 -97.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 0.0 111.764 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.546 ' H ' ' HG3' ' C' ' 7' ' ' GLU . 9.7 mm-40 -68.74 4.82 1.28 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.91 0.386 . . . . 0.0 111.435 171.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' C' ' 6' ' ' LEU . 2.7 mp0 -81.5 15.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.445 ' O ' HG22 ' C' ' 13' ' ' ILE . 75.0 mtm -99.5 -143.21 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.481 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -47.58 -35.38 9.03 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.438 ' O ' HG23 ' C' ' 16' ' ' VAL . 51.0 m -49.25 -48.44 45.77 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.445 HG22 ' O ' ' C' ' 10' ' ' MET . 9.9 tt -84.22 -25.26 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.288 0.566 . . . . 0.0 111.08 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.517 ' HA ' HD21 ' C' ' 17' ' ' ASN . 89.3 m-20 -85.02 -27.84 26.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.58 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 50.6 m -65.07 -31.67 73.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 51.7 t -69.83 -34.34 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.971 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.517 HD21 ' HA ' ' C' ' 14' ' ' ASN . 6.4 m-80 -57.43 -46.27 83.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.775 0.322 . . . . 0.0 110.749 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.9 -15.97 61.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.712 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -88.04 -38.0 15.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 43.3 mt -74.1 -33.9 63.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.45 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . 0.491 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 23.4 m-80 -78.53 69.62 4.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 10.01 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.696 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.91 -67.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.594 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 0.2 OUTLIER -100.44 92.56 5.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 122.616 0.366 . . . . 0.0 110.365 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 126.56 3.14 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 119.833 -1.175 . . . . 0.0 111.668 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.5 ptpt -149.4 146.09 27.3 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.479 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.505 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -115.21 110.68 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.466 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.6 m -85.93 115.6 23.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' C' ' 17' ' ' ASN . 16.5 mt -102.63 132.27 48.85 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.877 0.37 . . . . 0.0 111.82 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 26.4 p -149.58 137.55 20.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.553 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.41 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 88.8 mtp -118.32 128.07 54.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -133.04 92.78 3.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.155 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.91 -93.55 0.41 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.167 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.6 p-10 -107.87 21.73 16.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.68 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.4 tt0 -138.79 145.54 40.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.558 0.694 . . . . 0.0 112.465 -169.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.85 105.07 7.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.476 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 54.5 pttt -109.13 104.95 14.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.638 0.732 . . . . 0.0 109.113 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -104.2 119.35 38.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -104.68 139.09 40.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 26.6 t -109.9 119.19 38.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 42.8 t -93.39 173.78 7.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.288 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' C' ' 41' ' ' SER . 12.4 m120 80.19 26.5 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.757 1.286 . . . . 0.0 110.102 -171.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.28 27.09 16.05 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.061 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.12 67.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.979 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.442 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.0 m-30 -60.19 143.14 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.813 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.82 -169.26 45.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.548 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.572 ' CG1' ' HB3' ' C' ' 68' ' ' GLU . 7.7 mt -48.95 -59.28 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 CA-C-O 121.052 0.453 . . . . 0.0 111.891 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 10.3 t 173.31 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.855 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -166.69 54.4 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.525 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.654 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 5.7 pt-20 -156.45 152.04 26.95 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.73 0.3 . . . . 0.0 111.409 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.466 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 p-10 -97.31 129.62 44.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.662 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.6 mptp? -127.64 133.05 49.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.642 ' ND2' HG13 ' C' ' 94' ' ' ILE . 8.9 t30 -87.48 107.73 18.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.851 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.754 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -113.38 165.62 12.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.869 -171.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.22 167.53 40.64 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.694 -1.241 . . . . 0.0 115.245 174.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.528 HG12 HG13 ' C' ' 91' ' ' ILE . 50.2 mt -131.24 131.47 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.901 -0.65 . . . . 0.0 110.414 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 54.0 m-85 -126.02 122.47 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.808 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -112.46 117.36 55.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 61.21 32.02 19.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.316 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.58 80.06 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.0 OUTLIER -112.95 142.75 45.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.713 0.256 . . . . 0.0 110.799 -178.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.54 100.44 2.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.32 -39.7 13.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.174 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -154.25 153.35 31.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.098 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.58 HG21 ' O ' ' C' ' 54' ' ' TRP . 60.0 m -150.08 142.43 24.27 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -158.6 -179.39 8.03 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.251 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -118.91 127.07 53.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.167 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.754 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 2.1 mt-10 -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.654 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 3.7 ptmm? -76.56 -2.41 32.29 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.581 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.481 ' HB2' HD11 ' C' ' 75' ' ' ILE . 5.4 m -74.74 -170.24 1.02 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 68.6 p -88.36 116.82 26.85 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.179 -0.951 . . . . 0.0 108.749 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.601 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 11.1 t -58.17 -17.21 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.751 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.32 -44.66 8.6 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.748 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -69.17 -28.48 66.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' C' ' 70' ' ' SER . 73.1 mt -66.92 -66.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.539 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -59.78 -48.16 82.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.285 -170.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.565 HD21 ' ND2' ' C' ' 80' ' ' ASN . 12.3 m120 -76.18 -15.63 60.01 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.39 -39.92 81.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.8 mt -58.49 -27.7 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.44 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.565 ' ND2' HD21 ' C' ' 77' ' ' ASN . 7.3 m-20 -77.64 -35.79 52.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.227 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 10.7 mmpt? -52.2 -42.99 63.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.8 mt -56.21 -32.91 64.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.68 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.4 80.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.018 0.823 . . . . 0.0 111.083 -171.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.449 HG21 ' N ' ' C' ' 86' ' ' GLY . 11.8 mt -68.34 124.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.238 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.573 ' HZ1' ' HB3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -91.74 34.83 0.97 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.852 175.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.449 ' N ' HG21 ' C' ' 84' ' ' ILE . . . -79.98 143.6 25.44 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.19 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.6 Cg_endo -80.29 -43.65 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.38 2.054 . . . . 0.0 111.293 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.422 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 40.3 p90 -139.26 128.77 24.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 63.4 mt -121.38 126.15 74.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.615 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -98.9 98.97 9.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.411 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.576 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.3 tt -98.83 104.42 15.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 168.09 19.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.86 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.37 0.605 . . . . 0.0 111.32 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.642 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.599 -166.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.542 0.21 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -164.08 -17.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.225 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.413 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 15.7 mp0 -85.25 14.1 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.861 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.16 -51.08 69.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.418 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.64 -9.31 47.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.259 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.43 169.15 11.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.048 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.481 ' HA ' ' CD2' ' C' ' 88' ' ' TYR . 58.7 mt-10 -94.29 4.28 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' C' ' 12' ' ' SER . 44.8 mt-10 71.14 -10.47 0.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.507 0.723 . . . . 0.0 112.924 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' C' ' 89' ' ' ILE . 10.7 mm-40 -83.93 15.46 3.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.409 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 20.0 mmt -90.44 -143.54 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . 0.409 ' H ' ' HB3' ' C' ' 10' ' ' MET . 4.1 m-20 -56.78 -14.16 3.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' C' ' 8' ' ' GLU . 48.3 t -54.33 -39.45 67.07 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.114 0.259 . . . . 0.0 110.438 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.506 HD12 ' SD ' ' C' ' 31' ' ' MET . 13.1 pt -90.81 -25.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.896 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -64.93 -44.35 89.78 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.757 0.313 . . . . 0.0 110.627 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -57.46 -35.86 70.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.504 HG12 ' O ' ' C' ' 91' ' ' ILE . 61.8 t -68.34 -35.74 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.341 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.59 -41.54 99.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 110.132 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.37 -20.62 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.355 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' C' ' 19' ' ' LYS . 5.5 mmpt? -88.88 -35.22 16.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 110.658 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.487 HD13 HD21 ' C' ' 29' ' ' LEU . 98.9 mt -76.37 -33.14 58.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 28.7 m-80 -79.98 60.05 3.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.544 0.688 . . . . 0.0 109.838 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.447 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -94.21 -34.43 12.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.264 -173.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' C' ' 26' ' ' LYS . . . 166.98 -93.7 0.11 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.464 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -72.66 91.76 1.47 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 125.59 5.19 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.642 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' C' ' 21' ' ' ASN . 8.0 ptpt -152.34 155.63 38.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.39 129.68 43.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.548 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.4 m -107.83 99.36 8.83 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.487 HD21 HD13 ' C' ' 20' ' ' LEU . 0.6 OUTLIER -93.39 136.13 33.96 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 120.818 0.342 . . . . 0.0 111.672 -171.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -153.35 130.62 11.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.273 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.507 ' HG3' ' CD2' ' C' ' 36' ' ' LEU . 1.6 mpt? -103.71 137.49 41.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.981 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -136.04 91.46 2.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.701 0.286 . . . . 0.0 110.278 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.02 -95.03 0.12 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.079 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.5 p-10 -108.03 22.6 15.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.643 0.259 . . . . 0.0 110.938 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.688 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 25.9 tt0 -139.15 137.04 35.74 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.553 0.692 . . . . 0.0 112.398 -170.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' C' ' 31' ' ' MET . 0.6 OUTLIER -113.62 129.67 56.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -142.89 140.78 31.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -152.56 134.54 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.54 0.209 . . . . 0.0 110.996 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 62.0 p -98.28 145.45 26.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 m -125.59 116.61 22.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 49.2 m -100.66 -179.47 4.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.741 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.48 31.1 0.61 Allowed 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 124.584 1.178 . . . . 0.0 109.609 -168.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.52 32.58 22.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.112 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 1.03 86.34 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.262 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -66.63 145.67 55.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 111.055 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.71 -160.39 20.19 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.629 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.4 OUTLIER -48.51 -53.04 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 8.2 t 166.87 -62.81 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.273 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -150.37 -33.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 47.9 mm-40 -91.31 167.15 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -163.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.85 92.58 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.238 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.453 ' HB3' ' OE2' ' C' ' 68' ' ' GLU . 10.3 mptt -101.03 157.47 16.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -116.6 120.61 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.0 112.544 -174.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.542 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -102.85 166.56 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.737 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.74 150.13 11.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.117 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.3 mp -108.93 122.96 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 122.735 -0.274 . . . . 0.0 110.705 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -108.38 138.58 44.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.93 117.12 45.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.71 26.2 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.439 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.08 4.91 74.02 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.521 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.67 139.88 52.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.039 0.42 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 53.2 mtmt -82.0 136.87 35.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.721 0.296 . . . . 0.0 111.668 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.93 -39.47 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.695 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -144.7 145.93 31.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.542 HG21 ' O ' ' C' ' 54' ' ' TRP . 66.2 m -136.88 141.93 42.76 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.531 ' CD1' HG22 ' C' ' 75' ' ' ILE . 45.7 p90 -153.85 -175.14 5.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.446 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' C' ' 53' ' ' ASN . 16.8 m120 -126.73 139.48 53.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.287 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.474 ' CD ' ' HD1' ' C' ' 54' ' ' TRP . 3.1 mp0 -62.24 -15.75 49.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.498 ' HB3' HD11 ' C' ' 47' ' ' ILE . 2.4 ptmm? -82.56 1.92 35.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.919 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.6 m -81.54 -173.95 4.68 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.549 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.8 p -97.36 117.54 31.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.56 -21.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.518 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.71 -32.67 23.79 Favored Glycine 0 CA--C 1.504 -0.595 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.988 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -75.52 -38.49 59.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.549 HG12 ' O ' ' C' ' 71' ' ' THR . 42.3 mm -68.09 -58.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.514 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 20.3 m -59.74 -51.45 69.72 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.484 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.704 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -69.92 -18.94 63.41 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.734 -175.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 46.1 m-20 -68.03 -46.88 69.95 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 167.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' C' ' 76' ' ' SER . 96.2 mt -54.56 -29.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.296 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.704 HD21 ' ND2' ' C' ' 77' ' ' ASN . 69.9 m-20 -87.3 -37.35 17.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.327 -172.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 54.2 pttt -60.9 -26.03 67.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 18.5 mt -57.44 -29.05 63.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.819 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.688 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.3 m120 39.52 86.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.941 0.775 . . . . 0.0 110.679 -170.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.4 HG22 ' N ' ' C' ' 86' ' ' GLY . 15.9 mt -80.37 129.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.921 -168.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.4 OUTLIER -87.96 36.64 0.77 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.69 175.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.4 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -82.38 134.66 13.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.291 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -80.98 -47.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.545 2.163 . . . . 0.0 111.708 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' C' ' 7' ' ' GLU . 6.5 m-85 -125.71 99.54 6.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.489 ' H ' ' NE2' ' C' ' 9' ' ' GLN . 19.2 mm -100.54 125.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.424 0.631 . . . . 0.0 110.664 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.03 99.56 9.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.49 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.504 ' O ' HG12 ' C' ' 16' ' ' VAL . 3.4 tt -101.96 99.45 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.814 0.816 . . . . 0.0 109.018 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -161.54 166.12 27.51 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.634 -173.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.613 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -104.19 163.41 12.43 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.312 173.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.513 HG13 HD21 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.649 -161.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.32 -29.48 2.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.069 0.462 . . . . 0.0 109.91 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -90.23 23.36 2.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.92 0.867 . . . . 0.0 109.785 173.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -58.01 -39.13 77.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.835 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.84 -66.03 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.914 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.86 135.3 38.86 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.469 ' HG3' ' HG ' ' C' ' 12' ' ' SER . 23.3 tp10 -100.65 25.29 7.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.774 0.797 . . . . 0.0 109.851 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.17 -45.1 9.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.907 -167.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.574 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.2 mp0 -90.08 15.86 9.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' C' ' 10' ' ' MET . 0.0 OUTLIER -110.77 -151.96 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -44.76 -33.71 2.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.469 ' HG ' ' HG3' ' C' ' 7' ' ' GLU . 14.5 m -50.63 -48.76 57.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.677 0.275 . . . . 0.0 111.605 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tt -85.75 -28.09 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.113 0.482 . . . . 0.0 110.674 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.8 -35.72 75.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.983 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -63.69 -29.82 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 96.8 t -72.49 -35.64 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.647 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.98 -42.2 98.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.67 -24.42 63.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.43 -31.5 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.824 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 98.8 mt -84.88 -33.25 22.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.682 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' C' ' 26' ' ' LYS . 24.4 m-80 -78.73 78.45 5.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.701 ' NZ ' ' HB2' ' C' ' 24' ' ' LYS . 0.6 OUTLIER -120.22 7.09 10.72 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -165.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.32 -76.12 0.4 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.328 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.701 ' HB2' ' NZ ' ' C' ' 22' ' ' LYS . 47.7 mttm -75.51 -158.32 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' C' ' 24' ' ' LYS . . . -42.74 144.21 1.2 Allowed Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 114.615 0.606 . . . . 0.0 114.615 -174.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' C' ' 40' ' ' SER . 12.7 ptpt -151.14 144.61 24.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.464 HD12 HD11 ' C' ' 20' ' ' LEU . 3.3 mp -102.15 136.73 41.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.03 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 9.4 t -115.62 99.83 7.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.441 HD22 HD12 ' C' ' 20' ' ' LEU . 1.3 mm? -86.71 127.84 34.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.916 0.389 . . . . 0.0 111.482 -173.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.6 m -142.09 128.89 20.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.806 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.574 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 30.2 mtt -100.17 121.9 42.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -133.54 91.09 2.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.645 0.26 . . . . 0.0 110.973 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.9 -108.33 1.53 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.161 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.47 21.53 5.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.081 0.44 . . . . 0.0 110.867 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.573 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.8 tt0 -142.93 141.1 31.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.594 0.712 . . . . 0.0 112.105 -169.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.94 122.69 45.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 164.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -127.38 140.35 52.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.66 119.07 5.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 47.0 p -98.03 146.57 25.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 53.2 p -112.0 118.62 35.94 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 21.7 m -88.5 177.21 6.86 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.018 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.436 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.6 OUTLIER 72.54 33.61 1.38 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.285 0.991 . . . . 0.0 109.399 -172.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.8 33.45 23.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.594 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.32 6.92 89.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.189 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 21.4 m-85 -64.02 151.96 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.336 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.73 174.06 46.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.096 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.43 HG13 ' HB3' ' C' ' 68' ' ' GLU . 49.1 mm -60.57 -67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 121.182 0.515 . . . . 0.0 109.714 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 21.5 t -148.48 -88.42 0.08 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.308 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -177.31 25.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.535 0.683 . . . . 0.0 110.338 -173.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.56 146.12 50.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.159 0.504 . . . . 0.0 111.037 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.42 109.7 15.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.088 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 5.9 mptp? -121.18 137.7 54.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.591 ' ND2' HG13 ' C' ' 94' ' ' ILE . 11.4 t30 -88.57 108.53 19.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.676 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.39 162.74 13.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.495 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.72 139.71 6.92 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.159 -1.496 . . . . 0.0 116.141 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -112.75 129.17 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.443 167.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.43 106.99 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.327 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.0 123.01 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 53.76 33.41 16.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.329 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.68 60.79 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.041 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.52 119.71 21.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 5.4 ttpm? -71.2 120.88 17.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.55 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.54 -33.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.559 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.08 143.87 29.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.14 0.495 . . . . 0.0 110.598 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.676 HG21 ' O ' ' C' ' 54' ' ' TRP . 69.2 m -135.76 139.98 43.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' C' ' 75' ' ' ILE . 52.2 p90 -148.45 177.77 9.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.173 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 67.4 m-20 -122.71 139.33 54.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.862 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.43 ' HB3' HG13 ' C' ' 47' ' ' ILE . 26.5 mt-10 -66.36 -14.21 61.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -82.97 -1.26 51.99 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -87.44 -177.9 6.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -83.22 115.6 22.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.95 -15.29 11.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.697 -169.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.81 -43.3 7.29 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.656 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -69.71 -28.55 65.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' C' ' 66' ' ' PHE . 41.0 mm -70.27 -65.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.18 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.571 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.9 m -59.19 -46.64 87.89 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.767 -171.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.761 ' ND2' HD21 ' C' ' 80' ' ' ASN . 12.0 m120 -76.79 -14.83 59.88 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 19.8 m-20 -60.26 -45.62 92.64 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' C' ' 76' ' ' SER . 78.8 mt -57.22 -30.55 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.1 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.761 HD21 ' ND2' ' C' ' 77' ' ' ASN . 33.3 m-20 -90.72 -28.67 18.15 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.43 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 11.5 mmpt? -55.04 -36.02 65.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.7 mt -56.41 -31.79 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.573 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.5 OUTLIER 39.11 79.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 0.0 110.073 -168.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.42 HG22 ' N ' ' C' ' 86' ' ' GLY . 25.6 mt -69.04 131.92 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.003 -168.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -86.69 41.51 0.96 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.323 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.42 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -89.26 129.58 9.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.746 -172.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.22 -38.35 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.418 2.079 . . . . 0.0 110.748 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -150.72 113.28 4.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.119 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.436 HG12 ' SD ' ' C' ' 31' ' ' MET . 15.0 pt -123.01 153.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.876 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.27 129.32 54.33 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.226 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.424 HG23 ' CZ3' ' C' ' 54' ' ' TRP . 3.4 mt -126.89 100.23 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.681 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.37 15.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 174.51 7.32 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.35 -177.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.591 HG13 ' ND2' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.348 -169.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.504 0.192 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 73.87 -42.41 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.893 0.877 . . . . 0.0 112.855 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' C' ' 8' ' ' GLU . 41.1 mt-30 -52.13 -29.98 24.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.487 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -36.02 -54.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.673 1.233 . . . . 0.0 112.478 172.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.29 -18.8 23.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.818 -175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.45 -81.97 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.952 0.406 . . . . 0.0 112.059 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' C' ' 8' ' ' GLU . 3.3 pt-20 -102.45 -95.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.526 ' H ' ' HG3' ' C' ' 7' ' ' GLU . 4.9 mm-40 66.7 -33.62 0.2 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.926 0.891 . . . . 0.0 111.951 -172.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' C' ' 7' ' ' GLU . 8.2 mt-30 -66.9 -5.29 11.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.489 175.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 95.7 mmm -108.53 -140.94 0.38 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -41.43 -33.6 0.44 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -53.63 -51.38 63.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.801 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.464 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.4 tt -87.03 -25.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' C' ' 17' ' ' ASN . 83.2 m-20 -72.48 -26.64 61.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.128 -0.358 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.8 t -63.33 -33.64 75.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.9 t -69.6 -34.01 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.053 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' C' ' 14' ' ' ASN . 78.9 m-20 -56.98 -43.42 81.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.02 0.438 . . . . 0.0 110.149 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -76.16 -19.92 58.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.95 -27.78 28.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.188 0.518 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 72.5 mt -91.51 -32.05 15.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.97 73.43 9.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -107.7 -40.7 5.22 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.486 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -168.69 -74.68 0.04 OUTLIER Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.378 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.626 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.3 ttmm -105.81 162.55 13.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 167.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.92 85.32 0.03 OUTLIER Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.199 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.449 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 7.7 ptpt -126.13 128.35 47.18 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.164 0.506 . . . . 0.0 111.169 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 23.7 tp -115.31 126.29 54.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.519 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.1 m -108.52 106.22 16.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.064 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.42 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.7 mm? -90.33 144.67 25.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.017 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.408 ' HB3' ' CE ' ' C' ' 37' ' ' LYS . 39.5 t -158.6 136.39 10.4 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.565 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -96.81 146.03 25.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -141.41 88.73 2.17 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.76 -99.3 0.08 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.33 26.46 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 110.362 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.702 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.2 tt0 -139.01 138.78 37.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.324 0.583 . . . . 0.0 111.654 -171.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -119.06 122.59 42.47 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 167.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.408 ' CE ' ' HB3' ' C' ' 30' ' ' SER . 0.0 OUTLIER -130.79 145.33 51.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.85 133.61 14.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.705 0.288 . . . . 0.0 110.535 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 51.9 p -100.56 144.46 29.52 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.0 p -121.51 118.36 29.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.626 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 30.6 m -104.76 -179.93 4.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.377 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.68 38.73 1.63 Allowed 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 124.208 0.942 . . . . 0.0 108.812 -169.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.68 20.64 12.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.081 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.51 79.19 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.299 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.503 ' O ' HG23 ' C' ' 72' ' ' VAL . 45.1 m-85 -75.92 -179.05 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.866 0.333 . . . . 0.0 111.063 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.54 -159.63 33.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.39 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 11.8 mt -49.21 -67.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.486 0.714 . . . . 0.0 112.53 -172.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 5.4 t 171.05 -75.3 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.788 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -155.31 62.23 0.62 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.352 0.261 . . . . 0.0 111.356 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.664 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 11.6 pt-20 -169.13 176.13 5.41 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.401 -0.187 . . . . 0.0 110.946 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.52 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 12.6 t70 -127.61 113.79 16.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.51 0.506 . . . . 0.0 110.78 -173.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.445 ' HG2' HD11 ' C' ' 47' ' ' ILE . 9.6 mmmm -118.25 158.56 24.93 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.454 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER -108.93 123.21 48.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.474 0.654 . . . . 0.0 110.557 179.049 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.49 ' O ' HG21 ' C' ' 65' ' ' THR . 0.0 OUTLIER -113.06 166.4 11.46 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.078 -168.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.8 155.89 22.82 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.636 -1.269 . . . . 0.0 115.796 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -116.45 129.38 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.365 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.4 OUTLIER -127.61 99.73 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' C' ' 89' ' ' ILE . 7.4 p -84.11 125.77 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.645 -0.659 . . . . 0.0 109.967 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.49 26.21 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.878 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.41 4.45 76.98 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.977 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 35.9 tt0 -108.24 120.17 41.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.963 0.381 . . . . 0.0 110.609 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 27.6 ttpp -74.55 117.58 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.11 -30.23 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.023 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -137.39 144.63 42.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.49 HG21 ' O ' ' C' ' 54' ' ' TRP . 28.1 m -145.99 141.89 28.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' C' ' 75' ' ' ILE . 45.6 p90 -162.24 -170.65 2.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.407 ' OD1' ' HG2' ' C' ' 69' ' ' LYS . 48.7 t-20 -117.53 138.38 51.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.545 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' C' ' 47' ' ' ILE . 1.9 tt0 -72.84 -29.53 63.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.295 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.664 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 9.4 ptmt -86.66 11.65 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -76.91 -151.15 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.53 ' O ' HG12 ' C' ' 75' ' ' ILE . 18.0 p -106.92 112.24 25.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.024 -1.047 . . . . 0.0 108.984 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' C' ' 45' ' ' TYR . 6.8 t -59.39 -16.47 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.491 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.99 -46.49 7.67 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.094 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -66.79 -36.43 82.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.567 HG22 ' CD1' ' C' ' 66' ' ' PHE . 50.6 mm -68.01 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.542 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 13.5 m -70.59 -44.29 67.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -167.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.754 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -69.56 -17.62 63.58 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.951 -177.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 5.7 m-20 -64.56 -49.63 70.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 167.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' C' ' 76' ' ' SER . 81.1 mt -52.33 -32.64 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.291 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.754 HD21 ' ND2' ' C' ' 77' ' ' ASN . 62.9 m-20 -85.07 -36.3 21.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.37 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 56.6 mtmt -57.92 -30.55 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 109.788 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.3 mt -58.8 -27.98 65.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.577 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.702 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 41.77 82.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.895 0.855 . . . . 0.0 110.713 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.93 127.56 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.249 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -81.26 29.42 0.35 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.296 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.49 112.16 0.6 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.75 -14.16 10.23 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.054 . . . . 0.0 113.278 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -97.19 98.38 9.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' C' ' 58' ' ' VAL . 55.3 mt -125.48 132.68 70.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.5 0.667 . . . . 0.0 112.464 -168.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -90.29 97.37 11.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.127 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.477 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.1 tt -109.58 96.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 122.646 1.212 . . . . 0.0 107.983 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -152.97 177.32 10.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.263 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 163.53 13.11 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.882 174.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.454 HG12 ' O ' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.321 -166.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' C' ' 4' ' ' LYS . 12.8 m120 70.41 -52.1 0.65 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.98 0.912 . . . . 0.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -83.06 22.32 0.97 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' C' ' 2' ' ' ASN . 21.9 ttmm -49.24 -48.41 45.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.999 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.74 25.9 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.004 0.431 . . . . 0.0 111.316 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.57 -82.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.706 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.35 -79.5 0.52 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.394 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 65.09 17.62 11.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.424 ' HA ' ' HE2' ' C' ' 31' ' ' MET . 37.7 mt-30 -85.99 15.66 4.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.352 176.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.403 ' O ' HG23 ' C' ' 13' ' ' ILE . 96.6 mmm -105.27 -144.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.175 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.45 -29.43 58.64 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -41.43 75.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 111.319 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.403 HG23 ' O ' ' C' ' 10' ' ' MET . 0.0 OUTLIER -90.62 -30.02 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.535 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.524 ' HA ' HD21 ' C' ' 17' ' ' ASN . 77.2 m-20 -72.68 -24.97 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.118 -0.364 . . . . 0.0 110.933 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -57.88 -36.79 72.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.401 HG12 ' O ' ' C' ' 91' ' ' ILE . 61.1 t -68.43 -32.76 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.524 HD21 ' HA ' ' C' ' 14' ' ' ASN . 8.2 m-80 -59.1 -38.4 79.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 109.97 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -70.36 -40.02 74.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.75 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -40.15 80.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.628 0.728 . . . . 0.0 109.734 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.586 HD21 ' CZ2' ' C' ' 54' ' ' TRP . 36.7 mt -67.19 -41.24 86.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.8 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . 0.438 ' OD1' ' HE2' ' C' ' 26' ' ' LYS . 28.1 m-80 -80.46 37.13 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.528 0.68 . . . . 0.0 110.603 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' C' ' 20' ' ' LEU . 18.3 pttm -48.25 -42.05 29.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.302 1.441 . . . . 0.0 112.84 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.7 -71.23 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -85.84 -166.83 1.64 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 163.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' C' ' 45' ' ' TYR . . . 41.54 74.73 0.15 Allowed Glycine 0 CA--C 1.488 -1.601 0 O-C-N 124.272 0.982 . . . . 0.0 114.515 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.769 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.8 mmpt? -89.14 78.41 7.38 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.974 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.539 ' HB3' HD13 ' C' ' 20' ' ' LEU . 10.8 tp -88.07 105.94 17.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.336 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -101.15 108.08 19.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.579 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mp -112.62 142.63 44.99 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.361 0.601 . . . . 0.0 112.088 -171.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -144.58 129.74 18.62 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.029 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.521 ' CG ' HD21 ' C' ' 36' ' ' LEU . 71.4 mtm -103.49 145.89 29.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -148.34 92.03 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.424 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.28 -93.45 0.29 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.989 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -108.63 15.02 24.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.598 0.199 . . . . 0.0 111.065 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.677 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.6 tt0 -134.05 139.28 45.89 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.598 0.713 . . . . 0.0 112.454 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.521 HD21 ' CG ' ' C' ' 31' ' ' MET . 3.2 tm? -128.31 120.68 27.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.689 169.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -132.49 139.59 48.01 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.408 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -151.1 145.91 25.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.846 -171.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 74.8 p -118.86 150.77 39.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.769 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 4.1 p -124.32 116.47 22.66 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.315 0.578 . . . . 0.0 111.087 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.673 ' H ' ' HB2' ' C' ' 26' ' ' LYS . 21.6 m -89.5 -178.93 5.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.813 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.02 42.83 15.32 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.822 0.701 . . . . 0.0 109.541 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.96 21.9 12.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.476 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.49 23.44 78.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.456 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.443 ' O ' ' HA2' ' C' ' 25' ' ' GLY . 33.2 m-85 -68.19 158.81 32.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.994 0.397 . . . . 0.0 110.722 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.75 -101.87 0.56 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.311 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.565 HD13 ' HB3' ' C' ' 68' ' ' GLU . 18.6 mt -107.6 -67.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.525 0.679 . . . . 0.0 110.42 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.7 p -176.16 -68.09 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.37 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -149.35 -32.94 0.21 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.413 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.553 ' O ' HD12 ' C' ' 47' ' ' ILE . 13.8 pt-20 -88.21 178.98 6.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.55 139.94 53.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.473 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 28.1 mmmt -115.72 157.35 24.41 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.744 ' ND2' HG13 ' C' ' 94' ' ' ILE . 10.6 t30 -98.3 105.11 17.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.396 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.586 ' CZ2' HD21 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.06 165.99 10.7 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.187 -172.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.46 159.35 28.25 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.602 -1.285 . . . . 0.0 115.318 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.549 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -121.14 128.45 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.773 174.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.1 m-85 -124.04 122.49 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 48.7 t -105.86 111.18 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 60.11 24.88 14.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.084 0.468 . . . . 0.0 110.052 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.14 16.81 58.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.862 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.6 OUTLIER -107.01 128.1 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 0.0 111.357 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -72.12 107.44 4.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 m -95.58 -31.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.365 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -159.35 147.88 17.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.497 HG23 ' O ' ' C' ' 54' ' ' TRP . 71.3 m -140.62 147.78 39.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.79 -173.76 2.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.459 0.572 . . . . 0.0 112.117 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 20.1 m120 -114.37 139.5 49.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.7 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.565 ' HB3' HD13 ' C' ' 47' ' ' ILE . 63.6 tt0 -68.12 -15.83 63.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 14.5 ptmm? -83.66 -5.52 59.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -70.54 159.94 33.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 9.5 p -74.33 112.31 10.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' C' ' 27' ' ' LEU . 2.6 t -58.36 -14.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.71 -170.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.71 -38.96 14.96 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.088 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -72.71 -34.59 67.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.75 -59.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.408 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 66.5 p -58.12 -58.56 7.92 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.125 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.777 ' ND2' HD21 ' C' ' 80' ' ' ASN . 1.1 m120 -67.95 -17.05 64.33 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -67.01 -48.21 69.08 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.497 ' HA ' ' CD1' ' C' ' 82' ' ' LEU . 75.2 mt -56.85 -32.64 39.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.902 174.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.777 HD21 ' ND2' ' C' ' 77' ' ' ASN . 41.7 m-20 -84.06 -22.1 31.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.393 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 67.8 mttm -62.71 -40.95 98.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.3 mt -54.88 -35.43 64.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.224 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.677 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.6 m120 44.08 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 -166.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.82 113.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.475 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.493 ' HZ1' ' HB3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -84.45 64.6 8.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.211 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.68 156.96 26.1 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.585 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.517 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.2 Cg_endo -80.49 -55.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.501 2.134 . . . . 0.0 112.531 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.517 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.0 p90 -124.05 132.86 53.73 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.498 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 64.7 mt -130.3 132.09 65.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.511 0.672 . . . . 0.0 111.889 -169.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 29.2 mm-40 -95.22 98.18 10.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.603 174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.549 HG13 HG13 ' C' ' 56' ' ' ILE . 7.7 tt -108.25 97.94 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 177.24 9.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.818 -168.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.23 163.61 12.67 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.637 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.744 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -165.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.481 0.181 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -143.61 -36.94 0.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.58 ' HA ' ' OE1' ' C' ' 3' ' ' GLN . 5.9 mm-40 -88.28 12.68 13.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.316 0.579 . . . . 0.0 109.843 175.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -48.02 -59.37 3.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.395 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.01 -9.55 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.901 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.402 ' N ' HD21 ' C' ' 6' ' ' LEU . 3.2 mm? -90.54 -171.86 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.441 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.41 -12.5 43.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' C' ' 88' ' ' TYR . 42.7 mt-10 72.07 6.5 5.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.225 0.536 . . . . 0.0 111.294 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -121.84 19.39 10.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.151 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mtp -72.82 -145.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.3 m-20 -59.9 -16.52 30.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 31.3 t -46.34 -50.78 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.29 0.369 . . . . 0.0 111.317 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.415 HG22 ' HE1' ' C' ' 31' ' ' MET . 2.5 pp -91.27 -21.68 6.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.144 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 5.5 m-20 -63.97 -46.95 82.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.951 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' SER . . . . . 0.645 ' O ' ' HG2' ' C' ' 19' ' ' LYS . 42.6 t -55.42 -41.71 73.14 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.08 -34.5 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.575 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.57 -40.09 95.76 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -72.42 -27.4 62.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.869 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' C' ' 15' ' ' SER . 0.2 OUTLIER -79.82 -34.27 39.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.206 0.526 . . . . 0.0 110.14 -177.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' C' ' 27' ' ' LEU . 93.3 mt -80.21 -38.97 30.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.808 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -79.38 71.64 5.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.43 0.633 . . . . 0.0 109.557 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.474 ' HE3' ' CB ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -113.83 -13.73 12.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.162 -171.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 146.04 -73.21 0.32 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -174.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.474 ' CB ' ' HE3' ' C' ' 22' ' ' LYS . 2.3 mttp -72.17 -159.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -43.1 130.75 5.57 Favored Glycine 0 CA--C 1.512 -0.137 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.7 ptpt -132.05 142.87 49.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.985 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.529 ' HB2' HD11 ' C' ' 20' ' ' LEU . 4.1 mp -117.76 125.34 50.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 42.1 m -94.96 101.26 13.02 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.44 129.4 38.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.613 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -151.24 144.37 24.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.414 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.415 ' HE1' HG22 ' C' ' 13' ' ' ILE . 2.4 mpt? -105.36 146.22 29.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.34 . . . . 0.0 110.319 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -147.86 89.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.229 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.14 -101.43 0.19 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.037 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.81 34.14 2.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.738 0.78 . . . . 0.0 109.305 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.434 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 50.7 tt0 -140.9 139.9 34.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.379 0.609 . . . . 0.0 112.048 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -122.22 105.37 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 167.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.582 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 63.2 pttt -106.25 131.68 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 117.67 6.45 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.25 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 69.8 p -102.43 151.28 22.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.086 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.1 p -111.56 119.51 38.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.545 176.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 12.1 t -103.4 177.65 4.78 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.76 33.6 0.19 Allowed 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 124.619 1.199 . . . . 0.0 110.514 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.43 37.08 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.098 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.81 1.3 89.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.305 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -64.01 135.22 56.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.018 0.409 . . . . 0.0 110.359 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 150.67 50.75 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.777 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 40.6 mt -57.15 -54.56 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 121.872 0.844 . . . . 0.0 110.952 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -127.37 -173.72 2.98 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.063 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -132.52 13.9 4.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.96 0.886 . . . . 0.0 109.011 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' C' ' 52' ' ' LYS . 30.8 mt-10 -131.28 161.38 32.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.943 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.43 91.9 6.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 111.293 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 4.8 mptp? -94.37 144.67 25.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.575 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.2 102.02 14.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.656 0.598 . . . . 0.0 110.359 175.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.499 ' CZ3' HG23 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -105.11 159.28 15.97 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.5 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.459 ' C ' HD13 ' C' ' 56' ' ' ILE . . . -165.17 166.85 38.49 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 118.267 -1.92 . . . . 0.0 116.114 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.459 HD13 ' C ' ' C' ' 55' ' ' GLY . 2.3 mp -120.34 132.31 70.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.509 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 79.7 m-85 -120.84 111.44 17.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -93.76 115.21 32.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.69 34.33 23.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.003 0.43 . . . . 0.0 110.424 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.24 8.9 87.5 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.317 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 37.7 tt0 -107.92 126.96 53.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.281 0.541 . . . . 0.0 110.57 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -72.8 102.03 3.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.849 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.17 -46.57 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.264 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.51 149.43 50.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.472 HG21 ' O ' ' C' ' 54' ' ' TRP . 63.7 m -145.33 143.3 30.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -155.57 -174.95 5.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.796 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 11.6 m120 -128.37 140.99 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.869 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -67.53 -13.16 61.81 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -87.74 -6.17 58.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.021 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -83.69 177.84 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.332 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.47 ' O ' HG12 ' C' ' 75' ' ' ILE . 22.3 p -81.32 112.41 18.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.4 ' CG2' HG13 ' C' ' 47' ' ' ILE . 1.7 t -60.56 -14.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.229 -173.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.53 -38.25 12.67 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -73.89 -30.88 62.85 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.47 HG12 ' O ' ' C' ' 71' ' ' THR . 36.4 mm -67.48 -64.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.714 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.62 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 63.0 p -63.45 -58.26 7.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -169.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.527 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.0 m120 -72.73 -16.38 61.66 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -172.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.52 -41.32 97.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.62 ' HB ' ' O ' ' C' ' 76' ' ' SER . 85.6 mt -55.95 -25.44 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.123 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.5 OUTLIER -83.98 -32.19 25.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.233 -176.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.97 -38.5 76.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.0 -28.81 66.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.386 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.434 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 37.43 85.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.354 1.034 . . . . 0.0 111.567 -173.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -64.34 143.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.728 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 25.42 11.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.656 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.33 167.7 12.38 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.187 -172.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.618 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.7 Cg_endo -81.31 -72.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.835 2.357 . . . . 0.0 113.22 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.618 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 10.1 p90 -103.55 113.75 27.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.592 0.711 . . . . 0.0 109.993 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.74 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.618 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -91.49 98.35 11.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.411 0.624 . . . . 0.0 110.755 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.499 HG23 ' CZ3' ' C' ' 54' ' ' TRP . 5.0 mt -95.89 104.43 15.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -156.34 143.96 19.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 121.388 0.614 . . . . 0.0 111.602 -172.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 24.6 tm0? -66.0 140.41 58.29 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.872 174.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.575 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.76 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.236 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.521 0.677 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -126.93 -15.82 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.479 ' OE1' ' HG2' ' C' ' 8' ' ' GLU . 42.0 mt-30 -90.13 21.12 3.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.962 0.887 . . . . 0.0 109.205 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -84.03 -43.36 15.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.684 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.28 -36.25 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.445 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.67 134.02 34.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.174 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -81.45 23.7 0.61 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.479 ' HG2' ' OE1' ' C' ' 3' ' ' GLN . 54.9 mt-10 75.62 20.64 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.77 18.91 3.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.2 -0.313 . . . . 0.0 111.552 173.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 37.9 mtm -80.14 -144.83 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 110.799 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . 0.435 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.8 m-20 -61.45 -17.84 56.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.476 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -52.59 -46.28 66.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.6 pt -89.15 -26.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.81 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.435 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 79.2 m-20 -65.62 -37.15 85.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 47.7 t -54.68 -41.52 70.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 57.4 t -66.21 -37.17 79.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.403 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -67.75 -33.31 74.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.574 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -80.11 -18.7 49.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.671 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -90.61 -38.7 12.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 68.4 mt -80.17 -36.42 35.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.033 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -81.51 74.87 8.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.638 ' NZ ' HG21 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -111.5 -23.01 10.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.858 -172.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.61 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 165.12 -79.99 0.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.648 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 10.3 mttt -73.81 -159.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.442 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.33 141.54 1.15 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 -173.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.4 ptpt -149.95 140.17 22.19 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.057 -167.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 6.1 tt -108.39 125.48 51.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.393 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 20.8 m -104.16 123.86 48.05 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.452 ' N ' HD13 ' C' ' 29' ' ' LEU . 5.0 mp -94.58 134.16 37.43 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' C' ' 37' ' ' LYS . 7.0 t -159.59 142.39 13.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.727 170.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 137.98 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.816 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -136.95 89.8 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.767 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.16 -93.31 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.13 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -114.74 31.01 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.175 0.512 . . . . 0.0 110.216 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.671 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 17.1 tt0 -143.98 124.48 13.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -171.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.02 104.93 16.9 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 166.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -100.26 146.74 26.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 118.52 6.78 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.594 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.5 p -99.07 141.47 31.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.916 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 21.7 p -116.93 118.9 33.71 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.069 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.541 ' HB2' ' CD ' ' C' ' 26' ' ' LYS . 45.0 m -91.97 176.42 6.52 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.246 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.5 m120 72.19 36.12 1.15 Allowed 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.261 0.976 . . . . 0.0 109.424 -169.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.63 35.42 26.08 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.476 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.36 79.87 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.274 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 24.0 m-85 -69.69 -179.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.063 0.459 . . . . 0.0 110.872 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.35 169.9 32.21 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.162 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.638 HG21 ' NZ ' ' C' ' 22' ' ' LYS . 47.3 mm -54.04 -64.46 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 121.816 0.817 . . . . 0.0 110.907 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.8 t -174.9 -155.67 0.06 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.087 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -87.81 -15.99 35.32 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.29 0.567 . . . . 0.0 110.257 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 43.2 mt-10 -83.43 127.79 33.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.438 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.79 139.05 31.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -125.52 158.63 34.04 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.493 ' O ' HG13 ' C' ' 94' ' ' ILE . 2.2 p-10 -97.17 103.87 15.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.722 0.772 . . . . 0.0 109.591 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.616 ' O ' HG21 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.18 156.36 17.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.811 -171.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -139.98 132.8 5.71 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 119.459 -1.353 . . . . 0.0 115.582 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.405 HG22 ' CG1' ' C' ' 63' ' ' VAL . 3.0 mp -120.63 126.6 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.069 -0.565 . . . . 0.0 109.487 170.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.74 137.87 47.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.425 HG23 HG12 ' C' ' 63' ' ' VAL . 65.0 t -101.5 117.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 15.5 m120 56.71 30.37 17.47 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.351 0.407 . . . . 0.0 111.243 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 6.96 73.85 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.053 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -107.73 119.91 40.77 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.532 -0.393 . . . . 0.0 110.578 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -57.91 119.06 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.162 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.425 HG12 HG23 ' C' ' 58' ' ' VAL . 4.3 p -119.52 -43.01 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.981 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -137.07 152.39 49.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.616 HG21 ' O ' ' C' ' 54' ' ' TRP . 85.3 m -145.61 148.02 32.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' C' ' 75' ' ' ILE . 45.9 p90 -155.83 172.37 18.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.699 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.62 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.516 ' O ' HG12 ' C' ' 47' ' ' ILE . 4.2 tt0 -52.68 -40.11 62.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.688 -169.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 20.1 pttp -72.91 -0.84 14.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -169.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -71.32 -176.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.2 p -74.23 108.91 7.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 t -60.57 -11.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.951 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.24 -38.35 8.49 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.0 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -74.17 -28.79 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' C' ' 66' ' ' PHE . 50.7 mm -73.77 -64.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.083 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.581 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 8.6 m -60.71 -48.73 80.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.991 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.494 HD21 ' CG ' ' C' ' 80' ' ' ASN . 7.7 m120 -75.6 -15.5 60.34 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.517 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.1 OUTLIER -59.46 -44.85 92.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 166.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' C' ' 76' ' ' SER . 76.6 mt -56.42 -23.27 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.175 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -87.48 -34.39 18.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.106 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' C' ' 78' ' ' ASP . 57.7 mtmt -55.87 -38.89 70.73 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 1.6 mt -60.14 -29.45 68.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.142 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.671 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.66 86.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.275 -170.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.14 99.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.438 -169.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -64.77 125.84 26.07 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.411 162.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 162.79 158.68 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.911 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.562 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.0 Cg_endo -81.15 -62.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.454 2.102 . . . . 0.0 112.585 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.562 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 16.0 p90 -128.37 137.72 52.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.992 0.425 . . . . 0.0 110.166 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.4 mt -122.34 136.45 59.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.97 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -92.2 99.91 12.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.498 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 30.0 mm -113.89 98.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.06 160.73 6.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.36 173.12 12.66 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.831 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.493 HG13 ' O ' ' C' ' 53' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.424 -175.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' C' ' 4' ' ' LYS . 12.3 m120 -90.38 -39.1 12.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 122.378 -0.201 . . . . 0.0 111.214 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.623 ' CB ' ' HA ' ' C' ' 7' ' ' GLU . 87.4 mt-30 -83.44 19.24 1.6 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.795 0.807 . . . . 0.0 110.084 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' C' ' 2' ' ' ASN . 55.2 tptt -65.42 -56.83 10.32 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.715 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.44 -69.42 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.18 0.514 . . . . 0.0 109.744 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -90.89 96.5 10.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.621 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.623 ' HA ' ' CB ' ' C' ' 3' ' ' GLN . 16.7 tt0 -78.84 -99.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 0.0 109.989 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' C' ' 10' ' ' MET . 32.7 mt-10 -130.3 14.35 5.6 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.726 0.774 . . . . 0.0 109.785 163.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.99 20.44 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.974 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.424 ' H ' ' C ' ' C' ' 8' ' ' GLU . 54.1 mtt -68.49 -150.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.925 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -60.35 -9.52 3.63 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.419 ' O ' HG21 ' C' ' 16' ' ' VAL . 15.3 m -48.89 -49.87 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.673 0.389 . . . . 0.0 111.353 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.43 -18.81 7.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.212 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -69.24 -46.16 68.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -56.3 -34.69 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.477 0.656 . . . . 0.0 109.481 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.419 HG21 ' O ' ' C' ' 12' ' ' SER . 93.9 t -69.43 -37.18 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -63.39 -46.7 85.25 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 110.514 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.6 -19.86 65.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.589 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -90.15 -40.22 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.09 0.471 . . . . 0.0 110.378 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.1 mt -83.22 -32.31 26.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.304 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -92.8 79.06 4.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.358 0.599 . . . . 0.0 109.431 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.58 ' NZ ' HG21 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -114.17 -30.69 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.948 -170.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 173.1 -73.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.623 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 54.7 mttp -71.25 -158.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.538 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -45.6 142.47 4.18 Favored Glycine 0 CA--C 1.497 -1.085 0 O-C-N 123.357 0.411 . . . . 0.0 113.547 -177.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.9 ptpt -144.35 150.08 37.2 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.834 -165.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' C' ' 38' ' ' ALA . 0.5 OUTLIER -122.84 113.33 19.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.82 -170.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 74.0 m -103.03 126.2 50.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' C' ' 91' ' ' ILE . 0.7 OUTLIER -98.98 137.76 37.05 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -171.347 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 29.1 m -147.25 130.85 16.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.511 171.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.489 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.7 mtt -122.68 138.67 54.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.329 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -148.68 91.2 1.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.11 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.26 -93.61 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.706 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -108.81 33.17 4.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 109.774 -177.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.739 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.0 tt0 -149.72 139.55 21.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.526 0.679 . . . . 0.0 112.525 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.489 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.4 tm? -118.39 127.58 53.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 167.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 23.6 pttm -130.38 105.78 8.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' C' ' 27' ' ' LEU . . . -111.94 128.25 56.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.4 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -103.48 148.75 25.55 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.073 0.463 . . . . 0.0 110.41 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 64.9 p -119.41 138.25 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.338 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 14.7 m -117.35 179.49 4.03 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 80.18 23.41 0.42 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.424 1.078 . . . . 0.0 111.197 -176.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.4 50.06 13.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.393 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -3.36 86.72 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.59 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.9 m-85 -66.07 152.88 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.862 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.11 163.18 31.53 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.194 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.58 HG21 ' NZ ' ' C' ' 22' ' ' LYS . 34.3 mm -51.55 -63.24 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.16 0.981 . . . . 0.0 111.169 177.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -156.98 -176.52 6.02 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.492 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.39 45.76 1.48 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.584 0.707 . . . . 0.0 109.792 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -140.85 145.23 35.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.102 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.69 114.28 16.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 12.4 mptt -126.37 129.95 49.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.739 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.532 HD21 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -89.24 99.19 12.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.945 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.667 ' O ' HG22 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.874 -175.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.18 167.27 40.42 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.832 -1.651 . . . . 0.0 115.649 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.503 HG12 HG13 ' C' ' 91' ' ' ILE . 87.1 mt -125.99 128.2 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.582 -0.809 . . . . 0.0 111.697 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.7 m-85 -123.03 111.26 16.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.207 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -104.86 128.05 58.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.466 ' HA ' ' CE1' ' C' ' 88' ' ' TYR . 77.0 m-20 54.69 24.71 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.817 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 27.7 29.27 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.543 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.9 pt-20 -143.82 151.13 39.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.292 0.546 . . . . 0.0 110.108 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -82.86 137.86 34.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.78 -32.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -161.9 135.83 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.084 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.667 HG22 ' O ' ' C' ' 54' ' ' TRP . 79.3 m -124.07 142.52 51.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.401 ' CD2' HD11 ' C' ' 75' ' ' ILE . 38.4 p90 -152.72 -178.01 6.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.594 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 13.9 m120 -124.89 130.44 52.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.048 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.491 ' HG2' HG13 ' C' ' 47' ' ' ILE . 31.2 mt-10 -62.89 -22.55 66.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.57 2.04 27.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.443 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -87.01 -179.64 6.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 23.3 p -77.7 118.19 19.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' C' ' 75' ' ' ILE . 2.1 t -64.53 -12.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.8 -41.4 9.74 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.122 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.61 -34.34 78.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.435 ' O ' HG13 ' C' ' 79' ' ' ILE . 74.2 mt -65.45 -68.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.462 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.58 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 3.4 m -56.42 -56.17 24.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.495 HD21 ' ND2' ' C' ' 80' ' ' ASN . 10.2 m120 -76.43 -15.08 60.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.88 -39.64 83.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 166.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' C' ' 76' ' ' SER . 71.7 mt -58.94 -25.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.79 173.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.495 ' ND2' HD21 ' C' ' 77' ' ' ASN . 7.2 m-20 -80.51 -34.16 35.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.61 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -56.53 -38.37 71.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.3 mt -55.81 -35.9 66.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.084 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.739 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 8.1 m120 37.61 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.94 0.775 . . . . 0.0 110.824 -168.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.42 137.82 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.733 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.3 OUTLIER -94.88 113.89 25.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.086 174.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.61 148.82 6.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.367 -1.397 . . . . 0.0 112.929 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.536 ' HG2' ' CD2' ' C' ' 88' ' ' TYR . 98.2 Cg_endo -80.85 -43.81 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.772 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.536 ' CD2' ' HG2' ' C' ' 87' ' ' PRO . 31.8 p90 -123.68 129.65 51.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.475 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 77.1 mt -123.29 123.72 68.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.505 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -92.25 115.08 27.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.528 HG12 ' CH2' ' C' ' 54' ' ' TRP . 15.5 tt -115.98 103.25 14.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.978 0.894 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 159.26 22.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.567 -172.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.4 OUTLIER -90.81 163.04 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.34 0.59 . . . . 0.0 111.077 176.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.532 HG13 HD21 ' C' ' 53' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.808 -167.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.521 ' OD1' ' HB2' ' C' ' 4' ' ' LYS . 10.7 t0 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.56 -16.32 2.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.658 0.266 . . . . 0.0 111.155 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.413 ' HB3' ' HG3' ' C' ' 8' ' ' GLU . 2.8 mp0 -64.82 -24.93 67.7 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.521 ' HB2' ' OD1' ' C' ' 1' ' ' ASP . 29.5 ttmt -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.903 174.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.08 -51.55 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.36 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.97 -84.92 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -50.75 -60.53 2.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -162.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.703 ' HB2' ' NE2' ' C' ' 9' ' ' GLN . 24.3 mt-10 -63.74 -14.7 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.881 0.372 . . . . 0.0 111.925 -172.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.703 ' NE2' ' HB2' ' C' ' 8' ' ' GLU . 16.0 mp0 -122.66 18.3 10.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.58 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mmm -58.6 163.05 3.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.87 -21.54 30.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.091 -165.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -52.19 -42.38 63.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.033 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.09 -32.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.009 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.558 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 11.7 m120 -64.7 -43.75 92.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.707 0.289 . . . . 0.0 111.662 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 -22.55 63.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 50.4 t -85.7 -33.07 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.262 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 12.8 m120 -57.1 -48.0 79.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.22 -16.31 56.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.856 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -80.46 -42.19 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.01 -36.63 75.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.8 76.12 7.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.721 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.579 ' HZ1' HD12 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -118.53 7.34 11.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.12 -68.65 0.54 Allowed Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.515 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.416 ' HB3' ' H ' ' C' ' 25' ' ' GLY . 37.7 mttp -82.16 -160.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.563 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.61 137.88 2.34 Favored Glycine 0 CA--C 1.497 -1.06 0 O-C-N 123.846 0.716 . . . . 0.0 114.863 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.576 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 11.9 ptpt -147.2 162.1 39.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.767 -168.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.424 HD22 HD12 ' C' ' 29' ' ' LEU . 0.6 OUTLIER -138.92 130.08 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.705 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 16.3 t -106.03 106.13 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.486 HD23 HD21 ' C' ' 17' ' ' ASN . 2.2 mm? -92.61 132.14 37.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.241 0.217 . . . . 0.0 111.36 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.1 m -145.91 129.65 17.15 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.747 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.483 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 62.1 mtm -129.31 129.17 44.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.051 -174.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.679 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 4.3 t-20 -150.96 107.01 3.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.165 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.8 -97.26 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.502 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.38 30.21 6.88 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.389 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 11.1 pt20 -126.7 129.65 48.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.325 0.583 . . . . 0.0 111.562 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.6 tm? -130.76 127.14 38.15 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.627 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -144.04 128.94 18.44 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -145.77 118.73 8.75 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.679 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 48.8 p -102.88 152.05 21.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.716 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.56 ' OG ' ' HB ' ' C' ' 72' ' ' VAL . 40.2 t -117.36 118.08 31.27 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 30.7 t -96.98 178.06 5.41 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.88 32.29 0.51 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 124.284 0.99 . . . . 0.0 109.16 -167.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.33 31.66 20.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.214 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.75 80.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.76 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -69.54 168.79 13.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.739 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.37 -175.62 43.37 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.277 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.589 HG12 ' O ' ' C' ' 68' ' ' GLU . 15.3 mm -64.63 -61.74 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.2 t -170.11 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.01 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -157.49 -45.83 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -77.24 150.81 35.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.986 0.422 . . . . 0.0 111.06 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -97.82 126.74 43.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.45 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -111.5 157.36 20.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.439 HD21 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -96.16 112.69 24.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.547 0.689 . . . . 0.0 110.858 178.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.617 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.4 166.56 10.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.351 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.86 150.91 21.16 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.305 -1.426 . . . . 0.0 115.81 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 49.6 mt -124.55 136.06 61.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.985 169.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.425 ' O ' HG21 ' C' ' 89' ' ' ILE . 3.9 m-85 -131.19 134.46 46.52 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.406 HG23 HG12 ' C' ' 63' ' ' VAL . 85.6 t -102.41 114.96 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.16 31.08 19.41 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.337 0.398 . . . . 0.0 111.333 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.9 5.38 73.89 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.307 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.57 126.01 52.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.047 0.424 . . . . 0.0 110.187 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.01 126.07 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.619 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.406 HG12 HG23 ' C' ' 58' ' ' VAL . 1.7 p -120.36 -37.29 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -148.47 152.73 37.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.596 0.236 . . . . 0.0 110.743 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.617 HG23 ' O ' ' C' ' 54' ' ' TRP . 33.2 m -140.54 146.01 37.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.86 -177.86 6.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.23 0.468 . . . . 0.0 111.399 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.04 135.73 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.589 ' O ' HG12 ' C' ' 47' ' ' ILE . 1.3 tt0 -60.1 -47.16 87.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.805 -173.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.8 -2.89 10.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.6 m -71.01 -174.87 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 4.6 p -77.98 104.19 8.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.56 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 2.9 t -60.36 -12.11 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.898 -173.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' C' ' 76' ' ' SER . . . -87.71 -29.12 22.12 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.821 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -81.15 -28.45 35.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.13 -52.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.708 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.638 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.1 p -53.98 -60.79 2.86 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.054 -175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.561 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -70.48 -16.98 62.97 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.694 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 1.3 m-20 -62.68 -41.15 98.94 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 166.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.5 mt -57.83 -22.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.291 175.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -83.82 -38.99 20.52 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.677 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 18.5 ptmt -62.56 -27.77 69.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.78 -31.67 66.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.55 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 37.19 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.083 1.489 . . . . 0.0 113.335 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' C' ' 34' ' ' ASN . 1.6 tp -42.08 145.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.111 -174.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -149.59 18.6 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.613 0.721 . . . . 0.0 109.164 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.85 162.19 14.2 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.768 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' C' ' 8' ' ' GLU . 84.2 Cg_endo -80.27 -35.39 0.65 Allowed 'Trans proline' 0 CA--C 1.518 -0.284 0 C-N-CA 122.652 2.234 . . . . 0.0 111.487 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -158.81 132.36 7.45 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.834 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.425 HG21 ' O ' ' C' ' 57' ' ' PHE . 70.1 mt -134.81 139.27 47.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.433 -173.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 23.8 mm-40 -91.2 103.49 16.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.96 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 mm -100.75 96.23 4.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -158.56 167.75 28.76 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.467 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 1.9 pt20 -100.25 162.35 13.01 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.402 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.439 HG13 HD21 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 -163.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.575 0.226 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' C' ' 4' ' ' LYS . 19.9 m120 -124.55 -31.89 3.19 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.545 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.576 ' HB3' ' HA ' ' C' ' 7' ' ' GLU . 1.1 mp0 -83.81 22.99 1.04 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.047 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' C' ' 2' ' ' ASN . 25.8 ttpp -54.76 -36.02 64.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.909 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.17 -70.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.231 0.539 . . . . 0.0 110.431 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.26 96.35 10.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.125 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.576 ' HA ' ' HB3' ' C' ' 3' ' ' GLN . 46.1 mt-10 -59.94 -18.16 43.14 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -147.63 -19.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 -167.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -112.79 19.35 17.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.277 -165.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 5.8 mmt -65.04 -171.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -43.31 -36.69 1.94 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.487 0.715 . . . . 0.0 112.841 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 55.2 m -43.04 -54.01 4.54 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.835 0.709 . . . . 0.0 111.918 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -91.12 -19.82 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.549 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.03 -47.78 64.54 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.73 0.3 . . . . 0.0 110.748 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 26.9 p -57.3 -34.45 68.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.79 -37.39 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.58 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.15 -39.29 82.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.169 0.509 . . . . 0.0 109.843 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -78.33 -18.12 55.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.407 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -90.1 -42.58 11.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.676 0.274 . . . . 0.0 110.423 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.08 -32.01 68.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.48 71.07 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.519 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -109.21 -40.55 4.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.519 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -175.07 -68.98 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.675 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.6 ttmm -97.06 -174.59 3.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 166.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' C' ' 24' ' ' LYS . . . 30.73 89.92 0.01 OUTLIER Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.0 ptpt -128.68 125.34 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.579 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.445 HD23 ' HG ' ' C' ' 29' ' ' LEU . 1.5 tt -107.2 115.42 30.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.232 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 18.3 t -86.16 113.94 22.6 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.445 ' HG ' HD23 ' C' ' 27' ' ' LEU . 0.2 OUTLIER -112.72 123.14 49.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.652 0.263 . . . . 0.0 110.823 -173.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 12.5 p -151.43 142.71 23.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.674 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.45 135.44 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.326 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.626 ' OD1' ' HE3' ' C' ' 37' ' ' LYS . 11.9 m120 -139.25 91.68 2.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.564 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.74 -94.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.472 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.25 30.3 7.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.747 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.752 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.3 tt0 -143.64 138.9 29.3 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 2.8 tm? -106.2 106.38 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 164.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.626 ' HE3' ' OD1' ' C' ' 32' ' ' ASN . 22.3 pttp -98.93 151.45 20.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.68 141.57 22.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.396 0.617 . . . . 0.0 112.299 -173.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.4 p -121.44 146.94 46.39 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.903 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 m -127.8 117.12 21.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.4 m -101.94 177.67 4.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.474 -176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.589 ' OD1' ' HG3' ' C' ' 24' ' ' LYS . 0.3 OUTLIER 65.75 42.82 3.38 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.219 0.95 . . . . 0.0 108.859 -167.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 63.39 21.5 12.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.266 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.38 24.38 76.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.701 -0.762 . . . . 0.0 113.33 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.5 ' O ' HG21 ' C' ' 72' ' ' VAL . 35.2 m-85 -80.21 -179.01 6.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.83 0.315 . . . . 0.0 111.249 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.17 -162.64 38.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.324 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.675 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 6.8 mt -49.59 -67.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 112.118 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.6 p 173.57 -73.7 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.976 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -140.67 -16.08 0.91 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.816 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.66 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 4.8 pt-20 -99.43 173.88 6.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.09 121.85 40.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.135 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -124.13 135.44 53.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 111.198 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.714 ' ND2' HG13 ' C' ' 94' ' ' ILE . 9.0 t30 -89.08 116.49 27.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.684 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.547 ' O ' HG22 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.2 163.39 13.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.0 147.22 8.86 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.327 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.523 HG13 HG13 ' C' ' 91' ' ' ILE . 2.6 mp -107.63 129.84 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.067 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 52.9 m-85 -129.94 122.2 28.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.534 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' C' ' 63' ' ' VAL . 4.6 p -108.88 117.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 60.19 28.01 17.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.129 0.49 . . . . 0.0 110.462 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.9 16.46 79.91 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.388 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 30.5 mt-10 -107.06 147.56 29.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.617 0.722 . . . . 0.0 111.064 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.537 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 41.9 tptt -81.77 120.53 25.27 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.037 -169.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.42 ' CG2' HG13 ' C' ' 58' ' ' VAL . 41.2 t -109.71 -70.16 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.923 0.392 . . . . 0.0 110.929 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -137.89 143.66 40.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.909 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.547 HG22 ' O ' ' C' ' 54' ' ' TRP . 67.7 m -136.15 143.21 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' C' ' 75' ' ' ILE . 44.3 p90 -159.75 -172.61 3.74 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -116.91 137.39 52.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.85 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' C' ' 47' ' ' ILE . 0.7 OUTLIER -71.36 -28.68 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.44 -172.174 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.66 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 13.2 ptmm? -93.14 19.22 8.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.844 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 p -76.15 -119.97 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -131.7 107.66 8.95 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 166.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.5 HG21 ' O ' ' C' ' 45' ' ' TYR . 20.7 t -55.96 -24.33 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.043 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.31 -31.34 42.32 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.525 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.22 -33.96 67.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.584 HG22 ' CD1' ' C' ' 66' ' ' PHE . 27.5 mm -78.39 -54.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.158 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.653 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 64.3 p -53.61 -52.61 59.29 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.437 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.475 HD21 ' CG ' ' C' ' 80' ' ' ASN . 7.3 m120 -77.48 -16.44 58.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -64.35 -37.89 89.09 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' C' ' 76' ' ' SER . 82.4 mt -60.31 -22.27 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.979 173.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -81.31 -34.49 31.88 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.545 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -53.13 -41.97 65.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.1 mt -58.83 -30.32 67.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.821 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.752 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.21 85.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.153 0.908 . . . . 0.0 111.227 -170.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 17.2 mm -55.06 138.54 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -169.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.27 170.51 9.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.029 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.34 173.34 15.44 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.352 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.477 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.3 Cg_endo -80.71 -47.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.487 2.125 . . . . 0.0 112.094 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.477 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 44.1 p90 -150.29 141.54 23.2 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.16 132.67 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.496 . . . . 0.0 111.022 -172.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -91.83 98.71 11.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.558 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.523 HG13 HG13 ' C' ' 56' ' ' ILE . 13.8 tt -101.13 99.06 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 173.38 17.06 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.348 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 158.86 16.37 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.934 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.714 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 -166.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 70.13 17.7 7.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.29 0.636 . . . . 0.0 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' C' ' 6' ' ' LEU . 1.6 mp0 -91.92 22.76 4.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.134 0.492 . . . . 0.0 110.193 170.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -65.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.004 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.26 -31.21 16.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.677 0.751 . . . . 0.0 109.883 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.45 HD21 ' O ' ' C' ' 87' ' ' PRO . 42.0 mt -90.78 61.82 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.831 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 9.4 tp10 -65.84 24.95 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.832 1.253 . . . . 0.0 113.865 -171.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -144.62 8.47 1.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.362 -0.836 . . . . 0.0 112.095 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.14 18.22 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.912 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 22.2 mmt -70.4 -162.95 0.06 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.421 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -52.26 -23.34 5.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.051 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -49.47 -43.93 45.51 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.148 0.28 . . . . 0.0 110.968 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.422 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 6.7 mt -88.7 -23.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.221 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.04 -49.0 49.65 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.931 -0.48 . . . . 0.0 110.672 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -57.98 -32.54 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.797 0.808 . . . . 0.0 109.429 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' C' ' 13' ' ' ILE . 2.2 t -67.99 -39.29 81.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.915 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.67 -36.44 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.333 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -77.3 -20.17 55.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.665 176.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.19 -34.25 61.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.951 0.881 . . . . 0.0 108.886 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' C' ' 26' ' ' LYS . 49.6 mt -78.05 -40.26 39.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.616 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.11 82.58 4.18 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.624 ' NZ ' HG21 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -5.8 9.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.55 -75.77 0.23 Allowed Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.842 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.6 ttmt -87.36 -156.85 0.36 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.445 ' O ' HD12 ' C' ' 47' ' ' ILE . . . -18.78 106.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.563 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 0.5 OUTLIER -114.08 171.68 7.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.847 -175.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' C' ' 39' ' ' THR . 3.3 tt -156.74 115.47 3.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -173.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 69.3 m -93.9 127.5 39.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.456 ' CD2' HD11 ' C' ' 91' ' ' ILE . 86.7 mt -97.62 139.01 34.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -176.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -148.43 128.12 13.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.826 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.439 ' HG3' HD22 ' C' ' 36' ' ' LEU . 2.9 mpp? -116.7 133.18 56.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.88 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' C' ' 35' ' ' GLN . 5.2 p-10 -149.0 90.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.234 0.54 . . . . 0.0 111.653 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.24 -93.58 0.04 OUTLIER Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.556 173.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -105.71 32.36 4.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 110.494 -176.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.608 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.1 tt0 -150.18 142.01 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.439 HD22 ' HG3' ' C' ' 31' ' ' MET . 3.0 tm? -122.93 116.98 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.494 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 17.3 pttm -123.47 144.81 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -146.05 167.64 22.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.345 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 68.5 p -139.77 143.45 36.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.447 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 68.1 m -127.72 117.43 21.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.129 0.49 . . . . 0.0 109.688 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.563 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 67.9 m -100.81 179.56 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.7 m120 69.57 45.48 0.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 124.299 0.999 . . . . 0.0 109.026 -164.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.65 23.63 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.81 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' C' ' 71' ' ' THR . . . 69.38 21.69 76.06 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.949 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.75 -178.86 1.01 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.207 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.58 159.5 53.15 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.095 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 32.5 mm -52.31 -60.04 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-O 121.516 0.674 . . . . 0.0 111.067 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' C' ' 49' ' ' TYR . 45.5 t -135.62 -84.72 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.875 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.521 ' HB3' ' O ' ' C' ' 48' ' ' SER . 34.1 p90 179.59 -22.88 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.573 ' CG ' ' HE3' ' C' ' 52' ' ' LYS . 0.4 OUTLIER -97.8 172.63 7.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.377 0.608 . . . . 0.0 111.373 -178.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.81 107.18 19.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.813 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.573 ' HE3' ' CG ' ' C' ' 50' ' ' GLU . 27.0 mmtp -120.57 154.24 35.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.855 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' C' ' 93' ' ' GLN . 0.8 OUTLIER -89.25 101.85 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.917 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.495 ' O ' HG22 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.43 159.76 15.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.724 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.402 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -158.09 153.75 24.9 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 118.191 -1.957 . . . . 0.0 116.434 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.412 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.5 mp -120.84 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.172 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.432 ' CE2' ' HG2' ' C' ' 62' ' ' LYS . 36.2 m-85 -126.8 156.34 41.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.2 113.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 110.053 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 54.42 39.39 30.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.535 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.78 -3.62 86.01 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.336 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 148.14 28.99 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.432 ' HG2' ' CE2' ' C' ' 57' ' ' PHE . 53.5 mtpt -91.74 137.93 31.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.991 0.424 . . . . 0.0 110.813 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.93 -50.77 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.077 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -150.49 152.34 34.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.484 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.495 HG22 ' O ' ' C' ' 54' ' ' TRP . 89.2 m -128.07 126.87 42.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.528 ' CG ' HG23 ' C' ' 75' ' ' ILE . 11.5 p90 -133.18 178.49 6.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.031 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 28.6 m-80 -121.77 142.04 50.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.691 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' C' ' 47' ' ' ILE . 5.4 mt-10 -65.24 -10.8 34.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.34 -2.52 52.01 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.26 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -88.29 157.72 18.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' C' ' 44' ' ' GLY . 30.9 p -76.72 113.07 13.97 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -16.22 7.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.185 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.62 -36.32 38.2 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.953 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -77.07 -31.06 55.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.528 HG23 ' CG ' ' C' ' 66' ' ' PHE . 49.5 mm -75.16 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.26 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.627 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 96.6 p -58.76 -50.71 72.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -171.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.497 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.1 m120 -79.33 -17.34 54.73 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -172.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -34.47 74.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.606 167.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' C' ' 76' ' ' SER . 91.6 mt -61.1 -20.83 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.978 173.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.9 OUTLIER -76.01 -43.48 44.02 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.875 179.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -51.87 -38.06 54.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.525 0.679 . . . . 0.0 109.512 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.581 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.6 mt -55.96 -33.1 64.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.885 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.608 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 38.0 79.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.928 0.768 . . . . 0.0 111.201 -172.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.07 136.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.403 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 1.4 ptpt -81.96 39.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.677 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.65 128.15 9.48 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.027 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.45 ' O ' HD21 ' C' ' 6' ' ' LEU . 97.7 Cg_endo -80.39 -40.31 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.263 1.975 . . . . 0.0 110.851 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.78 97.85 5.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -103.45 124.4 57.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.531 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.78 100.75 9.18 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.026 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.456 HD11 ' CD2' ' C' ' 29' ' ' LEU . 4.5 mt -95.19 98.63 8.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.12 149.55 24.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.193 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 53' ' ' ASN . 6.6 tt0 -73.8 144.41 45.57 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.641 -176.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.455 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.599 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' C' ' 4' ' ' LYS . 18.0 t0 . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -138.84 -17.71 1.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -76.0 -8.45 56.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.117 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.469 ' HB2' ' OD1' ' C' ' 1' ' ' ASP . 15.7 ttmm -57.7 -39.03 76.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.51 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.45 -11.6 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.971 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.39 -153.67 0.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.777 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.678 ' HB3' ' NE2' ' C' ' 9' ' ' GLN . 3.4 mp0 -91.99 -13.8 30.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 5.3 mm-40 72.34 -5.73 1.72 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.42 0.688 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.678 ' NE2' ' HB3' ' C' ' 7' ' ' GLU . 11.1 mt-30 -87.6 16.61 5.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.46 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.426 ' O ' HG13 ' C' ' 13' ' ' ILE . 1.5 mpt? -82.95 -143.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -53.44 -18.93 3.03 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.469 ' O ' HG22 ' C' ' 16' ' ' VAL . 68.9 m -54.44 -33.24 59.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.493 HG23 ' SD ' ' C' ' 31' ' ' MET . 2.4 pp -89.55 -27.79 5.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.987 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -73.31 -43.65 60.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.689 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -58.25 -33.46 69.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.348 0.594 . . . . 0.0 109.448 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 76.3 t -74.13 -34.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.252 175.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.465 HD22 ' HB2' ' C' ' 29' ' ' LEU . 7.7 m-80 -58.99 -40.29 84.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -75.39 -15.85 60.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.358 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -87.93 -31.58 19.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.487 0.66 . . . . 0.0 109.578 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 79.4 mt -82.94 -39.87 20.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.559 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -77.14 64.41 2.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 109.597 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -103.58 7.95 37.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.211 -172.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.42 -61.87 0.64 Allowed Glycine 0 CA--C 1.504 -0.613 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.722 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 26.9 mmmt -79.28 -159.47 0.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.105 175.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -48.71 143.38 8.01 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 121.568 -0.349 . . . . 0.0 113.652 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.722 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 5.8 ptpt -150.44 135.8 17.97 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.455 -164.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.6 mp -92.04 126.92 37.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.881 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 23.8 m -95.65 99.5 11.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' C' ' 17' ' ' ASN . 16.2 mt -82.58 126.2 32.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 46.9 t -146.4 129.19 16.25 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.601 ' SD ' ' HG2' ' C' ' 9' ' ' GLN . 0.5 OUTLIER -113.25 124.04 51.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.47 91.08 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.56 -99.43 0.25 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.115 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.88 13.28 29.29 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.947 0.374 . . . . 0.0 111.147 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.689 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.4 tt0 -136.77 147.26 46.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.617 0.722 . . . . 0.0 112.189 -170.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.426 HD13 ' HG3' ' C' ' 31' ' ' MET . 9.6 tp -130.78 113.56 14.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.885 171.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 19.7 pttp -122.9 104.53 9.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -112.37 118.9 36.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.159 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 42.1 p -97.09 148.06 23.4 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.271 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 67.1 p -109.66 119.46 39.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.487 -175.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.439 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 18.4 t -95.19 175.62 6.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.425 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 4.4 m-20 63.21 31.39 15.6 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.679 0.612 . . . . 0.0 110.32 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.96 10.54 7.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.789 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.1 24.76 28.56 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.167 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.547 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 52.5 m-85 -72.43 -179.24 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.578 0.689 . . . . 0.0 110.31 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.46 -157.62 29.73 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.332 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.544 ' H ' ' HA ' ' C' ' 69' ' ' LYS . 75.7 mt -49.9 -65.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 C-N-CA 123.265 0.626 . . . . 0.0 111.125 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 27.5 t 173.25 -72.68 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.898 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -140.95 -32.51 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.71 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.476 ' O ' HD13 ' C' ' 47' ' ' ILE . 12.7 pt-20 -85.07 177.6 7.85 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.183 -0.323 . . . . 0.0 110.754 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.448 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 27.8 t70 -123.78 141.95 51.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 32.6 mmtm -124.02 153.15 41.74 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.759 173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -98.88 112.6 24.65 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.454 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.576 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -102.53 162.08 13.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.691 -173.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.99 150.51 21.13 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.653 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.477 HG12 HG13 ' C' ' 91' ' ' ILE . 46.5 mt -120.21 135.23 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 170.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' C' ' 62' ' ' LYS . 58.0 m-85 -133.07 148.88 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.6 p -143.56 129.98 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.38 27.96 12.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.132 0.491 . . . . 0.0 111.171 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 1.35 81.39 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.829 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 11.6 pt-20 -112.57 157.33 21.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.642 0.721 . . . . 0.0 110.426 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.422 ' HG2' ' CE1' ' C' ' 57' ' ' PHE . 60.4 mtpt -76.85 131.65 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.68 -49.61 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.346 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -157.0 161.79 39.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.823 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -145.85 159.72 42.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.1 p90 -168.72 -178.41 3.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.0 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -119.89 121.97 40.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.712 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' C' ' 47' ' ' ILE . 43.6 tp10 -61.0 -22.73 64.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.544 ' HA ' ' H ' ' C' ' 47' ' ' ILE . 22.8 ptmt -85.22 4.89 32.6 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.906 -0.496 . . . . 0.0 111.77 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -75.29 -118.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.423 ' O ' HG12 ' C' ' 75' ' ' ILE . 1.5 p -131.22 108.07 9.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 169.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.489 HG22 ' O ' ' C' ' 45' ' ' TYR . 48.0 t -56.72 -22.23 15.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.667 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . 0.48 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.8 -39.17 25.42 Favored Glycine 0 CA--C 1.504 -0.644 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.417 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -68.68 -40.42 80.11 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.472 HG21 ' CD1' ' C' ' 66' ' ' PHE . 48.3 mm -64.79 -63.62 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 50.4 m -53.64 -63.72 1.06 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -169.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.804 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -70.09 -16.78 63.18 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.466 -0.893 . . . . 0.0 113.289 -171.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.631 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 35.8 m-20 -73.75 -37.0 65.2 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.6 168.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 89.4 mt -60.09 -32.59 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.743 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.804 HD21 ' ND2' ' C' ' 77' ' ' ASN . 32.0 m-20 -85.38 -34.39 21.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.052 -172.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 56.4 pttt -57.81 -26.99 62.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 16.4 mt -61.32 -25.73 67.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.767 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.689 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 40.12 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.898 0.856 . . . . 0.0 111.949 -172.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.2 113.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.648 -169.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.456 ' H ' ' HE3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -93.21 119.63 32.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.128 174.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.47 147.99 6.58 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.65 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.46 -37.45 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.285 1.99 . . . . 0.0 111.825 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.3 98.87 6.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -99.76 125.86 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.553 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -122.82 123.64 41.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.862 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.576 HG12 ' CH2' ' C' ' 54' ' ' TRP . 20.1 tt -129.43 99.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 151.56 25.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.447 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -85.65 163.89 18.02 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.946 176.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.332 -164.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.443 0.164 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 64.34 18.92 11.58 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.143 0.577 . . . . 0.0 111.972 177.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -69.42 -34.48 74.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -64.28 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.698 176.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.37 -68.95 0.76 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.309 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.614 ' O ' ' HG3' ' C' ' 10' ' ' MET . 9.0 mp -92.34 -75.71 0.48 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.602 -174.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -33.92 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -161.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' C' ' 88' ' ' TYR . 13.5 mp0 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.008 0.432 . . . . 0.0 111.862 -174.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -83.86 15.06 3.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.201 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' C' ' 6' ' ' LEU . 61.0 mtm -87.81 -144.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 176.135 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 18.5 m120 -61.67 -9.02 5.28 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.4 m -49.77 -44.9 49.09 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.13 0.269 . . . . 0.0 110.634 175.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.411 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 21.5 pt -90.85 -24.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.163 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.485 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 2.2 m-20 -64.97 -36.34 84.1 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.921 0.391 . . . . 0.0 110.119 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 37.1 t -55.37 -35.91 65.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.532 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 76.1 t -71.29 -37.53 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.181 174.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' C' ' 28' ' ' SER . 33.4 m-80 -65.88 -47.08 76.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.765 -177.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -68.68 -17.17 64.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.324 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -90.33 -38.2 13.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.266 0.555 . . . . 0.0 110.466 -176.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 55.9 mt -86.57 -26.92 24.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -80.32 84.63 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.485 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -120.7 -40.43 2.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.411 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.485 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . 174.89 -68.95 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -172.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.696 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 45.9 mttp -76.09 -159.03 0.1 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.79 130.49 1.86 Allowed Glycine 0 CA--C 1.501 -0.787 0 O-C-N 123.898 0.749 . . . . 0.0 114.398 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.696 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.9 OUTLIER -134.63 143.4 47.28 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.721 -173.304 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.39 123.44 46.44 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.032 0.444 . . . . 0.0 111.156 -174.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 44.3 m -100.53 104.28 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.152 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.76 133.16 35.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -145.15 131.68 19.8 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.931 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 79.7 mtp -115.54 134.86 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.854 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.577 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 17.9 m120 -134.58 89.49 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.508 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.63 -93.23 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.566 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.9 OUTLIER -108.92 29.58 7.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.556 0.217 . . . . 0.0 110.959 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.658 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 47.7 tt0 -143.88 140.7 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.536 0.684 . . . . 0.0 111.934 -168.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.3 tm? -118.92 118.98 33.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 171.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.577 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 44.8 pttt -129.18 104.56 7.61 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -118.16 119.4 34.6 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 67.8 p -98.01 145.14 26.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.145 0.498 . . . . 0.0 111.193 -174.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 16.6 p -109.61 119.14 38.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.373 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 16.3 t -95.34 -170.39 2.16 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.04 18.54 0.48 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.448 1.093 . . . . 0.0 110.593 -170.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.24 34.21 23.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.673 173.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.13 -18.24 46.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.178 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -57.79 140.15 52.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.311 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -79.51 156.06 40.45 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.709 -174.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.547 ' O ' ' HB2' ' C' ' 24' ' ' LYS . 70.2 mt -56.08 -53.32 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.533 0.683 . . . . 0.0 112.104 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.6 ' HB2' ' OE2' ' C' ' 68' ' ' GLU . 31.2 t -116.61 176.93 4.89 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.912 -169.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -119.61 3.85 11.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.68 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 27.6 mt-10 -125.3 171.24 10.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.442 176.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.58 96.27 10.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.164 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' C' ' 50' ' ' GLU . 17.9 mmmt -98.98 158.98 15.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.793 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.569 HD21 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -101.18 110.86 22.93 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.491 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.534 ' CH2' HG22 ' C' ' 91' ' ' ILE . 0.2 OUTLIER -114.47 165.06 13.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -168.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.42 ' C ' HD13 ' C' ' 56' ' ' ILE . . . -174.12 165.86 37.67 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 119.174 -1.488 . . . . 0.0 115.741 172.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.42 HD13 ' C ' ' C' ' 55' ' ' GLY . 2.0 mp -116.19 134.1 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.983 176.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 82.3 m-85 -121.06 142.06 50.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 178.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -134.34 124.4 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.16 27.36 14.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.66 35.66 31.54 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.235 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 9.5 pt-20 -140.83 153.02 45.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -81.69 130.76 35.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 111.348 -177.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.422 ' CG2' HG13 ' C' ' 58' ' ' VAL . 53.7 t -105.89 -51.87 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.63 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -141.75 147.54 37.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.643 -176.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.403 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 2.3 t -131.89 158.12 42.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -167.82 -174.63 2.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.524 0.678 . . . . 0.0 112.725 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.04 140.22 49.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.743 -177.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.6 ' OE2' ' HB2' ' C' ' 48' ' ' SER . 19.8 tt0 -79.13 -6.83 57.44 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -168.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.0 ptmt -104.18 6.51 35.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.996 -0.44 . . . . 0.0 111.396 -177.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 39.4 p -81.84 -163.57 0.67 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.48 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 20.0 p -93.54 106.94 18.86 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . 0.51 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.2 t -59.68 -15.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.335 -169.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 -35.66 14.68 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.071 -178.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . 0.434 ' N ' HD21 ' C' ' 74' ' ' ASN . 0.9 OUTLIER -69.28 -35.97 76.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.173 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' C' ' 78' ' ' ASP . 46.2 mm -70.96 -63.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.388 -178.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.524 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.0 m -58.15 -46.61 85.38 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.992 -170.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.778 ' ND2' HD21 ' C' ' 80' ' ' ASN . 9.5 m120 -72.89 -14.72 61.54 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.621 -0.832 . . . . 0.0 112.966 -177.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 51.6 m-20 -56.44 -51.76 67.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 165.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' C' ' 76' ' ' SER . 67.5 mt -54.25 -33.41 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.754 176.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.778 HD21 ' ND2' ' C' ' 77' ' ' ASN . 38.9 m-20 -87.8 -37.71 16.34 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.814 -169.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.484 ' CE ' ' HA ' ' C' ' 78' ' ' ASP . 51.2 mtmt -56.39 -28.61 59.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.285 0.564 . . . . 0.0 109.781 176.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.5 mt -59.14 -28.06 66.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.779 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.658 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.7 m120 39.79 75.82 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.717 0.77 . . . . 0.0 110.42 -170.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 25.2 mt -74.2 131.27 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.495 -171.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 2.3 ptpt -83.84 29.59 0.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.292 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.12 142.48 28.48 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.459 -175.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.62 -39.79 0.22 Allowed 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.743 2.296 . . . . 0.0 111.377 176.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.44 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 34.8 p90 -144.45 123.54 12.87 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.744 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.63 128.72 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.755 -175.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.16 110.42 22.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.269 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.534 HG22 ' CH2' ' C' ' 54' ' ' TRP . 5.5 mt -99.87 103.66 15.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.2 154.53 25.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.269 -172.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.23 162.29 19.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.435 0.636 . . . . 0.0 111.693 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.569 HG13 HD21 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.659 -170.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.4 ' HA ' ' SD ' ' C' ' 10' ' ' MET . 1.2 m-20 . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -98.44 -23.14 15.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.952 0.406 . . . . 0.0 110.138 177.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -90.72 18.44 6.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.698 0.761 . . . . 0.0 109.948 172.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.83 -60.42 2.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.855 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.46 -6.05 56.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.32 -99.27 0.11 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -178.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.28 -97.63 0.25 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' C' ' 10' ' ' MET . 3.2 mt-10 175.21 19.5 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -72.33 17.24 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.959 -0.463 . . . . 0.0 112.011 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.47 ' H ' ' C ' ' C' ' 8' ' ' GLU . 40.3 mtm -98.04 -141.45 0.3 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.603 -177.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -47.44 -26.92 1.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -175.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -47.8 -46.34 30.49 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.27 0.356 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -90.67 -22.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.268 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.83 -51.48 40.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.259 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 17.7 t -58.37 -32.69 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.521 0.677 . . . . 0.0 109.639 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.608 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 60.0 t -71.39 -34.47 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.064 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -62.74 -37.33 86.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.163 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.22 -30.98 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.571 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -78.21 -33.39 49.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.73 0.776 . . . . 0.0 109.803 -176.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 90.2 mt -80.91 -40.38 24.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.241 -176.364 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -81.77 67.02 7.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.43 0.633 . . . . 0.0 109.831 177.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -100.95 -17.26 16.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.469 -174.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.78 -64.56 0.36 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.306 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 24.3 mmmt -84.02 -157.48 0.27 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -38.82 131.32 1.83 Allowed Glycine 0 CA--C 1.503 -0.697 0 O-C-N 124.048 0.843 . . . . 0.0 115.158 -175.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.75 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.3 OUTLIER -143.15 144.44 32.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.144 -1.028 . . . . 0.0 110.061 -172.411 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.597 ' HG ' HD11 ' C' ' 20' ' ' LEU . 1.4 pt? -123.82 112.64 17.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.681 175.087 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.767 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.2 m -82.61 104.2 12.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.974 -176.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.421 HD11 HG23 ' C' ' 91' ' ' ILE . 13.3 mt -79.78 122.29 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.369 -170.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -129.69 128.51 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.167 172.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.402 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 53.8 mtt -132.24 116.83 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.249 -176.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 46.7 t30 -150.75 96.96 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.606 0.241 . . . . 0.0 111.32 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . 0.423 ' O ' HG21 ' C' ' 84' ' ' ILE . . . 67.15 -92.69 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.682 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -101.22 -20.83 15.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.593 0.711 . . . . 0.0 109.912 -176.657 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 17.4 pt20 -88.68 127.85 35.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.692 0.758 . . . . 0.0 111.899 -171.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.529 ' HB2' HG12 ' C' ' 84' ' ' ILE . 1.6 tm? -131.27 117.69 19.33 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 47.5 pttt -144.64 106.28 4.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.767 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.04 129.0 46.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 3.9 m -95.87 129.84 42.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.651 0.738 . . . . 0.0 110.198 -176.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.75 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 61.7 p -107.26 118.68 37.34 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.68 -176.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 m -121.61 179.14 4.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.757 -175.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.44 ' HB2' ' CE ' ' C' ' 26' ' ' LYS . 0.8 OUTLIER 66.57 42.17 2.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.276 0.985 . . . . 0.0 109.439 -169.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.19 27.47 17.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.98 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.75 19.07 72.91 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.589 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.427 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 36.1 m-85 -70.98 -178.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.204 0.502 . . . . 0.0 110.857 176.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.1 -154.67 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.848 -177.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' C' ' 24' ' ' LYS . 32.2 mt -50.19 -67.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 C-N-CA 123.56 0.744 . . . . 0.0 112.729 -177.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 23.3 t 173.06 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 124.655 1.222 . . . . 0.0 109.656 -175.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -156.07 49.32 0.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.138 0.494 . . . . 0.0 110.633 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.661 ' O ' HD13 ' C' ' 47' ' ' ILE . 12.9 pt-20 -169.05 -178.68 3.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.413 ' HB3' ' HD3' ' C' ' 69' ' ' LYS . 8.7 p-10 -128.8 126.51 40.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.72 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.608 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.5 mmmt -104.69 157.59 17.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.549 HD21 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -98.18 101.45 12.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.018 177.144 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.598 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -97.28 166.89 11.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.379 -174.761 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.1 166.68 39.88 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 118.535 -1.793 . . . . 0.0 116.484 176.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 mt -128.6 139.56 51.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 113.799 -1.201 . . . . 0.0 109.747 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 40.6 m-85 -134.02 113.51 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.432 -176.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.453 HG23 ' CG1' ' C' ' 63' ' ' VAL . 41.1 t -80.96 105.59 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.549 ' HA ' ' CE2' ' C' ' 88' ' ' TYR . 0.8 OUTLIER 62.82 28.66 16.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 110.481 -176.112 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.08 67.98 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.4 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.4 tt0 -107.68 123.56 48.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.465 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 86.9 tttt -61.9 103.28 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.372 0.606 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.453 ' CG1' HG23 ' C' ' 58' ' ' VAL . 0.9 OUTLIER -97.29 -53.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 177.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -130.46 149.14 52.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.598 HG23 ' O ' ' C' ' 54' ' ' TRP . 80.0 m -149.66 138.22 20.82 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -150.9 -175.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.644 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -116.93 134.27 54.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' CG1' ' C' ' 47' ' ' ILE . 27.7 tt0 -66.91 -13.58 61.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.423 -171.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.7 ptmm? -84.23 -17.59 39.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.736 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -62.07 154.9 25.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -64.82 111.44 2.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.271 -172.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.38 -15.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.912 -173.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.67 -39.08 14.88 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 120.052 -1.07 . . . . 0.0 111.432 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.05 -36.36 72.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.129 0.49 . . . . 0.0 109.697 177.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.53 -56.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.518 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 80.7 p -57.57 -58.81 6.69 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -171.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.831 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -68.23 -19.1 64.71 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.201 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 0.9 OUTLIER -74.73 -36.19 62.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.846 169.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' C' ' 76' ' ' SER . 58.9 mt -59.59 -31.86 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.81 0.814 . . . . 0.0 109.381 170.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.831 HD21 ' ND2' ' C' ' 77' ' ' ASN . 31.8 m-20 -81.78 -35.1 29.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.919 -172.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 16.0 ptpt -59.97 -31.08 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.9 mt -56.12 -31.47 63.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.224 177.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.19 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.543 1.152 . . . . 0.0 113.189 -173.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' C' ' 34' ' ' ASN . 9.5 mm -35.57 141.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.602 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -143.78 7.93 1.47 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.99 -178.678 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.54 -175.61 20.07 Favored Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 118.997 -1.573 . . . . 0.0 111.988 -173.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.561 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 84.3 Cg_endo -81.01 -87.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.493 2.129 . . . . 0.0 111.836 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.561 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 25.1 p90 -108.23 110.88 22.6 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.623 0.725 . . . . 0.0 110.284 178.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.09 126.53 74.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.85 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.68 141.36 28.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 -174.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.517 HG12 ' CH2' ' C' ' 54' ' ' TRP . 12.0 tt -136.07 99.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.322 1.058 . . . . 0.0 108.37 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 164.52 9.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.114 -171.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.43 ' CB ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -96.66 161.2 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.928 177.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.549 HG13 HD21 ' C' ' 53' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.986 -164.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -110.07 -20.18 12.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.282 0.563 . . . . 0.0 110.265 -177.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.495 ' HB3' ' H ' ' C' ' 8' ' ' GLU . 0.0 OUTLIER -84.38 7.2 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.308 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.548 ' HA ' ' CD2' ' C' ' 88' ' ' TYR . 83.4 tttt -62.37 -53.1 59.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.451 -173.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.4 -38.9 10.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.364 173.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' C' ' 10' ' ' MET . 2.6 mm? -92.08 -94.24 0.14 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -168.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.401 ' HB3' ' HB3' ' C' ' 3' ' ' GLN . 11.7 tp10 -48.27 -59.27 3.56 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -159.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.495 ' H ' ' HB3' ' C' ' 3' ' ' GLN . 21.6 mm-40 -60.11 -26.15 66.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.32 8.68 42.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.837 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' C' ' 6' ' ' LEU . 25.5 mmt -105.64 -142.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.81 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.79 -25.74 30.12 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -177.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -55.0 -50.06 69.93 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.468 HG21 ' O ' ' C' ' 10' ' ' MET . 4.9 tt -73.71 -36.18 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . 0.403 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 77.5 m-20 -72.15 -36.14 69.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.596 -177.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -57.69 -39.41 77.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 72.7 t -66.57 -33.95 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 174.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 11.7 m120 -59.63 -44.9 93.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.834 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.28 -17.02 61.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.566 179.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' C' ' 16' ' ' VAL . 23.3 tptm -87.12 -36.27 18.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.954 -177.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 14.9 mt -82.44 -26.03 33.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.139 -177.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -81.14 61.21 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' C' ' 25' ' ' GLY . 0.0 OUTLIER -91.75 -40.87 11.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.341 -166.683 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.76 -95.67 0.1 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' C' ' 48' ' ' SER . 29.6 ttmt -91.62 145.21 24.78 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.499 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 63.85 127.55 0.01 OUTLIER Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.524 -170.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.8 ptpt -151.14 140.45 21.36 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 121.962 -0.728 . . . . 0.0 112.187 177.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.473 ' N ' HD13 ' C' ' 27' ' ' LEU . 2.5 mp -117.76 124.02 47.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.136 -176.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 6.1 t -97.63 98.86 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 52.7 mt -80.53 136.05 36.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.068 0.461 . . . . 0.0 111.667 -173.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -141.91 128.91 20.75 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.945 171.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.442 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 51.2 mtt -118.31 114.72 23.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.826 -176.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -132.92 90.64 2.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.218 -174.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.86 -104.09 0.41 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.337 175.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.45 34.26 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 109.519 -177.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.57 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 33.4 tt0 -148.65 133.4 17.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.481 0.657 . . . . 0.0 112.656 -178.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.442 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 0.6 OUTLIER -112.89 123.23 49.83 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 165.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -137.0 140.33 42.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.94 132.5 14.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.676 -177.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -96.88 134.34 40.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 10.6 p -109.52 119.7 40.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.593 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.404 ' HB2' ' CG ' ' C' ' 26' ' ' LYS . 16.0 m -106.55 -178.71 3.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.405 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 77.34 27.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 124.439 1.087 . . . . 0.0 109.832 -174.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.27 31.97 17.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.583 174.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.06 -19.69 33.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.154 175.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -56.11 130.71 45.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.542 0.171 . . . . 0.0 110.944 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.92 -45.64 0.81 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 -174.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.594 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.2 OUTLIER -47.91 -46.03 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -159.824 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 73.7 m 75.92 -60.57 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.994 0.809 . . . . 0.0 110.927 -169.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -162.72 -46.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.136 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -139.79 -172.67 3.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.359 0.6 . . . . 0.0 112.134 -172.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 3.8 t70 -82.06 102.15 10.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.542 -177.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.3 28.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.851 176.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.508 HD21 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -95.78 106.55 18.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.69 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.656 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -95.86 158.74 15.31 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.004 -174.837 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.84 145.28 12.66 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.397 -1.382 . . . . 0.0 114.684 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 45.2 mt -130.73 132.27 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 173.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.38 160.54 30.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.2 p -144.55 126.66 10.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.487 ' HA ' ' CZ ' ' C' ' 88' ' ' TYR . 88.3 m-20 57.65 28.89 16.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 111.123 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.94 -3.31 84.66 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.62 177.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.0 pt-20 -107.64 149.91 27.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.515 0.658 . . . . 0.0 109.841 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -81.43 124.84 29.76 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.0 110.329 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 -52.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -138.35 155.56 48.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.151 -173.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.656 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.3 m -150.85 139.24 20.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.676 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' C' ' 75' ' ' ILE . 50.1 p90 -152.8 -170.37 3.61 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.486 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -134.19 157.72 45.53 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.084 0.24 . . . . 0.0 110.7 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' C' ' 47' ' ' ILE . 0.5 OUTLIER -59.3 -45.47 91.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.176 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -53.51 -38.69 63.97 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.8 p -68.86 122.42 18.59 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.403 ' O ' HG12 ' C' ' 75' ' ' ILE . 41.7 p -54.75 126.39 23.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.518 0.675 . . . . 0.0 111.047 -166.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -20.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.043 -175.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.5 -37.59 30.67 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.861 -176.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -75.22 -34.8 61.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.461 HG21 ' CD1' ' C' ' 66' ' ' PHE . 47.3 mm -70.84 -65.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.424 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.5 m -58.66 -52.4 65.85 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.446 -170.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.718 ' ND2' HD21 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -74.34 -17.85 60.77 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.991 -172.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.431 ' HA ' ' HE2' ' C' ' 81' ' ' LYS . 13.0 m-20 -66.52 -48.05 70.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 95.7 mt -52.89 -33.0 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.434 174.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.718 HD21 ' ND2' ' C' ' 77' ' ' ASN . 67.5 m-20 -84.45 -32.32 24.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.37 -173.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 58.2 mtmt -60.51 -29.4 69.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.6 mt -60.38 -26.54 66.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.555 178.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.57 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 12.3 m120 39.41 78.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.889 0.743 . . . . 0.0 110.742 -171.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.422 HG21 ' H ' ' C' ' 86' ' ' GLY . 8.9 mt -57.99 145.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.946 -172.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.59 20.0 6.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.401 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . 0.422 ' H ' HG21 ' C' ' 84' ' ' ILE . . . -85.77 141.03 18.43 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.955 -176.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -79.81 -45.16 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.895 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' C' ' 4' ' ' LYS . 32.1 p90 -131.06 123.57 28.97 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.421 ' N ' HD13 ' C' ' 89' ' ' ILE . 4.2 mp -112.8 136.93 47.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 40.8 mt-10 -99.51 98.73 9.58 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.976 0.417 . . . . 0.0 109.971 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -113.83 101.46 12.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.057 -178.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.02 147.99 4.88 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.14 157.41 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.358 0.599 . . . . 0.0 111.426 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.508 HG13 HD21 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.935 -163.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -151.22 -14.95 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.115 0.483 . . . . 0.0 110.538 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . 0.475 ' HA ' ' HB2' ' C' ' 6' ' ' LEU . 6.5 mt-30 -81.02 8.25 8.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.384 176.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -63.04 -44.44 95.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.753 177.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.44 -28.75 18.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.165 0.507 . . . . 0.0 110.988 177.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' C' ' 3' ' ' GLN . 54.3 mt -77.75 142.65 38.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.737 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -77.7 22.52 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -171.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -84.71 -40.0 17.86 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.436 ' NE2' ' HB2' ' C' ' 31' ' ' MET . 27.9 mm-40 -110.94 15.65 21.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 33.8 mmt -90.07 -153.69 0.3 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.1 -28.19 10.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.866 0.467 . . . . 0.0 112.074 -175.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 25.0 m -47.69 -52.13 19.39 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.685 0.616 . . . . 0.0 111.604 177.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.572 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 19.5 pt -91.89 -23.45 5.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.798 179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.73 -40.53 76.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 108.86 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.581 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 71.7 t -70.26 -40.26 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.22 173.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -61.91 -47.95 82.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.497 -176.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.38 -16.58 62.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.541 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.558 ' HB2' ' HZ3' ' C' ' 19' ' ' LYS . 4.4 ttmp? -88.82 -38.45 14.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.076 -177.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 24.8 mt -80.81 -33.04 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.139 -176.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -80.85 62.41 4.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -90.81 -24.02 20.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -174.247 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.97 -77.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.328 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.556 ' HA ' ' OD1' ' C' ' 42' ' ' ASN . 1.0 OUTLIER -83.75 92.62 7.77 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.351 0.595 . . . . 0.0 109.604 177.011 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.7 139.74 8.22 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.404 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.1 ptpt -152.65 136.02 15.88 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.662 -177.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.516 ' HB2' ' CD1' ' C' ' 20' ' ' LEU . 3.8 mp -113.56 122.54 47.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.756 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.5 t -105.33 111.82 24.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 30.1 mt -88.82 125.81 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.003 0.43 . . . . 0.0 111.457 -175.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.94 136.35 26.83 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.266 174.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.436 ' HB2' ' NE2' ' C' ' 9' ' ' GLN . 86.2 mtp -128.1 145.53 50.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -177.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.58 91.13 1.85 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.068 176.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.1 -94.58 0.46 Allowed Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.974 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.3 p-10 -106.21 26.54 9.66 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.684 -0.304 . . . . 0.0 111.323 -174.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.646 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 34.1 tt0 -141.06 137.72 33.09 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -170.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -122.72 114.72 20.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 167.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 21.6 pttm -124.84 106.04 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.86 0.838 . . . . 0.0 108.911 176.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.36 124.68 47.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.626 175.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -94.93 123.73 38.57 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 2.7 p -110.0 119.7 40.12 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.38 -174.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -116.1 -171.04 1.91 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.564 -174.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 81.51 12.71 0.68 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.74 1.275 . . . . 0.0 111.908 -176.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.17 45.86 26.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.68 -28.66 8.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.678 172.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -59.08 129.26 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.194 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.31 -70.57 1.22 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.283 -172.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.662 HD12 ' O ' ' C' ' 50' ' ' GLU . 2.3 mt -113.32 -63.8 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.837 0.827 . . . . 0.0 111.406 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p 174.64 -63.41 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.192 -172.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 9.4 t80 179.7 36.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 O-C-N 123.467 0.48 . . . . 0.0 110.297 175.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.662 ' O ' HD12 ' C' ' 47' ' ' ILE . 42.6 mt-10 -142.23 177.86 7.96 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.438 -175.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . 0.556 ' CG ' ' HE2' ' C' ' 69' ' ' LYS . 1.1 m-20 -103.74 122.08 44.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.298 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.494 ' HB2' HD11 ' C' ' 47' ' ' ILE . 6.2 mptp? -124.24 130.33 52.33 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 112.564 -178.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.584 HD22 HG13 ' C' ' 94' ' ' ILE . 0.5 OUTLIER -88.92 126.64 35.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.629 178.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.607 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.6 OUTLIER -135.78 166.17 23.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -166.176 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.94 158.21 29.62 Favored Glycine 0 C--N 1.347 1.162 0 C-N-CA 119.278 -1.439 . . . . 0.0 116.085 171.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.414 HG13 HG12 ' C' ' 91' ' ' ILE . 1.9 mp -113.03 138.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.338 -0.931 . . . . 0.0 110.684 174.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 3.7 m-85 -131.22 132.87 44.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.567 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 91.1 t -104.08 116.39 47.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.43 27.52 17.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.662 -175.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.62 72.8 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 7.3 pt-20 -107.96 133.54 52.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.921 0.861 . . . . 0.0 109.772 176.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -65.47 128.9 37.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.464 -176.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 95.7 t -111.13 -65.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.887 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 60.5 t80 -128.4 144.8 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 -177.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.6 t -126.55 145.05 50.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . 0.487 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 38.1 p90 -155.0 -178.66 7.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -175.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -118.07 128.86 55.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.642 172.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.647 ' CB ' HG12 ' C' ' 47' ' ' ILE . 37.9 mt-10 -61.84 -27.35 68.71 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.556 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.6 pttp -82.76 14.78 2.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.477 ' HB2' HD13 ' C' ' 75' ' ' ILE . 59.7 m -73.83 -116.92 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 165.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.438 ' O ' HG13 ' C' ' 75' ' ' ILE . 0.9 OUTLIER -134.01 122.2 22.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 165.545 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 t -59.25 -24.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.903 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . 0.633 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.02 -37.0 33.99 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.742 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -76.6 -30.87 57.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 177.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' C' ' 70' ' ' SER . 75.5 mt -71.0 -61.66 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 176.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.564 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -63.91 -52.53 59.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.32 -171.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.791 ' ND2' HD21 ' C' ' 80' ' ' ASN . 9.3 m120 -74.85 -16.01 60.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -171.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . 0.49 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.1 m-20 -59.7 -49.68 76.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 165.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.7 mt -53.32 -32.05 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.288 175.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.791 HD21 ' ND2' ' C' ' 77' ' ' ASN . 27.5 m-20 -88.2 -22.04 24.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.778 -172.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 31.6 mmtp -61.34 -36.47 80.25 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 5.2 mt -64.9 -24.05 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.181 -174.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . 0.646 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 9.5 m120 39.64 87.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.771 0.67 . . . . 0.0 111.384 -172.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.36 122.92 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.815 -172.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.1 OUTLIER -80.36 55.7 2.32 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.237 170.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.78 158.96 13.96 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.597 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 83.9 Cg_endo -81.65 -62.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.668 2.246 . . . . 0.0 111.792 177.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.597 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.9 p90 -134.06 129.65 36.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -102.94 120.25 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.713 -175.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.42 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 6.2 mm-40 -92.47 99.56 12.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.389 -176.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.514 HG23 ' CH2' ' C' ' 54' ' ' TRP . 7.0 mt -110.73 103.75 15.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -162.12 155.43 20.64 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.078 -177.357 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -79.03 164.34 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 179.659 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.584 HG13 HD22 ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.549 -170.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.534 0.207 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -139.41 -25.83 0.83 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.282 -172.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -64.87 -10.17 26.49 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.769 175.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -57.75 -29.84 65.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.668 176.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.23 -14.7 32.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.31 0.576 . . . . 0.0 110.452 177.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' C' ' 88' ' ' TYR . 78.1 mt -91.0 -151.46 0.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' C' ' 9' ' ' GLN . 1.9 mp0 -91.09 -30.77 16.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.83 -179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 67.59 -5.35 0.79 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.412 0.685 . . . . 0.0 111.698 -174.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' C' ' 7' ' ' GLU . 13.3 mt-30 -89.94 16.39 8.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.292 -178.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 10' ' ' MET . . . . . 0.652 ' O ' HG21 ' C' ' 13' ' ' ILE . 22.3 mmt -88.61 -146.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.007 177.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 11' ' ' ASN . . . . . 0.437 ' H ' ' HB3' ' C' ' 10' ' ' MET . 47.1 m-80 -53.87 -20.32 5.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -178.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.46 ' O ' HG22 ' C' ' 16' ' ' VAL . 1.2 m -51.55 -45.1 62.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.753 174.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.652 HG21 ' O ' ' C' ' 10' ' ' MET . 11.6 tt -80.26 -30.12 12.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.588 -177.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -71.87 -40.39 68.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -59.12 -32.76 70.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.033 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.46 HG22 ' O ' ' C' ' 12' ' ' SER . 98.3 t -70.8 -35.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.849 173.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.64 -47.73 84.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.824 0.345 . . . . 0.0 110.391 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.44 -21.2 64.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.722 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -85.37 -36.28 20.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.874 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 61.7 mt -75.89 -32.05 59.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.26 177.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.85 71.51 4.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.533 0.683 . . . . 0.0 109.669 173.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -95.21 10.11 37.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.996 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.98 -48.06 2.47 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -173.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.689 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.5 mmtt -72.01 -159.8 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 168.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' C' ' 46' ' ' GLY . . . -44.02 133.45 6.41 Favored Glycine 0 CA--C 1.502 -0.76 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.183 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 26' ' ' LYS . . . . . 0.689 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER -131.44 135.43 47.13 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.263 -0.469 . . . . 0.0 110.648 -171.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.569 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 2.1 tt -123.16 98.98 6.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 28' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 54.5 m -87.64 101.13 13.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.251 -178.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.08 129.39 42.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.358 -171.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -125.92 127.23 45.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.143 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 31' ' ' MET . . . . . 0.402 ' HE3' ' CD1' ' C' ' 84' ' ' ILE . 47.4 mtp -140.64 113.89 8.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.899 -177.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.563 ' HB2' ' OE1' ' C' ' 35' ' ' GLN . 58.4 m-80 -148.99 111.49 4.74 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.603 175.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.56 -98.49 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.837 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.27 30.28 6.87 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.105 0.479 . . . . 0.0 110.258 -178.94 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' C' C ' 35' ' ' GLN . . . . . 0.563 ' OE1' ' HB2' ' C' ' 32' ' ' ASN . 2.4 pt20 -122.94 123.45 40.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.618 . . . . 0.0 111.491 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 1.4 tp -132.25 112.19 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.552 170.02 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 37' ' ' LYS . . . . . 0.52 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 52.2 pttt -137.24 103.72 5.19 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 38' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -102.6 129.91 49.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.803 173.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' C' ' 28' ' ' SER . 76.0 p -105.44 147.8 27.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.07 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 17.3 p -128.59 157.74 40.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -177.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.432 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 20.1 t -151.6 -174.44 4.84 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.576 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.45 16.67 0.49 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.943 1.297 . . . . 0.0 111.679 -174.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.71 51.17 17.02 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 166.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.97 -21.12 41.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.909 174.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.44 112.58 6.83 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' C' ' 25' ' ' GLY . . . -78.89 -78.31 0.85 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.885 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 47' ' ' ILE . . . . . 0.571 ' CG1' ' HB2' ' C' ' 68' ' ' GLU . 26.5 mt -111.96 -67.33 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 CA-C-O 121.856 0.836 . . . . 0.0 109.063 173.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.4 p 178.88 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.641 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -141.31 -32.67 0.54 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.486 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.535 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 8.4 pt-20 -70.03 160.7 31.47 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.36 109.07 20.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.617 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.481 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.8 mmmt -101.76 141.11 35.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 173.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 53' ' ' ASN . . . . . 0.487 HD21 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -106.09 108.66 20.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.541 0.686 . . . . 0.0 111.109 -173.674 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' C' C ' 54' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -105.25 166.22 10.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.89 -174.019 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.49 160.2 32.14 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 118.976 -1.583 . . . . 0.0 115.39 173.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.512 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -119.61 136.01 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.759 -0.72 . . . . 0.0 110.2 174.119 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 57' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 30.8 m-85 -128.49 111.66 13.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.761 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.416 ' HA ' HG12 ' C' ' 89' ' ' ILE . 26.3 t -79.58 105.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 57.51 28.16 15.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 -174.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 12.9 64.24 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.025 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.8 tt0 -106.81 138.66 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.616 ' HE2' ' OG1' ' C' ' 65' ' ' THR . 13.5 tptm -68.29 130.96 44.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.462 -176.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.491 HG11 ' H ' ' C' ' 64' ' ' TYR . 2.3 p -129.39 -60.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.282 175.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 64' ' ' TYR . . . . . 0.491 ' H ' HG11 ' C' ' 63' ' ' VAL . 69.9 t80 -132.91 133.96 43.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.748 0.308 . . . . 0.0 110.258 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.616 ' OG1' ' HE2' ' C' ' 62' ' ' LYS . 24.5 m -128.28 144.83 51.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -157.97 174.6 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.314 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -121.83 132.22 54.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 68' ' ' GLU . . . . . 0.571 ' HB2' ' CG1' ' C' ' 47' ' ' ILE . 39.6 mt-10 -60.85 -24.41 65.89 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -75.42 4.21 7.76 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -174.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -74.23 -119.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 71' ' ' THR . . . . . 0.525 ' O ' HG12 ' C' ' 75' ' ' ILE . 20.5 p -131.52 122.65 26.51 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.42 -18.91 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.236 -172.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . 0.485 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.9 -45.38 10.59 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.276 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -62.35 -29.04 70.18 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 75' ' ' ILE . . . . . 0.525 HG12 ' O ' ' C' ' 71' ' ' THR . 51.3 mm -75.84 -66.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.145 178.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 76' ' ' SER . . . . . 0.569 ' OG ' ' HG ' ' C' ' 27' ' ' LEU . 16.3 m -51.13 -50.03 59.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 77' ' ' ASN . . . . . 0.703 HD21 ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -81.75 -17.57 47.27 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.909 -173.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.7 -34.87 67.42 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.314 166.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' C' ' 76' ' ' SER . 56.4 mt -58.52 -26.44 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.021 174.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 80' ' ' ASN . . . . . 0.703 ' ND2' HD21 ' C' ' 77' ' ' ASN . 38.5 m-20 -83.74 -27.22 29.08 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.567 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -56.61 -41.31 76.85 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.0 mt -54.77 -33.95 61.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.667 177.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.57 104.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.724 1.209 . . . . 0.0 113.762 -174.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 84' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 1.9 tp -45.23 148.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.655 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 85' ' ' LYS . . . . . 0.444 ' C ' ' HD2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -159.02 22.54 0.2 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.241 179.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.73 12.35 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.289 -168.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 87' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 73.2 Cg_endo -80.6 -42.02 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.851 2.367 . . . . 0.0 111.681 177.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 88' ' ' TYR . . . . . 0.424 ' HB3' ' O ' ' C' ' 6' ' ' LEU . 34.7 p90 -145.26 117.5 8.42 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' C' ' 58' ' ' VAL . 58.4 mt -132.93 132.38 59.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 -176.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.15 111.04 22.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.764 -175.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 91' ' ' ILE . . . . . 0.512 HG13 HG13 ' C' ' 56' ' ' ILE . 11.8 tt -108.72 98.17 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.02 156.9 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.795 -170.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 1.1 pt20 -86.78 163.33 17.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.288 0.566 . . . . 0.0 111.331 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 94' ' ' ILE . . . . . 0.487 HG13 HD21 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 -167.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' C' ' 9' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 32.5 mmt -77.0 -146.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -49.15 -25.97 2.51 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -52.54 -33.86 47.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.116 0.26 . . . . 0.0 111.51 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.579 HG13 ' N ' ' C' ' 14' ' ' ASN . 4.7 pt -90.54 -32.47 5.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.147 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.579 ' N ' HG13 ' C' ' 13' ' ' ILE . 16.6 m120 -71.11 -36.74 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.752 0.311 . . . . 0.0 110.242 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 19' ' ' LYS . 49.5 m -58.5 -33.96 70.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.695 HG11 ' HB ' ' C' ' 91' ' ' ILE . 71.3 t -68.32 -40.17 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.353 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -62.29 -41.81 98.81 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.704 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.13 -27.17 67.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.614 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' C' ' 15' ' ' SER . 94.1 mttt -85.27 -33.91 22.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.524 0.678 . . . . 0.0 110.286 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' C' ' 27' ' ' LEU . 29.3 mt -85.16 -32.44 22.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.088 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.585 0.707 . . . . 0.0 109.902 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 9.8 41.88 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.218 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.18 -69.73 0.5 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.545 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.678 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 24.2 tttt -76.01 -156.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.93 137.52 3.54 Favored Glycine 0 CA--C 1.498 -0.99 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.678 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.2 ptpt -147.32 132.2 18.07 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.343 -167.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.646 ' HB3' HD13 ' C' ' 20' ' ' LEU . 9.7 tt -105.63 125.76 51.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.446 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 31.8 m -103.31 135.05 45.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.109 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' C' ' 13' ' ' ILE . 5.8 mp -100.18 126.05 46.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.513 0.196 . . . . 0.0 111.444 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.5 t -152.49 144.95 24.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.467 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.454 ' HG3' HD23 ' C' ' 36' ' ' LEU . 1.9 mpt? -127.59 141.58 51.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 -176.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.53 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 18.1 m120 -133.07 88.86 2.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 173.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.78 -98.97 0.17 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.949 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.07 24.25 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.669 -0.312 . . . . 0.0 111.157 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.545 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 21.9 tt0 -143.27 108.25 4.94 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.548 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.679 ' CB ' HG13 ' C' ' 84' ' ' ILE . 3.1 tm? -88.03 124.87 34.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.669 166.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.53 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 41.6 pttt -129.1 103.38 6.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.79 118.87 37.82 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.932 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.0 p -98.4 138.89 34.97 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.29 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 t -111.23 119.51 39.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.333 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.437 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 23.6 t -94.84 -172.66 2.77 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.413 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 1.0 OUTLIER 70.73 27.94 3.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 123.854 0.722 . . . . 0.0 110.303 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.86 32.05 21.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.117 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 -6.63 78.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.308 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.486 ' O ' HG23 ' C' ' 72' ' ' VAL . 64.8 m-85 -63.3 161.36 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 0.0 110.47 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.493 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -85.51 166.72 40.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.348 -172.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.459 ' H ' HD12 ' C' ' 47' ' ' ILE . 3.7 mp -60.73 -54.62 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 122.196 0.998 . . . . 0.0 109.856 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 26.7 t -129.34 -169.85 2.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.851 -169.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -132.62 15.8 4.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.389 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.45 ' C ' ' HE3' ' C' ' 69' ' ' LYS . 33.1 mt-10 -125.17 163.13 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.748 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.82 105.31 11.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.552 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.49 140.89 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.7 OUTLIER -89.41 109.35 20.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.466 0.65 . . . . 0.0 109.967 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.629 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.52 165.63 11.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.241 -173.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.52 157.74 29.1 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 118.579 -1.772 . . . . 0.0 115.826 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.43 HG23 HG12 ' C' ' 91' ' ' ILE . 79.5 mt -126.55 137.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.106 -1.047 . . . . 0.0 110.619 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' C' ' 89' ' ' ILE . 7.3 m-85 -130.03 126.84 38.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.906 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 58' ' ' VAL . 8.3 p -103.38 111.42 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.184 0.516 . . . . 0.0 110.084 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.8 m120 49.64 43.75 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.575 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.36 -6.69 82.3 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.185 -0.531 . . . . 0.0 114.345 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -108.32 150.14 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.855 0.827 . . . . 0.0 111.072 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -73.59 132.57 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.064 0.459 . . . . 0.0 111.756 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.59 -61.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.728 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -148.74 147.4 28.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.856 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.629 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.5 m -134.14 133.04 40.57 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 49.3 p90 -150.85 -167.12 2.73 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -128.73 144.78 51.24 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.571 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 6.6 mt-10 -70.11 -20.88 63.16 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -175.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.45 ' HE3' ' C ' ' C' ' 50' ' ' GLU . 11.3 ptpt -89.21 7.52 34.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.381 . . . . 0.0 111.035 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.0 m -90.08 165.89 13.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.805 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.09 106.27 8.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.493 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 0.9 OUTLIER -59.11 -15.85 7.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.862 -173.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.64 -32.9 17.58 Favored Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.645 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.82 -29.13 50.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 45.8 mm -71.68 -57.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.777 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.518 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 37.7 p -60.27 -55.65 31.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.646 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 2.0 m-20 -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.6 OUTLIER -64.02 -46.98 82.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' C' ' 76' ' ' SER . 74.7 mt -53.87 -31.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.333 175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 9.9 m-20 -89.99 -24.16 21.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.55 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 64.0 mttm -55.68 -39.75 71.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 4.6 mt -61.1 -23.07 65.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.778 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.545 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.5 m-20 40.42 77.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.846 0.831 . . . . 0.0 110.833 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.679 HG13 ' CB ' ' C' ' 36' ' ' LEU . 0.5 OUTLIER -93.77 145.61 7.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.514 -171.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.507 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -81.16 4.46 20.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.356 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.19 109.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.335 0 O-C-N 124.077 0.861 . . . . 0.0 113.618 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 97.9 Cg_endo -82.26 -55.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.765 2.31 . . . . 0.0 112.28 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.445 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 88.2 t80 -107.95 98.75 8.28 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' C' ' 57' ' ' PHE . 20.9 pt -119.38 123.88 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.749 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.3 105.06 16.98 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.695 ' HB ' HG11 ' C' ' 16' ' ' VAL . 5.4 mt -97.22 99.71 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.407 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 92' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -163.82 148.15 10.34 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 5.0 pp0? -77.08 165.34 24.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.322 0.582 . . . . 0.0 111.072 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.486 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.863 -166.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.646 ' N ' HE21 ' C' ' 9' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.484 0.183 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.453 ' O ' HG22 ' C' ' 13' ' ' ILE . 1.0 OUTLIER -117.58 -147.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -41.59 -40.94 2.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -53.71 -39.36 65.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.497 HD13 ' ND2' ' C' ' 17' ' ' ASN . 0.0 OUTLIER -92.39 -33.2 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.538 ' HA ' HD22 ' C' ' 17' ' ' ASN . 20.8 m120 -69.84 -34.77 74.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.081 -0.387 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 40.1 t -59.27 -33.33 70.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.486 0.66 . . . . 0.0 109.29 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.485 HG21 ' O ' ' C' ' 91' ' ' ILE . 49.1 t -71.67 -35.23 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.141 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.538 HD22 ' HA ' ' C' ' 14' ' ' ASN . 16.1 m-80 -58.27 -45.47 87.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -69.03 -31.31 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.379 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.13 -35.17 37.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.196 0.522 . . . . 0.0 109.977 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' C' ' 27' ' ' LEU . 71.6 mt -69.2 -32.36 71.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.378 176.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ASN . . . . . 0.405 ' OD1' ' HD3' ' C' ' 26' ' ' LYS . 10.7 m-80 -78.41 58.69 2.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.515 0.674 . . . . 0.0 110.05 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.467 ' HD2' ' C ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -88.29 9.94 21.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.024 -175.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.47 -72.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.865 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.43 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.2 mttm -76.51 -157.71 0.09 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.369 0.268 . . . . 0.0 110.544 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -44.55 135.88 6.21 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' C' ' 40' ' ' SER . 9.8 ptpt -148.38 143.44 26.82 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.876 -162.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.615 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.8 mp -101.25 119.03 38.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.744 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 53.8 m -100.24 99.58 10.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.557 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.2 mm? -85.6 147.18 26.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 112.116 -171.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -151.13 129.13 11.76 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.076 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.0 mtt -101.9 118.64 37.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 16.9 m120 -130.74 90.08 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.813 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.79 0.6 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.965 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -102.32 33.71 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.951 0.881 . . . . 0.0 108.965 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.402 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 53.2 tt0 -144.62 138.95 27.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.973 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.4 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.6 tm? -116.37 102.81 9.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.579 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 64.4 pttt -105.96 133.22 51.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.1 118.48 6.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.941 -172.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 65.0 p -100.42 148.57 24.59 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.414 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.7 p -109.0 118.95 38.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.42 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 37.7 t -94.81 178.59 5.53 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.2 OUTLIER 63.08 37.68 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.689 0.618 . . . . 0.0 109.719 -169.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.43 24.99 10.83 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.611 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.94 19.06 73.65 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.09 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.687 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 17.8 m-85 -65.33 164.39 13.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.47 -160.36 35.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.159 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -52.99 -66.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.522 0.677 . . . . 0.0 112.165 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.583 ' H ' ' CD1' ' C' ' 47' ' ' ILE . 28.7 p -179.08 -48.1 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.004 -171.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.488 ' H ' HD13 ' C' ' 47' ' ' ILE . 68.5 t80 -171.45 -36.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.414 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -89.92 161.19 16.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -165.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' C' ' 69' ' ' LYS . 7.0 p-10 -94.21 118.22 31.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.327 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.658 ' HB2' ' CD ' ' C' ' 68' ' ' GLU . 14.1 mmmm -111.98 155.26 24.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.996 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -105.97 106.45 16.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.805 -170.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.624 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.59 164.17 11.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.785 -175.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.06 141.64 7.73 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.826 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.475 HD12 ' N ' ' C' ' 56' ' ' ILE . 3.3 mp -117.96 124.48 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 171.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 2.9 m-85 -119.23 141.6 48.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.37 114.64 40.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 63.35 36.34 11.67 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.812 0.695 . . . . 0.0 110.778 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.16 58.9 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.381 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 10.8 pt-20 -140.16 143.81 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.902 0.851 . . . . 0.0 110.913 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.47 116.54 10.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.385 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.59 -29.6 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.933 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -156.27 154.84 31.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.991 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 54' ' ' TRP . 68.5 m -149.55 146.69 27.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.4 -179.73 7.94 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.684 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 18.3 m120 -128.73 135.08 48.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.25 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.658 ' CD ' ' HB2' ' C' ' 52' ' ' LYS . 2.5 mp0 -60.48 -11.1 5.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -172.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' HD11 ' C' ' 47' ' ' ILE . 13.5 ptmm? -84.83 -4.55 59.13 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.6 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -81.06 155.06 26.51 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 11.2 p -71.97 121.32 18.91 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.618 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 45' ' ' TYR . 13.1 t -60.11 -11.76 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.971 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.46 -40.24 9.18 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.077 -1.058 . . . . 0.0 111.212 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.99 -35.6 74.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.426 ' O ' HG13 ' C' ' 79' ' ' ILE . 47.0 mm -67.9 -66.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.486 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.651 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.4 m -59.34 -58.59 7.97 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.593 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 26.0 m-20 -72.55 -16.84 61.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -171.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -34.79 69.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.505 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' C' ' 76' ' ' SER . 80.6 mt -56.06 -23.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.609 171.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.6 OUTLIER -79.79 -38.24 33.52 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.296 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -57.44 -34.1 68.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 109.355 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 3.2 mt -59.49 -28.06 66.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.402 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.1 m-20 36.66 82.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.568 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.03 148.14 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.856 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.58 45.55 2.78 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.296 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.92 158.0 17.52 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.383 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.04 -44.82 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.067 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -123.66 117.97 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.406 0.622 . . . . 0.0 109.949 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.75 125.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.784 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.15 99.68 12.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.536 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.557 HG21 ' HG ' ' C' ' 29' ' ' LEU . 20.1 mm -109.65 99.62 9.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.935 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 168.82 6.45 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.97 166.23 12.8 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.752 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.697 -169.497 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.633 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.4 mp0 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.784 0.326 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.69 -141.38 0.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.044 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -39.8 -36.61 0.45 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -52.65 -46.19 67.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.51 -29.84 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.935 0.397 . . . . 0.0 111.014 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.52 -20.28 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -60.26 -35.22 75.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 47.8 t -66.54 -37.71 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.399 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' C' ' 29' ' ' LEU . 0.9 OUTLIER -65.21 -39.92 93.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.504 -176.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.58 -27.22 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -87.75 -29.33 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.464 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 62.0 mt -70.76 -34.95 72.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.216 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.1 66.13 9.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.2 -25.29 16.44 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.19 -72.81 0.13 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.274 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -90.6 -177.27 4.98 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 168.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.3 100.24 0.01 OUTLIER Glycine 0 CA--C 1.5 -0.882 0 O-C-N 125.139 1.525 . . . . 0.0 116.118 166.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.546 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 8.2 ptpt -131.51 155.36 47.56 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.194 -170.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.499 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 0.6 OUTLIER -134.77 121.8 21.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.553 -173.035 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.8 m -113.39 112.42 23.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.512 HD13 ' ND2' ' C' ' 17' ' ' ASN . 5.9 mp -99.24 143.94 28.93 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.789 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.1 m -150.19 131.07 14.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.151 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.633 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 81.5 mtp -97.69 120.72 38.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.296 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -122.31 91.4 3.5 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.708 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 31.06 6.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.554 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 27.9 tt0 -143.07 137.45 29.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.219 0.533 . . . . 0.0 111.999 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -111.28 99.55 8.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.558 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 23.2 pttp -96.42 142.95 27.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.2 122.11 7.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -172.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 77.5 p -98.48 143.38 28.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.545 ' OG ' ' HA2' ' C' ' 73' ' ' GLY . 17.6 p -125.52 119.22 27.59 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.1 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 39.0 t -100.46 173.37 6.6 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.526 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' C' ' 41' ' ' SER . 6.5 m120 81.59 28.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.716 1.26 . . . . 0.0 111.398 -172.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.88 35.92 5.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 167.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' GLY . . . . . 0.405 ' O ' HG22 ' C' ' 71' ' ' THR . . . 102.53 -10.11 56.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.209 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 76.3 m-85 -70.03 141.56 52.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.3 -150.45 25.22 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.194 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' C' ' 68' ' ' GLU . 26.6 mm -66.79 -62.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.555 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -175.05 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.079 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -168.48 28.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 12.5 pt-20 -115.76 135.53 53.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.689 -175.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 32.0 t70 -90.38 109.47 20.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.323 0.582 . . . . 0.0 111.809 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' C' ' 68' ' ' GLU . 12.0 mptt -110.82 139.61 45.97 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.988 175.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -95.55 119.34 33.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.215 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -113.56 165.96 11.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.044 -169.099 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.18 158.11 27.51 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 119.077 -1.535 . . . . 0.0 115.788 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -114.84 132.95 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 114.771 -0.714 . . . . 0.0 111.015 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.8 OUTLIER -130.41 115.26 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.75 126.49 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.16 24.9 14.23 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.805 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 9.03 83.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.558 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 11.3 tp10 -107.79 120.72 43.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.959 0.409 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 39.7 ttpt -72.6 112.61 8.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.3 -29.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -148.92 134.14 18.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.23 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.426 HG23 ' O ' ' C' ' 54' ' ' TRP . 5.3 m -123.6 147.14 47.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' C' ' 75' ' ' ILE . 52.5 p90 -161.51 -175.23 4.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.824 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.56 135.58 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.407 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' C' ' 47' ' ' ILE . 17.3 tt0 -62.89 -34.87 78.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.714 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.3 pttp -79.42 1.59 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -74.4 -170.67 1.04 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.465 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.1 p -81.37 108.39 14.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.47 -16.72 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.117 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.545 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -80.24 -40.76 12.92 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -66.56 -33.55 75.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.487 ' O ' HG12 ' C' ' 79' ' ' ILE . 32.5 mm -76.05 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.415 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.6 m -54.43 -52.16 62.65 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.513 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 49.0 m-20 -75.91 -15.96 60.11 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.658 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -66.17 -37.25 85.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' C' ' 76' ' ' SER . 36.7 mm -56.4 -25.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.568 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.597 ' N ' HD22 ' C' ' 80' ' ' ASN . 0.6 OUTLIER -82.37 -38.28 24.4 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -50.21 -44.05 52.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -53.69 -36.01 61.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.755 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.554 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.2 m-20 38.34 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.996 0.81 . . . . 0.0 110.559 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.87 132.16 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.703 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.21 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.25 162.84 29.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.663 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.8 -35.47 0.39 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 123.113 2.542 . . . . 0.0 112.085 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.69 139.64 16.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.93 125.6 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.404 0.621 . . . . 0.0 111.557 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.416 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 15.6 mm-40 -97.26 99.21 10.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.517 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.4 mt -112.26 99.71 9.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 92' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -161.09 156.22 24.19 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 4.1 pp0? -81.59 164.77 21.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.95 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.495 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.814 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.137 -165.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.65 -143.98 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -168.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -59.41 -22.53 61.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.929 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.4 m -54.69 -33.27 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 110.297 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -86.52 -41.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -63.52 -37.3 86.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -54.75 -37.36 65.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.52 -36.52 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.487 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -66.35 -38.21 87.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.424 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.07 -30.7 71.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.925 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' NZ ' ' C' ' 19' ' ' LYS . 9.1 mtpm? -85.65 -37.19 19.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' C' ' 27' ' ' LEU . 75.6 mt -76.35 -33.71 58.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.592 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -81.55 52.57 1.9 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.931 0.872 . . . . 0.0 109.769 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' C' ' 47' ' ' ILE . 14.7 pttm -66.24 -40.57 90.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.108 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.15 0.48 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' C' ' 24' ' ' LYS . 10.9 mmpt? -70.64 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -40.44 145.64 0.39 Allowed Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' C' ' 40' ' ' SER . 10.7 ptpt -148.52 130.96 15.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.945 -169.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.7 mp -105.02 128.34 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.721 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.1 t -103.61 98.93 8.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.71 121.2 25.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.11 0.481 . . . . 0.0 110.868 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -130.62 134.89 47.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.602 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 73.6 mtp -118.93 134.45 55.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.956 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.02 91.01 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.661 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.28 -106.42 0.65 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.245 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 33.78 1.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.5 0.667 . . . . 0.0 109.902 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.621 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.4 tt0 -145.71 139.6 26.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.511 0.672 . . . . 0.0 112.335 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.15 118.98 28.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 25.6 pttm -127.18 107.93 10.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.758 0.79 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -115.67 121.59 42.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.66 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 45.0 p -96.57 151.21 19.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 40.9 m -123.7 118.58 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.323 0.582 . . . . 0.0 110.848 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 22.6 t -101.84 -176.61 3.18 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.36 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.46 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.9 OUTLIER 73.01 35.91 0.92 Allowed 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 124.246 0.967 . . . . 0.0 109.746 -170.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.03 19.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.731 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -3.66 65.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.475 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.46 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 55.4 m-85 -58.78 143.51 46.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.847 0.324 . . . . 0.0 110.89 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.09 -158.02 5.4 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' C' ' 68' ' ' GLU . 23.0 mt -67.52 -68.6 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 CA-C-O 122.115 0.96 . . . . 0.0 109.781 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -178.26 -146.68 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.833 -165.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -79.22 -24.23 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.464 ' OE1' ' HE2' ' C' ' 52' ' ' LYS . 6.4 pt-20 -73.28 137.26 44.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.545 0.688 . . . . 0.0 112.79 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.63 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 5.6 p-10 -90.62 145.41 24.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.051 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.4 mptp? -141.8 126.02 17.49 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.787 ' ND2' HG13 ' C' ' 94' ' ' ILE . 66.5 t30 -84.94 112.61 20.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.525 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.659 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.2 OUTLIER -121.05 161.23 22.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -169.046 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.9 159.18 31.7 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 118.952 -1.594 . . . . 0.0 116.655 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -114.96 131.49 67.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 113.974 -1.113 . . . . 0.0 110.853 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 1.9 m-85 -129.05 107.2 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.84 123.18 47.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.62 31.12 18.61 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 4.09 89.31 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.114 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.1 tp10 -106.48 121.13 43.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.969 0.385 . . . . 0.0 110.701 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 30.0 ttpp -75.05 117.68 17.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.57 -32.58 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.296 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -142.0 131.58 23.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -125.39 141.01 52.3 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.492 ' CD1' HD13 ' C' ' 75' ' ' ILE . 50.1 p90 -156.78 -173.35 4.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.277 0.844 . . . . 0.0 113.277 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 19.1 p-10 -131.55 131.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.081 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.659 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 34.0 mt-10 -67.02 -12.33 59.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.6 ptmm? -89.59 7.54 35.9 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.483 ' HB3' HD11 ' C' ' 75' ' ' ILE . 15.2 t -79.98 -147.83 0.05 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.09 117.18 32.57 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 2.4 t -64.47 -14.8 16.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.302 -167.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.38 -39.57 25.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.567 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.55 -30.68 68.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.492 HD13 ' CD1' ' C' ' 66' ' ' PHE . 67.7 mt -68.28 -70.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.261 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 2.5 m -65.38 -44.18 88.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -80.83 -15.24 56.9 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.426 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.31 -40.23 81.78 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' C' ' 76' ' ' SER . 63.1 mt -58.7 -28.78 38.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.467 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.491 ' CG ' ' HA ' ' C' ' 37' ' ' LYS . 7.9 m-20 -75.19 -37.6 61.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.249 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 7.2 mmpt? -54.43 -40.44 68.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 0.0 109.237 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -56.12 -34.78 66.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.699 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.621 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.26 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.164 0.915 . . . . 0.0 110.68 -168.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.66 131.07 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.325 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.98 43.27 0.77 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.514 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.87 138.02 14.09 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.097 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.37 -45.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.775 2.317 . . . . 0.0 111.445 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -140.3 123.36 16.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.02 133.92 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.363 0.602 . . . . 0.0 111.352 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.451 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 8.0 mm-40 -92.31 104.51 16.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.499 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.1 mt -112.71 100.85 11.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 92' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -157.37 171.4 20.46 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 5.1 pp0? -94.27 167.42 11.55 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.092 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.787 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.478 ' O ' HG13 ' C' ' 13' ' ' ILE . 62.7 mtt -82.29 -142.06 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -49.95 -17.2 0.35 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 41.0 m -53.88 -39.71 65.97 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.246 -0.284 . . . . 0.0 110.846 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 10' ' ' MET . 2.8 pp -91.58 -23.92 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.525 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 17.2 m120 -74.89 -32.58 61.88 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 122.304 -0.248 . . . . 0.0 111.003 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -62.26 -31.1 71.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.451 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.51 -34.69 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.868 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.5 m-20 -61.76 -39.82 92.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.407 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.46 -27.7 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.674 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.91 -28.57 18.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.099 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 34.7 mt -82.94 -28.35 29.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.413 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -88.19 74.49 8.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.82 -23.67 10.88 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -81.77 0.09 OUTLIER Glycine 0 CA--C 1.507 -0.414 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.234 -174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 14.9 ttmt -89.75 -179.22 5.71 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 29.89 90.33 0.01 OUTLIER Glycine 0 CA--C 1.503 -0.668 0 O-C-N 124.38 1.05 . . . . 0.0 115.496 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.0 OUTLIER -121.02 137.17 54.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.652 -173.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 31.6 tp -126.93 128.21 46.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.395 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 59.2 m -111.87 111.81 23.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.256 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.593 HD21 ' HB ' ' C' ' 91' ' ' ILE . 5.4 mp -86.92 144.58 26.89 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 111.574 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.4 p -155.09 129.78 9.23 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.473 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.422 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 63.4 mtt -128.02 132.33 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.962 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.414 ' HB3' ' CD ' ' C' ' 35' ' ' GLN . 6.3 t30 -151.23 92.66 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.569 0.223 . . . . 0.0 110.77 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.79 -93.94 1.18 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.37 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 19.6 t-20 -120.48 31.78 6.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.447 0.642 . . . . 0.0 109.909 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.547 ' N ' HG22 ' C' ' 84' ' ' ILE . 9.9 pt20 -127.92 130.7 48.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.312 0.577 . . . . 0.0 111.753 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.694 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tm? -124.16 119.03 28.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.783 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -140.37 130.99 25.59 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -143.78 120.1 10.9 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.932 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 44.1 p -97.47 126.12 42.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.4 p -109.27 118.72 37.45 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.582 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 t -103.18 -175.08 2.7 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 81.08 26.33 0.23 Allowed 'General case' 0 C--O 1.222 -0.353 0 O-C-N 124.494 1.121 . . . . 0.0 110.491 -171.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.02 38.35 23.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.93 -5.82 79.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.674 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -64.38 145.21 56.41 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.46 0.63 . . . . 0.0 110.526 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -85.33 -169.7 46.28 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.002 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' C' ' 68' ' ' GLU . 23.3 mm -59.14 -63.53 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-O 121.652 0.739 . . . . 0.0 110.84 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 p -164.06 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.634 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -169.24 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.873 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.63 136.07 49.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.426 -168.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.532 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 1.3 m-20 -75.15 118.43 18.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.417 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -139.28 132.72 30.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 14.7 p-10 -86.91 122.38 30.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.52 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -115.66 161.92 17.99 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.78 148.22 18.79 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.331 -1.414 . . . . 0.0 115.444 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 38.6 mt -122.27 127.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 164.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -121.7 109.04 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.949 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.434 HG23 HG13 ' C' ' 89' ' ' ILE . 2.5 p -90.08 105.74 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 62.36 29.45 17.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.704 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.74 5.19 78.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.766 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -109.08 141.99 40.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.853 0.358 . . . . 0.0 110.467 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -66.74 121.42 15.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.794 174.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -156.88 153.23 27.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.301 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -141.93 159.02 43.07 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 55.8 p90 -166.91 -172.87 2.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 111.39 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -129.42 138.51 51.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.139 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.522 ' HB3' HG13 ' C' ' 47' ' ' ILE . 10.1 mt-10 -62.96 -33.07 74.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.431 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.1 pttp -82.89 18.89 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.007 0.432 . . . . 0.0 111.367 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -88.87 -150.73 0.2 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 19.9 p -111.27 112.86 24.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.441 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.8 t -63.23 -12.33 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.057 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -84.55 -37.92 10.22 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.816 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -68.4 -35.18 77.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 51.5 mm -69.63 -60.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.925 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.676 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 75.2 p -51.73 -60.75 2.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.404 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 69.0 m-20 -73.26 -15.98 61.41 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -171.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' C' ' 81' ' ' LYS . 0.5 OUTLIER -69.65 -36.01 75.7 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.1 167.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.3 mt -58.36 -20.91 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.783 ' ND2' ' HA ' ' C' ' 37' ' ' LYS . 2.1 m120 -84.05 -35.91 23.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' C' ' 78' ' ' ASP . 52.0 mtpt -53.61 -39.92 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 6.1 mt -52.97 -37.33 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 38.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.694 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 2.4 tp -44.8 148.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.664 -174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -149.85 22.32 0.88 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.342 0.591 . . . . 0.0 109.718 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.04 171.55 15.29 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.849 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.79 -49.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.775 2.317 . . . . 0.0 113.407 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -132.87 103.35 6.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.363 0.601 . . . . 0.0 110.326 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.452 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.4 mp -122.43 129.62 75.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.145 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 37.9 mt-10 -106.56 119.2 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 0.0 111.658 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.593 ' HB ' HD21 ' C' ' 29' ' ' LEU . 34.4 mt -96.91 98.95 8.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 146.1 14.79 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.4 pt20 -83.16 166.97 18.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.218 0.532 . . . . 0.0 112.325 -173.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.782 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.777 0.322 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 86.9 mmm -66.53 178.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.283 0.563 . . . . 0.0 111.863 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -50.17 -19.6 0.81 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t -46.04 -51.95 12.77 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.569 0.543 . . . . 0.0 112.309 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.526 ' H ' HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -89.76 -18.58 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.567 -177.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -74.11 -50.95 17.25 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.3 -0.25 . . . . 0.0 111.388 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.3 m -58.3 -29.39 65.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.459 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 42.8 t -70.33 -40.09 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.71 172.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.31 -41.03 96.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.831 0.348 . . . . 0.0 110.439 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.47 -31.24 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.408 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.74 -35.42 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.123 0.487 . . . . 0.0 110.617 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.592 HD21 ' CZ2' ' C' ' 54' ' ' TRP . 73.3 mt -73.53 -37.37 65.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.347 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -79.59 68.92 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.814 0.816 . . . . 0.0 109.019 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' C' ' 47' ' ' ILE . 16.6 pttm -89.27 -7.4 55.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.992 -172.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.4 -50.73 0.76 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.743 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 22.5 mmtm -78.96 -160.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -41.34 137.94 2.11 Favored Glycine 0 CA--C 1.507 -0.434 0 O-C-N 123.535 0.522 . . . . 0.0 114.106 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.5 OUTLIER -141.34 143.21 33.9 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -168.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.0 mp -117.86 114.54 23.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 8.5 t -86.42 98.47 11.03 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 91' ' ' ILE . 39.0 mt -83.9 124.36 30.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.246 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 29.8 t -147.13 139.43 24.63 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 54.0 mtm -107.2 145.64 32.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.277 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -148.15 89.82 1.76 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 110.568 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.18 -94.11 0.31 Allowed Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.94 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.4 p-10 -112.94 26.61 10.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 110.512 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.595 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 8.0 tt0 -140.35 143.39 35.73 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.493 0.663 . . . . 0.0 111.951 -171.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.0 tm? -118.11 117.88 30.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 22.5 pttp -126.31 148.62 49.5 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.15 135.29 17.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.378 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -98.69 125.57 44.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 30.9 t -109.47 119.65 40.09 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.672 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 9.5 t -109.93 178.98 4.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 78.44 27.34 0.5 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.502 1.126 . . . . 0.0 110.639 -174.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.69 32.69 19.84 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.548 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.91 -14.08 66.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.121 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 39.7 m-85 -55.44 130.36 42.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.058 0.429 . . . . 0.0 110.359 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -73.85 -94.45 0.11 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.784 -0.643 . . . . 0.0 113.074 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' C' ' 52' ' ' LYS . 33.6 mt -110.51 -67.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.415 0.626 . . . . 0.0 109.755 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 177.36 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.192 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -166.4 -37.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.657 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 11.8 pt-20 -70.18 170.08 12.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.058 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.548 ' HB2' HD21 ' C' ' 67' ' ' ASN . 4.5 p-10 -125.35 152.97 44.04 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 111.33 -177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.596 ' HG2' HD11 ' C' ' 47' ' ' ILE . 8.6 mmmm -130.03 143.47 50.81 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.207 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.546 ' OD1' HG13 ' C' ' 94' ' ' ILE . 10.9 t-20 -92.34 105.04 17.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.464 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.63 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -113.82 165.85 12.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.128 -167.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.455 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -163.78 158.09 30.5 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 119.556 -1.306 . . . . 0.0 114.816 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.455 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.6 mp -119.79 129.39 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.869 169.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.536 ' CE1' ' HD3' ' C' ' 62' ' ' LYS . 40.6 m-85 -123.98 105.49 9.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.31 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.89 112.01 26.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 57.83 32.84 22.48 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.062 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.12 7.53 87.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.085 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.3 tp10 -107.01 139.05 42.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.883 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.536 ' HD3' ' CE1' ' C' ' 57' ' ' PHE . 14.3 mmmm -83.24 118.05 23.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.575 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -107.17 -24.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.358 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -160.22 147.91 16.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 110.778 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 54' ' ' TRP . 41.8 m -139.73 147.73 41.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' C' ' 75' ' ' ILE . 32.7 p90 -159.78 -178.73 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.121 -1.032 . . . . 0.0 113.523 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' C' ' 51' ' ' ASP . 51.5 t-20 -120.36 127.95 52.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.836 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 4.7 mt-10 -62.61 -21.53 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 21.0 ptmt -90.53 9.24 30.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.515 ' HB2' HD11 ' C' ' 75' ' ' ILE . 15.5 m -76.38 -118.8 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.299 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -131.71 115.67 16.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.496 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 3.3 t -60.65 -22.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -168.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.88 -37.4 19.36 Favored Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.004 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -72.14 -34.51 68.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' C' ' 70' ' ' SER . 81.9 mt -66.6 -65.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.395 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.638 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 70.8 p -62.42 -50.95 69.45 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -167.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.459 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 68.6 m-80 -79.29 -14.51 58.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -172.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.05 -38.83 92.13 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' C' ' 76' ' ' SER . 73.1 mt -59.29 -24.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.497 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -80.12 -40.03 28.29 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 8.0 mmpt? -50.72 -38.68 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 0.0 109.624 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.413 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.5 mt -52.25 -35.37 49.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.595 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.7 m-20 37.49 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.131 0.895 . . . . 0.0 110.957 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' C' ' 86' ' ' GLY . 31.5 mt -79.28 115.16 21.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.241 -166.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -66.83 35.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.638 169.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' C' ' 84' ' ' ILE . . . -98.74 159.42 20.29 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.096 -171.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 93.1 Cg_endo -80.5 -75.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.691 2.261 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.587 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 15.3 p90 -115.78 112.64 22.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.666 0.746 . . . . 0.0 109.487 171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.09 114.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.706 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -90.55 96.88 10.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.338 0.589 . . . . 0.0 110.13 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 29' ' ' LEU . 13.9 mt -96.35 100.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 145.89 22.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 29.5 pt20 -83.1 167.01 18.23 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.751 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.546 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.565 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' C' ' 31' ' ' MET . 39.3 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.027 0.441 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 71.1 mtp -81.36 -149.26 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.887 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.12 -10.69 11.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -56.62 -42.39 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.09 -28.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.8 -43.99 87.04 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.478 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' SER . . . . . 0.548 ' O ' ' HB2' ' C' ' 19' ' ' LYS . 22.3 m -56.97 -34.93 68.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.1 -31.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.208 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -61.31 -48.97 78.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.03 -14.25 60.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.094 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' C' ' 15' ' ' SER . 0.0 OUTLIER -80.52 -45.77 16.92 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' C' ' 27' ' ' LEU . 90.0 mt -78.42 -35.08 47.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.985 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -78.65 67.84 4.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.157 0.503 . . . . 0.0 109.961 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -104.6 -10.01 17.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.87 -76.6 0.19 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -99.57 -174.49 2.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.89 88.95 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 171.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.6 ptpt -128.97 143.44 50.88 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.646 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HB3' HD13 ' C' ' 20' ' ' LEU . 17.1 tp -125.94 127.98 46.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.366 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -99.98 110.68 23.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -79.84 135.32 36.43 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.028 0.531 . . . . 0.0 111.973 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 41.2 m -143.61 129.11 19.06 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.286 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.586 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 39.5 mtm -123.93 130.9 53.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -148.1 90.89 1.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.05 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.27 -97.67 0.06 OUTLIER Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.713 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -101.87 33.38 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.37 0.605 . . . . 0.0 109.882 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.401 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 26.9 tt0 -150.08 136.66 19.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.2 tm? -119.96 127.41 52.62 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 165.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -144.8 144.74 31.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.43 142.42 22.18 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.732 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 60.6 p -99.07 138.81 35.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 22.2 p -118.07 117.86 30.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.564 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.2 m -105.04 178.18 4.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.955 -175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' C' ' 26' ' ' LYS . 0.7 OUTLIER 70.1 38.98 1.41 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.323 1.014 . . . . 0.0 109.071 -168.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.13 27.75 16.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.732 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 11.92 82.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.523 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.45 ' O ' HG23 ' C' ' 72' ' ' VAL . 55.1 m-85 -74.69 176.1 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.248 0.524 . . . . 0.0 110.771 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -101.01 -154.98 26.97 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.634 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.518 HD13 ' HE3' ' C' ' 22' ' ' LYS . 15.9 mm -51.79 -67.08 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.486 0.66 . . . . 0.0 109.863 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 15.1 t 173.13 -67.78 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.335 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.05 -22.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 7.4 pt-20 -68.94 145.68 53.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 112.315 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.53 ' C ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 t70 -87.56 121.05 29.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.707 -174.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 3.3 mptp? -124.76 134.37 52.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.86 105.96 18.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.538 0.685 . . . . 0.0 111.077 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.579 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -108.66 167.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.61 -173.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.416 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -170.1 165.58 38.88 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 119.291 -1.433 . . . . 0.0 115.612 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.538 HG13 HG13 ' C' ' 91' ' ' ILE . 3.5 mp -124.63 129.54 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.17 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -120.1 117.42 27.9 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -115.62 123.17 70.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.677 0.275 . . . . 0.0 110.362 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' C' ' 87' ' ' PRO . 4.5 m-20 57.56 33.23 22.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.83 90.47 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.851 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.52 130.95 56.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.475 ' HD2' ' OG1' ' C' ' 65' ' ' THR . 40.0 ttpt -74.83 123.67 25.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.934 0.397 . . . . 0.0 110.5 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.69 -43.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -146.31 147.75 31.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.933 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' C' ' 54' ' ' TRP . 84.6 m -136.46 145.22 44.94 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.44 -170.92 2.96 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 51.3 t-20 -128.2 139.99 52.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.458 ' HB3' HG12 ' C' ' 47' ' ' ILE . 42.3 mt-10 -77.95 -11.29 59.89 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -81.59 -6.63 59.17 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.242 175.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -78.58 163.75 25.25 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -74.22 113.24 11.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.519 HG23 ' HA2' ' C' ' 46' ' ' GLY . 8.7 t -57.52 -15.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.943 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.95 -41.16 12.79 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.371 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -73.41 -33.01 64.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 38.3 mm -65.81 -61.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.532 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 68.2 p -64.8 -57.81 7.9 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.721 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 8.1 m-20 -67.69 -16.83 64.34 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -171.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.2 m-20 -64.95 -47.41 77.73 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.645 0.657 . . . . 0.0 109.291 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' C' ' 76' ' ' SER . 65.1 mt -56.78 -30.62 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.844 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 27.7 m-20 -89.67 -17.82 27.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 33.9 mmtp -62.76 -39.31 93.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 11.0 mt -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.302 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 93.1 m-20 39.51 72.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.625 0.726 . . . . 0.0 110.08 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' C' ' 86' ' ' GLY . 13.7 mt -54.36 139.99 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.451 -171.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -85.17 26.29 0.89 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.408 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -93.1 125.41 8.17 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.606 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.43 ' HD2' ' OD1' ' C' ' 59' ' ' ASN . 95.6 Cg_endo -79.83 -40.34 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.208 1.939 . . . . 0.0 111.035 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -126.89 120.64 29.68 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.586 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 73.4 mt -126.11 130.53 72.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.521 -172.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.33 98.47 11.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.983 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.579 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.8 tt -105.33 99.89 9.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.24 158.67 19.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.322 -171.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -84.52 158.79 20.86 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.428 ' H ' HG12 ' C' ' 94' ' ' ILE . 1.6 pt . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.977 -167.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' C' ' 9' ' ' GLN . 9.8 mt-30 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -81.36 -143.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.622 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.05 -9.77 11.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -48.94 -60.46 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.89 0.476 . . . . 0.0 111.83 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.58 ' H ' HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -84.83 -18.36 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.06 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 84.3 m-20 -72.46 -38.96 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.642 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 61.2 m -63.76 -30.18 71.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 89.7 t -68.25 -36.69 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.651 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.8 m-20 -59.87 -45.51 92.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.4 -32.03 70.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.292 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -87.41 -31.63 19.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.975 0.417 . . . . 0.0 110.994 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' C' ' 27' ' ' LEU . 50.8 mt -81.62 -31.41 32.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.705 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -82.67 65.1 7.63 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.446 ' CE ' HD12 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.52 -24.15 16.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.012 -173.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.46 -78.36 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.603 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.8 ttpt -98.87 -172.97 2.4 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 166.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.83 92.66 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 O-C-N 124.747 1.28 . . . . 0.0 115.703 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.0 ptpt -130.95 136.74 48.83 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.597 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.3 tp -116.48 122.09 43.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.581 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.9 m -108.05 104.54 14.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.292 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.689 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -82.53 138.43 34.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -142.76 129.35 20.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' C' ' 9' ' ' GLN . 36.0 mtm -130.81 125.02 32.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.236 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.487 ' H ' ' HG2' ' C' ' 35' ' ' GLN . 61.6 m-80 -148.42 97.21 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 110.654 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -94.63 0.8 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.459 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 19.0 t-20 -120.43 32.46 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.501 0.667 . . . . 0.0 109.835 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' C' ' 32' ' ' ASN . 2.3 pt20 -128.48 136.55 50.97 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.279 0.561 . . . . 0.0 111.607 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.667 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 0.7 OUTLIER -130.39 118.45 21.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 164.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.526 ' O ' ' HD2' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -145.66 103.2 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -109.52 126.66 53.77 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.286 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -96.65 137.76 35.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.075 0.464 . . . . 0.0 109.896 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 29.2 p -109.04 117.59 34.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.644 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 21.2 t -102.63 173.97 6.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.422 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 71.76 39.61 0.84 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.384 1.052 . . . . 0.0 109.569 -166.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.12 27.02 14.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.79 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.97 5.83 88.86 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.051 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 44.0 m-85 -65.03 156.47 31.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.579 ' O ' ' HG2' ' C' ' 24' ' ' LYS . . . -83.23 -166.52 39.87 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.463 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 15.6 mm -56.46 -61.9 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 121.489 0.662 . . . . 0.0 111.803 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.1 p 176.24 -74.15 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.983 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -159.88 20.99 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.358 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 42.1 mt-10 -115.95 141.87 47.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.765 -176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.501 ' HB2' HD21 ' C' ' 67' ' ' ASN . 7.0 p-10 -100.99 149.21 24.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.565 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.523 ' HG3' ' OE1' ' C' ' 68' ' ' GLU . 11.3 mmtp -132.9 146.23 51.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' C' ' 94' ' ' ILE . 6.5 t30 -96.28 99.25 10.97 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.753 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.557 ' HA ' ' CB ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -102.93 164.35 11.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.238 -166.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.53 143.9 10.2 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 119.403 -1.38 . . . . 0.0 115.114 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.405 HD12 ' N ' ' C' ' 56' ' ' ILE . 4.2 mp -118.85 124.82 73.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 5.2 m-85 -125.91 155.11 41.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.02 117.87 47.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.81 24.98 14.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.21 36.82 20.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.343 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 16.0 tp10 -133.62 131.11 39.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.82 124.5 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.98 -49.2 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.612 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 56.8 t80 -155.17 150.3 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.712 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 16.8 m -135.61 136.55 41.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 41.9 p90 -152.58 -177.9 6.52 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.793 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.501 HD21 ' HB2' ' C' ' 51' ' ' ASP . 52.0 t-20 -119.95 130.41 54.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.91 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.523 ' OE1' ' HG3' ' C' ' 52' ' ' LYS . 2.2 mt-10 -64.95 -27.06 68.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 13.7 ptmm? -79.55 2.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.374 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 11.5 m -74.63 178.24 5.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -76.63 110.84 11.53 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.39 -11.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.911 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.72 -41.24 13.12 Favored Glycine 0 CA--C 1.51 -0.238 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.971 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -71.54 -32.02 67.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.239 0.542 . . . . 0.0 109.587 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.479 ' O ' HG13 ' C' ' 79' ' ' ILE . 49.1 mm -69.62 -55.73 14.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.515 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' C' ' 38' ' ' ALA . 56.3 p -57.98 -64.65 0.84 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.636 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 6.6 m-20 -67.06 -17.74 65.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -172.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -45.57 66.07 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.479 HG13 ' O ' ' C' ' 75' ' ' ILE . 58.2 mt -57.65 -28.29 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' C' ' 38' ' ' ALA . 30.0 m-20 -85.86 -27.95 24.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.023 -177.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 68.1 mttm -60.32 -36.65 78.41 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 12.3 mt -52.35 -32.47 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 39.35 99.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.66 1.225 . . . . 0.0 112.769 -175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.667 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -42.67 144.42 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 113.965 -1.471 . . . . 0.0 112.867 -173.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.34 15.17 0.89 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.33 0.585 . . . . 0.0 109.586 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.31 179.91 28.41 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.682 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.58 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.5 Cg_endo -82.01 -77.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.668 2.245 . . . . 0.0 111.455 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.58 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.5 p90 -113.83 129.92 56.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 109.798 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.661 HG12 HD11 ' C' ' 84' ' ' ILE . 3.9 mp -116.01 136.71 52.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.374 -174.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 101.69 14.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' C' ' 29' ' ' LEU . 27.0 mm -103.4 98.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 151.56 3.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -91.42 171.7 9.02 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.225 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.824 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.149 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.692 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.423 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.7 mp0 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.465 ' O ' HG22 ' C' ' 13' ' ' ILE . 75.0 mtm -99.5 -143.21 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.481 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -47.58 -35.38 9.03 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' SER . . . . . 0.456 ' O ' HG23 ' C' ' 16' ' ' VAL . 51.0 m -49.25 -48.44 45.77 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 10' ' ' MET . 9.9 tt -84.22 -25.26 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.288 0.566 . . . . 0.0 111.08 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.556 ' HA ' HD22 ' C' ' 17' ' ' ASN . 89.3 m-20 -85.02 -27.84 26.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.58 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 50.6 m -65.07 -31.67 73.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.539 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 51.7 t -69.83 -34.34 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.971 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.556 HD22 ' HA ' ' C' ' 14' ' ' ASN . 6.4 m-80 -57.43 -46.27 83.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.775 0.322 . . . . 0.0 110.749 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.9 -15.97 61.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.712 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -88.04 -38.0 15.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 43.3 mt -74.1 -33.9 63.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.45 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 23.4 m-80 -78.53 69.62 4.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -102.0 10.01 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.696 -171.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.91 -67.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.594 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 0.2 OUTLIER -100.44 92.56 5.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 122.616 0.366 . . . . 0.0 110.365 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 126.56 3.14 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 119.833 -1.175 . . . . 0.0 111.668 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.5 ptpt -149.4 146.09 27.3 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.479 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -115.21 110.68 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.466 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.6 m -85.93 115.6 23.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' C' ' 17' ' ' ASN . 16.5 mt -102.63 132.27 48.85 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.877 0.37 . . . . 0.0 111.82 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 26.4 p -149.58 137.55 20.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.553 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 88.8 mtp -118.32 128.07 54.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -133.04 92.78 3.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.155 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.91 -93.55 0.41 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.167 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.6 p-10 -107.87 21.73 16.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.535 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 8.4 tt0 -138.79 145.54 40.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.558 0.694 . . . . 0.0 112.465 -169.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.413 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -128.85 105.07 7.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.474 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 54.5 pttt -109.13 104.95 14.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.638 0.732 . . . . 0.0 109.113 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -104.2 119.35 38.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -104.68 139.09 40.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 26.6 t -109.9 119.19 38.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 42.8 t -93.39 173.78 7.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.288 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' C' ' 41' ' ' SER . 12.4 m120 80.19 26.5 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.757 1.286 . . . . 0.0 110.102 -171.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.28 27.09 16.05 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.061 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.12 67.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.979 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.0 m-30 -60.19 143.14 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.813 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.82 -169.26 45.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.548 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.586 ' CG1' ' HB3' ' C' ' 68' ' ' GLU . 7.7 mt -48.95 -59.28 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 CA-C-O 121.052 0.453 . . . . 0.0 111.891 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 10.3 t 173.31 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.855 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -166.69 54.4 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.525 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 5.7 pt-20 -156.45 152.04 26.95 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.73 0.3 . . . . 0.0 111.409 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.476 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 p-10 -97.31 129.62 44.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.662 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.6 mptp? -127.64 133.05 49.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.491 ' OD1' HG13 ' C' ' 94' ' ' ILE . 2.3 t-20 -87.48 107.73 18.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.851 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.755 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -113.38 165.62 12.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.869 -171.017 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.22 167.53 40.64 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.694 -1.241 . . . . 0.0 115.245 174.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.549 HG12 HG13 ' C' ' 91' ' ' ILE . 50.2 mt -131.24 131.47 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.901 -0.65 . . . . 0.0 110.414 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 54.0 m-85 -126.02 122.47 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.808 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -112.46 117.36 55.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 61.21 32.02 19.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.316 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.58 80.06 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.0 OUTLIER -112.95 142.75 45.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.713 0.256 . . . . 0.0 110.799 -178.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.54 100.44 2.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.32 -39.7 13.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.174 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -154.25 153.35 31.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.098 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.586 HG23 ' O ' ' C' ' 54' ' ' TRP . 60.0 m -150.08 142.43 24.27 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -158.6 -179.39 8.03 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.251 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' C' ' 51' ' ' ASP . 46.2 t-20 -118.91 127.07 53.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.167 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.755 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 2.1 mt-10 -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 3.7 ptmm? -76.56 -2.41 32.29 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.581 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.559 ' HB2' HD11 ' C' ' 75' ' ' ILE . 5.4 m -74.74 -170.24 1.02 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 68.6 p -88.36 116.82 26.85 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.179 -0.951 . . . . 0.0 108.749 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.609 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 11.1 t -58.17 -17.21 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.751 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.32 -44.66 8.6 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.748 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -69.17 -28.48 66.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' C' ' 70' ' ' SER . 73.1 mt -66.92 -66.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -59.78 -48.16 82.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.285 -170.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.18 -15.63 60.01 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.39 -39.92 81.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.8 mt -58.49 -27.7 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.44 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' C' ' 37' ' ' LYS . 7.3 m-20 -77.64 -35.79 52.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.227 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 10.7 mmpt? -52.2 -42.99 63.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.8 mt -56.21 -32.91 64.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.535 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.0 OUTLIER 38.4 80.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.018 0.823 . . . . 0.0 111.083 -171.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.51 HG22 ' H ' ' C' ' 86' ' ' GLY . 11.8 mt -68.34 124.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.238 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -91.74 34.83 0.97 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.852 175.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.51 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -79.98 143.6 25.44 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.19 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.29 -43.65 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.38 2.054 . . . . 0.0 111.293 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -139.26 128.77 24.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 63.4 mt -121.38 126.15 74.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.615 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -98.9 98.97 9.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.411 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.597 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.3 tt -98.83 104.42 15.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 168.09 19.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.86 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.37 0.605 . . . . 0.0 111.32 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.491 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.599 -166.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.517 ' NE2' ' H ' ' C' ' 89' ' ' ILE . 10.7 mm-40 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 20.0 mmt -90.44 -143.54 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.408 ' H ' ' HB3' ' C' ' 10' ' ' MET . 4.1 m-20 -56.78 -14.16 3.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t -54.33 -39.45 67.07 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.114 0.259 . . . . 0.0 110.438 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.514 HD13 ' SD ' ' C' ' 31' ' ' MET . 13.1 pt -90.81 -25.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.896 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -64.93 -44.35 89.78 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.757 0.313 . . . . 0.0 110.627 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -57.46 -35.86 70.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.8 t -68.34 -35.74 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.341 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.59 -41.54 99.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 110.132 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.37 -20.62 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.355 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' C' ' 19' ' ' LYS . 5.5 mmpt? -88.88 -35.22 16.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 110.658 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.518 HD12 HD21 ' C' ' 29' ' ' LEU . 98.9 mt -76.37 -33.14 58.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 28.7 m-80 -79.98 60.05 3.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.544 0.688 . . . . 0.0 109.838 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -94.21 -34.43 12.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.264 -173.181 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HE3' ' C' ' 26' ' ' LYS . . . 166.98 -93.7 0.11 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.464 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -72.66 91.76 1.47 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 125.59 5.19 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.642 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' C' ' 21' ' ' ASN . 8.0 ptpt -152.34 155.63 38.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.39 129.68 43.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.548 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.4 m -107.83 99.36 8.83 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.518 HD21 HD12 ' C' ' 20' ' ' LEU . 0.6 OUTLIER -93.39 136.13 33.96 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 120.818 0.342 . . . . 0.0 111.672 -171.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -153.35 130.62 11.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.273 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.519 ' HG3' ' CD2' ' C' ' 36' ' ' LEU . 1.6 mpt? -103.71 137.49 41.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.981 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -136.04 91.46 2.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.701 0.286 . . . . 0.0 110.278 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.02 -95.03 0.12 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.079 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.5 p-10 -108.03 22.6 15.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.643 0.259 . . . . 0.0 110.938 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.558 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 25.9 tt0 -139.15 137.04 35.74 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.553 0.692 . . . . 0.0 112.398 -170.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.519 ' CD2' ' HG3' ' C' ' 31' ' ' MET . 0.6 OUTLIER -113.62 129.67 56.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -142.89 140.78 31.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.463 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -152.56 134.54 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.54 0.209 . . . . 0.0 110.996 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 62.0 p -98.28 145.45 26.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 35.8 m -125.59 116.61 22.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 49.2 m -100.66 -179.47 4.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.741 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.48 31.1 0.61 Allowed 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 124.584 1.178 . . . . 0.0 109.609 -168.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.52 32.58 22.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.112 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 1.03 86.34 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.262 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -66.63 145.67 55.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 111.055 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.71 -160.39 20.19 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.629 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.755 HD12 ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -48.51 -53.04 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.755 ' H ' HD12 ' C' ' 47' ' ' ILE . 8.2 t 166.87 -62.81 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.273 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -150.37 -33.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 47.9 mm-40 -91.31 167.15 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -163.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.85 92.58 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.238 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.468 ' HB3' ' OE2' ' C' ' 68' ' ' GLU . 10.3 mptt -101.03 157.47 16.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 1.4 p30 -116.6 120.61 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.0 112.544 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.549 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -102.85 166.56 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.737 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.74 150.13 11.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.117 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.3 mp -108.93 122.96 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 122.735 -0.274 . . . . 0.0 110.705 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -108.38 138.58 44.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.421 HG12 HG13 ' C' ' 63' ' ' VAL . 8.9 p -127.93 117.12 45.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.71 26.2 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.439 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.08 4.91 74.02 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.521 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.67 139.88 52.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.039 0.42 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 53.2 mtmt -82.0 136.87 35.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.721 0.296 . . . . 0.0 111.668 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.421 HG13 HG12 ' C' ' 58' ' ' VAL . 35.8 m -104.93 -39.47 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.695 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -144.7 145.93 31.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.549 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.2 m -136.88 141.93 42.76 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.541 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.7 p90 -153.85 -175.14 5.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.446 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -126.73 139.48 53.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.287 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.475 ' CD ' ' HD1' ' C' ' 54' ' ' TRP . 3.1 mp0 -62.24 -15.75 49.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.529 ' HB3' HD11 ' C' ' 47' ' ' ILE . 2.4 ptmm? -82.56 1.92 35.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.919 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.6 m -81.54 -173.95 4.68 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.562 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.8 p -97.36 117.54 31.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.56 -21.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.518 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.71 -32.67 23.79 Favored Glycine 0 CA--C 1.504 -0.595 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.988 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -75.52 -38.49 59.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.562 HG12 ' O ' ' C' ' 71' ' ' THR . 42.3 mm -68.09 -58.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.519 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 20.3 m -59.74 -51.45 69.72 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.484 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.536 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 3.9 m-20 -69.92 -18.94 63.41 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.734 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 46.1 m-20 -68.03 -46.88 69.95 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 167.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' C' ' 76' ' ' SER . 96.2 mt -54.56 -29.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.296 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 69.9 m-20 -87.3 -37.35 17.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.327 -172.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 54.2 pttt -60.9 -26.03 67.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 18.5 mt -57.44 -29.05 63.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.819 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.558 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 97.0 m-20 39.52 86.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.941 0.775 . . . . 0.0 110.679 -170.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.407 HG22 ' N ' ' C' ' 86' ' ' GLY . 15.9 mt -80.37 129.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.921 -168.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.4 OUTLIER -87.96 36.64 0.77 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.69 175.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.407 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -82.38 134.66 13.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.291 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.98 -47.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.545 2.163 . . . . 0.0 111.708 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -125.71 99.54 6.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.517 ' H ' ' NE2' ' C' ' 9' ' ' GLN . 19.2 mm -100.54 125.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.424 0.631 . . . . 0.0 110.664 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.03 99.56 9.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.49 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.516 ' O ' HG11 ' C' ' 16' ' ' VAL . 3.4 tt -101.96 99.45 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.814 0.816 . . . . 0.0 109.018 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -161.54 166.12 27.51 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.634 -173.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.626 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -104.19 163.41 12.43 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.312 173.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.499 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.649 -161.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.585 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.2 mp0 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.467 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 0.0 OUTLIER -110.77 -151.96 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.342 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.467 ' H ' ' HB3' ' C' ' 10' ' ' MET . 91.7 m-20 -44.76 -33.71 2.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -50.63 -48.76 57.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.677 0.275 . . . . 0.0 111.605 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.42 HD12 ' HE3' ' C' ' 31' ' ' MET . 5.3 tt -85.75 -28.09 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.113 0.482 . . . . 0.0 110.674 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 4.0 m-20 -69.8 -35.72 75.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.983 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -63.69 -29.82 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 96.8 t -72.49 -35.64 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.647 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.98 -42.2 98.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.67 -24.42 63.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.43 -31.5 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.824 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 27' ' ' LEU . 98.8 mt -84.88 -33.25 22.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.682 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ASN . . . . . 0.482 ' HA ' ' HB2' ' C' ' 26' ' ' LYS . 24.4 m-80 -78.73 78.45 5.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.724 ' NZ ' ' HB2' ' C' ' 24' ' ' LYS . 0.6 OUTLIER -120.22 7.09 10.72 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -165.567 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.32 -76.12 0.4 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.328 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.724 ' HB2' ' NZ ' ' C' ' 22' ' ' LYS . 47.7 mttm -75.51 -158.32 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.74 144.21 1.2 Allowed Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 114.615 0.606 . . . . 0.0 114.615 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' C' ' 40' ' ' SER . 12.7 ptpt -151.14 144.61 24.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 20' ' ' LEU . 3.3 mp -102.15 136.73 41.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.03 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 9.4 t -115.62 99.83 7.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -86.71 127.84 34.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.916 0.389 . . . . 0.0 111.482 -173.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.6 m -142.09 128.89 20.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.806 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.585 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 30.2 mtt -100.17 121.9 42.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -133.54 91.09 2.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.645 0.26 . . . . 0.0 110.973 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.9 -108.33 1.53 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.161 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.47 21.53 5.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.081 0.44 . . . . 0.0 110.867 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.427 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 21.8 tt0 -142.93 141.1 31.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.594 0.712 . . . . 0.0 112.105 -169.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.401 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.3 tm? -116.94 122.69 45.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 164.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -127.38 140.35 52.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.66 119.07 5.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 47.0 p -98.03 146.57 25.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 53.2 p -112.0 118.62 35.94 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 21.7 m -88.5 177.21 6.86 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.018 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.434 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.6 OUTLIER 72.54 33.61 1.38 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.285 0.991 . . . . 0.0 109.399 -172.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.8 33.45 23.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.594 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.32 6.92 89.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.189 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.434 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 21.4 m-85 -64.02 151.96 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.336 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -72.73 174.06 46.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.096 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.441 HG13 ' HB3' ' C' ' 68' ' ' GLU . 49.1 mm -60.57 -67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 121.182 0.515 . . . . 0.0 109.714 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 21.5 t -148.48 -88.42 0.08 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.308 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -177.31 25.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.535 0.683 . . . . 0.0 110.338 -173.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.56 146.12 50.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.159 0.504 . . . . 0.0 111.037 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.42 109.7 15.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.088 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 5.9 mptp? -121.18 137.7 54.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.426 ' OD1' HG13 ' C' ' 94' ' ' ILE . 3.1 t-20 -88.57 108.53 19.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.69 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.39 162.74 13.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.495 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.72 139.71 6.92 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.159 -1.496 . . . . 0.0 116.141 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -112.75 129.17 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.443 167.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.43 106.99 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.327 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 89' ' ' ILE . 11.2 m -94.0 123.01 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 53.76 33.41 16.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.329 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.68 60.79 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.041 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.52 119.71 21.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 5.4 ttpm? -71.2 120.88 17.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.55 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.54 -33.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.559 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.08 143.87 29.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.14 0.495 . . . . 0.0 110.598 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.69 HG23 ' O ' ' C' ' 54' ' ' TRP . 69.2 m -135.76 139.98 43.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.2 p90 -148.45 177.77 9.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.173 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 67.4 m-20 -122.71 139.33 54.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.862 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' C' ' 47' ' ' ILE . 26.5 mt-10 -66.36 -14.21 61.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -82.97 -1.26 51.99 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -87.44 -177.9 6.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.413 ' O ' HG12 ' C' ' 75' ' ' ILE . 15.1 p -83.22 115.6 22.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.47 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.5 t -60.95 -15.29 11.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.697 -169.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.81 -43.3 7.29 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.656 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -69.71 -28.55 65.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.457 HG21 ' CD1' ' C' ' 66' ' ' PHE . 41.0 mm -70.27 -65.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.18 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.58 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.9 m -59.19 -46.64 87.89 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.767 -171.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 41.2 m-80 -76.79 -14.83 59.88 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 19.8 m-20 -60.26 -45.62 92.64 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' C' ' 76' ' ' SER . 78.8 mt -57.22 -30.55 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.1 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' C' ' 77' ' ' ASN . 7.7 m120 -90.72 -28.67 18.15 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.43 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 11.5 mmpt? -55.04 -36.02 65.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.7 mt -56.41 -31.79 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.427 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.9 m-20 39.11 79.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 0.0 110.073 -168.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.43 HG22 ' N ' ' C' ' 86' ' ' GLY . 25.6 mt -69.04 131.92 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.003 -168.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -86.69 41.51 0.96 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.323 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.43 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -89.26 129.58 9.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.746 -172.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.22 -38.35 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.418 2.079 . . . . 0.0 110.748 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -150.72 113.28 4.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.119 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.451 HG12 ' SD ' ' C' ' 31' ' ' MET . 15.0 pt -123.01 153.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.876 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.27 129.32 54.33 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.226 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' C' ' 29' ' ' LEU . 3.4 mt -126.89 100.23 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.681 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.37 15.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 174.51 7.32 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.35 -177.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.426 HG13 ' OD1' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.348 -169.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.902 0.382 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 95.7 mmm -108.53 -140.94 0.38 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -41.43 -33.6 0.44 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -53.63 -51.38 63.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.801 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.472 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.4 tt -87.03 -25.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 17' ' ' ASN . 83.2 m-20 -72.48 -26.64 61.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.128 -0.358 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.8 t -63.33 -33.64 75.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.9 t -69.6 -34.01 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.053 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' C' ' 14' ' ' ASN . 78.9 m-20 -56.98 -43.42 81.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.02 0.438 . . . . 0.0 110.149 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -76.16 -19.92 58.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.95 -27.78 28.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.188 0.518 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' C' ' 27' ' ' LEU . 72.5 mt -91.51 -32.05 15.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.97 73.43 9.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -107.7 -40.7 5.22 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.003 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.52 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -168.69 -74.68 0.04 OUTLIER Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.378 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.3 ttmm -105.81 162.55 13.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 167.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.92 85.32 0.03 OUTLIER Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.199 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 7.7 ptpt -126.13 128.35 47.18 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.164 0.506 . . . . 0.0 111.169 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.49 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.7 tp -115.31 126.29 54.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.519 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.1 m -108.52 106.22 16.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.064 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.7 mm? -90.33 144.67 25.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.017 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.412 ' HB3' ' CE ' ' C' ' 37' ' ' LYS . 39.5 t -158.6 136.39 10.4 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.565 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.425 ' HE2' ' O ' ' C' ' 87' ' ' PRO . 2.3 mpt? -96.81 146.03 25.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -141.41 88.73 2.17 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.76 -99.3 0.08 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.33 26.46 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 110.362 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.708 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.2 tt0 -139.01 138.78 37.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.324 0.583 . . . . 0.0 111.654 -171.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -119.06 122.59 42.47 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 167.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.412 ' CE ' ' HB3' ' C' ' 30' ' ' SER . 0.0 OUTLIER -130.79 145.33 51.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.85 133.61 14.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.705 0.288 . . . . 0.0 110.535 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 51.9 p -100.56 144.46 29.52 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.0 p -121.51 118.36 29.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.626 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 30.6 m -104.76 -179.93 4.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.377 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.68 38.73 1.63 Allowed 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 124.208 0.942 . . . . 0.0 108.812 -169.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.68 20.64 12.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.081 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.51 79.19 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.299 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.467 ' O ' HG23 ' C' ' 72' ' ' VAL . 45.1 m-85 -75.92 -179.05 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.866 0.333 . . . . 0.0 111.063 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.54 -159.63 33.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.39 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.67 HD11 ' HB3' ' C' ' 68' ' ' GLU . 11.8 mt -49.21 -67.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.486 0.714 . . . . 0.0 112.53 -172.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 5.4 t 171.05 -75.3 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.788 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -155.31 62.23 0.62 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.352 0.261 . . . . 0.0 111.356 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.679 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 11.6 pt-20 -169.13 176.13 5.41 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.401 -0.187 . . . . 0.0 110.946 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 12.6 t70 -127.61 113.79 16.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.51 0.506 . . . . 0.0 110.78 -173.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -118.25 158.56 24.93 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.479 ' O ' HG12 ' C' ' 94' ' ' ILE . 9.2 p30 -108.93 123.21 48.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.474 0.654 . . . . 0.0 110.557 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.505 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -113.06 166.4 11.46 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.078 -168.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -173.8 155.89 22.82 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.636 -1.269 . . . . 0.0 115.796 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -116.45 129.38 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.365 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' C' ' 62' ' ' LYS . 0.4 OUTLIER -127.61 99.73 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.129 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 89' ' ' ILE . 7.4 p -84.11 125.77 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.645 -0.659 . . . . 0.0 109.967 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.49 26.21 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.878 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.41 4.45 76.98 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.977 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 35.9 tt0 -108.24 120.17 41.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.963 0.381 . . . . 0.0 110.609 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 27.6 ttpp -74.55 117.58 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.11 -30.23 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.023 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -137.39 144.63 42.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' C' ' 54' ' ' TRP . 28.1 m -145.99 141.89 28.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.6 p90 -162.24 -170.65 2.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.413 ' OD1' ' HG2' ' C' ' 69' ' ' LYS . 48.7 t-20 -117.53 138.38 51.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.545 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.67 ' HB3' HD11 ' C' ' 47' ' ' ILE . 1.9 tt0 -72.84 -29.53 63.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.295 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.679 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 9.4 ptmt -86.66 11.65 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -76.91 -151.15 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.546 ' O ' HG12 ' C' ' 75' ' ' ILE . 18.0 p -106.92 112.24 25.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.024 -1.047 . . . . 0.0 108.984 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.467 HG23 ' O ' ' C' ' 45' ' ' TYR . 6.8 t -59.39 -16.47 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.491 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.99 -46.49 7.67 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.094 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -66.79 -36.43 82.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.588 HG21 ' CD1' ' C' ' 66' ' ' PHE . 50.6 mm -68.01 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.542 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 13.5 m -70.59 -44.29 67.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -167.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.474 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 5.4 m-20 -69.56 -17.62 63.58 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.951 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 5.7 m-20 -64.56 -49.63 70.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 167.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 81.1 mt -52.33 -32.64 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.291 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -85.07 -36.3 21.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.37 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 56.6 mtmt -57.92 -30.55 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 109.788 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.3 mt -58.8 -27.98 65.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.577 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.708 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 41.77 82.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.895 0.855 . . . . 0.0 110.713 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.93 127.56 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.249 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -81.26 29.42 0.35 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.296 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.49 112.16 0.6 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.425 ' O ' ' HE2' ' C' ' 31' ' ' MET . 91.2 Cg_endo -81.75 -14.16 10.23 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.054 . . . . 0.0 113.278 -174.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -97.19 98.38 9.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' C' ' 58' ' ' VAL . 55.3 mt -125.48 132.68 70.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.5 0.667 . . . . 0.0 112.464 -168.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -90.29 97.37 11.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.127 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.545 HG21 ' HG ' ' C' ' 29' ' ' LEU . 14.1 tt -109.58 96.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 122.646 1.212 . . . . 0.0 107.983 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -152.97 177.32 10.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.263 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.9 OUTLIER -108.27 163.53 13.11 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.882 174.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.479 HG12 ' O ' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.321 -166.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.495 ' HA ' ' HE3' ' C' ' 31' ' ' MET . 37.7 mt-30 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.014 0.435 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.432 ' O ' HG22 ' C' ' 13' ' ' ILE . 96.6 mmm -105.27 -144.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.175 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.45 -29.43 58.64 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -41.43 75.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 111.319 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.432 HG22 ' O ' ' C' ' 10' ' ' MET . 0.0 OUTLIER -90.62 -30.02 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.535 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' HD22 ' C' ' 17' ' ' ASN . 77.2 m-20 -72.68 -24.97 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.118 -0.364 . . . . 0.0 110.933 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -57.88 -36.79 72.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.411 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.1 t -68.43 -32.76 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.563 HD22 ' HA ' ' C' ' 14' ' ' ASN . 8.2 m-80 -59.1 -38.4 79.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 109.97 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -70.36 -40.02 74.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.75 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -40.15 80.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.628 0.728 . . . . 0.0 109.734 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' C' ' 27' ' ' LEU . 36.7 mt -67.19 -41.24 86.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.8 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' C' ' 26' ' ' LYS . 28.1 m-80 -80.46 37.13 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.528 0.68 . . . . 0.0 110.603 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' C' ' 20' ' ' LEU . 18.3 pttm -48.25 -42.05 29.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.302 1.441 . . . . 0.0 112.84 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.7 -71.23 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -85.84 -166.83 1.64 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 163.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 45' ' ' TYR . . . 41.54 74.73 0.15 Allowed Glycine 0 CA--C 1.488 -1.601 0 O-C-N 124.272 0.982 . . . . 0.0 114.515 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.807 ' HB2' ' H ' ' C' ' 41' ' ' SER . 5.8 mmpt? -89.14 78.41 7.38 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.974 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.657 ' HB3' HD13 ' C' ' 20' ' ' LEU . 10.8 tp -88.07 105.94 17.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.336 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -101.15 108.08 19.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.579 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.417 HD22 HG21 ' C' ' 91' ' ' ILE . 1.3 mp -112.62 142.63 44.99 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.361 0.601 . . . . 0.0 112.088 -171.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -144.58 129.74 18.62 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.029 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.545 ' CG ' HD23 ' C' ' 36' ' ' LEU . 71.4 mtm -103.49 145.89 29.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -148.34 92.03 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.424 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.28 -93.45 0.29 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.989 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -108.63 15.02 24.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.598 0.199 . . . . 0.0 111.065 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.545 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 28.6 tt0 -134.05 139.28 45.89 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.598 0.713 . . . . 0.0 112.454 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.545 HD23 ' CG ' ' C' ' 31' ' ' MET . 3.2 tm? -128.31 120.68 27.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.689 169.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -132.49 139.59 48.01 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.601 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.466 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -151.1 145.91 25.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.846 -171.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 74.8 p -118.86 150.77 39.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 4.1 p -124.32 116.47 22.66 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.315 0.578 . . . . 0.0 111.087 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.807 ' H ' ' HB2' ' C' ' 26' ' ' LYS . 21.6 m -89.5 -178.93 5.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.813 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.02 42.83 15.32 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.822 0.701 . . . . 0.0 109.541 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.96 21.9 12.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.476 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.49 23.44 78.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.456 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.464 ' O ' ' HA2' ' C' ' 25' ' ' GLY . 33.2 m-85 -68.19 158.81 32.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.994 0.397 . . . . 0.0 110.722 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.75 -101.87 0.56 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.311 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' C' ' 68' ' ' GLU . 18.6 mt -107.6 -67.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.525 0.679 . . . . 0.0 110.42 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.7 p -176.16 -68.09 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.37 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -149.35 -32.94 0.21 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.413 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.552 ' O ' HD12 ' C' ' 47' ' ' ILE . 13.8 pt-20 -88.21 178.98 6.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.55 139.94 53.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 28.1 mmmt -115.72 157.35 24.41 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.608 ' OD1' HG13 ' C' ' 94' ' ' ILE . 2.8 t-20 -98.3 105.11 17.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.396 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.601 ' CZ2' HD21 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.06 165.99 10.7 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.187 -172.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.46 159.35 28.25 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.602 -1.285 . . . . 0.0 115.318 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -121.14 128.45 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.773 174.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.1 m-85 -124.04 122.49 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 48.7 t -105.86 111.18 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 60.11 24.88 14.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.084 0.468 . . . . 0.0 110.052 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.14 16.81 58.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.862 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.6 OUTLIER -107.01 128.1 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 0.0 111.357 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -72.12 107.44 4.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 m -95.58 -31.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.365 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -159.35 147.88 17.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 ' O ' ' C' ' 54' ' ' TRP . 71.3 m -140.62 147.78 39.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.79 -173.76 2.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.459 0.572 . . . . 0.0 112.117 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 20.1 m120 -114.37 139.5 49.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.7 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.6 ' HB3' HD11 ' C' ' 47' ' ' ILE . 63.6 tt0 -68.12 -15.83 63.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 14.5 ptmm? -83.66 -5.52 59.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -70.54 159.94 33.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 9.5 p -74.33 112.31 10.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' C' ' 27' ' ' LEU . 2.6 t -58.36 -14.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.71 -170.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.71 -38.96 14.96 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.088 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -72.71 -34.59 67.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.75 -59.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.408 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.432 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 66.5 p -58.12 -58.56 7.92 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.125 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.652 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 15.7 m-20 -67.95 -17.05 64.33 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -67.01 -48.21 69.08 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.499 ' HA ' ' CD1' ' C' ' 82' ' ' LEU . 75.2 mt -56.85 -32.64 39.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.902 174.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 41.7 m-20 -84.06 -22.1 31.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.393 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 67.8 mttm -62.71 -40.95 98.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.3 mt -54.88 -35.43 64.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.224 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.545 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 95.8 m-20 44.08 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 -166.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.82 113.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.475 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -84.45 64.6 8.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.211 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.68 156.96 26.1 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.585 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.487 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.2 Cg_endo -80.49 -55.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.501 2.134 . . . . 0.0 112.531 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.0 p90 -124.05 132.86 53.73 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.509 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 64.7 mt -130.3 132.09 65.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.511 0.672 . . . . 0.0 111.889 -169.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.22 98.18 10.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.603 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 56' ' ' ILE . 7.7 tt -108.25 97.94 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 177.24 9.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.818 -168.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.5 OUTLIER -106.23 163.61 12.67 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.637 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.608 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -165.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' C' ' 31' ' ' MET . 26.0 mt-30 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.593 0.235 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mtp -72.82 -145.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.3 m-20 -59.9 -16.52 30.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 31.3 t -46.34 -50.78 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.29 0.369 . . . . 0.0 111.317 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.412 HG13 ' H ' ' C' ' 13' ' ' ILE . 2.5 pp -91.27 -21.68 6.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.144 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 5.5 m-20 -63.97 -46.95 82.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.951 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' SER . . . . . 0.657 ' O ' ' HG2' ' C' ' 19' ' ' LYS . 42.6 t -55.42 -41.71 73.14 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.08 -34.5 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.575 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.57 -40.09 95.76 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -72.42 -27.4 62.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.869 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' C' ' 15' ' ' SER . 0.2 OUTLIER -79.82 -34.27 39.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.206 0.526 . . . . 0.0 110.14 -177.338 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 27' ' ' LEU . 93.3 mt -80.21 -38.97 30.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.808 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -79.38 71.64 5.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.43 0.633 . . . . 0.0 109.557 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.491 ' HE3' ' CB ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -113.83 -13.73 12.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.162 -171.224 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 146.04 -73.21 0.32 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -174.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.491 ' CB ' ' HE3' ' C' ' 22' ' ' LYS . 2.3 mttp -72.17 -159.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' C' ' 47' ' ' ILE . . . -43.1 130.75 5.57 Favored Glycine 0 CA--C 1.512 -0.137 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -173.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.7 ptpt -132.05 142.87 49.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.985 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 20' ' ' LEU . 4.1 mp -117.76 125.34 50.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 42.1 m -94.96 101.26 13.02 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.471 HD22 HD12 ' C' ' 91' ' ' ILE . 15.7 mt -92.44 129.4 38.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.613 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -151.24 144.37 24.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.414 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.416 ' HB2' ' OE1' ' C' ' 9' ' ' GLN . 2.4 mpt? -105.36 146.22 29.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.34 . . . . 0.0 110.319 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -147.86 89.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.229 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.14 -101.43 0.19 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.037 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.81 34.14 2.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.738 0.78 . . . . 0.0 109.305 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -140.9 139.9 34.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.379 0.609 . . . . 0.0 112.048 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -122.22 105.37 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 167.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.58 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 63.2 pttt -106.25 131.68 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 117.67 6.45 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.25 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 69.8 p -102.43 151.28 22.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.086 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.1 p -111.56 119.51 38.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.545 176.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 12.1 t -103.4 177.65 4.78 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.76 33.6 0.19 Allowed 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 124.619 1.199 . . . . 0.0 110.514 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.43 37.08 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.098 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.81 1.3 89.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.305 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -64.01 135.22 56.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.018 0.409 . . . . 0.0 110.359 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -64.39 150.67 50.75 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.777 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.496 HD11 HD11 ' C' ' 27' ' ' LEU . 40.6 mt -57.15 -54.56 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 121.872 0.844 . . . . 0.0 110.952 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 23.3 t -127.37 -173.72 2.98 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.063 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -132.52 13.9 4.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.96 0.886 . . . . 0.0 109.011 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.442 ' HB2' ' HE2' ' C' ' 52' ' ' LYS . 30.8 mt-10 -131.28 161.38 32.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.943 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.43 91.9 6.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 111.293 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 4.8 mptp? -94.37 144.67 25.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.572 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER -89.2 102.02 14.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.656 0.598 . . . . 0.0 110.359 175.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.565 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -105.11 159.28 15.97 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.5 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.484 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -165.17 166.85 38.49 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 118.267 -1.92 . . . . 0.0 116.114 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.484 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.3 mp -120.34 132.31 70.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.509 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 79.7 m-85 -120.84 111.44 17.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -93.76 115.21 32.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.69 34.33 23.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.003 0.43 . . . . 0.0 110.424 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.24 8.9 87.5 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.317 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 37.7 tt0 -107.92 126.96 53.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.281 0.541 . . . . 0.0 110.57 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -72.8 102.03 3.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.849 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.17 -46.57 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.264 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.51 149.43 50.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' C' ' 54' ' ' TRP . 63.7 m -145.33 143.3 30.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -155.57 -174.95 5.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.796 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 11.6 m120 -128.37 140.99 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.869 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' C' ' 48' ' ' SER . 20.5 mt-10 -67.53 -13.16 61.81 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -87.74 -6.17 58.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.021 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -83.69 177.84 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.332 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.486 ' O ' HG12 ' C' ' 75' ' ' ILE . 22.3 p -81.32 112.41 18.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.427 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.7 t -60.56 -14.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.229 -173.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.53 -38.25 12.67 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -73.89 -30.88 62.85 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.486 HG12 ' O ' ' C' ' 71' ' ' THR . 36.4 mm -67.48 -64.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.714 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.624 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 63.0 p -63.45 -58.26 7.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -169.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.537 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 61.6 m-20 -72.73 -16.38 61.66 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -172.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.52 -41.32 97.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' C' ' 76' ' ' SER . 85.6 mt -55.95 -25.44 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.123 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.593 ' N ' HD22 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -83.98 -32.19 25.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.233 -176.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.97 -38.5 76.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.0 -28.81 66.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.386 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 37.43 85.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.354 1.034 . . . . 0.0 111.567 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.473 HG21 HD12 ' C' ' 89' ' ' ILE . 27.3 mm -64.34 143.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.728 -168.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -112.36 25.42 11.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.656 -172.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.433 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -114.33 167.7 12.38 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.187 -172.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.574 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.7 Cg_endo -81.31 -72.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.835 2.357 . . . . 0.0 113.22 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.574 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 10.1 p90 -103.55 113.75 27.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.592 0.711 . . . . 0.0 109.993 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.473 HD12 HG21 ' C' ' 84' ' ' ILE . 19.3 mm -102.74 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.618 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -91.49 98.35 11.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.411 0.624 . . . . 0.0 110.755 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.565 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.0 mt -95.89 104.43 15.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 143.96 19.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 121.388 0.614 . . . . 0.0 111.602 -172.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 24.6 tm0? -66.0 140.41 58.29 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.872 174.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.572 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.76 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.236 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.639 0.257 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 37.9 mtm -80.14 -144.83 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 110.799 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.8 m-20 -61.45 -17.84 56.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.476 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -52.59 -46.28 66.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.6 pt -89.15 -26.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.81 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 79.2 m-20 -65.62 -37.15 85.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 47.7 t -54.68 -41.52 70.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 57.4 t -66.21 -37.17 79.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.403 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' C' ' 29' ' ' LEU . 33.5 m-80 -67.75 -33.31 74.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.574 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -80.11 -18.7 49.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.671 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -90.61 -38.7 12.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.546 HD13 ' HB3' ' C' ' 27' ' ' LEU . 68.4 mt -80.17 -36.42 35.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.033 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -81.51 74.87 8.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.889 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -111.5 -23.01 10.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.858 -172.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.625 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 165.12 -79.99 0.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.652 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 10.3 mttt -73.81 -159.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.33 141.54 1.15 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 -173.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.4 ptpt -149.95 140.17 22.19 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.057 -167.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' C' ' 20' ' ' LEU . 6.1 tt -108.39 125.48 51.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.393 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 20.8 m -104.16 123.86 48.05 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.456 ' N ' HD12 ' C' ' 29' ' ' LEU . 5.0 mp -94.58 134.16 37.43 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.453 ' HB3' ' HD2' ' C' ' 37' ' ' LYS . 7.0 t -159.59 142.39 13.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.727 170.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 137.98 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.816 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -136.95 89.8 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.767 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.16 -93.31 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.13 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -114.74 31.01 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.175 0.512 . . . . 0.0 110.216 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.513 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 26.7 tt0 -143.98 124.48 13.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -171.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.02 104.93 16.9 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 166.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -100.26 146.74 26.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 118.52 6.78 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.594 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.5 p -99.07 141.47 31.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.916 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 21.7 p -116.93 118.9 33.71 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.069 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CD ' ' C' ' 26' ' ' LYS . 45.0 m -91.97 176.42 6.52 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.246 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.5 m120 72.19 36.12 1.15 Allowed 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.261 0.976 . . . . 0.0 109.424 -169.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.63 35.42 26.08 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.476 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.36 79.87 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.274 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 24.0 m-85 -69.69 -179.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.063 0.459 . . . . 0.0 110.872 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.35 169.9 32.21 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.162 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.889 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 47.3 mm -54.04 -64.46 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 121.816 0.817 . . . . 0.0 110.907 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.8 t -174.9 -155.67 0.06 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.087 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -87.81 -15.99 35.32 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.29 0.567 . . . . 0.0 110.257 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 43.2 mt-10 -83.43 127.79 33.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.438 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.79 139.05 31.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -125.52 158.63 34.04 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.5 ' O ' HG13 ' C' ' 94' ' ' ILE . 3.1 p30 -97.17 103.87 15.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.722 0.772 . . . . 0.0 109.591 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.627 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.18 156.36 17.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.811 -171.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.431 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -139.98 132.8 5.71 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 119.459 -1.353 . . . . 0.0 115.582 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.501 HD12 ' N ' ' C' ' 56' ' ' ILE . 3.0 mp -120.63 126.6 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.069 -0.565 . . . . 0.0 109.487 170.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.74 137.87 47.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.585 HG23 HG11 ' C' ' 63' ' ' VAL . 65.0 t -101.5 117.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 15.5 m120 56.71 30.37 17.47 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.351 0.407 . . . . 0.0 111.243 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 6.96 73.85 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.053 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -107.73 119.91 40.77 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.532 -0.393 . . . . 0.0 110.578 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -57.91 119.06 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.162 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.585 HG11 HG23 ' C' ' 58' ' ' VAL . 4.3 p -119.52 -43.01 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.981 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -137.07 152.39 49.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.627 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.3 m -145.61 148.02 32.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' C' ' 75' ' ' ILE . 45.9 p90 -155.83 172.37 18.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.699 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.62 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.537 ' O ' HG12 ' C' ' 47' ' ' ILE . 4.2 tt0 -52.68 -40.11 62.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.688 -169.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 20.1 pttp -72.91 -0.84 14.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -169.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -71.32 -176.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.405 ' O ' HG12 ' C' ' 75' ' ' ILE . 28.2 p -74.23 108.91 7.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 t -60.57 -11.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.951 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.24 -38.35 8.49 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.0 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -74.17 -28.79 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.447 HG21 ' CD2' ' C' ' 66' ' ' PHE . 50.7 mm -73.77 -64.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.083 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.586 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 8.6 m -60.71 -48.73 80.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.991 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.479 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 75.6 m-20 -75.6 -15.5 60.34 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.1 OUTLIER -59.46 -44.85 92.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 166.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' C' ' 76' ' ' SER . 76.6 mt -56.42 -23.27 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.175 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -87.48 -34.39 18.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.106 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' C' ' 78' ' ' ASP . 57.7 mtmt -55.87 -38.89 70.73 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 1.6 mt -60.14 -29.45 68.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.142 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 0.9 OUTLIER 38.66 86.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.275 -170.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.14 99.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.438 -169.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -64.77 125.84 26.07 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.411 162.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 162.79 158.68 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.911 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.0 Cg_endo -81.15 -62.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.454 2.102 . . . . 0.0 112.585 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.54 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 16.0 p90 -128.37 137.72 52.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.992 0.425 . . . . 0.0 110.166 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.4 mt -122.34 136.45 59.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.97 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -92.2 99.91 12.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.498 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 30.0 mm -113.89 98.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.06 160.73 6.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.36 173.12 12.66 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.831 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.5 HG13 ' O ' ' C' ' 53' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.424 -175.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 54.1 mtt -68.49 -150.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.925 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -60.35 -9.52 3.63 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' SER . . . . . 0.426 ' O ' HG23 ' C' ' 16' ' ' VAL . 15.3 m -48.89 -49.87 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.673 0.389 . . . . 0.0 111.353 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.43 -18.81 7.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.212 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -69.24 -46.16 68.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -56.3 -34.69 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.477 0.656 . . . . 0.0 109.481 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 12' ' ' SER . 93.9 t -69.43 -37.18 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -63.39 -46.7 85.25 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 110.514 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.6 -19.86 65.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.589 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -90.15 -40.22 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.09 0.471 . . . . 0.0 110.378 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.1 mt -83.22 -32.31 26.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.304 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -92.8 79.06 4.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.358 0.599 . . . . 0.0 109.431 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.595 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -114.17 -30.69 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.948 -170.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.488 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 173.1 -73.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.628 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 54.7 mttp -71.25 -158.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.551 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -45.6 142.47 4.18 Favored Glycine 0 CA--C 1.497 -1.085 0 O-C-N 123.357 0.411 . . . . 0.0 113.547 -177.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.9 ptpt -144.35 150.08 37.2 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.834 -165.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' C' ' 38' ' ' ALA . 0.5 OUTLIER -122.84 113.33 19.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.82 -170.128 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 74.0 m -103.03 126.2 50.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HG ' HG21 ' C' ' 91' ' ' ILE . 0.7 OUTLIER -98.98 137.76 37.05 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -171.347 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 29.1 m -147.25 130.85 16.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.511 171.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.505 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.7 mtt -122.68 138.67 54.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.329 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -148.68 91.2 1.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.11 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.26 -93.61 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.706 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -108.81 33.17 4.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 109.774 -177.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.595 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 28.0 tt0 -149.72 139.55 21.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.526 0.679 . . . . 0.0 112.525 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.4 tm? -118.39 127.58 53.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 167.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 23.6 pttm -130.38 105.78 8.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' C' ' 27' ' ' LEU . . . -111.94 128.25 56.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.4 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -103.48 148.75 25.55 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.073 0.463 . . . . 0.0 110.41 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 64.9 p -119.41 138.25 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.338 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 14.7 m -117.35 179.49 4.03 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 80.18 23.41 0.42 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.424 1.078 . . . . 0.0 111.197 -176.063 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.4 50.06 13.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.393 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -3.36 86.72 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.59 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.9 m-85 -66.07 152.88 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.862 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.11 163.18 31.53 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.194 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.595 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 34.3 mm -51.55 -63.24 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.16 0.981 . . . . 0.0 111.169 177.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -156.98 -176.52 6.02 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.492 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.39 45.76 1.48 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.584 0.707 . . . . 0.0 109.792 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -140.85 145.23 35.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.102 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.69 114.28 16.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 12.4 mptt -126.37 129.95 49.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.739 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -89.24 99.19 12.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.945 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.679 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.874 -175.16 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.18 167.27 40.42 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.832 -1.651 . . . . 0.0 115.649 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.521 HG12 HG13 ' C' ' 91' ' ' ILE . 87.1 mt -125.99 128.2 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.582 -0.809 . . . . 0.0 111.697 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.7 m-85 -123.03 111.26 16.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.207 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -104.86 128.05 58.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CE1' ' C' ' 88' ' ' TYR . 77.0 m-20 54.69 24.71 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.817 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 27.7 29.27 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.543 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.9 pt-20 -143.82 151.13 39.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.292 0.546 . . . . 0.0 110.108 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -82.86 137.86 34.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.78 -32.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -161.9 135.83 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.084 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.679 HG23 ' O ' ' C' ' 54' ' ' TRP . 79.3 m -124.07 142.52 51.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' C' ' 75' ' ' ILE . 38.4 p90 -152.72 -178.01 6.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.594 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 13.9 m120 -124.89 130.44 52.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.048 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.486 ' HG2' HG13 ' C' ' 47' ' ' ILE . 31.2 mt-10 -62.89 -22.55 66.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.57 2.04 27.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.443 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -87.01 -179.64 6.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 23.3 p -77.7 118.19 19.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' C' ' 75' ' ' ILE . 2.1 t -64.53 -12.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -81.8 -41.4 9.74 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.122 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -64.61 -34.34 78.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.43 ' O ' HG13 ' C' ' 79' ' ' ILE . 74.2 mt -65.45 -68.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.462 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.587 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 3.4 m -56.42 -56.17 24.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -76.43 -15.08 60.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.88 -39.64 83.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 166.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' C' ' 76' ' ' SER . 71.7 mt -58.94 -25.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.79 173.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' C' ' 37' ' ' LYS . 7.2 m-20 -80.51 -34.16 35.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.61 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -56.53 -38.37 71.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.3 mt -55.81 -35.9 66.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.084 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.595 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 88.8 m-20 37.61 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.94 0.775 . . . . 0.0 110.824 -168.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.42 137.82 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.733 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.3 OUTLIER -94.88 113.89 25.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.086 174.445 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.61 148.82 6.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.367 -1.397 . . . . 0.0 112.929 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.549 ' HG2' ' CD2' ' C' ' 88' ' ' TYR . 98.2 Cg_endo -80.85 -43.81 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.772 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.549 ' CD2' ' HG2' ' C' ' 87' ' ' PRO . 31.8 p90 -123.68 129.65 51.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.483 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 77.1 mt -123.29 123.72 68.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.505 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -92.25 115.08 27.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.553 HG12 ' CH2' ' C' ' 54' ' ' TRP . 15.5 tt -115.98 103.25 14.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.978 0.894 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 159.26 22.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.567 -172.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.4 OUTLIER -90.81 163.04 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.34 0.59 . . . . 0.0 111.077 176.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.463 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.808 -167.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.449 ' O ' HG22 ' C' ' 13' ' ' ILE . 91.6 mmm -58.6 163.05 3.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.422 ' HA ' ' ND2' ' C' ' 14' ' ' ASN . 80.3 m-20 -56.87 -21.54 30.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.091 -165.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -52.19 -42.38 63.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.033 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.449 HG22 ' O ' ' C' ' 10' ' ' MET . 0.2 OUTLIER -87.09 -32.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.009 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.726 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 62.8 m-20 -64.7 -43.75 92.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.707 0.289 . . . . 0.0 111.662 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 -22.55 63.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 50.4 t -85.7 -33.07 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.262 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.726 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 82.6 m-20 -57.1 -48.0 79.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.22 -16.31 56.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.856 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -80.46 -42.19 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.01 -36.63 75.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.8 76.12 7.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.721 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.674 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -118.53 7.34 11.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.12 -68.65 0.54 Allowed Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.515 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' C' ' 25' ' ' GLY . 37.7 mttp -82.16 -160.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.578 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.61 137.88 2.34 Favored Glycine 0 CA--C 1.497 -1.06 0 O-C-N 123.846 0.716 . . . . 0.0 114.863 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 11.9 ptpt -147.2 162.1 39.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.767 -168.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.526 HD22 HD13 ' C' ' 29' ' ' LEU . 0.6 OUTLIER -138.92 130.08 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.705 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 16.3 t -106.03 106.13 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.677 ' HG ' HG21 ' C' ' 91' ' ' ILE . 2.2 mm? -92.61 132.14 37.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.241 0.217 . . . . 0.0 111.36 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.402 ' O ' HD22 ' C' ' 36' ' ' LEU . 18.1 m -145.91 129.65 17.15 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.747 172.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 62.1 mtm -129.31 129.17 44.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.051 -174.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.685 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 4.3 t-20 -150.96 107.01 3.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.165 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.8 -97.26 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.502 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 20.1 t-20 -121.38 30.21 6.88 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 2.9 pt20 -126.7 129.65 48.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.325 0.583 . . . . 0.0 111.562 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.722 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.6 tm? -130.76 127.14 38.15 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.618 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -144.04 128.94 18.44 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -145.77 118.73 8.75 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.679 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 48.8 p -102.88 152.05 21.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.716 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' C' ' 72' ' ' VAL . 40.2 t -117.36 118.08 31.27 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 30.7 t -96.98 178.06 5.41 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.88 32.29 0.51 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 124.284 0.99 . . . . 0.0 109.16 -167.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.33 31.66 20.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.214 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.75 80.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.76 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -69.54 168.79 13.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.739 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.37 -175.62 43.37 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.277 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.674 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 15.3 mm -64.63 -61.74 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.2 t -170.11 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.01 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -157.49 -45.83 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -77.24 150.81 35.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.986 0.422 . . . . 0.0 111.06 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -97.82 126.74 43.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.45 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -111.5 157.36 20.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.403 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -96.16 112.69 24.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.547 0.689 . . . . 0.0 110.858 178.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.676 ' HH2' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -103.4 166.56 10.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.351 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.86 150.91 21.16 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.305 -1.426 . . . . 0.0 115.81 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.414 HG23 HD13 ' C' ' 91' ' ' ILE . 49.6 mt -124.55 136.06 61.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.985 169.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.437 ' O ' HG23 ' C' ' 89' ' ' ILE . 3.9 m-85 -131.19 134.46 46.52 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.548 HG23 HG11 ' C' ' 63' ' ' VAL . 85.6 t -102.41 114.96 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.16 31.08 19.41 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.337 0.398 . . . . 0.0 111.333 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.9 5.38 73.89 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.307 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.57 126.01 52.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.047 0.424 . . . . 0.0 110.187 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.42 ' HD3' ' CE2' ' C' ' 57' ' ' PHE . 21.7 tptm -60.01 126.07 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.619 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' C' ' 58' ' ' VAL . 1.7 p -120.36 -37.29 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -148.47 152.73 37.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.596 0.236 . . . . 0.0 110.743 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 54' ' ' TRP . 33.2 m -140.54 146.01 37.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.86 -177.86 6.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.23 0.468 . . . . 0.0 111.399 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.04 135.73 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.598 ' O ' HG12 ' C' ' 47' ' ' ILE . 1.3 tt0 -60.1 -47.16 87.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.805 -173.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.8 -2.89 10.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.6 m -71.01 -174.87 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 4.6 p -77.98 104.19 8.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.566 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 2.9 t -60.36 -12.11 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.898 -173.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.71 -29.12 22.12 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.821 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -81.15 -28.45 35.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.13 -52.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.708 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.641 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.1 p -53.98 -60.79 2.86 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.054 -175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 68.2 m-20 -70.48 -16.98 62.97 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 1.3 m-20 -62.68 -41.15 98.94 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 166.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.5 mt -57.83 -22.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.291 175.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -83.82 -38.99 20.52 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.677 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 18.5 ptmt -62.56 -27.77 69.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.78 -31.67 66.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.55 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.19 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.083 1.489 . . . . 0.0 113.335 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.722 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.6 tp -42.08 145.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.111 -174.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -149.59 18.6 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.613 0.721 . . . . 0.0 109.164 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.85 162.19 14.2 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.768 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.27 -35.39 0.65 Allowed 'Trans proline' 0 CA--C 1.518 -0.284 0 C-N-CA 122.652 2.234 . . . . 0.0 111.487 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -158.81 132.36 7.45 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.834 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.65 HD12 HD11 ' C' ' 84' ' ' ILE . 70.1 mt -134.81 139.27 47.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.433 -173.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 23.8 mm-40 -91.2 103.49 16.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.96 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.677 HG21 ' HG ' ' C' ' 29' ' ' LEU . 15.7 mm -100.75 96.23 4.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -158.56 167.75 28.76 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 1.9 pt20 -100.25 162.35 13.01 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.402 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.455 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 -163.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 . . . . . 0 N--CA 1.461 0.107 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 5.8 mmt -65.04 -171.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -43.31 -36.69 1.94 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.487 0.715 . . . . 0.0 112.841 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 55.2 m -43.04 -54.01 4.54 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.835 0.709 . . . . 0.0 111.918 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -91.12 -19.82 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.549 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.03 -47.78 64.54 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.73 0.3 . . . . 0.0 110.748 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 26.9 p -57.3 -34.45 68.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.79 -37.39 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.58 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.15 -39.29 82.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.169 0.509 . . . . 0.0 109.843 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -78.33 -18.12 55.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.407 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -90.1 -42.58 11.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.676 0.274 . . . . 0.0 110.423 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.08 -32.01 68.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.48 71.07 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -109.21 -40.55 4.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.537 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -175.07 -68.98 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.6 ttmm -97.06 -174.59 3.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 166.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 30.73 89.92 0.01 OUTLIER Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.0 ptpt -128.68 125.34 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.579 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.479 HD22 ' HG ' ' C' ' 29' ' ' LEU . 1.5 tt -107.2 115.42 30.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.232 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 18.3 t -86.16 113.94 22.6 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.479 ' HG ' HD22 ' C' ' 27' ' ' LEU . 0.2 OUTLIER -112.72 123.14 49.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.652 0.263 . . . . 0.0 110.823 -173.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.408 ' O ' HD22 ' C' ' 36' ' ' LEU . 12.5 p -151.43 142.71 23.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.674 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.45 135.44 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.326 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.636 ' OD1' ' HE3' ' C' ' 37' ' ' LYS . 11.9 m120 -139.25 91.68 2.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.564 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.74 -94.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.472 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.25 30.3 7.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.747 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.609 ' OE1' ' HB3' ' C' ' 37' ' ' LYS . 7.3 tt0 -143.64 138.9 29.3 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 2.8 tm? -106.2 106.38 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 164.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.636 ' HE3' ' OD1' ' C' ' 32' ' ' ASN . 22.3 pttp -98.93 151.45 20.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.68 141.57 22.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.396 0.617 . . . . 0.0 112.299 -173.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.4 p -121.44 146.94 46.39 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.903 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 m -127.8 117.12 21.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.4 m -101.94 177.67 4.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.474 -176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' C' ' 24' ' ' LYS . 0.3 OUTLIER 65.75 42.82 3.38 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.219 0.95 . . . . 0.0 108.859 -167.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 63.39 21.5 12.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.266 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.38 24.38 76.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.701 -0.762 . . . . 0.0 113.33 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' VAL . 35.2 m-85 -80.21 -179.01 6.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.83 0.315 . . . . 0.0 111.249 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.17 -162.64 38.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.324 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 6.8 mt -49.59 -67.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 112.118 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.6 p 173.57 -73.7 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.976 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -140.67 -16.08 0.91 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.816 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 4.8 pt-20 -99.43 173.88 6.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.09 121.85 40.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.135 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.407 ' HB2' HD11 ' C' ' 47' ' ' ILE . 8.6 mptt -124.13 135.44 53.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 111.198 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.566 ' OD1' HG13 ' C' ' 94' ' ' ILE . 2.7 t-20 -89.08 116.49 27.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.684 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.559 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.2 163.39 13.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.0 147.22 8.86 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.327 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 91' ' ' ILE . 2.6 mp -107.63 129.84 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.067 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 52.9 m-85 -129.94 122.2 28.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.534 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 4.6 p -108.88 117.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 60.19 28.01 17.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.129 0.49 . . . . 0.0 110.462 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.9 16.46 79.91 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.388 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 30.5 mt-10 -107.06 147.56 29.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.617 0.722 . . . . 0.0 111.064 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.54 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 41.9 tptt -81.77 120.53 25.27 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.037 -169.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.406 ' CG2' HG12 ' C' ' 58' ' ' VAL . 41.2 t -109.71 -70.16 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.923 0.392 . . . . 0.0 110.929 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -137.89 143.66 40.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.909 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.559 HG23 ' O ' ' C' ' 54' ' ' TRP . 67.7 m -136.15 143.21 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.593 ' CD1' HG21 ' C' ' 75' ' ' ILE . 44.3 p90 -159.75 -172.61 3.74 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -116.91 137.39 52.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.85 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.655 ' HB3' HD11 ' C' ' 47' ' ' ILE . 0.7 OUTLIER -71.36 -28.68 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.44 -172.174 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 13.2 ptmm? -93.14 19.22 8.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.844 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 p -76.15 -119.97 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -131.7 107.66 8.95 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 166.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 45' ' ' TYR . 20.7 t -55.96 -24.33 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.043 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.31 -31.34 42.32 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.525 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -72.22 -33.96 67.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.593 HG21 ' CD1' ' C' ' 66' ' ' PHE . 27.5 mm -78.39 -54.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.158 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.659 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 64.3 p -53.61 -52.61 59.29 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.437 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.461 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 71.2 m-20 -77.48 -16.44 58.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -64.35 -37.89 89.09 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' C' ' 76' ' ' SER . 82.4 mt -60.31 -22.27 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.979 173.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -81.31 -34.49 31.88 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.545 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -53.13 -41.97 65.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.1 mt -58.83 -30.32 67.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.821 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.607 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.3 m-20 38.21 85.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.153 0.908 . . . . 0.0 111.227 -170.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 17.2 mm -55.06 138.54 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -169.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.27 170.51 9.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.029 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.34 173.34 15.44 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.352 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.3 Cg_endo -80.71 -47.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.487 2.125 . . . . 0.0 112.094 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.444 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 44.1 p90 -150.29 141.54 23.2 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.16 132.67 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.496 . . . . 0.0 111.022 -172.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -91.83 98.71 11.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.558 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 56' ' ' ILE . 13.8 tt -101.13 99.06 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 173.38 17.06 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.348 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -105.5 158.86 16.37 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.934 176.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.566 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 -166.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 22.2 mmt -70.4 -162.95 0.06 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.421 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.422 ' H ' ' HB3' ' C' ' 10' ' ' MET . 3.7 m-20 -52.26 -23.34 5.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -49.47 -43.93 45.51 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.148 0.28 . . . . 0.0 110.968 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.44 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 6.7 mt -88.7 -23.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.221 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.04 -49.0 49.65 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.931 -0.48 . . . . 0.0 110.672 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -57.98 -32.54 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.797 0.808 . . . . 0.0 109.429 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' C' ' 13' ' ' ILE . 2.2 t -67.99 -39.29 81.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.915 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' C' ' 29' ' ' LEU . 6.9 m-80 -65.67 -36.44 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -77.3 -20.17 55.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.665 176.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.19 -34.25 61.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.951 0.881 . . . . 0.0 108.886 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' C' ' 26' ' ' LYS . 49.6 mt -78.05 -40.26 39.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.616 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.11 82.58 4.18 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.733 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -5.8 9.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.55 -75.77 0.23 Allowed Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.842 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.6 ttmt -87.36 -156.85 0.36 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.479 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -18.78 106.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.589 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 0.5 OUTLIER -114.08 171.68 7.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.847 -175.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' C' ' 39' ' ' THR . 3.3 tt -156.74 115.47 3.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -173.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 69.3 m -93.9 127.5 39.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' C' ' 91' ' ' ILE . 86.7 mt -97.62 139.01 34.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -176.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.417 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 19.0 m -148.43 128.12 13.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.826 168.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.455 ' HG3' HD23 ' C' ' 36' ' ' LEU . 2.9 mpp? -116.7 133.18 56.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.88 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' C' ' 35' ' ' GLN . 5.2 p-10 -149.0 90.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.234 0.54 . . . . 0.0 111.653 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.24 -93.58 0.04 OUTLIER Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.556 173.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 18.1 t-20 -105.71 32.36 4.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 110.494 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.609 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.1 tt0 -150.18 142.01 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' C' ' 31' ' ' MET . 3.0 tm? -122.93 116.98 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 17.3 pttm -123.47 144.81 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -146.05 167.64 22.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.345 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 68.5 p -139.77 143.45 36.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.447 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 68.1 m -127.72 117.43 21.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.129 0.49 . . . . 0.0 109.688 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.589 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 67.9 m -100.81 179.56 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.7 m120 69.57 45.48 0.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 124.299 0.999 . . . . 0.0 109.026 -164.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.65 23.63 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.81 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' C' ' 71' ' ' THR . . . 69.38 21.69 76.06 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.949 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.75 -178.86 1.01 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.207 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.58 159.5 53.15 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.095 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.733 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 32.5 mm -52.31 -60.04 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-O 121.516 0.674 . . . . 0.0 111.067 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' C' ' 49' ' ' TYR . 45.5 t -135.62 -84.72 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.875 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' C' ' 48' ' ' SER . 34.1 p90 179.59 -22.88 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.589 ' CG ' ' HE3' ' C' ' 52' ' ' LYS . 0.4 OUTLIER -97.8 172.63 7.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.377 0.608 . . . . 0.0 111.373 -178.446 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.81 107.18 19.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.813 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.589 ' HE3' ' CG ' ' C' ' 50' ' ' GLU . 27.0 mmtp -120.57 154.24 35.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.855 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' C' ' 93' ' ' GLN . 0.8 OUTLIER -89.25 101.85 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.917 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.503 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.43 159.76 15.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.724 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -158.09 153.75 24.9 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 118.191 -1.957 . . . . 0.0 116.434 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.413 HD12 ' N ' ' C' ' 56' ' ' ILE . 3.5 mp -120.84 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.172 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' C' ' 62' ' ' LYS . 36.2 m-85 -126.8 156.34 41.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.2 113.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 110.053 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 54.42 39.39 30.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.535 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.78 -3.62 86.01 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.336 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 148.14 28.99 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' C' ' 57' ' ' PHE . 53.5 mtpt -91.74 137.93 31.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.991 0.424 . . . . 0.0 110.813 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.93 -50.77 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.077 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -150.49 152.34 34.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.484 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 89.2 m -128.07 126.87 42.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.543 ' CG ' HG21 ' C' ' 75' ' ' ILE . 11.5 p90 -133.18 178.49 6.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.031 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 28.6 m-80 -121.77 142.04 50.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.691 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.695 ' HG2' HG21 ' C' ' 47' ' ' ILE . 5.4 mt-10 -65.24 -10.8 34.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.34 -2.52 52.01 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.26 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -88.29 157.72 18.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' C' ' 44' ' ' GLY . 30.9 p -76.72 113.07 13.97 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -16.22 7.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.185 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.62 -36.32 38.2 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.953 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -77.07 -31.06 55.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.543 HG21 ' CG ' ' C' ' 66' ' ' PHE . 49.5 mm -75.16 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.26 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.635 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 96.6 p -58.76 -50.71 72.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -171.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.51 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 65.4 m-20 -79.33 -17.34 54.73 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -172.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -34.47 74.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.606 167.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' C' ' 76' ' ' SER . 91.6 mt -61.1 -20.83 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.978 173.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.9 OUTLIER -76.01 -43.48 44.02 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.875 179.104 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -51.87 -38.06 54.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.525 0.679 . . . . 0.0 109.512 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.6 mt -55.96 -33.1 64.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.885 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.609 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 38.0 79.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.928 0.768 . . . . 0.0 111.201 -172.108 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.07 136.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.403 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 1.4 ptpt -81.96 39.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.677 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.65 128.15 9.48 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.027 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.39 -40.31 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.263 1.975 . . . . 0.0 110.851 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.78 97.85 5.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -103.45 124.4 57.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.531 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.78 100.75 9.18 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.026 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' C' ' 29' ' ' LEU . 4.5 mt -95.19 98.63 8.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.12 149.55 24.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.193 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 53' ' ' ASN . 9.1 tt0 -73.8 144.41 45.57 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.641 -176.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.465 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.599 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.613 ' HG2' ' SD ' ' C' ' 31' ' ' MET . 11.1 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.447 ' O ' HG13 ' C' ' 13' ' ' ILE . 1.5 mpt? -82.95 -143.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' C' ' 10' ' ' MET . 33.1 m-80 -53.44 -18.93 3.03 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -174.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 12' ' ' SER . . . . . 0.494 ' O ' HG23 ' C' ' 16' ' ' VAL . 68.9 m -54.44 -33.24 59.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.503 HG21 ' SD ' ' C' ' 31' ' ' MET . 2.4 pp -89.55 -27.79 5.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.987 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -73.31 -43.65 60.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.689 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -58.25 -33.46 69.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.348 0.594 . . . . 0.0 109.448 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.634 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 76.3 t -74.13 -34.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.252 175.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.506 HD21 ' HB2' ' C' ' 29' ' ' LEU . 7.7 m-80 -58.99 -40.29 84.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -75.39 -15.85 60.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.358 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -87.93 -31.58 19.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.487 0.66 . . . . 0.0 109.578 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' C' ' 27' ' ' LEU . 79.4 mt -82.94 -39.87 20.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.559 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -77.14 64.41 2.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 109.597 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -103.58 7.95 37.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.211 -172.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.42 -61.87 0.64 Allowed Glycine 0 CA--C 1.504 -0.613 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.73 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 26.9 mmmt -79.28 -159.47 0.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.105 175.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -48.71 143.38 8.01 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 121.568 -0.349 . . . . 0.0 113.652 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.73 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 5.8 ptpt -150.44 135.8 17.97 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.455 -164.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.703 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.6 mp -92.04 126.92 37.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.881 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 23.8 m -95.65 99.5 11.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.52 HD13 HG23 ' C' ' 91' ' ' ILE . 16.2 mt -82.58 126.2 32.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 46.9 t -146.4 129.19 16.25 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.613 ' SD ' ' HG2' ' C' ' 9' ' ' GLN . 0.5 OUTLIER -113.25 124.04 51.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.47 91.08 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.56 -99.43 0.25 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.115 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.88 13.28 29.29 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.947 0.374 . . . . 0.0 111.147 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.6 tt0 -136.77 147.26 46.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.617 0.722 . . . . 0.0 112.189 -170.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.578 HD21 HD12 ' C' ' 91' ' ' ILE . 9.6 tp -130.78 113.56 14.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.885 171.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 19.7 pttp -122.9 104.53 9.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -112.37 118.9 36.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.159 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 42.1 p -97.09 148.06 23.4 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.271 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 67.1 p -109.66 119.46 39.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.487 -175.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.455 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 18.4 t -95.19 175.62 6.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.424 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 4.4 m-20 63.21 31.39 15.6 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.679 0.612 . . . . 0.0 110.32 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.96 10.54 7.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.789 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.1 24.76 28.56 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.167 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 52.5 m-85 -72.43 -179.24 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.578 0.689 . . . . 0.0 110.31 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.46 -157.62 29.73 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.332 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.591 ' H ' ' HA ' ' C' ' 69' ' ' LYS . 75.7 mt -49.9 -65.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 C-N-CA 123.265 0.626 . . . . 0.0 111.125 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 27.5 t 173.25 -72.68 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.898 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -140.95 -32.51 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.71 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.517 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.7 pt-20 -85.07 177.6 7.85 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.183 -0.323 . . . . 0.0 110.754 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 27.8 t70 -123.78 141.95 51.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 32.6 mmtm -124.02 153.15 41.74 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.759 173.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.4 OUTLIER -98.88 112.6 24.65 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.454 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.602 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -102.53 162.08 13.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.691 -173.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.99 150.51 21.13 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.653 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.516 HD11 HD13 ' C' ' 79' ' ' ILE . 46.5 mt -120.21 135.23 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 170.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.447 ' CE1' ' HG2' ' C' ' 62' ' ' LYS . 58.0 m-85 -133.07 148.88 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.643 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.6 p -143.56 129.98 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.38 27.96 12.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.132 0.491 . . . . 0.0 111.171 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 1.35 81.39 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.829 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 11.6 pt-20 -112.57 157.33 21.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.642 0.721 . . . . 0.0 110.426 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.447 ' HG2' ' CE1' ' C' ' 57' ' ' PHE . 60.4 mtpt -76.85 131.65 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.68 -49.61 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.346 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' C' ' 56' ' ' ILE . 62.3 t80 -157.0 161.79 39.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.823 -172.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -145.85 159.72 42.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.1 p90 -168.72 -178.41 3.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.0 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -119.89 121.97 40.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.712 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' C' ' 47' ' ' ILE . 43.6 tp10 -61.0 -22.73 64.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' C' ' 47' ' ' ILE . 22.8 ptmt -85.22 4.89 32.6 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.906 -0.496 . . . . 0.0 111.77 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -75.29 -118.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.438 ' O ' HG12 ' C' ' 75' ' ' ILE . 1.5 p -131.22 108.07 9.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 169.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.485 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 48.0 t -56.72 -22.23 15.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.667 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.8 -39.17 25.42 Favored Glycine 0 CA--C 1.504 -0.644 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.417 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -68.68 -40.42 80.11 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' C' ' 66' ' ' PHE . 48.3 mm -64.79 -63.62 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.562 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 50.4 m -53.64 -63.72 1.06 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -169.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.574 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.7 m-20 -70.09 -16.78 63.18 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.466 -0.893 . . . . 0.0 113.289 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 35.8 m-20 -73.75 -37.0 65.2 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.6 168.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' C' ' 76' ' ' SER . 89.4 mt -60.09 -32.59 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.743 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 32.0 m-20 -85.38 -34.39 21.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.052 -172.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 56.4 pttt -57.81 -26.99 62.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 16.4 mt -61.32 -25.73 67.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.767 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.695 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 40.12 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.898 0.856 . . . . 0.0 111.949 -172.581 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' C' ' 84' ' ' ILE . 37.6 mm -71.2 113.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.648 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.485 ' H ' ' HE3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -93.21 119.63 32.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.128 174.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.47 147.99 6.58 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.65 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.46 -37.45 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.285 1.99 . . . . 0.0 111.825 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.3 98.87 6.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -99.76 125.86 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.553 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -122.82 123.64 41.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.862 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.602 HG12 ' CH2' ' C' ' 54' ' ' TRP . 20.1 tt -129.43 99.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 151.56 25.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.447 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -85.65 163.89 18.02 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.946 176.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.48 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.332 -164.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.414 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 61.0 mtm -87.81 -144.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 176.135 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 18.5 m120 -61.67 -9.02 5.28 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.4 m -49.77 -44.9 49.09 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.13 0.269 . . . . 0.0 110.634 175.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 21.5 pt -90.85 -24.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.163 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 2.2 m-20 -64.97 -36.34 84.1 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.921 0.391 . . . . 0.0 110.119 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 37.1 t -55.37 -35.91 65.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.532 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 76.1 t -71.29 -37.53 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.181 174.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' C' ' 28' ' ' SER . 33.4 m-80 -65.88 -47.08 76.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.765 -177.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -68.68 -17.17 64.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.324 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -90.33 -38.2 13.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.266 0.555 . . . . 0.0 110.466 -176.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 55.9 mt -86.57 -26.92 24.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -80.32 84.63 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -120.7 -40.43 2.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.411 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . 174.89 -68.95 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -172.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.701 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 45.9 mttp -76.09 -159.03 0.1 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.79 130.49 1.86 Allowed Glycine 0 CA--C 1.501 -0.787 0 O-C-N 123.898 0.749 . . . . 0.0 114.398 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.701 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.9 OUTLIER -134.63 143.4 47.28 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.721 -173.304 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 32.4 tp -117.39 123.44 46.44 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.032 0.444 . . . . 0.0 111.156 -174.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 44.3 m -100.53 104.28 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.152 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.76 133.16 35.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -145.15 131.68 19.8 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.931 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 79.7 mtp -115.54 134.86 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.854 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.592 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 17.9 m120 -134.58 89.49 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.508 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.63 -93.23 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.566 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.9 OUTLIER -108.92 29.58 7.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.556 0.217 . . . . 0.0 110.959 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.521 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 8.0 tt0 -143.88 140.7 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.536 0.684 . . . . 0.0 111.934 -168.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.3 tm? -118.92 118.98 33.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 171.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.592 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 44.8 pttt -129.18 104.56 7.61 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -118.16 119.4 34.6 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 67.8 p -98.01 145.14 26.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.145 0.498 . . . . 0.0 111.193 -174.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 16.6 p -109.61 119.14 38.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.373 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 16.3 t -95.34 -170.39 2.16 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.04 18.54 0.48 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.448 1.093 . . . . 0.0 110.593 -170.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.24 34.21 23.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.673 173.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.13 -18.24 46.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.178 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -57.79 140.15 52.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.311 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' C' ' 24' ' ' LYS . . . -79.51 156.06 40.45 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.709 -174.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.57 ' HB ' ' HG2' ' C' ' 68' ' ' GLU . 70.2 mt -56.08 -53.32 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.533 0.683 . . . . 0.0 112.104 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.611 ' HB2' ' OE2' ' C' ' 68' ' ' GLU . 31.2 t -116.61 176.93 4.89 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.912 -169.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -119.61 3.85 11.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.68 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' C' ' 52' ' ' LYS . 27.6 mt-10 -125.3 171.24 10.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.442 176.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.58 96.27 10.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.164 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.486 ' HD3' ' HB2' ' C' ' 50' ' ' GLU . 17.9 mmmt -98.98 158.98 15.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.793 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -101.18 110.86 22.93 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.491 -176.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.2 OUTLIER -114.47 165.06 13.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -168.687 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.45 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -174.12 165.86 37.67 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 119.174 -1.488 . . . . 0.0 115.741 172.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.45 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.0 mp -116.19 134.1 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.983 176.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 82.3 m-85 -121.06 142.06 50.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 178.061 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -134.34 124.4 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.16 27.36 14.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.66 35.66 31.54 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.235 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 9.5 pt-20 -140.83 153.02 45.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -81.69 130.76 35.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 111.348 -177.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.426 ' CG2' HG12 ' C' ' 58' ' ' VAL . 53.7 t -105.89 -51.87 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.63 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -141.75 147.54 37.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.643 -176.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 2.3 t -131.89 158.12 42.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 54.8 p90 -167.82 -174.63 2.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.524 0.678 . . . . 0.0 112.725 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.04 140.22 49.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.743 -177.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.611 ' OE2' ' HB2' ' C' ' 48' ' ' SER . 19.8 tt0 -79.13 -6.83 57.44 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -168.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.0 ptmt -104.18 6.51 35.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.996 -0.44 . . . . 0.0 111.396 -177.473 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 39.4 p -81.84 -163.57 0.67 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.48 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 20.0 p -93.54 106.94 18.86 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.53 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.2 t -59.68 -15.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.335 -169.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 -35.66 14.68 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.071 -178.224 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.28 -35.97 76.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' C' ' 78' ' ' ASP . 46.2 mm -70.96 -63.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.388 -178.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.0 m -58.15 -46.61 85.38 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.992 -170.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.573 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 32.9 m-80 -72.89 -14.72 61.54 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.621 -0.832 . . . . 0.0 112.966 -177.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.512 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 51.6 m-20 -56.44 -51.76 67.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 165.069 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' C' ' 76' ' ' SER . 67.5 mt -54.25 -33.41 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.754 176.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 38.9 m-20 -87.8 -37.71 16.34 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.814 -169.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.499 ' CE ' ' HA ' ' C' ' 78' ' ' ASP . 51.2 mtmt -56.39 -28.61 59.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.285 0.564 . . . . 0.0 109.781 176.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.5 mt -59.14 -28.06 66.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.779 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.521 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 96.4 m-20 39.79 75.82 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.717 0.77 . . . . 0.0 110.42 -170.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.417 HG22 ' H ' ' C' ' 86' ' ' GLY . 25.2 mt -74.2 131.27 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.495 -171.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 2.3 ptpt -83.84 29.59 0.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.292 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.417 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -76.12 142.48 28.48 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.459 -175.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.62 -39.79 0.22 Allowed 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.743 2.296 . . . . 0.0 111.377 176.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -144.45 123.54 12.87 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.744 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.63 128.72 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.755 -175.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.16 110.42 22.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.269 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.586 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.5 mt -99.87 103.66 15.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.2 154.53 25.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.269 -172.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.23 162.29 19.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.435 0.636 . . . . 0.0 111.693 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.417 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.659 -170.086 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtm -98.04 -141.45 0.3 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.603 -177.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -47.44 -26.92 1.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -175.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -47.8 -46.34 30.49 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.27 0.356 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -90.67 -22.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.268 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.83 -51.48 40.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.259 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 17.7 t -58.37 -32.69 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.521 0.677 . . . . 0.0 109.639 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 60.0 t -71.39 -34.47 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.064 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -62.74 -37.33 86.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.163 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.22 -30.98 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.571 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -78.21 -33.39 49.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.73 0.776 . . . . 0.0 109.803 -176.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.647 HD13 ' HG ' ' C' ' 27' ' ' LEU . 90.2 mt -80.91 -40.38 24.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.241 -176.364 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -81.77 67.02 7.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.43 0.633 . . . . 0.0 109.831 177.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -100.95 -17.26 16.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.469 -174.863 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.78 -64.56 0.36 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.306 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 24.3 mmmt -84.02 -157.48 0.27 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -38.82 131.32 1.83 Allowed Glycine 0 CA--C 1.503 -0.697 0 O-C-N 124.048 0.843 . . . . 0.0 115.158 -175.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.764 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.3 OUTLIER -143.15 144.44 32.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.144 -1.028 . . . . 0.0 110.061 -172.411 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.647 ' HG ' HD13 ' C' ' 20' ' ' LEU . 1.4 pt? -123.82 112.64 17.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.681 175.087 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.784 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.2 m -82.61 104.2 12.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.974 -176.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.55 HD13 HG23 ' C' ' 91' ' ' ILE . 13.3 mt -79.78 122.29 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.369 -170.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.464 ' O ' HD22 ' C' ' 36' ' ' LEU . 5.8 m -129.69 128.51 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.167 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.457 ' HG2' HD23 ' C' ' 36' ' ' LEU . 53.8 mtt -132.24 116.83 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.249 -176.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 46.7 t30 -150.75 96.96 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.606 0.241 . . . . 0.0 111.32 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 33' ' ' GLY . . . . . 0.431 ' O ' HG22 ' C' ' 84' ' ' ILE . . . 67.15 -92.69 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.682 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -101.22 -20.83 15.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.593 0.711 . . . . 0.0 109.912 -176.657 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 17.4 pt20 -88.68 127.85 35.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.692 0.758 . . . . 0.0 111.899 -171.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.598 HD23 HG13 ' C' ' 84' ' ' ILE . 1.6 tm? -131.27 117.69 19.33 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 47.5 pttt -144.64 106.28 4.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.784 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.04 129.0 46.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 3.9 m -95.87 129.84 42.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.651 0.738 . . . . 0.0 110.198 -176.524 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 61.7 p -107.26 118.68 37.34 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.68 -176.451 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 m -121.61 179.14 4.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.757 -175.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.441 ' HB2' ' CE ' ' C' ' 26' ' ' LYS . 0.8 OUTLIER 66.57 42.17 2.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.276 0.985 . . . . 0.0 109.439 -169.977 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.19 27.47 17.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.98 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.75 19.07 72.91 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.589 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 36.1 m-85 -70.98 -178.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.204 0.502 . . . . 0.0 110.857 176.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.1 -154.67 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.848 -177.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.675 HD12 ' O ' ' C' ' 50' ' ' GLU . 32.2 mt -50.19 -67.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 C-N-CA 123.56 0.744 . . . . 0.0 112.729 -177.047 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 23.3 t 173.06 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 124.655 1.222 . . . . 0.0 109.656 -175.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -156.07 49.32 0.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.138 0.494 . . . . 0.0 110.633 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.9 pt-20 -169.05 -178.68 3.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' HD3' ' C' ' 69' ' ' LYS . 8.7 p-10 -128.8 126.51 40.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.72 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.5 mmmt -104.69 157.59 17.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.9 OUTLIER -98.18 101.45 12.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.018 177.144 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.625 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -97.28 166.89 11.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.379 -174.761 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.1 166.68 39.88 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 118.535 -1.793 . . . . 0.0 116.484 176.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.402 HG12 HG13 ' C' ' 91' ' ' ILE . 19.2 mt -128.6 139.56 51.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 113.799 -1.201 . . . . 0.0 109.747 175.02 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 40.6 m-85 -134.02 113.51 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.432 -176.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' C' ' 63' ' ' VAL . 41.1 t -80.96 105.59 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.541 ' HA ' ' CE2' ' C' ' 88' ' ' TYR . 2.3 m-20 62.82 28.66 16.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 110.481 -176.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.08 67.98 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.4 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.4 tt0 -107.68 123.56 48.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.487 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 86.9 tttt -61.9 103.28 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.372 0.606 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.467 ' CG1' HG23 ' C' ' 58' ' ' VAL . 0.9 OUTLIER -97.29 -53.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 177.981 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -130.46 149.14 52.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.625 HG23 ' O ' ' C' ' 54' ' ' TRP . 80.0 m -149.66 138.22 20.82 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -150.9 -175.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.644 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -116.93 134.27 54.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.449 ' C ' HG13 ' C' ' 47' ' ' ILE . 27.7 tt0 -66.91 -13.58 61.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.423 -171.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.7 ptmm? -84.23 -17.59 39.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.736 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -62.07 154.9 25.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -64.82 111.44 2.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.271 -172.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.38 -15.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.912 -173.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.67 -39.08 14.88 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 120.052 -1.07 . . . . 0.0 111.432 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.05 -36.36 72.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.129 0.49 . . . . 0.0 109.697 177.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.53 -56.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.531 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 80.7 p -57.57 -58.81 6.69 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -171.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.628 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.4 m-20 -68.23 -19.1 64.71 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.201 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 0.9 OUTLIER -74.73 -36.19 62.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.846 169.495 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' C' ' 76' ' ' SER . 58.9 mt -59.59 -31.86 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.81 0.814 . . . . 0.0 109.381 170.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 31.8 m-20 -81.78 -35.1 29.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.919 -172.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 16.0 ptpt -59.97 -31.08 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.9 mt -56.12 -31.47 63.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.224 177.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.19 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.543 1.152 . . . . 0.0 113.189 -173.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.598 HG13 HD23 ' C' ' 36' ' ' LEU . 9.5 mm -35.57 141.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.602 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -143.78 7.93 1.47 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.99 -178.678 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.54 -175.61 20.07 Favored Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 118.997 -1.573 . . . . 0.0 111.988 -173.134 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.52 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 84.3 Cg_endo -81.01 -87.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.493 2.129 . . . . 0.0 111.836 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' C' ' 59' ' ' ASN . 25.1 p90 -108.23 110.88 22.6 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.623 0.725 . . . . 0.0 110.284 178.348 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.09 126.53 74.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.85 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.68 141.36 28.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 -174.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.55 HG23 HD13 ' C' ' 29' ' ' LEU . 12.0 tt -136.07 99.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.322 1.058 . . . . 0.0 108.37 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 164.52 9.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.114 -171.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 4.3 pp0? -96.66 161.2 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.928 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.986 -164.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.493 ' O ' HG22 ' C' ' 13' ' ' ILE . 25.5 mmt -105.64 -142.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.81 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.79 -25.74 30.12 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -177.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -55.0 -50.06 69.93 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.493 HG22 ' O ' ' C' ' 10' ' ' MET . 4.9 tt -73.71 -36.18 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 77.5 m-20 -72.15 -36.14 69.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.596 -177.115 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -57.69 -39.41 77.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 72.7 t -66.57 -33.95 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 174.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 88.4 m-20 -59.63 -44.9 93.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.834 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.28 -17.02 61.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.566 179.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' C' ' 16' ' ' VAL . 23.3 tptm -87.12 -36.27 18.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.954 -177.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 14.9 mt -82.44 -26.03 33.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.139 -177.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -81.14 61.21 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' C' ' 25' ' ' GLY . 0.0 OUTLIER -91.75 -40.87 11.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.341 -166.683 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . -169.76 -95.67 0.1 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' C' ' 48' ' ' SER . 29.6 ttmt -91.62 145.21 24.78 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.06 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.504 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 63.85 127.55 0.01 OUTLIER Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.524 -170.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.8 ptpt -151.14 140.45 21.36 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 121.962 -0.728 . . . . 0.0 112.187 177.335 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.468 ' N ' HD12 ' C' ' 27' ' ' LEU . 2.5 mp -117.76 124.02 47.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.136 -176.259 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 6.1 t -97.63 98.86 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 52.7 mt -80.53 136.05 36.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.068 0.461 . . . . 0.0 111.667 -173.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -141.91 128.91 20.75 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.945 171.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.453 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 51.2 mtt -118.31 114.72 23.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.826 -176.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -132.92 90.64 2.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.218 -174.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.86 -104.09 0.41 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.337 175.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.45 34.26 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 109.519 -177.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.428 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 33.4 tt0 -148.65 133.4 17.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.481 0.657 . . . . 0.0 112.656 -178.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.453 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 0.6 OUTLIER -112.89 123.23 49.83 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 165.945 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -137.0 140.33 42.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.94 132.5 14.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.676 -177.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -96.88 134.34 40.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 10.6 p -109.52 119.7 40.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.593 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.412 ' HB2' ' CG ' ' C' ' 26' ' ' LYS . 16.0 m -106.55 -178.71 3.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.405 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 77.34 27.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 124.439 1.087 . . . . 0.0 109.832 -174.453 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.27 31.97 17.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.583 174.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.06 -19.69 33.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.154 175.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -56.11 130.71 45.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.542 0.171 . . . . 0.0 110.944 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.92 -45.64 0.81 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 -174.108 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.2 OUTLIER -47.91 -46.03 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -159.824 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' C' ' 24' ' ' LYS . 73.7 m 75.92 -60.57 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.994 0.809 . . . . 0.0 110.927 -169.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -162.72 -46.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.136 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -139.79 -172.67 3.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.359 0.6 . . . . 0.0 112.134 -172.161 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.576 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 3.8 t70 -82.06 102.15 10.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.542 -177.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.3 28.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.851 176.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.78 106.55 18.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.69 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.67 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -95.86 158.74 15.31 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.004 -174.837 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.84 145.28 12.66 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.397 -1.382 . . . . 0.0 114.684 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.49 HG23 HG12 ' C' ' 91' ' ' ILE . 45.2 mt -130.73 132.27 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 173.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.38 160.54 30.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.2 p -144.55 126.66 10.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' C' ' 88' ' ' TYR . 88.3 m-20 57.65 28.89 16.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 111.123 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.94 -3.31 84.66 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.62 177.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.0 pt-20 -107.64 149.91 27.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.515 0.658 . . . . 0.0 109.841 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -81.43 124.84 29.76 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.0 110.329 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 -52.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -138.35 155.56 48.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.151 -173.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.67 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.3 m -150.85 139.24 20.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.676 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' C' ' 75' ' ' ILE . 50.1 p90 -152.8 -170.37 3.61 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.486 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -134.19 157.72 45.53 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.084 0.24 . . . . 0.0 110.7 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' C' ' 47' ' ' ILE . 0.5 OUTLIER -59.3 -45.47 91.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.176 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -53.51 -38.69 63.97 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.979 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.8 p -68.86 122.42 18.59 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.42 ' O ' HG12 ' C' ' 75' ' ' ILE . 41.7 p -54.75 126.39 23.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.518 0.675 . . . . 0.0 111.047 -166.661 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -20.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.043 -175.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.5 -37.59 30.67 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.861 -176.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -75.22 -34.8 61.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.477 HG21 ' CD1' ' C' ' 66' ' ' PHE . 47.3 mm -70.84 -65.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.424 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.5 m -58.66 -52.4 65.85 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.446 -170.343 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 3.0 m-20 -74.34 -17.85 60.77 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.991 -172.676 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' C' ' 81' ' ' LYS . 13.0 m-20 -66.52 -48.05 70.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' C' ' 76' ' ' SER . 95.7 mt -52.89 -33.0 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.434 174.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.477 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 67.5 m-20 -84.45 -32.32 24.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.37 -173.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 58.2 mtmt -60.51 -29.4 69.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.6 mt -60.38 -26.54 66.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.555 178.478 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.428 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 91.5 m-20 39.41 78.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.889 0.743 . . . . 0.0 110.742 -171.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.503 HG22 ' H ' ' C' ' 86' ' ' GLY . 8.9 mt -57.99 145.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.946 -172.331 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.59 20.0 6.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.401 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 86' ' ' GLY . . . . . 0.503 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -85.77 141.03 18.43 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.955 -176.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -79.81 -45.16 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.895 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' C' ' 59' ' ' ASN . 32.1 p90 -131.06 123.57 28.97 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.439 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.2 mp -112.8 136.93 47.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -99.51 98.73 9.58 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.976 0.417 . . . . 0.0 109.971 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.49 HG12 HG23 ' C' ' 56' ' ' ILE . 10.1 mt -113.83 101.46 12.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.057 -178.137 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.02 147.99 4.88 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.502 ' H ' ' HG2' ' C' ' 93' ' ' GLN . 2.9 pt20 -75.14 157.41 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.358 0.599 . . . . 0.0 111.426 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.475 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.935 -163.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' C' ' 31' ' ' MET . 27.9 mm-40 . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.405 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 33.8 mmt -90.07 -153.69 0.3 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -176.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 11' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 88.9 m-20 -51.1 -28.19 10.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.866 0.467 . . . . 0.0 112.074 -175.127 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 25.0 m -47.69 -52.13 19.39 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.685 0.616 . . . . 0.0 111.604 177.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 19.5 pt -91.89 -23.45 5.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.798 179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.512 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 87.0 m-20 -69.73 -40.53 76.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -174.004 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 108.86 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 71.7 t -70.26 -40.26 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.22 173.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 17' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 85.3 m-20 -61.91 -47.95 82.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.497 -176.092 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.38 -16.58 62.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.541 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -88.82 -38.45 14.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.076 -177.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 24.8 mt -80.81 -33.04 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.139 -176.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -80.85 62.41 4.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -90.81 -24.02 20.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -174.247 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.97 -77.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.328 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.557 ' HA ' ' OD1' ' C' ' 42' ' ' ASN . 1.0 OUTLIER -83.75 92.62 7.77 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.351 0.595 . . . . 0.0 109.604 177.011 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.7 139.74 8.22 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.404 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.1 ptpt -152.65 136.02 15.88 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.662 -177.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' C' ' 20' ' ' LEU . 3.8 mp -113.56 122.54 47.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.762 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.5 t -105.33 111.82 24.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 30.1 mt -88.82 125.81 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.003 0.43 . . . . 0.0 111.457 -175.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.94 136.35 26.83 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.266 174.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 31' ' ' MET . . . . . 0.515 ' HG2' HD23 ' C' ' 36' ' ' LEU . 86.2 mtp -128.1 145.53 50.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -177.032 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -148.58 91.13 1.85 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.068 176.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.1 -94.58 0.46 Allowed Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.974 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.3 p-10 -106.21 26.54 9.66 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.684 -0.304 . . . . 0.0 111.323 -174.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.502 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 34.1 tt0 -141.06 137.72 33.09 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -170.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.515 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -122.72 114.72 20.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 167.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 21.6 pttm -124.84 106.04 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.86 0.838 . . . . 0.0 108.911 176.665 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.36 124.68 47.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.626 175.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -94.93 123.73 38.57 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 2.7 p -110.0 119.7 40.12 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.38 -174.012 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -116.1 -171.04 1.91 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.564 -174.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 81.51 12.71 0.68 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.74 1.275 . . . . 0.0 111.908 -176.817 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.17 45.86 26.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.68 -28.66 8.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.678 172.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -59.08 129.26 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.194 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -90.31 -70.57 1.22 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.283 -172.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.655 HG12 ' CB ' ' C' ' 68' ' ' GLU . 2.3 mt -113.32 -63.8 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.837 0.827 . . . . 0.0 111.406 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p 174.64 -63.41 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.192 -172.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 9.4 t80 179.7 36.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 O-C-N 123.467 0.48 . . . . 0.0 110.297 175.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.651 ' O ' HD12 ' C' ' 47' ' ' ILE . 42.6 mt-10 -142.23 177.86 7.96 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.438 -175.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.562 ' CG ' ' HE2' ' C' ' 69' ' ' LYS . 1.1 m-20 -103.74 122.08 44.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.298 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' C' ' 47' ' ' ILE . 6.2 mptp? -124.24 130.33 52.33 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 112.564 -178.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 53' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -88.92 126.64 35.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.629 178.924 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.617 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.6 OUTLIER -135.78 166.17 23.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -166.176 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.94 158.21 29.62 Favored Glycine 0 C--N 1.347 1.162 0 C-N-CA 119.278 -1.439 . . . . 0.0 116.085 171.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.426 HG13 HG12 ' C' ' 91' ' ' ILE . 1.9 mp -113.03 138.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.338 -0.931 . . . . 0.0 110.684 174.235 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 3.7 m-85 -131.22 132.87 44.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 91.1 t -104.08 116.39 47.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.43 27.52 17.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.662 -175.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.62 72.8 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 7.3 pt-20 -107.96 133.54 52.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.921 0.861 . . . . 0.0 109.772 176.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -65.47 128.9 37.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.464 -176.276 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.469 HG21 HG23 ' C' ' 58' ' ' VAL . 95.7 t -111.13 -65.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.887 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 60.5 t80 -128.4 144.8 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 -177.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.418 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 12.6 t -126.55 145.05 50.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.193 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 66' ' ' PHE . . . . . 0.493 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 38.1 p90 -155.0 -178.66 7.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -175.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -118.07 128.86 55.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.642 172.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.655 ' CB ' HG12 ' C' ' 47' ' ' ILE . 37.9 mt-10 -61.84 -27.35 68.71 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.562 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.6 pttp -82.76 14.78 2.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.493 ' HB2' HD11 ' C' ' 75' ' ' ILE . 59.7 m -73.83 -116.92 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 165.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.436 ' O ' HG13 ' C' ' 75' ' ' ILE . 0.9 OUTLIER -134.01 122.2 22.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 165.545 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 72' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 2.8 t -59.25 -24.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.903 -170.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.644 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.02 -37.0 33.99 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.742 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -76.6 -30.87 57.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 177.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' C' ' 70' ' ' SER . 75.5 mt -71.0 -61.66 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 176.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.576 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -63.91 -52.53 59.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.32 -171.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 77' ' ' ASN . . . . . 0.626 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 32.2 m-80 -74.85 -16.01 60.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -171.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 78' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.1 m-20 -59.7 -49.68 76.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 165.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.7 mt -53.32 -32.05 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.288 175.074 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' C' ' 77' ' ' ASN . 6.6 m120 -88.2 -22.04 24.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.778 -172.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 81' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 31.6 mmtp -61.34 -36.47 80.25 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 5.2 mt -64.9 -24.05 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.181 -174.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.502 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 91.6 m-20 39.64 87.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.771 0.67 . . . . 0.0 111.384 -172.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.36 122.92 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.815 -172.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.1 OUTLIER -80.36 55.7 2.32 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.237 170.917 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.78 158.96 13.96 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 87' ' ' PRO . . . . . 0.571 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 83.9 Cg_endo -81.65 -62.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.668 2.246 . . . . 0.0 111.792 177.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 88' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.9 p90 -134.06 129.65 36.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -102.94 120.25 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.713 -175.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.417 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 6.2 mm-40 -92.47 99.56 12.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.389 -176.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' C' ' 54' ' ' TRP . 7.0 mt -110.73 103.75 15.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -162.12 155.43 20.64 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.078 -177.357 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' C' ' 53' ' ' ASN . 0.1 OUTLIER -79.03 164.34 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 179.659 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 94' ' ' ILE . . . . . 0.408 HG21 ' HZ ' ' C' ' 57' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.549 -170.481 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' C' C ' 10' ' ' MET . . . . . 0.664 ' O ' HG22 ' C' ' 13' ' ' ILE . 22.3 mmt -88.61 -146.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.007 177.161 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -53.87 -20.32 5.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -178.01 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 12' ' ' SER . . . . . 0.471 ' O ' HG23 ' C' ' 16' ' ' VAL . 1.2 m -51.55 -45.1 62.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.753 174.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.664 HG22 ' O ' ' C' ' 10' ' ' MET . 11.6 tt -80.26 -30.12 12.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.588 -177.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -71.87 -40.39 68.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -59.12 -32.76 70.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.033 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.471 HG23 ' O ' ' C' ' 12' ' ' SER . 98.3 t -70.8 -35.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.849 173.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.64 -47.73 84.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.824 0.345 . . . . 0.0 110.391 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.44 -21.2 64.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.722 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -85.37 -36.28 20.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.874 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' C' ' 27' ' ' LEU . 61.7 mt -75.89 -32.05 59.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.26 177.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.85 71.51 4.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.533 0.683 . . . . 0.0 109.669 173.004 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -95.21 10.11 37.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.996 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.98 -48.06 2.47 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -173.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.694 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.5 mmtt -72.01 -159.8 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 168.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 25' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' C' ' 46' ' ' GLY . . . -44.02 133.45 6.41 Favored Glycine 0 CA--C 1.502 -0.76 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.183 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 26' ' ' LYS . . . . . 0.694 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER -131.44 135.43 47.13 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.263 -0.469 . . . . 0.0 110.648 -171.915 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.738 ' HB3' HD13 ' C' ' 20' ' ' LEU . 2.1 tt -123.16 98.98 6.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.272 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 28' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 54.5 m -87.64 101.13 13.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.251 -178.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -95.08 129.39 42.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.358 -171.485 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -125.92 127.23 45.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.143 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 47.4 mtp -140.64 113.89 8.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.899 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.568 ' HB2' ' OE1' ' C' ' 35' ' ' GLN . 58.4 m-80 -148.99 111.49 4.74 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.603 175.15 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.56 -98.49 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.837 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 18.2 t-20 -121.27 30.28 6.87 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.105 0.479 . . . . 0.0 110.258 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 35' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' C' ' 32' ' ' ASN . 2.4 pt20 -122.94 123.45 40.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.618 . . . . 0.0 111.491 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.655 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tp -132.25 112.19 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.552 170.02 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 37' ' ' LYS . . . . . 0.506 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 52.2 pttt -137.24 103.72 5.19 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 38' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -102.6 129.91 49.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.803 173.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' C' ' 28' ' ' SER . 76.0 p -105.44 147.8 27.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.07 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 17.3 p -128.59 157.74 40.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -177.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.443 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 20.1 t -151.6 -174.44 4.84 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.576 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 42' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' C' ' 42' ' ' ASN . 0.2 OUTLIER 81.45 16.67 0.49 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.943 1.297 . . . . 0.0 111.679 -174.946 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.71 51.17 17.02 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 166.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.97 -21.12 41.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.909 174.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.44 112.58 6.83 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HA3' ' C' ' 25' ' ' GLY . . . -78.89 -78.31 0.85 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.885 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 47' ' ' ILE . . . . . 0.857 HD13 ' HG2' ' C' ' 52' ' ' LYS . 26.5 mt -111.96 -67.33 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 CA-C-O 121.856 0.836 . . . . 0.0 109.063 173.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.4 p 178.88 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.641 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -141.31 -32.67 0.54 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.486 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.551 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 8.4 pt-20 -70.03 160.7 31.47 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.05 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 51' ' ' ASP . . . . . 0.402 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 7.3 m-20 -101.36 109.07 20.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.617 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.857 ' HG2' HD13 ' C' ' 47' ' ' ILE . 25.8 mmmt -101.76 141.11 35.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 173.596 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.09 108.66 20.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.541 0.686 . . . . 0.0 111.109 -173.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 54' ' ' TRP . . . . . 0.518 ' HZ2' HD11 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.25 166.22 10.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.89 -174.019 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.49 160.2 32.14 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 118.976 -1.583 . . . . 0.0 115.39 173.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -119.61 136.01 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.759 -0.72 . . . . 0.0 110.2 174.119 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 30.8 m-85 -128.49 111.66 13.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.761 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' C' ' 89' ' ' ILE . 26.3 t -79.58 105.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 57.51 28.16 15.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 -174.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 12.9 64.24 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.025 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.8 tt0 -106.81 138.66 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.625 ' HE2' ' OG1' ' C' ' 65' ' ' THR . 13.5 tptm -68.29 130.96 44.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.462 -176.579 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.522 HG13 ' H ' ' C' ' 64' ' ' TYR . 2.3 p -129.39 -60.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.282 175.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 64' ' ' TYR . . . . . 0.522 ' H ' HG13 ' C' ' 63' ' ' VAL . 69.9 t80 -132.91 133.96 43.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.748 0.308 . . . . 0.0 110.258 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.625 ' OG1' ' HE2' ' C' ' 62' ' ' LYS . 24.5 m -128.28 144.83 51.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -157.97 174.6 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.314 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 67' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 76.2 m-20 -121.83 132.22 54.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 68' ' ' GLU . . . . . 0.593 ' HB2' ' CG1' ' C' ' 47' ' ' ILE . 39.6 mt-10 -60.85 -24.41 65.89 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.242 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -75.42 4.21 7.76 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -174.166 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -74.23 -119.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 71' ' ' THR . . . . . 0.543 ' O ' HG12 ' C' ' 75' ' ' ILE . 20.5 p -131.52 122.65 26.51 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.242 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.42 -18.91 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.236 -172.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 73' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.9 -45.38 10.59 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.276 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -62.35 -29.04 70.18 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 75' ' ' ILE . . . . . 0.543 HG12 ' O ' ' C' ' 71' ' ' THR . 51.3 mm -75.84 -66.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.145 178.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 76' ' ' SER . . . . . 0.57 ' OG ' ' HG ' ' C' ' 27' ' ' LEU . 16.3 m -51.13 -50.03 59.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.259 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -81.75 -17.57 47.27 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.909 -173.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.7 -34.87 67.42 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.314 166.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' C' ' 76' ' ' SER . 56.4 mt -58.52 -26.44 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.021 174.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 80' ' ' ASN . . . . . 0.506 ' CG ' ' HA ' ' C' ' 37' ' ' LYS . 38.5 m-20 -83.74 -27.22 29.08 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.567 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -56.61 -41.31 76.85 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.0 mt -54.77 -33.95 61.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.667 177.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 83' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' C' ' 36' ' ' LEU . 0.9 OUTLIER 38.57 104.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.724 1.209 . . . . 0.0 113.762 -174.83 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 84' ' ' ILE . . . . . 0.655 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.9 tp -45.23 148.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.655 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 85' ' ' LYS . . . . . 0.448 ' HD2' ' C ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -159.02 22.54 0.2 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.241 179.554 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.73 12.35 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.289 -168.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.6 -42.02 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.851 2.367 . . . . 0.0 111.681 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -145.26 117.5 8.42 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' C' ' 58' ' ' VAL . 58.4 mt -132.93 132.38 59.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 -176.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.15 111.04 22.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.764 -175.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 91' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 56' ' ' ILE . 11.8 tt -108.72 98.17 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.02 156.9 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.795 -170.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 1.1 pt20 -86.78 163.33 17.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.288 0.566 . . . . 0.0 111.331 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 -167.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -152.99 -42.52 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 111.756 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.42 ' H ' ' CD ' ' C' ' 3' ' ' GLN . 2.1 mp0 -54.71 -22.66 14.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.604 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -37.74 -49.17 1.14 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.855 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.64 -21.16 21.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.18 -105.06 0.11 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 9.8 mp0 -93.17 -52.54 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.462 -175.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 34.9 mt-10 90.95 -39.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.562 1.164 . . . . 0.0 112.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' C' ' 9' ' ' GLN . 0.9 OUTLIER -74.15 18.12 0.16 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 32.5 mmt -77.0 -146.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -49.15 -25.97 2.51 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -52.54 -33.86 47.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.116 0.26 . . . . 0.0 111.51 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.579 HG13 ' N ' ' C' ' 14' ' ' ASN . 4.7 pt -90.54 -32.47 5.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.147 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.579 ' N ' HG13 ' C' ' 13' ' ' ILE . 16.6 m120 -71.11 -36.74 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.752 0.311 . . . . 0.0 110.242 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 19' ' ' LYS . 49.5 m -58.5 -33.96 70.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.695 HG11 ' HB ' ' C' ' 91' ' ' ILE . 71.3 t -68.32 -40.17 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.353 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -62.29 -41.81 98.81 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.704 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.13 -27.17 67.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.614 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' C' ' 15' ' ' SER . 94.1 mttt -85.27 -33.91 22.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.524 0.678 . . . . 0.0 110.286 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' C' ' 27' ' ' LEU . 29.3 mt -85.16 -32.44 22.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.088 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.585 0.707 . . . . 0.0 109.902 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 9.8 41.88 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.218 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.18 -69.73 0.5 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.545 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.678 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 24.2 tttt -76.01 -156.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.93 137.52 3.54 Favored Glycine 0 CA--C 1.498 -0.99 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.678 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.2 ptpt -147.32 132.2 18.07 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.343 -167.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.646 ' HB3' HD13 ' C' ' 20' ' ' LEU . 9.7 tt -105.63 125.76 51.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.446 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 31.8 m -103.31 135.05 45.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.109 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' C' ' 13' ' ' ILE . 5.8 mp -100.18 126.05 46.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.513 0.196 . . . . 0.0 111.444 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.5 t -152.49 144.95 24.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.467 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.454 ' HG3' HD23 ' C' ' 36' ' ' LEU . 1.9 mpt? -127.59 141.58 51.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 -176.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.53 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 18.1 m120 -133.07 88.86 2.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 173.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.78 -98.97 0.17 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.949 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.07 24.25 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.669 -0.312 . . . . 0.0 111.157 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.545 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 21.9 tt0 -143.27 108.25 4.94 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.548 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.679 ' CB ' HG13 ' C' ' 84' ' ' ILE . 3.1 tm? -88.03 124.87 34.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.669 166.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.53 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 41.6 pttt -129.1 103.38 6.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.79 118.87 37.82 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.932 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.0 p -98.4 138.89 34.97 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.29 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 t -111.23 119.51 39.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.333 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.437 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 23.6 t -94.84 -172.66 2.77 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.413 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 1.0 OUTLIER 70.73 27.94 3.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 123.854 0.722 . . . . 0.0 110.303 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.86 32.05 21.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.117 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 -6.63 78.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.308 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.486 ' O ' HG23 ' C' ' 72' ' ' VAL . 64.8 m-85 -63.3 161.36 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 0.0 110.47 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.493 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -85.51 166.72 40.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.348 -172.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.459 ' H ' HD12 ' C' ' 47' ' ' ILE . 3.7 mp -60.73 -54.62 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 122.196 0.998 . . . . 0.0 109.856 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 26.7 t -129.34 -169.85 2.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.851 -169.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -132.62 15.8 4.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.389 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.45 ' C ' ' HE3' ' C' ' 69' ' ' LYS . 33.1 mt-10 -125.17 163.13 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.748 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.82 105.31 11.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.552 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.49 140.89 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.7 OUTLIER -89.41 109.35 20.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.466 0.65 . . . . 0.0 109.967 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.629 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.52 165.63 11.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.241 -173.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.52 157.74 29.1 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 118.579 -1.772 . . . . 0.0 115.826 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.43 HG23 HG12 ' C' ' 91' ' ' ILE . 79.5 mt -126.55 137.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.106 -1.047 . . . . 0.0 110.619 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' C' ' 89' ' ' ILE . 7.3 m-85 -130.03 126.84 38.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.906 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 58' ' ' VAL . 8.3 p -103.38 111.42 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.184 0.516 . . . . 0.0 110.084 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.8 m120 49.64 43.75 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.575 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.36 -6.69 82.3 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.185 -0.531 . . . . 0.0 114.345 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -108.32 150.14 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.855 0.827 . . . . 0.0 111.072 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -73.59 132.57 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.064 0.459 . . . . 0.0 111.756 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.59 -61.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.728 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -148.74 147.4 28.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.856 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.629 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.5 m -134.14 133.04 40.57 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 49.3 p90 -150.85 -167.12 2.73 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -128.73 144.78 51.24 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.571 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 6.6 mt-10 -70.11 -20.88 63.16 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -175.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.45 ' HE3' ' C ' ' C' ' 50' ' ' GLU . 11.3 ptpt -89.21 7.52 34.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.381 . . . . 0.0 111.035 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.0 m -90.08 165.89 13.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.805 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.09 106.27 8.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.493 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 0.9 OUTLIER -59.11 -15.85 7.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.862 -173.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.64 -32.9 17.58 Favored Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.645 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.82 -29.13 50.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 45.8 mm -71.68 -57.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.777 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.518 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 37.7 p -60.27 -55.65 31.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.646 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 2.0 m-20 -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.6 OUTLIER -64.02 -46.98 82.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' C' ' 76' ' ' SER . 74.7 mt -53.87 -31.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.333 175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 9.9 m-20 -89.99 -24.16 21.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.55 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 64.0 mttm -55.68 -39.75 71.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 4.6 mt -61.1 -23.07 65.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.778 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.545 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.5 m-20 40.42 77.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.846 0.831 . . . . 0.0 110.833 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.679 HG13 ' CB ' ' C' ' 36' ' ' LEU . 0.5 OUTLIER -93.77 145.61 7.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.514 -171.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.507 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -81.16 4.46 20.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.356 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.19 109.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.335 0 O-C-N 124.077 0.861 . . . . 0.0 113.618 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 97.9 Cg_endo -82.26 -55.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.765 2.31 . . . . 0.0 112.28 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . 88.2 t80 -107.95 98.75 8.28 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' C' ' 57' ' ' PHE . 20.9 pt -119.38 123.88 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.749 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.3 105.06 16.98 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.695 ' HB ' HG11 ' C' ' 16' ' ' VAL . 5.4 mt -97.22 99.71 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.407 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -163.82 148.15 10.34 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 5.0 pp0? -77.08 165.34 24.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.322 0.582 . . . . 0.0 111.072 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.486 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.863 -166.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.972 0.415 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -138.55 -24.1 0.95 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.244 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' C' ' 10' ' ' MET . 22.2 mp0 -79.6 11.02 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.668 0.746 . . . . 0.0 110.523 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -64.23 -37.1 86.27 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.459 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.83 5.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.636 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.4 117.13 28.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.628 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' C' ' 10' ' ' MET . 48.7 mp0 -74.57 24.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' C' ' 8' ' ' GLU . 25.5 mt-10 -51.62 -59.36 4.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.37 0.605 . . . . 0.0 110.901 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' C' ' 3' ' ' GLN . 1.8 mp0 -99.18 17.59 19.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.345 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.457 ' HB2' ' HA ' ' C' ' 7' ' ' GLU . 1.0 OUTLIER -117.58 -147.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -41.59 -40.94 2.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -53.71 -39.36 65.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.497 HD13 ' ND2' ' C' ' 17' ' ' ASN . 0.0 OUTLIER -92.39 -33.2 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.538 ' HA ' HD22 ' C' ' 17' ' ' ASN . 20.8 m120 -69.84 -34.77 74.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.081 -0.387 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 40.1 t -59.27 -33.33 70.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.486 0.66 . . . . 0.0 109.29 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.485 HG21 ' O ' ' C' ' 91' ' ' ILE . 49.1 t -71.67 -35.23 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.141 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.538 HD22 ' HA ' ' C' ' 14' ' ' ASN . 16.1 m-80 -58.27 -45.47 87.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -69.03 -31.31 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.379 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.13 -35.17 37.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.196 0.522 . . . . 0.0 109.977 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' C' ' 27' ' ' LEU . 71.6 mt -69.2 -32.36 71.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.378 176.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ASN . . . . . 0.405 ' OD1' ' HD3' ' C' ' 26' ' ' LYS . 10.7 m-80 -78.41 58.69 2.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.515 0.674 . . . . 0.0 110.05 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.467 ' HD2' ' C ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -88.29 9.94 21.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.024 -175.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.47 -72.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.865 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.43 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.2 mttm -76.51 -157.71 0.09 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.369 0.268 . . . . 0.0 110.544 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -44.55 135.88 6.21 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' C' ' 40' ' ' SER . 9.8 ptpt -148.38 143.44 26.82 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.876 -162.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.615 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.8 mp -101.25 119.03 38.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.744 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 53.8 m -100.24 99.58 10.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.557 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.2 mm? -85.6 147.18 26.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 112.116 -171.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -151.13 129.13 11.76 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.076 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.0 mtt -101.9 118.64 37.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 16.9 m120 -130.74 90.08 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.813 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.79 0.6 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.965 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -102.32 33.71 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.951 0.881 . . . . 0.0 108.965 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.402 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 53.2 tt0 -144.62 138.95 27.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.973 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.4 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.6 tm? -116.37 102.81 9.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.579 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 64.4 pttt -105.96 133.22 51.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.1 118.48 6.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.941 -172.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 65.0 p -100.42 148.57 24.59 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.414 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.7 p -109.0 118.95 38.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.42 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 37.7 t -94.81 178.59 5.53 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.2 OUTLIER 63.08 37.68 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.689 0.618 . . . . 0.0 109.719 -169.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.43 24.99 10.83 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.611 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.94 19.06 73.65 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.09 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.687 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 17.8 m-85 -65.33 164.39 13.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.47 -160.36 35.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.159 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -52.99 -66.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.522 0.677 . . . . 0.0 112.165 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.583 ' H ' ' CD1' ' C' ' 47' ' ' ILE . 28.7 p -179.08 -48.1 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.004 -171.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.488 ' H ' HD13 ' C' ' 47' ' ' ILE . 68.5 t80 -171.45 -36.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.414 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -89.92 161.19 16.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -165.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' C' ' 69' ' ' LYS . 7.0 p-10 -94.21 118.22 31.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.327 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.658 ' HB2' ' CD ' ' C' ' 68' ' ' GLU . 14.1 mmmm -111.98 155.26 24.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.996 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -105.97 106.45 16.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.805 -170.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.624 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.59 164.17 11.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.785 -175.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.06 141.64 7.73 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.826 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.475 HD12 ' N ' ' C' ' 56' ' ' ILE . 3.3 mp -117.96 124.48 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 171.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 2.9 m-85 -119.23 141.6 48.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.37 114.64 40.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 63.35 36.34 11.67 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.812 0.695 . . . . 0.0 110.778 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.16 58.9 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.381 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 10.8 pt-20 -140.16 143.81 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.902 0.851 . . . . 0.0 110.913 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.47 116.54 10.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.385 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.59 -29.6 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.933 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -156.27 154.84 31.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.991 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 54' ' ' TRP . 68.5 m -149.55 146.69 27.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.4 -179.73 7.94 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.684 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 18.3 m120 -128.73 135.08 48.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.25 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.658 ' CD ' ' HB2' ' C' ' 52' ' ' LYS . 2.5 mp0 -60.48 -11.1 5.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -172.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' HD11 ' C' ' 47' ' ' ILE . 13.5 ptmm? -84.83 -4.55 59.13 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.6 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -81.06 155.06 26.51 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 11.2 p -71.97 121.32 18.91 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.618 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 45' ' ' TYR . 13.1 t -60.11 -11.76 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.971 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.46 -40.24 9.18 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.077 -1.058 . . . . 0.0 111.212 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.99 -35.6 74.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.426 ' O ' HG13 ' C' ' 79' ' ' ILE . 47.0 mm -67.9 -66.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.486 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.651 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.4 m -59.34 -58.59 7.97 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.593 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 26.0 m-20 -72.55 -16.84 61.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -171.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -34.79 69.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.505 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' C' ' 76' ' ' SER . 80.6 mt -56.06 -23.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.609 171.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.6 OUTLIER -79.79 -38.24 33.52 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.296 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -57.44 -34.1 68.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 109.355 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 3.2 mt -59.49 -28.06 66.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.402 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.1 m-20 36.66 82.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.568 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.03 148.14 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.856 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.58 45.55 2.78 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.296 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.92 158.0 17.52 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.383 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.04 -44.82 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.067 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -123.66 117.97 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.406 0.622 . . . . 0.0 109.949 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.75 125.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.784 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.15 99.68 12.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.536 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.557 HG21 ' HG ' ' C' ' 29' ' ' LEU . 20.1 mm -109.65 99.62 9.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.935 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 168.82 6.45 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.97 166.23 12.8 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.752 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.697 -169.497 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' C' ' 2' ' ' ASN . 16.5 t70 . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ASN . . . . . 0.447 ' O ' HD23 ' C' ' 6' ' ' LEU . 4.9 m-20 76.49 -13.86 0.87 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 112.667 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.515 ' HA ' ' HB2' ' C' ' 6' ' ' LEU . 15.7 mt-30 -72.77 2.9 5.8 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.77 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -62.76 -38.0 88.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.85 -1.73 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.972 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' C' ' 3' ' ' GLN . 4.3 mm? -89.8 179.15 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.08 0.467 . . . . 0.0 110.316 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.43 18.34 9.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.129 -171.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.422 ' HG3' ' OE1' ' C' ' 3' ' ' GLN . 15.0 mm-40 -66.33 -24.41 66.52 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.24 0.543 . . . . 0.0 110.607 176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.633 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.4 mp0 -80.51 12.46 3.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.567 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.69 -141.38 0.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.044 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -39.8 -36.61 0.45 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -52.65 -46.19 67.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.51 -29.84 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.935 0.397 . . . . 0.0 111.014 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.52 -20.28 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -60.26 -35.22 75.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 47.8 t -66.54 -37.71 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.399 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' C' ' 29' ' ' LEU . 0.9 OUTLIER -65.21 -39.92 93.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.504 -176.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.58 -27.22 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -87.75 -29.33 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.464 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 62.0 mt -70.76 -34.95 72.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.216 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.1 66.13 9.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.2 -25.29 16.44 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.19 -72.81 0.13 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.274 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -90.6 -177.27 4.98 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 168.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.3 100.24 0.01 OUTLIER Glycine 0 CA--C 1.5 -0.882 0 O-C-N 125.139 1.525 . . . . 0.0 116.118 166.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.546 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 8.2 ptpt -131.51 155.36 47.56 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.194 -170.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.499 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 0.6 OUTLIER -134.77 121.8 21.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.553 -173.035 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.8 m -113.39 112.42 23.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.512 HD13 ' ND2' ' C' ' 17' ' ' ASN . 5.9 mp -99.24 143.94 28.93 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.789 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.1 m -150.19 131.07 14.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.151 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.633 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 81.5 mtp -97.69 120.72 38.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.296 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -122.31 91.4 3.5 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.708 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 31.06 6.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.554 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 27.9 tt0 -143.07 137.45 29.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.219 0.533 . . . . 0.0 111.999 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -111.28 99.55 8.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.558 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 23.2 pttp -96.42 142.95 27.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.2 122.11 7.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -172.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 77.5 p -98.48 143.38 28.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.545 ' OG ' ' HA2' ' C' ' 73' ' ' GLY . 17.6 p -125.52 119.22 27.59 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.1 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 39.0 t -100.46 173.37 6.6 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.526 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' C' ' 41' ' ' SER . 6.5 m120 81.59 28.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.716 1.26 . . . . 0.0 111.398 -172.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.88 35.92 5.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 167.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' GLY . . . . . 0.405 ' O ' HG22 ' C' ' 71' ' ' THR . . . 102.53 -10.11 56.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.209 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 76.3 m-85 -70.03 141.56 52.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.3 -150.45 25.22 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.194 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' C' ' 68' ' ' GLU . 26.6 mm -66.79 -62.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.555 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -175.05 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.079 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -168.48 28.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 12.5 pt-20 -115.76 135.53 53.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.689 -175.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 32.0 t70 -90.38 109.47 20.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.323 0.582 . . . . 0.0 111.809 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' C' ' 68' ' ' GLU . 12.0 mptt -110.82 139.61 45.97 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.988 175.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -95.55 119.34 33.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.215 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -113.56 165.96 11.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.044 -169.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.18 158.11 27.51 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 119.077 -1.535 . . . . 0.0 115.788 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -114.84 132.95 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 114.771 -0.714 . . . . 0.0 111.015 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.8 OUTLIER -130.41 115.26 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.75 126.49 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.16 24.9 14.23 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.805 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 9.03 83.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.558 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 11.3 tp10 -107.79 120.72 43.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.959 0.409 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 39.7 ttpt -72.6 112.61 8.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.3 -29.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -148.92 134.14 18.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.23 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.426 HG23 ' O ' ' C' ' 54' ' ' TRP . 5.3 m -123.6 147.14 47.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' C' ' 75' ' ' ILE . 52.5 p90 -161.51 -175.23 4.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.824 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.56 135.58 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.407 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' C' ' 47' ' ' ILE . 17.3 tt0 -62.89 -34.87 78.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.714 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.3 pttp -79.42 1.59 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -74.4 -170.67 1.04 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.465 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.1 p -81.37 108.39 14.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.47 -16.72 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.117 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.545 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -80.24 -40.76 12.92 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -66.56 -33.55 75.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.487 ' O ' HG12 ' C' ' 79' ' ' ILE . 32.5 mm -76.05 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.415 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.6 m -54.43 -52.16 62.65 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.513 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 49.0 m-20 -75.91 -15.96 60.11 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.658 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -66.17 -37.25 85.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' C' ' 76' ' ' SER . 36.7 mm -56.4 -25.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.568 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.597 ' N ' HD22 ' C' ' 80' ' ' ASN . 0.6 OUTLIER -82.37 -38.28 24.4 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -50.21 -44.05 52.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -53.69 -36.01 61.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.755 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.554 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.2 m-20 38.34 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.996 0.81 . . . . 0.0 110.559 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.87 132.16 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.703 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.21 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.25 162.84 29.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.663 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.8 -35.47 0.39 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 123.113 2.542 . . . . 0.0 112.085 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.69 139.64 16.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.93 125.6 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.404 0.621 . . . . 0.0 111.557 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.416 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 15.6 mm-40 -97.26 99.21 10.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.517 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.4 mt -112.26 99.71 9.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -161.09 156.22 24.19 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 4.1 pp0? -81.59 164.77 21.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.95 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.495 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.814 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.137 -165.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' C' ' 3' ' ' GLN . 8.2 p30 -157.47 -10.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.569 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.561 ' HA ' ' OE1' ' C' ' 3' ' ' GLN . 8.3 mm-40 -90.66 21.99 3.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 173.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' C' ' 4' ' ' LYS . 0.4 OUTLIER -52.96 -44.89 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.978 -177.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -25.61 59.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.695 ' HB3' ' SD ' ' C' ' 10' ' ' MET . 64.4 mt -91.7 -166.06 1.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.89 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 24.0 mm-40 -89.22 -10.87 45.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 32.2 mt-10 76.07 -44.96 0.51 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.204 0.602 . . . . 0.0 111.274 178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -76.27 17.3 0.37 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.673 0.789 . . . . 0.0 111.934 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' C' ' 6' ' ' LEU . 87.1 mtp -87.65 -143.98 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -168.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -59.41 -22.53 61.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.929 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.4 m -54.69 -33.27 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 110.297 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -86.52 -41.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -63.52 -37.3 86.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -54.75 -37.36 65.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.52 -36.52 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.487 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -66.35 -38.21 87.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.424 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.07 -30.7 71.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.925 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' NZ ' ' C' ' 19' ' ' LYS . 9.1 mtpm? -85.65 -37.19 19.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' C' ' 27' ' ' LEU . 75.6 mt -76.35 -33.71 58.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.592 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -81.55 52.57 1.9 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.931 0.872 . . . . 0.0 109.769 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' C' ' 47' ' ' ILE . 14.7 pttm -66.24 -40.57 90.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.108 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.15 0.48 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' C' ' 24' ' ' LYS . 10.9 mmpt? -70.64 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -40.44 145.64 0.39 Allowed Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' C' ' 40' ' ' SER . 10.7 ptpt -148.52 130.96 15.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.945 -169.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.7 mp -105.02 128.34 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.721 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.1 t -103.61 98.93 8.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.71 121.2 25.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.11 0.481 . . . . 0.0 110.868 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -130.62 134.89 47.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.602 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 73.6 mtp -118.93 134.45 55.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.956 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.02 91.01 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.661 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.28 -106.42 0.65 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.245 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 33.78 1.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.5 0.667 . . . . 0.0 109.902 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.621 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.4 tt0 -145.71 139.6 26.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.511 0.672 . . . . 0.0 112.335 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.15 118.98 28.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 25.6 pttm -127.18 107.93 10.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.758 0.79 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -115.67 121.59 42.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.66 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 45.0 p -96.57 151.21 19.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 40.9 m -123.7 118.58 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.323 0.582 . . . . 0.0 110.848 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 22.6 t -101.84 -176.61 3.18 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.36 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.46 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.9 OUTLIER 73.01 35.91 0.92 Allowed 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 124.246 0.967 . . . . 0.0 109.746 -170.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.03 19.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.731 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -3.66 65.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.475 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.46 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 55.4 m-85 -58.78 143.51 46.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.847 0.324 . . . . 0.0 110.89 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.09 -158.02 5.4 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' C' ' 68' ' ' GLU . 23.0 mt -67.52 -68.6 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 CA-C-O 122.115 0.96 . . . . 0.0 109.781 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -178.26 -146.68 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.833 -165.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -79.22 -24.23 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.464 ' OE1' ' HE2' ' C' ' 52' ' ' LYS . 6.4 pt-20 -73.28 137.26 44.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.545 0.688 . . . . 0.0 112.79 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.63 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 5.6 p-10 -90.62 145.41 24.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.051 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.4 mptp? -141.8 126.02 17.49 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.787 ' ND2' HG13 ' C' ' 94' ' ' ILE . 66.5 t30 -84.94 112.61 20.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.525 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.659 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.2 OUTLIER -121.05 161.23 22.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -169.046 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.9 159.18 31.7 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 118.952 -1.594 . . . . 0.0 116.655 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -114.96 131.49 67.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 113.974 -1.113 . . . . 0.0 110.853 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 1.9 m-85 -129.05 107.2 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.84 123.18 47.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.62 31.12 18.61 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 4.09 89.31 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.114 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.1 tp10 -106.48 121.13 43.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.969 0.385 . . . . 0.0 110.701 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 30.0 ttpp -75.05 117.68 17.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.57 -32.58 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.296 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -142.0 131.58 23.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -125.39 141.01 52.3 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.492 ' CD1' HD13 ' C' ' 75' ' ' ILE . 50.1 p90 -156.78 -173.35 4.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.277 0.844 . . . . 0.0 113.277 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 19.1 p-10 -131.55 131.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.081 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.659 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 34.0 mt-10 -67.02 -12.33 59.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.6 ptmm? -89.59 7.54 35.9 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.483 ' HB3' HD11 ' C' ' 75' ' ' ILE . 15.2 t -79.98 -147.83 0.05 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.09 117.18 32.57 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 2.4 t -64.47 -14.8 16.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.302 -167.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.38 -39.57 25.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.567 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.55 -30.68 68.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.492 HD13 ' CD1' ' C' ' 66' ' ' PHE . 67.7 mt -68.28 -70.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.261 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 2.5 m -65.38 -44.18 88.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -80.83 -15.24 56.9 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.426 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.31 -40.23 81.78 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' C' ' 76' ' ' SER . 63.1 mt -58.7 -28.78 38.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.467 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.491 ' CG ' ' HA ' ' C' ' 37' ' ' LYS . 7.9 m-20 -75.19 -37.6 61.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.249 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 7.2 mmpt? -54.43 -40.44 68.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 0.0 109.237 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -56.12 -34.78 66.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.699 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.621 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.26 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.164 0.915 . . . . 0.0 110.68 -168.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.66 131.07 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.325 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.98 43.27 0.77 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.514 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.87 138.02 14.09 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.097 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.37 -45.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.775 2.317 . . . . 0.0 111.445 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . 82.1 t80 -140.3 123.36 16.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.02 133.92 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.363 0.602 . . . . 0.0 111.352 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.451 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 8.0 mm-40 -92.31 104.51 16.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.499 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.1 mt -112.71 100.85 11.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -157.37 171.4 20.46 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 5.1 pp0? -94.27 167.42 11.55 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.092 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.787 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -103.0 -28.87 11.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.774 0.321 . . . . 0.0 110.551 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.523 ' HG2' ' HB2' ' C' ' 10' ' ' MET . 20.2 mp0 -89.7 22.1 3.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.43 -41.99 81.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.644 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.78 -7.19 53.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 98.6 mt -91.88 -161.73 0.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.117 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.442 ' HB3' ' NE2' ' C' ' 9' ' ' GLN . 1.6 mp0 -63.67 -28.47 69.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 41.9 mt-10 81.43 -32.31 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.707 0.803 . . . . 0.0 111.468 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' C' ' 7' ' ' GLU . 0.1 OUTLIER -73.87 17.99 0.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.284 0.634 . . . . 0.0 112.287 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.523 ' HB2' ' HG2' ' C' ' 3' ' ' GLN . 62.7 mtt -82.29 -142.06 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -49.95 -17.2 0.35 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 41.0 m -53.88 -39.71 65.97 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.246 -0.284 . . . . 0.0 110.846 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 10' ' ' MET . 2.8 pp -91.58 -23.92 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.525 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 17.2 m120 -74.89 -32.58 61.88 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 122.304 -0.248 . . . . 0.0 111.003 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -62.26 -31.1 71.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.451 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.51 -34.69 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.868 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.5 m-20 -61.76 -39.82 92.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.407 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.46 -27.7 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.674 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.91 -28.57 18.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.099 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 34.7 mt -82.94 -28.35 29.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.413 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -88.19 74.49 8.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.82 -23.67 10.88 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -81.77 0.09 OUTLIER Glycine 0 CA--C 1.507 -0.414 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.234 -174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 14.9 ttmt -89.75 -179.22 5.71 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 29.89 90.33 0.01 OUTLIER Glycine 0 CA--C 1.503 -0.668 0 O-C-N 124.38 1.05 . . . . 0.0 115.496 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.0 OUTLIER -121.02 137.17 54.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.652 -173.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 31.6 tp -126.93 128.21 46.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.395 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 59.2 m -111.87 111.81 23.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.256 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.593 HD21 ' HB ' ' C' ' 91' ' ' ILE . 5.4 mp -86.92 144.58 26.89 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 111.574 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.4 p -155.09 129.78 9.23 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.473 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.422 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 63.4 mtt -128.02 132.33 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.962 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.414 ' HB3' ' CD ' ' C' ' 35' ' ' GLN . 6.3 t30 -151.23 92.66 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.569 0.223 . . . . 0.0 110.77 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.79 -93.94 1.18 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.37 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 19.6 t-20 -120.48 31.78 6.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.447 0.642 . . . . 0.0 109.909 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.547 ' N ' HG22 ' C' ' 84' ' ' ILE . 9.9 pt20 -127.92 130.7 48.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.312 0.577 . . . . 0.0 111.753 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.694 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tm? -124.16 119.03 28.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.783 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -140.37 130.99 25.59 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -143.78 120.1 10.9 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.932 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 44.1 p -97.47 126.12 42.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.4 p -109.27 118.72 37.45 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.582 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 t -103.18 -175.08 2.7 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 81.08 26.33 0.23 Allowed 'General case' 0 C--O 1.222 -0.353 0 O-C-N 124.494 1.121 . . . . 0.0 110.491 -171.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.02 38.35 23.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.93 -5.82 79.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.674 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -64.38 145.21 56.41 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.46 0.63 . . . . 0.0 110.526 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -85.33 -169.7 46.28 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.002 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' C' ' 68' ' ' GLU . 23.3 mm -59.14 -63.53 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-O 121.652 0.739 . . . . 0.0 110.84 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 p -164.06 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.634 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -169.24 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.873 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.63 136.07 49.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.426 -168.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.532 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 1.3 m-20 -75.15 118.43 18.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.417 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -139.28 132.72 30.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 14.7 p-10 -86.91 122.38 30.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.52 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -115.66 161.92 17.99 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.78 148.22 18.79 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.331 -1.414 . . . . 0.0 115.444 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 38.6 mt -122.27 127.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 164.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -121.7 109.04 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.949 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.434 HG23 HG13 ' C' ' 89' ' ' ILE . 2.5 p -90.08 105.74 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 62.36 29.45 17.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.704 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.74 5.19 78.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.766 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -109.08 141.99 40.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.853 0.358 . . . . 0.0 110.467 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -66.74 121.42 15.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.794 174.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -156.88 153.23 27.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.301 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -141.93 159.02 43.07 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 55.8 p90 -166.91 -172.87 2.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 111.39 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -129.42 138.51 51.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.139 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.522 ' HB3' HG13 ' C' ' 47' ' ' ILE . 10.1 mt-10 -62.96 -33.07 74.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.431 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.1 pttp -82.89 18.89 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.007 0.432 . . . . 0.0 111.367 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -88.87 -150.73 0.2 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 19.9 p -111.27 112.86 24.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.441 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.8 t -63.23 -12.33 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.057 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -84.55 -37.92 10.22 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.816 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -68.4 -35.18 77.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 51.5 mm -69.63 -60.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.925 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.676 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 75.2 p -51.73 -60.75 2.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.404 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 69.0 m-20 -73.26 -15.98 61.41 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -171.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' C' ' 81' ' ' LYS . 0.5 OUTLIER -69.65 -36.01 75.7 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.1 167.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.3 mt -58.36 -20.91 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.783 ' ND2' ' HA ' ' C' ' 37' ' ' LYS . 2.1 m120 -84.05 -35.91 23.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' C' ' 78' ' ' ASP . 52.0 mtpt -53.61 -39.92 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 6.1 mt -52.97 -37.33 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 38.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.694 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 2.4 tp -44.8 148.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.664 -174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -149.85 22.32 0.88 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.342 0.591 . . . . 0.0 109.718 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.04 171.55 15.29 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.849 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.79 -49.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.775 2.317 . . . . 0.0 113.407 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -132.87 103.35 6.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.363 0.601 . . . . 0.0 110.326 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.452 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.4 mp -122.43 129.62 75.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.145 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 37.9 mt-10 -106.56 119.2 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 0.0 111.658 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.593 ' HB ' HD21 ' C' ' 29' ' ' LEU . 34.4 mt -96.91 98.95 8.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 146.1 14.79 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.4 pt20 -83.16 166.97 18.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.218 0.532 . . . . 0.0 112.325 -173.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.782 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.59 0.233 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 71.51 5.47 5.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.73 0.812 . . . . 0.0 111.634 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.499 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 2.3 mp0 -67.55 -30.97 70.74 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.89 -20.56 23.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.272 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.6 -70.77 0.67 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.43 . . . . 0.0 111.944 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.32 -78.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -44.01 -62.95 0.97 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -165.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.499 ' HG2' ' HB3' ' C' ' 3' ' ' GLN . 1.7 mm-40 -60.09 -19.23 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -173.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -100.59 18.23 19.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.777 0.322 . . . . 0.0 111.641 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 86.9 mmm -66.53 178.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.283 0.563 . . . . 0.0 111.863 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -50.17 -19.6 0.81 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t -46.04 -51.95 12.77 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.569 0.543 . . . . 0.0 112.309 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.526 ' H ' HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -89.76 -18.58 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.567 -177.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -74.11 -50.95 17.25 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.3 -0.25 . . . . 0.0 111.388 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.3 m -58.3 -29.39 65.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.459 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 42.8 t -70.33 -40.09 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.71 172.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.31 -41.03 96.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.831 0.348 . . . . 0.0 110.439 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.47 -31.24 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.408 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.74 -35.42 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.123 0.487 . . . . 0.0 110.617 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.592 HD21 ' CZ2' ' C' ' 54' ' ' TRP . 73.3 mt -73.53 -37.37 65.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.347 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -79.59 68.92 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.814 0.816 . . . . 0.0 109.019 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' C' ' 47' ' ' ILE . 16.6 pttm -89.27 -7.4 55.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.992 -172.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.4 -50.73 0.76 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.743 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 22.5 mmtm -78.96 -160.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -41.34 137.94 2.11 Favored Glycine 0 CA--C 1.507 -0.434 0 O-C-N 123.535 0.522 . . . . 0.0 114.106 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.5 OUTLIER -141.34 143.21 33.9 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -168.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.0 mp -117.86 114.54 23.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 8.5 t -86.42 98.47 11.03 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 91' ' ' ILE . 39.0 mt -83.9 124.36 30.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.246 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 29.8 t -147.13 139.43 24.63 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 54.0 mtm -107.2 145.64 32.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.277 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -148.15 89.82 1.76 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 110.568 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.18 -94.11 0.31 Allowed Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.94 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.4 p-10 -112.94 26.61 10.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 110.512 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.595 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 8.0 tt0 -140.35 143.39 35.73 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.493 0.663 . . . . 0.0 111.951 -171.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.0 tm? -118.11 117.88 30.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 22.5 pttp -126.31 148.62 49.5 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.15 135.29 17.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.378 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -98.69 125.57 44.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 30.9 t -109.47 119.65 40.09 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.672 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 9.5 t -109.93 178.98 4.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 78.44 27.34 0.5 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.502 1.126 . . . . 0.0 110.639 -174.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.69 32.69 19.84 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.548 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.91 -14.08 66.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.121 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 39.7 m-85 -55.44 130.36 42.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.058 0.429 . . . . 0.0 110.359 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -73.85 -94.45 0.11 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.784 -0.643 . . . . 0.0 113.074 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' C' ' 52' ' ' LYS . 33.6 mt -110.51 -67.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.415 0.626 . . . . 0.0 109.755 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 177.36 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.192 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -166.4 -37.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.657 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 11.8 pt-20 -70.18 170.08 12.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.058 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.548 ' HB2' HD21 ' C' ' 67' ' ' ASN . 4.5 p-10 -125.35 152.97 44.04 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 111.33 -177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.596 ' HG2' HD11 ' C' ' 47' ' ' ILE . 8.6 mmmm -130.03 143.47 50.81 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.207 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.546 ' OD1' HG13 ' C' ' 94' ' ' ILE . 10.9 t-20 -92.34 105.04 17.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.464 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.63 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -113.82 165.85 12.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.128 -167.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.455 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -163.78 158.09 30.5 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 119.556 -1.306 . . . . 0.0 114.816 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.455 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.6 mp -119.79 129.39 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.869 169.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.536 ' CE1' ' HD3' ' C' ' 62' ' ' LYS . 40.6 m-85 -123.98 105.49 9.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.31 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.89 112.01 26.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 57.83 32.84 22.48 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.062 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.12 7.53 87.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.085 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.3 tp10 -107.01 139.05 42.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.883 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.536 ' HD3' ' CE1' ' C' ' 57' ' ' PHE . 14.3 mmmm -83.24 118.05 23.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.575 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -107.17 -24.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.358 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -160.22 147.91 16.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 110.778 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 54' ' ' TRP . 41.8 m -139.73 147.73 41.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' C' ' 75' ' ' ILE . 32.7 p90 -159.78 -178.73 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.121 -1.032 . . . . 0.0 113.523 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' C' ' 51' ' ' ASP . 51.5 t-20 -120.36 127.95 52.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.836 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 4.7 mt-10 -62.61 -21.53 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 21.0 ptmt -90.53 9.24 30.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.515 ' HB2' HD11 ' C' ' 75' ' ' ILE . 15.5 m -76.38 -118.8 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.299 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -131.71 115.67 16.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.496 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 3.3 t -60.65 -22.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -168.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.88 -37.4 19.36 Favored Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.004 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -72.14 -34.51 68.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' C' ' 70' ' ' SER . 81.9 mt -66.6 -65.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.395 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.638 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 70.8 p -62.42 -50.95 69.45 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -167.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.459 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 68.6 m-80 -79.29 -14.51 58.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -172.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.05 -38.83 92.13 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' C' ' 76' ' ' SER . 73.1 mt -59.29 -24.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.497 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -80.12 -40.03 28.29 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 8.0 mmpt? -50.72 -38.68 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 0.0 109.624 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.413 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.5 mt -52.25 -35.37 49.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.595 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.7 m-20 37.49 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.131 0.895 . . . . 0.0 110.957 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' C' ' 86' ' ' GLY . 31.5 mt -79.28 115.16 21.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.241 -166.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -66.83 35.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.638 169.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' C' ' 84' ' ' ILE . . . -98.74 159.42 20.29 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.096 -171.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 93.1 Cg_endo -80.5 -75.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.691 2.261 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.587 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 15.3 p90 -115.78 112.64 22.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.666 0.746 . . . . 0.0 109.487 171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.09 114.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.706 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -90.55 96.88 10.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.338 0.589 . . . . 0.0 110.13 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 29' ' ' LEU . 13.9 mt -96.35 100.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 145.89 22.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 29.5 pt20 -83.1 167.01 18.23 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.751 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.546 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.565 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -93.55 -32.85 13.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.383 0.611 . . . . 0.0 109.45 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.509 ' H ' ' CD ' ' C' ' 3' ' ' GLN . 19.0 mp0 -62.58 -17.92 61.06 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.55 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -45.99 -59.55 2.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.64 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.85 -23.23 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.706 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.72 174.36 8.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' C' ' 87' ' ' PRO . 6.4 mp0 -100.35 17.39 21.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.723 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' C' ' 3' ' ' GLN . 56.2 mt-10 66.5 18.99 10.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.499 0.666 . . . . 0.0 111.76 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' C' ' 31' ' ' MET . 39.3 mt-30 -82.31 17.2 1.75 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.717 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 71.1 mtp -81.36 -149.26 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.887 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.12 -10.69 11.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -56.62 -42.39 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.09 -28.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.8 -43.99 87.04 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.478 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' SER . . . . . 0.548 ' O ' ' HB2' ' C' ' 19' ' ' LYS . 22.3 m -56.97 -34.93 68.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.1 -31.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.208 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -61.31 -48.97 78.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.03 -14.25 60.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.094 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' C' ' 15' ' ' SER . 0.0 OUTLIER -80.52 -45.77 16.92 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' C' ' 27' ' ' LEU . 90.0 mt -78.42 -35.08 47.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.985 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -78.65 67.84 4.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.157 0.503 . . . . 0.0 109.961 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -104.6 -10.01 17.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.87 -76.6 0.19 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -99.57 -174.49 2.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.89 88.95 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 171.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.6 ptpt -128.97 143.44 50.88 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.646 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HB3' HD13 ' C' ' 20' ' ' LEU . 17.1 tp -125.94 127.98 46.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.366 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -99.98 110.68 23.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -79.84 135.32 36.43 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.028 0.531 . . . . 0.0 111.973 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 41.2 m -143.61 129.11 19.06 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.286 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.586 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 39.5 mtm -123.93 130.9 53.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -148.1 90.89 1.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.05 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.27 -97.67 0.06 OUTLIER Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.713 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -101.87 33.38 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.37 0.605 . . . . 0.0 109.882 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.401 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 26.9 tt0 -150.08 136.66 19.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.2 tm? -119.96 127.41 52.62 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 165.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -144.8 144.74 31.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.43 142.42 22.18 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.732 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 60.6 p -99.07 138.81 35.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 22.2 p -118.07 117.86 30.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.564 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.2 m -105.04 178.18 4.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.955 -175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' C' ' 26' ' ' LYS . 0.7 OUTLIER 70.1 38.98 1.41 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.323 1.014 . . . . 0.0 109.071 -168.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.13 27.75 16.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.732 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 11.92 82.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.523 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.45 ' O ' HG23 ' C' ' 72' ' ' VAL . 55.1 m-85 -74.69 176.1 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.248 0.524 . . . . 0.0 110.771 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -101.01 -154.98 26.97 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.634 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.518 HD13 ' HE3' ' C' ' 22' ' ' LYS . 15.9 mm -51.79 -67.08 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.486 0.66 . . . . 0.0 109.863 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 15.1 t 173.13 -67.78 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.335 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.05 -22.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 7.4 pt-20 -68.94 145.68 53.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 112.315 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.53 ' C ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 t70 -87.56 121.05 29.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.707 -174.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 3.3 mptp? -124.76 134.37 52.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.86 105.96 18.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.538 0.685 . . . . 0.0 111.077 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.579 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -108.66 167.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.61 -173.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.416 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -170.1 165.58 38.88 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 119.291 -1.433 . . . . 0.0 115.612 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.538 HG13 HG13 ' C' ' 91' ' ' ILE . 3.5 mp -124.63 129.54 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.17 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -120.1 117.42 27.9 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -115.62 123.17 70.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.677 0.275 . . . . 0.0 110.362 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' C' ' 87' ' ' PRO . 4.5 m-20 57.56 33.23 22.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.83 90.47 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.851 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.52 130.95 56.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.475 ' HD2' ' OG1' ' C' ' 65' ' ' THR . 40.0 ttpt -74.83 123.67 25.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.934 0.397 . . . . 0.0 110.5 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.69 -43.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -146.31 147.75 31.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.933 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' C' ' 54' ' ' TRP . 84.6 m -136.46 145.22 44.94 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.44 -170.92 2.96 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 51.3 t-20 -128.2 139.99 52.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.458 ' HB3' HG12 ' C' ' 47' ' ' ILE . 42.3 mt-10 -77.95 -11.29 59.89 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -81.59 -6.63 59.17 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.242 175.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -78.58 163.75 25.25 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -74.22 113.24 11.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.519 HG23 ' HA2' ' C' ' 46' ' ' GLY . 8.7 t -57.52 -15.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.943 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.95 -41.16 12.79 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.371 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -73.41 -33.01 64.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 38.3 mm -65.81 -61.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.532 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 68.2 p -64.8 -57.81 7.9 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.721 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 8.1 m-20 -67.69 -16.83 64.34 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -171.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.2 m-20 -64.95 -47.41 77.73 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.645 0.657 . . . . 0.0 109.291 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' C' ' 76' ' ' SER . 65.1 mt -56.78 -30.62 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.844 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 27.7 m-20 -89.67 -17.82 27.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 33.9 mmtp -62.76 -39.31 93.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 11.0 mt -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.302 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 93.1 m-20 39.51 72.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.625 0.726 . . . . 0.0 110.08 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' C' ' 86' ' ' GLY . 13.7 mt -54.36 139.99 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.451 -171.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -85.17 26.29 0.89 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.408 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -93.1 125.41 8.17 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.606 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' C' ' 7' ' ' GLU . 95.6 Cg_endo -79.83 -40.34 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.208 1.939 . . . . 0.0 111.035 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -126.89 120.64 29.68 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.586 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 73.4 mt -126.11 130.53 72.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.521 -172.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.33 98.47 11.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.983 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.579 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.8 tt -105.33 99.89 9.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.24 158.67 19.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.322 -171.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -84.52 158.79 20.86 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.428 ' H ' HG12 ' C' ' 94' ' ' ILE . 1.6 pt . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.977 -167.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ASN . . . . . 0.597 ' HB3' ' CB ' ' C' ' 4' ' ' LYS . 0.8 OUTLIER -118.47 132.49 56.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.442 ' HG3' HD12 ' C' ' 6' ' ' LEU . 20.2 mp0 -66.01 -9.28 28.94 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.597 ' CB ' ' HB3' ' C' ' 2' ' ' ASN . 3.8 ttmp? -42.78 -44.54 4.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.747 -1.57 . . . . 0.0 111.607 166.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.86 -15.04 30.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.0 110.781 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' C' ' 3' ' ' GLN . 82.8 mt -91.11 -153.1 0.3 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.47 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 8.1 mp0 -101.15 -11.56 19.47 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 4.9 mm-40 70.52 18.85 6.42 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.442 0.639 . . . . 0.0 110.498 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' C' ' 32' ' ' ASN . 65.7 mt-30 -70.38 -6.11 33.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.229 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -81.36 -143.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.622 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.05 -9.77 11.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -48.94 -60.46 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.89 0.476 . . . . 0.0 111.83 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.58 ' H ' HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -84.83 -18.36 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.06 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 84.3 m-20 -72.46 -38.96 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.642 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 61.2 m -63.76 -30.18 71.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 89.7 t -68.25 -36.69 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.651 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.8 m-20 -59.87 -45.51 92.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.4 -32.03 70.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.292 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -87.41 -31.63 19.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.975 0.417 . . . . 0.0 110.994 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' C' ' 27' ' ' LEU . 50.8 mt -81.62 -31.41 32.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.705 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -82.67 65.1 7.63 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.446 ' CE ' HD12 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.52 -24.15 16.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.012 -173.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.46 -78.36 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.603 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.8 ttpt -98.87 -172.97 2.4 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 166.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.83 92.66 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 O-C-N 124.747 1.28 . . . . 0.0 115.703 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.0 ptpt -130.95 136.74 48.83 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.597 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.3 tp -116.48 122.09 43.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.581 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.9 m -108.05 104.54 14.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.292 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.689 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -82.53 138.43 34.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -142.76 129.35 20.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' C' ' 9' ' ' GLN . 36.0 mtm -130.81 125.02 32.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.236 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.487 ' H ' ' HG2' ' C' ' 35' ' ' GLN . 61.6 m-80 -148.42 97.21 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 110.654 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -94.63 0.8 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.459 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 19.0 t-20 -120.43 32.46 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.501 0.667 . . . . 0.0 109.835 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' C' ' 32' ' ' ASN . 2.3 pt20 -128.48 136.55 50.97 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.279 0.561 . . . . 0.0 111.607 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.667 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 0.7 OUTLIER -130.39 118.45 21.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 164.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.526 ' O ' ' HD2' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -145.66 103.2 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -109.52 126.66 53.77 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.286 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -96.65 137.76 35.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.075 0.464 . . . . 0.0 109.896 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 29.2 p -109.04 117.59 34.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.644 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 21.2 t -102.63 173.97 6.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.422 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 71.76 39.61 0.84 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.384 1.052 . . . . 0.0 109.569 -166.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.12 27.02 14.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.79 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.97 5.83 88.86 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.051 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 44.0 m-85 -65.03 156.47 31.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.579 ' O ' ' HG2' ' C' ' 24' ' ' LYS . . . -83.23 -166.52 39.87 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.463 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 15.6 mm -56.46 -61.9 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 121.489 0.662 . . . . 0.0 111.803 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.1 p 176.24 -74.15 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.983 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -159.88 20.99 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.358 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 42.1 mt-10 -115.95 141.87 47.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.765 -176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.501 ' HB2' HD21 ' C' ' 67' ' ' ASN . 7.0 p-10 -100.99 149.21 24.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.565 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.523 ' HG3' ' OE1' ' C' ' 68' ' ' GLU . 11.3 mmtp -132.9 146.23 51.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' C' ' 94' ' ' ILE . 6.5 t30 -96.28 99.25 10.97 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.753 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.557 ' HA ' ' CB ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -102.93 164.35 11.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.238 -166.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.53 143.9 10.2 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 119.403 -1.38 . . . . 0.0 115.114 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.405 HD12 ' N ' ' C' ' 56' ' ' ILE . 4.2 mp -118.85 124.82 73.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 5.2 m-85 -125.91 155.11 41.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.02 117.87 47.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.81 24.98 14.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.21 36.82 20.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.343 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 16.0 tp10 -133.62 131.11 39.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.82 124.5 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.98 -49.2 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.612 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 56.8 t80 -155.17 150.3 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.712 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 16.8 m -135.61 136.55 41.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 41.9 p90 -152.58 -177.9 6.52 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.793 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.501 HD21 ' HB2' ' C' ' 51' ' ' ASP . 52.0 t-20 -119.95 130.41 54.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.91 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.523 ' OE1' ' HG3' ' C' ' 52' ' ' LYS . 2.2 mt-10 -64.95 -27.06 68.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 13.7 ptmm? -79.55 2.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.374 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 11.5 m -74.63 178.24 5.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -76.63 110.84 11.53 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.39 -11.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.911 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.72 -41.24 13.12 Favored Glycine 0 CA--C 1.51 -0.238 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.971 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -71.54 -32.02 67.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.239 0.542 . . . . 0.0 109.587 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.479 ' O ' HG13 ' C' ' 79' ' ' ILE . 49.1 mm -69.62 -55.73 14.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.515 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' C' ' 38' ' ' ALA . 56.3 p -57.98 -64.65 0.84 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.636 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 6.6 m-20 -67.06 -17.74 65.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -172.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -45.57 66.07 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.479 HG13 ' O ' ' C' ' 75' ' ' ILE . 58.2 mt -57.65 -28.29 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' C' ' 38' ' ' ALA . 30.0 m-20 -85.86 -27.95 24.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.023 -177.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 68.1 mttm -60.32 -36.65 78.41 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 12.3 mt -52.35 -32.47 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 39.35 99.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.66 1.225 . . . . 0.0 112.769 -175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.667 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -42.67 144.42 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 113.965 -1.471 . . . . 0.0 112.867 -173.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.34 15.17 0.89 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.33 0.585 . . . . 0.0 109.586 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.31 179.91 28.41 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.682 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.58 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.5 Cg_endo -82.01 -77.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.668 2.245 . . . . 0.0 111.455 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.58 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.5 p90 -113.83 129.92 56.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 109.798 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.661 HG12 HD11 ' C' ' 84' ' ' ILE . 3.9 mp -116.01 136.71 52.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.374 -174.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 101.69 14.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' C' ' 29' ' ' LEU . 27.0 mm -103.4 98.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 151.56 3.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -91.42 171.7 9.02 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.225 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.824 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.149 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.692 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 1' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' C' ' 3' ' ' GLN . 26.1 t70 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.564 0.221 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 47.9 t30 69.25 -4.68 1.24 Allowed 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.512 0.725 . . . . 0.0 112.778 174.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.636 ' HB3' ' CB ' ' C' ' 7' ' ' GLU . 46.6 mt-30 -90.82 22.37 3.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 110.465 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -51.01 -69.73 0.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.206 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.76 -70.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.415 0.626 . . . . 0.0 110.5 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' C' ' 9' ' ' GLN . 77.0 mt -90.69 97.1 10.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.187 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' C' ' 3' ' ' GLN . 6.0 pt-20 -79.29 -97.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 0.0 111.764 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.58 ' H ' ' HG3' ' C' ' 7' ' ' GLU . 9.7 mm-40 -68.74 4.82 1.28 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.91 0.386 . . . . 0.0 111.435 171.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' C' ' 6' ' ' LEU . 2.7 mp0 -81.5 15.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.465 ' O ' HG22 ' C' ' 13' ' ' ILE . 75.0 mtm -99.5 -143.21 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.481 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -47.58 -35.38 9.03 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' SER . . . . . 0.456 ' O ' HG23 ' C' ' 16' ' ' VAL . 51.0 m -49.25 -48.44 45.77 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 10' ' ' MET . 9.9 tt -84.22 -25.26 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.288 0.566 . . . . 0.0 111.08 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.556 ' HA ' HD22 ' C' ' 17' ' ' ASN . 89.3 m-20 -85.02 -27.84 26.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.58 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 50.6 m -65.07 -31.67 73.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.539 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 51.7 t -69.83 -34.34 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.971 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.556 HD22 ' HA ' ' C' ' 14' ' ' ASN . 6.4 m-80 -57.43 -46.27 83.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.775 0.322 . . . . 0.0 110.749 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.9 -15.97 61.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.712 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -88.04 -38.0 15.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 43.3 mt -74.1 -33.9 63.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.45 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 23.4 m-80 -78.53 69.62 4.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -102.0 10.01 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.696 -171.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.91 -67.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.594 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 0.2 OUTLIER -100.44 92.56 5.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 122.616 0.366 . . . . 0.0 110.365 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 126.56 3.14 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 119.833 -1.175 . . . . 0.0 111.668 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.5 ptpt -149.4 146.09 27.3 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.479 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -115.21 110.68 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.466 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.6 m -85.93 115.6 23.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' C' ' 17' ' ' ASN . 16.5 mt -102.63 132.27 48.85 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.877 0.37 . . . . 0.0 111.82 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 26.4 p -149.58 137.55 20.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.553 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 88.8 mtp -118.32 128.07 54.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -133.04 92.78 3.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.155 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.91 -93.55 0.41 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.167 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.6 p-10 -107.87 21.73 16.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.535 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 8.4 tt0 -138.79 145.54 40.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.558 0.694 . . . . 0.0 112.465 -169.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.413 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -128.85 105.07 7.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.474 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 54.5 pttt -109.13 104.95 14.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.638 0.732 . . . . 0.0 109.113 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -104.2 119.35 38.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -104.68 139.09 40.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 26.6 t -109.9 119.19 38.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 42.8 t -93.39 173.78 7.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.288 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' C' ' 41' ' ' SER . 12.4 m120 80.19 26.5 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.757 1.286 . . . . 0.0 110.102 -171.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.28 27.09 16.05 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.061 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.12 67.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.979 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.0 m-30 -60.19 143.14 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.813 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.82 -169.26 45.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.548 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.586 ' CG1' ' HB3' ' C' ' 68' ' ' GLU . 7.7 mt -48.95 -59.28 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 CA-C-O 121.052 0.453 . . . . 0.0 111.891 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 10.3 t 173.31 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.855 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -166.69 54.4 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.525 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 5.7 pt-20 -156.45 152.04 26.95 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.73 0.3 . . . . 0.0 111.409 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.476 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 p-10 -97.31 129.62 44.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.662 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.6 mptp? -127.64 133.05 49.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.491 ' OD1' HG13 ' C' ' 94' ' ' ILE . 2.3 t-20 -87.48 107.73 18.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.851 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.755 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -113.38 165.62 12.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.869 -171.017 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.22 167.53 40.64 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.694 -1.241 . . . . 0.0 115.245 174.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.549 HG12 HG13 ' C' ' 91' ' ' ILE . 50.2 mt -131.24 131.47 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.901 -0.65 . . . . 0.0 110.414 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 54.0 m-85 -126.02 122.47 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.808 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -112.46 117.36 55.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 61.21 32.02 19.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.316 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.58 80.06 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.0 OUTLIER -112.95 142.75 45.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.713 0.256 . . . . 0.0 110.799 -178.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.54 100.44 2.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.32 -39.7 13.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.174 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -154.25 153.35 31.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.098 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.586 HG23 ' O ' ' C' ' 54' ' ' TRP . 60.0 m -150.08 142.43 24.27 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -158.6 -179.39 8.03 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.251 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' C' ' 51' ' ' ASP . 46.2 t-20 -118.91 127.07 53.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.167 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.755 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 2.1 mt-10 -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 3.7 ptmm? -76.56 -2.41 32.29 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.581 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.559 ' HB2' HD11 ' C' ' 75' ' ' ILE . 5.4 m -74.74 -170.24 1.02 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 68.6 p -88.36 116.82 26.85 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.179 -0.951 . . . . 0.0 108.749 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.609 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 11.1 t -58.17 -17.21 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.751 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.32 -44.66 8.6 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.748 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -69.17 -28.48 66.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' C' ' 70' ' ' SER . 73.1 mt -66.92 -66.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -59.78 -48.16 82.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.285 -170.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.18 -15.63 60.01 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.39 -39.92 81.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.8 mt -58.49 -27.7 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.44 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' C' ' 37' ' ' LYS . 7.3 m-20 -77.64 -35.79 52.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.227 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 10.7 mmpt? -52.2 -42.99 63.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.8 mt -56.21 -32.91 64.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.535 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.0 OUTLIER 38.4 80.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.018 0.823 . . . . 0.0 111.083 -171.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.51 HG22 ' H ' ' C' ' 86' ' ' GLY . 11.8 mt -68.34 124.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.238 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -91.74 34.83 0.97 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.852 175.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.51 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -79.98 143.6 25.44 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.19 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.29 -43.65 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.38 2.054 . . . . 0.0 111.293 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -139.26 128.77 24.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 63.4 mt -121.38 126.15 74.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.615 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -98.9 98.97 9.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.411 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.597 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.3 tt -98.83 104.42 15.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 168.09 19.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.86 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.37 0.605 . . . . 0.0 111.32 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.491 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.599 -166.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.542 0.21 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -164.08 -17.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.225 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.459 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 15.7 mp0 -85.25 14.1 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.861 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.16 -51.08 69.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.418 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.64 -9.31 47.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.259 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.43 169.15 11.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.048 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' C' ' 88' ' ' TYR . 58.7 mt-10 -94.29 4.28 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' C' ' 12' ' ' SER . 44.8 mt-10 71.14 -10.47 0.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.507 0.723 . . . . 0.0 112.924 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.517 ' NE2' ' H ' ' C' ' 89' ' ' ILE . 10.7 mm-40 -83.93 15.46 3.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 20.0 mmt -90.44 -143.54 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.408 ' H ' ' HB3' ' C' ' 10' ' ' MET . 4.1 m-20 -56.78 -14.16 3.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' C' ' 8' ' ' GLU . 48.3 t -54.33 -39.45 67.07 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.114 0.259 . . . . 0.0 110.438 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.514 HD13 ' SD ' ' C' ' 31' ' ' MET . 13.1 pt -90.81 -25.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.896 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -64.93 -44.35 89.78 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.757 0.313 . . . . 0.0 110.627 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -57.46 -35.86 70.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.8 t -68.34 -35.74 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.341 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.59 -41.54 99.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 110.132 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.37 -20.62 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.355 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' C' ' 19' ' ' LYS . 5.5 mmpt? -88.88 -35.22 16.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 110.658 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.518 HD12 HD21 ' C' ' 29' ' ' LEU . 98.9 mt -76.37 -33.14 58.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 28.7 m-80 -79.98 60.05 3.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.544 0.688 . . . . 0.0 109.838 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -94.21 -34.43 12.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.264 -173.181 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HE3' ' C' ' 26' ' ' LYS . . . 166.98 -93.7 0.11 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.464 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -72.66 91.76 1.47 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 125.59 5.19 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.642 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' C' ' 21' ' ' ASN . 8.0 ptpt -152.34 155.63 38.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.39 129.68 43.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.548 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.4 m -107.83 99.36 8.83 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.518 HD21 HD12 ' C' ' 20' ' ' LEU . 0.6 OUTLIER -93.39 136.13 33.96 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 120.818 0.342 . . . . 0.0 111.672 -171.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -153.35 130.62 11.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.273 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.519 ' HG3' ' CD2' ' C' ' 36' ' ' LEU . 1.6 mpt? -103.71 137.49 41.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.981 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -136.04 91.46 2.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.701 0.286 . . . . 0.0 110.278 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.02 -95.03 0.12 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.079 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.5 p-10 -108.03 22.6 15.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.643 0.259 . . . . 0.0 110.938 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.558 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 25.9 tt0 -139.15 137.04 35.74 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.553 0.692 . . . . 0.0 112.398 -170.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.519 ' CD2' ' HG3' ' C' ' 31' ' ' MET . 0.6 OUTLIER -113.62 129.67 56.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -142.89 140.78 31.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.463 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -152.56 134.54 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.54 0.209 . . . . 0.0 110.996 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 62.0 p -98.28 145.45 26.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 35.8 m -125.59 116.61 22.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 49.2 m -100.66 -179.47 4.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.741 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.48 31.1 0.61 Allowed 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 124.584 1.178 . . . . 0.0 109.609 -168.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.52 32.58 22.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.112 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 1.03 86.34 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.262 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -66.63 145.67 55.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 111.055 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.71 -160.39 20.19 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.629 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.755 HD12 ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -48.51 -53.04 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.755 ' H ' HD12 ' C' ' 47' ' ' ILE . 8.2 t 166.87 -62.81 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.273 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -150.37 -33.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 47.9 mm-40 -91.31 167.15 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -163.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.85 92.58 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.238 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.468 ' HB3' ' OE2' ' C' ' 68' ' ' GLU . 10.3 mptt -101.03 157.47 16.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 1.4 p30 -116.6 120.61 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.0 112.544 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.549 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -102.85 166.56 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.737 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.74 150.13 11.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.117 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.3 mp -108.93 122.96 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 122.735 -0.274 . . . . 0.0 110.705 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -108.38 138.58 44.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.421 HG12 HG13 ' C' ' 63' ' ' VAL . 8.9 p -127.93 117.12 45.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.71 26.2 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.439 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.08 4.91 74.02 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.521 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.67 139.88 52.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.039 0.42 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 53.2 mtmt -82.0 136.87 35.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.721 0.296 . . . . 0.0 111.668 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.421 HG13 HG12 ' C' ' 58' ' ' VAL . 35.8 m -104.93 -39.47 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.695 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -144.7 145.93 31.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.549 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.2 m -136.88 141.93 42.76 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.541 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.7 p90 -153.85 -175.14 5.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.446 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -126.73 139.48 53.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.287 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.475 ' CD ' ' HD1' ' C' ' 54' ' ' TRP . 3.1 mp0 -62.24 -15.75 49.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.529 ' HB3' HD11 ' C' ' 47' ' ' ILE . 2.4 ptmm? -82.56 1.92 35.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.919 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.6 m -81.54 -173.95 4.68 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.562 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.8 p -97.36 117.54 31.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.56 -21.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.518 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.71 -32.67 23.79 Favored Glycine 0 CA--C 1.504 -0.595 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.988 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -75.52 -38.49 59.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.562 HG12 ' O ' ' C' ' 71' ' ' THR . 42.3 mm -68.09 -58.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.519 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 20.3 m -59.74 -51.45 69.72 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.484 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.536 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 3.9 m-20 -69.92 -18.94 63.41 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.734 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 46.1 m-20 -68.03 -46.88 69.95 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 167.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' C' ' 76' ' ' SER . 96.2 mt -54.56 -29.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.296 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 69.9 m-20 -87.3 -37.35 17.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.327 -172.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 54.2 pttt -60.9 -26.03 67.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 18.5 mt -57.44 -29.05 63.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.819 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.558 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 97.0 m-20 39.52 86.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.941 0.775 . . . . 0.0 110.679 -170.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.407 HG22 ' N ' ' C' ' 86' ' ' GLY . 15.9 mt -80.37 129.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.921 -168.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.4 OUTLIER -87.96 36.64 0.77 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.69 175.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.407 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -82.38 134.66 13.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.291 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.98 -47.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.545 2.163 . . . . 0.0 111.708 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' C' ' 7' ' ' GLU . 6.5 m-85 -125.71 99.54 6.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.517 ' H ' ' NE2' ' C' ' 9' ' ' GLN . 19.2 mm -100.54 125.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.424 0.631 . . . . 0.0 110.664 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.03 99.56 9.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.49 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.516 ' O ' HG11 ' C' ' 16' ' ' VAL . 3.4 tt -101.96 99.45 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.814 0.816 . . . . 0.0 109.018 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -161.54 166.12 27.51 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.634 -173.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.626 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -104.19 163.41 12.43 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.312 173.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.499 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.649 -161.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.32 -29.48 2.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.069 0.462 . . . . 0.0 109.91 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -90.23 23.36 2.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.92 0.867 . . . . 0.0 109.785 173.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -58.01 -39.13 77.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.835 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.84 -66.03 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.914 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.86 135.3 38.86 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.445 ' HG3' ' HG ' ' C' ' 12' ' ' SER . 23.3 tp10 -100.65 25.29 7.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.774 0.797 . . . . 0.0 109.851 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.17 -45.1 9.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.907 -167.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.585 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 1.9 mp0 -90.08 15.86 9.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.467 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 0.0 OUTLIER -110.77 -151.96 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.467 ' H ' ' HB3' ' C' ' 10' ' ' MET . 91.7 m-20 -44.76 -33.71 2.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' SER . . . . . 0.445 ' HG ' ' HG3' ' C' ' 7' ' ' GLU . 14.5 m -50.63 -48.76 57.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.677 0.275 . . . . 0.0 111.605 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.42 HD12 ' HE3' ' C' ' 31' ' ' MET . 5.3 tt -85.75 -28.09 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.113 0.482 . . . . 0.0 110.674 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 4.0 m-20 -69.8 -35.72 75.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.983 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -63.69 -29.82 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 96.8 t -72.49 -35.64 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.647 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.98 -42.2 98.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.67 -24.42 63.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.43 -31.5 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.824 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 27' ' ' LEU . 98.8 mt -84.88 -33.25 22.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.682 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ASN . . . . . 0.482 ' HA ' ' HB2' ' C' ' 26' ' ' LYS . 24.4 m-80 -78.73 78.45 5.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.724 ' NZ ' ' HB2' ' C' ' 24' ' ' LYS . 0.6 OUTLIER -120.22 7.09 10.72 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -165.567 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.32 -76.12 0.4 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.328 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.724 ' HB2' ' NZ ' ' C' ' 22' ' ' LYS . 47.7 mttm -75.51 -158.32 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.74 144.21 1.2 Allowed Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 114.615 0.606 . . . . 0.0 114.615 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' C' ' 40' ' ' SER . 12.7 ptpt -151.14 144.61 24.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 20' ' ' LEU . 3.3 mp -102.15 136.73 41.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.03 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 9.4 t -115.62 99.83 7.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -86.71 127.84 34.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.916 0.389 . . . . 0.0 111.482 -173.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.6 m -142.09 128.89 20.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.806 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.585 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 30.2 mtt -100.17 121.9 42.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -133.54 91.09 2.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.645 0.26 . . . . 0.0 110.973 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.9 -108.33 1.53 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.161 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.47 21.53 5.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.081 0.44 . . . . 0.0 110.867 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.427 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 21.8 tt0 -142.93 141.1 31.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.594 0.712 . . . . 0.0 112.105 -169.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.401 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.3 tm? -116.94 122.69 45.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 164.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -127.38 140.35 52.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.66 119.07 5.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 47.0 p -98.03 146.57 25.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 53.2 p -112.0 118.62 35.94 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 21.7 m -88.5 177.21 6.86 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.018 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.434 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.6 OUTLIER 72.54 33.61 1.38 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.285 0.991 . . . . 0.0 109.399 -172.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.8 33.45 23.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.594 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.32 6.92 89.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.189 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.434 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 21.4 m-85 -64.02 151.96 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.336 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -72.73 174.06 46.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.096 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.441 HG13 ' HB3' ' C' ' 68' ' ' GLU . 49.1 mm -60.57 -67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 121.182 0.515 . . . . 0.0 109.714 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 21.5 t -148.48 -88.42 0.08 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.308 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -177.31 25.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.535 0.683 . . . . 0.0 110.338 -173.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.56 146.12 50.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.159 0.504 . . . . 0.0 111.037 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.42 109.7 15.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.088 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 5.9 mptp? -121.18 137.7 54.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.426 ' OD1' HG13 ' C' ' 94' ' ' ILE . 3.1 t-20 -88.57 108.53 19.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.69 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.39 162.74 13.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.495 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.72 139.71 6.92 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.159 -1.496 . . . . 0.0 116.141 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -112.75 129.17 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.443 167.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.43 106.99 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.327 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 89' ' ' ILE . 11.2 m -94.0 123.01 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 53.76 33.41 16.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.329 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.68 60.79 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.041 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.52 119.71 21.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 5.4 ttpm? -71.2 120.88 17.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.55 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.54 -33.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.559 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.08 143.87 29.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.14 0.495 . . . . 0.0 110.598 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.69 HG23 ' O ' ' C' ' 54' ' ' TRP . 69.2 m -135.76 139.98 43.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.2 p90 -148.45 177.77 9.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.173 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 67.4 m-20 -122.71 139.33 54.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.862 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' C' ' 47' ' ' ILE . 26.5 mt-10 -66.36 -14.21 61.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -82.97 -1.26 51.99 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -87.44 -177.9 6.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.413 ' O ' HG12 ' C' ' 75' ' ' ILE . 15.1 p -83.22 115.6 22.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.47 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.5 t -60.95 -15.29 11.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.697 -169.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.81 -43.3 7.29 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.656 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -69.71 -28.55 65.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.457 HG21 ' CD1' ' C' ' 66' ' ' PHE . 41.0 mm -70.27 -65.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.18 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.58 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.9 m -59.19 -46.64 87.89 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.767 -171.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 41.2 m-80 -76.79 -14.83 59.88 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 19.8 m-20 -60.26 -45.62 92.64 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' C' ' 76' ' ' SER . 78.8 mt -57.22 -30.55 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.1 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' C' ' 77' ' ' ASN . 7.7 m120 -90.72 -28.67 18.15 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.43 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 11.5 mmpt? -55.04 -36.02 65.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.7 mt -56.41 -31.79 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.427 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.9 m-20 39.11 79.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 0.0 110.073 -168.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.43 HG22 ' N ' ' C' ' 86' ' ' GLY . 25.6 mt -69.04 131.92 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.003 -168.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -86.69 41.51 0.96 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.323 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.43 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -89.26 129.58 9.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.746 -172.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.22 -38.35 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.418 2.079 . . . . 0.0 110.748 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -150.72 113.28 4.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.119 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.451 HG12 ' SD ' ' C' ' 31' ' ' MET . 15.0 pt -123.01 153.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.876 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.27 129.32 54.33 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.226 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' C' ' 29' ' ' LEU . 3.4 mt -126.89 100.23 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.681 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.37 15.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 174.51 7.32 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.35 -177.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.426 HG13 ' OD1' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.348 -169.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.504 0.192 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 73.87 -42.41 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.893 0.877 . . . . 0.0 112.855 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' C' ' 8' ' ' GLU . 41.1 mt-30 -52.13 -29.98 24.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.487 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -36.02 -54.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.673 1.233 . . . . 0.0 112.478 172.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.29 -18.8 23.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.818 -175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.45 -81.97 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.952 0.406 . . . . 0.0 112.059 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' C' ' 8' ' ' GLU . 3.3 pt-20 -102.45 -95.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' C' ' 7' ' ' GLU . 4.9 mm-40 66.7 -33.62 0.2 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.926 0.891 . . . . 0.0 111.951 -172.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' C' ' 7' ' ' GLU . 8.2 mt-30 -66.9 -5.29 11.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.489 175.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 95.7 mmm -108.53 -140.94 0.38 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -41.43 -33.6 0.44 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -53.63 -51.38 63.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.801 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.472 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.4 tt -87.03 -25.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 17' ' ' ASN . 83.2 m-20 -72.48 -26.64 61.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.128 -0.358 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.8 t -63.33 -33.64 75.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.9 t -69.6 -34.01 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.053 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' C' ' 14' ' ' ASN . 78.9 m-20 -56.98 -43.42 81.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.02 0.438 . . . . 0.0 110.149 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -76.16 -19.92 58.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.95 -27.78 28.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.188 0.518 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' C' ' 27' ' ' LEU . 72.5 mt -91.51 -32.05 15.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.97 73.43 9.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -107.7 -40.7 5.22 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.003 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.52 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -168.69 -74.68 0.04 OUTLIER Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.378 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.3 ttmm -105.81 162.55 13.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 167.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.92 85.32 0.03 OUTLIER Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.199 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 7.7 ptpt -126.13 128.35 47.18 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.164 0.506 . . . . 0.0 111.169 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.49 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.7 tp -115.31 126.29 54.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.519 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.1 m -108.52 106.22 16.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.064 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.7 mm? -90.33 144.67 25.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.017 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.412 ' HB3' ' CE ' ' C' ' 37' ' ' LYS . 39.5 t -158.6 136.39 10.4 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.565 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.425 ' HE2' ' O ' ' C' ' 87' ' ' PRO . 2.3 mpt? -96.81 146.03 25.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -141.41 88.73 2.17 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.76 -99.3 0.08 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.33 26.46 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 110.362 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.708 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.2 tt0 -139.01 138.78 37.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.324 0.583 . . . . 0.0 111.654 -171.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -119.06 122.59 42.47 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 167.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.412 ' CE ' ' HB3' ' C' ' 30' ' ' SER . 0.0 OUTLIER -130.79 145.33 51.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.85 133.61 14.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.705 0.288 . . . . 0.0 110.535 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 51.9 p -100.56 144.46 29.52 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.0 p -121.51 118.36 29.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.626 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 30.6 m -104.76 -179.93 4.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.377 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.68 38.73 1.63 Allowed 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 124.208 0.942 . . . . 0.0 108.812 -169.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.68 20.64 12.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.081 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.51 79.19 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.299 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.467 ' O ' HG23 ' C' ' 72' ' ' VAL . 45.1 m-85 -75.92 -179.05 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.866 0.333 . . . . 0.0 111.063 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.54 -159.63 33.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.39 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.67 HD11 ' HB3' ' C' ' 68' ' ' GLU . 11.8 mt -49.21 -67.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.486 0.714 . . . . 0.0 112.53 -172.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 5.4 t 171.05 -75.3 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.788 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -155.31 62.23 0.62 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.352 0.261 . . . . 0.0 111.356 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.679 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 11.6 pt-20 -169.13 176.13 5.41 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.401 -0.187 . . . . 0.0 110.946 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 12.6 t70 -127.61 113.79 16.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.51 0.506 . . . . 0.0 110.78 -173.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -118.25 158.56 24.93 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.479 ' O ' HG12 ' C' ' 94' ' ' ILE . 9.2 p30 -108.93 123.21 48.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.474 0.654 . . . . 0.0 110.557 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.505 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -113.06 166.4 11.46 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.078 -168.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -173.8 155.89 22.82 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.636 -1.269 . . . . 0.0 115.796 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -116.45 129.38 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.365 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' C' ' 62' ' ' LYS . 0.4 OUTLIER -127.61 99.73 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 89' ' ' ILE . 7.4 p -84.11 125.77 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.645 -0.659 . . . . 0.0 109.967 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.49 26.21 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.878 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.41 4.45 76.98 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.977 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 35.9 tt0 -108.24 120.17 41.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.963 0.381 . . . . 0.0 110.609 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 27.6 ttpp -74.55 117.58 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.11 -30.23 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.023 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -137.39 144.63 42.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' C' ' 54' ' ' TRP . 28.1 m -145.99 141.89 28.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.6 p90 -162.24 -170.65 2.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.413 ' OD1' ' HG2' ' C' ' 69' ' ' LYS . 48.7 t-20 -117.53 138.38 51.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.545 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.67 ' HB3' HD11 ' C' ' 47' ' ' ILE . 1.9 tt0 -72.84 -29.53 63.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.295 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.679 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 9.4 ptmt -86.66 11.65 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -76.91 -151.15 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.546 ' O ' HG12 ' C' ' 75' ' ' ILE . 18.0 p -106.92 112.24 25.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.024 -1.047 . . . . 0.0 108.984 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.467 HG23 ' O ' ' C' ' 45' ' ' TYR . 6.8 t -59.39 -16.47 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.491 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.99 -46.49 7.67 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.094 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -66.79 -36.43 82.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.588 HG21 ' CD1' ' C' ' 66' ' ' PHE . 50.6 mm -68.01 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.542 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 13.5 m -70.59 -44.29 67.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -167.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.474 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 5.4 m-20 -69.56 -17.62 63.58 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.951 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 5.7 m-20 -64.56 -49.63 70.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 167.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 81.1 mt -52.33 -32.64 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.291 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -85.07 -36.3 21.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.37 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 56.6 mtmt -57.92 -30.55 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 109.788 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.3 mt -58.8 -27.98 65.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.577 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.708 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 41.77 82.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.895 0.855 . . . . 0.0 110.713 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.93 127.56 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.249 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -81.26 29.42 0.35 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.296 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.49 112.16 0.6 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.425 ' O ' ' HE2' ' C' ' 31' ' ' MET . 91.2 Cg_endo -81.75 -14.16 10.23 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.054 . . . . 0.0 113.278 -174.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -97.19 98.38 9.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' C' ' 58' ' ' VAL . 55.3 mt -125.48 132.68 70.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.5 0.667 . . . . 0.0 112.464 -168.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -90.29 97.37 11.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.127 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.545 HG21 ' HG ' ' C' ' 29' ' ' LEU . 14.1 tt -109.58 96.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 122.646 1.212 . . . . 0.0 107.983 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -152.97 177.32 10.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.263 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.9 OUTLIER -108.27 163.53 13.11 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.882 174.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.479 HG12 ' O ' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.321 -166.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' C' ' 4' ' ' LYS . 91.8 m-20 70.41 -52.1 0.65 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.98 0.912 . . . . 0.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -83.06 22.32 0.97 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' C' ' 2' ' ' ASN . 21.9 ttmm -49.24 -48.41 45.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.999 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.74 25.9 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.004 0.431 . . . . 0.0 111.316 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.57 -82.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.706 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.35 -79.5 0.52 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.394 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 65.09 17.62 11.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.495 ' HA ' ' HE3' ' C' ' 31' ' ' MET . 39.4 mt-30 -85.99 15.66 4.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.352 176.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.432 ' O ' HG22 ' C' ' 13' ' ' ILE . 96.6 mmm -105.27 -144.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.175 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.45 -29.43 58.64 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -41.43 75.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 111.319 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.432 HG22 ' O ' ' C' ' 10' ' ' MET . 0.0 OUTLIER -90.62 -30.02 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.535 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' HD22 ' C' ' 17' ' ' ASN . 77.2 m-20 -72.68 -24.97 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.118 -0.364 . . . . 0.0 110.933 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -57.88 -36.79 72.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.411 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.1 t -68.43 -32.76 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.563 HD22 ' HA ' ' C' ' 14' ' ' ASN . 8.2 m-80 -59.1 -38.4 79.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 109.97 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -70.36 -40.02 74.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.75 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -40.15 80.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.628 0.728 . . . . 0.0 109.734 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' C' ' 27' ' ' LEU . 36.7 mt -67.19 -41.24 86.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.8 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' C' ' 26' ' ' LYS . 28.1 m-80 -80.46 37.13 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.528 0.68 . . . . 0.0 110.603 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' C' ' 20' ' ' LEU . 18.3 pttm -48.25 -42.05 29.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.302 1.441 . . . . 0.0 112.84 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.7 -71.23 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -85.84 -166.83 1.64 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 163.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 45' ' ' TYR . . . 41.54 74.73 0.15 Allowed Glycine 0 CA--C 1.488 -1.601 0 O-C-N 124.272 0.982 . . . . 0.0 114.515 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.807 ' HB2' ' H ' ' C' ' 41' ' ' SER . 5.8 mmpt? -89.14 78.41 7.38 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.974 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.657 ' HB3' HD13 ' C' ' 20' ' ' LEU . 10.8 tp -88.07 105.94 17.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.336 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -101.15 108.08 19.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.579 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.417 HD22 HG21 ' C' ' 91' ' ' ILE . 1.3 mp -112.62 142.63 44.99 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.361 0.601 . . . . 0.0 112.088 -171.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -144.58 129.74 18.62 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.029 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.545 ' CG ' HD23 ' C' ' 36' ' ' LEU . 71.4 mtm -103.49 145.89 29.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -148.34 92.03 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.424 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.28 -93.45 0.29 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.989 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -108.63 15.02 24.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.598 0.199 . . . . 0.0 111.065 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.545 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 28.6 tt0 -134.05 139.28 45.89 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.598 0.713 . . . . 0.0 112.454 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.545 HD23 ' CG ' ' C' ' 31' ' ' MET . 3.2 tm? -128.31 120.68 27.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.689 169.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -132.49 139.59 48.01 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.466 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -151.1 145.91 25.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.846 -171.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 74.8 p -118.86 150.77 39.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 4.1 p -124.32 116.47 22.66 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.315 0.578 . . . . 0.0 111.087 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.807 ' H ' ' HB2' ' C' ' 26' ' ' LYS . 21.6 m -89.5 -178.93 5.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.813 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.02 42.83 15.32 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.822 0.701 . . . . 0.0 109.541 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.96 21.9 12.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.476 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.49 23.44 78.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.456 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.464 ' O ' ' HA2' ' C' ' 25' ' ' GLY . 33.2 m-85 -68.19 158.81 32.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.994 0.397 . . . . 0.0 110.722 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.75 -101.87 0.56 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.311 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' C' ' 68' ' ' GLU . 18.6 mt -107.6 -67.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.525 0.679 . . . . 0.0 110.42 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.7 p -176.16 -68.09 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.37 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -149.35 -32.94 0.21 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.413 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.552 ' O ' HD12 ' C' ' 47' ' ' ILE . 13.8 pt-20 -88.21 178.98 6.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.55 139.94 53.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 28.1 mmmt -115.72 157.35 24.41 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.608 ' OD1' HG13 ' C' ' 94' ' ' ILE . 2.8 t-20 -98.3 105.11 17.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.396 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.601 ' CZ2' HD21 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.06 165.99 10.7 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.187 -172.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.46 159.35 28.25 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.602 -1.285 . . . . 0.0 115.318 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -121.14 128.45 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.773 174.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.1 m-85 -124.04 122.49 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 48.7 t -105.86 111.18 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 60.11 24.88 14.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.084 0.468 . . . . 0.0 110.052 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.14 16.81 58.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.862 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.6 OUTLIER -107.01 128.1 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 0.0 111.357 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -72.12 107.44 4.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 m -95.58 -31.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.365 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -159.35 147.88 17.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 ' O ' ' C' ' 54' ' ' TRP . 71.3 m -140.62 147.78 39.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.79 -173.76 2.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.459 0.572 . . . . 0.0 112.117 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 20.1 m120 -114.37 139.5 49.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.7 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.6 ' HB3' HD11 ' C' ' 47' ' ' ILE . 63.6 tt0 -68.12 -15.83 63.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 14.5 ptmm? -83.66 -5.52 59.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -70.54 159.94 33.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 9.5 p -74.33 112.31 10.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' C' ' 27' ' ' LEU . 2.6 t -58.36 -14.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.71 -170.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.71 -38.96 14.96 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.088 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -72.71 -34.59 67.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.75 -59.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.408 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.432 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 66.5 p -58.12 -58.56 7.92 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.125 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.652 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 15.7 m-20 -67.95 -17.05 64.33 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -67.01 -48.21 69.08 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.499 ' HA ' ' CD1' ' C' ' 82' ' ' LEU . 75.2 mt -56.85 -32.64 39.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.902 174.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 41.7 m-20 -84.06 -22.1 31.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.393 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 67.8 mttm -62.71 -40.95 98.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.3 mt -54.88 -35.43 64.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.224 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.545 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 95.8 m-20 44.08 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 -166.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.82 113.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.475 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -84.45 64.6 8.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.211 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.68 156.96 26.1 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.585 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.487 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.2 Cg_endo -80.49 -55.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.501 2.134 . . . . 0.0 112.531 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.0 p90 -124.05 132.86 53.73 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.509 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 64.7 mt -130.3 132.09 65.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.511 0.672 . . . . 0.0 111.889 -169.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.22 98.18 10.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.603 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 56' ' ' ILE . 7.7 tt -108.25 97.94 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 177.24 9.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.818 -168.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.5 OUTLIER -106.23 163.61 12.67 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.637 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.608 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -165.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.481 0.181 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -143.61 -36.94 0.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.606 ' HA ' ' OE1' ' C' ' 3' ' ' GLN . 5.9 mm-40 -88.28 12.68 13.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.316 0.579 . . . . 0.0 109.843 175.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -48.02 -59.37 3.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.395 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.01 -9.55 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.901 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.54 -171.86 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.441 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.41 -12.5 43.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' C' ' 88' ' ' TYR . 42.7 mt-10 72.07 6.5 5.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.225 0.536 . . . . 0.0 111.294 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' C' ' 31' ' ' MET . 26.0 mt-30 -121.84 19.39 10.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.151 -175.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mtp -72.82 -145.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.3 m-20 -59.9 -16.52 30.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 31.3 t -46.34 -50.78 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.29 0.369 . . . . 0.0 111.317 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.412 HG13 ' H ' ' C' ' 13' ' ' ILE . 2.5 pp -91.27 -21.68 6.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.144 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 5.5 m-20 -63.97 -46.95 82.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.951 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' SER . . . . . 0.657 ' O ' ' HG2' ' C' ' 19' ' ' LYS . 42.6 t -55.42 -41.71 73.14 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.08 -34.5 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.575 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.57 -40.09 95.76 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -72.42 -27.4 62.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.869 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' C' ' 15' ' ' SER . 0.2 OUTLIER -79.82 -34.27 39.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.206 0.526 . . . . 0.0 110.14 -177.338 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 27' ' ' LEU . 93.3 mt -80.21 -38.97 30.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.808 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -79.38 71.64 5.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.43 0.633 . . . . 0.0 109.557 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.491 ' HE3' ' CB ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -113.83 -13.73 12.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.162 -171.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 146.04 -73.21 0.32 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -174.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.491 ' CB ' ' HE3' ' C' ' 22' ' ' LYS . 2.3 mttp -72.17 -159.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' C' ' 47' ' ' ILE . . . -43.1 130.75 5.57 Favored Glycine 0 CA--C 1.512 -0.137 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -173.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.7 ptpt -132.05 142.87 49.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.985 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 20' ' ' LEU . 4.1 mp -117.76 125.34 50.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 42.1 m -94.96 101.26 13.02 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.471 HD22 HD12 ' C' ' 91' ' ' ILE . 15.7 mt -92.44 129.4 38.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.613 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -151.24 144.37 24.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.414 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.416 ' HB2' ' OE1' ' C' ' 9' ' ' GLN . 2.4 mpt? -105.36 146.22 29.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.34 . . . . 0.0 110.319 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -147.86 89.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.229 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.14 -101.43 0.19 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.037 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.81 34.14 2.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.738 0.78 . . . . 0.0 109.305 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -140.9 139.9 34.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.379 0.609 . . . . 0.0 112.048 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -122.22 105.37 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 167.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.58 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 63.2 pttt -106.25 131.68 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 117.67 6.45 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.25 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 69.8 p -102.43 151.28 22.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.086 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.1 p -111.56 119.51 38.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.545 176.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 12.1 t -103.4 177.65 4.78 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.76 33.6 0.19 Allowed 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 124.619 1.199 . . . . 0.0 110.514 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.43 37.08 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.098 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.81 1.3 89.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.305 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -64.01 135.22 56.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.018 0.409 . . . . 0.0 110.359 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -64.39 150.67 50.75 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.777 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.496 HD11 HD11 ' C' ' 27' ' ' LEU . 40.6 mt -57.15 -54.56 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 121.872 0.844 . . . . 0.0 110.952 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 23.3 t -127.37 -173.72 2.98 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.063 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -132.52 13.9 4.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.96 0.886 . . . . 0.0 109.011 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.442 ' HB2' ' HE2' ' C' ' 52' ' ' LYS . 30.8 mt-10 -131.28 161.38 32.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.943 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.43 91.9 6.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 111.293 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 4.8 mptp? -94.37 144.67 25.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.572 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER -89.2 102.02 14.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.656 0.598 . . . . 0.0 110.359 175.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.565 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -105.11 159.28 15.97 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.5 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.484 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -165.17 166.85 38.49 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 118.267 -1.92 . . . . 0.0 116.114 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.484 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.3 mp -120.34 132.31 70.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.509 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 79.7 m-85 -120.84 111.44 17.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -93.76 115.21 32.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.69 34.33 23.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.003 0.43 . . . . 0.0 110.424 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.24 8.9 87.5 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.317 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 37.7 tt0 -107.92 126.96 53.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.281 0.541 . . . . 0.0 110.57 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -72.8 102.03 3.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.849 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.17 -46.57 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.264 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.51 149.43 50.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' C' ' 54' ' ' TRP . 63.7 m -145.33 143.3 30.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -155.57 -174.95 5.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.796 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 11.6 m120 -128.37 140.99 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.869 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' C' ' 48' ' ' SER . 20.5 mt-10 -67.53 -13.16 61.81 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -87.74 -6.17 58.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.021 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -83.69 177.84 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.332 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.486 ' O ' HG12 ' C' ' 75' ' ' ILE . 22.3 p -81.32 112.41 18.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.427 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.7 t -60.56 -14.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.229 -173.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.53 -38.25 12.67 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -73.89 -30.88 62.85 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.486 HG12 ' O ' ' C' ' 71' ' ' THR . 36.4 mm -67.48 -64.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.714 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.624 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 63.0 p -63.45 -58.26 7.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -169.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.537 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 61.6 m-20 -72.73 -16.38 61.66 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -172.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.52 -41.32 97.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' C' ' 76' ' ' SER . 85.6 mt -55.95 -25.44 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.123 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.593 ' N ' HD22 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -83.98 -32.19 25.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.233 -176.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.97 -38.5 76.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.0 -28.81 66.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.386 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 37.43 85.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.354 1.034 . . . . 0.0 111.567 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.473 HG21 HD12 ' C' ' 89' ' ' ILE . 27.3 mm -64.34 143.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.728 -168.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -112.36 25.42 11.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.656 -172.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.433 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -114.33 167.7 12.38 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.187 -172.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.574 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.7 Cg_endo -81.31 -72.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.835 2.357 . . . . 0.0 113.22 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.574 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 10.1 p90 -103.55 113.75 27.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.592 0.711 . . . . 0.0 109.993 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.473 HD12 HG21 ' C' ' 84' ' ' ILE . 19.3 mm -102.74 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.618 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -91.49 98.35 11.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.411 0.624 . . . . 0.0 110.755 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.565 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.0 mt -95.89 104.43 15.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 143.96 19.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 121.388 0.614 . . . . 0.0 111.602 -172.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 24.6 tm0? -66.0 140.41 58.29 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.872 174.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.572 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.76 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.236 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.521 0.677 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -126.93 -15.82 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.473 ' OE1' ' HG2' ' C' ' 8' ' ' GLU . 42.0 mt-30 -90.13 21.12 3.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.962 0.887 . . . . 0.0 109.205 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -84.03 -43.36 15.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.684 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.28 -36.25 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.445 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.67 134.02 34.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.174 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -81.45 23.7 0.61 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.473 ' HG2' ' OE1' ' C' ' 3' ' ' GLN . 54.9 mt-10 75.62 20.64 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.77 18.91 3.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.2 -0.313 . . . . 0.0 111.552 173.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 37.9 mtm -80.14 -144.83 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 110.799 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.8 m-20 -61.45 -17.84 56.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.476 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -52.59 -46.28 66.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.6 pt -89.15 -26.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.81 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 79.2 m-20 -65.62 -37.15 85.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 47.7 t -54.68 -41.52 70.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 57.4 t -66.21 -37.17 79.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.403 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' C' ' 29' ' ' LEU . 33.5 m-80 -67.75 -33.31 74.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.574 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -80.11 -18.7 49.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.671 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -90.61 -38.7 12.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.546 HD13 ' HB3' ' C' ' 27' ' ' LEU . 68.4 mt -80.17 -36.42 35.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.033 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -81.51 74.87 8.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.889 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -111.5 -23.01 10.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.858 -172.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.625 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 165.12 -79.99 0.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.652 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 10.3 mttt -73.81 -159.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.33 141.54 1.15 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 -173.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.4 ptpt -149.95 140.17 22.19 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.057 -167.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' C' ' 20' ' ' LEU . 6.1 tt -108.39 125.48 51.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.393 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 20.8 m -104.16 123.86 48.05 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.456 ' N ' HD12 ' C' ' 29' ' ' LEU . 5.0 mp -94.58 134.16 37.43 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.453 ' HB3' ' HD2' ' C' ' 37' ' ' LYS . 7.0 t -159.59 142.39 13.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.727 170.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 137.98 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.816 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -136.95 89.8 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.767 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.16 -93.31 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.13 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -114.74 31.01 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.175 0.512 . . . . 0.0 110.216 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.513 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 26.7 tt0 -143.98 124.48 13.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -171.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.02 104.93 16.9 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 166.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -100.26 146.74 26.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 118.52 6.78 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.594 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.5 p -99.07 141.47 31.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.916 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 21.7 p -116.93 118.9 33.71 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.069 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CD ' ' C' ' 26' ' ' LYS . 45.0 m -91.97 176.42 6.52 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.246 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.5 m120 72.19 36.12 1.15 Allowed 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.261 0.976 . . . . 0.0 109.424 -169.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.63 35.42 26.08 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.476 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.36 79.87 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.274 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 24.0 m-85 -69.69 -179.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.063 0.459 . . . . 0.0 110.872 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.35 169.9 32.21 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.162 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.889 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 47.3 mm -54.04 -64.46 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 121.816 0.817 . . . . 0.0 110.907 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.8 t -174.9 -155.67 0.06 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.087 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -87.81 -15.99 35.32 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.29 0.567 . . . . 0.0 110.257 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 43.2 mt-10 -83.43 127.79 33.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.438 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.79 139.05 31.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -125.52 158.63 34.04 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.5 ' O ' HG13 ' C' ' 94' ' ' ILE . 3.1 p30 -97.17 103.87 15.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.722 0.772 . . . . 0.0 109.591 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.627 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.18 156.36 17.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.811 -171.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.431 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -139.98 132.8 5.71 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 119.459 -1.353 . . . . 0.0 115.582 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.501 HD12 ' N ' ' C' ' 56' ' ' ILE . 3.0 mp -120.63 126.6 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.069 -0.565 . . . . 0.0 109.487 170.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.74 137.87 47.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.585 HG23 HG11 ' C' ' 63' ' ' VAL . 65.0 t -101.5 117.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 15.5 m120 56.71 30.37 17.47 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.351 0.407 . . . . 0.0 111.243 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 6.96 73.85 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.053 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -107.73 119.91 40.77 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.532 -0.393 . . . . 0.0 110.578 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -57.91 119.06 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.162 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.585 HG11 HG23 ' C' ' 58' ' ' VAL . 4.3 p -119.52 -43.01 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.981 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -137.07 152.39 49.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.627 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.3 m -145.61 148.02 32.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' C' ' 75' ' ' ILE . 45.9 p90 -155.83 172.37 18.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.699 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.62 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.537 ' O ' HG12 ' C' ' 47' ' ' ILE . 4.2 tt0 -52.68 -40.11 62.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.688 -169.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 20.1 pttp -72.91 -0.84 14.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -169.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -71.32 -176.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.405 ' O ' HG12 ' C' ' 75' ' ' ILE . 28.2 p -74.23 108.91 7.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 t -60.57 -11.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.951 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.24 -38.35 8.49 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.0 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -74.17 -28.79 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.447 HG21 ' CD2' ' C' ' 66' ' ' PHE . 50.7 mm -73.77 -64.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.083 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.586 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 8.6 m -60.71 -48.73 80.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.991 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.479 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 75.6 m-20 -75.6 -15.5 60.34 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.1 OUTLIER -59.46 -44.85 92.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 166.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' C' ' 76' ' ' SER . 76.6 mt -56.42 -23.27 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.175 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -87.48 -34.39 18.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.106 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' C' ' 78' ' ' ASP . 57.7 mtmt -55.87 -38.89 70.73 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 1.6 mt -60.14 -29.45 68.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.142 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 0.9 OUTLIER 38.66 86.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.275 -170.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.14 99.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.438 -169.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -64.77 125.84 26.07 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.411 162.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 162.79 158.68 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.911 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.0 Cg_endo -81.15 -62.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.454 2.102 . . . . 0.0 112.585 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.54 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 16.0 p90 -128.37 137.72 52.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.992 0.425 . . . . 0.0 110.166 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.4 mt -122.34 136.45 59.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.97 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -92.2 99.91 12.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.498 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 30.0 mm -113.89 98.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.06 160.73 6.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.36 173.12 12.66 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.831 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.5 HG13 ' O ' ' C' ' 53' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.424 -175.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' C' ' 4' ' ' LYS . 82.1 m-20 -90.38 -39.1 12.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 122.378 -0.201 . . . . 0.0 111.214 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.658 ' CB ' ' HA ' ' C' ' 7' ' ' GLU . 87.4 mt-30 -83.44 19.24 1.6 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.795 0.807 . . . . 0.0 110.084 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' C' ' 2' ' ' ASN . 55.2 tptt -65.42 -56.83 10.32 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.715 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.44 -69.42 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.18 0.514 . . . . 0.0 109.744 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -90.89 96.5 10.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.621 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.658 ' HA ' ' CB ' ' C' ' 3' ' ' GLN . 16.7 tt0 -78.84 -99.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 0.0 109.989 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' C' ' 88' ' ' TYR . 32.7 mt-10 -130.3 14.35 5.6 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.726 0.774 . . . . 0.0 109.785 163.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.99 20.44 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.974 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 54.1 mtt -68.49 -150.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.925 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -60.35 -9.52 3.63 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' SER . . . . . 0.426 ' O ' HG23 ' C' ' 16' ' ' VAL . 15.3 m -48.89 -49.87 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.673 0.389 . . . . 0.0 111.353 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.43 -18.81 7.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.212 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -69.24 -46.16 68.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -56.3 -34.69 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.477 0.656 . . . . 0.0 109.481 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 12' ' ' SER . 93.9 t -69.43 -37.18 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -63.39 -46.7 85.25 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 110.514 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.6 -19.86 65.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.589 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -90.15 -40.22 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.09 0.471 . . . . 0.0 110.378 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.1 mt -83.22 -32.31 26.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.304 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -92.8 79.06 4.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.358 0.599 . . . . 0.0 109.431 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.595 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -114.17 -30.69 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.948 -170.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.488 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 173.1 -73.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.628 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 54.7 mttp -71.25 -158.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.551 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -45.6 142.47 4.18 Favored Glycine 0 CA--C 1.497 -1.085 0 O-C-N 123.357 0.411 . . . . 0.0 113.547 -177.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.9 ptpt -144.35 150.08 37.2 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.834 -165.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' C' ' 38' ' ' ALA . 0.5 OUTLIER -122.84 113.33 19.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.82 -170.128 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 74.0 m -103.03 126.2 50.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HG ' HG21 ' C' ' 91' ' ' ILE . 0.7 OUTLIER -98.98 137.76 37.05 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -171.347 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 29.1 m -147.25 130.85 16.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.511 171.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.505 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.7 mtt -122.68 138.67 54.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.329 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -148.68 91.2 1.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.11 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.26 -93.61 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.706 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -108.81 33.17 4.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 109.774 -177.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.595 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 28.0 tt0 -149.72 139.55 21.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.526 0.679 . . . . 0.0 112.525 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.4 tm? -118.39 127.58 53.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 167.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 23.6 pttm -130.38 105.78 8.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' C' ' 27' ' ' LEU . . . -111.94 128.25 56.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.4 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -103.48 148.75 25.55 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.073 0.463 . . . . 0.0 110.41 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 64.9 p -119.41 138.25 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.338 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 14.7 m -117.35 179.49 4.03 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 80.18 23.41 0.42 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.424 1.078 . . . . 0.0 111.197 -176.063 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.4 50.06 13.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.393 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -3.36 86.72 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.59 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.9 m-85 -66.07 152.88 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.862 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.11 163.18 31.53 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.194 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.595 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 34.3 mm -51.55 -63.24 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.16 0.981 . . . . 0.0 111.169 177.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -156.98 -176.52 6.02 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.492 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.39 45.76 1.48 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.584 0.707 . . . . 0.0 109.792 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -140.85 145.23 35.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.102 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.69 114.28 16.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 12.4 mptt -126.37 129.95 49.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.739 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -89.24 99.19 12.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.945 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.679 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.874 -175.16 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.18 167.27 40.42 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.832 -1.651 . . . . 0.0 115.649 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.521 HG12 HG13 ' C' ' 91' ' ' ILE . 87.1 mt -125.99 128.2 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.582 -0.809 . . . . 0.0 111.697 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.7 m-85 -123.03 111.26 16.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.207 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -104.86 128.05 58.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CE1' ' C' ' 88' ' ' TYR . 77.0 m-20 54.69 24.71 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.817 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 27.7 29.27 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.543 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.9 pt-20 -143.82 151.13 39.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.292 0.546 . . . . 0.0 110.108 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -82.86 137.86 34.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.78 -32.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -161.9 135.83 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.084 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.679 HG23 ' O ' ' C' ' 54' ' ' TRP . 79.3 m -124.07 142.52 51.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' C' ' 75' ' ' ILE . 38.4 p90 -152.72 -178.01 6.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.594 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 13.9 m120 -124.89 130.44 52.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.048 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.486 ' HG2' HG13 ' C' ' 47' ' ' ILE . 31.2 mt-10 -62.89 -22.55 66.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.57 2.04 27.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.443 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -87.01 -179.64 6.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 23.3 p -77.7 118.19 19.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' C' ' 75' ' ' ILE . 2.1 t -64.53 -12.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -81.8 -41.4 9.74 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.122 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -64.61 -34.34 78.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.43 ' O ' HG13 ' C' ' 79' ' ' ILE . 74.2 mt -65.45 -68.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.462 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.587 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 3.4 m -56.42 -56.17 24.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -76.43 -15.08 60.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.88 -39.64 83.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 166.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' C' ' 76' ' ' SER . 71.7 mt -58.94 -25.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.79 173.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' C' ' 37' ' ' LYS . 7.2 m-20 -80.51 -34.16 35.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.61 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -56.53 -38.37 71.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.3 mt -55.81 -35.9 66.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.084 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.595 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 88.8 m-20 37.61 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.94 0.775 . . . . 0.0 110.824 -168.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.42 137.82 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.733 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.3 OUTLIER -94.88 113.89 25.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.086 174.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.61 148.82 6.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.367 -1.397 . . . . 0.0 112.929 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.549 ' HG2' ' CD2' ' C' ' 88' ' ' TYR . 98.2 Cg_endo -80.85 -43.81 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.772 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.549 ' CD2' ' HG2' ' C' ' 87' ' ' PRO . 31.8 p90 -123.68 129.65 51.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.483 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 77.1 mt -123.29 123.72 68.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.505 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -92.25 115.08 27.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.553 HG12 ' CH2' ' C' ' 54' ' ' TRP . 15.5 tt -115.98 103.25 14.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.978 0.894 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 159.26 22.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.567 -172.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.4 OUTLIER -90.81 163.04 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.34 0.59 . . . . 0.0 111.077 176.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.463 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.808 -167.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 1' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' C' ' 4' ' ' LYS . 10.7 t0 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.56 -16.32 2.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.658 0.266 . . . . 0.0 111.155 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.433 ' HB3' ' HG3' ' C' ' 8' ' ' GLU . 2.8 mp0 -64.82 -24.93 67.7 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.522 ' HB2' ' OD1' ' C' ' 1' ' ' ASP . 29.5 ttmt -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.903 174.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.08 -51.55 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.36 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.97 -84.92 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' C' ' 10' ' ' MET . 37.5 mm-40 -50.75 -60.53 2.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -162.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.713 ' HB2' ' NE2' ' C' ' 9' ' ' GLN . 24.3 mt-10 -63.74 -14.7 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.881 0.372 . . . . 0.0 111.925 -172.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.713 ' NE2' ' HB2' ' C' ' 8' ' ' GLU . 16.0 mp0 -122.66 18.3 10.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.58 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.449 ' O ' HG22 ' C' ' 13' ' ' ILE . 91.6 mmm -58.6 163.05 3.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.422 ' HA ' ' ND2' ' C' ' 14' ' ' ASN . 80.3 m-20 -56.87 -21.54 30.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.091 -165.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -52.19 -42.38 63.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.033 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.449 HG22 ' O ' ' C' ' 10' ' ' MET . 0.2 OUTLIER -87.09 -32.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.009 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.726 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 62.8 m-20 -64.7 -43.75 92.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.707 0.289 . . . . 0.0 111.662 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 -22.55 63.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 50.4 t -85.7 -33.07 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.262 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.726 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 82.6 m-20 -57.1 -48.0 79.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.22 -16.31 56.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.856 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -80.46 -42.19 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.01 -36.63 75.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.8 76.12 7.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.721 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.674 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -118.53 7.34 11.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.12 -68.65 0.54 Allowed Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.515 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' C' ' 25' ' ' GLY . 37.7 mttp -82.16 -160.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.578 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.61 137.88 2.34 Favored Glycine 0 CA--C 1.497 -1.06 0 O-C-N 123.846 0.716 . . . . 0.0 114.863 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 11.9 ptpt -147.2 162.1 39.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.767 -168.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.526 HD22 HD13 ' C' ' 29' ' ' LEU . 0.6 OUTLIER -138.92 130.08 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.705 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 16.3 t -106.03 106.13 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.677 ' HG ' HG21 ' C' ' 91' ' ' ILE . 2.2 mm? -92.61 132.14 37.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.241 0.217 . . . . 0.0 111.36 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.402 ' O ' HD22 ' C' ' 36' ' ' LEU . 18.1 m -145.91 129.65 17.15 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.747 172.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 62.1 mtm -129.31 129.17 44.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.051 -174.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.685 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 4.3 t-20 -150.96 107.01 3.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.165 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.8 -97.26 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.502 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 20.1 t-20 -121.38 30.21 6.88 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 2.9 pt20 -126.7 129.65 48.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.325 0.583 . . . . 0.0 111.562 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.722 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.6 tm? -130.76 127.14 38.15 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.618 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -144.04 128.94 18.44 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -145.77 118.73 8.75 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.679 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 48.8 p -102.88 152.05 21.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.716 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' C' ' 72' ' ' VAL . 40.2 t -117.36 118.08 31.27 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 30.7 t -96.98 178.06 5.41 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.88 32.29 0.51 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 124.284 0.99 . . . . 0.0 109.16 -167.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.33 31.66 20.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.214 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.75 80.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.76 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -69.54 168.79 13.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.739 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.37 -175.62 43.37 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.277 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.674 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 15.3 mm -64.63 -61.74 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.2 t -170.11 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.01 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -157.49 -45.83 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -77.24 150.81 35.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.986 0.422 . . . . 0.0 111.06 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -97.82 126.74 43.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.45 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -111.5 157.36 20.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.403 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -96.16 112.69 24.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.547 0.689 . . . . 0.0 110.858 178.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.676 ' HH2' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -103.4 166.56 10.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.351 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.86 150.91 21.16 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.305 -1.426 . . . . 0.0 115.81 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.414 HG23 HD13 ' C' ' 91' ' ' ILE . 49.6 mt -124.55 136.06 61.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.985 169.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.437 ' O ' HG23 ' C' ' 89' ' ' ILE . 3.9 m-85 -131.19 134.46 46.52 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.548 HG23 HG11 ' C' ' 63' ' ' VAL . 85.6 t -102.41 114.96 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.16 31.08 19.41 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.337 0.398 . . . . 0.0 111.333 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.9 5.38 73.89 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.307 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.57 126.01 52.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.047 0.424 . . . . 0.0 110.187 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.42 ' HD3' ' CE2' ' C' ' 57' ' ' PHE . 21.7 tptm -60.01 126.07 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.619 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' C' ' 58' ' ' VAL . 1.7 p -120.36 -37.29 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -148.47 152.73 37.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.596 0.236 . . . . 0.0 110.743 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 54' ' ' TRP . 33.2 m -140.54 146.01 37.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.86 -177.86 6.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.23 0.468 . . . . 0.0 111.399 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.04 135.73 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.598 ' O ' HG12 ' C' ' 47' ' ' ILE . 1.3 tt0 -60.1 -47.16 87.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.805 -173.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.8 -2.89 10.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.6 m -71.01 -174.87 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 4.6 p -77.98 104.19 8.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.566 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 2.9 t -60.36 -12.11 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.898 -173.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.71 -29.12 22.12 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.821 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -81.15 -28.45 35.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.13 -52.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.708 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.641 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.1 p -53.98 -60.79 2.86 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.054 -175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 68.2 m-20 -70.48 -16.98 62.97 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 1.3 m-20 -62.68 -41.15 98.94 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 166.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.5 mt -57.83 -22.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.291 175.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -83.82 -38.99 20.52 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.677 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 18.5 ptmt -62.56 -27.77 69.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.78 -31.67 66.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.55 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.19 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.083 1.489 . . . . 0.0 113.335 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.722 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.6 tp -42.08 145.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.111 -174.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -149.59 18.6 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.613 0.721 . . . . 0.0 109.164 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.85 162.19 14.2 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.768 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' C' ' 8' ' ' GLU . 84.2 Cg_endo -80.27 -35.39 0.65 Allowed 'Trans proline' 0 CA--C 1.518 -0.284 0 C-N-CA 122.652 2.234 . . . . 0.0 111.487 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -158.81 132.36 7.45 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.834 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.65 HD12 HD11 ' C' ' 84' ' ' ILE . 70.1 mt -134.81 139.27 47.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.433 -173.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 23.8 mm-40 -91.2 103.49 16.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.96 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.677 HG21 ' HG ' ' C' ' 29' ' ' LEU . 15.7 mm -100.75 96.23 4.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -158.56 167.75 28.76 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 1.9 pt20 -100.25 162.35 13.01 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.402 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.455 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 -163.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.575 0.226 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' C' ' 4' ' ' LYS . 19.9 m120 -124.55 -31.89 3.19 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.545 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.662 ' HB3' ' HA ' ' C' ' 7' ' ' GLU . 0.8 OUTLIER -83.81 22.99 1.04 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.047 175.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' C' ' 2' ' ' ASN . 25.8 ttpp -54.76 -36.02 64.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.909 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.17 -70.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.231 0.539 . . . . 0.0 110.431 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.26 96.35 10.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.125 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.662 ' HA ' ' HB3' ' C' ' 3' ' ' GLN . 46.1 mt-10 -59.94 -18.16 43.14 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -147.63 -19.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 -167.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -112.79 19.35 17.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.277 -165.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 5.8 mmt -65.04 -171.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -43.31 -36.69 1.94 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.487 0.715 . . . . 0.0 112.841 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 55.2 m -43.04 -54.01 4.54 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.835 0.709 . . . . 0.0 111.918 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -91.12 -19.82 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.549 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.03 -47.78 64.54 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.73 0.3 . . . . 0.0 110.748 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 26.9 p -57.3 -34.45 68.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.79 -37.39 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.58 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.15 -39.29 82.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.169 0.509 . . . . 0.0 109.843 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -78.33 -18.12 55.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.407 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -90.1 -42.58 11.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.676 0.274 . . . . 0.0 110.423 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.08 -32.01 68.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.48 71.07 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -109.21 -40.55 4.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.537 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -175.07 -68.98 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.6 ttmm -97.06 -174.59 3.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 166.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 30.73 89.92 0.01 OUTLIER Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.0 ptpt -128.68 125.34 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.579 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.479 HD22 ' HG ' ' C' ' 29' ' ' LEU . 1.5 tt -107.2 115.42 30.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.232 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 18.3 t -86.16 113.94 22.6 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.479 ' HG ' HD22 ' C' ' 27' ' ' LEU . 0.2 OUTLIER -112.72 123.14 49.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.652 0.263 . . . . 0.0 110.823 -173.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.408 ' O ' HD22 ' C' ' 36' ' ' LEU . 12.5 p -151.43 142.71 23.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.674 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.45 135.44 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.326 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.636 ' OD1' ' HE3' ' C' ' 37' ' ' LYS . 11.9 m120 -139.25 91.68 2.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.564 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.74 -94.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.472 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.25 30.3 7.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.747 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.609 ' OE1' ' HB3' ' C' ' 37' ' ' LYS . 7.3 tt0 -143.64 138.9 29.3 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 2.8 tm? -106.2 106.38 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 164.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.636 ' HE3' ' OD1' ' C' ' 32' ' ' ASN . 22.3 pttp -98.93 151.45 20.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.68 141.57 22.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.396 0.617 . . . . 0.0 112.299 -173.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.4 p -121.44 146.94 46.39 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.903 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 m -127.8 117.12 21.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.4 m -101.94 177.67 4.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.474 -176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' C' ' 24' ' ' LYS . 0.3 OUTLIER 65.75 42.82 3.38 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.219 0.95 . . . . 0.0 108.859 -167.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 63.39 21.5 12.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.266 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.38 24.38 76.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.701 -0.762 . . . . 0.0 113.33 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' VAL . 35.2 m-85 -80.21 -179.01 6.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.83 0.315 . . . . 0.0 111.249 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.17 -162.64 38.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.324 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 6.8 mt -49.59 -67.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 112.118 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.6 p 173.57 -73.7 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.976 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -140.67 -16.08 0.91 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.816 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 4.8 pt-20 -99.43 173.88 6.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.09 121.85 40.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.135 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.407 ' HB2' HD11 ' C' ' 47' ' ' ILE . 8.6 mptt -124.13 135.44 53.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 111.198 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.566 ' OD1' HG13 ' C' ' 94' ' ' ILE . 2.7 t-20 -89.08 116.49 27.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.684 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.559 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.2 163.39 13.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.0 147.22 8.86 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.327 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 91' ' ' ILE . 2.6 mp -107.63 129.84 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.067 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 52.9 m-85 -129.94 122.2 28.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.534 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 4.6 p -108.88 117.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 60.19 28.01 17.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.129 0.49 . . . . 0.0 110.462 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.9 16.46 79.91 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.388 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 30.5 mt-10 -107.06 147.56 29.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.617 0.722 . . . . 0.0 111.064 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.54 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 41.9 tptt -81.77 120.53 25.27 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.037 -169.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.406 ' CG2' HG12 ' C' ' 58' ' ' VAL . 41.2 t -109.71 -70.16 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.923 0.392 . . . . 0.0 110.929 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -137.89 143.66 40.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.909 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.559 HG23 ' O ' ' C' ' 54' ' ' TRP . 67.7 m -136.15 143.21 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.593 ' CD1' HG21 ' C' ' 75' ' ' ILE . 44.3 p90 -159.75 -172.61 3.74 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -116.91 137.39 52.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.85 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.655 ' HB3' HD11 ' C' ' 47' ' ' ILE . 0.7 OUTLIER -71.36 -28.68 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.44 -172.174 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 13.2 ptmm? -93.14 19.22 8.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.844 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 p -76.15 -119.97 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -131.7 107.66 8.95 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 166.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 45' ' ' TYR . 20.7 t -55.96 -24.33 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.043 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.31 -31.34 42.32 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.525 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -72.22 -33.96 67.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.593 HG21 ' CD1' ' C' ' 66' ' ' PHE . 27.5 mm -78.39 -54.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.158 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.659 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 64.3 p -53.61 -52.61 59.29 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.437 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.461 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 71.2 m-20 -77.48 -16.44 58.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -64.35 -37.89 89.09 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' C' ' 76' ' ' SER . 82.4 mt -60.31 -22.27 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.979 173.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -81.31 -34.49 31.88 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.545 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -53.13 -41.97 65.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.1 mt -58.83 -30.32 67.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.821 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.607 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 1.3 m-20 38.21 85.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.153 0.908 . . . . 0.0 111.227 -170.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 17.2 mm -55.06 138.54 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -169.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.27 170.51 9.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.029 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.34 173.34 15.44 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.352 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.3 Cg_endo -80.71 -47.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.487 2.125 . . . . 0.0 112.094 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.444 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 44.1 p90 -150.29 141.54 23.2 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.16 132.67 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.496 . . . . 0.0 111.022 -172.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -91.83 98.71 11.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.558 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 56' ' ' ILE . 13.8 tt -101.13 99.06 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 173.38 17.06 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.348 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -105.5 158.86 16.37 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.934 176.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.566 HG13 ' OD1' ' C' ' 53' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 -166.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 70.13 17.7 7.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.29 0.636 . . . . 0.0 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' C' ' 6' ' ' LEU . 1.6 mp0 -91.92 22.76 4.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.134 0.492 . . . . 0.0 110.193 170.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -65.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.004 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.26 -31.21 16.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.677 0.751 . . . . 0.0 109.883 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.456 HD22 ' O ' ' C' ' 87' ' ' PRO . 42.0 mt -90.78 61.82 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.831 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 9.4 tp10 -65.84 24.95 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.832 1.253 . . . . 0.0 113.865 -171.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -144.62 8.47 1.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.362 -0.836 . . . . 0.0 112.095 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.14 18.22 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.912 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 22.2 mmt -70.4 -162.95 0.06 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.421 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.422 ' H ' ' HB3' ' C' ' 10' ' ' MET . 3.7 m-20 -52.26 -23.34 5.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -49.47 -43.93 45.51 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.148 0.28 . . . . 0.0 110.968 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.44 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 6.7 mt -88.7 -23.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.221 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.04 -49.0 49.65 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.931 -0.48 . . . . 0.0 110.672 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -57.98 -32.54 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.797 0.808 . . . . 0.0 109.429 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' C' ' 13' ' ' ILE . 2.2 t -67.99 -39.29 81.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.915 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' C' ' 29' ' ' LEU . 6.9 m-80 -65.67 -36.44 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -77.3 -20.17 55.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.665 176.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.19 -34.25 61.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.951 0.881 . . . . 0.0 108.886 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' C' ' 26' ' ' LYS . 49.6 mt -78.05 -40.26 39.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.616 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.11 82.58 4.18 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.733 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -5.8 9.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.55 -75.77 0.23 Allowed Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.842 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.6 ttmt -87.36 -156.85 0.36 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.479 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -18.78 106.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.589 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 0.5 OUTLIER -114.08 171.68 7.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.847 -175.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' C' ' 39' ' ' THR . 3.3 tt -156.74 115.47 3.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -173.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 69.3 m -93.9 127.5 39.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' C' ' 91' ' ' ILE . 86.7 mt -97.62 139.01 34.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -176.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.417 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 19.0 m -148.43 128.12 13.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.826 168.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.455 ' HG3' HD23 ' C' ' 36' ' ' LEU . 2.9 mpp? -116.7 133.18 56.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.88 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' C' ' 35' ' ' GLN . 5.2 p-10 -149.0 90.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.234 0.54 . . . . 0.0 111.653 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.24 -93.58 0.04 OUTLIER Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.556 173.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 18.1 t-20 -105.71 32.36 4.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 110.494 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.609 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.1 tt0 -150.18 142.01 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' C' ' 31' ' ' MET . 3.0 tm? -122.93 116.98 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 17.3 pttm -123.47 144.81 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -146.05 167.64 22.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.345 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 68.5 p -139.77 143.45 36.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.447 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 68.1 m -127.72 117.43 21.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.129 0.49 . . . . 0.0 109.688 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.589 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 67.9 m -100.81 179.56 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.7 m120 69.57 45.48 0.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 124.299 0.999 . . . . 0.0 109.026 -164.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.65 23.63 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.81 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' C' ' 71' ' ' THR . . . 69.38 21.69 76.06 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.949 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.75 -178.86 1.01 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.207 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.58 159.5 53.15 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.095 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.733 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 32.5 mm -52.31 -60.04 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-O 121.516 0.674 . . . . 0.0 111.067 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' C' ' 49' ' ' TYR . 45.5 t -135.62 -84.72 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.875 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' C' ' 48' ' ' SER . 34.1 p90 179.59 -22.88 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.589 ' CG ' ' HE3' ' C' ' 52' ' ' LYS . 0.4 OUTLIER -97.8 172.63 7.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.377 0.608 . . . . 0.0 111.373 -178.446 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.81 107.18 19.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.813 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.589 ' HE3' ' CG ' ' C' ' 50' ' ' GLU . 27.0 mmtp -120.57 154.24 35.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.855 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' C' ' 93' ' ' GLN . 0.8 OUTLIER -89.25 101.85 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.917 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.503 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.43 159.76 15.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.724 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -158.09 153.75 24.9 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 118.191 -1.957 . . . . 0.0 116.434 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.413 HD12 ' N ' ' C' ' 56' ' ' ILE . 3.5 mp -120.84 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.172 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' C' ' 62' ' ' LYS . 36.2 m-85 -126.8 156.34 41.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.2 113.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 110.053 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 54.42 39.39 30.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.535 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.78 -3.62 86.01 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.336 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 148.14 28.99 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' C' ' 57' ' ' PHE . 53.5 mtpt -91.74 137.93 31.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.991 0.424 . . . . 0.0 110.813 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.93 -50.77 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.077 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -150.49 152.34 34.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.484 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 89.2 m -128.07 126.87 42.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.543 ' CG ' HG21 ' C' ' 75' ' ' ILE . 11.5 p90 -133.18 178.49 6.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.031 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 28.6 m-80 -121.77 142.04 50.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.691 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.695 ' HG2' HG21 ' C' ' 47' ' ' ILE . 5.4 mt-10 -65.24 -10.8 34.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.34 -2.52 52.01 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.26 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -88.29 157.72 18.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' C' ' 44' ' ' GLY . 30.9 p -76.72 113.07 13.97 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -16.22 7.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.185 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.62 -36.32 38.2 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.953 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -77.07 -31.06 55.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.543 HG21 ' CG ' ' C' ' 66' ' ' PHE . 49.5 mm -75.16 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.26 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.635 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 96.6 p -58.76 -50.71 72.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -171.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.51 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 65.4 m-20 -79.33 -17.34 54.73 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -172.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -34.47 74.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.606 167.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' C' ' 76' ' ' SER . 91.6 mt -61.1 -20.83 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.978 173.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.9 OUTLIER -76.01 -43.48 44.02 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.875 179.104 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -51.87 -38.06 54.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.525 0.679 . . . . 0.0 109.512 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.6 mt -55.96 -33.1 64.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.885 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.609 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 38.0 79.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.928 0.768 . . . . 0.0 111.201 -172.108 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.07 136.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.403 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 1.4 ptpt -81.96 39.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.677 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.65 128.15 9.48 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.027 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.456 ' O ' HD22 ' C' ' 6' ' ' LEU . 97.7 Cg_endo -80.39 -40.31 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.263 1.975 . . . . 0.0 110.851 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.78 97.85 5.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -103.45 124.4 57.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.531 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.78 100.75 9.18 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.026 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' C' ' 29' ' ' LEU . 4.5 mt -95.19 98.63 8.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.12 149.55 24.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.193 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 53' ' ' ASN . 9.1 tt0 -73.8 144.41 45.57 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.641 -176.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.465 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.599 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 1' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' C' ' 4' ' ' LYS . 18.0 t0 . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -138.84 -17.71 1.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.0 -8.45 56.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.117 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.467 ' HB2' ' OD1' ' C' ' 1' ' ' ASP . 15.7 ttmm -57.7 -39.03 76.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.51 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.45 -11.6 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.971 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.39 -153.67 0.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.777 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.685 ' HB3' ' NE2' ' C' ' 9' ' ' GLN . 3.4 mp0 -91.99 -13.8 30.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 5.3 mm-40 72.34 -5.73 1.72 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.42 0.688 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' C' ' 7' ' ' GLU . 11.1 mt-30 -87.6 16.61 5.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.46 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.447 ' O ' HG13 ' C' ' 13' ' ' ILE . 1.5 mpt? -82.95 -143.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' C' ' 10' ' ' MET . 33.1 m-80 -53.44 -18.93 3.03 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -174.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 12' ' ' SER . . . . . 0.494 ' O ' HG23 ' C' ' 16' ' ' VAL . 68.9 m -54.44 -33.24 59.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.503 HG21 ' SD ' ' C' ' 31' ' ' MET . 2.4 pp -89.55 -27.79 5.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.987 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -73.31 -43.65 60.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.689 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -58.25 -33.46 69.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.348 0.594 . . . . 0.0 109.448 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.634 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 76.3 t -74.13 -34.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.252 175.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.506 HD21 ' HB2' ' C' ' 29' ' ' LEU . 7.7 m-80 -58.99 -40.29 84.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -75.39 -15.85 60.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.358 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -87.93 -31.58 19.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.487 0.66 . . . . 0.0 109.578 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' C' ' 27' ' ' LEU . 79.4 mt -82.94 -39.87 20.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.559 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -77.14 64.41 2.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 109.597 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -103.58 7.95 37.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.211 -172.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.42 -61.87 0.64 Allowed Glycine 0 CA--C 1.504 -0.613 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.73 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 26.9 mmmt -79.28 -159.47 0.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.105 175.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -48.71 143.38 8.01 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 121.568 -0.349 . . . . 0.0 113.652 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.73 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 5.8 ptpt -150.44 135.8 17.97 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.455 -164.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.703 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.6 mp -92.04 126.92 37.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.881 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 23.8 m -95.65 99.5 11.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.52 HD13 HG23 ' C' ' 91' ' ' ILE . 16.2 mt -82.58 126.2 32.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 46.9 t -146.4 129.19 16.25 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.613 ' SD ' ' HG2' ' C' ' 9' ' ' GLN . 0.5 OUTLIER -113.25 124.04 51.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.47 91.08 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.56 -99.43 0.25 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.115 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.88 13.28 29.29 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.947 0.374 . . . . 0.0 111.147 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.6 tt0 -136.77 147.26 46.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.617 0.722 . . . . 0.0 112.189 -170.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.578 HD21 HD12 ' C' ' 91' ' ' ILE . 9.6 tp -130.78 113.56 14.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.885 171.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 19.7 pttp -122.9 104.53 9.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -112.37 118.9 36.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.159 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 42.1 p -97.09 148.06 23.4 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.271 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 67.1 p -109.66 119.46 39.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.487 -175.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.455 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 18.4 t -95.19 175.62 6.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.424 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 4.4 m-20 63.21 31.39 15.6 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.679 0.612 . . . . 0.0 110.32 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.96 10.54 7.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.789 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.1 24.76 28.56 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.167 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 52.5 m-85 -72.43 -179.24 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.578 0.689 . . . . 0.0 110.31 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.46 -157.62 29.73 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.332 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.591 ' H ' ' HA ' ' C' ' 69' ' ' LYS . 75.7 mt -49.9 -65.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 C-N-CA 123.265 0.626 . . . . 0.0 111.125 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 27.5 t 173.25 -72.68 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.898 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -140.95 -32.51 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.71 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.517 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.7 pt-20 -85.07 177.6 7.85 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.183 -0.323 . . . . 0.0 110.754 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 27.8 t70 -123.78 141.95 51.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 32.6 mmtm -124.02 153.15 41.74 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.759 173.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.4 OUTLIER -98.88 112.6 24.65 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.454 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.602 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -102.53 162.08 13.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.691 -173.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.99 150.51 21.13 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.653 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.516 HD11 HD13 ' C' ' 79' ' ' ILE . 46.5 mt -120.21 135.23 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 170.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.447 ' CE1' ' HG2' ' C' ' 62' ' ' LYS . 58.0 m-85 -133.07 148.88 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.643 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.6 p -143.56 129.98 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.38 27.96 12.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.132 0.491 . . . . 0.0 111.171 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 1.35 81.39 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.829 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 11.6 pt-20 -112.57 157.33 21.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.642 0.721 . . . . 0.0 110.426 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.447 ' HG2' ' CE1' ' C' ' 57' ' ' PHE . 60.4 mtpt -76.85 131.65 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.68 -49.61 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.346 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' C' ' 56' ' ' ILE . 62.3 t80 -157.0 161.79 39.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.823 -172.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -145.85 159.72 42.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.1 p90 -168.72 -178.41 3.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.0 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -119.89 121.97 40.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.712 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' C' ' 47' ' ' ILE . 43.6 tp10 -61.0 -22.73 64.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' C' ' 47' ' ' ILE . 22.8 ptmt -85.22 4.89 32.6 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.906 -0.496 . . . . 0.0 111.77 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -75.29 -118.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.438 ' O ' HG12 ' C' ' 75' ' ' ILE . 1.5 p -131.22 108.07 9.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 169.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.485 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 48.0 t -56.72 -22.23 15.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.667 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.8 -39.17 25.42 Favored Glycine 0 CA--C 1.504 -0.644 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.417 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -68.68 -40.42 80.11 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' C' ' 66' ' ' PHE . 48.3 mm -64.79 -63.62 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.562 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 50.4 m -53.64 -63.72 1.06 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -169.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.574 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.7 m-20 -70.09 -16.78 63.18 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.466 -0.893 . . . . 0.0 113.289 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 35.8 m-20 -73.75 -37.0 65.2 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.6 168.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' C' ' 76' ' ' SER . 89.4 mt -60.09 -32.59 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.743 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 32.0 m-20 -85.38 -34.39 21.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.052 -172.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 56.4 pttt -57.81 -26.99 62.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 16.4 mt -61.32 -25.73 67.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.767 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.695 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 40.12 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.898 0.856 . . . . 0.0 111.949 -172.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' C' ' 84' ' ' ILE . 37.6 mm -71.2 113.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.648 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.485 ' H ' ' HE3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -93.21 119.63 32.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.128 174.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.47 147.99 6.58 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.65 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.46 -37.45 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.285 1.99 . . . . 0.0 111.825 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.3 98.87 6.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -99.76 125.86 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.553 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -122.82 123.64 41.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.862 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.602 HG12 ' CH2' ' C' ' 54' ' ' TRP . 20.1 tt -129.43 99.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 151.56 25.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.447 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -85.65 163.89 18.02 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.946 176.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.48 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.332 -164.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.443 0.164 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 64.34 18.92 11.58 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.143 0.577 . . . . 0.0 111.972 177.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -69.42 -34.48 74.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -64.28 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.698 176.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.37 -68.95 0.76 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.309 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' C' ' 10' ' ' MET . 9.0 mp -92.34 -75.71 0.48 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.602 -174.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.451 ' O ' ' HE2' ' C' ' 10' ' ' MET . 44.7 mm-40 -33.92 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -161.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' C' ' 88' ' ' TYR . 13.5 mp0 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.008 0.432 . . . . 0.0 111.862 -174.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -83.86 15.06 3.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.201 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' C' ' 6' ' ' LEU . 61.0 mtm -87.81 -144.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 176.135 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 18.5 m120 -61.67 -9.02 5.28 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.4 m -49.77 -44.9 49.09 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.13 0.269 . . . . 0.0 110.634 175.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 21.5 pt -90.85 -24.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.163 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 2.2 m-20 -64.97 -36.34 84.1 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.921 0.391 . . . . 0.0 110.119 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 37.1 t -55.37 -35.91 65.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.532 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 76.1 t -71.29 -37.53 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.181 174.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' C' ' 28' ' ' SER . 33.4 m-80 -65.88 -47.08 76.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.765 -177.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -68.68 -17.17 64.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.324 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -90.33 -38.2 13.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.266 0.555 . . . . 0.0 110.466 -176.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 55.9 mt -86.57 -26.92 24.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -80.32 84.63 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -120.7 -40.43 2.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.411 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . 174.89 -68.95 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -172.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.701 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 45.9 mttp -76.09 -159.03 0.1 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.79 130.49 1.86 Allowed Glycine 0 CA--C 1.501 -0.787 0 O-C-N 123.898 0.749 . . . . 0.0 114.398 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.701 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.9 OUTLIER -134.63 143.4 47.28 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.721 -173.304 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 32.4 tp -117.39 123.44 46.44 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.032 0.444 . . . . 0.0 111.156 -174.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 44.3 m -100.53 104.28 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.152 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.76 133.16 35.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -145.15 131.68 19.8 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.931 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 79.7 mtp -115.54 134.86 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.854 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.592 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 17.9 m120 -134.58 89.49 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.508 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.63 -93.23 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.566 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.9 OUTLIER -108.92 29.58 7.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.556 0.217 . . . . 0.0 110.959 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.521 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 8.0 tt0 -143.88 140.7 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.536 0.684 . . . . 0.0 111.934 -168.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.3 tm? -118.92 118.98 33.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 171.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.592 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 44.8 pttt -129.18 104.56 7.61 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -118.16 119.4 34.6 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 67.8 p -98.01 145.14 26.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.145 0.498 . . . . 0.0 111.193 -174.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 16.6 p -109.61 119.14 38.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.373 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 16.3 t -95.34 -170.39 2.16 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.04 18.54 0.48 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.448 1.093 . . . . 0.0 110.593 -170.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.24 34.21 23.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.673 173.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.13 -18.24 46.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.178 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -57.79 140.15 52.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.311 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' C' ' 24' ' ' LYS . . . -79.51 156.06 40.45 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.709 -174.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.57 ' HB ' ' HG2' ' C' ' 68' ' ' GLU . 70.2 mt -56.08 -53.32 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.533 0.683 . . . . 0.0 112.104 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.611 ' HB2' ' OE2' ' C' ' 68' ' ' GLU . 31.2 t -116.61 176.93 4.89 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.912 -169.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -119.61 3.85 11.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.68 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' C' ' 52' ' ' LYS . 27.6 mt-10 -125.3 171.24 10.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.442 176.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.58 96.27 10.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.164 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.486 ' HD3' ' HB2' ' C' ' 50' ' ' GLU . 17.9 mmmt -98.98 158.98 15.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.793 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -101.18 110.86 22.93 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.491 -176.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.2 OUTLIER -114.47 165.06 13.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -168.687 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.45 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -174.12 165.86 37.67 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 119.174 -1.488 . . . . 0.0 115.741 172.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.45 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.0 mp -116.19 134.1 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.983 176.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 82.3 m-85 -121.06 142.06 50.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 178.061 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -134.34 124.4 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.16 27.36 14.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.66 35.66 31.54 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.235 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 9.5 pt-20 -140.83 153.02 45.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -81.69 130.76 35.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 111.348 -177.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.426 ' CG2' HG12 ' C' ' 58' ' ' VAL . 53.7 t -105.89 -51.87 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.63 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -141.75 147.54 37.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.643 -176.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 2.3 t -131.89 158.12 42.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 54.8 p90 -167.82 -174.63 2.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.524 0.678 . . . . 0.0 112.725 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.04 140.22 49.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.743 -177.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.611 ' OE2' ' HB2' ' C' ' 48' ' ' SER . 19.8 tt0 -79.13 -6.83 57.44 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -168.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.0 ptmt -104.18 6.51 35.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.996 -0.44 . . . . 0.0 111.396 -177.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 39.4 p -81.84 -163.57 0.67 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.48 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 20.0 p -93.54 106.94 18.86 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.53 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.2 t -59.68 -15.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.335 -169.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 -35.66 14.68 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.071 -178.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.28 -35.97 76.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' C' ' 78' ' ' ASP . 46.2 mm -70.96 -63.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.388 -178.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.0 m -58.15 -46.61 85.38 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.992 -170.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.573 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 32.9 m-80 -72.89 -14.72 61.54 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.621 -0.832 . . . . 0.0 112.966 -177.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.512 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 51.6 m-20 -56.44 -51.76 67.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 165.069 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' C' ' 76' ' ' SER . 67.5 mt -54.25 -33.41 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.754 176.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 38.9 m-20 -87.8 -37.71 16.34 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.814 -169.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.499 ' CE ' ' HA ' ' C' ' 78' ' ' ASP . 51.2 mtmt -56.39 -28.61 59.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.285 0.564 . . . . 0.0 109.781 176.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.5 mt -59.14 -28.06 66.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.779 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.521 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 96.4 m-20 39.79 75.82 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.717 0.77 . . . . 0.0 110.42 -170.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.417 HG22 ' H ' ' C' ' 86' ' ' GLY . 25.2 mt -74.2 131.27 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.495 -171.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 2.3 ptpt -83.84 29.59 0.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.292 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.417 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -76.12 142.48 28.48 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.459 -175.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.62 -39.79 0.22 Allowed 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.743 2.296 . . . . 0.0 111.377 176.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 34.8 p90 -144.45 123.54 12.87 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.744 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.63 128.72 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.755 -175.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.16 110.42 22.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.269 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.586 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.5 mt -99.87 103.66 15.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.2 154.53 25.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.269 -172.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.23 162.29 19.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.435 0.636 . . . . 0.0 111.693 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.417 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.659 -170.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 1' ' ' ASP . . . . . 0.411 ' HA ' ' SD ' ' C' ' 10' ' ' MET . 1.2 m-20 . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -98.44 -23.14 15.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.952 0.406 . . . . 0.0 110.138 177.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -90.72 18.44 6.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.698 0.761 . . . . 0.0 109.948 172.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.83 -60.42 2.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.855 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.46 -6.05 56.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.32 -99.27 0.11 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -178.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.28 -97.63 0.25 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' C' ' 10' ' ' MET . 3.2 mt-10 175.21 19.5 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -72.33 17.24 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.959 -0.463 . . . . 0.0 112.011 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.415 ' H ' ' C ' ' C' ' 8' ' ' GLU . 40.3 mtm -98.04 -141.45 0.3 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.603 -177.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -47.44 -26.92 1.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -175.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -47.8 -46.34 30.49 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.27 0.356 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -90.67 -22.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.268 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.83 -51.48 40.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.259 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 17.7 t -58.37 -32.69 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.521 0.677 . . . . 0.0 109.639 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 60.0 t -71.39 -34.47 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.064 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -62.74 -37.33 86.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.163 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.22 -30.98 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.571 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -78.21 -33.39 49.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.73 0.776 . . . . 0.0 109.803 -176.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.647 HD13 ' HG ' ' C' ' 27' ' ' LEU . 90.2 mt -80.91 -40.38 24.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.241 -176.364 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -81.77 67.02 7.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.43 0.633 . . . . 0.0 109.831 177.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -100.95 -17.26 16.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.469 -174.863 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.78 -64.56 0.36 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.306 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 24.3 mmmt -84.02 -157.48 0.27 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -38.82 131.32 1.83 Allowed Glycine 0 CA--C 1.503 -0.697 0 O-C-N 124.048 0.843 . . . . 0.0 115.158 -175.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.764 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.3 OUTLIER -143.15 144.44 32.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.144 -1.028 . . . . 0.0 110.061 -172.411 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.647 ' HG ' HD13 ' C' ' 20' ' ' LEU . 1.4 pt? -123.82 112.64 17.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.681 175.087 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.784 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.2 m -82.61 104.2 12.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.974 -176.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.55 HD13 HG23 ' C' ' 91' ' ' ILE . 13.3 mt -79.78 122.29 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.369 -170.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.464 ' O ' HD22 ' C' ' 36' ' ' LEU . 5.8 m -129.69 128.51 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.167 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.457 ' HG2' HD23 ' C' ' 36' ' ' LEU . 53.8 mtt -132.24 116.83 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.249 -176.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 46.7 t30 -150.75 96.96 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.606 0.241 . . . . 0.0 111.32 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 33' ' ' GLY . . . . . 0.431 ' O ' HG22 ' C' ' 84' ' ' ILE . . . 67.15 -92.69 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.682 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -101.22 -20.83 15.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.593 0.711 . . . . 0.0 109.912 -176.657 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 17.4 pt20 -88.68 127.85 35.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.692 0.758 . . . . 0.0 111.899 -171.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.598 HD23 HG13 ' C' ' 84' ' ' ILE . 1.6 tm? -131.27 117.69 19.33 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 47.5 pttt -144.64 106.28 4.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.784 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.04 129.0 46.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 3.9 m -95.87 129.84 42.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.651 0.738 . . . . 0.0 110.198 -176.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 61.7 p -107.26 118.68 37.34 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.68 -176.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 m -121.61 179.14 4.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.757 -175.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.441 ' HB2' ' CE ' ' C' ' 26' ' ' LYS . 0.8 OUTLIER 66.57 42.17 2.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.276 0.985 . . . . 0.0 109.439 -169.977 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.19 27.47 17.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.98 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.75 19.07 72.91 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.589 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 36.1 m-85 -70.98 -178.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.204 0.502 . . . . 0.0 110.857 176.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.1 -154.67 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.848 -177.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.675 HD12 ' O ' ' C' ' 50' ' ' GLU . 32.2 mt -50.19 -67.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 C-N-CA 123.56 0.744 . . . . 0.0 112.729 -177.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 23.3 t 173.06 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 124.655 1.222 . . . . 0.0 109.656 -175.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -156.07 49.32 0.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.138 0.494 . . . . 0.0 110.633 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.9 pt-20 -169.05 -178.68 3.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' HD3' ' C' ' 69' ' ' LYS . 8.7 p-10 -128.8 126.51 40.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.72 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.5 mmmt -104.69 157.59 17.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.9 OUTLIER -98.18 101.45 12.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.018 177.144 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.625 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -97.28 166.89 11.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.379 -174.761 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.1 166.68 39.88 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 118.535 -1.793 . . . . 0.0 116.484 176.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.402 HG12 HG13 ' C' ' 91' ' ' ILE . 19.2 mt -128.6 139.56 51.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 113.799 -1.201 . . . . 0.0 109.747 175.02 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 40.6 m-85 -134.02 113.51 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.432 -176.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' C' ' 63' ' ' VAL . 41.1 t -80.96 105.59 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.541 ' HA ' ' CE2' ' C' ' 88' ' ' TYR . 2.3 m-20 62.82 28.66 16.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 110.481 -176.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.08 67.98 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.4 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.4 tt0 -107.68 123.56 48.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.487 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 86.9 tttt -61.9 103.28 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.372 0.606 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.467 ' CG1' HG23 ' C' ' 58' ' ' VAL . 0.9 OUTLIER -97.29 -53.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 177.981 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -130.46 149.14 52.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.625 HG23 ' O ' ' C' ' 54' ' ' TRP . 80.0 m -149.66 138.22 20.82 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -150.9 -175.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.644 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -116.93 134.27 54.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.449 ' C ' HG13 ' C' ' 47' ' ' ILE . 27.7 tt0 -66.91 -13.58 61.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.423 -171.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.7 ptmm? -84.23 -17.59 39.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.736 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -62.07 154.9 25.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -64.82 111.44 2.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.271 -172.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.38 -15.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.912 -173.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.67 -39.08 14.88 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 120.052 -1.07 . . . . 0.0 111.432 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.05 -36.36 72.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.129 0.49 . . . . 0.0 109.697 177.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.53 -56.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.531 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 80.7 p -57.57 -58.81 6.69 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -171.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.628 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.4 m-20 -68.23 -19.1 64.71 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.201 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 0.9 OUTLIER -74.73 -36.19 62.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.846 169.495 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' C' ' 76' ' ' SER . 58.9 mt -59.59 -31.86 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.81 0.814 . . . . 0.0 109.381 170.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 31.8 m-20 -81.78 -35.1 29.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.919 -172.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 16.0 ptpt -59.97 -31.08 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.9 mt -56.12 -31.47 63.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.224 177.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.19 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.543 1.152 . . . . 0.0 113.189 -173.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.598 HG13 HD23 ' C' ' 36' ' ' LEU . 9.5 mm -35.57 141.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.602 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -143.78 7.93 1.47 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.99 -178.678 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.54 -175.61 20.07 Favored Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 118.997 -1.573 . . . . 0.0 111.988 -173.134 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.52 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 84.3 Cg_endo -81.01 -87.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.493 2.129 . . . . 0.0 111.836 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' C' ' 59' ' ' ASN . 25.1 p90 -108.23 110.88 22.6 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.623 0.725 . . . . 0.0 110.284 178.348 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.09 126.53 74.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.85 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.68 141.36 28.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 -174.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.55 HG23 HD13 ' C' ' 29' ' ' LEU . 12.0 tt -136.07 99.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.322 1.058 . . . . 0.0 108.37 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 164.52 9.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.114 -171.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 4.3 pp0? -96.66 161.2 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.928 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.986 -164.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -110.07 -20.18 12.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.282 0.563 . . . . 0.0 110.265 -177.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.534 ' HB3' ' H ' ' C' ' 8' ' ' GLU . 0.0 OUTLIER -84.38 7.2 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.308 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.546 ' HA ' ' CD2' ' C' ' 88' ' ' TYR . 83.4 tttt -62.37 -53.1 59.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.451 -173.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.44 ' HB3' HD22 ' C' ' 6' ' ' LEU . . . -94.4 -38.9 10.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.364 173.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' C' ' 10' ' ' MET . 2.6 mm? -92.08 -94.24 0.14 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -168.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.27 -59.27 3.56 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -159.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' C' ' 3' ' ' GLN . 21.6 mm-40 -60.11 -26.15 66.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.32 8.68 42.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.837 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' C' ' 6' ' ' LEU . 25.5 mmt -105.64 -142.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.81 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.79 -25.74 30.12 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -177.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -55.0 -50.06 69.93 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.493 HG22 ' O ' ' C' ' 10' ' ' MET . 4.9 tt -73.71 -36.18 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 77.5 m-20 -72.15 -36.14 69.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.596 -177.115 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -57.69 -39.41 77.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 72.7 t -66.57 -33.95 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 174.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 88.4 m-20 -59.63 -44.9 93.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.834 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.28 -17.02 61.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.566 179.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' C' ' 16' ' ' VAL . 23.3 tptm -87.12 -36.27 18.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.954 -177.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 14.9 mt -82.44 -26.03 33.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.139 -177.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -81.14 61.21 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' C' ' 25' ' ' GLY . 0.0 OUTLIER -91.75 -40.87 11.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.341 -166.683 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . -169.76 -95.67 0.1 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' C' ' 48' ' ' SER . 29.6 ttmt -91.62 145.21 24.78 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.06 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.504 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 63.85 127.55 0.01 OUTLIER Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.524 -170.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.8 ptpt -151.14 140.45 21.36 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 121.962 -0.728 . . . . 0.0 112.187 177.335 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.468 ' N ' HD12 ' C' ' 27' ' ' LEU . 2.5 mp -117.76 124.02 47.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.136 -176.259 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 6.1 t -97.63 98.86 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 52.7 mt -80.53 136.05 36.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.068 0.461 . . . . 0.0 111.667 -173.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -141.91 128.91 20.75 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.945 171.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.453 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 51.2 mtt -118.31 114.72 23.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.826 -176.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -132.92 90.64 2.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.218 -174.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.86 -104.09 0.41 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.337 175.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.45 34.26 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 109.519 -177.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.428 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 33.4 tt0 -148.65 133.4 17.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.481 0.657 . . . . 0.0 112.656 -178.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.453 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 0.6 OUTLIER -112.89 123.23 49.83 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 165.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -137.0 140.33 42.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.94 132.5 14.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.676 -177.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -96.88 134.34 40.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 10.6 p -109.52 119.7 40.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.593 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.412 ' HB2' ' CG ' ' C' ' 26' ' ' LYS . 16.0 m -106.55 -178.71 3.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.405 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 77.34 27.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 124.439 1.087 . . . . 0.0 109.832 -174.453 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.27 31.97 17.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.583 174.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.06 -19.69 33.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.154 175.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -56.11 130.71 45.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.542 0.171 . . . . 0.0 110.944 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.92 -45.64 0.81 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 -174.108 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.2 OUTLIER -47.91 -46.03 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -159.824 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' C' ' 24' ' ' LYS . 73.7 m 75.92 -60.57 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.994 0.809 . . . . 0.0 110.927 -169.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -162.72 -46.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.136 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -139.79 -172.67 3.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.359 0.6 . . . . 0.0 112.134 -172.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.576 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 3.8 t70 -82.06 102.15 10.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.542 -177.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.3 28.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.851 176.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.78 106.55 18.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.69 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.67 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -95.86 158.74 15.31 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.004 -174.837 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.84 145.28 12.66 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.397 -1.382 . . . . 0.0 114.684 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.49 HG23 HG12 ' C' ' 91' ' ' ILE . 45.2 mt -130.73 132.27 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 173.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.38 160.54 30.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.2 p -144.55 126.66 10.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' C' ' 88' ' ' TYR . 88.3 m-20 57.65 28.89 16.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 111.123 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.94 -3.31 84.66 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.62 177.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.0 pt-20 -107.64 149.91 27.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.515 0.658 . . . . 0.0 109.841 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -81.43 124.84 29.76 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.0 110.329 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 -52.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -138.35 155.56 48.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.151 -173.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.67 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.3 m -150.85 139.24 20.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.676 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' C' ' 75' ' ' ILE . 50.1 p90 -152.8 -170.37 3.61 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.486 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -134.19 157.72 45.53 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.084 0.24 . . . . 0.0 110.7 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' C' ' 47' ' ' ILE . 0.5 OUTLIER -59.3 -45.47 91.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.176 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -53.51 -38.69 63.97 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.8 p -68.86 122.42 18.59 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.42 ' O ' HG12 ' C' ' 75' ' ' ILE . 41.7 p -54.75 126.39 23.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.518 0.675 . . . . 0.0 111.047 -166.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -20.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.043 -175.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.5 -37.59 30.67 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.861 -176.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -75.22 -34.8 61.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.477 HG21 ' CD1' ' C' ' 66' ' ' PHE . 47.3 mm -70.84 -65.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.424 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.5 m -58.66 -52.4 65.85 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.446 -170.343 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' C' ' 81' ' ' LYS . 3.0 m-20 -74.34 -17.85 60.77 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.991 -172.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' C' ' 81' ' ' LYS . 13.0 m-20 -66.52 -48.05 70.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' C' ' 76' ' ' SER . 95.7 mt -52.89 -33.0 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.434 174.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.477 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 67.5 m-20 -84.45 -32.32 24.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.37 -173.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 58.2 mtmt -60.51 -29.4 69.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.6 mt -60.38 -26.54 66.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.555 178.478 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.428 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 91.5 m-20 39.41 78.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.889 0.743 . . . . 0.0 110.742 -171.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.503 HG22 ' H ' ' C' ' 86' ' ' GLY . 8.9 mt -57.99 145.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.946 -172.331 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.59 20.0 6.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.401 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 86' ' ' GLY . . . . . 0.503 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -85.77 141.03 18.43 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.955 -176.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -79.81 -45.16 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.895 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' C' ' 4' ' ' LYS . 32.1 p90 -131.06 123.57 28.97 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.439 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.2 mp -112.8 136.93 47.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -99.51 98.73 9.58 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.976 0.417 . . . . 0.0 109.971 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.49 HG12 HG23 ' C' ' 56' ' ' ILE . 10.1 mt -113.83 101.46 12.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.057 -178.137 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.02 147.99 4.88 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.502 ' H ' ' HG2' ' C' ' 93' ' ' GLN . 2.9 pt20 -75.14 157.41 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.358 0.599 . . . . 0.0 111.426 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.475 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.935 -163.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' C' C ' 2' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' C' ' 3' ' ' GLN . 8.5 p30 -151.22 -14.95 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.115 0.483 . . . . 0.0 110.538 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.491 ' HA ' ' HB2' ' C' ' 6' ' ' LEU . 50.1 mt-30 -81.02 8.25 8.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.384 176.079 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -63.04 -44.44 95.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.753 177.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.44 -28.75 18.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.165 0.507 . . . . 0.0 110.988 177.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' C' ' 3' ' ' GLN . 54.3 mt -77.75 142.65 38.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.737 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -77.7 22.52 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -171.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -84.71 -40.0 17.86 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' C' ' 31' ' ' MET . 27.9 mm-40 -110.94 15.65 21.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.405 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 33.8 mmt -90.07 -153.69 0.3 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -176.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 11' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 88.9 m-20 -51.1 -28.19 10.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.866 0.467 . . . . 0.0 112.074 -175.127 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 25.0 m -47.69 -52.13 19.39 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.685 0.616 . . . . 0.0 111.604 177.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 19.5 pt -91.89 -23.45 5.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.798 179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.512 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 87.0 m-20 -69.73 -40.53 76.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -174.004 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 108.86 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 71.7 t -70.26 -40.26 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.22 173.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 17' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 85.3 m-20 -61.91 -47.95 82.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.497 -176.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.38 -16.58 62.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.541 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -88.82 -38.45 14.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.076 -177.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 24.8 mt -80.81 -33.04 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.139 -176.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -80.85 62.41 4.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -90.81 -24.02 20.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -174.247 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.97 -77.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.328 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.557 ' HA ' ' OD1' ' C' ' 42' ' ' ASN . 1.0 OUTLIER -83.75 92.62 7.77 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.351 0.595 . . . . 0.0 109.604 177.011 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.7 139.74 8.22 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.404 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.1 ptpt -152.65 136.02 15.88 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.662 -177.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' C' ' 20' ' ' LEU . 3.8 mp -113.56 122.54 47.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.762 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.5 t -105.33 111.82 24.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 30.1 mt -88.82 125.81 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.003 0.43 . . . . 0.0 111.457 -175.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.94 136.35 26.83 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.266 174.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 31' ' ' MET . . . . . 0.515 ' HG2' HD23 ' C' ' 36' ' ' LEU . 86.2 mtp -128.1 145.53 50.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -177.032 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -148.58 91.13 1.85 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.068 176.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.1 -94.58 0.46 Allowed Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.974 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.3 p-10 -106.21 26.54 9.66 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.684 -0.304 . . . . 0.0 111.323 -174.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.502 ' HG3' ' OD1' ' C' ' 83' ' ' ASN . 34.1 tt0 -141.06 137.72 33.09 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -170.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.515 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -122.72 114.72 20.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 167.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 21.6 pttm -124.84 106.04 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.86 0.838 . . . . 0.0 108.911 176.665 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.36 124.68 47.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.626 175.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -94.93 123.73 38.57 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 2.7 p -110.0 119.7 40.12 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.38 -174.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -116.1 -171.04 1.91 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.564 -174.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 81.51 12.71 0.68 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.74 1.275 . . . . 0.0 111.908 -176.817 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.17 45.86 26.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.68 -28.66 8.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.678 172.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -59.08 129.26 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.194 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -90.31 -70.57 1.22 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.283 -172.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.655 HG12 ' CB ' ' C' ' 68' ' ' GLU . 2.3 mt -113.32 -63.8 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.837 0.827 . . . . 0.0 111.406 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p 174.64 -63.41 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.192 -172.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 9.4 t80 179.7 36.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 O-C-N 123.467 0.48 . . . . 0.0 110.297 175.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.651 ' O ' HD12 ' C' ' 47' ' ' ILE . 42.6 mt-10 -142.23 177.86 7.96 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.438 -175.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.562 ' CG ' ' HE2' ' C' ' 69' ' ' LYS . 1.1 m-20 -103.74 122.08 44.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.298 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' C' ' 47' ' ' ILE . 6.2 mptp? -124.24 130.33 52.33 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 112.564 -178.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 53' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -88.92 126.64 35.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.629 178.924 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.617 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.6 OUTLIER -135.78 166.17 23.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -166.176 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.94 158.21 29.62 Favored Glycine 0 C--N 1.347 1.162 0 C-N-CA 119.278 -1.439 . . . . 0.0 116.085 171.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.426 HG13 HG12 ' C' ' 91' ' ' ILE . 1.9 mp -113.03 138.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.338 -0.931 . . . . 0.0 110.684 174.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 3.7 m-85 -131.22 132.87 44.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 91.1 t -104.08 116.39 47.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.43 27.52 17.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.662 -175.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.62 72.8 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 7.3 pt-20 -107.96 133.54 52.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.921 0.861 . . . . 0.0 109.772 176.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -65.47 128.9 37.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.464 -176.276 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.469 HG21 HG23 ' C' ' 58' ' ' VAL . 95.7 t -111.13 -65.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.887 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 60.5 t80 -128.4 144.8 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 -177.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.418 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 12.6 t -126.55 145.05 50.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.193 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 66' ' ' PHE . . . . . 0.493 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 38.1 p90 -155.0 -178.66 7.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -175.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -118.07 128.86 55.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.642 172.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.655 ' CB ' HG12 ' C' ' 47' ' ' ILE . 37.9 mt-10 -61.84 -27.35 68.71 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.562 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.6 pttp -82.76 14.78 2.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.493 ' HB2' HD11 ' C' ' 75' ' ' ILE . 59.7 m -73.83 -116.92 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 165.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.436 ' O ' HG13 ' C' ' 75' ' ' ILE . 0.9 OUTLIER -134.01 122.2 22.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 165.545 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 72' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 2.8 t -59.25 -24.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.903 -170.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.644 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.02 -37.0 33.99 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.742 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -76.6 -30.87 57.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 177.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' C' ' 70' ' ' SER . 75.5 mt -71.0 -61.66 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 176.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.576 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -63.91 -52.53 59.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.32 -171.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 77' ' ' ASN . . . . . 0.626 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 32.2 m-80 -74.85 -16.01 60.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -171.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 78' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.1 m-20 -59.7 -49.68 76.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 165.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.7 mt -53.32 -32.05 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.288 175.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' C' ' 77' ' ' ASN . 6.6 m120 -88.2 -22.04 24.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.778 -172.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 81' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 31.6 mmtp -61.34 -36.47 80.25 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 5.2 mt -64.9 -24.05 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.181 -174.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.502 ' OD1' ' HG3' ' C' ' 35' ' ' GLN . 91.6 m-20 39.64 87.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.771 0.67 . . . . 0.0 111.384 -172.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.36 122.92 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.815 -172.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.1 OUTLIER -80.36 55.7 2.32 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.237 170.917 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.78 158.96 13.96 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 87' ' ' PRO . . . . . 0.571 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 83.9 Cg_endo -81.65 -62.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.668 2.246 . . . . 0.0 111.792 177.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.9 p90 -134.06 129.65 36.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -102.94 120.25 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.713 -175.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.417 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 6.2 mm-40 -92.47 99.56 12.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.389 -176.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' C' ' 54' ' ' TRP . 7.0 mt -110.73 103.75 15.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -162.12 155.43 20.64 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.078 -177.357 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' C' ' 53' ' ' ASN . 0.1 OUTLIER -79.03 164.34 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 179.659 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 94' ' ' ILE . . . . . 0.408 HG21 ' HZ ' ' C' ' 57' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.549 -170.481 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.534 0.207 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -139.41 -25.83 0.83 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.282 -172.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 3' ' ' GLN . . . . . 0.416 ' HG2' HD12 ' C' ' 6' ' ' LEU . 58.4 mt-30 -64.87 -10.17 26.49 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.769 175.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -57.75 -29.84 65.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.668 176.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.23 -14.7 32.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.31 0.576 . . . . 0.0 110.452 177.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' C' ' 88' ' ' TYR . 78.1 mt -91.0 -151.46 0.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -91.09 -30.77 16.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.83 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 67.59 -5.35 0.79 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.412 0.685 . . . . 0.0 111.698 -174.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.94 16.39 8.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.292 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 10' ' ' MET . . . . . 0.664 ' O ' HG22 ' C' ' 13' ' ' ILE . 22.3 mmt -88.61 -146.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.007 177.161 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -53.87 -20.32 5.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -178.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 12' ' ' SER . . . . . 0.471 ' O ' HG23 ' C' ' 16' ' ' VAL . 1.2 m -51.55 -45.1 62.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.753 174.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.664 HG22 ' O ' ' C' ' 10' ' ' MET . 11.6 tt -80.26 -30.12 12.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.588 -177.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -71.87 -40.39 68.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -59.12 -32.76 70.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.033 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.471 HG23 ' O ' ' C' ' 12' ' ' SER . 98.3 t -70.8 -35.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.849 173.014 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.64 -47.73 84.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.824 0.345 . . . . 0.0 110.391 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.44 -21.2 64.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.722 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -85.37 -36.28 20.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.874 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' C' ' 27' ' ' LEU . 61.7 mt -75.89 -32.05 59.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.26 177.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.85 71.51 4.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.533 0.683 . . . . 0.0 109.669 173.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -95.21 10.11 37.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.996 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.98 -48.06 2.47 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -173.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.694 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.5 mmtt -72.01 -159.8 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 168.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 25' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' C' ' 46' ' ' GLY . . . -44.02 133.45 6.41 Favored Glycine 0 CA--C 1.502 -0.76 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.183 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 26' ' ' LYS . . . . . 0.694 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER -131.44 135.43 47.13 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.263 -0.469 . . . . 0.0 110.648 -171.915 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.738 ' HB3' HD13 ' C' ' 20' ' ' LEU . 2.1 tt -123.16 98.98 6.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 28' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 54.5 m -87.64 101.13 13.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.251 -178.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -95.08 129.39 42.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.358 -171.485 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -125.92 127.23 45.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.143 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 47.4 mtp -140.64 113.89 8.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.899 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.568 ' HB2' ' OE1' ' C' ' 35' ' ' GLN . 58.4 m-80 -148.99 111.49 4.74 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.603 175.15 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.56 -98.49 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.837 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 18.2 t-20 -121.27 30.28 6.87 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.105 0.479 . . . . 0.0 110.258 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 35' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' C' ' 32' ' ' ASN . 2.4 pt20 -122.94 123.45 40.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.618 . . . . 0.0 111.491 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.655 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tp -132.25 112.19 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.552 170.02 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 37' ' ' LYS . . . . . 0.506 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 52.2 pttt -137.24 103.72 5.19 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 38' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -102.6 129.91 49.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.803 173.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' C' ' 28' ' ' SER . 76.0 p -105.44 147.8 27.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.07 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 17.3 p -128.59 157.74 40.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -177.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.443 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 20.1 t -151.6 -174.44 4.84 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.576 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 42' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' C' ' 42' ' ' ASN . 0.2 OUTLIER 81.45 16.67 0.49 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.943 1.297 . . . . 0.0 111.679 -174.946 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.71 51.17 17.02 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 166.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.97 -21.12 41.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.909 174.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.44 112.58 6.83 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HA3' ' C' ' 25' ' ' GLY . . . -78.89 -78.31 0.85 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.885 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 47' ' ' ILE . . . . . 0.857 HD13 ' HG2' ' C' ' 52' ' ' LYS . 26.5 mt -111.96 -67.33 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 CA-C-O 121.856 0.836 . . . . 0.0 109.063 173.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.4 p 178.88 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.641 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -141.31 -32.67 0.54 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.486 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.551 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 8.4 pt-20 -70.03 160.7 31.47 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.05 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 51' ' ' ASP . . . . . 0.402 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 7.3 m-20 -101.36 109.07 20.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.617 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.857 ' HG2' HD13 ' C' ' 47' ' ' ILE . 25.8 mmmt -101.76 141.11 35.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 173.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.09 108.66 20.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.541 0.686 . . . . 0.0 111.109 -173.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 54' ' ' TRP . . . . . 0.518 ' HZ2' HD11 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.25 166.22 10.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.89 -174.019 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.49 160.2 32.14 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 118.976 -1.583 . . . . 0.0 115.39 173.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -119.61 136.01 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.759 -0.72 . . . . 0.0 110.2 174.119 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 30.8 m-85 -128.49 111.66 13.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.761 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' C' ' 89' ' ' ILE . 26.3 t -79.58 105.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 57.51 28.16 15.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 -174.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 12.9 64.24 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.025 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.8 tt0 -106.81 138.66 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.625 ' HE2' ' OG1' ' C' ' 65' ' ' THR . 13.5 tptm -68.29 130.96 44.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.462 -176.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.522 HG13 ' H ' ' C' ' 64' ' ' TYR . 2.3 p -129.39 -60.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.282 175.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 64' ' ' TYR . . . . . 0.522 ' H ' HG13 ' C' ' 63' ' ' VAL . 69.9 t80 -132.91 133.96 43.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.748 0.308 . . . . 0.0 110.258 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.625 ' OG1' ' HE2' ' C' ' 62' ' ' LYS . 24.5 m -128.28 144.83 51.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -157.97 174.6 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.314 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 67' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 76.2 m-20 -121.83 132.22 54.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 68' ' ' GLU . . . . . 0.593 ' HB2' ' CG1' ' C' ' 47' ' ' ILE . 39.6 mt-10 -60.85 -24.41 65.89 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.242 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -75.42 4.21 7.76 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -174.166 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -74.23 -119.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 71' ' ' THR . . . . . 0.543 ' O ' HG12 ' C' ' 75' ' ' ILE . 20.5 p -131.52 122.65 26.51 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.242 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.42 -18.91 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.236 -172.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.9 -45.38 10.59 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.276 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -62.35 -29.04 70.18 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 75' ' ' ILE . . . . . 0.543 HG12 ' O ' ' C' ' 71' ' ' THR . 51.3 mm -75.84 -66.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.145 178.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 76' ' ' SER . . . . . 0.57 ' OG ' ' HG ' ' C' ' 27' ' ' LEU . 16.3 m -51.13 -50.03 59.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.259 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 77' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -81.75 -17.57 47.27 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.909 -173.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.7 -34.87 67.42 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.314 166.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' C' ' 76' ' ' SER . 56.4 mt -58.52 -26.44 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.021 174.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 80' ' ' ASN . . . . . 0.506 ' CG ' ' HA ' ' C' ' 37' ' ' LYS . 38.5 m-20 -83.74 -27.22 29.08 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.567 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -56.61 -41.31 76.85 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.0 mt -54.77 -33.95 61.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.667 177.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 83' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' C' ' 36' ' ' LEU . 0.9 OUTLIER 38.57 104.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.724 1.209 . . . . 0.0 113.762 -174.83 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 84' ' ' ILE . . . . . 0.655 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.9 tp -45.23 148.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.655 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 85' ' ' LYS . . . . . 0.448 ' HD2' ' C ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -159.02 22.54 0.2 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.241 179.554 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.73 12.35 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.289 -168.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.6 -42.02 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.851 2.367 . . . . 0.0 111.681 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 88' ' ' TYR . . . . . 0.432 ' HB3' ' O ' ' C' ' 6' ' ' LEU . 34.7 p90 -145.26 117.5 8.42 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' C' ' 58' ' ' VAL . 58.4 mt -132.93 132.38 59.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 -176.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.15 111.04 22.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.764 -175.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 91' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 56' ' ' ILE . 11.8 tt -108.72 98.17 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.02 156.9 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.795 -170.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 1.1 pt20 -86.78 163.33 17.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.288 0.566 . . . . 0.0 111.331 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 -167.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' C' ' 9' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 32.5 mmt -77.0 -146.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -49.15 -25.97 2.51 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -52.54 -33.86 47.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.116 0.26 . . . . 0.0 111.51 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.579 HG13 ' N ' ' C' ' 14' ' ' ASN . 4.7 pt -90.54 -32.47 5.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.147 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.579 ' N ' HG13 ' C' ' 13' ' ' ILE . 16.6 m120 -71.11 -36.74 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.752 0.311 . . . . 0.0 110.242 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 19' ' ' LYS . 49.5 m -58.5 -33.96 70.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.695 HG11 ' HB ' ' C' ' 91' ' ' ILE . 71.3 t -68.32 -40.17 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.353 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -62.29 -41.81 98.81 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.704 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.13 -27.17 67.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.614 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' C' ' 15' ' ' SER . 94.1 mttt -85.27 -33.91 22.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.524 0.678 . . . . 0.0 110.286 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' C' ' 27' ' ' LEU . 29.3 mt -85.16 -32.44 22.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.088 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.585 0.707 . . . . 0.0 109.902 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 9.8 41.88 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.218 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.18 -69.73 0.5 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.545 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.678 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 24.2 tttt -76.01 -156.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.93 137.52 3.54 Favored Glycine 0 CA--C 1.498 -0.99 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.678 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.2 ptpt -147.32 132.2 18.07 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.343 -167.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.646 ' HB3' HD13 ' C' ' 20' ' ' LEU . 9.7 tt -105.63 125.76 51.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.446 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 31.8 m -103.31 135.05 45.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.109 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' C' ' 13' ' ' ILE . 5.8 mp -100.18 126.05 46.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.513 0.196 . . . . 0.0 111.444 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.5 t -152.49 144.95 24.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.467 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.454 ' HG3' HD23 ' C' ' 36' ' ' LEU . 1.9 mpt? -127.59 141.58 51.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 -176.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.53 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 18.1 m120 -133.07 88.86 2.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 173.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.78 -98.97 0.17 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.949 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.07 24.25 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.669 -0.312 . . . . 0.0 111.157 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.9 tt0 -143.27 108.25 4.94 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.548 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.679 ' CB ' HG13 ' C' ' 84' ' ' ILE . 3.1 tm? -88.03 124.87 34.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.669 166.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.53 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 41.6 pttt -129.1 103.38 6.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.79 118.87 37.82 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.932 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.0 p -98.4 138.89 34.97 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.29 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 t -111.23 119.51 39.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.333 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.437 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 23.6 t -94.84 -172.66 2.77 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.413 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 1.0 OUTLIER 70.73 27.94 3.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 123.854 0.722 . . . . 0.0 110.303 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.86 32.05 21.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.117 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 -6.63 78.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.308 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.486 ' O ' HG23 ' C' ' 72' ' ' VAL . 64.8 m-85 -63.3 161.36 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 0.0 110.47 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.493 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -85.51 166.72 40.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.348 -172.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.459 ' H ' HD12 ' C' ' 47' ' ' ILE . 3.7 mp -60.73 -54.62 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 122.196 0.998 . . . . 0.0 109.856 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 26.7 t -129.34 -169.85 2.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.851 -169.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -132.62 15.8 4.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.389 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.45 ' C ' ' HE3' ' C' ' 69' ' ' LYS . 33.1 mt-10 -125.17 163.13 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.748 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.82 105.31 11.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.552 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.49 140.89 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.515 HD22 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.41 109.35 20.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.466 0.65 . . . . 0.0 109.967 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.629 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.52 165.63 11.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.241 -173.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.52 157.74 29.1 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 118.579 -1.772 . . . . 0.0 115.826 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.43 HG23 HG12 ' C' ' 91' ' ' ILE . 79.5 mt -126.55 137.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.106 -1.047 . . . . 0.0 110.619 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' C' ' 89' ' ' ILE . 7.3 m-85 -130.03 126.84 38.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.906 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 58' ' ' VAL . 8.3 p -103.38 111.42 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.184 0.516 . . . . 0.0 110.084 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.8 m120 49.64 43.75 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.575 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.36 -6.69 82.3 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.185 -0.531 . . . . 0.0 114.345 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -108.32 150.14 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.855 0.827 . . . . 0.0 111.072 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -73.59 132.57 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.064 0.459 . . . . 0.0 111.756 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.59 -61.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.728 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -148.74 147.4 28.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.856 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.629 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.5 m -134.14 133.04 40.57 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 49.3 p90 -150.85 -167.12 2.73 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -128.73 144.78 51.24 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.571 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 6.6 mt-10 -70.11 -20.88 63.16 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -175.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.45 ' HE3' ' C ' ' C' ' 50' ' ' GLU . 11.3 ptpt -89.21 7.52 34.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.381 . . . . 0.0 111.035 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.0 m -90.08 165.89 13.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.805 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.09 106.27 8.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.493 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 0.9 OUTLIER -59.11 -15.85 7.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.862 -173.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.64 -32.9 17.58 Favored Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.645 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.82 -29.13 50.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 45.8 mm -71.68 -57.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.777 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.518 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 37.7 p -60.27 -55.65 31.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.876 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.1 OUTLIER -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.6 OUTLIER -64.02 -46.98 82.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' C' ' 76' ' ' SER . 74.7 mt -53.87 -31.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.333 175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.876 HD22 ' ND2' ' C' ' 77' ' ' ASN . 9.9 m-20 -89.99 -24.16 21.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.55 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 64.0 mttm -55.68 -39.75 71.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 4.6 mt -61.1 -23.07 65.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.778 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.695 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 40.42 77.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.846 0.831 . . . . 0.0 110.833 -174.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.679 HG13 ' CB ' ' C' ' 36' ' ' LEU . 0.5 OUTLIER -93.77 145.61 7.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.514 -171.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.507 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -81.16 4.46 20.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.356 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.19 109.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.335 0 O-C-N 124.077 0.861 . . . . 0.0 113.618 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 97.9 Cg_endo -82.26 -55.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.765 2.31 . . . . 0.0 112.28 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.445 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 88.2 t80 -107.95 98.75 8.28 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' C' ' 57' ' ' PHE . 20.9 pt -119.38 123.88 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.749 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.3 105.06 16.98 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.695 ' HB ' HG11 ' C' ' 16' ' ' VAL . 5.4 mt -97.22 99.71 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.407 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -163.82 148.15 10.34 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -77.08 165.34 24.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.322 0.582 . . . . 0.0 111.072 -177.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.515 HG13 HD22 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.863 -166.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.646 ' N ' HE21 ' C' ' 9' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.484 0.183 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.453 ' O ' HG22 ' C' ' 13' ' ' ILE . 1.0 OUTLIER -117.58 -147.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -41.59 -40.94 2.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -53.71 -39.36 65.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.497 HD13 ' ND2' ' C' ' 17' ' ' ASN . 0.0 OUTLIER -92.39 -33.2 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.538 ' HA ' HD22 ' C' ' 17' ' ' ASN . 20.8 m120 -69.84 -34.77 74.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.081 -0.387 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 40.1 t -59.27 -33.33 70.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.486 0.66 . . . . 0.0 109.29 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.485 HG21 ' O ' ' C' ' 91' ' ' ILE . 49.1 t -71.67 -35.23 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.141 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.538 HD22 ' HA ' ' C' ' 14' ' ' ASN . 16.1 m-80 -58.27 -45.47 87.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -69.03 -31.31 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.379 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.13 -35.17 37.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.196 0.522 . . . . 0.0 109.977 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' C' ' 27' ' ' LEU . 71.6 mt -69.2 -32.36 71.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.378 176.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.405 ' OD1' ' HD3' ' C' ' 26' ' ' LYS . 10.7 m-80 -78.41 58.69 2.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.515 0.674 . . . . 0.0 110.05 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.467 ' HD2' ' C ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -88.29 9.94 21.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.024 -175.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.47 -72.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.865 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.43 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.2 mttm -76.51 -157.71 0.09 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.369 0.268 . . . . 0.0 110.544 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -44.55 135.88 6.21 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' C' ' 40' ' ' SER . 9.8 ptpt -148.38 143.44 26.82 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.876 -162.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.615 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.8 mp -101.25 119.03 38.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.744 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 53.8 m -100.24 99.58 10.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.557 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.2 mm? -85.6 147.18 26.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 112.116 -171.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -151.13 129.13 11.76 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.076 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.0 mtt -101.9 118.64 37.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 16.9 m120 -130.74 90.08 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.813 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.79 0.6 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.965 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -102.32 33.71 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.951 0.881 . . . . 0.0 108.965 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.546 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 53.2 tt0 -144.62 138.95 27.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.973 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.4 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.6 tm? -116.37 102.81 9.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.579 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 64.4 pttt -105.96 133.22 51.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.1 118.48 6.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.941 -172.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 65.0 p -100.42 148.57 24.59 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.414 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.7 p -109.0 118.95 38.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.42 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 37.7 t -94.81 178.59 5.53 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.2 OUTLIER 63.08 37.68 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.689 0.618 . . . . 0.0 109.719 -169.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.43 24.99 10.83 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.611 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.94 19.06 73.65 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.09 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.687 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 17.8 m-85 -65.33 164.39 13.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.47 -160.36 35.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.159 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -52.99 -66.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.522 0.677 . . . . 0.0 112.165 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.583 ' H ' ' CD1' ' C' ' 47' ' ' ILE . 28.7 p -179.08 -48.1 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.004 -171.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.488 ' H ' HD13 ' C' ' 47' ' ' ILE . 68.5 t80 -171.45 -36.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.414 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -89.92 161.19 16.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -165.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' C' ' 69' ' ' LYS . 7.0 p-10 -94.21 118.22 31.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.327 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.658 ' HB2' ' CD ' ' C' ' 68' ' ' GLU . 14.1 mmmm -111.98 155.26 24.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.996 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.464 HD22 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -105.97 106.45 16.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.805 -170.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.624 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.59 164.17 11.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.785 -175.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.06 141.64 7.73 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.826 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.475 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.3 mp -117.96 124.48 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 171.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 2.9 m-85 -119.23 141.6 48.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.37 114.64 40.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 63.35 36.34 11.67 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.812 0.695 . . . . 0.0 110.778 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.16 58.9 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.381 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 10.8 pt-20 -140.16 143.81 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.902 0.851 . . . . 0.0 110.913 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.47 116.54 10.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.385 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.59 -29.6 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.933 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -156.27 154.84 31.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.991 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 54' ' ' TRP . 68.5 m -149.55 146.69 27.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.4 -179.73 7.94 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.684 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 18.3 m120 -128.73 135.08 48.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.25 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.658 ' CD ' ' HB2' ' C' ' 52' ' ' LYS . 2.5 mp0 -60.48 -11.1 5.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -172.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' HD11 ' C' ' 47' ' ' ILE . 13.5 ptmm? -84.83 -4.55 59.13 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.6 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -81.06 155.06 26.51 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 11.2 p -71.97 121.32 18.91 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.618 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 45' ' ' TYR . 13.1 t -60.11 -11.76 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.971 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.46 -40.24 9.18 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.077 -1.058 . . . . 0.0 111.212 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.99 -35.6 74.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.426 ' O ' HG13 ' C' ' 79' ' ' ILE . 47.0 mm -67.9 -66.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.486 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.651 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.4 m -59.34 -58.59 7.97 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.593 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 1.4 m120 -72.55 -16.84 61.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -171.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -34.79 69.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.505 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' C' ' 76' ' ' SER . 80.6 mt -56.06 -23.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.609 171.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.6 OUTLIER -79.79 -38.24 33.52 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.296 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -57.44 -34.1 68.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 109.355 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 3.2 mt -59.49 -28.06 66.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 36.66 82.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.568 -174.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.03 148.14 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.856 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.424 ' HB3' ' ND2' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -129.58 45.55 2.78 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.296 -174.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.92 158.0 17.52 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.383 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.04 -44.82 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.067 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -123.66 117.97 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.406 0.622 . . . . 0.0 109.949 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.75 125.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.784 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.15 99.68 12.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.536 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.557 HG21 ' HG ' ' C' ' 29' ' ' LEU . 20.1 mm -109.65 99.62 9.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.935 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 168.82 6.45 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -91.97 166.23 12.8 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.752 178.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.464 HG13 HD22 ' C' ' 53' ' ' ASN . 6.7 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.697 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.633 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.4 mp0 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.784 0.326 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.69 -141.38 0.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.044 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -39.8 -36.61 0.45 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -52.65 -46.19 67.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.51 -29.84 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.935 0.397 . . . . 0.0 111.014 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.52 -20.28 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -60.26 -35.22 75.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 47.8 t -66.54 -37.71 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.399 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' C' ' 29' ' ' LEU . 0.9 OUTLIER -65.21 -39.92 93.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.504 -176.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.58 -27.22 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -87.75 -29.33 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.464 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 62.0 mt -70.76 -34.95 72.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.216 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.1 66.13 9.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.2 -25.29 16.44 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.19 -72.81 0.13 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.274 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -90.6 -177.27 4.98 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 168.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.3 100.24 0.01 OUTLIER Glycine 0 CA--C 1.5 -0.882 0 O-C-N 125.139 1.525 . . . . 0.0 116.118 166.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.546 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 8.2 ptpt -131.51 155.36 47.56 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.194 -170.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.499 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 0.6 OUTLIER -134.77 121.8 21.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.553 -173.035 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.8 m -113.39 112.42 23.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.512 HD13 ' ND2' ' C' ' 17' ' ' ASN . 5.9 mp -99.24 143.94 28.93 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.789 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.1 m -150.19 131.07 14.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.151 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.633 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 81.5 mtp -97.69 120.72 38.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.296 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -122.31 91.4 3.5 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.708 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 31.06 6.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.707 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 27.9 tt0 -143.07 137.45 29.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.219 0.533 . . . . 0.0 111.999 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -111.28 99.55 8.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.558 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 23.2 pttp -96.42 142.95 27.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.2 122.11 7.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -172.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 77.5 p -98.48 143.38 28.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.545 ' OG ' ' HA2' ' C' ' 73' ' ' GLY . 17.6 p -125.52 119.22 27.59 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.1 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 39.0 t -100.46 173.37 6.6 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.526 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' C' ' 41' ' ' SER . 6.5 m120 81.59 28.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.716 1.26 . . . . 0.0 111.398 -172.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.88 35.92 5.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 167.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . 0.405 ' O ' HG22 ' C' ' 71' ' ' THR . . . 102.53 -10.11 56.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.209 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 76.3 m-85 -70.03 141.56 52.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.3 -150.45 25.22 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.194 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' C' ' 68' ' ' GLU . 26.6 mm -66.79 -62.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.555 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -175.05 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.079 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -168.48 28.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 12.5 pt-20 -115.76 135.53 53.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.689 -175.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 32.0 t70 -90.38 109.47 20.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.323 0.582 . . . . 0.0 111.809 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' C' ' 68' ' ' GLU . 12.0 mptt -110.82 139.61 45.97 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.988 175.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -95.55 119.34 33.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.215 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -113.56 165.96 11.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.044 -169.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.18 158.11 27.51 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 119.077 -1.535 . . . . 0.0 115.788 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -114.84 132.95 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 114.771 -0.714 . . . . 0.0 111.015 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.8 OUTLIER -130.41 115.26 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.75 126.49 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.16 24.9 14.23 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.805 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 9.03 83.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.558 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 11.3 tp10 -107.79 120.72 43.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.959 0.409 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 39.7 ttpt -72.6 112.61 8.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.3 -29.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -148.92 134.14 18.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.23 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.426 HG23 ' O ' ' C' ' 54' ' ' TRP . 5.3 m -123.6 147.14 47.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' C' ' 75' ' ' ILE . 52.5 p90 -161.51 -175.23 4.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.824 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.56 135.58 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.407 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' C' ' 47' ' ' ILE . 17.3 tt0 -62.89 -34.87 78.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.714 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.3 pttp -79.42 1.59 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -74.4 -170.67 1.04 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.465 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.1 p -81.37 108.39 14.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.47 -16.72 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.117 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.545 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -80.24 -40.76 12.92 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -33.55 75.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.487 ' O ' HG12 ' C' ' 79' ' ' ILE . 32.5 mm -76.05 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.415 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.6 m -54.43 -52.16 62.65 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.513 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.7 m120 -75.91 -15.96 60.11 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.658 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -66.17 -37.25 85.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' C' ' 76' ' ' SER . 36.7 mm -56.4 -25.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.568 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.597 HD22 ' N ' ' C' ' 80' ' ' ASN . 0.6 OUTLIER -82.37 -38.28 24.4 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -50.21 -44.05 52.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -53.69 -36.01 61.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.755 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.707 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.34 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.996 0.81 . . . . 0.0 110.559 -169.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.87 132.16 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.703 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.21 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.25 162.84 29.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.663 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.8 -35.47 0.39 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 123.113 2.542 . . . . 0.0 112.085 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.69 139.64 16.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.93 125.6 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.404 0.621 . . . . 0.0 111.557 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.416 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 15.6 mm-40 -97.26 99.21 10.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.517 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.4 mt -112.26 99.71 9.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -161.09 156.22 24.19 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -81.59 164.77 21.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.95 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.495 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.814 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.137 -165.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.65 -143.98 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -168.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -59.41 -22.53 61.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.929 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.4 m -54.69 -33.27 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 110.297 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -86.52 -41.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -63.52 -37.3 86.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -54.75 -37.36 65.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.52 -36.52 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.487 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -66.35 -38.21 87.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.424 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.07 -30.7 71.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.925 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.46 ' NZ ' ' HB3' ' C' ' 19' ' ' LYS . 9.1 mtpm? -85.65 -37.19 19.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' C' ' 27' ' ' LEU . 75.6 mt -76.35 -33.71 58.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.592 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -81.55 52.57 1.9 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.931 0.872 . . . . 0.0 109.769 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' C' ' 47' ' ' ILE . 14.7 pttm -66.24 -40.57 90.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.108 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.15 0.48 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' C' ' 24' ' ' LYS . 10.9 mmpt? -70.64 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -40.44 145.64 0.39 Allowed Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' C' ' 40' ' ' SER . 10.7 ptpt -148.52 130.96 15.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.945 -169.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.7 mp -105.02 128.34 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.721 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.1 t -103.61 98.93 8.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.71 121.2 25.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.11 0.481 . . . . 0.0 110.868 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -130.62 134.89 47.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.602 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 73.6 mtp -118.93 134.45 55.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.956 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -149.02 91.01 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.661 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.28 -106.42 0.65 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.245 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 33.78 1.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.5 0.667 . . . . 0.0 109.902 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.621 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.4 tt0 -145.71 139.6 26.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.511 0.672 . . . . 0.0 112.335 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.15 118.98 28.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 25.6 pttm -127.18 107.93 10.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.758 0.79 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -115.67 121.59 42.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.66 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 45.0 p -96.57 151.21 19.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 40.9 m -123.7 118.58 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.323 0.582 . . . . 0.0 110.848 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 22.6 t -101.84 -176.61 3.18 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.36 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.46 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.9 OUTLIER 73.01 35.91 0.92 Allowed 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 124.246 0.967 . . . . 0.0 109.746 -170.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.03 19.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.731 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -3.66 65.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.475 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.46 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 55.4 m-85 -58.78 143.51 46.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.847 0.324 . . . . 0.0 110.89 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.09 -158.02 5.4 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' C' ' 68' ' ' GLU . 23.0 mt -67.52 -68.6 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 CA-C-O 122.115 0.96 . . . . 0.0 109.781 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -178.26 -146.68 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.833 -165.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -79.22 -24.23 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.464 ' OE1' ' HE2' ' C' ' 52' ' ' LYS . 6.4 pt-20 -73.28 137.26 44.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.545 0.688 . . . . 0.0 112.79 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.63 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 5.6 p-10 -90.62 145.41 24.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.051 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.4 mptp? -141.8 126.02 17.49 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.787 ' ND2' HG13 ' C' ' 94' ' ' ILE . 66.5 t30 -84.94 112.61 20.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.525 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.659 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.2 OUTLIER -121.05 161.23 22.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -169.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.9 159.18 31.7 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 118.952 -1.594 . . . . 0.0 116.655 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -114.96 131.49 67.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 113.974 -1.113 . . . . 0.0 110.853 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 1.9 m-85 -129.05 107.2 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.84 123.18 47.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.62 31.12 18.61 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 4.09 89.31 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.114 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.1 tp10 -106.48 121.13 43.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.969 0.385 . . . . 0.0 110.701 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 30.0 ttpp -75.05 117.68 17.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.57 -32.58 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.296 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -142.0 131.58 23.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -125.39 141.01 52.3 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.492 ' CD1' HD13 ' C' ' 75' ' ' ILE . 50.1 p90 -156.78 -173.35 4.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.277 0.844 . . . . 0.0 113.277 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 19.1 p-10 -131.55 131.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.081 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.659 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 34.0 mt-10 -67.02 -12.33 59.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.6 ptmm? -89.59 7.54 35.9 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.483 ' HB3' HD11 ' C' ' 75' ' ' ILE . 15.2 t -79.98 -147.83 0.05 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.09 117.18 32.57 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 2.4 t -64.47 -14.8 16.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.302 -167.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.38 -39.57 25.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.567 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.55 -30.68 68.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.492 HD13 ' CD1' ' C' ' 66' ' ' PHE . 67.7 mt -68.28 -70.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.261 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 2.5 m -65.38 -44.18 88.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.504 HD22 ' ND2' ' C' ' 80' ' ' ASN . 11.6 m120 -80.83 -15.24 56.9 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.426 -171.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.31 -40.23 81.78 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' C' ' 76' ' ' SER . 63.1 mt -58.7 -28.78 38.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.467 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.504 ' ND2' HD22 ' C' ' 77' ' ' ASN . 7.9 m-20 -75.19 -37.6 61.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.249 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 7.2 mmpt? -54.43 -40.44 68.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 0.0 109.237 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -56.12 -34.78 66.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.699 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.621 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.26 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.164 0.915 . . . . 0.0 110.68 -168.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.66 131.07 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.325 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.98 43.27 0.77 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.514 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.87 138.02 14.09 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.097 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.37 -45.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.775 2.317 . . . . 0.0 111.445 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -140.3 123.36 16.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.02 133.92 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.363 0.602 . . . . 0.0 111.352 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.451 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 8.0 mm-40 -92.31 104.51 16.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.499 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.1 mt -112.71 100.85 11.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -157.37 171.4 20.46 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -94.27 167.42 11.55 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.092 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.787 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.478 ' O ' HG13 ' C' ' 13' ' ' ILE . 62.7 mtt -82.29 -142.06 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -49.95 -17.2 0.35 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 41.0 m -53.88 -39.71 65.97 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.246 -0.284 . . . . 0.0 110.846 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 10' ' ' MET . 2.8 pp -91.58 -23.92 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.525 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 17.2 m120 -74.89 -32.58 61.88 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 122.304 -0.248 . . . . 0.0 111.003 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -62.26 -31.1 71.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.451 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.51 -34.69 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.868 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.5 m-20 -61.76 -39.82 92.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.407 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.46 -27.7 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.674 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.91 -28.57 18.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.099 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 34.7 mt -82.94 -28.35 29.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.413 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -88.19 74.49 8.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.82 -23.67 10.88 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -81.77 0.09 OUTLIER Glycine 0 CA--C 1.507 -0.414 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.234 -174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 14.9 ttmt -89.75 -179.22 5.71 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 29.89 90.33 0.01 OUTLIER Glycine 0 CA--C 1.503 -0.668 0 O-C-N 124.38 1.05 . . . . 0.0 115.496 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.0 OUTLIER -121.02 137.17 54.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.652 -173.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 31.6 tp -126.93 128.21 46.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.395 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 59.2 m -111.87 111.81 23.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.256 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.593 HD21 ' HB ' ' C' ' 91' ' ' ILE . 5.4 mp -86.92 144.58 26.89 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 111.574 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.4 p -155.09 129.78 9.23 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.473 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.422 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 63.4 mtt -128.02 132.33 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.962 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.414 ' HB3' ' CD ' ' C' ' 35' ' ' GLN . 6.3 t30 -151.23 92.66 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.569 0.223 . . . . 0.0 110.77 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.79 -93.94 1.18 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.37 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.48 31.78 6.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.447 0.642 . . . . 0.0 109.909 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.547 ' N ' HG22 ' C' ' 84' ' ' ILE . 9.9 pt20 -127.92 130.7 48.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.312 0.577 . . . . 0.0 111.753 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.694 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tm? -124.16 119.03 28.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.633 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -140.37 130.99 25.59 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -143.78 120.1 10.9 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.932 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 44.1 p -97.47 126.12 42.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.4 p -109.27 118.72 37.45 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.582 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 t -103.18 -175.08 2.7 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 81.08 26.33 0.23 Allowed 'General case' 0 C--O 1.222 -0.353 0 O-C-N 124.494 1.121 . . . . 0.0 110.491 -171.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.02 38.35 23.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.93 -5.82 79.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.674 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -64.38 145.21 56.41 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.46 0.63 . . . . 0.0 110.526 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -85.33 -169.7 46.28 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.002 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' C' ' 68' ' ' GLU . 23.3 mm -59.14 -63.53 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-O 121.652 0.739 . . . . 0.0 110.84 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 p -164.06 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.634 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -169.24 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.873 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.63 136.07 49.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.426 -168.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.532 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 1.3 m-20 -75.15 118.43 18.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.417 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -139.28 132.72 30.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 14.7 p-10 -86.91 122.38 30.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.52 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -115.66 161.92 17.99 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.78 148.22 18.79 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.331 -1.414 . . . . 0.0 115.444 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 38.6 mt -122.27 127.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 164.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -121.7 109.04 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.949 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.434 HG23 HG13 ' C' ' 89' ' ' ILE . 2.5 p -90.08 105.74 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 62.36 29.45 17.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.704 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.74 5.19 78.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.766 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -109.08 141.99 40.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.853 0.358 . . . . 0.0 110.467 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -66.74 121.42 15.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.794 174.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -156.88 153.23 27.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.301 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -141.93 159.02 43.07 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 55.8 p90 -166.91 -172.87 2.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 111.39 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -129.42 138.51 51.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.139 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.522 ' HB3' HG13 ' C' ' 47' ' ' ILE . 10.1 mt-10 -62.96 -33.07 74.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.431 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.1 pttp -82.89 18.89 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.007 0.432 . . . . 0.0 111.367 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -88.87 -150.73 0.2 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 19.9 p -111.27 112.86 24.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.441 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.8 t -63.23 -12.33 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.057 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -84.55 -37.92 10.22 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.816 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -68.4 -35.18 77.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 51.5 mm -69.63 -60.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.925 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.676 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 75.2 p -51.73 -60.75 2.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.554 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.6 m120 -73.26 -15.98 61.41 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -171.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' C' ' 81' ' ' LYS . 0.5 OUTLIER -69.65 -36.01 75.7 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.1 167.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.3 mt -58.36 -20.91 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.633 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.7 OUTLIER -84.05 -35.91 23.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' C' ' 78' ' ' ASP . 52.0 mtpt -53.61 -39.92 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 6.1 mt -52.97 -37.33 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.694 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 2.4 tp -44.8 148.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.664 -174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -149.85 22.32 0.88 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.342 0.591 . . . . 0.0 109.718 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.04 171.55 15.29 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.849 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.79 -49.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.775 2.317 . . . . 0.0 113.407 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -132.87 103.35 6.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.363 0.601 . . . . 0.0 110.326 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.452 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.4 mp -122.43 129.62 75.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.145 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 37.9 mt-10 -106.56 119.2 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 0.0 111.658 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.593 ' HB ' HD21 ' C' ' 29' ' ' LEU . 34.4 mt -96.91 98.95 8.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 146.1 14.79 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.4 pt20 -83.16 166.97 18.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.218 0.532 . . . . 0.0 112.325 -173.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.782 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.777 0.322 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 86.9 mmm -66.53 178.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.283 0.563 . . . . 0.0 111.863 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -50.17 -19.6 0.81 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t -46.04 -51.95 12.77 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.569 0.543 . . . . 0.0 112.309 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.526 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -89.76 -18.58 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.567 -177.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -74.11 -50.95 17.25 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.3 -0.25 . . . . 0.0 111.388 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.3 m -58.3 -29.39 65.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.459 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 42.8 t -70.33 -40.09 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.71 172.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.31 -41.03 96.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.831 0.348 . . . . 0.0 110.439 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.47 -31.24 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.408 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.74 -35.42 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.123 0.487 . . . . 0.0 110.617 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.592 HD21 ' CZ2' ' C' ' 54' ' ' TRP . 73.3 mt -73.53 -37.37 65.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.347 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -79.59 68.92 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.814 0.816 . . . . 0.0 109.019 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' C' ' 47' ' ' ILE . 16.6 pttm -89.27 -7.4 55.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.992 -172.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.4 -50.73 0.76 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.743 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 22.5 mmtm -78.96 -160.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -41.34 137.94 2.11 Favored Glycine 0 CA--C 1.507 -0.434 0 O-C-N 123.535 0.522 . . . . 0.0 114.106 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.5 OUTLIER -141.34 143.21 33.9 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -168.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.0 mp -117.86 114.54 23.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 8.5 t -86.42 98.47 11.03 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 91' ' ' ILE . 39.0 mt -83.9 124.36 30.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.246 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 29.8 t -147.13 139.43 24.63 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 54.0 mtm -107.2 145.64 32.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.277 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -148.15 89.82 1.76 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 110.568 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.18 -94.11 0.31 Allowed Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.94 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.4 p-10 -112.94 26.61 10.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 110.512 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.745 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.0 tt0 -140.35 143.39 35.73 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.493 0.663 . . . . 0.0 111.951 -171.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.0 tm? -118.11 117.88 30.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 22.5 pttp -126.31 148.62 49.5 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.15 135.29 17.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.378 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -98.69 125.57 44.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 30.9 t -109.47 119.65 40.09 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.672 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 9.5 t -109.93 178.98 4.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 78.44 27.34 0.5 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.502 1.126 . . . . 0.0 110.639 -174.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.69 32.69 19.84 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.548 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.91 -14.08 66.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.121 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 39.7 m-85 -55.44 130.36 42.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.058 0.429 . . . . 0.0 110.359 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -73.85 -94.45 0.11 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.784 -0.643 . . . . 0.0 113.074 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' C' ' 52' ' ' LYS . 33.6 mt -110.51 -67.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.415 0.626 . . . . 0.0 109.755 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 177.36 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.192 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -166.4 -37.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.657 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 11.8 pt-20 -70.18 170.08 12.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.058 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.548 ' HB2' HD21 ' C' ' 67' ' ' ASN . 4.5 p-10 -125.35 152.97 44.04 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 111.33 -177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.596 ' HG2' HD11 ' C' ' 47' ' ' ILE . 8.6 mmmm -130.03 143.47 50.81 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.207 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.688 ' ND2' HG13 ' C' ' 94' ' ' ILE . 5.3 t30 -92.34 105.04 17.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.464 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.63 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -113.82 165.85 12.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.128 -167.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.455 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -163.78 158.09 30.5 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 119.556 -1.306 . . . . 0.0 114.816 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.455 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.6 mp -119.79 129.39 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.869 169.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.536 ' CE1' ' HD3' ' C' ' 62' ' ' LYS . 40.6 m-85 -123.98 105.49 9.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.31 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.89 112.01 26.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 57.83 32.84 22.48 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.062 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.12 7.53 87.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.085 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.3 tp10 -107.01 139.05 42.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.883 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.536 ' HD3' ' CE1' ' C' ' 57' ' ' PHE . 14.3 mmmm -83.24 118.05 23.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.575 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -107.17 -24.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.358 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -160.22 147.91 16.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 110.778 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 54' ' ' TRP . 41.8 m -139.73 147.73 41.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' C' ' 75' ' ' ILE . 32.7 p90 -159.78 -178.73 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.121 -1.032 . . . . 0.0 113.523 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' C' ' 51' ' ' ASP . 51.5 t-20 -120.36 127.95 52.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.836 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 4.7 mt-10 -62.61 -21.53 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 21.0 ptmt -90.53 9.24 30.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.515 ' HB2' HD11 ' C' ' 75' ' ' ILE . 15.5 m -76.38 -118.8 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.299 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -131.71 115.67 16.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.496 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 3.3 t -60.65 -22.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -168.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.88 -37.4 19.36 Favored Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.004 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -72.14 -34.51 68.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' C' ' 70' ' ' SER . 81.9 mt -66.6 -65.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.395 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.638 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 70.8 p -62.42 -50.95 69.45 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -167.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.459 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 27.4 m120 -79.29 -14.51 58.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -172.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.05 -38.83 92.13 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' C' ' 76' ' ' SER . 73.1 mt -59.29 -24.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.497 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -80.12 -40.03 28.29 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 8.0 mmpt? -50.72 -38.68 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 0.0 109.624 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.413 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.5 mt -52.25 -35.37 49.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.745 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 37.49 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.131 0.895 . . . . 0.0 110.957 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' C' ' 86' ' ' GLY . 31.5 mt -79.28 115.16 21.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.241 -166.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -66.83 35.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.638 169.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' C' ' 84' ' ' ILE . . . -98.74 159.42 20.29 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.096 -171.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 93.1 Cg_endo -80.5 -75.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.691 2.261 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.587 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 15.3 p90 -115.78 112.64 22.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.666 0.746 . . . . 0.0 109.487 171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.09 114.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.706 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -90.55 96.88 10.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.338 0.589 . . . . 0.0 110.13 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 29' ' ' LEU . 13.9 mt -96.35 100.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 145.89 22.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.8 pt20 -83.1 167.01 18.23 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.751 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.688 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.565 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.45 HE21 ' HB2' ' C' ' 9' ' ' GLN . 4.3 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.027 0.441 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 71.1 mtp -81.36 -149.26 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.887 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.12 -10.69 11.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -56.62 -42.39 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.09 -28.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.8 -43.99 87.04 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.478 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . 0.548 ' O ' ' HB2' ' C' ' 19' ' ' LYS . 22.3 m -56.97 -34.93 68.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.1 -31.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.208 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -61.31 -48.97 78.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.03 -14.25 60.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.094 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' C' ' 15' ' ' SER . 0.0 OUTLIER -80.52 -45.77 16.92 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' C' ' 27' ' ' LEU . 90.0 mt -78.42 -35.08 47.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.985 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -78.65 67.84 4.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.157 0.503 . . . . 0.0 109.961 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -104.6 -10.01 17.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.87 -76.6 0.19 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -99.57 -174.49 2.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.89 88.95 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 171.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.6 ptpt -128.97 143.44 50.88 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.646 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HB3' HD13 ' C' ' 20' ' ' LEU . 17.1 tp -125.94 127.98 46.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.366 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -99.98 110.68 23.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -79.84 135.32 36.43 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.028 0.531 . . . . 0.0 111.973 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 41.2 m -143.61 129.11 19.06 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.286 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.586 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 39.5 mtm -123.93 130.9 53.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -148.1 90.89 1.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.05 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.27 -97.67 0.06 OUTLIER Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.713 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.87 33.38 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.37 0.605 . . . . 0.0 109.882 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.551 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.9 tt0 -150.08 136.66 19.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.2 tm? -119.96 127.41 52.62 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 165.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -144.8 144.74 31.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.43 142.42 22.18 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.732 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 60.6 p -99.07 138.81 35.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 22.2 p -118.07 117.86 30.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.564 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.2 m -105.04 178.18 4.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.955 -175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' C' ' 26' ' ' LYS . 0.7 OUTLIER 70.1 38.98 1.41 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.323 1.014 . . . . 0.0 109.071 -168.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.13 27.75 16.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.732 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 11.92 82.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.523 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.45 ' O ' HG23 ' C' ' 72' ' ' VAL . 55.1 m-85 -74.69 176.1 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.248 0.524 . . . . 0.0 110.771 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -101.01 -154.98 26.97 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.634 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.518 HD13 ' HE3' ' C' ' 22' ' ' LYS . 15.9 mm -51.79 -67.08 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.486 0.66 . . . . 0.0 109.863 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 15.1 t 173.13 -67.78 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.335 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.05 -22.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 7.4 pt-20 -68.94 145.68 53.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 112.315 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.53 ' C ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 t70 -87.56 121.05 29.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.707 -174.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 3.3 mptp? -124.76 134.37 52.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.529 HD22 HG13 ' C' ' 94' ' ' ILE . 0.9 OUTLIER -96.86 105.96 18.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.538 0.685 . . . . 0.0 111.077 -177.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.579 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -108.66 167.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.61 -173.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.416 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -170.1 165.58 38.88 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 119.291 -1.433 . . . . 0.0 115.612 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.538 HG13 HG13 ' C' ' 91' ' ' ILE . 3.5 mp -124.63 129.54 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.17 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -120.1 117.42 27.9 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -115.62 123.17 70.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.677 0.275 . . . . 0.0 110.362 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' C' ' 87' ' ' PRO . 4.5 m-20 57.56 33.23 22.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.83 90.47 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.851 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.52 130.95 56.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.475 ' HD2' ' OG1' ' C' ' 65' ' ' THR . 40.0 ttpt -74.83 123.67 25.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.934 0.397 . . . . 0.0 110.5 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.69 -43.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -146.31 147.75 31.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.933 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' C' ' 54' ' ' TRP . 84.6 m -136.46 145.22 44.94 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.44 -170.92 2.96 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 51.3 t-20 -128.2 139.99 52.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.458 ' HB3' HG12 ' C' ' 47' ' ' ILE . 42.3 mt-10 -77.95 -11.29 59.89 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -81.59 -6.63 59.17 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.242 175.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -78.58 163.75 25.25 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -74.22 113.24 11.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.519 HG23 ' HA2' ' C' ' 46' ' ' GLY . 8.7 t -57.52 -15.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.943 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.95 -41.16 12.79 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.371 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -73.41 -33.01 64.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 38.3 mm -65.81 -61.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.532 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 68.2 p -64.8 -57.81 7.9 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.786 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.6 OUTLIER -67.69 -16.83 64.34 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -171.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.2 m-20 -64.95 -47.41 77.73 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.645 0.657 . . . . 0.0 109.291 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' C' ' 76' ' ' SER . 65.1 mt -56.78 -30.62 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.844 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.786 HD22 ' ND2' ' C' ' 77' ' ' ASN . 27.7 m-20 -89.67 -17.82 27.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 33.9 mmtp -62.76 -39.31 93.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 11.0 mt -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.302 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.551 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.8 m120 39.51 72.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.625 0.726 . . . . 0.0 110.08 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' C' ' 86' ' ' GLY . 13.7 mt -54.36 139.99 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.451 -171.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -85.17 26.29 0.89 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.408 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -93.1 125.41 8.17 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.606 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.43 ' HD2' ' OD1' ' C' ' 59' ' ' ASN . 95.6 Cg_endo -79.83 -40.34 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.208 1.939 . . . . 0.0 111.035 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -126.89 120.64 29.68 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.586 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 73.4 mt -126.11 130.53 72.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.521 -172.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.33 98.47 11.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.983 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.579 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.8 tt -105.33 99.89 9.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.24 158.67 19.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.322 -171.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -84.52 158.79 20.86 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.529 HG13 HD22 ' C' ' 53' ' ' ASN . 1.6 pt . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.977 -167.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' C' ' 9' ' ' GLN . 9.8 mt-30 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -81.36 -143.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.622 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.05 -9.77 11.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -48.94 -60.46 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.89 0.476 . . . . 0.0 111.83 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.58 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -84.83 -18.36 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.06 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 84.3 m-20 -72.46 -38.96 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.642 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 61.2 m -63.76 -30.18 71.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 89.7 t -68.25 -36.69 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.651 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.8 m-20 -59.87 -45.51 92.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.4 -32.03 70.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.292 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -87.41 -31.63 19.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.975 0.417 . . . . 0.0 110.994 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' C' ' 27' ' ' LEU . 50.8 mt -81.62 -31.41 32.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.705 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -82.67 65.1 7.63 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.446 ' CE ' HD12 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.52 -24.15 16.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.012 -173.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.46 -78.36 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.603 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.8 ttpt -98.87 -172.97 2.4 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 166.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.83 92.66 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 O-C-N 124.747 1.28 . . . . 0.0 115.703 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.0 ptpt -130.95 136.74 48.83 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.597 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.3 tp -116.48 122.09 43.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.581 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.9 m -108.05 104.54 14.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.292 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.689 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -82.53 138.43 34.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -142.76 129.35 20.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' C' ' 9' ' ' GLN . 36.0 mtm -130.81 125.02 32.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.236 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.487 ' H ' ' HG2' ' C' ' 35' ' ' GLN . 61.6 m-80 -148.42 97.21 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 110.654 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -94.63 0.8 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.459 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.43 32.46 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.501 0.667 . . . . 0.0 109.835 -175.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' C' ' 32' ' ' ASN . 2.3 pt20 -128.48 136.55 50.97 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.279 0.561 . . . . 0.0 111.607 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.667 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 0.7 OUTLIER -130.39 118.45 21.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 164.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.526 ' O ' ' HD2' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -145.66 103.2 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -109.52 126.66 53.77 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.286 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -96.65 137.76 35.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.075 0.464 . . . . 0.0 109.896 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 29.2 p -109.04 117.59 34.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.644 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 21.2 t -102.63 173.97 6.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.422 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 71.76 39.61 0.84 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.384 1.052 . . . . 0.0 109.569 -166.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.12 27.02 14.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.79 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.97 5.83 88.86 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.051 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 44.0 m-85 -65.03 156.47 31.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.579 ' O ' ' HG2' ' C' ' 24' ' ' LYS . . . -83.23 -166.52 39.87 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.463 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 15.6 mm -56.46 -61.9 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 121.489 0.662 . . . . 0.0 111.803 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.1 p 176.24 -74.15 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.983 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -159.88 20.99 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.358 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 42.1 mt-10 -115.95 141.87 47.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.765 -176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.501 ' HB2' HD21 ' C' ' 67' ' ' ASN . 7.0 p-10 -100.99 149.21 24.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.565 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.523 ' HG3' ' OE1' ' C' ' 68' ' ' GLU . 11.3 mmtp -132.9 146.23 51.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' C' ' 94' ' ' ILE . 6.5 t30 -96.28 99.25 10.97 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.753 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.557 ' HA ' ' CB ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -102.93 164.35 11.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.238 -166.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.53 143.9 10.2 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 119.403 -1.38 . . . . 0.0 115.114 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.405 HD12 ' N ' ' C' ' 56' ' ' ILE . 4.2 mp -118.85 124.82 73.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 5.2 m-85 -125.91 155.11 41.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.02 117.87 47.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.81 24.98 14.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.21 36.82 20.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.343 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 16.0 tp10 -133.62 131.11 39.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.82 124.5 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.98 -49.2 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.612 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 56.8 t80 -155.17 150.3 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.712 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 16.8 m -135.61 136.55 41.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 41.9 p90 -152.58 -177.9 6.52 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.793 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.501 HD21 ' HB2' ' C' ' 51' ' ' ASP . 52.0 t-20 -119.95 130.41 54.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.91 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.523 ' OE1' ' HG3' ' C' ' 52' ' ' LYS . 2.2 mt-10 -64.95 -27.06 68.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 13.7 ptmm? -79.55 2.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.374 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 11.5 m -74.63 178.24 5.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -76.63 110.84 11.53 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.39 -11.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.911 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.72 -41.24 13.12 Favored Glycine 0 CA--C 1.51 -0.238 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.971 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -71.54 -32.02 67.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.239 0.542 . . . . 0.0 109.587 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.479 ' O ' HG13 ' C' ' 79' ' ' ILE . 49.1 mm -69.62 -55.73 14.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.515 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' C' ' 38' ' ' ALA . 56.3 p -57.98 -64.65 0.84 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.839 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -67.06 -17.74 65.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -172.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -45.57 66.07 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.479 HG13 ' O ' ' C' ' 75' ' ' ILE . 58.2 mt -57.65 -28.29 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.839 HD22 ' ND2' ' C' ' 77' ' ' ASN . 30.0 m-20 -85.86 -27.95 24.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.023 -177.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 68.1 mttm -60.32 -36.65 78.41 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 12.3 mt -52.35 -32.47 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.35 99.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.66 1.225 . . . . 0.0 112.769 -175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.667 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -42.67 144.42 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 113.965 -1.471 . . . . 0.0 112.867 -173.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.34 15.17 0.89 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.33 0.585 . . . . 0.0 109.586 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.31 179.91 28.41 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.682 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.58 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.5 Cg_endo -82.01 -77.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.668 2.245 . . . . 0.0 111.455 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.58 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.5 p90 -113.83 129.92 56.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 109.798 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.661 HG12 HD11 ' C' ' 84' ' ' ILE . 3.9 mp -116.01 136.71 52.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.374 -174.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 101.69 14.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' C' ' 29' ' ' LEU . 27.0 mm -103.4 98.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 151.56 3.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -91.42 171.7 9.02 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.225 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.824 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.149 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.692 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.423 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.7 mp0 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.465 ' O ' HG22 ' C' ' 13' ' ' ILE . 75.0 mtm -99.5 -143.21 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.481 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -47.58 -35.38 9.03 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . 0.456 ' O ' HG23 ' C' ' 16' ' ' VAL . 51.0 m -49.25 -48.44 45.77 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 10' ' ' MET . 9.9 tt -84.22 -25.26 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.288 0.566 . . . . 0.0 111.08 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.556 ' HA ' HD22 ' C' ' 17' ' ' ASN . 89.3 m-20 -85.02 -27.84 26.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.58 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 50.6 m -65.07 -31.67 73.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.539 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 51.7 t -69.83 -34.34 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.971 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.556 HD22 ' HA ' ' C' ' 14' ' ' ASN . 6.4 m-80 -57.43 -46.27 83.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.775 0.322 . . . . 0.0 110.749 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.9 -15.97 61.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.712 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -88.04 -38.0 15.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 43.3 mt -74.1 -33.9 63.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.45 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 23.4 m-80 -78.53 69.62 4.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.435 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -102.0 10.01 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.696 -171.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.91 -67.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.594 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 0.2 OUTLIER -100.44 92.56 5.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 122.616 0.366 . . . . 0.0 110.365 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 126.56 3.14 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 119.833 -1.175 . . . . 0.0 111.668 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.5 ptpt -149.4 146.09 27.3 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.479 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -115.21 110.68 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.466 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.6 m -85.93 115.6 23.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' C' ' 17' ' ' ASN . 16.5 mt -102.63 132.27 48.85 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.877 0.37 . . . . 0.0 111.82 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 26.4 p -149.58 137.55 20.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.553 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 88.8 mtp -118.32 128.07 54.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -133.04 92.78 3.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.155 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.91 -93.55 0.41 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.167 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.6 p-10 -107.87 21.73 16.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.685 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.4 tt0 -138.79 145.54 40.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.558 0.694 . . . . 0.0 112.465 -169.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.413 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -128.85 105.07 7.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.474 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 54.5 pttt -109.13 104.95 14.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.638 0.732 . . . . 0.0 109.113 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -104.2 119.35 38.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -104.68 139.09 40.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 26.6 t -109.9 119.19 38.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 42.8 t -93.39 173.78 7.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.288 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' C' ' 41' ' ' SER . 12.4 m120 80.19 26.5 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.757 1.286 . . . . 0.0 110.102 -171.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.28 27.09 16.05 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.061 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.12 67.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.979 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.0 m-30 -60.19 143.14 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.813 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.82 -169.26 45.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.548 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.586 ' CG1' ' HB3' ' C' ' 68' ' ' GLU . 7.7 mt -48.95 -59.28 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 CA-C-O 121.052 0.453 . . . . 0.0 111.891 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 10.3 t 173.31 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.855 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -166.69 54.4 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.525 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 5.7 pt-20 -156.45 152.04 26.95 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.73 0.3 . . . . 0.0 111.409 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.476 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 p-10 -97.31 129.62 44.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.662 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.6 mptp? -127.64 133.05 49.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.651 ' ND2' HG13 ' C' ' 94' ' ' ILE . 8.9 t30 -87.48 107.73 18.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.851 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.755 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -113.38 165.62 12.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.869 -171.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.22 167.53 40.64 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.694 -1.241 . . . . 0.0 115.245 174.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.549 HG12 HG13 ' C' ' 91' ' ' ILE . 50.2 mt -131.24 131.47 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.901 -0.65 . . . . 0.0 110.414 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 54.0 m-85 -126.02 122.47 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.808 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -112.46 117.36 55.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 61.21 32.02 19.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.316 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.58 80.06 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.0 OUTLIER -112.95 142.75 45.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.713 0.256 . . . . 0.0 110.799 -178.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.54 100.44 2.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.32 -39.7 13.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.174 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -154.25 153.35 31.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.098 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.586 HG23 ' O ' ' C' ' 54' ' ' TRP . 60.0 m -150.08 142.43 24.27 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -158.6 -179.39 8.03 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.251 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' C' ' 51' ' ' ASP . 46.2 t-20 -118.91 127.07 53.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.167 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.755 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 2.1 mt-10 -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 3.7 ptmm? -76.56 -2.41 32.29 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.581 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.559 ' HB2' HD11 ' C' ' 75' ' ' ILE . 5.4 m -74.74 -170.24 1.02 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 68.6 p -88.36 116.82 26.85 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.179 -0.951 . . . . 0.0 108.749 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.609 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 11.1 t -58.17 -17.21 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.751 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.32 -44.66 8.6 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.748 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -69.17 -28.48 66.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' C' ' 70' ' ' SER . 73.1 mt -66.92 -66.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -59.78 -48.16 82.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.285 -170.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.596 HD22 ' ND2' ' C' ' 80' ' ' ASN . 12.3 m120 -76.18 -15.63 60.01 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.39 -39.92 81.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.8 mt -58.49 -27.7 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.44 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.596 ' ND2' HD22 ' C' ' 77' ' ' ASN . 7.3 m-20 -77.64 -35.79 52.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.227 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 10.7 mmpt? -52.2 -42.99 63.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.8 mt -56.21 -32.91 64.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.685 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.4 80.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.018 0.823 . . . . 0.0 111.083 -171.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.51 HG22 ' H ' ' C' ' 86' ' ' GLY . 11.8 mt -68.34 124.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.238 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -91.74 34.83 0.97 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.852 175.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.51 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -79.98 143.6 25.44 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.19 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.29 -43.65 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.38 2.054 . . . . 0.0 111.293 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -139.26 128.77 24.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 63.4 mt -121.38 126.15 74.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.615 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -98.9 98.97 9.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.411 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.597 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.3 tt -98.83 104.42 15.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 168.09 19.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.86 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.37 0.605 . . . . 0.0 111.32 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.651 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.599 -166.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.517 ' NE2' ' H ' ' C' ' 89' ' ' ILE . 10.7 mm-40 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 20.0 mmt -90.44 -143.54 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.408 ' H ' ' HB3' ' C' ' 10' ' ' MET . 4.1 m-20 -56.78 -14.16 3.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t -54.33 -39.45 67.07 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.114 0.259 . . . . 0.0 110.438 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.514 HD13 ' SD ' ' C' ' 31' ' ' MET . 13.1 pt -90.81 -25.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.896 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -64.93 -44.35 89.78 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.757 0.313 . . . . 0.0 110.627 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -57.46 -35.86 70.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.8 t -68.34 -35.74 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.341 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.59 -41.54 99.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 110.132 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.37 -20.62 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.355 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' C' ' 19' ' ' LYS . 5.5 mmpt? -88.88 -35.22 16.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 110.658 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.518 HD12 HD21 ' C' ' 29' ' ' LEU . 98.9 mt -76.37 -33.14 58.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 28.7 m-80 -79.98 60.05 3.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.544 0.688 . . . . 0.0 109.838 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -94.21 -34.43 12.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.264 -173.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HE3' ' C' ' 26' ' ' LYS . . . 166.98 -93.7 0.11 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.464 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -72.66 91.76 1.47 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 125.59 5.19 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.642 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' C' ' 21' ' ' ASN . 8.0 ptpt -152.34 155.63 38.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.39 129.68 43.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.548 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.4 m -107.83 99.36 8.83 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.518 HD21 HD12 ' C' ' 20' ' ' LEU . 0.6 OUTLIER -93.39 136.13 33.96 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 120.818 0.342 . . . . 0.0 111.672 -171.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -153.35 130.62 11.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.273 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.519 ' HG3' ' CD2' ' C' ' 36' ' ' LEU . 1.6 mpt? -103.71 137.49 41.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.981 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -136.04 91.46 2.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.701 0.286 . . . . 0.0 110.278 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.02 -95.03 0.12 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.079 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.5 p-10 -108.03 22.6 15.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.643 0.259 . . . . 0.0 110.938 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.701 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 25.9 tt0 -139.15 137.04 35.74 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.553 0.692 . . . . 0.0 112.398 -170.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.519 ' CD2' ' HG3' ' C' ' 31' ' ' MET . 0.6 OUTLIER -113.62 129.67 56.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -142.89 140.78 31.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.463 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -152.56 134.54 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.54 0.209 . . . . 0.0 110.996 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 62.0 p -98.28 145.45 26.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 35.8 m -125.59 116.61 22.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 49.2 m -100.66 -179.47 4.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.741 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.48 31.1 0.61 Allowed 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 124.584 1.178 . . . . 0.0 109.609 -168.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.52 32.58 22.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.112 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 1.03 86.34 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.262 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -66.63 145.67 55.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 111.055 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.71 -160.39 20.19 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.629 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.755 HD12 ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -48.51 -53.04 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.755 ' H ' HD12 ' C' ' 47' ' ' ILE . 8.2 t 166.87 -62.81 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.273 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -150.37 -33.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 47.9 mm-40 -91.31 167.15 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -163.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.85 92.58 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.238 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.468 ' HB3' ' OE2' ' C' ' 68' ' ' GLU . 10.3 mptt -101.03 157.47 16.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -116.6 120.61 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.0 112.544 -174.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.549 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -102.85 166.56 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.737 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.74 150.13 11.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.117 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.3 mp -108.93 122.96 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 122.735 -0.274 . . . . 0.0 110.705 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -108.38 138.58 44.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.421 HG12 HG13 ' C' ' 63' ' ' VAL . 8.9 p -127.93 117.12 45.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.71 26.2 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.439 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.08 4.91 74.02 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.521 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.67 139.88 52.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.039 0.42 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 53.2 mtmt -82.0 136.87 35.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.721 0.296 . . . . 0.0 111.668 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.421 HG13 HG12 ' C' ' 58' ' ' VAL . 35.8 m -104.93 -39.47 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.695 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -144.7 145.93 31.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.549 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.2 m -136.88 141.93 42.76 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.541 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.7 p90 -153.85 -175.14 5.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.446 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' C' ' 53' ' ' ASN . 16.8 m120 -126.73 139.48 53.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.287 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.475 ' CD ' ' HD1' ' C' ' 54' ' ' TRP . 3.1 mp0 -62.24 -15.75 49.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.529 ' HB3' HD11 ' C' ' 47' ' ' ILE . 2.4 ptmm? -82.56 1.92 35.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.919 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.6 m -81.54 -173.95 4.68 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.562 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.8 p -97.36 117.54 31.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.56 -21.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.518 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.71 -32.67 23.79 Favored Glycine 0 CA--C 1.504 -0.595 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.988 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -75.52 -38.49 59.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.562 HG12 ' O ' ' C' ' 71' ' ' THR . 42.3 mm -68.09 -58.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.519 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 20.3 m -59.74 -51.45 69.72 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.484 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.728 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -69.92 -18.94 63.41 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.734 -175.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 46.1 m-20 -68.03 -46.88 69.95 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 167.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' C' ' 76' ' ' SER . 96.2 mt -54.56 -29.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.296 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.728 HD22 ' ND2' ' C' ' 77' ' ' ASN . 69.9 m-20 -87.3 -37.35 17.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.327 -172.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 54.2 pttt -60.9 -26.03 67.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 18.5 mt -57.44 -29.05 63.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.819 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.701 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.3 m120 39.52 86.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.941 0.775 . . . . 0.0 110.679 -170.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.407 HG22 ' N ' ' C' ' 86' ' ' GLY . 15.9 mt -80.37 129.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.921 -168.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.4 OUTLIER -87.96 36.64 0.77 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.69 175.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.407 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -82.38 134.66 13.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.291 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.98 -47.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.545 2.163 . . . . 0.0 111.708 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -125.71 99.54 6.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.517 ' H ' ' NE2' ' C' ' 9' ' ' GLN . 19.2 mm -100.54 125.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.424 0.631 . . . . 0.0 110.664 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.03 99.56 9.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.49 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.516 ' O ' HG11 ' C' ' 16' ' ' VAL . 3.4 tt -101.96 99.45 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.814 0.816 . . . . 0.0 109.018 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -161.54 166.12 27.51 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.634 -173.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.626 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -104.19 163.41 12.43 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.312 173.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.587 HG13 HD22 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.649 -161.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.585 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.2 mp0 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.467 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 0.0 OUTLIER -110.77 -151.96 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.467 ' H ' ' HB3' ' C' ' 10' ' ' MET . 91.7 m-20 -44.76 -33.71 2.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -50.63 -48.76 57.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.677 0.275 . . . . 0.0 111.605 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.42 HD12 ' HE3' ' C' ' 31' ' ' MET . 5.3 tt -85.75 -28.09 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.113 0.482 . . . . 0.0 110.674 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 4.0 m-20 -69.8 -35.72 75.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.983 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -63.69 -29.82 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 96.8 t -72.49 -35.64 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.647 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.98 -42.2 98.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.67 -24.42 63.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.43 -31.5 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.824 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 27' ' ' LEU . 98.8 mt -84.88 -33.25 22.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.682 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.482 ' HA ' ' HB2' ' C' ' 26' ' ' LYS . 24.4 m-80 -78.73 78.45 5.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.724 ' NZ ' ' HB2' ' C' ' 24' ' ' LYS . 0.6 OUTLIER -120.22 7.09 10.72 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -165.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.32 -76.12 0.4 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.328 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.724 ' HB2' ' NZ ' ' C' ' 22' ' ' LYS . 47.7 mttm -75.51 -158.32 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.74 144.21 1.2 Allowed Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 114.615 0.606 . . . . 0.0 114.615 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' C' ' 40' ' ' SER . 12.7 ptpt -151.14 144.61 24.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 20' ' ' LEU . 3.3 mp -102.15 136.73 41.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.03 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 9.4 t -115.62 99.83 7.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -86.71 127.84 34.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.916 0.389 . . . . 0.0 111.482 -173.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.6 m -142.09 128.89 20.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.806 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.585 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 30.2 mtt -100.17 121.9 42.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -133.54 91.09 2.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.645 0.26 . . . . 0.0 110.973 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.9 -108.33 1.53 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.161 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.47 21.53 5.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.081 0.44 . . . . 0.0 110.867 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.576 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.8 tt0 -142.93 141.1 31.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.594 0.712 . . . . 0.0 112.105 -169.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.401 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.3 tm? -116.94 122.69 45.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 164.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -127.38 140.35 52.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.66 119.07 5.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 47.0 p -98.03 146.57 25.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 53.2 p -112.0 118.62 35.94 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 21.7 m -88.5 177.21 6.86 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.018 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.434 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.6 OUTLIER 72.54 33.61 1.38 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.285 0.991 . . . . 0.0 109.399 -172.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.8 33.45 23.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.594 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.32 6.92 89.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.189 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.434 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 21.4 m-85 -64.02 151.96 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.336 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -72.73 174.06 46.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.096 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.441 HG13 ' HB3' ' C' ' 68' ' ' GLU . 49.1 mm -60.57 -67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 121.182 0.515 . . . . 0.0 109.714 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 21.5 t -148.48 -88.42 0.08 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.308 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -177.31 25.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.535 0.683 . . . . 0.0 110.338 -173.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.56 146.12 50.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.159 0.504 . . . . 0.0 111.037 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.42 109.7 15.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.088 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 5.9 mptp? -121.18 137.7 54.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.589 ' ND2' HG13 ' C' ' 94' ' ' ILE . 11.4 t30 -88.57 108.53 19.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.69 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.39 162.74 13.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.495 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.72 139.71 6.92 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.159 -1.496 . . . . 0.0 116.141 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -112.75 129.17 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.443 167.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.43 106.99 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.327 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 89' ' ' ILE . 11.2 m -94.0 123.01 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 53.76 33.41 16.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.329 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.68 60.79 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.041 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.52 119.71 21.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 5.4 ttpm? -71.2 120.88 17.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.55 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.54 -33.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.559 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.08 143.87 29.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.14 0.495 . . . . 0.0 110.598 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.69 HG23 ' O ' ' C' ' 54' ' ' TRP . 69.2 m -135.76 139.98 43.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.2 p90 -148.45 177.77 9.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.173 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 67.4 m-20 -122.71 139.33 54.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.862 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' C' ' 47' ' ' ILE . 26.5 mt-10 -66.36 -14.21 61.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -82.97 -1.26 51.99 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -87.44 -177.9 6.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.413 ' O ' HG12 ' C' ' 75' ' ' ILE . 15.1 p -83.22 115.6 22.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.47 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.5 t -60.95 -15.29 11.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.697 -169.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.81 -43.3 7.29 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.656 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -69.71 -28.55 65.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.457 HG21 ' CD1' ' C' ' 66' ' ' PHE . 41.0 mm -70.27 -65.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.18 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.58 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.9 m -59.19 -46.64 87.89 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.767 -171.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.791 ' ND2' HD22 ' C' ' 80' ' ' ASN . 12.0 m120 -76.79 -14.83 59.88 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 19.8 m-20 -60.26 -45.62 92.64 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' C' ' 76' ' ' SER . 78.8 mt -57.22 -30.55 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.1 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.791 HD22 ' ND2' ' C' ' 77' ' ' ASN . 33.3 m-20 -90.72 -28.67 18.15 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.43 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 11.5 mmpt? -55.04 -36.02 65.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.7 mt -56.41 -31.79 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.576 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.5 OUTLIER 39.11 79.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 0.0 110.073 -168.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.43 HG22 ' N ' ' C' ' 86' ' ' GLY . 25.6 mt -69.04 131.92 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.003 -168.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -86.69 41.51 0.96 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.323 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.43 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -89.26 129.58 9.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.746 -172.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.22 -38.35 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.418 2.079 . . . . 0.0 110.748 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -150.72 113.28 4.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.119 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.451 HG12 ' SD ' ' C' ' 31' ' ' MET . 15.0 pt -123.01 153.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.876 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.27 129.32 54.33 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.226 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' C' ' 29' ' ' LEU . 3.4 mt -126.89 100.23 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.681 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.37 15.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 174.51 7.32 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.35 -177.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.589 HG13 ' ND2' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.348 -169.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.902 0.382 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 95.7 mmm -108.53 -140.94 0.38 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -41.43 -33.6 0.44 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -53.63 -51.38 63.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.801 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.472 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.4 tt -87.03 -25.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 17' ' ' ASN . 83.2 m-20 -72.48 -26.64 61.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.128 -0.358 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.8 t -63.33 -33.64 75.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.9 t -69.6 -34.01 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.053 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' C' ' 14' ' ' ASN . 78.9 m-20 -56.98 -43.42 81.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.02 0.438 . . . . 0.0 110.149 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -76.16 -19.92 58.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.95 -27.78 28.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.188 0.518 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' C' ' 27' ' ' LEU . 72.5 mt -91.51 -32.05 15.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.97 73.43 9.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -107.7 -40.7 5.22 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.003 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.52 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -168.69 -74.68 0.04 OUTLIER Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.378 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.3 ttmm -105.81 162.55 13.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 167.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.92 85.32 0.03 OUTLIER Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.199 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 7.7 ptpt -126.13 128.35 47.18 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.164 0.506 . . . . 0.0 111.169 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.49 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.7 tp -115.31 126.29 54.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.519 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.1 m -108.52 106.22 16.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.064 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.7 mm? -90.33 144.67 25.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.017 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.412 ' HB3' ' CE ' ' C' ' 37' ' ' LYS . 39.5 t -158.6 136.39 10.4 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.565 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.425 ' HE2' ' O ' ' C' ' 87' ' ' PRO . 2.3 mpt? -96.81 146.03 25.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -141.41 88.73 2.17 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.76 -99.3 0.08 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.33 26.46 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 110.362 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.708 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.2 tt0 -139.01 138.78 37.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.324 0.583 . . . . 0.0 111.654 -171.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -119.06 122.59 42.47 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 167.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.412 ' CE ' ' HB3' ' C' ' 30' ' ' SER . 0.0 OUTLIER -130.79 145.33 51.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.85 133.61 14.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.705 0.288 . . . . 0.0 110.535 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 51.9 p -100.56 144.46 29.52 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.0 p -121.51 118.36 29.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.626 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 30.6 m -104.76 -179.93 4.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.377 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.68 38.73 1.63 Allowed 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 124.208 0.942 . . . . 0.0 108.812 -169.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.68 20.64 12.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.081 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.51 79.19 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.299 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.467 ' O ' HG23 ' C' ' 72' ' ' VAL . 45.1 m-85 -75.92 -179.05 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.866 0.333 . . . . 0.0 111.063 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.54 -159.63 33.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.39 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.67 HD11 ' HB3' ' C' ' 68' ' ' GLU . 11.8 mt -49.21 -67.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.486 0.714 . . . . 0.0 112.53 -172.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 5.4 t 171.05 -75.3 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.788 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -155.31 62.23 0.62 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.352 0.261 . . . . 0.0 111.356 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.679 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 11.6 pt-20 -169.13 176.13 5.41 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.401 -0.187 . . . . 0.0 110.946 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 12.6 t70 -127.61 113.79 16.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.51 0.506 . . . . 0.0 110.78 -173.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -118.25 158.56 24.93 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.479 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER -108.93 123.21 48.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.474 0.654 . . . . 0.0 110.557 179.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.505 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -113.06 166.4 11.46 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.078 -168.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -173.8 155.89 22.82 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.636 -1.269 . . . . 0.0 115.796 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -116.45 129.38 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.365 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' C' ' 62' ' ' LYS . 0.4 OUTLIER -127.61 99.73 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 89' ' ' ILE . 7.4 p -84.11 125.77 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.645 -0.659 . . . . 0.0 109.967 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.49 26.21 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.878 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.41 4.45 76.98 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.977 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 35.9 tt0 -108.24 120.17 41.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.963 0.381 . . . . 0.0 110.609 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 27.6 ttpp -74.55 117.58 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.11 -30.23 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.023 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -137.39 144.63 42.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' C' ' 54' ' ' TRP . 28.1 m -145.99 141.89 28.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.6 p90 -162.24 -170.65 2.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.413 ' OD1' ' HG2' ' C' ' 69' ' ' LYS . 48.7 t-20 -117.53 138.38 51.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.545 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.67 ' HB3' HD11 ' C' ' 47' ' ' ILE . 1.9 tt0 -72.84 -29.53 63.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.295 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.679 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 9.4 ptmt -86.66 11.65 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -76.91 -151.15 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.546 ' O ' HG12 ' C' ' 75' ' ' ILE . 18.0 p -106.92 112.24 25.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.024 -1.047 . . . . 0.0 108.984 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.467 HG23 ' O ' ' C' ' 45' ' ' TYR . 6.8 t -59.39 -16.47 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.491 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.99 -46.49 7.67 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.094 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -66.79 -36.43 82.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.588 HG21 ' CD1' ' C' ' 66' ' ' PHE . 50.6 mm -68.01 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.542 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 13.5 m -70.59 -44.29 67.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -167.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.793 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -69.56 -17.62 63.58 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.951 -177.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 5.7 m-20 -64.56 -49.63 70.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 167.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 81.1 mt -52.33 -32.64 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.291 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.793 HD22 ' ND2' ' C' ' 77' ' ' ASN . 62.9 m-20 -85.07 -36.3 21.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.37 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 56.6 mtmt -57.92 -30.55 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 109.788 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.3 mt -58.8 -27.98 65.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.577 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.708 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 41.77 82.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.895 0.855 . . . . 0.0 110.713 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.93 127.56 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.249 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -81.26 29.42 0.35 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.296 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.49 112.16 0.6 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.425 ' O ' ' HE2' ' C' ' 31' ' ' MET . 91.2 Cg_endo -81.75 -14.16 10.23 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.054 . . . . 0.0 113.278 -174.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -97.19 98.38 9.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' C' ' 58' ' ' VAL . 55.3 mt -125.48 132.68 70.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.5 0.667 . . . . 0.0 112.464 -168.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -90.29 97.37 11.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.127 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.545 HG21 ' HG ' ' C' ' 29' ' ' LEU . 14.1 tt -109.58 96.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 122.646 1.212 . . . . 0.0 107.983 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -152.97 177.32 10.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.263 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.9 OUTLIER -108.27 163.53 13.11 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.882 174.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.479 HG12 ' O ' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.321 -166.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.495 ' HA ' ' HE3' ' C' ' 31' ' ' MET . 37.7 mt-30 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.014 0.435 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.432 ' O ' HG22 ' C' ' 13' ' ' ILE . 96.6 mmm -105.27 -144.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.175 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.45 -29.43 58.64 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -41.43 75.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 111.319 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.432 HG22 ' O ' ' C' ' 10' ' ' MET . 0.0 OUTLIER -90.62 -30.02 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.535 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' HD22 ' C' ' 17' ' ' ASN . 77.2 m-20 -72.68 -24.97 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.118 -0.364 . . . . 0.0 110.933 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -57.88 -36.79 72.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.411 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.1 t -68.43 -32.76 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.563 HD22 ' HA ' ' C' ' 14' ' ' ASN . 8.2 m-80 -59.1 -38.4 79.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 109.97 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -70.36 -40.02 74.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.75 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -40.15 80.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.628 0.728 . . . . 0.0 109.734 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' C' ' 27' ' ' LEU . 36.7 mt -67.19 -41.24 86.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.8 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' C' ' 26' ' ' LYS . 28.1 m-80 -80.46 37.13 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.528 0.68 . . . . 0.0 110.603 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' C' ' 20' ' ' LEU . 18.3 pttm -48.25 -42.05 29.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.302 1.441 . . . . 0.0 112.84 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.7 -71.23 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -85.84 -166.83 1.64 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 163.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 45' ' ' TYR . . . 41.54 74.73 0.15 Allowed Glycine 0 CA--C 1.488 -1.601 0 O-C-N 124.272 0.982 . . . . 0.0 114.515 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.807 ' HB2' ' H ' ' C' ' 41' ' ' SER . 5.8 mmpt? -89.14 78.41 7.38 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.974 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.657 ' HB3' HD13 ' C' ' 20' ' ' LEU . 10.8 tp -88.07 105.94 17.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.336 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -101.15 108.08 19.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.579 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.417 HD22 HG21 ' C' ' 91' ' ' ILE . 1.3 mp -112.62 142.63 44.99 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.361 0.601 . . . . 0.0 112.088 -171.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -144.58 129.74 18.62 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.029 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.545 ' CG ' HD23 ' C' ' 36' ' ' LEU . 71.4 mtm -103.49 145.89 29.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -148.34 92.03 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.424 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.28 -93.45 0.29 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.989 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -108.63 15.02 24.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.598 0.199 . . . . 0.0 111.065 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.691 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.6 tt0 -134.05 139.28 45.89 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.598 0.713 . . . . 0.0 112.454 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.545 HD23 ' CG ' ' C' ' 31' ' ' MET . 3.2 tm? -128.31 120.68 27.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.689 169.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -132.49 139.59 48.01 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.466 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -151.1 145.91 25.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.846 -171.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 74.8 p -118.86 150.77 39.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 4.1 p -124.32 116.47 22.66 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.315 0.578 . . . . 0.0 111.087 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.807 ' H ' ' HB2' ' C' ' 26' ' ' LYS . 21.6 m -89.5 -178.93 5.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.813 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.02 42.83 15.32 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.822 0.701 . . . . 0.0 109.541 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.96 21.9 12.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.476 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.49 23.44 78.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.456 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.464 ' O ' ' HA2' ' C' ' 25' ' ' GLY . 33.2 m-85 -68.19 158.81 32.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.994 0.397 . . . . 0.0 110.722 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.75 -101.87 0.56 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.311 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' C' ' 68' ' ' GLU . 18.6 mt -107.6 -67.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.525 0.679 . . . . 0.0 110.42 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.7 p -176.16 -68.09 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.37 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -149.35 -32.94 0.21 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.413 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.552 ' O ' HD12 ' C' ' 47' ' ' ILE . 13.8 pt-20 -88.21 178.98 6.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.55 139.94 53.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 28.1 mmmt -115.72 157.35 24.41 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.753 ' ND2' HG13 ' C' ' 94' ' ' ILE . 10.6 t30 -98.3 105.11 17.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.396 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.601 ' CZ2' HD21 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.06 165.99 10.7 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.187 -172.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.46 159.35 28.25 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.602 -1.285 . . . . 0.0 115.318 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -121.14 128.45 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.773 174.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.1 m-85 -124.04 122.49 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 48.7 t -105.86 111.18 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 60.11 24.88 14.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.084 0.468 . . . . 0.0 110.052 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.14 16.81 58.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.862 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.6 OUTLIER -107.01 128.1 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 0.0 111.357 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -72.12 107.44 4.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 m -95.58 -31.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.365 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -159.35 147.88 17.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 ' O ' ' C' ' 54' ' ' TRP . 71.3 m -140.62 147.78 39.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.79 -173.76 2.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.459 0.572 . . . . 0.0 112.117 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 20.1 m120 -114.37 139.5 49.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.7 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.6 ' HB3' HD11 ' C' ' 47' ' ' ILE . 63.6 tt0 -68.12 -15.83 63.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 14.5 ptmm? -83.66 -5.52 59.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -70.54 159.94 33.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 9.5 p -74.33 112.31 10.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' C' ' 27' ' ' LEU . 2.6 t -58.36 -14.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.71 -170.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.71 -38.96 14.96 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.088 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -72.71 -34.59 67.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.75 -59.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.408 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.432 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 66.5 p -58.12 -58.56 7.92 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.125 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.807 ' ND2' HD22 ' C' ' 80' ' ' ASN . 1.1 m120 -67.95 -17.05 64.33 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -67.01 -48.21 69.08 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.499 ' HA ' ' CD1' ' C' ' 82' ' ' LEU . 75.2 mt -56.85 -32.64 39.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.902 174.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.807 HD22 ' ND2' ' C' ' 77' ' ' ASN . 41.7 m-20 -84.06 -22.1 31.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.393 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 67.8 mttm -62.71 -40.95 98.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.3 mt -54.88 -35.43 64.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.224 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.691 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.6 m120 44.08 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 -166.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.82 113.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.475 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -84.45 64.6 8.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.211 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.68 156.96 26.1 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.585 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.487 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.2 Cg_endo -80.49 -55.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.501 2.134 . . . . 0.0 112.531 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.0 p90 -124.05 132.86 53.73 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.509 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 64.7 mt -130.3 132.09 65.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.511 0.672 . . . . 0.0 111.889 -169.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.22 98.18 10.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.603 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 56' ' ' ILE . 7.7 tt -108.25 97.94 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 177.24 9.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.818 -168.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.5 OUTLIER -106.23 163.61 12.67 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.637 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.753 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -165.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' C' ' 31' ' ' MET . 26.0 mt-30 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.593 0.235 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mtp -72.82 -145.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.3 m-20 -59.9 -16.52 30.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 31.3 t -46.34 -50.78 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.29 0.369 . . . . 0.0 111.317 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.412 ' H ' HG13 ' C' ' 13' ' ' ILE . 2.5 pp -91.27 -21.68 6.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.144 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 5.5 m-20 -63.97 -46.95 82.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.951 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . 0.657 ' O ' ' HG2' ' C' ' 19' ' ' LYS . 42.6 t -55.42 -41.71 73.14 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.08 -34.5 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.575 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.57 -40.09 95.76 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -72.42 -27.4 62.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.869 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' C' ' 15' ' ' SER . 0.2 OUTLIER -79.82 -34.27 39.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.206 0.526 . . . . 0.0 110.14 -177.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 27' ' ' LEU . 93.3 mt -80.21 -38.97 30.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.808 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -79.38 71.64 5.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.43 0.633 . . . . 0.0 109.557 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.491 ' HE3' ' CB ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -113.83 -13.73 12.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.162 -171.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 146.04 -73.21 0.32 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -174.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.491 ' CB ' ' HE3' ' C' ' 22' ' ' LYS . 2.3 mttp -72.17 -159.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' C' ' 47' ' ' ILE . . . -43.1 130.75 5.57 Favored Glycine 0 CA--C 1.512 -0.137 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -173.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.7 ptpt -132.05 142.87 49.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.985 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 20' ' ' LEU . 4.1 mp -117.76 125.34 50.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 42.1 m -94.96 101.26 13.02 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.471 HD22 HD12 ' C' ' 91' ' ' ILE . 15.7 mt -92.44 129.4 38.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.613 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -151.24 144.37 24.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.414 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.416 ' HB2' ' OE1' ' C' ' 9' ' ' GLN . 2.4 mpt? -105.36 146.22 29.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.34 . . . . 0.0 110.319 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -147.86 89.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.229 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.14 -101.43 0.19 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.037 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.81 34.14 2.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.738 0.78 . . . . 0.0 109.305 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.438 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 50.7 tt0 -140.9 139.9 34.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.379 0.609 . . . . 0.0 112.048 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -122.22 105.37 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 167.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.58 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 63.2 pttt -106.25 131.68 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 117.67 6.45 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.25 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 69.8 p -102.43 151.28 22.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.086 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.1 p -111.56 119.51 38.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.545 176.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 12.1 t -103.4 177.65 4.78 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.76 33.6 0.19 Allowed 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 124.619 1.199 . . . . 0.0 110.514 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.43 37.08 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.098 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.81 1.3 89.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.305 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -64.01 135.22 56.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.018 0.409 . . . . 0.0 110.359 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -64.39 150.67 50.75 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.777 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.496 HD11 HD11 ' C' ' 27' ' ' LEU . 40.6 mt -57.15 -54.56 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 121.872 0.844 . . . . 0.0 110.952 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 23.3 t -127.37 -173.72 2.98 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.063 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -132.52 13.9 4.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.96 0.886 . . . . 0.0 109.011 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.442 ' HB2' ' HE2' ' C' ' 52' ' ' LYS . 30.8 mt-10 -131.28 161.38 32.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.943 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.43 91.9 6.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 111.293 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 4.8 mptp? -94.37 144.67 25.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.572 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.2 102.02 14.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.656 0.598 . . . . 0.0 110.359 175.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.565 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -105.11 159.28 15.97 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.5 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.484 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -165.17 166.85 38.49 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 118.267 -1.92 . . . . 0.0 116.114 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.484 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.3 mp -120.34 132.31 70.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.509 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 79.7 m-85 -120.84 111.44 17.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -93.76 115.21 32.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.69 34.33 23.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.003 0.43 . . . . 0.0 110.424 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.24 8.9 87.5 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.317 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 37.7 tt0 -107.92 126.96 53.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.281 0.541 . . . . 0.0 110.57 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -72.8 102.03 3.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.849 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.17 -46.57 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.264 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.51 149.43 50.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' C' ' 54' ' ' TRP . 63.7 m -145.33 143.3 30.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -155.57 -174.95 5.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.796 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 11.6 m120 -128.37 140.99 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.869 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' C' ' 48' ' ' SER . 20.5 mt-10 -67.53 -13.16 61.81 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -87.74 -6.17 58.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.021 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -83.69 177.84 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.332 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.486 ' O ' HG12 ' C' ' 75' ' ' ILE . 22.3 p -81.32 112.41 18.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.427 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.7 t -60.56 -14.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.229 -173.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.53 -38.25 12.67 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -73.89 -30.88 62.85 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.486 HG12 ' O ' ' C' ' 71' ' ' THR . 36.4 mm -67.48 -64.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.714 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.624 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 63.0 p -63.45 -58.26 7.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -169.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.544 HD22 ' CG ' ' C' ' 80' ' ' ASN . 4.0 m120 -72.73 -16.38 61.66 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -172.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.52 -41.32 97.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' C' ' 76' ' ' SER . 85.6 mt -55.95 -25.44 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.123 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.593 HD22 ' N ' ' C' ' 80' ' ' ASN . 0.5 OUTLIER -83.98 -32.19 25.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.233 -176.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.97 -38.5 76.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.0 -28.81 66.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.386 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.438 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 37.43 85.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.354 1.034 . . . . 0.0 111.567 -173.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.473 HG21 HD12 ' C' ' 89' ' ' ILE . 27.3 mm -64.34 143.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.728 -168.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -112.36 25.42 11.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.656 -172.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.433 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -114.33 167.7 12.38 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.187 -172.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.574 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.7 Cg_endo -81.31 -72.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.835 2.357 . . . . 0.0 113.22 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.574 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 10.1 p90 -103.55 113.75 27.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.592 0.711 . . . . 0.0 109.993 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.473 HD12 HG21 ' C' ' 84' ' ' ILE . 19.3 mm -102.74 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.618 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -91.49 98.35 11.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.411 0.624 . . . . 0.0 110.755 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.565 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.0 mt -95.89 104.43 15.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 143.96 19.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 121.388 0.614 . . . . 0.0 111.602 -172.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 24.6 tm0? -66.0 140.41 58.29 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.872 174.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.572 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.76 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.236 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.639 0.257 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 37.9 mtm -80.14 -144.83 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 110.799 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.8 m-20 -61.45 -17.84 56.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.476 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -52.59 -46.28 66.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.6 pt -89.15 -26.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.81 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 79.2 m-20 -65.62 -37.15 85.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 47.7 t -54.68 -41.52 70.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 57.4 t -66.21 -37.17 79.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.403 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' C' ' 29' ' ' LEU . 33.5 m-80 -67.75 -33.31 74.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.574 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -80.11 -18.7 49.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.671 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -90.61 -38.7 12.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.546 HD13 ' HB3' ' C' ' 27' ' ' LEU . 68.4 mt -80.17 -36.42 35.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.033 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -81.51 74.87 8.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.889 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -111.5 -23.01 10.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.858 -172.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.625 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 165.12 -79.99 0.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.652 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 10.3 mttt -73.81 -159.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.33 141.54 1.15 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 -173.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.4 ptpt -149.95 140.17 22.19 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.057 -167.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' C' ' 20' ' ' LEU . 6.1 tt -108.39 125.48 51.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.393 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 20.8 m -104.16 123.86 48.05 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.456 HD12 ' N ' ' C' ' 29' ' ' LEU . 5.0 mp -94.58 134.16 37.43 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.453 ' HB3' ' HD2' ' C' ' 37' ' ' LYS . 7.0 t -159.59 142.39 13.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.727 170.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 137.98 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.816 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -136.95 89.8 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.767 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.16 -93.31 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.13 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -114.74 31.01 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.175 0.512 . . . . 0.0 110.216 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.661 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 17.1 tt0 -143.98 124.48 13.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -171.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.02 104.93 16.9 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 166.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -100.26 146.74 26.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 118.52 6.78 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.594 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.5 p -99.07 141.47 31.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.916 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 21.7 p -116.93 118.9 33.71 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.069 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CD ' ' C' ' 26' ' ' LYS . 45.0 m -91.97 176.42 6.52 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.246 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.5 m120 72.19 36.12 1.15 Allowed 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.261 0.976 . . . . 0.0 109.424 -169.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.63 35.42 26.08 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.476 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.36 79.87 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.274 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 24.0 m-85 -69.69 -179.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.063 0.459 . . . . 0.0 110.872 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.35 169.9 32.21 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.162 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.889 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 47.3 mm -54.04 -64.46 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 121.816 0.817 . . . . 0.0 110.907 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.8 t -174.9 -155.67 0.06 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.087 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -87.81 -15.99 35.32 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.29 0.567 . . . . 0.0 110.257 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 43.2 mt-10 -83.43 127.79 33.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.438 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.79 139.05 31.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -125.52 158.63 34.04 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.5 ' O ' HG13 ' C' ' 94' ' ' ILE . 2.2 p-10 -97.17 103.87 15.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.722 0.772 . . . . 0.0 109.591 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.627 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.18 156.36 17.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.811 -171.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.431 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -139.98 132.8 5.71 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 119.459 -1.353 . . . . 0.0 115.582 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.0 mp -120.63 126.6 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.069 -0.565 . . . . 0.0 109.487 170.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.74 137.87 47.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.585 HG23 HG11 ' C' ' 63' ' ' VAL . 65.0 t -101.5 117.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 15.5 m120 56.71 30.37 17.47 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.351 0.407 . . . . 0.0 111.243 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 6.96 73.85 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.053 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -107.73 119.91 40.77 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.532 -0.393 . . . . 0.0 110.578 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -57.91 119.06 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.162 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.585 HG11 HG23 ' C' ' 58' ' ' VAL . 4.3 p -119.52 -43.01 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.981 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -137.07 152.39 49.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.627 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.3 m -145.61 148.02 32.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' C' ' 75' ' ' ILE . 45.9 p90 -155.83 172.37 18.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.699 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.62 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.537 ' O ' HG12 ' C' ' 47' ' ' ILE . 4.2 tt0 -52.68 -40.11 62.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.688 -169.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 20.1 pttp -72.91 -0.84 14.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -169.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -71.32 -176.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.405 ' O ' HG12 ' C' ' 75' ' ' ILE . 28.2 p -74.23 108.91 7.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 t -60.57 -11.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.951 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.24 -38.35 8.49 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.0 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -74.17 -28.79 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.447 HG21 ' CD2' ' C' ' 66' ' ' PHE . 50.7 mm -73.77 -64.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.083 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.586 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 8.6 m -60.71 -48.73 80.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.991 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.539 HD22 ' CG ' ' C' ' 80' ' ' ASN . 7.7 m120 -75.6 -15.5 60.34 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.1 OUTLIER -59.46 -44.85 92.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 166.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' C' ' 76' ' ' SER . 76.6 mt -56.42 -23.27 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.175 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -87.48 -34.39 18.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.106 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' C' ' 78' ' ' ASP . 57.7 mtmt -55.87 -38.89 70.73 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 1.6 mt -60.14 -29.45 68.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.142 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.661 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.66 86.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.275 -170.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.14 99.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.438 -169.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.517 ' CD ' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -64.77 125.84 26.07 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.411 162.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 162.79 158.68 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.911 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.0 Cg_endo -81.15 -62.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.454 2.102 . . . . 0.0 112.585 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.54 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 16.0 p90 -128.37 137.72 52.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.992 0.425 . . . . 0.0 110.166 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.4 mt -122.34 136.45 59.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.97 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -92.2 99.91 12.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.498 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 30.0 mm -113.89 98.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.06 160.73 6.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.36 173.12 12.66 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.831 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.5 HG13 ' O ' ' C' ' 53' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.424 -175.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.785 0.326 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 54.1 mtt -68.49 -150.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.925 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -60.35 -9.52 3.63 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . 0.426 ' O ' HG23 ' C' ' 16' ' ' VAL . 15.3 m -48.89 -49.87 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.673 0.389 . . . . 0.0 111.353 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.43 -18.81 7.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.212 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -69.24 -46.16 68.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -56.3 -34.69 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.477 0.656 . . . . 0.0 109.481 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 12' ' ' SER . 93.9 t -69.43 -37.18 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -63.39 -46.7 85.25 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 110.514 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.6 -19.86 65.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.589 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -90.15 -40.22 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.09 0.471 . . . . 0.0 110.378 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.1 mt -83.22 -32.31 26.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.304 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -92.8 79.06 4.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.358 0.599 . . . . 0.0 109.431 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.595 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -114.17 -30.69 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.948 -170.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.488 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 173.1 -73.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.628 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 54.7 mttp -71.25 -158.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.551 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -45.6 142.47 4.18 Favored Glycine 0 CA--C 1.497 -1.085 0 O-C-N 123.357 0.411 . . . . 0.0 113.547 -177.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.9 ptpt -144.35 150.08 37.2 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.834 -165.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' C' ' 38' ' ' ALA . 0.5 OUTLIER -122.84 113.33 19.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.82 -170.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 74.0 m -103.03 126.2 50.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HG ' HG21 ' C' ' 91' ' ' ILE . 0.7 OUTLIER -98.98 137.76 37.05 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -171.347 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 29.1 m -147.25 130.85 16.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.511 171.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.505 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.7 mtt -122.68 138.67 54.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.329 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -148.68 91.2 1.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.11 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.26 -93.61 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.706 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -108.81 33.17 4.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 109.774 -177.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.745 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.0 tt0 -149.72 139.55 21.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.526 0.679 . . . . 0.0 112.525 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.4 tm? -118.39 127.58 53.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 167.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 23.6 pttm -130.38 105.78 8.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' C' ' 27' ' ' LEU . . . -111.94 128.25 56.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.4 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -103.48 148.75 25.55 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.073 0.463 . . . . 0.0 110.41 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 64.9 p -119.41 138.25 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.338 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 14.7 m -117.35 179.49 4.03 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 80.18 23.41 0.42 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.424 1.078 . . . . 0.0 111.197 -176.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.4 50.06 13.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.393 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -3.36 86.72 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.59 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.9 m-85 -66.07 152.88 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.862 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.11 163.18 31.53 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.194 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.595 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 34.3 mm -51.55 -63.24 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.16 0.981 . . . . 0.0 111.169 177.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -156.98 -176.52 6.02 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.492 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.39 45.76 1.48 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.584 0.707 . . . . 0.0 109.792 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -140.85 145.23 35.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.102 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.69 114.28 16.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 12.4 mptt -126.37 129.95 49.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.739 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.577 HD22 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -89.24 99.19 12.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.945 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.679 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.874 -175.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.18 167.27 40.42 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.832 -1.651 . . . . 0.0 115.649 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.521 HG12 HG13 ' C' ' 91' ' ' ILE . 87.1 mt -125.99 128.2 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.582 -0.809 . . . . 0.0 111.697 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.7 m-85 -123.03 111.26 16.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.207 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -104.86 128.05 58.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CE1' ' C' ' 88' ' ' TYR . 77.0 m-20 54.69 24.71 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.817 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 27.7 29.27 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.543 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.9 pt-20 -143.82 151.13 39.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.292 0.546 . . . . 0.0 110.108 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -82.86 137.86 34.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.78 -32.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -161.9 135.83 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.084 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.679 HG23 ' O ' ' C' ' 54' ' ' TRP . 79.3 m -124.07 142.52 51.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' C' ' 75' ' ' ILE . 38.4 p90 -152.72 -178.01 6.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.594 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 13.9 m120 -124.89 130.44 52.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.048 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.486 ' HG2' HG13 ' C' ' 47' ' ' ILE . 31.2 mt-10 -62.89 -22.55 66.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.57 2.04 27.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.443 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -87.01 -179.64 6.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 23.3 p -77.7 118.19 19.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' C' ' 75' ' ' ILE . 2.1 t -64.53 -12.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -81.8 -41.4 9.74 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.122 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.61 -34.34 78.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.43 ' O ' HG13 ' C' ' 79' ' ' ILE . 74.2 mt -65.45 -68.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.462 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.587 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 3.4 m -56.42 -56.17 24.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.538 HD22 ' ND2' ' C' ' 80' ' ' ASN . 10.2 m120 -76.43 -15.08 60.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.88 -39.64 83.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 166.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' C' ' 76' ' ' SER . 71.7 mt -58.94 -25.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.79 173.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.538 ' ND2' HD22 ' C' ' 77' ' ' ASN . 7.2 m-20 -80.51 -34.16 35.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.61 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -56.53 -38.37 71.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.3 mt -55.81 -35.9 66.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.084 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.745 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 8.1 m120 37.61 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.94 0.775 . . . . 0.0 110.824 -168.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.42 137.82 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.733 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.3 OUTLIER -94.88 113.89 25.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.086 174.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.61 148.82 6.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.367 -1.397 . . . . 0.0 112.929 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.549 ' HG2' ' CD2' ' C' ' 88' ' ' TYR . 98.2 Cg_endo -80.85 -43.81 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.772 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.549 ' CD2' ' HG2' ' C' ' 87' ' ' PRO . 31.8 p90 -123.68 129.65 51.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.483 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 77.1 mt -123.29 123.72 68.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.505 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -92.25 115.08 27.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.553 HG12 ' CH2' ' C' ' 54' ' ' TRP . 15.5 tt -115.98 103.25 14.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.978 0.894 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 159.26 22.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.567 -172.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.4 OUTLIER -90.81 163.04 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.34 0.59 . . . . 0.0 111.077 176.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.577 HG13 HD22 ' C' ' 53' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.808 -167.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.449 ' O ' HG22 ' C' ' 13' ' ' ILE . 91.6 mmm -58.6 163.05 3.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.87 -21.54 30.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.091 -165.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -52.19 -42.38 63.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.033 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.449 HG22 ' O ' ' C' ' 10' ' ' MET . 0.2 OUTLIER -87.09 -32.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.009 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.576 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 11.7 m120 -64.7 -43.75 92.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.707 0.289 . . . . 0.0 111.662 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 -22.55 63.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 50.4 t -85.7 -33.07 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.262 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.576 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 12.8 m120 -57.1 -48.0 79.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.22 -16.31 56.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.856 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -80.46 -42.19 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.01 -36.63 75.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.8 76.12 7.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.721 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.674 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -118.53 7.34 11.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.12 -68.65 0.54 Allowed Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.515 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' C' ' 25' ' ' GLY . 37.7 mttp -82.16 -160.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.578 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.61 137.88 2.34 Favored Glycine 0 CA--C 1.497 -1.06 0 O-C-N 123.846 0.716 . . . . 0.0 114.863 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 11.9 ptpt -147.2 162.1 39.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.767 -168.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.526 HD22 HD13 ' C' ' 29' ' ' LEU . 0.6 OUTLIER -138.92 130.08 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.705 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 16.3 t -106.03 106.13 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.677 ' HG ' HG21 ' C' ' 91' ' ' ILE . 2.2 mm? -92.61 132.14 37.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.241 0.217 . . . . 0.0 111.36 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.402 ' O ' HD22 ' C' ' 36' ' ' LEU . 18.1 m -145.91 129.65 17.15 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.747 172.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 62.1 mtm -129.31 129.17 44.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.051 -174.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.685 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 4.3 t-20 -150.96 107.01 3.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.165 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.8 -97.26 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.502 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.38 30.21 6.88 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.389 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 11.1 pt20 -126.7 129.65 48.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.325 0.583 . . . . 0.0 111.562 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.722 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.6 tm? -130.76 127.14 38.15 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.618 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -144.04 128.94 18.44 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -145.77 118.73 8.75 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.679 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 48.8 p -102.88 152.05 21.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.716 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' C' ' 72' ' ' VAL . 40.2 t -117.36 118.08 31.27 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 30.7 t -96.98 178.06 5.41 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.88 32.29 0.51 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 124.284 0.99 . . . . 0.0 109.16 -167.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.33 31.66 20.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.214 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.75 80.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.76 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -69.54 168.79 13.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.739 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.37 -175.62 43.37 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.277 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.674 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 15.3 mm -64.63 -61.74 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.2 t -170.11 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.01 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -157.49 -45.83 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -77.24 150.81 35.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.986 0.422 . . . . 0.0 111.06 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -97.82 126.74 43.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.45 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -111.5 157.36 20.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.482 HD22 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -96.16 112.69 24.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.547 0.689 . . . . 0.0 110.858 178.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.676 ' HH2' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -103.4 166.56 10.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.351 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.86 150.91 21.16 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.305 -1.426 . . . . 0.0 115.81 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.414 HG23 HD13 ' C' ' 91' ' ' ILE . 49.6 mt -124.55 136.06 61.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.985 169.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.437 ' O ' HG23 ' C' ' 89' ' ' ILE . 3.9 m-85 -131.19 134.46 46.52 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.548 HG23 HG11 ' C' ' 63' ' ' VAL . 85.6 t -102.41 114.96 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.16 31.08 19.41 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.337 0.398 . . . . 0.0 111.333 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.9 5.38 73.89 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.307 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.57 126.01 52.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.047 0.424 . . . . 0.0 110.187 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.42 ' HD3' ' CE2' ' C' ' 57' ' ' PHE . 21.7 tptm -60.01 126.07 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.619 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' C' ' 58' ' ' VAL . 1.7 p -120.36 -37.29 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -148.47 152.73 37.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.596 0.236 . . . . 0.0 110.743 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 54' ' ' TRP . 33.2 m -140.54 146.01 37.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.86 -177.86 6.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.23 0.468 . . . . 0.0 111.399 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.04 135.73 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.598 ' O ' HG12 ' C' ' 47' ' ' ILE . 1.3 tt0 -60.1 -47.16 87.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.805 -173.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.8 -2.89 10.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.6 m -71.01 -174.87 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 4.6 p -77.98 104.19 8.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.566 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 2.9 t -60.36 -12.11 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.898 -173.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.71 -29.12 22.12 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.821 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -81.15 -28.45 35.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.13 -52.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.708 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.641 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.1 p -53.98 -60.79 2.86 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.054 -175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -70.48 -16.98 62.97 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 1.3 m-20 -62.68 -41.15 98.94 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 166.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.5 mt -57.83 -22.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.291 175.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -83.82 -38.99 20.52 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.677 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 18.5 ptmt -62.56 -27.77 69.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.78 -31.67 66.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.55 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 37.19 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.083 1.489 . . . . 0.0 113.335 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.722 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.6 tp -42.08 145.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.111 -174.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -149.59 18.6 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.613 0.721 . . . . 0.0 109.164 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.85 162.19 14.2 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.768 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.27 -35.39 0.65 Allowed 'Trans proline' 0 CA--C 1.518 -0.284 0 C-N-CA 122.652 2.234 . . . . 0.0 111.487 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -158.81 132.36 7.45 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.834 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.65 HD12 HD11 ' C' ' 84' ' ' ILE . 70.1 mt -134.81 139.27 47.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.433 -173.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 23.8 mm-40 -91.2 103.49 16.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.96 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.677 HG21 ' HG ' ' C' ' 29' ' ' LEU . 15.7 mm -100.75 96.23 4.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -158.56 167.75 28.76 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 1.9 pt20 -100.25 162.35 13.01 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.402 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.482 HG13 HD22 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 -163.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 . . . . . 0 N--CA 1.461 0.107 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 5.8 mmt -65.04 -171.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -43.31 -36.69 1.94 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.487 0.715 . . . . 0.0 112.841 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 55.2 m -43.04 -54.01 4.54 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.835 0.709 . . . . 0.0 111.918 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -91.12 -19.82 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.549 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.03 -47.78 64.54 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.73 0.3 . . . . 0.0 110.748 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 26.9 p -57.3 -34.45 68.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.79 -37.39 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.58 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.15 -39.29 82.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.169 0.509 . . . . 0.0 109.843 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -78.33 -18.12 55.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.407 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -90.1 -42.58 11.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.676 0.274 . . . . 0.0 110.423 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.08 -32.01 68.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.48 71.07 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -109.21 -40.55 4.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.537 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -175.07 -68.98 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.6 ttmm -97.06 -174.59 3.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 166.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 30.73 89.92 0.01 OUTLIER Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.0 ptpt -128.68 125.34 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.579 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.479 HD22 ' HG ' ' C' ' 29' ' ' LEU . 1.5 tt -107.2 115.42 30.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.232 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 18.3 t -86.16 113.94 22.6 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.479 ' HG ' HD22 ' C' ' 27' ' ' LEU . 0.2 OUTLIER -112.72 123.14 49.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.652 0.263 . . . . 0.0 110.823 -173.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.408 ' O ' HD22 ' C' ' 36' ' ' LEU . 12.5 p -151.43 142.71 23.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.674 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.45 135.44 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.326 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.636 ' OD1' ' HE3' ' C' ' 37' ' ' LYS . 11.9 m120 -139.25 91.68 2.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.564 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.74 -94.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.472 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.25 30.3 7.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.747 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.746 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.3 tt0 -143.64 138.9 29.3 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 2.8 tm? -106.2 106.38 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 164.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.636 ' HE3' ' OD1' ' C' ' 32' ' ' ASN . 22.3 pttp -98.93 151.45 20.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.68 141.57 22.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.396 0.617 . . . . 0.0 112.299 -173.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.4 p -121.44 146.94 46.39 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.903 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 m -127.8 117.12 21.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.4 m -101.94 177.67 4.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.474 -176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' C' ' 24' ' ' LYS . 0.3 OUTLIER 65.75 42.82 3.38 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.219 0.95 . . . . 0.0 108.859 -167.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 63.39 21.5 12.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.266 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.38 24.38 76.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.701 -0.762 . . . . 0.0 113.33 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' VAL . 35.2 m-85 -80.21 -179.01 6.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.83 0.315 . . . . 0.0 111.249 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.17 -162.64 38.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.324 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 6.8 mt -49.59 -67.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 112.118 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.6 p 173.57 -73.7 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.976 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -140.67 -16.08 0.91 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.816 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 4.8 pt-20 -99.43 173.88 6.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.09 121.85 40.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.135 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.407 ' HB2' HD11 ' C' ' 47' ' ' ILE . 8.6 mptt -124.13 135.44 53.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 111.198 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.716 ' ND2' HG13 ' C' ' 94' ' ' ILE . 9.0 t30 -89.08 116.49 27.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.684 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.559 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.2 163.39 13.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.0 147.22 8.86 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.327 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 91' ' ' ILE . 2.6 mp -107.63 129.84 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.067 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 52.9 m-85 -129.94 122.2 28.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.534 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 4.6 p -108.88 117.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 60.19 28.01 17.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.129 0.49 . . . . 0.0 110.462 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.9 16.46 79.91 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.388 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 30.5 mt-10 -107.06 147.56 29.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.617 0.722 . . . . 0.0 111.064 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.54 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 41.9 tptt -81.77 120.53 25.27 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.037 -169.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.406 ' CG2' HG12 ' C' ' 58' ' ' VAL . 41.2 t -109.71 -70.16 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.923 0.392 . . . . 0.0 110.929 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -137.89 143.66 40.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.909 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.559 HG23 ' O ' ' C' ' 54' ' ' TRP . 67.7 m -136.15 143.21 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.593 ' CD1' HG21 ' C' ' 75' ' ' ILE . 44.3 p90 -159.75 -172.61 3.74 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -116.91 137.39 52.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.85 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.655 ' HB3' HD11 ' C' ' 47' ' ' ILE . 0.7 OUTLIER -71.36 -28.68 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.44 -172.174 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 13.2 ptmm? -93.14 19.22 8.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.844 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 p -76.15 -119.97 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -131.7 107.66 8.95 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 166.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 45' ' ' TYR . 20.7 t -55.96 -24.33 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.043 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.31 -31.34 42.32 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.525 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.22 -33.96 67.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.593 HG21 ' CD1' ' C' ' 66' ' ' PHE . 27.5 mm -78.39 -54.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.158 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.659 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 64.3 p -53.61 -52.61 59.29 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.437 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' C' ' 80' ' ' ASN . 7.3 m120 -77.48 -16.44 58.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -64.35 -37.89 89.09 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' C' ' 76' ' ' SER . 82.4 mt -60.31 -22.27 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.979 173.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.516 ' CG ' HD22 ' C' ' 77' ' ' ASN . 0.8 OUTLIER -81.31 -34.49 31.88 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.545 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -53.13 -41.97 65.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.1 mt -58.83 -30.32 67.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.821 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.21 85.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.153 0.908 . . . . 0.0 111.227 -170.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 17.2 mm -55.06 138.54 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -169.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.27 170.51 9.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.029 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.34 173.34 15.44 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.352 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.3 Cg_endo -80.71 -47.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.487 2.125 . . . . 0.0 112.094 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.444 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 44.1 p90 -150.29 141.54 23.2 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.16 132.67 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.496 . . . . 0.0 111.022 -172.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -91.83 98.71 11.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.558 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 56' ' ' ILE . 13.8 tt -101.13 99.06 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 173.38 17.06 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.348 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -105.5 158.86 16.37 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.934 176.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.716 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 -166.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 22.2 mmt -70.4 -162.95 0.06 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.421 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.422 ' H ' ' HB3' ' C' ' 10' ' ' MET . 3.7 m-20 -52.26 -23.34 5.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -49.47 -43.93 45.51 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.148 0.28 . . . . 0.0 110.968 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.44 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 6.7 mt -88.7 -23.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.221 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.04 -49.0 49.65 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.931 -0.48 . . . . 0.0 110.672 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -57.98 -32.54 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.797 0.808 . . . . 0.0 109.429 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' C' ' 13' ' ' ILE . 2.2 t -67.99 -39.29 81.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.915 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' C' ' 29' ' ' LEU . 6.9 m-80 -65.67 -36.44 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -77.3 -20.17 55.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.665 176.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.19 -34.25 61.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.951 0.881 . . . . 0.0 108.886 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' C' ' 26' ' ' LYS . 49.6 mt -78.05 -40.26 39.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.616 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.11 82.58 4.18 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.733 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -5.8 9.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.55 -75.77 0.23 Allowed Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.842 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.6 ttmt -87.36 -156.85 0.36 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.479 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -18.78 106.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.589 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 0.5 OUTLIER -114.08 171.68 7.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.847 -175.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' C' ' 39' ' ' THR . 3.3 tt -156.74 115.47 3.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -173.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 69.3 m -93.9 127.5 39.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' C' ' 91' ' ' ILE . 86.7 mt -97.62 139.01 34.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -176.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.417 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 19.0 m -148.43 128.12 13.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.826 168.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.455 ' HG3' HD23 ' C' ' 36' ' ' LEU . 2.9 mpp? -116.7 133.18 56.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.88 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' C' ' 35' ' ' GLN . 5.2 p-10 -149.0 90.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.234 0.54 . . . . 0.0 111.653 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.24 -93.58 0.04 OUTLIER Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.556 173.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -105.71 32.36 4.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 110.494 -176.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.609 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.1 tt0 -150.18 142.01 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' C' ' 31' ' ' MET . 3.0 tm? -122.93 116.98 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 17.3 pttm -123.47 144.81 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -146.05 167.64 22.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.345 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 68.5 p -139.77 143.45 36.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.447 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 68.1 m -127.72 117.43 21.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.129 0.49 . . . . 0.0 109.688 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.589 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 67.9 m -100.81 179.56 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.7 m120 69.57 45.48 0.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 124.299 0.999 . . . . 0.0 109.026 -164.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.65 23.63 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.81 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' C' ' 71' ' ' THR . . . 69.38 21.69 76.06 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.949 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.75 -178.86 1.01 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.207 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.58 159.5 53.15 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.095 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.733 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 32.5 mm -52.31 -60.04 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-O 121.516 0.674 . . . . 0.0 111.067 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' C' ' 49' ' ' TYR . 45.5 t -135.62 -84.72 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.875 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' C' ' 48' ' ' SER . 34.1 p90 179.59 -22.88 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.589 ' CG ' ' HE3' ' C' ' 52' ' ' LYS . 0.4 OUTLIER -97.8 172.63 7.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.377 0.608 . . . . 0.0 111.373 -178.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.81 107.18 19.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.813 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.589 ' HE3' ' CG ' ' C' ' 50' ' ' GLU . 27.0 mmtp -120.57 154.24 35.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.855 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' C' ' 93' ' ' GLN . 0.8 OUTLIER -89.25 101.85 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.917 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.503 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.43 159.76 15.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.724 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -158.09 153.75 24.9 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 118.191 -1.957 . . . . 0.0 116.434 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.413 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.5 mp -120.84 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.172 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' C' ' 62' ' ' LYS . 36.2 m-85 -126.8 156.34 41.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.2 113.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 110.053 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 54.42 39.39 30.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.535 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.78 -3.62 86.01 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.336 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 148.14 28.99 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' C' ' 57' ' ' PHE . 53.5 mtpt -91.74 137.93 31.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.991 0.424 . . . . 0.0 110.813 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.93 -50.77 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.077 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -150.49 152.34 34.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.484 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 89.2 m -128.07 126.87 42.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.543 ' CG ' HG21 ' C' ' 75' ' ' ILE . 11.5 p90 -133.18 178.49 6.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.031 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 28.6 m-80 -121.77 142.04 50.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.691 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.695 ' HG2' HG21 ' C' ' 47' ' ' ILE . 5.4 mt-10 -65.24 -10.8 34.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.34 -2.52 52.01 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.26 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -88.29 157.72 18.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' C' ' 44' ' ' GLY . 30.9 p -76.72 113.07 13.97 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -16.22 7.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.185 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.62 -36.32 38.2 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.953 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -77.07 -31.06 55.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.543 HG21 ' CG ' ' C' ' 66' ' ' PHE . 49.5 mm -75.16 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.26 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.635 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 96.6 p -58.76 -50.71 72.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -171.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.519 HD22 ' CG ' ' C' ' 80' ' ' ASN . 4.1 m120 -79.33 -17.34 54.73 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -172.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -34.47 74.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.606 167.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' C' ' 76' ' ' SER . 91.6 mt -61.1 -20.83 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.978 173.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.519 ' CG ' HD22 ' C' ' 77' ' ' ASN . 0.9 OUTLIER -76.01 -43.48 44.02 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.875 179.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -51.87 -38.06 54.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.525 0.679 . . . . 0.0 109.512 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.6 mt -55.96 -33.1 64.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.885 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.609 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 38.0 79.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.928 0.768 . . . . 0.0 111.201 -172.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.07 136.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.403 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 1.4 ptpt -81.96 39.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.677 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.65 128.15 9.48 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.027 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.39 -40.31 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.263 1.975 . . . . 0.0 110.851 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.78 97.85 5.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -103.45 124.4 57.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.531 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.78 100.75 9.18 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.026 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' C' ' 29' ' ' LEU . 4.5 mt -95.19 98.63 8.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.12 149.55 24.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.193 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 53' ' ' ASN . 6.6 tt0 -73.8 144.41 45.57 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.641 -176.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.465 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.599 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.613 ' HG2' ' SD ' ' C' ' 31' ' ' MET . 11.1 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.447 ' O ' HG13 ' C' ' 13' ' ' ILE . 1.5 mpt? -82.95 -143.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' C' ' 10' ' ' MET . 33.1 m-80 -53.44 -18.93 3.03 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -174.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . 0.494 ' O ' HG23 ' C' ' 16' ' ' VAL . 68.9 m -54.44 -33.24 59.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.503 HG21 ' SD ' ' C' ' 31' ' ' MET . 2.4 pp -89.55 -27.79 5.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.987 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -73.31 -43.65 60.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.689 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -58.25 -33.46 69.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.348 0.594 . . . . 0.0 109.448 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.634 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 76.3 t -74.13 -34.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.252 175.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.506 HD21 ' HB2' ' C' ' 29' ' ' LEU . 7.7 m-80 -58.99 -40.29 84.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -75.39 -15.85 60.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.358 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -87.93 -31.58 19.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.487 0.66 . . . . 0.0 109.578 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' C' ' 27' ' ' LEU . 79.4 mt -82.94 -39.87 20.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.559 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -77.14 64.41 2.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 109.597 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -103.58 7.95 37.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.211 -172.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.42 -61.87 0.64 Allowed Glycine 0 CA--C 1.504 -0.613 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.73 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 26.9 mmmt -79.28 -159.47 0.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.105 175.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -48.71 143.38 8.01 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 121.568 -0.349 . . . . 0.0 113.652 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.73 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 5.8 ptpt -150.44 135.8 17.97 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.455 -164.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.703 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.6 mp -92.04 126.92 37.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.881 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 23.8 m -95.65 99.5 11.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.52 HD13 HG23 ' C' ' 91' ' ' ILE . 16.2 mt -82.58 126.2 32.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 46.9 t -146.4 129.19 16.25 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.613 ' SD ' ' HG2' ' C' ' 9' ' ' GLN . 0.5 OUTLIER -113.25 124.04 51.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.47 91.08 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.56 -99.43 0.25 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.115 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.88 13.28 29.29 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.947 0.374 . . . . 0.0 111.147 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.4 tt0 -136.77 147.26 46.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.617 0.722 . . . . 0.0 112.189 -170.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.578 HD21 HD12 ' C' ' 91' ' ' ILE . 9.6 tp -130.78 113.56 14.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.885 171.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 19.7 pttp -122.9 104.53 9.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -112.37 118.9 36.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.159 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 42.1 p -97.09 148.06 23.4 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.271 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 67.1 p -109.66 119.46 39.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.487 -175.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.455 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 18.4 t -95.19 175.62 6.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.424 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 4.4 m-20 63.21 31.39 15.6 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.679 0.612 . . . . 0.0 110.32 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.96 10.54 7.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.789 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.1 24.76 28.56 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.167 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 52.5 m-85 -72.43 -179.24 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.578 0.689 . . . . 0.0 110.31 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.46 -157.62 29.73 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.332 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.591 ' H ' ' HA ' ' C' ' 69' ' ' LYS . 75.7 mt -49.9 -65.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 C-N-CA 123.265 0.626 . . . . 0.0 111.125 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 27.5 t 173.25 -72.68 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.898 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -140.95 -32.51 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.71 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.517 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.7 pt-20 -85.07 177.6 7.85 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.183 -0.323 . . . . 0.0 110.754 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 27.8 t70 -123.78 141.95 51.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 32.6 mmtm -124.02 153.15 41.74 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.759 173.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -98.88 112.6 24.65 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.454 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.602 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -102.53 162.08 13.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.691 -173.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.99 150.51 21.13 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.653 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.516 HD11 HD13 ' C' ' 79' ' ' ILE . 46.5 mt -120.21 135.23 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 170.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.447 ' CE1' ' HG2' ' C' ' 62' ' ' LYS . 58.0 m-85 -133.07 148.88 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.643 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.6 p -143.56 129.98 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.38 27.96 12.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.132 0.491 . . . . 0.0 111.171 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 1.35 81.39 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.829 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 11.6 pt-20 -112.57 157.33 21.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.642 0.721 . . . . 0.0 110.426 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.447 ' HG2' ' CE1' ' C' ' 57' ' ' PHE . 60.4 mtpt -76.85 131.65 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.68 -49.61 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.346 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' C' ' 56' ' ' ILE . 62.3 t80 -157.0 161.79 39.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.823 -172.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -145.85 159.72 42.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.1 p90 -168.72 -178.41 3.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.0 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -119.89 121.97 40.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.712 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' C' ' 47' ' ' ILE . 43.6 tp10 -61.0 -22.73 64.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' C' ' 47' ' ' ILE . 22.8 ptmt -85.22 4.89 32.6 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.906 -0.496 . . . . 0.0 111.77 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -75.29 -118.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.438 ' O ' HG12 ' C' ' 75' ' ' ILE . 1.5 p -131.22 108.07 9.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 169.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.485 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 48.0 t -56.72 -22.23 15.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.667 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.8 -39.17 25.42 Favored Glycine 0 CA--C 1.504 -0.644 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.417 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -68.68 -40.42 80.11 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' C' ' 66' ' ' PHE . 48.3 mm -64.79 -63.62 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.562 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 50.4 m -53.64 -63.72 1.06 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -169.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.842 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -70.09 -16.78 63.18 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.466 -0.893 . . . . 0.0 113.289 -171.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 35.8 m-20 -73.75 -37.0 65.2 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.6 168.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' C' ' 76' ' ' SER . 89.4 mt -60.09 -32.59 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.743 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.842 HD22 ' ND2' ' C' ' 77' ' ' ASN . 32.0 m-20 -85.38 -34.39 21.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.052 -172.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 56.4 pttt -57.81 -26.99 62.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 16.4 mt -61.32 -25.73 67.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.767 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.695 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 40.12 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.898 0.856 . . . . 0.0 111.949 -172.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' C' ' 84' ' ' ILE . 37.6 mm -71.2 113.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.648 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.485 ' H ' ' HE3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -93.21 119.63 32.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.128 174.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.47 147.99 6.58 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.65 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.46 -37.45 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.285 1.99 . . . . 0.0 111.825 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.3 98.87 6.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -99.76 125.86 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.553 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -122.82 123.64 41.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.862 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.602 HG12 ' CH2' ' C' ' 54' ' ' TRP . 20.1 tt -129.43 99.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 151.56 25.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.447 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -85.65 163.89 18.02 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.946 176.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.48 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.332 -164.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.414 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 61.0 mtm -87.81 -144.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 176.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 18.5 m120 -61.67 -9.02 5.28 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.4 m -49.77 -44.9 49.09 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.13 0.269 . . . . 0.0 110.634 175.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 21.5 pt -90.85 -24.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.163 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 2.2 m-20 -64.97 -36.34 84.1 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.921 0.391 . . . . 0.0 110.119 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 37.1 t -55.37 -35.91 65.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.532 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 76.1 t -71.29 -37.53 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.181 174.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' C' ' 28' ' ' SER . 33.4 m-80 -65.88 -47.08 76.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.765 -177.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -68.68 -17.17 64.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.324 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -90.33 -38.2 13.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.266 0.555 . . . . 0.0 110.466 -176.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 55.9 mt -86.57 -26.92 24.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -80.32 84.63 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -120.7 -40.43 2.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.411 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . 174.89 -68.95 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -172.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.701 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 45.9 mttp -76.09 -159.03 0.1 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.79 130.49 1.86 Allowed Glycine 0 CA--C 1.501 -0.787 0 O-C-N 123.898 0.749 . . . . 0.0 114.398 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.701 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.9 OUTLIER -134.63 143.4 47.28 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.721 -173.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 32.4 tp -117.39 123.44 46.44 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.032 0.444 . . . . 0.0 111.156 -174.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 44.3 m -100.53 104.28 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.152 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.76 133.16 35.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -145.15 131.68 19.8 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.931 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 79.7 mtp -115.54 134.86 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.854 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.592 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 17.9 m120 -134.58 89.49 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.508 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.63 -93.23 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.566 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.9 OUTLIER -108.92 29.58 7.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.556 0.217 . . . . 0.0 110.959 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.671 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 47.7 tt0 -143.88 140.7 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.536 0.684 . . . . 0.0 111.934 -168.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.3 tm? -118.92 118.98 33.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 171.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.592 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 44.8 pttt -129.18 104.56 7.61 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -118.16 119.4 34.6 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 67.8 p -98.01 145.14 26.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.145 0.498 . . . . 0.0 111.193 -174.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 16.6 p -109.61 119.14 38.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.373 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 16.3 t -95.34 -170.39 2.16 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.04 18.54 0.48 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.448 1.093 . . . . 0.0 110.593 -170.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.24 34.21 23.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.673 173.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.13 -18.24 46.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.178 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -57.79 140.15 52.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.311 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' C' ' 24' ' ' LYS . . . -79.51 156.06 40.45 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.709 -174.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.57 ' HB ' ' HG2' ' C' ' 68' ' ' GLU . 70.2 mt -56.08 -53.32 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.533 0.683 . . . . 0.0 112.104 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.611 ' HB2' ' OE2' ' C' ' 68' ' ' GLU . 31.2 t -116.61 176.93 4.89 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.912 -169.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -119.61 3.85 11.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.68 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' C' ' 52' ' ' LYS . 27.6 mt-10 -125.3 171.24 10.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.442 176.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.58 96.27 10.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.164 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.486 ' HD3' ' HB2' ' C' ' 50' ' ' GLU . 17.9 mmmt -98.98 158.98 15.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.793 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.627 HD22 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -101.18 110.86 22.93 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.491 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.2 OUTLIER -114.47 165.06 13.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -168.687 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.45 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -174.12 165.86 37.67 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 119.174 -1.488 . . . . 0.0 115.741 172.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.45 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.0 mp -116.19 134.1 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.983 176.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 82.3 m-85 -121.06 142.06 50.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 178.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -134.34 124.4 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.16 27.36 14.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.66 35.66 31.54 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.235 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 9.5 pt-20 -140.83 153.02 45.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -81.69 130.76 35.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 111.348 -177.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.426 ' CG2' HG12 ' C' ' 58' ' ' VAL . 53.7 t -105.89 -51.87 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.63 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -141.75 147.54 37.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.643 -176.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 2.3 t -131.89 158.12 42.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 54.8 p90 -167.82 -174.63 2.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.524 0.678 . . . . 0.0 112.725 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.04 140.22 49.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.743 -177.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.611 ' OE2' ' HB2' ' C' ' 48' ' ' SER . 19.8 tt0 -79.13 -6.83 57.44 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -168.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.0 ptmt -104.18 6.51 35.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.996 -0.44 . . . . 0.0 111.396 -177.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 39.4 p -81.84 -163.57 0.67 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.48 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 20.0 p -93.54 106.94 18.86 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.53 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.2 t -59.68 -15.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.335 -169.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 -35.66 14.68 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.071 -178.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . 0.439 HD22 ' N ' ' C' ' 74' ' ' ASN . 0.9 OUTLIER -69.28 -35.97 76.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.173 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' C' ' 78' ' ' ASP . 46.2 mm -70.96 -63.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.388 -178.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.0 m -58.15 -46.61 85.38 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.992 -170.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.808 ' ND2' HD22 ' C' ' 80' ' ' ASN . 9.5 m120 -72.89 -14.72 61.54 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.621 -0.832 . . . . 0.0 112.966 -177.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.512 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 51.6 m-20 -56.44 -51.76 67.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 165.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' C' ' 76' ' ' SER . 67.5 mt -54.25 -33.41 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.754 176.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.808 HD22 ' ND2' ' C' ' 77' ' ' ASN . 38.9 m-20 -87.8 -37.71 16.34 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.814 -169.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.499 ' CE ' ' HA ' ' C' ' 78' ' ' ASP . 51.2 mtmt -56.39 -28.61 59.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.285 0.564 . . . . 0.0 109.781 176.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.5 mt -59.14 -28.06 66.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.779 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.671 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.7 m120 39.79 75.82 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.717 0.77 . . . . 0.0 110.42 -170.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.417 HG22 ' H ' ' C' ' 86' ' ' GLY . 25.2 mt -74.2 131.27 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.495 -171.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 2.3 ptpt -83.84 29.59 0.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.292 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.417 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -76.12 142.48 28.48 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.459 -175.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.62 -39.79 0.22 Allowed 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.743 2.296 . . . . 0.0 111.377 176.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -144.45 123.54 12.87 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.744 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.63 128.72 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.755 -175.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.16 110.42 22.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.269 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.586 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.5 mt -99.87 103.66 15.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.2 154.53 25.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.269 -172.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.23 162.29 19.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.435 0.636 . . . . 0.0 111.693 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.627 HG13 HD22 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.659 -170.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtm -98.04 -141.45 0.3 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.603 -177.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -47.44 -26.92 1.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -175.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -47.8 -46.34 30.49 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.27 0.356 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -90.67 -22.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.268 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.83 -51.48 40.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.259 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 17.7 t -58.37 -32.69 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.521 0.677 . . . . 0.0 109.639 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 60.0 t -71.39 -34.47 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.064 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -62.74 -37.33 86.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.163 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.22 -30.98 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.571 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -78.21 -33.39 49.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.73 0.776 . . . . 0.0 109.803 -176.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.647 HD13 ' HG ' ' C' ' 27' ' ' LEU . 90.2 mt -80.91 -40.38 24.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.241 -176.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -81.77 67.02 7.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.43 0.633 . . . . 0.0 109.831 177.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -100.95 -17.26 16.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.469 -174.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.78 -64.56 0.36 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.306 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 24.3 mmmt -84.02 -157.48 0.27 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -38.82 131.32 1.83 Allowed Glycine 0 CA--C 1.503 -0.697 0 O-C-N 124.048 0.843 . . . . 0.0 115.158 -175.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.764 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.3 OUTLIER -143.15 144.44 32.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.144 -1.028 . . . . 0.0 110.061 -172.411 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.647 ' HG ' HD13 ' C' ' 20' ' ' LEU . 1.4 pt? -123.82 112.64 17.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.681 175.087 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.784 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.2 m -82.61 104.2 12.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.974 -176.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.55 HD13 HG23 ' C' ' 91' ' ' ILE . 13.3 mt -79.78 122.29 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.369 -170.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.464 ' O ' HD22 ' C' ' 36' ' ' LEU . 5.8 m -129.69 128.51 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.167 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.457 ' HG2' HD23 ' C' ' 36' ' ' LEU . 53.8 mtt -132.24 116.83 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.249 -176.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 46.7 t30 -150.75 96.96 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.606 0.241 . . . . 0.0 111.32 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . 0.431 ' O ' HG22 ' C' ' 84' ' ' ILE . . . 67.15 -92.69 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.682 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -101.22 -20.83 15.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.593 0.711 . . . . 0.0 109.912 -176.657 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 17.4 pt20 -88.68 127.85 35.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.692 0.758 . . . . 0.0 111.899 -171.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.598 HD23 HG13 ' C' ' 84' ' ' ILE . 1.6 tm? -131.27 117.69 19.33 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 47.5 pttt -144.64 106.28 4.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.784 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.04 129.0 46.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 3.9 m -95.87 129.84 42.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.651 0.738 . . . . 0.0 110.198 -176.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 61.7 p -107.26 118.68 37.34 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.68 -176.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 m -121.61 179.14 4.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.757 -175.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.441 ' HB2' ' CE ' ' C' ' 26' ' ' LYS . 0.8 OUTLIER 66.57 42.17 2.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.276 0.985 . . . . 0.0 109.439 -169.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.19 27.47 17.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.98 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.75 19.07 72.91 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.589 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 36.1 m-85 -70.98 -178.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.204 0.502 . . . . 0.0 110.857 176.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.1 -154.67 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.848 -177.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.675 HD12 ' O ' ' C' ' 50' ' ' GLU . 32.2 mt -50.19 -67.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 C-N-CA 123.56 0.744 . . . . 0.0 112.729 -177.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 23.3 t 173.06 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 124.655 1.222 . . . . 0.0 109.656 -175.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -156.07 49.32 0.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.138 0.494 . . . . 0.0 110.633 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.9 pt-20 -169.05 -178.68 3.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' HD3' ' C' ' 69' ' ' LYS . 8.7 p-10 -128.8 126.51 40.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.72 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.5 mmmt -104.69 157.59 17.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.601 HD22 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -98.18 101.45 12.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.018 177.144 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.625 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -97.28 166.89 11.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.379 -174.761 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.1 166.68 39.88 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 118.535 -1.793 . . . . 0.0 116.484 176.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.402 HG12 HG13 ' C' ' 91' ' ' ILE . 19.2 mt -128.6 139.56 51.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 113.799 -1.201 . . . . 0.0 109.747 175.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 40.6 m-85 -134.02 113.51 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.432 -176.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' C' ' 63' ' ' VAL . 41.1 t -80.96 105.59 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.553 HD22 ' N ' ' C' ' 59' ' ' ASN . 0.8 OUTLIER 62.82 28.66 16.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 110.481 -176.112 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.08 67.98 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.4 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.4 tt0 -107.68 123.56 48.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.487 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 86.9 tttt -61.9 103.28 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.372 0.606 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.467 ' CG1' HG23 ' C' ' 58' ' ' VAL . 0.9 OUTLIER -97.29 -53.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 177.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -130.46 149.14 52.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.625 HG23 ' O ' ' C' ' 54' ' ' TRP . 80.0 m -149.66 138.22 20.82 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -150.9 -175.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.644 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -116.93 134.27 54.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.449 ' C ' HG13 ' C' ' 47' ' ' ILE . 27.7 tt0 -66.91 -13.58 61.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.423 -171.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.7 ptmm? -84.23 -17.59 39.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.736 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -62.07 154.9 25.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -64.82 111.44 2.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.271 -172.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.38 -15.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.912 -173.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.67 -39.08 14.88 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 120.052 -1.07 . . . . 0.0 111.432 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.05 -36.36 72.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.129 0.49 . . . . 0.0 109.697 177.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.53 -56.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.531 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 80.7 p -57.57 -58.81 6.69 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -171.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.878 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -68.23 -19.1 64.71 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.201 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 0.9 OUTLIER -74.73 -36.19 62.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.846 169.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' C' ' 76' ' ' SER . 58.9 mt -59.59 -31.86 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.81 0.814 . . . . 0.0 109.381 170.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.878 HD22 ' ND2' ' C' ' 77' ' ' ASN . 31.8 m-20 -81.78 -35.1 29.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.919 -172.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 16.0 ptpt -59.97 -31.08 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.9 mt -56.12 -31.47 63.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.224 177.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.19 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.543 1.152 . . . . 0.0 113.189 -173.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.598 HG13 HD23 ' C' ' 36' ' ' LEU . 9.5 mm -35.57 141.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.602 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -143.78 7.93 1.47 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.99 -178.678 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.54 -175.61 20.07 Favored Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 118.997 -1.573 . . . . 0.0 111.988 -173.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.52 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 84.3 Cg_endo -81.01 -87.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.493 2.129 . . . . 0.0 111.836 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' C' ' 59' ' ' ASN . 25.1 p90 -108.23 110.88 22.6 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.623 0.725 . . . . 0.0 110.284 178.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.09 126.53 74.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.85 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.68 141.36 28.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 -174.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.55 HG23 HD13 ' C' ' 29' ' ' LEU . 12.0 tt -136.07 99.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.322 1.058 . . . . 0.0 108.37 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 164.52 9.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.114 -171.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -96.66 161.2 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.928 177.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.601 HG13 HD22 ' C' ' 53' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.986 -164.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.493 ' O ' HG22 ' C' ' 13' ' ' ILE . 25.5 mmt -105.64 -142.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.81 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.79 -25.74 30.12 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -177.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -55.0 -50.06 69.93 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.493 HG22 ' O ' ' C' ' 10' ' ' MET . 4.9 tt -73.71 -36.18 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.413 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 77.5 m-20 -72.15 -36.14 69.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.596 -177.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -57.69 -39.41 77.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 72.7 t -66.57 -33.95 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 174.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 11.7 m120 -59.63 -44.9 93.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.834 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.28 -17.02 61.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.566 179.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' C' ' 16' ' ' VAL . 23.3 tptm -87.12 -36.27 18.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.954 -177.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 14.9 mt -82.44 -26.03 33.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.139 -177.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -81.14 61.21 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' C' ' 25' ' ' GLY . 0.0 OUTLIER -91.75 -40.87 11.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.341 -166.683 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . -169.76 -95.67 0.1 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' C' ' 48' ' ' SER . 29.6 ttmt -91.62 145.21 24.78 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.504 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 63.85 127.55 0.01 OUTLIER Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.524 -170.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.8 ptpt -151.14 140.45 21.36 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 121.962 -0.728 . . . . 0.0 112.187 177.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.468 HD12 ' N ' ' C' ' 27' ' ' LEU . 2.5 mp -117.76 124.02 47.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.136 -176.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 6.1 t -97.63 98.86 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 52.7 mt -80.53 136.05 36.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.068 0.461 . . . . 0.0 111.667 -173.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -141.91 128.91 20.75 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.945 171.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.453 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 51.2 mtt -118.31 114.72 23.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.826 -176.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -132.92 90.64 2.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.218 -174.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.86 -104.09 0.41 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.337 175.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.45 34.26 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 109.519 -177.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.578 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 33.4 tt0 -148.65 133.4 17.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.481 0.657 . . . . 0.0 112.656 -178.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.453 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 0.6 OUTLIER -112.89 123.23 49.83 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 165.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -137.0 140.33 42.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.94 132.5 14.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.676 -177.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -96.88 134.34 40.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 10.6 p -109.52 119.7 40.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.593 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.412 ' HB2' ' CG ' ' C' ' 26' ' ' LYS . 16.0 m -106.55 -178.71 3.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.405 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 77.34 27.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 124.439 1.087 . . . . 0.0 109.832 -174.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.27 31.97 17.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.583 174.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.06 -19.69 33.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.154 175.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -56.11 130.71 45.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.542 0.171 . . . . 0.0 110.944 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.92 -45.64 0.81 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 -174.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.2 OUTLIER -47.91 -46.03 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -159.824 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' C' ' 24' ' ' LYS . 73.7 m 75.92 -60.57 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.994 0.809 . . . . 0.0 110.927 -169.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -162.72 -46.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.136 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -139.79 -172.67 3.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.359 0.6 . . . . 0.0 112.134 -172.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.576 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 3.8 t70 -82.06 102.15 10.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.542 -177.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.3 28.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.851 176.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.562 HD22 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -95.78 106.55 18.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.69 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.67 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -95.86 158.74 15.31 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.004 -174.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.84 145.28 12.66 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.397 -1.382 . . . . 0.0 114.684 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.49 HG23 HG12 ' C' ' 91' ' ' ILE . 45.2 mt -130.73 132.27 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 173.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.38 160.54 30.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.2 p -144.55 126.66 10.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' C' ' 88' ' ' TYR . 88.3 m-20 57.65 28.89 16.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 111.123 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.94 -3.31 84.66 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.62 177.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.0 pt-20 -107.64 149.91 27.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.515 0.658 . . . . 0.0 109.841 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -81.43 124.84 29.76 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.0 110.329 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 -52.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -138.35 155.56 48.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.151 -173.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.67 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.3 m -150.85 139.24 20.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.676 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' C' ' 75' ' ' ILE . 50.1 p90 -152.8 -170.37 3.61 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.486 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -134.19 157.72 45.53 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.084 0.24 . . . . 0.0 110.7 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' C' ' 47' ' ' ILE . 0.5 OUTLIER -59.3 -45.47 91.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.176 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -53.51 -38.69 63.97 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.8 p -68.86 122.42 18.59 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.42 ' O ' HG12 ' C' ' 75' ' ' ILE . 41.7 p -54.75 126.39 23.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.518 0.675 . . . . 0.0 111.047 -166.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -20.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.043 -175.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.5 -37.59 30.67 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.861 -176.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -75.22 -34.8 61.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.477 HG21 ' CD1' ' C' ' 66' ' ' PHE . 47.3 mm -70.84 -65.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.424 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.5 m -58.66 -52.4 65.85 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.446 -170.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.75 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -74.34 -17.85 60.77 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.991 -172.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' C' ' 81' ' ' LYS . 13.0 m-20 -66.52 -48.05 70.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' C' ' 76' ' ' SER . 95.7 mt -52.89 -33.0 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.434 174.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.75 HD22 ' ND2' ' C' ' 77' ' ' ASN . 67.5 m-20 -84.45 -32.32 24.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.37 -173.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 58.2 mtmt -60.51 -29.4 69.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.6 mt -60.38 -26.54 66.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.555 178.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.578 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 12.3 m120 39.41 78.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.889 0.743 . . . . 0.0 110.742 -171.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.503 HG22 ' H ' ' C' ' 86' ' ' GLY . 8.9 mt -57.99 145.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.946 -172.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.59 20.0 6.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.401 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . 0.503 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -85.77 141.03 18.43 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.955 -176.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -79.81 -45.16 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.895 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' C' ' 59' ' ' ASN . 32.1 p90 -131.06 123.57 28.97 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.439 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.2 mp -112.8 136.93 47.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -99.51 98.73 9.58 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.976 0.417 . . . . 0.0 109.971 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.49 HG12 HG23 ' C' ' 56' ' ' ILE . 10.1 mt -113.83 101.46 12.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.057 -178.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.02 147.99 4.88 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.502 ' H ' ' HG2' ' C' ' 93' ' ' GLN . 1.1 pt20 -75.14 157.41 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.358 0.599 . . . . 0.0 111.426 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.562 HG13 HD22 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.935 -163.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' C' ' 31' ' ' MET . 27.9 mm-40 . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.405 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 33.8 mmt -90.07 -153.69 0.3 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -176.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 15.6 m120 -51.1 -28.19 10.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.866 0.467 . . . . 0.0 112.074 -175.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 25.0 m -47.69 -52.13 19.39 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.685 0.616 . . . . 0.0 111.604 177.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 19.5 pt -91.89 -23.45 5.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.798 179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 13.4 m120 -69.73 -40.53 76.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -174.004 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 108.86 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 71.7 t -70.26 -40.26 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.22 173.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . 0.435 HD21 ' HB2' ' C' ' 29' ' ' LEU . 13.9 m120 -61.91 -47.95 82.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.497 -176.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.38 -16.58 62.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.541 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -88.82 -38.45 14.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.076 -177.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 24.8 mt -80.81 -33.04 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.139 -176.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -80.85 62.41 4.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -90.81 -24.02 20.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -174.247 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.97 -77.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.328 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.557 ' HA ' ' OD1' ' C' ' 42' ' ' ASN . 1.0 OUTLIER -83.75 92.62 7.77 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.351 0.595 . . . . 0.0 109.604 177.011 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.7 139.74 8.22 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.404 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.1 ptpt -152.65 136.02 15.88 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.662 -177.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' C' ' 20' ' ' LEU . 3.8 mp -113.56 122.54 47.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.762 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.5 t -105.33 111.82 24.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.435 ' HB2' HD21 ' C' ' 17' ' ' ASN . 30.1 mt -88.82 125.81 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.003 0.43 . . . . 0.0 111.457 -175.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.94 136.35 26.83 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.266 174.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . 0.515 ' HG2' HD23 ' C' ' 36' ' ' LEU . 86.2 mtp -128.1 145.53 50.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -177.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.58 91.13 1.85 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.068 176.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.1 -94.58 0.46 Allowed Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.974 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.3 p-10 -106.21 26.54 9.66 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.684 -0.304 . . . . 0.0 111.323 -174.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.648 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 34.1 tt0 -141.06 137.72 33.09 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -170.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.515 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -122.72 114.72 20.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 167.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 21.6 pttm -124.84 106.04 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.86 0.838 . . . . 0.0 108.911 176.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.36 124.68 47.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.626 175.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -94.93 123.73 38.57 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 2.7 p -110.0 119.7 40.12 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.38 -174.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -116.1 -171.04 1.91 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.564 -174.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 81.51 12.71 0.68 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.74 1.275 . . . . 0.0 111.908 -176.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.17 45.86 26.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.68 -28.66 8.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.678 172.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -59.08 129.26 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.194 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -90.31 -70.57 1.22 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.283 -172.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.655 HG12 ' CB ' ' C' ' 68' ' ' GLU . 2.3 mt -113.32 -63.8 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.837 0.827 . . . . 0.0 111.406 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p 174.64 -63.41 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.192 -172.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 9.4 t80 179.7 36.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 O-C-N 123.467 0.48 . . . . 0.0 110.297 175.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.651 ' O ' HD12 ' C' ' 47' ' ' ILE . 42.6 mt-10 -142.23 177.86 7.96 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.438 -175.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.562 ' CG ' ' HE2' ' C' ' 69' ' ' LYS . 1.1 m-20 -103.74 122.08 44.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.298 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' C' ' 47' ' ' ILE . 6.2 mptp? -124.24 130.33 52.33 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 112.564 -178.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.619 HD21 HG13 ' C' ' 94' ' ' ILE . 0.5 OUTLIER -88.92 126.64 35.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.629 178.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.617 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.6 OUTLIER -135.78 166.17 23.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -166.176 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.94 158.21 29.62 Favored Glycine 0 C--N 1.347 1.162 0 C-N-CA 119.278 -1.439 . . . . 0.0 116.085 171.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.426 HG13 HG12 ' C' ' 91' ' ' ILE . 1.9 mp -113.03 138.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.338 -0.931 . . . . 0.0 110.684 174.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 3.7 m-85 -131.22 132.87 44.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 91.1 t -104.08 116.39 47.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.43 27.52 17.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.662 -175.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.62 72.8 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 7.3 pt-20 -107.96 133.54 52.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.921 0.861 . . . . 0.0 109.772 176.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -65.47 128.9 37.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.464 -176.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.469 HG21 HG23 ' C' ' 58' ' ' VAL . 95.7 t -111.13 -65.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.887 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 60.5 t80 -128.4 144.8 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 -177.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.418 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 12.6 t -126.55 145.05 50.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.193 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . 0.493 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 38.1 p90 -155.0 -178.66 7.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -175.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -118.07 128.86 55.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.642 172.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.655 ' CB ' HG12 ' C' ' 47' ' ' ILE . 37.9 mt-10 -61.84 -27.35 68.71 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.562 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.6 pttp -82.76 14.78 2.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.493 ' HB2' HD11 ' C' ' 75' ' ' ILE . 59.7 m -73.83 -116.92 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 165.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.436 ' O ' HG13 ' C' ' 75' ' ' ILE . 0.9 OUTLIER -134.01 122.2 22.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 165.545 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 2.8 t -59.25 -24.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.903 -170.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.644 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.02 -37.0 33.99 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.742 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -76.6 -30.87 57.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 177.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' C' ' 70' ' ' SER . 75.5 mt -71.0 -61.66 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 176.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.576 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -63.91 -52.53 59.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.32 -171.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.828 ' ND2' HD22 ' C' ' 80' ' ' ASN . 9.3 m120 -74.85 -16.01 60.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -171.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.1 m-20 -59.7 -49.68 76.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 165.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.7 mt -53.32 -32.05 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.288 175.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.828 HD22 ' ND2' ' C' ' 77' ' ' ASN . 27.5 m-20 -88.2 -22.04 24.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.778 -172.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 31.6 mmtp -61.34 -36.47 80.25 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 5.2 mt -64.9 -24.05 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.181 -174.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.648 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 9.5 m120 39.64 87.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.771 0.67 . . . . 0.0 111.384 -172.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.36 122.92 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.815 -172.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.1 OUTLIER -80.36 55.7 2.32 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.237 170.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.78 158.96 13.96 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . 0.571 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 83.9 Cg_endo -81.65 -62.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.668 2.246 . . . . 0.0 111.792 177.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.9 p90 -134.06 129.65 36.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -102.94 120.25 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.713 -175.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.417 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 6.2 mm-40 -92.47 99.56 12.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.389 -176.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' C' ' 54' ' ' TRP . 7.0 mt -110.73 103.75 15.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -162.12 155.43 20.64 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.078 -177.357 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -79.03 164.34 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 179.659 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.619 HG13 HD21 ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.549 -170.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' C' C ' 10' ' ' MET . . . . . 0.664 ' O ' HG22 ' C' ' 13' ' ' ILE . 22.3 mmt -88.61 -146.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.007 177.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -53.87 -20.32 5.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -178.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . 0.471 ' O ' HG23 ' C' ' 16' ' ' VAL . 1.2 m -51.55 -45.1 62.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.753 174.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.664 HG22 ' O ' ' C' ' 10' ' ' MET . 11.6 tt -80.26 -30.12 12.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.588 -177.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -71.87 -40.39 68.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -59.12 -32.76 70.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.033 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.471 HG23 ' O ' ' C' ' 12' ' ' SER . 98.3 t -70.8 -35.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.849 173.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.64 -47.73 84.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.824 0.345 . . . . 0.0 110.391 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.44 -21.2 64.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.722 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -85.37 -36.28 20.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.874 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' C' ' 27' ' ' LEU . 61.7 mt -75.89 -32.05 59.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.26 177.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.85 71.51 4.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.533 0.683 . . . . 0.0 109.669 173.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -95.21 10.11 37.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.996 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.98 -48.06 2.47 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -173.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.694 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.5 mmtt -72.01 -159.8 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 168.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' C' ' 46' ' ' GLY . . . -44.02 133.45 6.41 Favored Glycine 0 CA--C 1.502 -0.76 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.183 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 26' ' ' LYS . . . . . 0.694 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER -131.44 135.43 47.13 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.263 -0.469 . . . . 0.0 110.648 -171.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.738 ' HB3' HD13 ' C' ' 20' ' ' LEU . 2.1 tt -123.16 98.98 6.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 28' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 54.5 m -87.64 101.13 13.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.251 -178.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -95.08 129.39 42.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.358 -171.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -125.92 127.23 45.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.143 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 47.4 mtp -140.64 113.89 8.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.899 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.568 ' HB2' ' OE1' ' C' ' 35' ' ' GLN . 58.4 m-80 -148.99 111.49 4.74 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.603 175.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.56 -98.49 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.837 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.27 30.28 6.87 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.105 0.479 . . . . 0.0 110.258 -178.94 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 35' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' C' ' 32' ' ' ASN . 2.4 pt20 -122.94 123.45 40.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.618 . . . . 0.0 111.491 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.655 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tp -132.25 112.19 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.552 170.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 37' ' ' LYS . . . . . 0.506 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 52.2 pttt -137.24 103.72 5.19 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 38' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -102.6 129.91 49.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.803 173.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' C' ' 28' ' ' SER . 76.0 p -105.44 147.8 27.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.07 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 17.3 p -128.59 157.74 40.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -177.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.443 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 20.1 t -151.6 -174.44 4.84 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.576 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 42' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' C' ' 42' ' ' ASN . 0.2 OUTLIER 81.45 16.67 0.49 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.943 1.297 . . . . 0.0 111.679 -174.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.71 51.17 17.02 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 166.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.97 -21.12 41.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.909 174.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.44 112.58 6.83 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HA3' ' C' ' 25' ' ' GLY . . . -78.89 -78.31 0.85 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.885 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 47' ' ' ILE . . . . . 0.857 HD13 ' HG2' ' C' ' 52' ' ' LYS . 26.5 mt -111.96 -67.33 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 CA-C-O 121.856 0.836 . . . . 0.0 109.063 173.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.4 p 178.88 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.641 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -141.31 -32.67 0.54 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.486 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.551 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 8.4 pt-20 -70.03 160.7 31.47 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.05 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 51' ' ' ASP . . . . . 0.402 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 7.3 m-20 -101.36 109.07 20.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.617 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.857 ' HG2' HD13 ' C' ' 47' ' ' ILE . 25.8 mmmt -101.76 141.11 35.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 173.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 53' ' ' ASN . . . . . 0.526 HD22 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -106.09 108.66 20.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.541 0.686 . . . . 0.0 111.109 -173.674 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 54' ' ' TRP . . . . . 0.518 ' HZ2' HD11 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.25 166.22 10.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.89 -174.019 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.49 160.2 32.14 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 118.976 -1.583 . . . . 0.0 115.39 173.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -119.61 136.01 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.759 -0.72 . . . . 0.0 110.2 174.119 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 30.8 m-85 -128.49 111.66 13.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.761 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' C' ' 89' ' ' ILE . 26.3 t -79.58 105.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 57.51 28.16 15.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 -174.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 12.9 64.24 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.025 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.8 tt0 -106.81 138.66 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.625 ' HE2' ' OG1' ' C' ' 65' ' ' THR . 13.5 tptm -68.29 130.96 44.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.462 -176.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.522 HG13 ' H ' ' C' ' 64' ' ' TYR . 2.3 p -129.39 -60.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.282 175.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 64' ' ' TYR . . . . . 0.522 ' H ' HG13 ' C' ' 63' ' ' VAL . 69.9 t80 -132.91 133.96 43.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.748 0.308 . . . . 0.0 110.258 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.625 ' OG1' ' HE2' ' C' ' 62' ' ' LYS . 24.5 m -128.28 144.83 51.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -157.97 174.6 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.314 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 67' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 76.2 m-20 -121.83 132.22 54.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 68' ' ' GLU . . . . . 0.593 ' HB2' ' CG1' ' C' ' 47' ' ' ILE . 39.6 mt-10 -60.85 -24.41 65.89 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -75.42 4.21 7.76 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -174.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -74.23 -119.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . 0.543 ' O ' HG12 ' C' ' 75' ' ' ILE . 20.5 p -131.52 122.65 26.51 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.42 -18.91 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.236 -172.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 73' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.9 -45.38 10.59 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.276 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -62.35 -29.04 70.18 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 75' ' ' ILE . . . . . 0.543 HG12 ' O ' ' C' ' 71' ' ' THR . 51.3 mm -75.84 -66.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.145 178.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 76' ' ' SER . . . . . 0.57 ' OG ' ' HG ' ' C' ' 27' ' ' LEU . 16.3 m -51.13 -50.03 59.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 77' ' ' ASN . . . . . 0.754 HD22 ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -81.75 -17.57 47.27 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.909 -173.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.7 -34.87 67.42 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.314 166.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' C' ' 76' ' ' SER . 56.4 mt -58.52 -26.44 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.021 174.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 80' ' ' ASN . . . . . 0.754 ' ND2' HD22 ' C' ' 77' ' ' ASN . 38.5 m-20 -83.74 -27.22 29.08 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.567 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -56.61 -41.31 76.85 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.0 mt -54.77 -33.95 61.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.667 177.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 83' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' C' ' 36' ' ' LEU . 0.1 OUTLIER 38.57 104.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.724 1.209 . . . . 0.0 113.762 -174.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 84' ' ' ILE . . . . . 0.655 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.9 tp -45.23 148.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.655 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 85' ' ' LYS . . . . . 0.448 ' C ' ' HD2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -159.02 22.54 0.2 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.241 179.554 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.73 12.35 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.289 -168.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.6 -42.02 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.851 2.367 . . . . 0.0 111.681 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -145.26 117.5 8.42 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' C' ' 58' ' ' VAL . 58.4 mt -132.93 132.38 59.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 -176.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.15 111.04 22.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.764 -175.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 91' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 56' ' ' ILE . 11.8 tt -108.72 98.17 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.02 156.9 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.795 -170.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 1.1 pt20 -86.78 163.33 17.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.288 0.566 . . . . 0.0 111.331 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 94' ' ' ILE . . . . . 0.526 HG13 HD22 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 -167.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -152.99 -42.52 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 111.756 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.42 ' CD ' ' H ' ' C' ' 3' ' ' GLN . 2.1 mp0 -54.71 -22.66 14.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.604 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -37.74 -49.17 1.14 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.855 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.64 -21.16 21.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.18 -105.06 0.11 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 9.8 mp0 -93.17 -52.54 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.462 -175.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 34.9 mt-10 90.95 -39.58 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.562 1.164 . . . . 0.0 112.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' C' ' 9' ' ' GLN . 0.9 OUTLIER -74.15 18.12 0.16 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 32.5 mmt -77.0 -146.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -49.15 -25.97 2.51 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -52.54 -33.86 47.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.116 0.26 . . . . 0.0 111.51 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.579 HG13 ' N ' ' C' ' 14' ' ' ASN . 4.7 pt -90.54 -32.47 5.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.147 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.579 ' N ' HG13 ' C' ' 13' ' ' ILE . 16.6 m120 -71.11 -36.74 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.752 0.311 . . . . 0.0 110.242 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 19' ' ' LYS . 49.5 m -58.5 -33.96 70.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.695 HG11 ' HB ' ' C' ' 91' ' ' ILE . 71.3 t -68.32 -40.17 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.353 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -62.29 -41.81 98.81 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.704 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.13 -27.17 67.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.614 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' C' ' 15' ' ' SER . 94.1 mttt -85.27 -33.91 22.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.524 0.678 . . . . 0.0 110.286 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' C' ' 27' ' ' LEU . 29.3 mt -85.16 -32.44 22.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.088 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -81.95 59.99 4.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.585 0.707 . . . . 0.0 109.902 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 9.8 41.88 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.218 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.18 -69.73 0.5 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.545 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.678 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 24.2 tttt -76.01 -156.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.93 137.52 3.54 Favored Glycine 0 CA--C 1.498 -0.99 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.678 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 4.2 ptpt -147.32 132.2 18.07 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.343 -167.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.646 ' HB3' HD13 ' C' ' 20' ' ' LEU . 9.7 tt -105.63 125.76 51.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.446 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 31.8 m -103.31 135.05 45.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.109 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' C' ' 13' ' ' ILE . 5.8 mp -100.18 126.05 46.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.513 0.196 . . . . 0.0 111.444 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 18.5 t -152.49 144.95 24.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.467 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.454 ' HG3' HD23 ' C' ' 36' ' ' LEU . 1.9 mpt? -127.59 141.58 51.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 -176.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.53 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 18.1 m120 -133.07 88.86 2.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 173.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.78 -98.97 0.17 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.949 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.07 24.25 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.669 -0.312 . . . . 0.0 111.157 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.9 tt0 -143.27 108.25 4.94 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.548 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.679 ' CB ' HG13 ' C' ' 84' ' ' ILE . 3.1 tm? -88.03 124.87 34.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.669 166.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.53 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 41.6 pttt -129.1 103.38 6.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.79 118.87 37.82 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.932 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.0 p -98.4 138.89 34.97 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.29 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 t -111.23 119.51 39.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.333 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.437 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 23.6 t -94.84 -172.66 2.77 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.413 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 1.0 OUTLIER 70.73 27.94 3.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 123.854 0.722 . . . . 0.0 110.303 -172.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.86 32.05 21.86 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.117 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 -6.63 78.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.308 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.486 ' O ' HG23 ' C' ' 72' ' ' VAL . 64.8 m-85 -63.3 161.36 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 0.0 110.47 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.493 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -85.51 166.72 40.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.348 -172.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.459 ' H ' HD12 ' C' ' 47' ' ' ILE . 3.7 mp -60.73 -54.62 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 122.196 0.998 . . . . 0.0 109.856 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 26.7 t -129.34 -169.85 2.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.851 -169.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -132.62 15.8 4.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.389 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.45 ' C ' ' HE3' ' C' ' 69' ' ' LYS . 33.1 mt-10 -125.17 163.13 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.748 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.82 105.31 11.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.552 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.49 140.89 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.515 HD22 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.41 109.35 20.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.466 0.65 . . . . 0.0 109.967 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.629 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.52 165.63 11.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.241 -173.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.52 157.74 29.1 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 118.579 -1.772 . . . . 0.0 115.826 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.43 HG23 HG12 ' C' ' 91' ' ' ILE . 79.5 mt -126.55 137.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.106 -1.047 . . . . 0.0 110.619 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' C' ' 89' ' ' ILE . 7.3 m-85 -130.03 126.84 38.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.906 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.433 ' O ' HG13 ' C' ' 58' ' ' VAL . 8.3 p -103.38 111.42 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.184 0.516 . . . . 0.0 110.084 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.8 m120 49.64 43.75 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.575 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.36 -6.69 82.3 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.185 -0.531 . . . . 0.0 114.345 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -108.32 150.14 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.855 0.827 . . . . 0.0 111.072 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -73.59 132.57 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.064 0.459 . . . . 0.0 111.756 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.59 -61.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.728 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -148.74 147.4 28.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.856 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.629 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.5 m -134.14 133.04 40.57 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 49.3 p90 -150.85 -167.12 2.73 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -173.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -128.73 144.78 51.24 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.922 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.571 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 6.6 mt-10 -70.11 -20.88 63.16 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -175.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.45 ' HE3' ' C ' ' C' ' 50' ' ' GLU . 11.3 ptpt -89.21 7.52 34.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.381 . . . . 0.0 111.035 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.0 m -90.08 165.89 13.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.805 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.09 106.27 8.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.493 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 0.9 OUTLIER -59.11 -15.85 7.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.862 -173.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.64 -32.9 17.58 Favored Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.645 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.82 -29.13 50.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 45.8 mm -71.68 -57.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.777 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.518 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 37.7 p -60.27 -55.65 31.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.876 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.1 OUTLIER -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.6 OUTLIER -64.02 -46.98 82.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' C' ' 76' ' ' SER . 74.7 mt -53.87 -31.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.333 175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.876 HD22 ' ND2' ' C' ' 77' ' ' ASN . 9.9 m-20 -89.99 -24.16 21.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.55 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 64.0 mttm -55.68 -39.75 71.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 4.6 mt -61.1 -23.07 65.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.778 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.695 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 40.42 77.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.846 0.831 . . . . 0.0 110.833 -174.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.679 HG13 ' CB ' ' C' ' 36' ' ' LEU . 0.5 OUTLIER -93.77 145.61 7.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.514 -171.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.507 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -81.16 4.46 20.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.356 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.19 109.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.335 0 O-C-N 124.077 0.861 . . . . 0.0 113.618 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 97.9 Cg_endo -82.26 -55.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.765 2.31 . . . . 0.0 112.28 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . 88.2 t80 -107.95 98.75 8.28 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' C' ' 57' ' ' PHE . 20.9 pt -119.38 123.88 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.749 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.3 105.06 16.98 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.695 ' HB ' HG11 ' C' ' 16' ' ' VAL . 5.4 mt -97.22 99.71 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.407 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -163.82 148.15 10.34 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -77.08 165.34 24.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.322 0.582 . . . . 0.0 111.072 -177.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.515 HG13 HD22 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.863 -166.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.972 0.415 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -138.55 -24.1 0.95 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.244 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' C' ' 10' ' ' MET . 22.2 mp0 -79.6 11.02 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.668 0.746 . . . . 0.0 110.523 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -64.23 -37.1 86.27 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.459 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.83 5.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.636 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.4 117.13 28.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.628 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.457 ' HA ' ' HB2' ' C' ' 10' ' ' MET . 48.7 mp0 -74.57 24.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' C' ' 8' ' ' GLU . 25.5 mt-10 -51.62 -59.36 4.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.37 0.605 . . . . 0.0 110.901 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.646 ' N ' HE21 ' C' ' 9' ' ' GLN . 0.0 OUTLIER -99.18 17.59 19.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.345 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.457 ' HB2' ' HA ' ' C' ' 7' ' ' GLU . 1.0 OUTLIER -117.58 -147.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -41.59 -40.94 2.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -53.71 -39.36 65.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.497 HD13 ' ND2' ' C' ' 17' ' ' ASN . 0.0 OUTLIER -92.39 -33.2 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.818 0.342 . . . . 0.0 111.247 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.538 ' HA ' HD22 ' C' ' 17' ' ' ASN . 20.8 m120 -69.84 -34.77 74.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.081 -0.387 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 40.1 t -59.27 -33.33 70.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.486 0.66 . . . . 0.0 109.29 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.485 HG21 ' O ' ' C' ' 91' ' ' ILE . 49.1 t -71.67 -35.23 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.141 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.538 HD22 ' HA ' ' C' ' 14' ' ' ASN . 16.1 m-80 -58.27 -45.47 87.8 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.066 0.46 . . . . 0.0 110.397 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -69.03 -31.31 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.379 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -80.13 -35.17 37.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.196 0.522 . . . . 0.0 109.977 -176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' C' ' 27' ' ' LEU . 71.6 mt -69.2 -32.36 71.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.378 176.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.405 ' OD1' ' HD3' ' C' ' 26' ' ' LYS . 10.7 m-80 -78.41 58.69 2.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.515 0.674 . . . . 0.0 110.05 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.467 ' HD2' ' C ' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -88.29 9.94 21.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.024 -175.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.47 -72.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.865 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.43 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.2 mttm -76.51 -157.71 0.09 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.369 0.268 . . . . 0.0 110.544 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -44.55 135.88 6.21 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' C' ' 40' ' ' SER . 9.8 ptpt -148.38 143.44 26.82 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.876 -162.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.615 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.8 mp -101.25 119.03 38.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.744 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 53.8 m -100.24 99.58 10.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.557 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.2 mm? -85.6 147.18 26.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 112.116 -171.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -151.13 129.13 11.76 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.076 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.0 mtt -101.9 118.64 37.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 16.9 m120 -130.74 90.08 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.813 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.79 0.6 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.965 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -102.32 33.71 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.951 0.881 . . . . 0.0 108.965 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.546 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 53.2 tt0 -144.62 138.95 27.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.973 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.4 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.6 tm? -116.37 102.81 9.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.579 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 64.4 pttt -105.96 133.22 51.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.1 118.48 6.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.941 -172.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 65.0 p -100.42 148.57 24.59 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.414 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.7 p -109.0 118.95 38.12 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.42 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 37.7 t -94.81 178.59 5.53 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.2 OUTLIER 63.08 37.68 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.689 0.618 . . . . 0.0 109.719 -169.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.43 24.99 10.83 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.611 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.94 19.06 73.65 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.09 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.687 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 17.8 m-85 -65.33 164.39 13.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.47 -160.36 35.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.159 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -52.99 -66.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.522 0.677 . . . . 0.0 112.165 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.583 ' H ' ' CD1' ' C' ' 47' ' ' ILE . 28.7 p -179.08 -48.1 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.004 -171.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.488 ' H ' HD13 ' C' ' 47' ' ' ILE . 68.5 t80 -171.45 -36.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.414 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -89.92 161.19 16.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -165.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' C' ' 69' ' ' LYS . 7.0 p-10 -94.21 118.22 31.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.327 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.658 ' HB2' ' CD ' ' C' ' 68' ' ' GLU . 14.1 mmmm -111.98 155.26 24.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.996 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.464 HD22 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -105.97 106.45 16.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.805 -170.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.624 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.59 164.17 11.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.785 -175.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.06 141.64 7.73 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.826 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.475 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.3 mp -117.96 124.48 73.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 171.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 2.9 m-85 -119.23 141.6 48.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.37 114.64 40.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 63.35 36.34 11.67 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.812 0.695 . . . . 0.0 110.778 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.16 58.9 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.381 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 10.8 pt-20 -140.16 143.81 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.902 0.851 . . . . 0.0 110.913 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -70.47 116.54 10.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.385 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.3 m -96.59 -29.6 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.933 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -156.27 154.84 31.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.991 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 54' ' ' TRP . 68.5 m -149.55 146.69 27.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -160.4 -179.73 7.94 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.684 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 18.3 m120 -128.73 135.08 48.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.25 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.658 ' CD ' ' HB2' ' C' ' 52' ' ' LYS . 2.5 mp0 -60.48 -11.1 5.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -172.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' HD11 ' C' ' 47' ' ' ILE . 13.5 ptmm? -84.83 -4.55 59.13 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.6 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -81.06 155.06 26.51 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 11.2 p -71.97 121.32 18.91 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.618 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 45' ' ' TYR . 13.1 t -60.11 -11.76 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.971 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.46 -40.24 9.18 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 120.077 -1.058 . . . . 0.0 111.212 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.99 -35.6 74.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.426 ' O ' HG13 ' C' ' 79' ' ' ILE . 47.0 mm -67.9 -66.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.486 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.651 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.4 m -59.34 -58.59 7.97 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.593 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 1.4 m120 -72.55 -16.84 61.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -171.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -34.79 69.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.505 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' C' ' 76' ' ' SER . 80.6 mt -56.06 -23.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.609 171.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' C' ' 77' ' ' ASN . 0.6 OUTLIER -79.79 -38.24 33.52 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.296 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -57.44 -34.1 68.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 109.355 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 3.2 mt -59.49 -28.06 66.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 36.66 82.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.568 -174.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 35.9 mm -58.03 148.14 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.856 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.424 ' HB3' ' ND2' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -129.58 45.55 2.78 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.296 -174.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.92 158.0 17.52 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.383 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.04 -44.82 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.464 2.109 . . . . 0.0 112.067 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -123.66 117.97 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.406 0.622 . . . . 0.0 109.949 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.75 125.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.784 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.15 99.68 12.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.536 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.557 HG21 ' HG ' ' C' ' 29' ' ' LEU . 20.1 mm -109.65 99.62 9.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.935 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 168.82 6.45 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -91.97 166.23 12.8 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.752 178.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.464 HG13 HD22 ' C' ' 53' ' ' ASN . 6.7 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.697 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' C' ' 2' ' ' ASN . 16.5 t70 . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.447 ' O ' HD23 ' C' ' 6' ' ' LEU . 0.9 OUTLIER 76.49 -13.86 0.87 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 112.667 175.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.572 ' NE2' ' HG3' ' C' ' 8' ' ' GLU . 6.4 mt-30 -72.77 2.9 5.8 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.77 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -62.76 -38.0 88.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.85 -1.73 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.972 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' C' ' 3' ' ' GLN . 4.3 mm? -89.8 179.15 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.08 0.467 . . . . 0.0 110.316 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.43 18.34 9.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.129 -171.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.572 ' HG3' ' NE2' ' C' ' 3' ' ' GLN . 15.0 mm-40 -66.33 -24.41 66.52 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.24 0.543 . . . . 0.0 110.607 176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.633 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.4 mp0 -80.51 12.46 3.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.567 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.69 -141.38 0.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.044 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -39.8 -36.61 0.45 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -52.65 -46.19 67.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.51 -29.84 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.935 0.397 . . . . 0.0 111.014 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.52 -20.28 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -60.26 -35.22 75.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 47.8 t -66.54 -37.71 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.399 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.512 ' ND2' HD13 ' C' ' 29' ' ' LEU . 0.9 OUTLIER -65.21 -39.92 93.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.504 -176.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.58 -27.22 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -87.75 -29.33 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.464 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 62.0 mt -70.76 -34.95 72.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.216 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.1 66.13 9.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.2 -25.29 16.44 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.19 -72.81 0.13 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.274 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -90.6 -177.27 4.98 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 168.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.3 100.24 0.01 OUTLIER Glycine 0 CA--C 1.5 -0.882 0 O-C-N 125.139 1.525 . . . . 0.0 116.118 166.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.546 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 8.2 ptpt -131.51 155.36 47.56 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.194 -170.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.499 ' HG ' ' OG ' ' C' ' 76' ' ' SER . 0.6 OUTLIER -134.77 121.8 21.23 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.553 -173.035 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.8 m -113.39 112.42 23.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.512 HD13 ' ND2' ' C' ' 17' ' ' ASN . 5.9 mp -99.24 143.94 28.93 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.789 -172.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.1 m -150.19 131.07 14.22 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.151 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.633 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 81.5 mtp -97.69 120.72 38.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.296 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -122.31 91.4 3.5 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.66 0.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.708 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 31.06 6.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.707 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 27.9 tt0 -143.07 137.45 29.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.219 0.533 . . . . 0.0 111.999 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -111.28 99.55 8.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.558 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 23.2 pttp -96.42 142.95 27.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.2 122.11 7.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -172.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 77.5 p -98.48 143.38 28.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.545 ' OG ' ' HA2' ' C' ' 73' ' ' GLY . 17.6 p -125.52 119.22 27.59 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.1 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 39.0 t -100.46 173.37 6.6 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.526 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' C' ' 41' ' ' SER . 6.5 m120 81.59 28.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.716 1.26 . . . . 0.0 111.398 -172.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 47.88 35.92 5.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 167.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . 0.405 ' O ' HG22 ' C' ' 71' ' ' THR . . . 102.53 -10.11 56.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.209 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 76.3 m-85 -70.03 141.56 52.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.976 0.417 . . . . 0.0 110.165 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.3 -150.45 25.22 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.194 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' C' ' 68' ' ' GLU . 26.6 mm -66.79 -62.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.555 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -175.05 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.079 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -168.48 28.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 12.5 pt-20 -115.76 135.53 53.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.689 -175.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 32.0 t70 -90.38 109.47 20.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.323 0.582 . . . . 0.0 111.809 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' C' ' 68' ' ' GLU . 12.0 mptt -110.82 139.61 45.97 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.988 175.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -95.55 119.34 33.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.215 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -113.56 165.96 11.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.044 -169.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.18 158.11 27.51 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 119.077 -1.535 . . . . 0.0 115.788 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -114.84 132.95 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 114.771 -0.714 . . . . 0.0 111.015 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 0.8 OUTLIER -130.41 115.26 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.75 126.49 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.16 24.9 14.23 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.805 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.86 9.03 83.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.558 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 11.3 tp10 -107.79 120.72 43.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.959 0.409 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 39.7 ttpt -72.6 112.61 8.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.3 -29.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -148.92 134.14 18.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.23 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.426 HG23 ' O ' ' C' ' 54' ' ' TRP . 5.3 m -123.6 147.14 47.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' C' ' 75' ' ' ILE . 52.5 p90 -161.51 -175.23 4.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.824 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.56 135.58 53.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.407 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' C' ' 47' ' ' ILE . 17.3 tt0 -62.89 -34.87 78.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.714 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.3 pttp -79.42 1.59 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -74.4 -170.67 1.04 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.465 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.1 p -81.37 108.39 14.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.47 -16.72 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.117 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.545 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -80.24 -40.76 12.92 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -33.55 75.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.487 ' O ' HG12 ' C' ' 79' ' ' ILE . 32.5 mm -76.05 -61.27 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.415 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.6 m -54.43 -52.16 62.65 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.513 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 2.7 m120 -75.91 -15.96 60.11 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.658 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -66.17 -37.25 85.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' C' ' 76' ' ' SER . 36.7 mm -56.4 -25.41 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.568 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.597 HD22 ' N ' ' C' ' 80' ' ' ASN . 0.6 OUTLIER -82.37 -38.28 24.4 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -50.21 -44.05 52.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -53.69 -36.01 61.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.755 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.707 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.34 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.996 0.81 . . . . 0.0 110.559 -169.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.87 132.16 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.703 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.21 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.25 162.84 29.19 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.598 -1.287 . . . . 0.0 112.663 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.8 -35.47 0.39 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 123.113 2.542 . . . . 0.0 112.085 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.69 139.64 16.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.93 125.6 68.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.404 0.621 . . . . 0.0 111.557 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.416 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 15.6 mm-40 -97.26 99.21 10.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.517 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.4 mt -112.26 99.71 9.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -161.09 156.22 24.19 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -81.59 164.77 21.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.95 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.495 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.814 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.137 -165.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' C' ' 3' ' ' GLN . 8.2 p30 -157.47 -10.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.569 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.561 ' HA ' ' OE1' ' C' ' 3' ' ' GLN . 8.3 mm-40 -90.66 21.99 3.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 173.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' C' ' 4' ' ' LYS . 0.4 OUTLIER -52.96 -44.89 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.978 -177.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -25.61 59.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.695 ' HB3' ' SD ' ' C' ' 10' ' ' MET . 64.4 mt -91.7 -166.06 1.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.89 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 24.0 mm-40 -89.22 -10.87 45.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 32.2 mt-10 76.07 -44.96 0.51 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.204 0.602 . . . . 0.0 111.274 178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -76.27 17.3 0.37 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.673 0.789 . . . . 0.0 111.934 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' C' ' 6' ' ' LEU . 87.1 mtp -87.65 -143.98 0.13 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -168.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -59.41 -22.53 61.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.929 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.4 m -54.69 -33.27 60.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 110.297 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mm -86.52 -41.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -63.52 -37.3 86.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -54.75 -37.36 65.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.52 -36.52 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.487 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -66.35 -38.21 87.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.424 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -66.07 -30.7 71.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.967 0.413 . . . . 0.0 110.925 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.46 ' NZ ' ' HB3' ' C' ' 19' ' ' LYS . 9.1 mtpm? -85.65 -37.19 19.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 -174.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' C' ' 27' ' ' LEU . 75.6 mt -76.35 -33.71 58.95 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.592 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -81.55 52.57 1.9 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.931 0.872 . . . . 0.0 109.769 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.599 ' HE3' HG12 ' C' ' 47' ' ' ILE . 14.7 pttm -66.24 -40.57 90.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.108 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.15 0.48 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' C' ' 24' ' ' LYS . 10.9 mmpt? -70.64 -159.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -40.44 145.64 0.39 Allowed Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.654 ' O ' ' HA ' ' C' ' 40' ' ' SER . 10.7 ptpt -148.52 130.96 15.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.945 -169.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.7 mp -105.02 128.34 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.721 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.1 t -103.61 98.93 8.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.71 121.2 25.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.11 0.481 . . . . 0.0 110.868 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 47.0 t -130.62 134.89 47.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.602 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 73.6 mtp -118.93 134.45 55.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.956 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -149.02 91.01 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.661 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.28 -106.42 0.65 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.245 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 33.78 1.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.5 0.667 . . . . 0.0 109.902 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.621 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.4 tt0 -145.71 139.6 26.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.511 0.672 . . . . 0.0 112.335 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.15 118.98 28.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 25.6 pttm -127.18 107.93 10.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.758 0.79 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -115.67 121.59 42.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.66 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 45.0 p -96.57 151.21 19.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 40.9 m -123.7 118.58 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.323 0.582 . . . . 0.0 110.848 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 22.6 t -101.84 -176.61 3.18 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.36 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.46 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.9 OUTLIER 73.01 35.91 0.92 Allowed 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 124.246 0.967 . . . . 0.0 109.746 -170.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.03 19.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.731 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -3.66 65.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.475 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.46 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 55.4 m-85 -58.78 143.51 46.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.847 0.324 . . . . 0.0 110.89 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.09 -158.02 5.4 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' C' ' 68' ' ' GLU . 23.0 mt -67.52 -68.6 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 CA-C-O 122.115 0.96 . . . . 0.0 109.781 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -178.26 -146.68 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.833 -165.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -79.22 -24.23 43.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.464 ' OE1' ' HE2' ' C' ' 52' ' ' LYS . 6.4 pt-20 -73.28 137.26 44.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.545 0.688 . . . . 0.0 112.79 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.63 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 5.6 p-10 -90.62 145.41 24.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.051 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.63 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.4 mptp? -141.8 126.02 17.49 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.787 ' ND2' HG13 ' C' ' 94' ' ' ILE . 66.5 t30 -84.94 112.61 20.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.525 -177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.659 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.2 OUTLIER -121.05 161.23 22.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -169.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.9 159.18 31.7 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 118.952 -1.594 . . . . 0.0 116.655 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -114.96 131.49 67.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 113.974 -1.113 . . . . 0.0 110.853 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 1.9 m-85 -129.05 107.2 9.41 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.84 123.18 47.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 19.6 m120 56.62 31.12 18.61 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 4.09 89.31 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.114 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.1 tp10 -106.48 121.13 43.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.969 0.385 . . . . 0.0 110.701 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 30.0 ttpp -75.05 117.68 17.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.57 -32.58 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.296 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -142.0 131.58 23.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -125.39 141.01 52.3 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.492 ' CD1' HD13 ' C' ' 75' ' ' ILE . 50.1 p90 -156.78 -173.35 4.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.277 0.844 . . . . 0.0 113.277 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 19.1 p-10 -131.55 131.26 43.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.081 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.659 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 34.0 mt-10 -67.02 -12.33 59.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.6 ptmm? -89.59 7.54 35.9 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.652 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.483 ' HB3' HD11 ' C' ' 75' ' ' ILE . 15.2 t -79.98 -147.83 0.05 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.09 117.18 32.57 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 2.4 t -64.47 -14.8 16.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.302 -167.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.38 -39.57 25.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.567 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.55 -30.68 68.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.492 HD13 ' CD1' ' C' ' 66' ' ' PHE . 67.7 mt -68.28 -70.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.261 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 2.5 m -65.38 -44.18 88.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.504 HD22 ' ND2' ' C' ' 80' ' ' ASN . 11.6 m120 -80.83 -15.24 56.9 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.426 -171.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.31 -40.23 81.78 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' C' ' 76' ' ' SER . 63.1 mt -58.7 -28.78 38.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.467 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.504 ' ND2' HD22 ' C' ' 77' ' ' ASN . 7.9 m-20 -75.19 -37.6 61.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.249 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 7.2 mmpt? -54.43 -40.44 68.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 0.0 109.237 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.6 mt -56.12 -34.78 66.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.699 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.621 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.26 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.164 0.915 . . . . 0.0 110.68 -168.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.66 131.07 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.325 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.98 43.27 0.77 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.514 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.87 138.02 14.09 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.097 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.37 -45.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.775 2.317 . . . . 0.0 111.445 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . 82.1 t80 -140.3 123.36 16.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.02 133.92 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.363 0.602 . . . . 0.0 111.352 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.451 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 8.0 mm-40 -92.31 104.51 16.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.499 HG22 ' CH2' ' C' ' 54' ' ' TRP . 3.1 mt -112.71 100.85 11.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -157.37 171.4 20.46 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -94.27 167.42 11.55 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.092 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.787 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -103.0 -28.87 11.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.774 0.321 . . . . 0.0 110.551 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.523 ' HG2' ' HB2' ' C' ' 10' ' ' MET . 20.2 mp0 -89.7 22.1 3.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.43 -41.99 81.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.644 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.78 -7.19 53.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 98.6 mt -91.88 -161.73 0.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.117 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.442 ' HB3' ' NE2' ' C' ' 9' ' ' GLN . 1.6 mp0 -63.67 -28.47 69.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 41.9 mt-10 81.43 -32.31 0.1 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.707 0.803 . . . . 0.0 111.468 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' C' ' 7' ' ' GLU . 0.1 OUTLIER -73.87 17.99 0.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.284 0.634 . . . . 0.0 112.287 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.523 ' HB2' ' HG2' ' C' ' 3' ' ' GLN . 62.7 mtt -82.29 -142.06 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -49.95 -17.2 0.35 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 41.0 m -53.88 -39.71 65.97 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.246 -0.284 . . . . 0.0 110.846 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 10' ' ' MET . 2.8 pp -91.58 -23.92 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.525 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 17.2 m120 -74.89 -32.58 61.88 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 122.304 -0.248 . . . . 0.0 111.003 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 7.9 p -62.26 -31.1 71.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.356 0.598 . . . . 0.0 109.451 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.51 -34.69 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.868 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.5 m-20 -61.76 -39.82 92.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.407 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.46 -27.7 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.674 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.91 -28.57 18.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.099 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 34.7 mt -82.94 -28.35 29.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.413 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -88.19 74.49 8.76 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.82 -23.67 10.88 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -81.77 0.09 OUTLIER Glycine 0 CA--C 1.507 -0.414 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.234 -174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 14.9 ttmt -89.75 -179.22 5.71 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 29.89 90.33 0.01 OUTLIER Glycine 0 CA--C 1.503 -0.668 0 O-C-N 124.38 1.05 . . . . 0.0 115.496 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.0 OUTLIER -121.02 137.17 54.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.652 -173.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 31.6 tp -126.93 128.21 46.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.395 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 59.2 m -111.87 111.81 23.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.256 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.593 HD21 ' HB ' ' C' ' 91' ' ' ILE . 5.4 mp -86.92 144.58 26.89 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.453 0.701 . . . . 0.0 111.574 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 39.4 p -155.09 129.78 9.23 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.473 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.422 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 63.4 mtt -128.02 132.33 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.962 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.414 ' HB3' ' CD ' ' C' ' 35' ' ' GLN . 6.3 t30 -151.23 92.66 1.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.569 0.223 . . . . 0.0 110.77 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.79 -93.94 1.18 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.37 174.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.48 31.78 6.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.447 0.642 . . . . 0.0 109.909 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.547 ' N ' HG22 ' C' ' 84' ' ' ILE . 9.9 pt20 -127.92 130.7 48.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.312 0.577 . . . . 0.0 111.753 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.694 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tm? -124.16 119.03 28.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.633 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -140.37 130.99 25.59 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -143.78 120.1 10.9 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.932 -174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 44.1 p -97.47 126.12 42.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.4 p -109.27 118.72 37.45 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.582 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 t -103.18 -175.08 2.7 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 81.08 26.33 0.23 Allowed 'General case' 0 C--O 1.222 -0.353 0 O-C-N 124.494 1.121 . . . . 0.0 110.491 -171.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 52.02 38.35 23.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 171.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.93 -5.82 79.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.674 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -64.38 145.21 56.41 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.46 0.63 . . . . 0.0 110.526 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -85.33 -169.7 46.28 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.002 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' C' ' 68' ' ' GLU . 23.3 mm -59.14 -63.53 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-O 121.652 0.739 . . . . 0.0 110.84 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 p -164.06 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.634 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -169.24 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.873 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.63 136.07 49.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.426 -168.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.532 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 1.3 m-20 -75.15 118.43 18.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.417 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -139.28 132.72 30.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 14.7 p-10 -86.91 122.38 30.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.52 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -115.66 161.92 17.99 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.78 148.22 18.79 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.331 -1.414 . . . . 0.0 115.444 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' C' ' 90' ' ' GLU . 38.6 mt -122.27 127.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 164.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -121.7 109.04 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.949 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.434 HG23 HG13 ' C' ' 89' ' ' ILE . 2.5 p -90.08 105.74 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 62.36 29.45 17.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.704 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.74 5.19 78.4 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.766 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -109.08 141.99 40.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.853 0.358 . . . . 0.0 110.467 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -66.74 121.42 15.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.794 174.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -156.88 153.23 27.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.301 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -141.93 159.02 43.07 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' C' ' 54' ' ' TRP . 55.8 p90 -166.91 -172.87 2.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 111.39 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -129.42 138.51 51.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.139 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.522 ' HB3' HG13 ' C' ' 47' ' ' ILE . 10.1 mt-10 -62.96 -33.07 74.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.431 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.1 pttp -82.89 18.89 1.48 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.007 0.432 . . . . 0.0 111.367 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -88.87 -150.73 0.2 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 19.9 p -111.27 112.86 24.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.441 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.8 t -63.23 -12.33 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.057 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -84.55 -37.92 10.22 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.816 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -68.4 -35.18 77.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 51.5 mm -69.63 -60.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.925 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.676 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 75.2 p -51.73 -60.75 2.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.554 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 4.6 m120 -73.26 -15.98 61.41 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -171.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' C' ' 81' ' ' LYS . 0.5 OUTLIER -69.65 -36.01 75.7 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.1 167.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.3 mt -58.36 -20.91 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.785 172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.633 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.7 OUTLIER -84.05 -35.91 23.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.607 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' C' ' 78' ' ' ASP . 52.0 mtpt -53.61 -39.92 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 6.1 mt -52.97 -37.33 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.694 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 2.4 tp -44.8 148.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.664 -174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -149.85 22.32 0.88 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.342 0.591 . . . . 0.0 109.718 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.04 171.55 15.29 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.849 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.79 -49.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.775 2.317 . . . . 0.0 113.407 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -132.87 103.35 6.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.363 0.601 . . . . 0.0 110.326 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.452 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.4 mp -122.43 129.62 75.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.145 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 37.9 mt-10 -106.56 119.2 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.921 0.391 . . . . 0.0 111.658 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.593 ' HB ' HD21 ' C' ' 29' ' ' LEU . 34.4 mt -96.91 98.95 8.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 146.1 14.79 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.4 pt20 -83.16 166.97 18.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.218 0.532 . . . . 0.0 112.325 -173.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.782 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.59 0.233 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 71.51 5.47 5.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.73 0.812 . . . . 0.0 111.634 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.499 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 2.3 mp0 -67.55 -30.97 70.74 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -56.89 -20.56 23.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.272 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.6 -70.77 0.67 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.43 . . . . 0.0 111.944 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.32 -78.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -44.01 -62.95 0.97 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -165.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.499 ' HG2' ' HB3' ' C' ' 3' ' ' GLN . 1.7 mm-40 -60.09 -19.23 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -173.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -100.59 18.23 19.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.777 0.322 . . . . 0.0 111.641 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 86.9 mmm -66.53 178.52 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.283 0.563 . . . . 0.0 111.863 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -50.17 -19.6 0.81 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t -46.04 -51.95 12.77 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.569 0.543 . . . . 0.0 112.309 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.526 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -89.76 -18.58 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.567 -177.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -74.11 -50.95 17.25 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.3 -0.25 . . . . 0.0 111.388 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.3 m -58.3 -29.39 65.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.364 0.602 . . . . 0.0 109.459 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 42.8 t -70.33 -40.09 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.71 172.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -61.31 -41.03 96.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.831 0.348 . . . . 0.0 110.439 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.47 -31.24 71.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.408 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -81.74 -35.42 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.123 0.487 . . . . 0.0 110.617 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.592 HD21 ' CZ2' ' C' ' 54' ' ' TRP . 73.3 mt -73.53 -37.37 65.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.347 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -79.59 68.92 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.814 0.816 . . . . 0.0 109.019 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' C' ' 47' ' ' ILE . 16.6 pttm -89.27 -7.4 55.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.992 -172.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.4 -50.73 0.76 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.743 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 22.5 mmtm -78.96 -160.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -41.34 137.94 2.11 Favored Glycine 0 CA--C 1.507 -0.434 0 O-C-N 123.535 0.522 . . . . 0.0 114.106 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.743 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.5 OUTLIER -141.34 143.21 33.9 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -168.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.0 mp -117.86 114.54 23.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 8.5 t -86.42 98.47 11.03 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 91' ' ' ILE . 39.0 mt -83.9 124.36 30.91 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.246 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 29.8 t -147.13 139.43 24.63 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 54.0 mtm -107.2 145.64 32.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.277 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -148.15 89.82 1.76 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.01 0.433 . . . . 0.0 110.568 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.18 -94.11 0.31 Allowed Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.94 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.4 p-10 -112.94 26.61 10.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 110.512 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.745 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.0 tt0 -140.35 143.39 35.73 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.493 0.663 . . . . 0.0 111.951 -171.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.0 tm? -118.11 117.88 30.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 22.5 pttp -126.31 148.62 49.5 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.15 135.29 17.9 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.378 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -98.69 125.57 44.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 30.9 t -109.47 119.65 40.09 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.672 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 9.5 t -109.93 178.98 4.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER 78.44 27.34 0.5 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.502 1.126 . . . . 0.0 110.639 -174.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.69 32.69 19.84 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.548 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.91 -14.08 66.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.121 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.444 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 39.7 m-85 -55.44 130.36 42.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.058 0.429 . . . . 0.0 110.359 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -73.85 -94.45 0.11 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.784 -0.643 . . . . 0.0 113.074 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' C' ' 52' ' ' LYS . 33.6 mt -110.51 -67.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.415 0.626 . . . . 0.0 109.755 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 177.36 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.192 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -166.4 -37.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.657 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 11.8 pt-20 -70.18 170.08 12.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.058 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.548 ' HB2' HD21 ' C' ' 67' ' ' ASN . 4.5 p-10 -125.35 152.97 44.04 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 111.33 -177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.596 ' HG2' HD11 ' C' ' 47' ' ' ILE . 8.6 mmmm -130.03 143.47 50.81 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.207 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.688 ' ND2' HG13 ' C' ' 94' ' ' ILE . 5.3 t30 -92.34 105.04 17.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.464 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.63 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -113.82 165.85 12.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.128 -167.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.455 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -163.78 158.09 30.5 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 119.556 -1.306 . . . . 0.0 114.816 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.455 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.6 mp -119.79 129.39 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.869 169.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.536 ' CE1' ' HD3' ' C' ' 62' ' ' LYS . 40.6 m-85 -123.98 105.49 9.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.31 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.89 112.01 26.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 57.83 32.84 22.48 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.062 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.12 7.53 87.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.085 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 8.3 tp10 -107.01 139.05 42.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.883 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.536 ' HD3' ' CE1' ' C' ' 57' ' ' PHE . 14.3 mmmm -83.24 118.05 23.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.575 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -107.17 -24.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.358 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -160.22 147.91 16.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 110.778 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 54' ' ' TRP . 41.8 m -139.73 147.73 41.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' C' ' 75' ' ' ILE . 32.7 p90 -159.78 -178.73 7.27 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.121 -1.032 . . . . 0.0 113.523 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' C' ' 51' ' ' ASP . 51.5 t-20 -120.36 127.95 52.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.836 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 4.7 mt-10 -62.61 -21.53 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 21.0 ptmt -90.53 9.24 30.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.515 ' HB2' HD11 ' C' ' 75' ' ' ILE . 15.5 m -76.38 -118.8 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.299 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -131.71 115.67 16.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.496 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 3.3 t -60.65 -22.21 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -168.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.88 -37.4 19.36 Favored Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.004 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -72.14 -34.51 68.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' C' ' 70' ' ' SER . 81.9 mt -66.6 -65.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.395 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.638 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 70.8 p -62.42 -50.95 69.45 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -167.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.459 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 27.4 m120 -79.29 -14.51 58.97 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -172.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.05 -38.83 92.13 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' C' ' 76' ' ' SER . 73.1 mt -59.29 -24.33 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.497 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.8 OUTLIER -80.12 -40.03 28.29 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.529 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 8.0 mmpt? -50.72 -38.68 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 0.0 109.624 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.413 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.5 mt -52.25 -35.37 49.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.745 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 37.49 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.131 0.895 . . . . 0.0 110.957 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' C' ' 86' ' ' GLY . 31.5 mt -79.28 115.16 21.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.241 -166.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -66.83 35.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.638 169.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' C' ' 84' ' ' ILE . . . -98.74 159.42 20.29 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.096 -171.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 93.1 Cg_endo -80.5 -75.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.691 2.261 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.587 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 15.3 p90 -115.78 112.64 22.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.666 0.746 . . . . 0.0 109.487 171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.09 114.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.706 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -90.55 96.88 10.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.338 0.589 . . . . 0.0 110.13 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 29' ' ' LEU . 13.9 mt -96.35 100.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 145.89 22.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 4.8 pt20 -83.1 167.01 18.23 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.751 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.688 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.565 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -93.55 -32.85 13.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.383 0.611 . . . . 0.0 109.45 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.509 ' CD ' ' H ' ' C' ' 3' ' ' GLN . 19.0 mp0 -62.58 -17.92 61.06 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.55 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -45.99 -59.55 2.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.64 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.85 -23.23 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.706 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.72 174.36 8.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.969 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.492 ' HB2' ' NE2' ' C' ' 9' ' ' GLN . 6.4 mp0 -100.35 17.39 21.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.723 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' C' ' 3' ' ' GLN . 56.2 mt-10 66.5 18.99 10.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.499 0.666 . . . . 0.0 111.76 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' C' ' 7' ' ' GLU . 4.3 mt-30 -82.31 17.2 1.75 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.717 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 71.1 mtp -81.36 -149.26 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.887 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.12 -10.69 11.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -56.62 -42.39 78.72 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.09 -28.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.8 -43.99 87.04 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.478 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . 0.548 ' O ' ' HB2' ' C' ' 19' ' ' LYS . 22.3 m -56.97 -34.93 68.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.1 -31.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.208 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -61.31 -48.97 78.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.03 -14.25 60.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.094 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' C' ' 15' ' ' SER . 0.0 OUTLIER -80.52 -45.77 16.92 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' C' ' 27' ' ' LEU . 90.0 mt -78.42 -35.08 47.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.985 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -78.65 67.84 4.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.157 0.503 . . . . 0.0 109.961 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -104.6 -10.01 17.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.87 -76.6 0.19 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -99.57 -174.49 2.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.89 88.95 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.002 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 171.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.6 ptpt -128.97 143.44 50.88 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.646 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.463 ' HB3' HD13 ' C' ' 20' ' ' LEU . 17.1 tp -125.94 127.98 46.82 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.366 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -99.98 110.68 23.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 mp -79.84 135.32 36.43 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.028 0.531 . . . . 0.0 111.973 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 41.2 m -143.61 129.11 19.06 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.286 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.586 ' SD ' ' HB ' ' C' ' 89' ' ' ILE . 39.5 mtm -123.93 130.9 53.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -148.1 90.89 1.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.05 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.27 -97.67 0.06 OUTLIER Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.713 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.87 33.38 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.37 0.605 . . . . 0.0 109.882 -176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.551 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.9 tt0 -150.08 136.66 19.1 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.2 tm? -119.96 127.41 52.62 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 165.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -144.8 144.74 31.31 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.43 142.42 22.18 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.732 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 60.6 p -99.07 138.81 35.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 22.2 p -118.07 117.86 30.35 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.564 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.2 m -105.04 178.18 4.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.955 -175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' C' ' 26' ' ' LYS . 0.7 OUTLIER 70.1 38.98 1.41 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.323 1.014 . . . . 0.0 109.071 -168.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.13 27.75 16.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.732 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 11.92 82.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.523 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.45 ' O ' HG23 ' C' ' 72' ' ' VAL . 55.1 m-85 -74.69 176.1 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.248 0.524 . . . . 0.0 110.771 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -101.01 -154.98 26.97 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.634 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.518 HD13 ' HE3' ' C' ' 22' ' ' LYS . 15.9 mm -51.79 -67.08 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.486 0.66 . . . . 0.0 109.863 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 15.1 t 173.13 -67.78 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.335 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.05 -22.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 7.4 pt-20 -68.94 145.68 53.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 112.315 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.53 ' C ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 t70 -87.56 121.05 29.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.707 -174.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 3.3 mptp? -124.76 134.37 52.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.529 HD22 HG13 ' C' ' 94' ' ' ILE . 0.9 OUTLIER -96.86 105.96 18.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.538 0.685 . . . . 0.0 111.077 -177.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.579 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -108.66 167.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.61 -173.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.416 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -170.1 165.58 38.88 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 119.291 -1.433 . . . . 0.0 115.612 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.538 HG13 HG13 ' C' ' 91' ' ' ILE . 3.5 mp -124.63 129.54 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.17 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -120.1 117.42 27.9 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -115.62 123.17 70.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.677 0.275 . . . . 0.0 110.362 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' C' ' 87' ' ' PRO . 4.5 m-20 57.56 33.23 22.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.83 90.47 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.851 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.52 130.95 56.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.475 ' HD2' ' OG1' ' C' ' 65' ' ' THR . 40.0 ttpt -74.83 123.67 25.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.934 0.397 . . . . 0.0 110.5 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.69 -43.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -146.31 147.75 31.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.933 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' C' ' 54' ' ' TRP . 84.6 m -136.46 145.22 44.94 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -160.44 -170.92 2.96 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 51.3 t-20 -128.2 139.99 52.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.458 ' HB3' HG12 ' C' ' 47' ' ' ILE . 42.3 mt-10 -77.95 -11.29 59.89 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 0.0 OUTLIER -81.59 -6.63 59.17 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.242 175.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -78.58 163.75 25.25 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -74.22 113.24 11.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.519 HG23 ' HA2' ' C' ' 46' ' ' GLY . 8.7 t -57.52 -15.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.943 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.95 -41.16 12.79 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.371 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -73.41 -33.01 64.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 38.3 mm -65.81 -61.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.532 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 68.2 p -64.8 -57.81 7.9 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.786 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.6 OUTLIER -67.69 -16.83 64.34 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -171.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.2 m-20 -64.95 -47.41 77.73 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.645 0.657 . . . . 0.0 109.291 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' C' ' 76' ' ' SER . 65.1 mt -56.78 -30.62 33.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.844 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.786 HD22 ' ND2' ' C' ' 77' ' ' ASN . 27.7 m-20 -89.67 -17.82 27.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 33.9 mmtp -62.76 -39.31 93.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 11.0 mt -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.302 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.551 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.8 m120 39.51 72.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.625 0.726 . . . . 0.0 110.08 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' C' ' 86' ' ' GLY . 13.7 mt -54.36 139.99 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.451 -171.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -85.17 26.29 0.89 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.408 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -93.1 125.41 8.17 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.606 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' C' ' 7' ' ' GLU . 95.6 Cg_endo -79.83 -40.34 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.208 1.939 . . . . 0.0 111.035 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -126.89 120.64 29.68 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.586 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 73.4 mt -126.11 130.53 72.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.521 -172.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.33 98.47 11.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.983 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.579 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.8 tt -105.33 99.89 9.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.24 158.67 19.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.322 -171.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -84.52 158.79 20.86 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.529 HG13 HD22 ' C' ' 53' ' ' ASN . 1.6 pt . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.977 -167.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.597 ' HB3' ' CB ' ' C' ' 4' ' ' LYS . 0.8 OUTLIER -118.47 132.49 56.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.442 ' HG3' HD12 ' C' ' 6' ' ' LEU . 20.2 mp0 -66.01 -9.28 28.94 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.597 ' CB ' ' HB3' ' C' ' 2' ' ' ASN . 3.8 ttmp? -42.78 -44.54 4.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.747 -1.57 . . . . 0.0 111.607 166.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.86 -15.04 30.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.0 110.781 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' C' ' 3' ' ' GLN . 82.8 mt -91.11 -153.1 0.3 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.47 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' C' ' 8' ' ' GLU . 8.1 mp0 -101.15 -11.56 19.47 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 4.9 mm-40 70.52 18.85 6.42 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.442 0.639 . . . . 0.0 110.498 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' C' ' 9' ' ' GLN . 9.8 mt-30 -70.38 -6.11 33.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.229 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -81.36 -143.48 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.622 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.05 -9.77 11.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -48.94 -60.46 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.89 0.476 . . . . 0.0 111.83 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.58 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -84.83 -18.36 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.06 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' ' ND2' ' C' ' 17' ' ' ASN . 84.3 m-20 -72.46 -38.96 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.642 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 61.2 m -63.76 -30.18 71.31 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 89.7 t -68.25 -36.69 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.651 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' C' ' 14' ' ' ASN . 94.8 m-20 -59.87 -45.51 92.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -60.4 -32.03 70.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.292 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -87.41 -31.63 19.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.975 0.417 . . . . 0.0 110.994 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' C' ' 27' ' ' LEU . 50.8 mt -81.62 -31.41 32.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.705 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -82.67 65.1 7.63 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.446 ' CE ' HD12 ' C' ' 47' ' ' ILE . 0.1 OUTLIER -95.52 -24.15 16.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.012 -173.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.46 -78.36 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.603 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.8 ttpt -98.87 -172.97 2.4 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 166.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 32.83 92.66 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 O-C-N 124.747 1.28 . . . . 0.0 115.703 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.0 ptpt -130.95 136.74 48.83 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.597 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.3 tp -116.48 122.09 43.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.581 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.9 m -108.05 104.54 14.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.292 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.689 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -82.53 138.43 34.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -142.76 129.35 20.25 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.993 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' C' ' 9' ' ' GLN . 36.0 mtm -130.81 125.02 32.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.236 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.487 ' H ' ' HG2' ' C' ' 35' ' ' GLN . 61.6 m-80 -148.42 97.21 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 110.654 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.98 -94.63 0.8 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.459 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -120.43 32.46 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.501 0.667 . . . . 0.0 109.835 -175.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' C' ' 32' ' ' ASN . 2.3 pt20 -128.48 136.55 50.97 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.279 0.561 . . . . 0.0 111.607 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.667 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 0.7 OUTLIER -130.39 118.45 21.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 164.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.526 ' O ' ' HD2' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -145.66 103.2 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -109.52 126.66 53.77 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.286 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -96.65 137.76 35.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.075 0.464 . . . . 0.0 109.896 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 29.2 p -109.04 117.59 34.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.644 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 21.2 t -102.63 173.97 6.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.422 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 71.76 39.61 0.84 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.384 1.052 . . . . 0.0 109.569 -166.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.12 27.02 14.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.79 172.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.97 5.83 88.86 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.051 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD2' ' O ' ' C' ' 42' ' ' ASN . 44.0 m-85 -65.03 156.47 31.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.579 ' O ' ' HG2' ' C' ' 24' ' ' LYS . . . -83.23 -166.52 39.87 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.463 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 15.6 mm -56.46 -61.9 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 121.489 0.662 . . . . 0.0 111.803 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.1 p 176.24 -74.15 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.983 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -159.88 20.99 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.358 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 42.1 mt-10 -115.95 141.87 47.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.765 -176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.501 ' HB2' HD21 ' C' ' 67' ' ' ASN . 7.0 p-10 -100.99 149.21 24.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.565 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.523 ' HG3' ' OE1' ' C' ' 68' ' ' GLU . 11.3 mmtp -132.9 146.23 51.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' C' ' 94' ' ' ILE . 6.5 t30 -96.28 99.25 10.97 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.753 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.557 ' HA ' ' CB ' ' C' ' 93' ' ' GLN . 0.0 OUTLIER -102.93 164.35 11.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.238 -166.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.53 143.9 10.2 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 119.403 -1.38 . . . . 0.0 115.114 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.405 HD12 ' N ' ' C' ' 56' ' ' ILE . 4.2 mp -118.85 124.82 73.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 5.2 m-85 -125.91 155.11 41.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.02 117.87 47.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.81 24.98 14.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.21 36.82 20.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.343 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 16.0 tp10 -133.62 131.11 39.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -55.82 124.5 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.98 -49.2 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.612 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 56.8 t80 -155.17 150.3 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.712 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 16.8 m -135.61 136.55 41.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 41.9 p90 -152.58 -177.9 6.52 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.793 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.501 HD21 ' HB2' ' C' ' 51' ' ' ASP . 52.0 t-20 -119.95 130.41 54.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.91 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.523 ' OE1' ' HG3' ' C' ' 52' ' ' LYS . 2.2 mt-10 -64.95 -27.06 68.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 13.7 ptmm? -79.55 2.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.374 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 11.5 m -74.63 178.24 5.52 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -76.63 110.84 11.53 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.39 -11.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.911 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.72 -41.24 13.12 Favored Glycine 0 CA--C 1.51 -0.238 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.971 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -71.54 -32.02 67.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.239 0.542 . . . . 0.0 109.587 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.479 ' O ' HG13 ' C' ' 79' ' ' ILE . 49.1 mm -69.62 -55.73 14.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.515 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' C' ' 38' ' ' ALA . 56.3 p -57.98 -64.65 0.84 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.839 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -67.06 -17.74 65.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -172.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -45.57 66.07 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.479 HG13 ' O ' ' C' ' 75' ' ' ILE . 58.2 mt -57.65 -28.29 31.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.839 HD22 ' ND2' ' C' ' 77' ' ' ASN . 30.0 m-20 -85.86 -27.95 24.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.023 -177.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 68.1 mttm -60.32 -36.65 78.41 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 12.3 mt -52.35 -32.47 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.35 99.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.66 1.225 . . . . 0.0 112.769 -175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.667 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.0 OUTLIER -42.67 144.42 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 113.965 -1.471 . . . . 0.0 112.867 -173.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.34 15.17 0.89 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.33 0.585 . . . . 0.0 109.586 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.31 179.91 28.41 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.682 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.58 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.5 Cg_endo -82.01 -77.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.668 2.245 . . . . 0.0 111.455 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.58 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.5 p90 -113.83 129.92 56.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 109.798 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.661 HG12 HD11 ' C' ' 84' ' ' ILE . 3.9 mp -116.01 136.71 52.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.374 -174.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 101.69 14.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' C' ' 29' ' ' LEU . 27.0 mm -103.4 98.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 151.56 3.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -173.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -91.42 171.7 9.02 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.225 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.824 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.149 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.692 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' C' ' 3' ' ' GLN . 26.1 t70 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.564 0.221 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' C' ' 2' ' ' ASN . 1.7 t-20 69.25 -4.68 1.24 Allowed 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.512 0.725 . . . . 0.0 112.778 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.636 ' HB3' ' CB ' ' C' ' 7' ' ' GLU . 46.6 mt-30 -90.82 22.37 3.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 110.465 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -51.01 -69.73 0.1 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.206 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.76 -70.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.415 0.626 . . . . 0.0 110.5 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' C' ' 9' ' ' GLN . 77.0 mt -90.69 97.1 10.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.187 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' C' ' 3' ' ' GLN . 6.0 pt-20 -79.29 -97.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 0.0 111.764 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.58 ' H ' ' HG3' ' C' ' 7' ' ' GLU . 9.7 mm-40 -68.74 4.82 1.28 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.91 0.386 . . . . 0.0 111.435 171.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' C' ' 6' ' ' LEU . 2.7 mp0 -81.5 15.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.465 ' O ' HG22 ' C' ' 13' ' ' ILE . 75.0 mtm -99.5 -143.21 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.481 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -47.58 -35.38 9.03 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . 0.456 ' O ' HG23 ' C' ' 16' ' ' VAL . 51.0 m -49.25 -48.44 45.77 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 10' ' ' MET . 9.9 tt -84.22 -25.26 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.288 0.566 . . . . 0.0 111.08 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.556 ' HA ' HD22 ' C' ' 17' ' ' ASN . 89.3 m-20 -85.02 -27.84 26.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.58 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 50.6 m -65.07 -31.67 73.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.539 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 51.7 t -69.83 -34.34 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.971 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.556 HD22 ' HA ' ' C' ' 14' ' ' ASN . 6.4 m-80 -57.43 -46.27 83.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.775 0.322 . . . . 0.0 110.749 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.9 -15.97 61.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.712 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -88.04 -38.0 15.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 43.3 mt -74.1 -33.9 63.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.45 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 23.4 m-80 -78.53 69.62 4.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.435 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -102.0 10.01 39.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.696 -171.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.91 -67.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.594 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 0.2 OUTLIER -100.44 92.56 5.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 122.616 0.366 . . . . 0.0 110.365 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 126.56 3.14 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 119.833 -1.175 . . . . 0.0 111.668 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' C' ' 40' ' ' SER . 7.5 ptpt -149.4 146.09 27.3 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.479 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CG1' ' C' ' 72' ' ' VAL . 3.7 mp -115.21 110.68 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.466 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.6 m -85.93 115.6 23.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.53 ' HB2' HD21 ' C' ' 17' ' ' ASN . 16.5 mt -102.63 132.27 48.85 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.877 0.37 . . . . 0.0 111.82 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 26.4 p -149.58 137.55 20.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.553 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 88.8 mtp -118.32 128.07 54.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -133.04 92.78 3.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.155 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.91 -93.55 0.41 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.167 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.6 p-10 -107.87 21.73 16.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.685 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 8.4 tt0 -138.79 145.54 40.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.558 0.694 . . . . 0.0 112.465 -169.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.413 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -128.85 105.07 7.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.474 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 54.5 pttt -109.13 104.95 14.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.638 0.732 . . . . 0.0 109.113 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -104.2 119.35 38.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -104.68 139.09 40.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 26.6 t -109.9 119.19 38.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' C' ' 42' ' ' ASN . 42.8 t -93.39 173.78 7.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.288 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' C' ' 41' ' ' SER . 12.4 m120 80.19 26.5 0.32 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.757 1.286 . . . . 0.0 110.102 -171.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.28 27.09 16.05 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.061 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.12 67.38 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.979 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.0 m-30 -60.19 143.14 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.813 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.82 -169.26 45.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.548 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.586 ' CG1' ' HB3' ' C' ' 68' ' ' GLU . 7.7 mt -48.95 -59.28 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 CA-C-O 121.052 0.453 . . . . 0.0 111.891 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 10.3 t 173.31 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.855 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -166.69 54.4 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 110.525 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 5.7 pt-20 -156.45 152.04 26.95 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.73 0.3 . . . . 0.0 111.409 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.476 ' O ' ' HD2' ' C' ' 52' ' ' LYS . 9.2 p-10 -97.31 129.62 44.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.662 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' C' ' 51' ' ' ASP . 5.6 mptp? -127.64 133.05 49.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.651 ' ND2' HG13 ' C' ' 94' ' ' ILE . 8.9 t30 -87.48 107.73 18.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.851 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.755 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.0 OUTLIER -113.38 165.62 12.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.869 -171.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.22 167.53 40.64 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.694 -1.241 . . . . 0.0 115.245 174.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.549 HG12 HG13 ' C' ' 91' ' ' ILE . 50.2 mt -131.24 131.47 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.901 -0.65 . . . . 0.0 110.414 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 54.0 m-85 -126.02 122.47 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.808 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -112.46 117.36 55.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 61.21 32.02 19.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.316 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.58 80.06 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.0 OUTLIER -112.95 142.75 45.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.713 0.256 . . . . 0.0 110.799 -178.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.54 100.44 2.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.32 -39.7 13.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.174 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -154.25 153.35 31.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.098 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.586 HG23 ' O ' ' C' ' 54' ' ' TRP . 60.0 m -150.08 142.43 24.27 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -158.6 -179.39 8.03 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.251 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' C' ' 51' ' ' ASP . 46.2 t-20 -118.91 127.07 53.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.167 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.755 ' HG3' ' CD1' ' C' ' 54' ' ' TRP . 2.1 mt-10 -63.24 -26.05 68.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 3.7 ptmm? -76.56 -2.41 32.29 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.581 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.559 ' HB2' HD11 ' C' ' 75' ' ' ILE . 5.4 m -74.74 -170.24 1.02 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 68.6 p -88.36 116.82 26.85 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.179 -0.951 . . . . 0.0 108.749 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.609 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 11.1 t -58.17 -17.21 8.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.751 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.32 -44.66 8.6 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.748 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -69.17 -28.48 66.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' C' ' 70' ' ' SER . 73.1 mt -66.92 -66.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.548 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -59.78 -48.16 82.78 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.285 -170.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.596 HD22 ' ND2' ' C' ' 80' ' ' ASN . 12.3 m120 -76.18 -15.63 60.01 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.39 -39.92 81.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.8 mt -58.49 -27.7 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.44 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.596 ' ND2' HD22 ' C' ' 77' ' ' ASN . 7.3 m-20 -77.64 -35.79 52.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.227 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' C' ' 81' ' ' LYS . 10.7 mmpt? -52.2 -42.99 63.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.8 mt -56.21 -32.91 64.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.685 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.3 OUTLIER 38.4 80.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.018 0.823 . . . . 0.0 111.083 -171.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.51 HG22 ' H ' ' C' ' 86' ' ' GLY . 11.8 mt -68.34 124.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.238 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.0 OUTLIER -91.74 34.83 0.97 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.852 175.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.51 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -79.98 143.6 25.44 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.19 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.29 -43.65 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.38 2.054 . . . . 0.0 111.293 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -139.26 128.77 24.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 63.4 mt -121.38 126.15 74.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.615 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -98.9 98.97 9.98 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.411 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.597 HG12 ' CH2' ' C' ' 54' ' ' TRP . 14.3 tt -98.83 104.42 15.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 168.09 19.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.86 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.37 0.605 . . . . 0.0 111.32 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.651 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.599 -166.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.542 0.21 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -164.08 -17.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.225 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.459 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 15.7 mp0 -85.25 14.1 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.861 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.16 -51.08 69.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.418 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.64 -9.31 47.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.259 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.43 169.15 11.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.048 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' C' ' 88' ' ' TYR . 58.7 mt-10 -94.29 4.28 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' C' ' 12' ' ' SER . 44.8 mt-10 71.14 -10.47 0.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.507 0.723 . . . . 0.0 112.924 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.517 ' NE2' ' H ' ' C' ' 89' ' ' ILE . 10.7 mm-40 -83.93 15.46 3.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 20.0 mmt -90.44 -143.54 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.408 ' H ' ' HB3' ' C' ' 10' ' ' MET . 4.1 m-20 -56.78 -14.16 3.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' C' ' 8' ' ' GLU . 48.3 t -54.33 -39.45 67.07 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.114 0.259 . . . . 0.0 110.438 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.514 HD13 ' SD ' ' C' ' 31' ' ' MET . 13.1 pt -90.81 -25.01 5.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.896 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -64.93 -44.35 89.78 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.757 0.313 . . . . 0.0 110.627 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -57.46 -35.86 70.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.516 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.8 t -68.34 -35.74 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.341 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.59 -41.54 99.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 110.132 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.37 -20.62 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.355 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' C' ' 19' ' ' LYS . 5.5 mmpt? -88.88 -35.22 16.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.139 0.495 . . . . 0.0 110.658 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.518 HD12 HD21 ' C' ' 29' ' ' LEU . 98.9 mt -76.37 -33.14 58.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' C' ' 26' ' ' LYS . 28.7 m-80 -79.98 60.05 3.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.544 0.688 . . . . 0.0 109.838 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' C' ' 22' ' ' LYS . 0.0 OUTLIER -94.21 -34.43 12.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.264 -173.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HE3' ' C' ' 26' ' ' LYS . . . 166.98 -93.7 0.11 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.464 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -72.66 91.76 1.47 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 125.59 5.19 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.642 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' C' ' 21' ' ' ASN . 8.0 ptpt -152.34 155.63 38.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.39 129.68 43.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.548 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 14.4 m -107.83 99.36 8.83 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.518 HD21 HD12 ' C' ' 20' ' ' LEU . 0.6 OUTLIER -93.39 136.13 33.96 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 120.818 0.342 . . . . 0.0 111.672 -171.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -153.35 130.62 11.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.273 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.519 ' HG3' ' CD2' ' C' ' 36' ' ' LEU . 1.6 mpt? -103.71 137.49 41.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.981 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -136.04 91.46 2.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.701 0.286 . . . . 0.0 110.278 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.02 -95.03 0.12 Allowed Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.079 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.5 p-10 -108.03 22.6 15.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.643 0.259 . . . . 0.0 110.938 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.701 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 25.9 tt0 -139.15 137.04 35.74 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.553 0.692 . . . . 0.0 112.398 -170.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.519 ' CD2' ' HG3' ' C' ' 31' ' ' MET . 0.6 OUTLIER -113.62 129.67 56.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -142.89 140.78 31.34 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.463 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -152.56 134.54 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.54 0.209 . . . . 0.0 110.996 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 62.0 p -98.28 145.45 26.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 35.8 m -125.59 116.61 22.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 49.2 m -100.66 -179.47 4.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.741 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.48 31.1 0.61 Allowed 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 124.584 1.178 . . . . 0.0 109.609 -168.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.52 32.58 22.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.112 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 1.03 86.34 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.262 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -66.63 145.67 55.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.84 0.353 . . . . 0.0 111.055 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.71 -160.39 20.19 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.629 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.755 HD12 ' H ' ' C' ' 48' ' ' SER . 0.4 OUTLIER -48.51 -53.04 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.755 ' H ' HD12 ' C' ' 47' ' ' ILE . 8.2 t 166.87 -62.81 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.273 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -150.37 -33.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 47.9 mm-40 -91.31 167.15 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -163.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.85 92.58 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.238 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.468 ' HB3' ' OE2' ' C' ' 68' ' ' GLU . 10.3 mptt -101.03 157.47 16.73 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.5 OUTLIER -116.6 120.61 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.582 0.706 . . . . 0.0 112.544 -174.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.549 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -102.85 166.56 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.737 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.74 150.13 11.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.117 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.3 mp -108.93 122.96 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 122.735 -0.274 . . . . 0.0 110.705 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -108.38 138.58 44.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.421 HG12 HG13 ' C' ' 63' ' ' VAL . 8.9 p -127.93 117.12 45.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.71 26.2 15.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.439 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.08 4.91 74.02 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.521 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.67 139.88 52.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.039 0.42 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 53.2 mtmt -82.0 136.87 35.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.721 0.296 . . . . 0.0 111.668 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.421 HG13 HG12 ' C' ' 58' ' ' VAL . 35.8 m -104.93 -39.47 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.695 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -144.7 145.93 31.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.549 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.2 m -136.88 141.93 42.76 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.541 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.7 p90 -153.85 -175.14 5.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.446 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' C' ' 53' ' ' ASN . 16.8 m120 -126.73 139.48 53.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.287 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.475 ' CD ' ' HD1' ' C' ' 54' ' ' TRP . 3.1 mp0 -62.24 -15.75 49.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.529 ' HB3' HD11 ' C' ' 47' ' ' ILE . 2.4 ptmm? -82.56 1.92 35.63 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.919 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.6 m -81.54 -173.95 4.68 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.562 ' O ' HG12 ' C' ' 75' ' ' ILE . 32.8 p -97.36 117.54 31.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.56 -21.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.518 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.71 -32.67 23.79 Favored Glycine 0 CA--C 1.504 -0.595 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.988 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -75.52 -38.49 59.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.562 HG12 ' O ' ' C' ' 71' ' ' THR . 42.3 mm -68.09 -58.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.519 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 20.3 m -59.74 -51.45 69.72 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.484 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.728 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -69.92 -18.94 63.41 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.734 -175.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 46.1 m-20 -68.03 -46.88 69.95 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 167.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' C' ' 76' ' ' SER . 96.2 mt -54.56 -29.87 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.296 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.728 HD22 ' ND2' ' C' ' 77' ' ' ASN . 69.9 m-20 -87.3 -37.35 17.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.327 -172.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 54.2 pttt -60.9 -26.03 67.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 18.5 mt -57.44 -29.05 63.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.819 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.701 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.3 m120 39.52 86.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.941 0.775 . . . . 0.0 110.679 -170.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.407 HG22 ' N ' ' C' ' 86' ' ' GLY . 15.9 mt -80.37 129.69 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.921 -168.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.4 OUTLIER -87.96 36.64 0.77 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.69 175.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.407 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -82.38 134.66 13.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.291 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.98 -47.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.545 2.163 . . . . 0.0 111.708 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' C' ' 7' ' ' GLU . 6.5 m-85 -125.71 99.54 6.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.517 ' H ' ' NE2' ' C' ' 9' ' ' GLN . 19.2 mm -100.54 125.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.424 0.631 . . . . 0.0 110.664 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.03 99.56 9.17 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.49 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.516 ' O ' HG11 ' C' ' 16' ' ' VAL . 3.4 tt -101.96 99.45 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.814 0.816 . . . . 0.0 109.018 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' C' ' 92' ' ' LYS . 0.0 OUTLIER -161.54 166.12 27.51 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.634 -173.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.626 ' HB2' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -104.19 163.41 12.43 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.312 173.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.587 HG13 HD22 ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.649 -161.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -126.32 -29.48 2.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.069 0.462 . . . . 0.0 109.91 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -90.23 23.36 2.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.92 0.867 . . . . 0.0 109.785 173.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -58.01 -39.13 77.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.835 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.84 -66.03 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.914 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.86 135.3 38.86 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.445 ' HG3' ' HG ' ' C' ' 12' ' ' SER . 23.3 tp10 -100.65 25.29 7.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.774 0.797 . . . . 0.0 109.851 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.17 -45.1 9.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.907 -167.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.585 ' HG3' ' SD ' ' C' ' 31' ' ' MET . 2.2 mp0 -90.08 15.86 9.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.467 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 0.0 OUTLIER -110.77 -151.96 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.467 ' H ' ' HB3' ' C' ' 10' ' ' MET . 91.7 m-20 -44.76 -33.71 2.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . 0.445 ' HG ' ' HG3' ' C' ' 7' ' ' GLU . 14.5 m -50.63 -48.76 57.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.677 0.275 . . . . 0.0 111.605 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.42 HD12 ' HE3' ' C' ' 31' ' ' MET . 5.3 tt -85.75 -28.09 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.113 0.482 . . . . 0.0 110.674 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 4.0 m-20 -69.8 -35.72 75.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.983 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -63.69 -29.82 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 96.8 t -72.49 -35.64 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.647 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.98 -42.2 98.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.67 -24.42 63.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -82.43 -31.5 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.824 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 27' ' ' LEU . 98.8 mt -84.88 -33.25 22.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.682 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.482 ' HA ' ' HB2' ' C' ' 26' ' ' LYS . 24.4 m-80 -78.73 78.45 5.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.724 ' NZ ' ' HB2' ' C' ' 24' ' ' LYS . 0.6 OUTLIER -120.22 7.09 10.72 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -165.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.32 -76.12 0.4 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.328 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.724 ' HB2' ' NZ ' ' C' ' 22' ' ' LYS . 47.7 mttm -75.51 -158.32 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.74 144.21 1.2 Allowed Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 114.615 0.606 . . . . 0.0 114.615 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' C' ' 40' ' ' SER . 12.7 ptpt -151.14 144.61 24.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 20' ' ' LEU . 3.3 mp -102.15 136.73 41.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.03 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 9.4 t -115.62 99.83 7.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.3 mm? -86.71 127.84 34.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.916 0.389 . . . . 0.0 111.482 -173.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.6 m -142.09 128.89 20.52 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.806 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.585 ' SD ' ' HG3' ' C' ' 9' ' ' GLN . 30.2 mtt -100.17 121.9 42.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -133.54 91.09 2.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.645 0.26 . . . . 0.0 110.973 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.9 -108.33 1.53 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.161 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.47 21.53 5.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.081 0.44 . . . . 0.0 110.867 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.576 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 21.8 tt0 -142.93 141.1 31.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.594 0.712 . . . . 0.0 112.105 -169.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.401 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.3 tm? -116.94 122.69 45.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 164.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -127.38 140.35 52.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.66 119.07 5.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 47.0 p -98.03 146.57 25.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 53.2 p -112.0 118.62 35.94 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 21.7 m -88.5 177.21 6.86 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.018 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.434 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 0.6 OUTLIER 72.54 33.61 1.38 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.285 0.991 . . . . 0.0 109.399 -172.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.8 33.45 23.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.594 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.32 6.92 89.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.189 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.434 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 21.4 m-85 -64.02 151.96 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.336 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -72.73 174.06 46.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.096 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.441 HG13 ' HB3' ' C' ' 68' ' ' GLU . 49.1 mm -60.57 -67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 121.182 0.515 . . . . 0.0 109.714 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 21.5 t -148.48 -88.42 0.08 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.308 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -177.31 25.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.535 0.683 . . . . 0.0 110.338 -173.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.56 146.12 50.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.159 0.504 . . . . 0.0 111.037 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.42 109.7 15.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.088 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 5.9 mptp? -121.18 137.7 54.55 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.589 ' ND2' HG13 ' C' ' 94' ' ' ILE . 11.4 t30 -88.57 108.53 19.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.69 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.39 162.74 13.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.495 -176.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.72 139.71 6.92 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.159 -1.496 . . . . 0.0 116.141 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.7 mp -112.75 129.17 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.443 167.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.43 106.99 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.327 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 89' ' ' ILE . 11.2 m -94.0 123.01 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 53.76 33.41 16.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.329 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.68 60.79 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.041 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.52 119.71 21.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 5.4 ttpm? -71.2 120.88 17.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.55 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.54 -33.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.559 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -146.08 143.87 29.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.14 0.495 . . . . 0.0 110.598 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.69 HG23 ' O ' ' C' ' 54' ' ' TRP . 69.2 m -135.76 139.98 43.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.2 p90 -148.45 177.77 9.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.173 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 67.4 m-20 -122.71 139.33 54.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.862 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' C' ' 47' ' ' ILE . 26.5 mt-10 -66.36 -14.21 61.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -82.97 -1.26 51.99 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -87.44 -177.9 6.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.413 ' O ' HG12 ' C' ' 75' ' ' ILE . 15.1 p -83.22 115.6 22.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.47 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.5 t -60.95 -15.29 11.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.697 -169.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.81 -43.3 7.29 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.656 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -69.71 -28.55 65.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.457 HG21 ' CD1' ' C' ' 66' ' ' PHE . 41.0 mm -70.27 -65.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.18 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.58 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 16.9 m -59.19 -46.64 87.89 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.767 -171.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.791 ' ND2' HD22 ' C' ' 80' ' ' ASN . 12.0 m120 -76.79 -14.83 59.88 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 19.8 m-20 -60.26 -45.62 92.64 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' C' ' 76' ' ' SER . 78.8 mt -57.22 -30.55 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.1 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.791 HD22 ' ND2' ' C' ' 77' ' ' ASN . 33.3 m-20 -90.72 -28.67 18.15 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.43 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 11.5 mmpt? -55.04 -36.02 65.1 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.7 mt -56.41 -31.79 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.576 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.5 OUTLIER 39.11 79.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 0.0 110.073 -168.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.43 HG22 ' N ' ' C' ' 86' ' ' GLY . 25.6 mt -69.04 131.92 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.003 -168.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -86.69 41.51 0.96 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.323 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.43 ' N ' HG22 ' C' ' 84' ' ' ILE . . . -89.26 129.58 9.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.746 -172.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.22 -38.35 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.418 2.079 . . . . 0.0 110.748 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -150.72 113.28 4.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.119 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.451 HG12 ' SD ' ' C' ' 31' ' ' MET . 15.0 pt -123.01 153.15 27.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.876 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.27 129.32 54.33 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.226 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' C' ' 29' ' ' LEU . 3.4 mt -126.89 100.23 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.681 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.37 15.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 174.51 7.32 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.35 -177.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.589 HG13 ' ND2' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.348 -169.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.504 0.192 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 73.87 -42.41 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.893 0.877 . . . . 0.0 112.855 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' C' ' 8' ' ' GLU . 41.1 mt-30 -52.13 -29.98 24.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.487 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -36.02 -54.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.673 1.233 . . . . 0.0 112.478 172.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.29 -18.8 23.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.818 -175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.45 -81.97 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.952 0.406 . . . . 0.0 112.059 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' C' ' 8' ' ' GLU . 3.3 pt-20 -102.45 -95.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' C' ' 7' ' ' GLU . 4.9 mm-40 66.7 -33.62 0.2 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.926 0.891 . . . . 0.0 111.951 -172.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' C' ' 7' ' ' GLU . 8.2 mt-30 -66.9 -5.29 11.95 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.489 175.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 95.7 mmm -108.53 -140.94 0.38 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -41.43 -33.6 0.44 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -53.63 -51.38 63.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.801 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.472 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.4 tt -87.03 -25.98 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' C' ' 17' ' ' ASN . 83.2 m-20 -72.48 -26.64 61.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.128 -0.358 . . . . 0.0 110.715 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.8 t -63.33 -33.64 75.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 71.9 t -69.6 -34.01 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.053 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' C' ' 14' ' ' ASN . 78.9 m-20 -56.98 -43.42 81.65 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.02 0.438 . . . . 0.0 110.149 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -76.16 -19.92 58.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.455 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.95 -27.78 28.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.188 0.518 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' C' ' 27' ' ' LEU . 72.5 mt -91.51 -32.05 15.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.97 73.43 9.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -107.7 -40.7 5.22 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.003 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.52 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -168.69 -74.68 0.04 OUTLIER Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.378 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.3 ttmm -105.81 162.55 13.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 167.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.92 85.32 0.03 OUTLIER Glycine 0 CA--C 1.498 -0.985 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.199 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 7.7 ptpt -126.13 128.35 47.18 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.164 0.506 . . . . 0.0 111.169 -173.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.49 ' HB3' HD13 ' C' ' 20' ' ' LEU . 23.7 tp -115.31 126.29 54.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.519 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 49.1 m -108.52 106.22 16.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.064 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' C' ' 91' ' ' ILE . 1.7 mm? -90.33 144.67 25.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.017 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.412 ' HB3' ' CE ' ' C' ' 37' ' ' LYS . 39.5 t -158.6 136.39 10.4 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.565 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.425 ' HE2' ' O ' ' C' ' 87' ' ' PRO . 2.3 mpt? -96.81 146.03 25.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -141.41 88.73 2.17 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.76 -99.3 0.08 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.053 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.33 26.46 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 0.0 110.362 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.708 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.2 tt0 -139.01 138.78 37.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.324 0.583 . . . . 0.0 111.654 -171.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -119.06 122.59 42.47 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 167.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.412 ' CE ' ' HB3' ' C' ' 30' ' ' SER . 0.0 OUTLIER -130.79 145.33 51.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -151.85 133.61 14.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.705 0.288 . . . . 0.0 110.535 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 51.9 p -100.56 144.46 29.52 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.0 p -121.51 118.36 29.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.626 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 30.6 m -104.76 -179.93 4.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.377 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.68 38.73 1.63 Allowed 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 124.208 0.942 . . . . 0.0 108.812 -169.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.68 20.64 12.2 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.081 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.51 79.19 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.299 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.467 ' O ' HG23 ' C' ' 72' ' ' VAL . 45.1 m-85 -75.92 -179.05 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.866 0.333 . . . . 0.0 111.063 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.54 -159.63 33.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.39 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.67 HD11 ' HB3' ' C' ' 68' ' ' GLU . 11.8 mt -49.21 -67.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.486 0.714 . . . . 0.0 112.53 -172.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 5.4 t 171.05 -75.3 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.788 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -155.31 62.23 0.62 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.352 0.261 . . . . 0.0 111.356 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.679 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 11.6 pt-20 -169.13 176.13 5.41 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.401 -0.187 . . . . 0.0 110.946 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 12.6 t70 -127.61 113.79 16.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.51 0.506 . . . . 0.0 110.78 -173.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -118.25 158.56 24.93 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.479 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.4 OUTLIER -108.93 123.21 48.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.474 0.654 . . . . 0.0 110.557 179.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.505 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -113.06 166.4 11.46 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.078 -168.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -173.8 155.89 22.82 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 119.636 -1.269 . . . . 0.0 115.796 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' C' ' 62' ' ' LYS . 2.0 mp -116.45 129.38 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.365 177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' C' ' 62' ' ' LYS . 0.4 OUTLIER -127.61 99.73 5.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 173.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 89' ' ' ILE . 7.4 p -84.11 125.77 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.645 -0.659 . . . . 0.0 109.967 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.49 26.21 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.878 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.41 4.45 76.98 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.977 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 35.9 tt0 -108.24 120.17 41.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.963 0.381 . . . . 0.0 110.609 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' C' ' 56' ' ' ILE . 27.6 ttpp -74.55 117.58 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.11 -30.23 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.023 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -137.39 144.63 42.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.49 HG23 ' O ' ' C' ' 54' ' ' TRP . 28.1 m -145.99 141.89 28.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' C' ' 75' ' ' ILE . 45.6 p90 -162.24 -170.65 2.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.413 ' OD1' ' HG2' ' C' ' 69' ' ' LYS . 48.7 t-20 -117.53 138.38 51.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.545 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.67 ' HB3' HD11 ' C' ' 47' ' ' ILE . 1.9 tt0 -72.84 -29.53 63.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.295 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.679 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 9.4 ptmt -86.66 11.65 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -76.91 -151.15 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.546 ' O ' HG12 ' C' ' 75' ' ' ILE . 18.0 p -106.92 112.24 25.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.024 -1.047 . . . . 0.0 108.984 171.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.467 HG23 ' O ' ' C' ' 45' ' ' TYR . 6.8 t -59.39 -16.47 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.491 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.99 -46.49 7.67 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.094 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -66.79 -36.43 82.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.588 HG21 ' CD1' ' C' ' 66' ' ' PHE . 50.6 mm -68.01 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.542 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 13.5 m -70.59 -44.29 67.61 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -167.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.793 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.5 OUTLIER -69.56 -17.62 63.58 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.951 -177.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 5.7 m-20 -64.56 -49.63 70.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 167.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' C' ' 76' ' ' SER . 81.1 mt -52.33 -32.64 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.291 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.793 HD22 ' ND2' ' C' ' 77' ' ' ASN . 62.9 m-20 -85.07 -36.3 21.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.37 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 56.6 mtmt -57.92 -30.55 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 109.788 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.3 mt -58.8 -27.98 65.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.577 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.708 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 41.77 82.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.895 0.855 . . . . 0.0 110.713 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.93 127.56 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.249 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -81.26 29.42 0.35 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.296 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.49 112.16 0.6 Allowed Glycine 0 N--CA 1.434 -1.447 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.425 ' O ' ' HE2' ' C' ' 31' ' ' MET . 91.2 Cg_endo -81.75 -14.16 10.23 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.054 . . . . 0.0 113.278 -174.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -97.19 98.38 9.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' C' ' 58' ' ' VAL . 55.3 mt -125.48 132.68 70.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.5 0.667 . . . . 0.0 112.464 -168.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -90.29 97.37 11.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.127 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.545 HG21 ' HG ' ' C' ' 29' ' ' LEU . 14.1 tt -109.58 96.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 122.646 1.212 . . . . 0.0 107.983 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -152.97 177.32 10.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.263 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.9 OUTLIER -108.27 163.53 13.11 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.882 174.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.479 HG12 ' O ' ' C' ' 53' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.321 -166.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' C' ' 4' ' ' LYS . 12.8 m120 70.41 -52.1 0.65 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.98 0.912 . . . . 0.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -83.06 22.32 0.97 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' C' ' 2' ' ' ASN . 21.9 ttmm -49.24 -48.41 45.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.999 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.74 25.9 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.004 0.431 . . . . 0.0 111.316 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.57 -82.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.706 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.35 -79.5 0.52 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.394 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 65.09 17.62 11.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.495 ' HA ' ' HE3' ' C' ' 31' ' ' MET . 37.7 mt-30 -85.99 15.66 4.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.352 176.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.432 ' O ' HG22 ' C' ' 13' ' ' ILE . 96.6 mmm -105.27 -144.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.175 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.45 -29.43 58.64 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -41.43 75.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 111.319 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.432 HG22 ' O ' ' C' ' 10' ' ' MET . 0.0 OUTLIER -90.62 -30.02 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.535 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.563 ' HA ' HD22 ' C' ' 17' ' ' ASN . 77.2 m-20 -72.68 -24.97 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.118 -0.364 . . . . 0.0 110.933 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -57.88 -36.79 72.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.411 HG11 ' O ' ' C' ' 91' ' ' ILE . 61.1 t -68.43 -32.76 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.563 HD22 ' HA ' ' C' ' 14' ' ' ASN . 8.2 m-80 -59.1 -38.4 79.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.998 0.428 . . . . 0.0 109.97 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -70.36 -40.02 74.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.75 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -40.15 80.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.628 0.728 . . . . 0.0 109.734 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' C' ' 27' ' ' LEU . 36.7 mt -67.19 -41.24 86.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.8 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' C' ' 26' ' ' LYS . 28.1 m-80 -80.46 37.13 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.528 0.68 . . . . 0.0 110.603 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' C' ' 20' ' ' LEU . 18.3 pttm -48.25 -42.05 29.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.302 1.441 . . . . 0.0 112.84 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.7 -71.23 0.08 OUTLIER Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -85.84 -166.83 1.64 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 163.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' C' ' 45' ' ' TYR . . . 41.54 74.73 0.15 Allowed Glycine 0 CA--C 1.488 -1.601 0 O-C-N 124.272 0.982 . . . . 0.0 114.515 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.807 ' HB2' ' H ' ' C' ' 41' ' ' SER . 5.8 mmpt? -89.14 78.41 7.38 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.974 -171.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.657 ' HB3' HD13 ' C' ' 20' ' ' LEU . 10.8 tp -88.07 105.94 17.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.336 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -101.15 108.08 19.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.579 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.417 HD22 HG21 ' C' ' 91' ' ' ILE . 1.3 mp -112.62 142.63 44.99 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.361 0.601 . . . . 0.0 112.088 -171.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -144.58 129.74 18.62 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.029 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.545 ' CG ' HD23 ' C' ' 36' ' ' LEU . 71.4 mtm -103.49 145.89 29.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -148.34 92.03 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.424 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.28 -93.45 0.29 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.989 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -108.63 15.02 24.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.598 0.199 . . . . 0.0 111.065 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.691 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.6 tt0 -134.05 139.28 45.89 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.598 0.713 . . . . 0.0 112.454 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.545 HD23 ' CG ' ' C' ' 31' ' ' MET . 3.2 tm? -128.31 120.68 27.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.689 169.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' C' ' 37' ' ' LYS . 0.0 OUTLIER -132.49 139.59 48.01 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.466 ' H ' ' ND2' ' C' ' 80' ' ' ASN . . . -151.1 145.91 25.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.846 -171.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 74.8 p -118.86 150.77 39.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 4.1 p -124.32 116.47 22.66 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.315 0.578 . . . . 0.0 111.087 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.807 ' H ' ' HB2' ' C' ' 26' ' ' LYS . 21.6 m -89.5 -178.93 5.7 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.813 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.02 42.83 15.32 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.822 0.701 . . . . 0.0 109.541 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.96 21.9 12.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.476 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.49 23.44 78.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.456 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.464 ' O ' ' HA2' ' C' ' 25' ' ' GLY . 33.2 m-85 -68.19 158.81 32.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.994 0.397 . . . . 0.0 110.722 176.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.75 -101.87 0.56 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.311 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' C' ' 68' ' ' GLU . 18.6 mt -107.6 -67.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.525 0.679 . . . . 0.0 110.42 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.7 p -176.16 -68.09 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.37 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -149.35 -32.94 0.21 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.413 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.552 ' O ' HD12 ' C' ' 47' ' ' ILE . 13.8 pt-20 -88.21 178.98 6.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.55 139.94 53.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.491 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 28.1 mmmt -115.72 157.35 24.41 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.753 ' ND2' HG13 ' C' ' 94' ' ' ILE . 10.6 t30 -98.3 105.11 17.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.396 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.601 ' CZ2' HD21 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.06 165.99 10.7 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.187 -172.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.46 159.35 28.25 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.602 -1.285 . . . . 0.0 115.318 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -121.14 128.45 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.773 174.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.1 m-85 -124.04 122.49 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 48.7 t -105.86 111.18 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 60.11 24.88 14.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.084 0.468 . . . . 0.0 110.052 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.14 16.81 58.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.862 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 0.6 OUTLIER -107.01 128.1 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 0.0 111.357 178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -72.12 107.44 4.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 m -95.58 -31.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.365 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -159.35 147.88 17.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 ' O ' ' C' ' 54' ' ' TRP . 71.3 m -140.62 147.78 39.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -165.79 -173.76 2.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.459 0.572 . . . . 0.0 112.117 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 20.1 m120 -114.37 139.5 49.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.7 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.6 ' HB3' HD11 ' C' ' 47' ' ' ILE . 63.6 tt0 -68.12 -15.83 63.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 14.5 ptmm? -83.66 -5.52 59.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -70.54 159.94 33.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 9.5 p -74.33 112.31 10.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' C' ' 27' ' ' LEU . 2.6 t -58.36 -14.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.71 -170.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.71 -38.96 14.96 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.088 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -72.71 -34.59 67.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.75 -59.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.408 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.432 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 66.5 p -58.12 -58.56 7.92 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.125 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.807 ' ND2' HD22 ' C' ' 80' ' ' ASN . 1.1 m120 -67.95 -17.05 64.33 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.2 OUTLIER -67.01 -48.21 69.08 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.499 ' HA ' ' CD1' ' C' ' 82' ' ' LEU . 75.2 mt -56.85 -32.64 39.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.902 174.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.807 HD22 ' ND2' ' C' ' 77' ' ' ASN . 41.7 m-20 -84.06 -22.1 31.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.393 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 67.8 mttm -62.71 -40.95 98.75 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 8.3 mt -54.88 -35.43 64.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.224 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.691 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 10.6 m120 44.08 85.23 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 -166.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.82 113.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.475 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -84.45 64.6 8.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.211 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.68 156.96 26.1 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.585 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.487 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.2 Cg_endo -80.49 -55.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.501 2.134 . . . . 0.0 112.531 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.0 p90 -124.05 132.86 53.73 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.509 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 64.7 mt -130.3 132.09 65.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.511 0.672 . . . . 0.0 111.889 -169.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.22 98.18 10.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.603 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.562 HG13 HG13 ' C' ' 56' ' ' ILE . 7.7 tt -108.25 97.94 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 177.24 9.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.818 -168.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.5 OUTLIER -106.23 163.61 12.67 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.637 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.753 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -165.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.481 0.181 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -143.61 -36.94 0.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.973 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.606 ' HA ' ' OE1' ' C' ' 3' ' ' GLN . 5.9 mm-40 -88.28 12.68 13.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.316 0.579 . . . . 0.0 109.843 175.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -48.02 -59.37 3.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.395 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.01 -9.55 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.901 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.54 -171.86 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.441 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -88.41 -12.5 43.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' C' ' 88' ' ' TYR . 42.7 mt-10 72.07 6.5 5.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.225 0.536 . . . . 0.0 111.294 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' C' ' 31' ' ' MET . 26.0 mt-30 -121.84 19.39 10.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.151 -175.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 91.6 mtp -72.82 -145.98 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.3 m-20 -59.9 -16.52 30.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 31.3 t -46.34 -50.78 15.91 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.29 0.369 . . . . 0.0 111.317 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.412 ' H ' HG13 ' C' ' 13' ' ' ILE . 2.5 pp -91.27 -21.68 6.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.144 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 5.5 m-20 -63.97 -46.95 82.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.951 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . 0.657 ' O ' ' HG2' ' C' ' 19' ' ' LYS . 42.6 t -55.42 -41.71 73.14 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.08 -34.5 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.575 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.57 -40.09 95.76 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -72.42 -27.4 62.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.869 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' C' ' 15' ' ' SER . 0.2 OUTLIER -79.82 -34.27 39.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.206 0.526 . . . . 0.0 110.14 -177.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 27' ' ' LEU . 93.3 mt -80.21 -38.97 30.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.808 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -79.38 71.64 5.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.43 0.633 . . . . 0.0 109.557 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.491 ' HE3' ' CB ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -113.83 -13.73 12.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.162 -171.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 146.04 -73.21 0.32 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -174.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.491 ' CB ' ' HE3' ' C' ' 22' ' ' LYS . 2.3 mttp -72.17 -159.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' C' ' 47' ' ' ILE . . . -43.1 130.75 5.57 Favored Glycine 0 CA--C 1.512 -0.137 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -173.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.7 ptpt -132.05 142.87 49.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.985 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 20' ' ' LEU . 4.1 mp -117.76 125.34 50.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 42.1 m -94.96 101.26 13.02 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.471 HD22 HD12 ' C' ' 91' ' ' ILE . 15.7 mt -92.44 129.4 38.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.613 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -151.24 144.37 24.66 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.414 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.416 ' HB2' ' OE1' ' C' ' 9' ' ' GLN . 2.4 mpt? -105.36 146.22 29.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.34 . . . . 0.0 110.319 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -147.86 89.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.229 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.14 -101.43 0.19 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.037 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.81 34.14 2.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.738 0.78 . . . . 0.0 109.305 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.438 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 50.7 tt0 -140.9 139.9 34.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.379 0.609 . . . . 0.0 112.048 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -122.22 105.37 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 167.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.58 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 63.2 pttt -106.25 131.68 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 117.67 6.45 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.25 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 69.8 p -102.43 151.28 22.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.086 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 62.1 p -111.56 119.51 38.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.545 176.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 12.1 t -103.4 177.65 4.78 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.76 33.6 0.19 Allowed 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 124.619 1.199 . . . . 0.0 110.514 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.43 37.08 25.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.098 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.81 1.3 89.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.305 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -64.01 135.22 56.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.018 0.409 . . . . 0.0 110.359 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' C' ' 72' ' ' VAL . . . -64.39 150.67 50.75 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.777 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.496 HD11 HD11 ' C' ' 27' ' ' LEU . 40.6 mt -57.15 -54.56 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 121.872 0.844 . . . . 0.0 110.952 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' C' ' 68' ' ' GLU . 23.3 t -127.37 -173.72 2.98 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.063 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -132.52 13.9 4.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.96 0.886 . . . . 0.0 109.011 -173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.442 ' HB2' ' HE2' ' C' ' 52' ' ' LYS . 30.8 mt-10 -131.28 161.38 32.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.943 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.43 91.9 6.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 111.293 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 4.8 mptp? -94.37 144.67 25.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.44 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.572 ' O ' HG12 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -89.2 102.02 14.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.656 0.598 . . . . 0.0 110.359 175.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.565 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -105.11 159.28 15.97 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.5 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.484 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -165.17 166.85 38.49 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 118.267 -1.92 . . . . 0.0 116.114 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.484 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.3 mp -120.34 132.31 70.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.486 -0.857 . . . . 0.0 110.509 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 79.7 m-85 -120.84 111.44 17.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -93.76 115.21 32.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.69 34.33 23.72 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.003 0.43 . . . . 0.0 110.424 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.24 8.9 87.5 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.317 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 37.7 tt0 -107.92 126.96 53.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.281 0.541 . . . . 0.0 110.57 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -72.8 102.03 3.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.849 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.17 -46.57 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.264 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.51 149.43 50.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' C' ' 54' ' ' TRP . 63.7 m -145.33 143.3 30.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -155.57 -174.95 5.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.796 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 11.6 m120 -128.37 140.99 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.869 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' C' ' 48' ' ' SER . 20.5 mt-10 -67.53 -13.16 61.81 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -87.74 -6.17 58.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.021 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -83.69 177.84 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.332 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.486 ' O ' HG12 ' C' ' 75' ' ' ILE . 22.3 p -81.32 112.41 18.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.427 HG23 ' HA2' ' C' ' 46' ' ' GLY . 1.7 t -60.56 -14.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.229 -173.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.53 -38.25 12.67 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.158 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -73.89 -30.88 62.85 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.486 HG12 ' O ' ' C' ' 71' ' ' THR . 36.4 mm -67.48 -64.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.714 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.624 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 63.0 p -63.45 -58.26 7.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -169.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.544 HD22 ' CG ' ' C' ' 80' ' ' ASN . 4.0 m120 -72.73 -16.38 61.66 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -172.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.52 -41.32 97.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' C' ' 76' ' ' SER . 85.6 mt -55.95 -25.44 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.123 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.593 HD22 ' N ' ' C' ' 80' ' ' ASN . 0.5 OUTLIER -83.98 -32.19 25.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.233 -176.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.97 -38.5 76.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.0 -28.81 66.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.386 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.438 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 37.43 85.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.354 1.034 . . . . 0.0 111.567 -173.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.473 HG21 HD12 ' C' ' 89' ' ' ILE . 27.3 mm -64.34 143.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.728 -168.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -112.36 25.42 11.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.656 -172.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.433 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -114.33 167.7 12.38 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.187 -172.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.574 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 92.7 Cg_endo -81.31 -72.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.835 2.357 . . . . 0.0 113.22 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.574 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 10.1 p90 -103.55 113.75 27.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.592 0.711 . . . . 0.0 109.993 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.473 HD12 HG21 ' C' ' 84' ' ' ILE . 19.3 mm -102.74 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.618 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -91.49 98.35 11.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.411 0.624 . . . . 0.0 110.755 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.565 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.0 mt -95.89 104.43 15.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 143.96 19.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 121.388 0.614 . . . . 0.0 111.602 -172.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 24.6 tm0? -66.0 140.41 58.29 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.872 174.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.572 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.76 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.236 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.521 0.677 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -126.93 -15.82 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.473 ' OE1' ' HG2' ' C' ' 8' ' ' GLU . 42.0 mt-30 -90.13 21.12 3.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.962 0.887 . . . . 0.0 109.205 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -84.03 -43.36 15.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.684 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.28 -36.25 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.445 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.67 134.02 34.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.174 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -81.45 23.7 0.61 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.473 ' HG2' ' OE1' ' C' ' 3' ' ' GLN . 54.9 mt-10 75.62 20.64 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 173.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.77 18.91 3.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.2 -0.313 . . . . 0.0 111.552 173.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 37.9 mtm -80.14 -144.83 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 110.799 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 94.8 m-20 -61.45 -17.84 56.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.476 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -52.59 -46.28 66.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 15.6 pt -89.15 -26.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.81 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 79.2 m-20 -65.62 -37.15 85.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 47.7 t -54.68 -41.52 70.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 57.4 t -66.21 -37.17 79.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.403 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' C' ' 29' ' ' LEU . 33.5 m-80 -67.75 -33.31 74.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.574 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -80.11 -18.7 49.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.671 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -90.61 -38.7 12.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.546 HD13 ' HB3' ' C' ' 27' ' ' LEU . 68.4 mt -80.17 -36.42 35.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.033 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -81.51 74.87 8.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.401 0.619 . . . . 0.0 109.368 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.889 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -111.5 -23.01 10.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.858 -172.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.625 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 165.12 -79.99 0.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.652 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 10.3 mttt -73.81 -159.09 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.33 141.54 1.15 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 -173.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.4 ptpt -149.95 140.17 22.19 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.057 -167.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' C' ' 20' ' ' LEU . 6.1 tt -108.39 125.48 51.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.393 -177.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 20.8 m -104.16 123.86 48.05 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.456 HD12 ' N ' ' C' ' 29' ' ' LEU . 5.0 mp -94.58 134.16 37.43 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -174.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.453 ' HB3' ' HD2' ' C' ' 37' ' ' LYS . 7.0 t -159.59 142.39 13.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.727 170.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 137.98 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.816 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -136.95 89.8 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.767 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.16 -93.31 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.13 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -114.74 31.01 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.175 0.512 . . . . 0.0 110.216 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.661 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 17.1 tt0 -143.98 124.48 13.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.715 -171.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.02 104.93 16.9 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 166.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -100.26 146.74 26.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -176.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -149.36 118.52 6.78 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.594 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.5 p -99.07 141.47 31.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.916 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 21.7 p -116.93 118.9 33.71 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.069 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CD ' ' C' ' 26' ' ' LYS . 45.0 m -91.97 176.42 6.52 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.246 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.5 m120 72.19 36.12 1.15 Allowed 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.261 0.976 . . . . 0.0 109.424 -169.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.63 35.42 26.08 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.476 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.36 79.87 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.274 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.405 ' HD1' ' O ' ' C' ' 42' ' ' ASN . 24.0 m-85 -69.69 -179.76 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.063 0.459 . . . . 0.0 110.872 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.35 169.9 32.21 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.162 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.889 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 47.3 mm -54.04 -64.46 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-O 121.816 0.817 . . . . 0.0 110.907 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.8 t -174.9 -155.67 0.06 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.087 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -87.81 -15.99 35.32 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.29 0.567 . . . . 0.0 110.257 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' C' ' 69' ' ' LYS . 43.2 mt-10 -83.43 127.79 33.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.438 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.79 139.05 31.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -125.52 158.63 34.04 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.5 ' O ' HG13 ' C' ' 94' ' ' ILE . 2.2 p-10 -97.17 103.87 15.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.722 0.772 . . . . 0.0 109.591 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.627 ' O ' HG23 ' C' ' 65' ' ' THR . 0.1 OUTLIER -99.18 156.36 17.0 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.811 -171.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.431 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -139.98 132.8 5.71 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 119.459 -1.353 . . . . 0.0 115.582 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.0 mp -120.63 126.6 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.069 -0.565 . . . . 0.0 109.487 170.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.74 137.87 47.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.585 HG23 HG11 ' C' ' 63' ' ' VAL . 65.0 t -101.5 117.96 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 15.5 m120 56.71 30.37 17.47 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.351 0.407 . . . . 0.0 111.243 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.25 6.96 73.85 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.053 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -107.73 119.91 40.77 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.532 -0.393 . . . . 0.0 110.578 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -57.91 119.06 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.162 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.585 HG11 HG23 ' C' ' 58' ' ' VAL . 4.3 p -119.52 -43.01 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.981 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -137.07 152.39 49.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.627 HG23 ' O ' ' C' ' 54' ' ' TRP . 85.3 m -145.61 148.02 32.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' C' ' 75' ' ' ILE . 45.9 p90 -155.83 172.37 18.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.699 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.62 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.537 ' O ' HG12 ' C' ' 47' ' ' ILE . 4.2 tt0 -52.68 -40.11 62.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.688 -169.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 20.1 pttp -72.91 -0.84 14.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -169.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -71.32 -176.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.405 ' O ' HG12 ' C' ' 75' ' ' ILE . 28.2 p -74.23 108.91 7.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 t -60.57 -11.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.951 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.24 -38.35 8.49 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.0 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -74.17 -28.79 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.447 HG21 ' CD2' ' C' ' 66' ' ' PHE . 50.7 mm -73.77 -64.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.083 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.586 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 8.6 m -60.71 -48.73 80.49 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.991 -170.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.539 HD22 ' CG ' ' C' ' 80' ' ' ASN . 7.7 m120 -75.6 -15.5 60.34 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 0.1 OUTLIER -59.46 -44.85 92.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 166.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' C' ' 76' ' ' SER . 76.6 mt -56.42 -23.27 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.175 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -87.48 -34.39 18.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.106 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' C' ' 78' ' ' ASP . 57.7 mtmt -55.87 -38.89 70.73 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 1.6 mt -60.14 -29.45 68.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.142 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.661 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.66 86.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.275 -170.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.14 99.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.928 -1.033 . . . . 0.0 113.438 -169.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.517 ' CD ' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -64.77 125.84 26.07 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.411 162.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 162.79 158.68 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.911 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.0 Cg_endo -81.15 -62.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.454 2.102 . . . . 0.0 112.585 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.54 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 16.0 p90 -128.37 137.72 52.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.992 0.425 . . . . 0.0 110.166 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.4 mt -122.34 136.45 59.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.97 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -92.2 99.91 12.62 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.498 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . . . . . . . . . 30.0 mm -113.89 98.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.06 160.73 6.57 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.36 173.12 12.66 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.831 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.5 HG13 ' O ' ' C' ' 53' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.424 -175.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' C' ' 4' ' ' LYS . 12.3 m120 -90.38 -39.1 12.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 122.378 -0.201 . . . . 0.0 111.214 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.658 ' CB ' ' HA ' ' C' ' 7' ' ' GLU . 87.4 mt-30 -83.44 19.24 1.6 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.795 0.807 . . . . 0.0 110.084 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' C' ' 2' ' ' ASN . 55.2 tptt -65.42 -56.83 10.32 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.715 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.44 -69.42 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.18 0.514 . . . . 0.0 109.744 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -90.89 96.5 10.66 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.621 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.658 ' HA ' ' CB ' ' C' ' 3' ' ' GLN . 16.7 tt0 -78.84 -99.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 0.0 109.989 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' C' ' 88' ' ' TYR . 32.7 mt-10 -130.3 14.35 5.6 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.726 0.774 . . . . 0.0 109.785 163.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.99 20.44 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.974 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 54.1 mtt -68.49 -150.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.925 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -60.35 -9.52 3.63 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . 0.426 ' O ' HG23 ' C' ' 16' ' ' VAL . 15.3 m -48.89 -49.87 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.673 0.389 . . . . 0.0 111.353 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.43 -18.81 7.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.212 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -69.24 -46.16 68.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -56.3 -34.69 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.477 0.656 . . . . 0.0 109.481 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 12' ' ' SER . 93.9 t -69.43 -37.18 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -63.39 -46.7 85.25 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.707 0.289 . . . . 0.0 110.514 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.6 -19.86 65.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.589 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -90.15 -40.22 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.09 0.471 . . . . 0.0 110.378 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.1 mt -83.22 -32.31 26.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.304 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -92.8 79.06 4.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.358 0.599 . . . . 0.0 109.431 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.595 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -114.17 -30.69 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.948 -170.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.488 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . 173.1 -73.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.628 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 54.7 mttp -71.25 -158.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.551 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -45.6 142.47 4.18 Favored Glycine 0 CA--C 1.497 -1.085 0 O-C-N 123.357 0.411 . . . . 0.0 113.547 -177.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' C' ' 40' ' ' SER . 4.9 ptpt -144.35 150.08 37.2 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.834 -165.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' C' ' 38' ' ' ALA . 0.5 OUTLIER -122.84 113.33 19.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.82 -170.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 74.0 m -103.03 126.2 50.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HG ' HG21 ' C' ' 91' ' ' ILE . 0.7 OUTLIER -98.98 137.76 37.05 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -171.347 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 29.1 m -147.25 130.85 16.83 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.511 171.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.505 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 38.7 mtt -122.68 138.67 54.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.329 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -148.68 91.2 1.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.11 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.26 -93.61 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.706 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -108.81 33.17 4.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 109.774 -177.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.745 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 28.0 tt0 -149.72 139.55 21.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.526 0.679 . . . . 0.0 112.525 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 2.4 tm? -118.39 127.58 53.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 167.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 23.6 pttm -130.38 105.78 8.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' C' ' 27' ' ' LEU . . . -111.94 128.25 56.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.4 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -103.48 148.75 25.55 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.073 0.463 . . . . 0.0 110.41 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 64.9 p -119.41 138.25 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.338 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 14.7 m -117.35 179.49 4.03 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 0.7 OUTLIER 80.18 23.41 0.42 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.424 1.078 . . . . 0.0 111.197 -176.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.4 50.06 13.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.393 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -3.36 86.72 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.59 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' C' ' 42' ' ' ASN . 5.9 m-85 -66.07 152.88 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.862 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.11 163.18 31.53 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.194 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.595 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 34.3 mm -51.55 -63.24 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.16 0.981 . . . . 0.0 111.169 177.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -156.98 -176.52 6.02 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.492 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -114.39 45.76 1.48 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.584 0.707 . . . . 0.0 109.792 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -140.85 145.23 35.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.102 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.69 114.28 16.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' C' ' 67' ' ' ASN . 12.4 mptt -126.37 129.95 49.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.739 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.577 HD22 HG13 ' C' ' 94' ' ' ILE . 1.3 p-10 -89.24 99.19 12.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.945 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.679 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.874 -175.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.18 167.27 40.42 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 118.832 -1.651 . . . . 0.0 115.649 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.521 HG12 HG13 ' C' ' 91' ' ' ILE . 87.1 mt -125.99 128.2 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.582 -0.809 . . . . 0.0 111.697 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 24.7 m-85 -123.03 111.26 16.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.207 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -104.86 128.05 58.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CE1' ' C' ' 88' ' ' TYR . 77.0 m-20 54.69 24.71 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.817 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 27.7 29.27 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.543 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.9 pt-20 -143.82 151.13 39.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.292 0.546 . . . . 0.0 110.108 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -82.86 137.86 34.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.78 -32.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.109 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -161.9 135.83 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.084 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.679 HG23 ' O ' ' C' ' 54' ' ' TRP . 79.3 m -124.07 142.52 51.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' C' ' 75' ' ' ILE . 38.4 p90 -152.72 -178.01 6.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.594 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 13.9 m120 -124.89 130.44 52.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.048 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.486 ' HG2' HG13 ' C' ' 47' ' ' ILE . 31.2 mt-10 -62.89 -22.55 66.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.57 2.04 27.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.443 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -87.01 -179.64 6.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 23.3 p -77.7 118.19 19.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' C' ' 75' ' ' ILE . 2.1 t -64.53 -12.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -81.8 -41.4 9.74 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.122 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.61 -34.34 78.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.43 ' O ' HG13 ' C' ' 79' ' ' ILE . 74.2 mt -65.45 -68.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.462 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.587 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 3.4 m -56.42 -56.17 24.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.538 HD22 ' ND2' ' C' ' 80' ' ' ASN . 10.2 m120 -76.43 -15.08 60.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.88 -39.64 83.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 166.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' C' ' 76' ' ' SER . 71.7 mt -58.94 -25.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.79 173.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.538 ' ND2' HD22 ' C' ' 77' ' ' ASN . 7.2 m-20 -80.51 -34.16 35.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.61 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -56.53 -38.37 71.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.3 mt -55.81 -35.9 66.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.084 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.745 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 8.1 m120 37.61 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.94 0.775 . . . . 0.0 110.824 -168.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.5 mt -64.42 137.82 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.733 -169.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.3 OUTLIER -94.88 113.89 25.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.086 174.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.61 148.82 6.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.367 -1.397 . . . . 0.0 112.929 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.549 ' HG2' ' CD2' ' C' ' 88' ' ' TYR . 98.2 Cg_endo -80.85 -43.81 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.772 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.549 ' CD2' ' HG2' ' C' ' 87' ' ' PRO . 31.8 p90 -123.68 129.65 51.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.483 ' HB ' ' SD ' ' C' ' 31' ' ' MET . 77.1 mt -123.29 123.72 68.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.505 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -92.25 115.08 27.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.986 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.553 HG12 ' CH2' ' C' ' 54' ' ' TRP . 15.5 tt -115.98 103.25 14.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.978 0.894 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 159.26 22.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.567 -172.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.4 OUTLIER -90.81 163.04 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.34 0.59 . . . . 0.0 111.077 176.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.577 HG13 HD22 ' C' ' 53' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.808 -167.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' C' ' 4' ' ' LYS . 10.7 t0 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.56 -16.32 2.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.658 0.266 . . . . 0.0 111.155 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.433 ' HB3' ' HG3' ' C' ' 8' ' ' GLU . 2.8 mp0 -64.82 -24.93 67.7 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.522 ' HB2' ' OD1' ' C' ' 1' ' ' ASP . 29.5 ttmt -59.04 -34.45 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.903 174.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.08 -51.55 4.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.36 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.97 -84.92 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' C' ' 10' ' ' MET . 37.5 mm-40 -50.75 -60.53 2.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -162.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.713 ' HB2' ' NE2' ' C' ' 9' ' ' GLN . 24.3 mt-10 -63.74 -14.7 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.881 0.372 . . . . 0.0 111.925 -172.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.713 ' NE2' ' HB2' ' C' ' 8' ' ' GLU . 16.0 mp0 -122.66 18.3 10.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.58 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.449 ' O ' HG22 ' C' ' 13' ' ' ILE . 91.6 mmm -58.6 163.05 3.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.87 -21.54 30.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.091 -165.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -52.19 -42.38 63.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.033 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.449 HG22 ' O ' ' C' ' 10' ' ' MET . 0.2 OUTLIER -87.09 -32.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.009 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.576 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 11.7 m120 -64.7 -43.75 92.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.707 0.289 . . . . 0.0 111.662 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 -22.55 63.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 50.4 t -85.7 -33.07 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.262 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.576 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 12.8 m120 -57.1 -48.0 79.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.22 -16.31 56.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.856 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -80.46 -42.19 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.01 -36.63 75.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.8 76.12 7.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.721 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.674 ' HZ1' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -118.53 7.34 11.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.12 -68.65 0.54 Allowed Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.515 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' C' ' 25' ' ' GLY . 37.7 mttp -82.16 -160.11 0.35 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.578 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . -41.61 137.88 2.34 Favored Glycine 0 CA--C 1.497 -1.06 0 O-C-N 123.846 0.716 . . . . 0.0 114.863 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' C' ' 41' ' ' SER . 11.9 ptpt -147.2 162.1 39.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.767 -168.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.526 HD22 HD13 ' C' ' 29' ' ' LEU . 0.6 OUTLIER -138.92 130.08 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.705 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 16.3 t -106.03 106.13 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.677 ' HG ' HG21 ' C' ' 91' ' ' ILE . 2.2 mm? -92.61 132.14 37.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.241 0.217 . . . . 0.0 111.36 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.402 ' O ' HD22 ' C' ' 36' ' ' LEU . 18.1 m -145.91 129.65 17.15 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.747 172.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 62.1 mtm -129.31 129.17 44.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.051 -174.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.685 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 4.3 t-20 -150.96 107.01 3.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.165 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.8 -97.26 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.502 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.38 30.21 6.88 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.389 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 11.1 pt20 -126.7 129.65 48.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.325 0.583 . . . . 0.0 111.562 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.722 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.6 tm? -130.76 127.14 38.15 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.618 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 0.0 OUTLIER -144.04 128.94 18.44 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -145.77 118.73 8.75 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.679 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 48.8 p -102.88 152.05 21.73 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.716 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' C' ' 72' ' ' VAL . 40.2 t -117.36 118.08 31.27 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' C' ' 26' ' ' LYS . 30.7 t -96.98 178.06 5.41 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.88 32.29 0.51 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 124.284 0.99 . . . . 0.0 109.16 -167.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.33 31.66 20.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.214 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.75 80.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.76 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -69.54 168.79 13.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.739 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.37 -175.62 43.37 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.277 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.674 HG23 ' HZ1' ' C' ' 22' ' ' LYS . 15.3 mm -64.63 -61.74 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.2 t -170.11 -81.1 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.01 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -157.49 -45.83 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -77.24 150.81 35.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.986 0.422 . . . . 0.0 111.06 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -97.82 126.74 43.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.45 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -111.5 157.36 20.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.482 HD22 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -96.16 112.69 24.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.547 0.689 . . . . 0.0 110.858 178.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.676 ' HH2' HG22 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -103.4 166.56 10.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.351 -174.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.86 150.91 21.16 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 119.305 -1.426 . . . . 0.0 115.81 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.414 HG23 HD13 ' C' ' 91' ' ' ILE . 49.6 mt -124.55 136.06 61.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.985 169.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.437 ' O ' HG23 ' C' ' 89' ' ' ILE . 3.9 m-85 -131.19 134.46 46.52 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.548 HG23 HG11 ' C' ' 63' ' ' VAL . 85.6 t -102.41 114.96 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.16 31.08 19.41 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.337 0.398 . . . . 0.0 111.333 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.9 5.38 73.89 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.307 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.57 126.01 52.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.047 0.424 . . . . 0.0 110.187 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.42 ' HD3' ' CE2' ' C' ' 57' ' ' PHE . 21.7 tptm -60.01 126.07 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.619 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' C' ' 58' ' ' VAL . 1.7 p -120.36 -37.29 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -148.47 152.73 37.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.596 0.236 . . . . 0.0 110.743 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.626 HG23 ' O ' ' C' ' 54' ' ' TRP . 33.2 m -140.54 146.01 37.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.86 -177.86 6.88 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.23 0.468 . . . . 0.0 111.399 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -115.04 135.73 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.598 ' O ' HG12 ' C' ' 47' ' ' ILE . 1.3 tt0 -60.1 -47.16 87.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.805 -173.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.8 -2.89 10.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.6 m -71.01 -174.87 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 4.6 p -77.98 104.19 8.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.566 ' HB ' ' OG ' ' C' ' 40' ' ' SER . 2.9 t -60.36 -12.11 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.898 -173.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.71 -29.12 22.12 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.821 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -81.15 -28.45 35.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.13 -52.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.708 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.641 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.1 p -53.98 -60.79 2.86 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.054 -175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -70.48 -16.98 62.97 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 1.3 m-20 -62.68 -41.15 98.94 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 166.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' C' ' 76' ' ' SER . 68.5 mt -57.83 -22.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.291 175.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.618 ' OD1' ' HA ' ' C' ' 37' ' ' LYS . 0.6 OUTLIER -83.82 -38.99 20.52 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.677 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 18.5 ptmt -62.56 -27.77 69.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.78 -31.67 66.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.55 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 37.19 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 125.083 1.489 . . . . 0.0 113.335 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.722 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.6 tp -42.08 145.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.111 -174.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -149.59 18.6 0.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.613 0.721 . . . . 0.0 109.164 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.85 162.19 14.2 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.768 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' C' ' 8' ' ' GLU . 84.2 Cg_endo -80.27 -35.39 0.65 Allowed 'Trans proline' 0 CA--C 1.518 -0.284 0 C-N-CA 122.652 2.234 . . . . 0.0 111.487 176.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -158.81 132.36 7.45 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.834 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.65 HD12 HD11 ' C' ' 84' ' ' ILE . 70.1 mt -134.81 139.27 47.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.433 -173.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' C' ' 56' ' ' ILE . 23.8 mm-40 -91.2 103.49 16.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.96 -175.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.677 HG21 ' HG ' ' C' ' 29' ' ' LEU . 15.7 mm -100.75 96.23 4.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -158.56 167.75 28.76 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' C' ' 54' ' ' TRP . 1.9 pt20 -100.25 162.35 13.01 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.402 172.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.482 HG13 HD22 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 -163.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.575 0.226 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' C' ' 4' ' ' LYS . 19.9 m120 -124.55 -31.89 3.19 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.545 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.662 ' HB3' ' HA ' ' C' ' 7' ' ' GLU . 1.1 mp0 -83.81 22.99 1.04 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.047 175.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' C' ' 2' ' ' ASN . 25.8 ttpp -54.76 -36.02 64.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.909 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.17 -70.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.231 0.539 . . . . 0.0 110.431 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 93.9 mt -90.26 96.35 10.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.125 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.662 ' HA ' ' HB3' ' C' ' 3' ' ' GLN . 46.1 mt-10 -59.94 -18.16 43.14 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -147.63 -19.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 -167.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -112.79 19.35 17.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.277 -165.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . . . . . . . . . 5.8 mmt -65.04 -171.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -43.31 -36.69 1.94 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.487 0.715 . . . . 0.0 112.841 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 55.2 m -43.04 -54.01 4.54 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.835 0.709 . . . . 0.0 111.918 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -91.12 -19.82 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.549 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.03 -47.78 64.54 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.73 0.3 . . . . 0.0 110.748 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 26.9 p -57.3 -34.45 68.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.79 -37.39 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.58 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.15 -39.29 82.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.169 0.509 . . . . 0.0 109.843 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -78.33 -18.12 55.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.407 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -90.1 -42.58 11.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.676 0.274 . . . . 0.0 110.423 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 45.8 mt -71.08 -32.01 68.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.48 71.07 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -109.21 -40.55 4.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.537 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . -175.07 -68.98 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 15.6 ttmm -97.06 -174.59 3.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 166.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 30.73 89.92 0.01 OUTLIER Glycine 0 CA--C 1.495 -1.179 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 167.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.0 ptpt -128.68 125.34 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.579 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.479 HD22 ' HG ' ' C' ' 29' ' ' LEU . 1.5 tt -107.2 115.42 30.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.232 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 18.3 t -86.16 113.94 22.6 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.479 ' HG ' HD22 ' C' ' 27' ' ' LEU . 0.2 OUTLIER -112.72 123.14 49.62 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.652 0.263 . . . . 0.0 110.823 -173.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.408 ' O ' HD22 ' C' ' 36' ' ' LEU . 12.5 p -151.43 142.71 23.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.674 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.45 135.44 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.326 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.636 ' OD1' ' HE3' ' C' ' 37' ' ' LYS . 11.9 m120 -139.25 91.68 2.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.564 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.74 -94.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.472 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.25 30.3 7.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.747 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.746 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 7.3 tt0 -143.64 138.9 29.3 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' C' ' 84' ' ' ILE . 2.8 tm? -106.2 106.38 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 164.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.636 ' HE3' ' OD1' ' C' ' 32' ' ' ASN . 22.3 pttp -98.93 151.45 20.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.68 141.57 22.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.396 0.617 . . . . 0.0 112.299 -173.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 61.4 p -121.44 146.94 46.39 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.903 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 38.5 m -127.8 117.12 21.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 18.4 m -101.94 177.67 4.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.474 -176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' C' ' 24' ' ' LYS . 0.3 OUTLIER 65.75 42.82 3.38 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.219 0.95 . . . . 0.0 108.859 -167.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 63.39 21.5 12.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.266 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.38 24.38 76.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.701 -0.762 . . . . 0.0 113.33 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.484 ' O ' HG23 ' C' ' 72' ' ' VAL . 35.2 m-85 -80.21 -179.01 6.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.83 0.315 . . . . 0.0 111.249 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.17 -162.64 38.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.324 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' C' ' 24' ' ' LYS . 6.8 mt -49.59 -67.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 112.118 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.6 p 173.57 -73.7 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.976 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -140.67 -16.08 0.91 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.816 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 4.8 pt-20 -99.43 173.88 6.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.09 121.85 40.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.135 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.407 ' HB2' HD11 ' C' ' 47' ' ' ILE . 8.6 mptt -124.13 135.44 53.52 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.373 0.606 . . . . 0.0 111.198 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.716 ' ND2' HG13 ' C' ' 94' ' ' ILE . 9.0 t30 -89.08 116.49 27.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.684 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.559 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -108.2 163.39 13.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.0 147.22 8.86 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.327 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 91' ' ' ILE . 2.6 mp -107.63 129.84 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.067 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 52.9 m-85 -129.94 122.2 28.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.534 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' C' ' 61' ' ' GLU . 4.6 p -108.88 117.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 60.19 28.01 17.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.129 0.49 . . . . 0.0 110.462 -173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.9 16.46 79.91 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.388 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 30.5 mt-10 -107.06 147.56 29.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.617 0.722 . . . . 0.0 111.064 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.54 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 41.9 tptt -81.77 120.53 25.27 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.037 -169.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.406 ' CG2' HG12 ' C' ' 58' ' ' VAL . 41.2 t -109.71 -70.16 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.923 0.392 . . . . 0.0 110.929 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -137.89 143.66 40.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.909 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.559 HG23 ' O ' ' C' ' 54' ' ' TRP . 67.7 m -136.15 143.21 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.593 ' CD1' HG21 ' C' ' 75' ' ' ILE . 44.3 p90 -159.75 -172.61 3.74 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -116.91 137.39 52.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.85 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.655 ' HB3' HD11 ' C' ' 47' ' ' ILE . 0.7 OUTLIER -71.36 -28.68 64.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.44 -172.174 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' C' ' 50' ' ' GLU . 13.2 ptmm? -93.14 19.22 8.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.844 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 14.2 p -76.15 -119.97 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -131.7 107.66 8.95 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 166.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 45' ' ' TYR . 20.7 t -55.96 -24.33 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.043 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.31 -31.34 42.32 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.525 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.22 -33.96 67.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.593 HG21 ' CD1' ' C' ' 66' ' ' PHE . 27.5 mm -78.39 -54.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.158 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.659 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 64.3 p -53.61 -52.61 59.29 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.437 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' C' ' 80' ' ' ASN . 7.3 m120 -77.48 -16.44 58.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -64.35 -37.89 89.09 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' C' ' 76' ' ' SER . 82.4 mt -60.31 -22.27 24.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.979 173.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.516 ' CG ' HD22 ' C' ' 77' ' ' ASN . 0.8 OUTLIER -81.31 -34.49 31.88 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.545 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -53.13 -41.97 65.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 2.1 mt -58.83 -30.32 67.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.821 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.2 OUTLIER 38.21 85.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.153 0.908 . . . . 0.0 111.227 -170.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 36' ' ' LEU . 17.2 mm -55.06 138.54 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -169.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.27 170.51 9.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.029 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.34 173.34 15.44 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.352 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 85.3 Cg_endo -80.71 -47.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.487 2.125 . . . . 0.0 112.094 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.444 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 44.1 p90 -150.29 141.54 23.2 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.16 132.67 68.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.496 . . . . 0.0 111.022 -172.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -91.83 98.71 11.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.558 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.535 HG13 HG13 ' C' ' 56' ' ' ILE . 13.8 tt -101.13 99.06 7.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.76 173.38 17.06 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.348 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -105.5 158.86 16.37 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.934 176.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.716 HG13 ' ND2' ' C' ' 53' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.223 -166.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 70.13 17.7 7.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.29 0.636 . . . . 0.0 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' C' ' 6' ' ' LEU . 1.6 mp0 -91.92 22.76 4.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.134 0.492 . . . . 0.0 110.193 170.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -65.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.004 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.26 -31.21 16.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.677 0.751 . . . . 0.0 109.883 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.456 HD22 ' O ' ' C' ' 87' ' ' PRO . 42.0 mt -90.78 61.82 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.831 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 9.4 tp10 -65.84 24.95 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.832 1.253 . . . . 0.0 113.865 -171.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -144.62 8.47 1.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.362 -0.836 . . . . 0.0 112.095 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.14 18.22 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.912 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 22.2 mmt -70.4 -162.95 0.06 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.421 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.422 ' H ' ' HB3' ' C' ' 10' ' ' MET . 3.7 m-20 -52.26 -23.34 5.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -49.47 -43.93 45.51 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.148 0.28 . . . . 0.0 110.968 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.44 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 6.7 mt -88.7 -23.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.221 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -71.04 -49.0 49.65 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.931 -0.48 . . . . 0.0 110.672 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -57.98 -32.54 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.797 0.808 . . . . 0.0 109.429 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' C' ' 13' ' ' ILE . 2.2 t -67.99 -39.29 81.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.915 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' C' ' 29' ' ' LEU . 6.9 m-80 -65.67 -36.44 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -77.3 -20.17 55.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.665 176.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.19 -34.25 61.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.951 0.881 . . . . 0.0 108.886 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' C' ' 26' ' ' LYS . 49.6 mt -78.05 -40.26 39.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.616 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.11 82.58 4.18 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.733 ' NZ ' HG23 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -5.8 9.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.55 -75.77 0.23 Allowed Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.842 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' C' ' 47' ' ' ILE . 18.6 ttmt -87.36 -156.85 0.36 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.479 ' O ' HD13 ' C' ' 47' ' ' ILE . . . -18.78 106.63 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.589 ' HD2' ' HB2' ' C' ' 41' ' ' SER . 0.5 OUTLIER -114.08 171.68 7.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.847 -175.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' C' ' 39' ' ' THR . 3.3 tt -156.74 115.47 3.35 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -173.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 69.3 m -93.9 127.5 39.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' C' ' 91' ' ' ILE . 86.7 mt -97.62 139.01 34.17 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -176.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.417 ' HB2' ' HG3' ' C' ' 37' ' ' LYS . 19.0 m -148.43 128.12 13.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.826 168.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.455 ' HG3' HD23 ' C' ' 36' ' ' LEU . 2.9 mpp? -116.7 133.18 56.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.88 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' C' ' 35' ' ' GLN . 5.2 p-10 -149.0 90.16 1.73 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.234 0.54 . . . . 0.0 111.653 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.24 -93.58 0.04 OUTLIER Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.556 173.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.2 OUTLIER -105.71 32.36 4.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 110.494 -176.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.609 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 35.1 tt0 -150.18 142.01 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' C' ' 31' ' ' MET . 3.0 tm? -122.93 116.98 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' C' ' 80' ' ' ASN . 17.3 pttm -123.47 144.81 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -146.05 167.64 22.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.345 -172.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 68.5 p -139.77 143.45 36.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.447 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 68.1 m -127.72 117.43 21.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.129 0.49 . . . . 0.0 109.688 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.589 ' HB2' ' HD2' ' C' ' 26' ' ' LYS . 67.9 m -100.81 179.56 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.951 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' C' ' 41' ' ' SER . 1.7 m120 69.57 45.48 0.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 124.299 0.999 . . . . 0.0 109.026 -164.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.65 23.63 11.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.81 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' C' ' 71' ' ' THR . . . 69.38 21.69 76.06 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.949 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -67.75 -178.86 1.01 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.207 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.58 159.5 53.15 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.095 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.733 HG23 ' NZ ' ' C' ' 22' ' ' LYS . 32.5 mm -52.31 -60.04 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-O 121.516 0.674 . . . . 0.0 111.067 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' C' ' 49' ' ' TYR . 45.5 t -135.62 -84.72 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.875 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' C' ' 48' ' ' SER . 34.1 p90 179.59 -22.88 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.589 ' CG ' ' HE3' ' C' ' 52' ' ' LYS . 0.4 OUTLIER -97.8 172.63 7.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.377 0.608 . . . . 0.0 111.373 -178.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.81 107.18 19.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.813 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.589 ' HE3' ' CG ' ' C' ' 50' ' ' GLU . 27.0 mmtp -120.57 154.24 35.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.855 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' C' ' 93' ' ' GLN . 0.8 OUTLIER -89.25 101.85 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.917 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.503 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -105.43 159.76 15.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.724 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -158.09 153.75 24.9 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 118.191 -1.957 . . . . 0.0 116.434 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.413 ' N ' HD12 ' C' ' 56' ' ' ILE . 3.5 mp -120.84 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.172 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' C' ' 62' ' ' LYS . 36.2 m-85 -126.8 156.34 41.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.2 113.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 110.053 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 54.42 39.39 30.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.535 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.78 -3.62 86.01 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.336 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 148.14 28.99 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' C' ' 57' ' ' PHE . 53.5 mtpt -91.74 137.93 31.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.991 0.424 . . . . 0.0 110.813 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.93 -50.77 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.077 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -150.49 152.34 34.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.484 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.503 HG23 ' O ' ' C' ' 54' ' ' TRP . 89.2 m -128.07 126.87 42.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.543 ' CG ' HG21 ' C' ' 75' ' ' ILE . 11.5 p90 -133.18 178.49 6.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.031 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 28.6 m-80 -121.77 142.04 50.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.691 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.695 ' HG2' HG21 ' C' ' 47' ' ' ILE . 5.4 mt-10 -65.24 -10.8 34.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.34 -2.52 52.01 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.26 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -88.29 157.72 18.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' C' ' 44' ' ' GLY . 30.9 p -76.72 113.07 13.97 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -16.22 7.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.185 -177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.62 -36.32 38.2 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.953 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -77.07 -31.06 55.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.543 HG21 ' CG ' ' C' ' 66' ' ' PHE . 49.5 mm -75.16 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.26 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.635 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 96.6 p -58.76 -50.71 72.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -171.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.519 HD22 ' CG ' ' C' ' 80' ' ' ASN . 4.1 m120 -79.33 -17.34 54.73 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -172.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -34.47 74.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.606 167.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' C' ' 76' ' ' SER . 91.6 mt -61.1 -20.83 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.978 173.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.519 ' CG ' HD22 ' C' ' 77' ' ' ASN . 0.9 OUTLIER -76.01 -43.48 44.02 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.875 179.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -51.87 -38.06 54.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.525 0.679 . . . . 0.0 109.512 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.6 mt -55.96 -33.1 64.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.885 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.609 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.4 OUTLIER 38.0 79.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.928 0.768 . . . . 0.0 111.201 -172.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.07 136.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.403 -170.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 1.4 ptpt -81.96 39.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.677 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.65 128.15 9.48 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.027 -170.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.456 ' O ' HD22 ' C' ' 6' ' ' LEU . 97.7 Cg_endo -80.39 -40.31 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.263 1.975 . . . . 0.0 110.851 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -122.78 97.85 5.63 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -103.45 124.4 57.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.531 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.78 100.75 9.18 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.026 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' C' ' 29' ' ' LEU . 4.5 mt -95.19 98.63 8.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.12 149.55 24.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.193 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' C' ' 53' ' ' ASN . 6.6 tt0 -73.8 144.41 45.57 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.641 -176.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.465 HG12 ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.599 -175.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' C' ' 4' ' ' LYS . 18.0 t0 . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -138.84 -17.71 1.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -76.0 -8.45 56.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.117 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.467 ' HB2' ' OD1' ' C' ' 1' ' ' ASP . 15.7 ttmm -57.7 -39.03 76.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.51 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.45 -11.6 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.971 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.39 -153.67 0.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.777 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.685 ' HB3' ' NE2' ' C' ' 9' ' ' GLN . 3.4 mp0 -91.99 -13.8 30.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' C' ' 7' ' ' GLU . 5.3 mm-40 72.34 -5.73 1.72 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.42 0.688 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' C' ' 7' ' ' GLU . 11.1 mt-30 -87.6 16.61 5.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.46 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.447 ' O ' HG13 ' C' ' 13' ' ' ILE . 1.5 mpt? -82.95 -143.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' C' ' 10' ' ' MET . 33.1 m-80 -53.44 -18.93 3.03 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -174.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . 0.494 ' O ' HG23 ' C' ' 16' ' ' VAL . 68.9 m -54.44 -33.24 59.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.503 HG21 ' SD ' ' C' ' 31' ' ' MET . 2.4 pp -89.55 -27.79 5.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.987 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -73.31 -43.65 60.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.689 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -58.25 -33.46 69.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.348 0.594 . . . . 0.0 109.448 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.634 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 76.3 t -74.13 -34.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.252 175.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.506 HD21 ' HB2' ' C' ' 29' ' ' LEU . 7.7 m-80 -58.99 -40.29 84.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -75.39 -15.85 60.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.358 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -87.93 -31.58 19.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.487 0.66 . . . . 0.0 109.578 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' C' ' 27' ' ' LEU . 79.4 mt -82.94 -39.87 20.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.559 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -77.14 64.41 2.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 109.597 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -103.58 7.95 37.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.211 -172.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.42 -61.87 0.64 Allowed Glycine 0 CA--C 1.504 -0.613 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.73 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 26.9 mmmt -79.28 -159.47 0.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.105 175.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -48.71 143.38 8.01 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 121.568 -0.349 . . . . 0.0 113.652 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.73 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 5.8 ptpt -150.44 135.8 17.97 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.455 -164.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.703 ' HB2' HD13 ' C' ' 20' ' ' LEU . 3.6 mp -92.04 126.92 37.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.881 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 23.8 m -95.65 99.5 11.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.52 HD13 HG23 ' C' ' 91' ' ' ILE . 16.2 mt -82.58 126.2 32.03 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 46.9 t -146.4 129.19 16.25 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.613 ' SD ' ' HG2' ' C' ' 9' ' ' GLN . 0.5 OUTLIER -113.25 124.04 51.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -129.47 91.08 3.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.56 -99.43 0.25 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.115 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.88 13.28 29.29 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.947 0.374 . . . . 0.0 111.147 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.695 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 26.4 tt0 -136.77 147.26 46.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.617 0.722 . . . . 0.0 112.189 -170.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.578 HD21 HD12 ' C' ' 91' ' ' ILE . 9.6 tp -130.78 113.56 14.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.885 171.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 19.7 pttp -122.9 104.53 9.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -112.37 118.9 36.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.159 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 42.1 p -97.09 148.06 23.4 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.271 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 67.1 p -109.66 119.46 39.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.487 -175.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.455 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 18.4 t -95.19 175.62 6.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.424 ' O ' ' HD1' ' C' ' 45' ' ' TYR . 4.4 m-20 63.21 31.39 15.6 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.679 0.612 . . . . 0.0 110.32 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.96 10.54 7.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.789 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.1 24.76 28.56 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.167 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 52.5 m-85 -72.43 -179.24 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.578 0.689 . . . . 0.0 110.31 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.46 -157.62 29.73 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.332 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.591 ' H ' ' HA ' ' C' ' 69' ' ' LYS . 75.7 mt -49.9 -65.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 C-N-CA 123.265 0.626 . . . . 0.0 111.125 175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 27.5 t 173.25 -72.68 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.898 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -140.95 -32.51 0.56 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.71 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.517 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.7 pt-20 -85.07 177.6 7.85 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.183 -0.323 . . . . 0.0 110.754 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' C' ' 52' ' ' LYS . 27.8 t70 -123.78 141.95 51.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -174.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 51' ' ' ASP . 32.6 mmtm -124.02 153.15 41.74 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.759 173.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' C' ' 93' ' ' GLN . 0.6 OUTLIER -98.88 112.6 24.65 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.454 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.602 ' CH2' HG12 ' C' ' 91' ' ' ILE . 0.0 OUTLIER -102.53 162.08 13.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.691 -173.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.99 150.51 21.13 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 119.59 -1.29 . . . . 0.0 114.653 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.516 HD11 HD13 ' C' ' 79' ' ' ILE . 46.5 mt -120.21 135.23 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 170.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.447 ' CE1' ' HG2' ' C' ' 62' ' ' LYS . 58.0 m-85 -133.07 148.88 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.643 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.6 p -143.56 129.98 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.38 27.96 12.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.132 0.491 . . . . 0.0 111.171 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 1.35 81.39 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.829 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 11.6 pt-20 -112.57 157.33 21.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.642 0.721 . . . . 0.0 110.426 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.447 ' HG2' ' CE1' ' C' ' 57' ' ' PHE . 60.4 mtpt -76.85 131.65 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.68 -49.61 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.346 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' C' ' 56' ' ' ILE . 62.3 t80 -157.0 161.79 39.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.823 -172.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -145.85 159.72 42.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' C' ' 75' ' ' ILE . 52.1 p90 -168.72 -178.41 3.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.0 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -119.89 121.97 40.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.712 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' C' ' 47' ' ' ILE . 43.6 tp10 -61.0 -22.73 64.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' C' ' 47' ' ' ILE . 22.8 ptmt -85.22 4.89 32.6 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.906 -0.496 . . . . 0.0 111.77 -176.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -75.29 -118.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.438 ' O ' HG12 ' C' ' 75' ' ' ILE . 1.5 p -131.22 108.07 9.44 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 169.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.485 ' CG1' ' HG ' ' C' ' 27' ' ' LEU . 48.0 t -56.72 -22.23 15.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.667 -174.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.8 -39.17 25.42 Favored Glycine 0 CA--C 1.504 -0.644 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.417 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -68.68 -40.42 80.11 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' C' ' 66' ' ' PHE . 48.3 mm -64.79 -63.62 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.562 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 50.4 m -53.64 -63.72 1.06 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -169.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.842 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -70.09 -16.78 63.18 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.466 -0.893 . . . . 0.0 113.289 -171.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 35.8 m-20 -73.75 -37.0 65.2 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.6 168.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' C' ' 76' ' ' SER . 89.4 mt -60.09 -32.59 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.743 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.842 HD22 ' ND2' ' C' ' 77' ' ' ASN . 32.0 m-20 -85.38 -34.39 21.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.052 -172.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 56.4 pttt -57.81 -26.99 62.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 16.4 mt -61.32 -25.73 67.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.767 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.695 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 0.6 OUTLIER 40.12 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.898 0.856 . . . . 0.0 111.949 -172.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' C' ' 84' ' ' ILE . 37.6 mm -71.2 113.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.648 -169.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.485 ' H ' ' HE3' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -93.21 119.63 32.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.128 174.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.47 147.99 6.58 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.65 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.46 -37.45 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.285 1.99 . . . . 0.0 111.825 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.3 98.87 6.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -99.76 125.86 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.553 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -122.82 123.64 41.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.862 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.602 HG12 ' CH2' ' C' ' 54' ' ' TRP . 20.1 tt -129.43 99.7 4.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 151.56 25.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.447 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -85.65 163.89 18.02 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.946 176.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.48 ' H ' HG12 ' C' ' 94' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.332 -164.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.443 0.164 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 64.34 18.92 11.58 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.143 0.577 . . . . 0.0 111.972 177.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -69.42 -34.48 74.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -64.28 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.698 176.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.37 -68.95 0.76 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.309 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' C' ' 10' ' ' MET . 9.0 mp -92.34 -75.71 0.48 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.602 -174.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.451 ' O ' ' HE2' ' C' ' 10' ' ' MET . 44.7 mm-40 -33.92 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -161.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' C' ' 88' ' ' TYR . 13.5 mp0 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.008 0.432 . . . . 0.0 111.862 -174.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -83.86 15.06 3.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.201 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' C' ' 6' ' ' LEU . 61.0 mtm -87.81 -144.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 176.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 18.5 m120 -61.67 -9.02 5.28 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 18.4 m -49.77 -44.9 49.09 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.13 0.269 . . . . 0.0 110.634 175.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 21.5 pt -90.85 -24.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.163 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 2.2 m-20 -64.97 -36.34 84.1 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.921 0.391 . . . . 0.0 110.119 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 37.1 t -55.37 -35.91 65.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.532 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' C' ' 13' ' ' ILE . 76.1 t -71.29 -37.53 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.181 174.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' C' ' 28' ' ' SER . 33.4 m-80 -65.88 -47.08 76.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.765 -177.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -68.68 -17.17 64.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.324 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -90.33 -38.2 13.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.266 0.555 . . . . 0.0 110.466 -176.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' C' ' 27' ' ' LEU . 55.9 mt -86.57 -26.92 24.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -80.32 84.63 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' C' ' 23' ' ' GLY . 0.0 OUTLIER -120.7 -40.43 2.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.411 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' C' ' 22' ' ' LYS . . . 174.89 -68.95 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -172.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.701 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 45.9 mttp -76.09 -159.03 0.1 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -38.79 130.49 1.86 Allowed Glycine 0 CA--C 1.501 -0.787 0 O-C-N 123.898 0.749 . . . . 0.0 114.398 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.701 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.9 OUTLIER -134.63 143.4 47.28 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.721 -173.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' C' ' 20' ' ' LEU . 32.4 tp -117.39 123.44 46.44 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.032 0.444 . . . . 0.0 111.156 -174.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 44.3 m -100.53 104.28 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.152 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.76 133.16 35.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 17.3 t -145.15 131.68 19.8 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.931 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 79.7 mtp -115.54 134.86 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.854 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.592 ' OD1' ' HE2' ' C' ' 37' ' ' LYS . 17.9 m120 -134.58 89.49 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.508 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.63 -93.23 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.566 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 0.9 OUTLIER -108.92 29.58 7.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.556 0.217 . . . . 0.0 110.959 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.671 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 47.7 tt0 -143.88 140.7 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.536 0.684 . . . . 0.0 111.934 -168.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' C' ' 80' ' ' ASN . 2.3 tm? -118.92 118.98 33.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 171.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.592 ' HE2' ' OD1' ' C' ' 32' ' ' ASN . 44.8 pttt -129.18 104.56 7.61 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -118.16 119.4 34.6 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 67.8 p -98.01 145.14 26.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.145 0.498 . . . . 0.0 111.193 -174.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 16.6 p -109.61 119.14 38.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.373 -179.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 16.3 t -95.34 -170.39 2.16 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 81.04 18.54 0.48 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.448 1.093 . . . . 0.0 110.593 -170.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.24 34.21 23.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.673 173.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.13 -18.24 46.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.178 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -57.79 140.15 52.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.311 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' C' ' 24' ' ' LYS . . . -79.51 156.06 40.45 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.709 -174.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.57 ' HB ' ' HG2' ' C' ' 68' ' ' GLU . 70.2 mt -56.08 -53.32 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.533 0.683 . . . . 0.0 112.104 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.611 ' HB2' ' OE2' ' C' ' 68' ' ' GLU . 31.2 t -116.61 176.93 4.89 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.912 -169.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -119.61 3.85 11.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.68 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' C' ' 52' ' ' LYS . 27.6 mt-10 -125.3 171.24 10.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.442 176.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.58 96.27 10.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.164 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.486 ' HD3' ' HB2' ' C' ' 50' ' ' GLU . 17.9 mmmt -98.98 158.98 15.28 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.793 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.627 HD22 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -101.18 110.86 22.93 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.491 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' C' ' 91' ' ' ILE . 0.2 OUTLIER -114.47 165.06 13.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -168.687 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.45 ' C ' HD12 ' C' ' 56' ' ' ILE . . . -174.12 165.86 37.67 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 119.174 -1.488 . . . . 0.0 115.741 172.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.45 HD12 ' C ' ' C' ' 55' ' ' GLY . 2.0 mp -116.19 134.1 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 114.481 -0.859 . . . . 0.0 110.983 176.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 82.3 m-85 -121.06 142.06 50.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 178.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 12.7 p -134.34 124.4 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 171.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.16 27.36 14.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.66 35.66 31.54 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.235 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 9.5 pt-20 -140.83 153.02 45.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -81.69 130.76 35.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 111.348 -177.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.426 ' CG2' HG12 ' C' ' 58' ' ' VAL . 53.7 t -105.89 -51.87 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.63 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -141.75 147.54 37.53 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.643 -176.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 2.3 t -131.89 158.12 42.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' C' ' 75' ' ' ILE . 54.8 p90 -167.82 -174.63 2.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.524 0.678 . . . . 0.0 112.725 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.04 140.22 49.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.743 -177.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.611 ' OE2' ' HB2' ' C' ' 48' ' ' SER . 19.8 tt0 -79.13 -6.83 57.44 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -168.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 22.0 ptmt -104.18 6.51 35.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.996 -0.44 . . . . 0.0 111.396 -177.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 39.4 p -81.84 -163.57 0.67 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.48 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 20.0 p -93.54 106.94 18.86 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.53 HG23 ' HA2' ' C' ' 46' ' ' GLY . 2.2 t -59.68 -15.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.335 -169.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 -35.66 14.68 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.071 -178.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . 0.439 HD22 ' N ' ' C' ' 74' ' ' ASN . 0.9 OUTLIER -69.28 -35.97 76.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.173 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' C' ' 78' ' ' ASP . 46.2 mm -70.96 -63.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.388 -178.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.537 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 19.0 m -58.15 -46.61 85.38 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.992 -170.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.808 ' ND2' HD22 ' C' ' 80' ' ' ASN . 9.5 m120 -72.89 -14.72 61.54 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.621 -0.832 . . . . 0.0 112.966 -177.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.512 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 51.6 m-20 -56.44 -51.76 67.2 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 165.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' C' ' 76' ' ' SER . 67.5 mt -54.25 -33.41 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.754 176.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.808 HD22 ' ND2' ' C' ' 77' ' ' ASN . 38.9 m-20 -87.8 -37.71 16.34 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.814 -169.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.499 ' CE ' ' HA ' ' C' ' 78' ' ' ASP . 51.2 mtmt -56.39 -28.61 59.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.285 0.564 . . . . 0.0 109.781 176.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.5 mt -59.14 -28.06 66.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.779 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.671 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 11.7 m120 39.79 75.82 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.717 0.77 . . . . 0.0 110.42 -170.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.417 HG22 ' H ' ' C' ' 86' ' ' GLY . 25.2 mt -74.2 131.27 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.495 -171.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 2.3 ptpt -83.84 29.59 0.53 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.292 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.417 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -76.12 142.48 28.48 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.459 -175.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.62 -39.79 0.22 Allowed 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.743 2.296 . . . . 0.0 111.377 176.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 34.8 p90 -144.45 123.54 12.87 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.744 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.63 128.72 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.755 -175.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.16 110.42 22.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.269 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.586 HG22 ' CZ3' ' C' ' 54' ' ' TRP . 5.5 mt -99.87 103.66 15.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.2 154.53 25.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.269 -172.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.23 162.29 19.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.435 0.636 . . . . 0.0 111.693 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.627 HG13 HD22 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.659 -170.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . 0.411 ' HA ' ' SD ' ' C' ' 10' ' ' MET . 1.2 m-20 . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -98.44 -23.14 15.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.952 0.406 . . . . 0.0 110.138 177.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -90.72 18.44 6.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.698 0.761 . . . . 0.0 109.948 172.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.83 -60.42 2.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.855 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.46 -6.05 56.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.0 mt -91.32 -99.27 0.11 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -178.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.28 -97.63 0.25 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' C' ' 10' ' ' MET . 3.2 mt-10 175.21 19.5 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -72.33 17.24 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.959 -0.463 . . . . 0.0 112.011 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.415 ' H ' ' C ' ' C' ' 8' ' ' GLU . 40.3 mtm -98.04 -141.45 0.3 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.603 -177.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -47.44 -26.92 1.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -175.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -47.8 -46.34 30.49 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.27 0.356 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -90.67 -22.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.268 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.83 -51.48 40.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.259 -177.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 17.7 t -58.37 -32.69 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.521 0.677 . . . . 0.0 109.639 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 60.0 t -71.39 -34.47 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.064 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -62.74 -37.33 86.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.163 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.22 -30.98 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.571 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -78.21 -33.39 49.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.73 0.776 . . . . 0.0 109.803 -176.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.647 HD13 ' HG ' ' C' ' 27' ' ' LEU . 90.2 mt -80.91 -40.38 24.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.241 -176.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -81.77 67.02 7.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.43 0.633 . . . . 0.0 109.831 177.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' C' ' 47' ' ' ILE . 0.0 OUTLIER -100.95 -17.26 16.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.469 -174.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.78 -64.56 0.36 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.306 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 24.3 mmmt -84.02 -157.48 0.27 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' C' ' 45' ' ' TYR . . . -38.82 131.32 1.83 Allowed Glycine 0 CA--C 1.503 -0.697 0 O-C-N 124.048 0.843 . . . . 0.0 115.158 -175.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.764 ' O ' ' HA ' ' C' ' 40' ' ' SER . 0.3 OUTLIER -143.15 144.44 32.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.144 -1.028 . . . . 0.0 110.061 -172.411 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.647 ' HG ' HD13 ' C' ' 20' ' ' LEU . 1.4 pt? -123.82 112.64 17.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.681 175.087 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.784 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 66.2 m -82.61 104.2 12.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.974 -176.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.55 HD13 HG23 ' C' ' 91' ' ' ILE . 13.3 mt -79.78 122.29 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.369 -170.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.464 ' O ' HD22 ' C' ' 36' ' ' LEU . 5.8 m -129.69 128.51 42.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.167 172.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.457 ' HG2' HD23 ' C' ' 36' ' ' LEU . 53.8 mtt -132.24 116.83 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.249 -176.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' C' ' 35' ' ' GLN . 46.7 t30 -150.75 96.96 2.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.606 0.241 . . . . 0.0 111.32 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . 0.431 ' O ' HG22 ' C' ' 84' ' ' ILE . . . 67.15 -92.69 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.682 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -101.22 -20.83 15.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.593 0.711 . . . . 0.0 109.912 -176.657 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' C' ' 32' ' ' ASN . 17.4 pt20 -88.68 127.85 35.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.692 0.758 . . . . 0.0 111.899 -171.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.598 HD23 HG13 ' C' ' 84' ' ' ILE . 1.6 tm? -131.27 117.69 19.33 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 47.5 pttt -144.64 106.28 4.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.784 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.04 129.0 46.83 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' C' ' 27' ' ' LEU . 3.9 m -95.87 129.84 42.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.651 0.738 . . . . 0.0 110.198 -176.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 61.7 p -107.26 118.68 37.34 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.68 -176.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 18.1 m -121.61 179.14 4.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.757 -175.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.441 ' HB2' ' CE ' ' C' ' 26' ' ' LYS . 0.8 OUTLIER 66.57 42.17 2.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.276 0.985 . . . . 0.0 109.439 -169.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.19 27.47 17.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.98 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.75 19.07 72.91 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.589 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' C' ' 25' ' ' GLY . 36.1 m-85 -70.98 -178.46 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.204 0.502 . . . . 0.0 110.857 176.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.1 -154.67 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.848 -177.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.675 HD12 ' O ' ' C' ' 50' ' ' GLU . 32.2 mt -50.19 -67.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 C-N-CA 123.56 0.744 . . . . 0.0 112.729 -177.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' C' ' 47' ' ' ILE . 23.3 t 173.06 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 124.655 1.222 . . . . 0.0 109.656 -175.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -156.07 49.32 0.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.138 0.494 . . . . 0.0 110.633 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.675 ' O ' HD12 ' C' ' 47' ' ' ILE . 12.9 pt-20 -169.05 -178.68 3.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' HD3' ' C' ' 69' ' ' LYS . 8.7 p-10 -128.8 126.51 40.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.72 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' C' ' 47' ' ' ILE . 25.5 mmmt -104.69 157.59 17.08 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.601 HD22 HG13 ' C' ' 94' ' ' ILE . 0.7 OUTLIER -98.18 101.45 12.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.018 177.144 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.625 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -97.28 166.89 11.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.379 -174.761 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.1 166.68 39.88 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 118.535 -1.793 . . . . 0.0 116.484 176.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.402 HG12 HG13 ' C' ' 91' ' ' ILE . 19.2 mt -128.6 139.56 51.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 113.799 -1.201 . . . . 0.0 109.747 175.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 40.6 m-85 -134.02 113.51 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.432 -176.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' C' ' 63' ' ' VAL . 41.1 t -80.96 105.59 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.553 HD22 ' N ' ' C' ' 59' ' ' ASN . 0.8 OUTLIER 62.82 28.66 16.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 110.481 -176.112 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.08 67.98 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.4 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.4 tt0 -107.68 123.56 48.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.487 ' HE3' ' OG1' ' C' ' 65' ' ' THR . 86.9 tttt -61.9 103.28 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.372 0.606 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.467 ' CG1' HG23 ' C' ' 58' ' ' VAL . 0.9 OUTLIER -97.29 -53.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 177.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -130.46 149.14 52.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -173.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.625 HG23 ' O ' ' C' ' 54' ' ' TRP . 80.0 m -149.66 138.22 20.82 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -150.9 -175.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.644 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -116.93 134.27 54.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.449 ' C ' HG13 ' C' ' 47' ' ' ILE . 27.7 tt0 -66.91 -13.58 61.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.423 -171.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' C' ' 50' ' ' GLU . 12.7 ptmm? -84.23 -17.59 39.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.736 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 26.5 m -62.07 154.9 25.52 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -64.82 111.44 2.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.271 -172.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.38 -15.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.912 -173.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.67 -39.08 14.88 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 120.052 -1.07 . . . . 0.0 111.432 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.05 -36.36 72.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.129 0.49 . . . . 0.0 109.697 177.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.53 -56.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.531 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 80.7 p -57.57 -58.81 6.69 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -171.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.878 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -68.23 -19.1 64.71 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.201 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' C' ' 81' ' ' LYS . 0.9 OUTLIER -74.73 -36.19 62.64 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.846 169.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' C' ' 76' ' ' SER . 58.9 mt -59.59 -31.86 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.81 0.814 . . . . 0.0 109.381 170.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.878 HD22 ' ND2' ' C' ' 77' ' ' ASN . 31.8 m-20 -81.78 -35.1 29.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.919 -172.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' C' ' 78' ' ' ASP . 16.0 ptpt -59.97 -31.08 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 13.9 mt -56.12 -31.47 63.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.224 177.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 39.19 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.543 1.152 . . . . 0.0 113.189 -173.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.598 HG13 HD23 ' C' ' 36' ' ' LEU . 9.5 mm -35.57 141.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.602 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -143.78 7.93 1.47 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.99 -178.678 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.54 -175.61 20.07 Favored Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 118.997 -1.573 . . . . 0.0 111.988 -173.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.52 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 84.3 Cg_endo -81.01 -87.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.493 2.129 . . . . 0.0 111.836 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' C' ' 59' ' ' ASN . 25.1 p90 -108.23 110.88 22.6 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.623 0.725 . . . . 0.0 110.284 178.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.09 126.53 74.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.85 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.68 141.36 28.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.876 -174.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.55 HG23 HD13 ' C' ' 29' ' ' LEU . 12.0 tt -136.07 99.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.322 1.058 . . . . 0.0 108.37 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 164.52 9.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.114 -171.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 0.0 OUTLIER -96.66 161.2 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.928 177.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.601 HG13 HD22 ' C' ' 53' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.986 -164.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -110.07 -20.18 12.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.282 0.563 . . . . 0.0 110.265 -177.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.534 ' HB3' ' H ' ' C' ' 8' ' ' GLU . 0.0 OUTLIER -84.38 7.2 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.308 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.546 ' HA ' ' CD2' ' C' ' 88' ' ' TYR . 83.4 tttt -62.37 -53.1 59.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.451 -173.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.44 ' HB3' HD22 ' C' ' 6' ' ' LEU . . . -94.4 -38.9 10.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.364 173.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' C' ' 10' ' ' MET . 2.6 mm? -92.08 -94.24 0.14 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -168.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.27 -59.27 3.56 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -159.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' C' ' 3' ' ' GLN . 21.6 mm-40 -60.11 -26.15 66.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.32 8.68 42.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.837 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' C' ' 6' ' ' LEU . 25.5 mmt -105.64 -142.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.81 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.79 -25.74 30.12 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -177.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -55.0 -50.06 69.93 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.493 HG22 ' O ' ' C' ' 10' ' ' MET . 4.9 tt -73.71 -36.18 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 111.126 -178.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.413 ' HA ' ' OD1' ' C' ' 17' ' ' ASN . 77.5 m-20 -72.15 -36.14 69.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.596 -177.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -57.69 -39.41 77.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 72.7 t -66.57 -33.95 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 174.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' C' ' 14' ' ' ASN . 11.7 m120 -59.63 -44.9 93.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.834 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.28 -17.02 61.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.566 179.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' C' ' 16' ' ' VAL . 23.3 tptm -87.12 -36.27 18.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.954 -177.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 14.9 mt -82.44 -26.03 33.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.139 -177.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -81.14 61.21 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' C' ' 25' ' ' GLY . 0.0 OUTLIER -91.75 -40.87 11.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.341 -166.683 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' C' ' 22' ' ' LYS . . . -169.76 -95.67 0.1 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' C' ' 48' ' ' SER . 29.6 ttmt -91.62 145.21 24.78 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.504 ' O ' ' HE2' ' C' ' 22' ' ' LYS . . . 63.85 127.55 0.01 OUTLIER Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.248 -0.977 . . . . 0.0 113.524 -170.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' C' ' 40' ' ' SER . 3.8 ptpt -151.14 140.45 21.36 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 121.962 -0.728 . . . . 0.0 112.187 177.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.468 HD12 ' N ' ' C' ' 27' ' ' LEU . 2.5 mp -117.76 124.02 47.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.136 -176.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 6.1 t -97.63 98.86 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 52.7 mt -80.53 136.05 36.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.068 0.461 . . . . 0.0 111.667 -173.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -141.91 128.91 20.75 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.945 171.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.453 ' HG2' ' CD2' ' C' ' 36' ' ' LEU . 51.2 mtt -118.31 114.72 23.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.826 -176.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -132.92 90.64 2.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.218 -174.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.86 -104.09 0.41 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.337 175.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.45 34.26 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 109.519 -177.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.578 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 33.4 tt0 -148.65 133.4 17.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.481 0.657 . . . . 0.0 112.656 -178.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.453 ' CD2' ' HG2' ' C' ' 31' ' ' MET . 0.6 OUTLIER -112.89 123.23 49.83 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 165.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -137.0 140.33 42.07 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -150.94 132.5 14.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.676 -177.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -96.88 134.34 40.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 10.6 p -109.52 119.7 40.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.593 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.412 ' HB2' ' CG ' ' C' ' 26' ' ' LYS . 16.0 m -106.55 -178.71 3.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.405 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 77.34 27.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 124.439 1.087 . . . . 0.0 109.832 -174.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.27 31.97 17.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.583 174.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.06 -19.69 33.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.154 175.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -56.11 130.71 45.23 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.542 0.171 . . . . 0.0 110.944 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.92 -45.64 0.81 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 -174.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' C' ' 48' ' ' SER . 0.2 OUTLIER -47.91 -46.03 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -159.824 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' C' ' 24' ' ' LYS . 73.7 m 75.92 -60.57 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.994 0.809 . . . . 0.0 110.927 -169.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -162.72 -46.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.636 0.255 . . . . 0.0 111.136 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -139.79 -172.67 3.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.359 0.6 . . . . 0.0 112.134 -172.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.576 ' HA ' ' HD3' ' C' ' 69' ' ' LYS . 3.8 t70 -82.06 102.15 10.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.542 -177.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.65 141.3 28.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.851 176.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.562 HD22 HG13 ' C' ' 94' ' ' ILE . 1.1 p-10 -95.78 106.55 18.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.69 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.67 ' O ' HG23 ' C' ' 65' ' ' THR . 0.0 OUTLIER -95.86 158.74 15.31 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.004 -174.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.84 145.28 12.66 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.397 -1.382 . . . . 0.0 114.684 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.49 HG23 HG12 ' C' ' 91' ' ' ILE . 45.2 mt -130.73 132.27 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 173.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.38 160.54 30.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 7.2 p -144.55 126.66 10.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' C' ' 88' ' ' TYR . 88.3 m-20 57.65 28.89 16.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 111.123 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.94 -3.31 84.66 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.62 177.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 9.0 pt-20 -107.64 149.91 27.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.515 0.658 . . . . 0.0 109.841 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -81.43 124.84 29.76 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.0 110.329 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.96 -52.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -138.35 155.56 48.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.151 -173.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.67 HG23 ' O ' ' C' ' 54' ' ' TRP . 66.3 m -150.85 139.24 20.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.676 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' C' ' 75' ' ' ILE . 50.1 p90 -152.8 -170.37 3.61 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.486 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -134.19 157.72 45.53 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.084 0.24 . . . . 0.0 110.7 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' C' ' 47' ' ' ILE . 0.5 OUTLIER -59.3 -45.47 91.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.176 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' C' ' 51' ' ' ASP . 0.0 OUTLIER -53.51 -38.69 63.97 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 10.8 p -68.86 122.42 18.59 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.42 ' O ' HG12 ' C' ' 75' ' ' ILE . 41.7 p -54.75 126.39 23.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.518 0.675 . . . . 0.0 111.047 -166.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -20.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.043 -175.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.5 -37.59 30.67 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.861 -176.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -75.22 -34.8 61.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.477 HG21 ' CD1' ' C' ' 66' ' ' PHE . 47.3 mm -70.84 -65.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.424 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.557 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 25.5 m -58.66 -52.4 65.85 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.446 -170.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.75 ' ND2' HD22 ' C' ' 80' ' ' ASN . 0.2 OUTLIER -74.34 -17.85 60.77 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.784 -0.767 . . . . 0.0 112.991 -172.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' C' ' 81' ' ' LYS . 13.0 m-20 -66.52 -48.05 70.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' C' ' 76' ' ' SER . 95.7 mt -52.89 -33.0 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.434 174.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.75 HD22 ' ND2' ' C' ' 77' ' ' ASN . 67.5 m-20 -84.45 -32.32 24.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.37 -173.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' C' ' 77' ' ' ASN . 58.2 mtmt -60.51 -29.4 69.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 10.6 mt -60.38 -26.54 66.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.555 178.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.578 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 12.3 m120 39.41 78.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.889 0.743 . . . . 0.0 110.742 -171.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.503 HG22 ' H ' ' C' ' 86' ' ' GLY . 8.9 mt -57.99 145.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.946 -172.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.59 20.0 6.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.401 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . 0.503 ' H ' HG22 ' C' ' 84' ' ' ILE . . . -85.77 141.03 18.43 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.955 -176.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 89.6 Cg_endo -79.81 -45.16 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.895 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' C' ' 4' ' ' LYS . 32.1 p90 -131.06 123.57 28.97 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.439 ' N ' HD12 ' C' ' 89' ' ' ILE . 4.2 mp -112.8 136.93 47.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -99.51 98.73 9.58 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.976 0.417 . . . . 0.0 109.971 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.49 HG12 HG23 ' C' ' 56' ' ' ILE . 10.1 mt -113.83 101.46 12.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.057 -178.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.02 147.99 4.88 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.502 ' H ' ' HG2' ' C' ' 93' ' ' GLN . 1.1 pt20 -75.14 157.41 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.358 0.599 . . . . 0.0 111.426 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.562 HG13 HD22 ' C' ' 53' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.935 -163.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' C' ' 3' ' ' GLN . 3.5 p-10 -151.22 -14.95 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.115 0.483 . . . . 0.0 110.538 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.491 ' HA ' ' HB2' ' C' ' 6' ' ' LEU . 6.5 mt-30 -81.02 8.25 8.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.384 176.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -63.04 -44.44 95.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.753 177.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.44 -28.75 18.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.165 0.507 . . . . 0.0 110.988 177.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' C' ' 3' ' ' GLN . 54.3 mt -77.75 142.65 38.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.737 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -77.7 22.52 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -171.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -84.71 -40.0 17.86 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' C' ' 31' ' ' MET . 27.9 mm-40 -110.94 15.65 21.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -178.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.405 ' HB3' ' H ' ' C' ' 11' ' ' ASN . 33.8 mmt -90.07 -153.69 0.3 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -176.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' C' ' 14' ' ' ASN . 15.6 m120 -51.1 -28.19 10.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.866 0.467 . . . . 0.0 112.074 -175.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 25.0 m -47.69 -52.13 19.39 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.685 0.616 . . . . 0.0 111.604 177.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 19.5 pt -91.89 -23.45 5.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.798 179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' C' ' 11' ' ' ASN . 13.4 m120 -69.73 -40.53 76.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -174.004 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 108.86 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' C' ' 20' ' ' LEU . 71.7 t -70.26 -40.26 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.22 173.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . 0.435 HD21 ' HB2' ' C' ' 29' ' ' LEU . 13.9 m120 -61.91 -47.95 82.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.497 -176.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.38 -16.58 62.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.541 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -88.82 -38.45 14.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.076 -177.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' C' ' 16' ' ' VAL . 24.8 mt -80.81 -33.04 35.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.139 -176.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -80.85 62.41 4.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' C' ' 24' ' ' LYS . 0.0 OUTLIER -90.81 -24.02 20.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -174.247 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.97 -77.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.328 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.557 ' HA ' ' OD1' ' C' ' 42' ' ' ASN . 1.0 OUTLIER -83.75 92.62 7.77 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.351 0.595 . . . . 0.0 109.604 177.011 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.7 139.74 8.22 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.404 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' C' ' 40' ' ' SER . 5.1 ptpt -152.65 136.02 15.88 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.662 -177.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' C' ' 20' ' ' LEU . 3.8 mp -113.56 122.54 47.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.762 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 7.5 t -105.33 111.82 24.69 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.435 ' HB2' HD21 ' C' ' 17' ' ' ASN . 30.1 mt -88.82 125.81 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.003 0.43 . . . . 0.0 111.457 -175.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.94 136.35 26.83 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.266 174.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . 0.515 ' HG2' HD23 ' C' ' 36' ' ' LEU . 86.2 mtp -128.1 145.53 50.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -177.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.58 91.13 1.85 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.068 176.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.1 -94.58 0.46 Allowed Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.974 178.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' C' ' 85' ' ' LYS . 1.3 p-10 -106.21 26.54 9.66 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.684 -0.304 . . . . 0.0 111.323 -174.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.648 ' HG3' ' ND2' ' C' ' 83' ' ' ASN . 34.1 tt0 -141.06 137.72 33.09 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -170.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.515 HD23 ' HG2' ' C' ' 31' ' ' MET . 3.4 tm? -122.72 114.72 20.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 167.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' C' ' 37' ' ' LYS . 21.6 pttm -124.84 106.04 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.86 0.838 . . . . 0.0 108.911 176.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -101.36 124.68 47.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.626 175.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -94.93 123.73 38.57 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 2.7 p -110.0 119.7 40.12 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.38 -174.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -116.1 -171.04 1.91 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.564 -174.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' C' ' 24' ' ' LYS . 0.2 OUTLIER 81.51 12.71 0.68 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.74 1.275 . . . . 0.0 111.908 -176.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.17 45.86 26.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 168.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.68 -28.66 8.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.678 172.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -59.08 129.26 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.194 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' C' ' 72' ' ' VAL . . . -90.31 -70.57 1.22 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.283 -172.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.655 HG12 ' CB ' ' C' ' 68' ' ' GLU . 2.3 mt -113.32 -63.8 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.837 0.827 . . . . 0.0 111.406 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p 174.64 -63.41 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.192 -172.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 9.4 t80 179.7 36.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 O-C-N 123.467 0.48 . . . . 0.0 110.297 175.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.651 ' O ' HD12 ' C' ' 47' ' ' ILE . 42.6 mt-10 -142.23 177.86 7.96 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.438 -175.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.562 ' CG ' ' HE2' ' C' ' 69' ' ' LYS . 1.1 m-20 -103.74 122.08 44.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.298 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' C' ' 47' ' ' ILE . 6.2 mptp? -124.24 130.33 52.33 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 112.564 -178.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.619 HD21 HG13 ' C' ' 94' ' ' ILE . 0.5 OUTLIER -88.92 126.64 35.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.629 178.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.617 ' CD1' ' HG3' ' C' ' 68' ' ' GLU . 0.6 OUTLIER -135.78 166.17 23.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -166.176 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' C' ' 65' ' ' THR . . . -170.94 158.21 29.62 Favored Glycine 0 C--N 1.347 1.162 0 C-N-CA 119.278 -1.439 . . . . 0.0 116.085 171.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.426 HG13 HG12 ' C' ' 91' ' ' ILE . 1.9 mp -113.03 138.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.338 -0.931 . . . . 0.0 110.684 174.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 3.7 m-85 -131.22 132.87 44.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 91.1 t -104.08 116.39 47.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.43 27.52 17.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.662 -175.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.62 72.8 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' C' ' 58' ' ' VAL . 7.3 pt-20 -107.96 133.54 52.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.921 0.861 . . . . 0.0 109.772 176.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -65.47 128.9 37.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.464 -176.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.469 HG21 HG23 ' C' ' 58' ' ' VAL . 95.7 t -111.13 -65.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.887 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' C' ' 66' ' ' PHE . 60.5 t80 -128.4 144.8 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 -177.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.418 ' HA ' ' HA2' ' C' ' 55' ' ' GLY . 12.6 t -126.55 145.05 50.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.193 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . 0.493 ' HB3' ' CE1' ' C' ' 64' ' ' TYR . 38.1 p90 -155.0 -178.66 7.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -175.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -118.07 128.86 55.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.642 172.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.655 ' CB ' HG12 ' C' ' 47' ' ' ILE . 37.9 mt-10 -61.84 -27.35 68.71 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.562 ' HE2' ' CG ' ' C' ' 51' ' ' ASP . 20.6 pttp -82.76 14.78 2.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -171.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.493 ' HB2' HD11 ' C' ' 75' ' ' ILE . 59.7 m -73.83 -116.92 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 165.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.436 ' O ' HG13 ' C' ' 75' ' ' ILE . 0.9 OUTLIER -134.01 122.2 22.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 165.545 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' C' ' 46' ' ' GLY . 2.8 t -59.25 -24.55 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.903 -170.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.644 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.02 -37.0 33.99 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.742 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -76.6 -30.87 57.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 177.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' C' ' 70' ' ' SER . 75.5 mt -71.0 -61.66 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.509 176.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.576 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 9.7 m -63.91 -52.53 59.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.32 -171.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.828 ' ND2' HD22 ' C' ' 80' ' ' ASN . 9.3 m120 -74.85 -16.01 60.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -171.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' C' ' 82' ' ' LEU . 1.1 m-20 -59.7 -49.68 76.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 165.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' C' ' 76' ' ' SER . 88.7 mt -53.32 -32.05 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.288 175.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.828 HD22 ' ND2' ' C' ' 77' ' ' ASN . 27.5 m-20 -88.2 -22.04 24.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.778 -172.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' C' ' 77' ' ' ASN . 31.6 mmtp -61.34 -36.47 80.25 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' C' ' 78' ' ' ASP . 5.2 mt -64.9 -24.05 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.181 -174.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.648 ' ND2' ' HG3' ' C' ' 35' ' ' GLN . 9.5 m120 39.64 87.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.771 0.67 . . . . 0.0 111.384 -172.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.36 122.92 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.815 -172.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' C' ' 34' ' ' ASN . 0.1 OUTLIER -80.36 55.7 2.32 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.237 170.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.78 158.96 13.96 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . 0.571 ' HG2' ' H ' ' C' ' 88' ' ' TYR . 83.9 Cg_endo -81.65 -62.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.668 2.246 . . . . 0.0 111.792 177.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' C' ' 87' ' ' PRO . 35.9 p90 -134.06 129.65 36.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -102.94 120.25 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.713 -175.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.417 ' HB3' ' HE3' ' C' ' 92' ' ' LYS . 6.2 mm-40 -92.47 99.56 12.28 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.389 -176.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.54 HG22 ' CH2' ' C' ' 54' ' ' TRP . 7.0 mt -110.73 103.75 15.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' C' ' 90' ' ' GLU . 0.0 OUTLIER -162.12 155.43 20.64 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.078 -177.357 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' C' ' 53' ' ' ASN . 0.0 OUTLIER -79.03 164.34 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 179.659 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.619 HG13 HD21 ' C' ' 53' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.549 -170.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.534 0.207 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -139.41 -25.83 0.83 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.282 -172.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 3' ' ' GLN . . . . . 0.416 ' HG2' HD12 ' C' ' 6' ' ' LEU . 58.4 mt-30 -64.87 -10.17 26.49 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.763 0.316 . . . . 0.0 110.769 175.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -57.75 -29.84 65.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.668 176.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.23 -14.7 32.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.31 0.576 . . . . 0.0 110.452 177.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' C' ' 88' ' ' TYR . 78.1 mt -91.0 -151.46 0.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.848 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -91.09 -30.77 16.55 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.83 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 67.59 -5.35 0.79 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.412 0.685 . . . . 0.0 111.698 -174.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.94 16.39 8.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.292 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 10' ' ' MET . . . . . 0.664 ' O ' HG22 ' C' ' 13' ' ' ILE . 22.3 mmt -88.61 -146.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.007 177.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 11' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -53.87 -20.32 5.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -178.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . 0.471 ' O ' HG23 ' C' ' 16' ' ' VAL . 1.2 m -51.55 -45.1 62.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.753 174.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.664 HG22 ' O ' ' C' ' 10' ' ' MET . 11.6 tt -80.26 -30.12 12.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.588 -177.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -71.87 -40.39 68.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -59.12 -32.76 70.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.033 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.471 HG23 ' O ' ' C' ' 12' ' ' SER . 98.3 t -70.8 -35.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.849 173.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.64 -47.73 84.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.824 0.345 . . . . 0.0 110.391 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.44 -21.2 64.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.722 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -85.37 -36.28 20.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.874 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' C' ' 27' ' ' LEU . 61.7 mt -75.89 -32.05 59.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.26 177.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.85 71.51 4.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.533 0.683 . . . . 0.0 109.669 173.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -95.21 10.11 37.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.996 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.98 -48.06 2.47 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -173.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.694 ' O ' ' HE2' ' C' ' 26' ' ' LYS . 60.5 mmtt -72.01 -159.8 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 168.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' C' ' 46' ' ' GLY . . . -44.02 133.45 6.41 Favored Glycine 0 CA--C 1.502 -0.76 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.183 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 26' ' ' LYS . . . . . 0.694 ' HE2' ' O ' ' C' ' 24' ' ' LYS . 0.1 OUTLIER -131.44 135.43 47.13 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.263 -0.469 . . . . 0.0 110.648 -171.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.738 ' HB3' HD13 ' C' ' 20' ' ' LEU . 2.1 tt -123.16 98.98 6.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 28' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' C' ' 38' ' ' ALA . 54.5 m -87.64 101.13 13.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.251 -178.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -95.08 129.39 42.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.358 -171.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -125.92 127.23 45.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.143 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 31' ' ' MET . . . . . . . . . . . . . 47.4 mtp -140.64 113.89 8.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.899 -177.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.568 ' HB2' ' OE1' ' C' ' 35' ' ' GLN . 58.4 m-80 -148.99 111.49 4.74 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.603 175.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.56 -98.49 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.837 176.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' C' ' 84' ' ' ILE . 0.2 OUTLIER -121.27 30.28 6.87 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.105 0.479 . . . . 0.0 110.258 -178.94 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 35' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' C' ' 32' ' ' ASN . 2.4 pt20 -122.94 123.45 40.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.618 . . . . 0.0 111.491 -179.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.655 ' HB2' ' H ' ' C' ' 84' ' ' ILE . 1.4 tp -132.25 112.19 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.552 170.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 37' ' ' LYS . . . . . 0.506 ' HA ' ' CG ' ' C' ' 80' ' ' ASN . 52.2 pttt -137.24 103.72 5.19 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 38' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 28' ' ' SER . . . -102.6 129.91 49.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.803 173.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' C' ' 28' ' ' SER . 76.0 p -105.44 147.8 27.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.07 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' C' ' 26' ' ' LYS . 17.3 p -128.59 157.74 40.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -177.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.443 ' HB3' ' CD ' ' C' ' 26' ' ' LYS . 20.1 t -151.6 -174.44 4.84 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.576 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 42' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' C' ' 42' ' ' ASN . 0.2 OUTLIER 81.45 16.67 0.49 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.943 1.297 . . . . 0.0 111.679 -174.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . 49.71 51.17 17.02 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 166.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.97 -21.12 41.24 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.909 174.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.44 112.58 6.83 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HA3' ' C' ' 25' ' ' GLY . . . -78.89 -78.31 0.85 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.885 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 47' ' ' ILE . . . . . 0.857 HD13 ' HG2' ' C' ' 52' ' ' LYS . 26.5 mt -111.96 -67.33 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 CA-C-O 121.856 0.836 . . . . 0.0 109.063 173.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.4 p 178.88 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.641 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -141.31 -32.67 0.54 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.486 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.551 ' O ' ' HD2' ' C' ' 69' ' ' LYS . 8.4 pt-20 -70.03 160.7 31.47 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.05 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 51' ' ' ASP . . . . . 0.402 ' OD1' ' HD3' ' C' ' 69' ' ' LYS . 7.3 m-20 -101.36 109.07 20.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.617 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.857 ' HG2' HD13 ' C' ' 47' ' ' ILE . 25.8 mmmt -101.76 141.11 35.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 173.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 53' ' ' ASN . . . . . 0.526 HD22 HG13 ' C' ' 94' ' ' ILE . 0.6 OUTLIER -106.09 108.66 20.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.541 0.686 . . . . 0.0 111.109 -173.674 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 54' ' ' TRP . . . . . 0.518 ' HZ2' HD11 ' C' ' 20' ' ' LEU . 0.0 OUTLIER -105.25 166.22 10.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.89 -174.019 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.49 160.2 32.14 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 118.976 -1.583 . . . . 0.0 115.39 173.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 91' ' ' ILE . 3.3 mp -119.61 136.01 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.759 -0.72 . . . . 0.0 110.2 174.119 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' C' ' 61' ' ' GLU . 30.8 m-85 -128.49 111.66 13.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.761 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' C' ' 89' ' ' ILE . 26.3 t -79.58 105.06 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 57.51 28.16 15.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 -174.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 12.9 64.24 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.025 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' C' ' 57' ' ' PHE . 39.8 tt0 -106.81 138.66 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.625 ' HE2' ' OG1' ' C' ' 65' ' ' THR . 13.5 tptm -68.29 130.96 44.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.462 -176.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.522 HG13 ' H ' ' C' ' 64' ' ' TYR . 2.3 p -129.39 -60.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.282 175.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 64' ' ' TYR . . . . . 0.522 ' H ' HG13 ' C' ' 63' ' ' VAL . 69.9 t80 -132.91 133.96 43.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.748 0.308 . . . . 0.0 110.258 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.625 ' OG1' ' HE2' ' C' ' 62' ' ' LYS . 24.5 m -128.28 144.83 51.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -157.97 174.6 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.314 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 67' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 52' ' ' LYS . 76.2 m-20 -121.83 132.22 54.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 68' ' ' GLU . . . . . 0.593 ' HB2' ' CG1' ' C' ' 47' ' ' ILE . 39.6 mt-10 -60.85 -24.41 65.89 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' C' ' 47' ' ' ILE . 0.0 OUTLIER -75.42 4.21 7.76 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -174.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -74.23 -119.46 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . 0.543 ' O ' HG12 ' C' ' 75' ' ' ILE . 20.5 p -131.52 122.65 26.51 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.42 -18.91 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.236 -172.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' C' ' 40' ' ' SER . . . -77.9 -45.38 10.59 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.276 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -62.35 -29.04 70.18 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 75' ' ' ILE . . . . . 0.543 HG12 ' O ' ' C' ' 71' ' ' THR . 51.3 mm -75.84 -66.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.145 178.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 76' ' ' SER . . . . . 0.57 ' OG ' ' HG ' ' C' ' 27' ' ' LEU . 16.3 m -51.13 -50.03 59.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 77' ' ' ASN . . . . . 0.754 HD22 ' ND2' ' C' ' 80' ' ' ASN . 5.8 m120 -81.75 -17.57 47.27 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.909 -173.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.7 -34.87 67.42 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.314 166.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' C' ' 76' ' ' SER . 56.4 mt -58.52 -26.44 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.021 174.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 80' ' ' ASN . . . . . 0.754 ' ND2' HD22 ' C' ' 77' ' ' ASN . 38.5 m-20 -83.74 -27.22 29.08 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.567 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -56.61 -41.31 76.85 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' C' ' 79' ' ' ILE . 5.0 mt -54.77 -33.95 61.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.667 177.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 83' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' C' ' 36' ' ' LEU . 0.1 OUTLIER 38.57 104.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.724 1.209 . . . . 0.0 113.762 -174.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 84' ' ' ILE . . . . . 0.655 ' H ' ' HB2' ' C' ' 36' ' ' LEU . 1.9 tp -45.23 148.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.655 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 85' ' ' LYS . . . . . 0.448 ' C ' ' HD2' ' C' ' 85' ' ' LYS . 0.0 OUTLIER -159.02 22.54 0.2 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.241 179.554 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.73 12.35 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.289 -168.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.6 -42.02 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.851 2.367 . . . . 0.0 111.681 177.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 88' ' ' TYR . . . . . 0.432 ' HB3' ' O ' ' C' ' 6' ' ' LEU . 34.7 p90 -145.26 117.5 8.42 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' C' ' 58' ' ' VAL . 58.4 mt -132.93 132.38 59.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 -176.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.15 111.04 22.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.764 -175.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 91' ' ' ILE . . . . . 0.534 HG13 HG13 ' C' ' 56' ' ' ILE . 11.8 tt -108.72 98.17 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.02 156.9 13.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.795 -170.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' C' ' 54' ' ' TRP . 1.1 pt20 -86.78 163.33 17.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.288 0.566 . . . . 0.0 111.331 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 94' ' ' ILE . . . . . 0.526 HG13 HD22 ' C' ' 53' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 -167.571 . . . . . . . . 2 2 . 1 stop_ save_